1

1. CS p4 [M2201048] In cadrul bolii pulmonare cronice obstructive exista corelatii intre: (pag.1601,1602)\*\ In the chronic
obstructive pulmonary disease correlations exist between:
A) [ ] fumatul tigaretelor si bronsita cronica apreciata postmortem\*\ Cigarette smoking and chronic bronchitis appreciated
postmortem
B) [ ] expunerea la fumul de tigara si unele simptome respiratorii ca:tusea,wheezingul si hemoptizia\*\ exposure to cigarette
smoke and some respiratory symptoms: cough, wheezing and haemoptysis
C) [ ] exacerbarea bronsitei cronice si perioadele de intensa poluare cu NO2\*\exacerbation of chronic bronchitis and periods of
intense pollution by NO2
D) [ ] extinderea in periferia plamanului a desenului bronhoalveolar alaturi de cresterea transparentei retrosternale si evidentierea
postmortem a emfizemului sever si extensiv\*\ enlargement of bronchoalveolar shape in the lung periphery along with increased
retrosternal transparency and postmortem evidence of severe and extensive emphysema
E) [x] intensitatea reactiilor inflamatorii din bronsita cronica si reactivitatea bronsica\*\ the intensity of inflammatory reactions in
chronic bronchitis and bronchial reactivity
---------------------------------------------------------------------
2. CS p4 [M2201028] Morfopatologia bronsitei cronice cuprinde (p1601)\*\Morphopathology of chronic bronchitis consists of
A) [ ]hipertrofia glandelor producatoare de surfactant\*\ hypertrophy of gland producing surfactant
B) [ ]hipertrofia glandelor din submucoasa cailor aeriene mici\*\ hypertrophy of glands of submucosa in small airways
C) [x]hipertrofia glandelor din caile aeriene mari, cartilaginoase\*\hypertrophy of the glands of large airways, cartilage
D) [ ]infiltrate limfocitare in mucoasa\*\lymphocyte infiltration in the mucosa
E) [ ]prezenta leucocitelor in submucoasa\*\ presence of leukocyte in submucosa
---------------------------------------------------------------------
3. CS p4 [M1601021] Care dintre urmatorii factori nu sunt implicati in etiologia BPOC (pg 1601)\*\Which of the following
factors are involved in the etiology of COPD
A) [ ]Fumatul\*\Smoking
B) [ ]Factori genetici\*\ Genetic factors
C) [x]Alcoolismul\*\ Alcoholism
D) [ ]Infectiile bronsice\*\bronchial infections
E) [ ]Inhalarea cronica a diferitilor iritanti bronsici\*\Chronic inhalation of various bronchial irritants
---------------------------------------------------------------------
4. CS p4 [M2201036] Concentratiile plasmatice eficiente ale teofilinei in bronsita cronica sunt (pg 1606)\*\Effective plasma
concentrations of theophylline in chronic bronchitis is (pg 1606)
A) [ ] 1-2mg/l\*\1-2mg/l
B) [ ] 5-10mg/l\*\ 5-10mg/l
C) [x]10-15mg/l\*\ 10-15mg/l
D) [ ] 20-25mg/l\*\ 10-15mg/l
E) [ ] 50mg/l\*\ 50mg/l
---------------------------------------------------------------------
5. CS p4 [M1101130] Despre agregarea familiala se poate spune: \*\About family aggregation we can say:
A) [x]copii parintilor fumatori trec prin episoade respiratorii mai severe si mai frecvente si au o prevalenta mai mare a
simptomelor respiratorii cronice \*\Children of parents smoking have more severe and frequent respiratory episodes and have a
higher prevalence of chronic respiratory symptoms
B) [ ]agregarea familiala nu a fost demonstrata\*\familial aggregation has not been demonstrated
C) [ ]la copiii parintilor fumatori , prevalenta simptomelor respiratorii este mai mica\*\In children of parents smoking, the
prevalence of respiratory symptoms is less
D) [ ]nefumatorii care stau in compania fumatorilor au nivelul CO in sange mai scazut\*\ non-smokers who are in the company of
smokers have lower blood level of CO
E) [ ]factorii genetici nu au nici un rol\*\ genetic factors have no role
---------------------------------------------------------------------
6. CS p4 [M1601024] In BPOC predominant emfizematos presiunea oxigenului arterial este in jurul valorii de (pg 1604)\*\ In
COPD predominantly emfizematous, arterial oxygen pressure is around
A) [ ]50 mmHg\*\ 50 mmHg
B) [ ]60 mmHg\*\ 60 mmHg
C) [x]70 mmHg\*\ 70 mmHg
D) [ ]peste 80 mmHg\*\more than 80 mmHg
E) [ ]sub 50 mmHg\*\ below 50 mmHg
---------------------------------------------------------------------
7. CS p4 [M2801273] Urmatoarele elemente sunt caracteristice BPOC cu predominanta emfizemului, cu exceptia: (1604)\*\The
following elements are characteristic of COPD with predominant emphysema, except:
A) [ ]cresterea capacitatii pulmonare totale(CPT)\*\increasing total lung capacity (CPT)
B) [ ]tipul constitutional astenic,cu pierdere ponderala evidenta\*\ asthenic constitutional type, with obvious weight loss
C) [ ]scaderea debitelor maximale expiratorii\*\ reduction of maximum expiratory flow
D) [x] hipercapnia\*\ hypercapnia
E) [ ]scaderea capacitatii de transfer a CO\*\decreased CO transfer

2
8. CS p4 [M2201040] Mecanismele prin care fumatul contribuie la patogeneza bronsitei cronice nu cuprind (pg 1601)\*\ The
mechanisms by which smoking contributes to the pathogenesis of chronic bronchitis do not include
A) [ ]inhibarea antiproteazelor\*\ inhibition of antiprotease
B) [ ]alterarea miscarii cililor\*\ alteration of cilia movement
C) [x]inhibarea functiei eozinofilelor alveolare\*\ inhibition of eosinophil function of alveolar
D) [ ]cresterea acuta a rezistentei cailor respiratorii mediata vagal\*\ prominent increase in the respiratory airways mediated by
vagal impulses
E) [ ]inhibrea functiei macrofagelor alveolare\*\ inhibition of alveolar macrophage function
---------------------------------------------------------------------
9. CM p5 [M2801269] La toti pacientii cu insuficienta respiratorie,minimul de investigatii cuprinde: ()\*\in all patients with
respiratory failure, the minimum investigations include: ()
A) [x] radiografia toracica\*\chest radiograph
B) [ ] CT \*\CT
C) [x] electrocardiograma\*\ electrocardiogram
D) [ ] ecocardiograma\*\echocardiogram
E) [x] examinarea sputei\*\examination of sputum
---------------------------------------------------------------------
10. CM p5 [M2801251] Pacientul cu boala pulmonara obstructiva cronica , cu predominanta emfizemului se caracterizeaza prin :
()\*\The patient with chronic obstructive pulmonary disease with predominant emphysema is characterized by:
A) [ ]tuse cu expectoratie abundenta\*\ cough with abundant expectoration
B) [ ]presiunea partiala a oxigenului de 40 mmHg\*\partial pressure of oxygen of 40 mmHg
C) [x]volum rezidual crescut\*\residual volume increased \*\elastic recoil is usually normal to increased
D) [ ]reculul elastic este de obicei normal spre crescut\*\ elastic recoil is usually normal to increased
E) [x]retentia si cordul pulmonar apar cand VEMS este scazut mult sub 25 %\*\ retention and cor pulmonale occurs when FEV is
decreased below 25%
---------------------------------------------------------------------
11. CM p5 [M2801263] Urmatoarele afirmatii cu privire la drogurile beta2-selective sunt adevarate: () \*\ The following
statements on beta2-selective drugs are true: ()
A) [ ] cele mai folosite sunt terbutalina, metoprololul,albuterol \*\ The most used are terbutaline, metoprolol, albuterol
B) [x] pot fi administrate oral dar si prin aerosoli \*\can be administered orally but also by aerosol
C) [x] izoproterenolul are mai multe efecte cardiace adverse decat albuterolul, terbutalina si metaproterenolul \*\ izoproterenol
has more cardiac side effects than albuterol,terbutaline and metaproterenol
D) [x] mai des sunt folosite ca medicatie bronhodilatatoare: terbutalina, albuterolul, metaproterenolul \*\ medications often are
used as bronchodilators: terbutaline, albuterol, metaproterenol
E) [ ] izoproterenolul este singurul folosit \*\ izoproterenol is only used
---------------------------------------------------------------------
12. CM p5 [M1601111] Efectele fiziopatologice ale leziunilor emfizematoase constau in: ((pag. 1602))\*\Pathophysiological
effects of emphysematous lesion are: ((p. 1602))
A) [x]Reducerea reculului elastic al plamanului \*\ reduction of lung elastic rebound
B) [ ]Inflamarea cronica a cailor aeriene \*\ chronic inflammation of the airways
C) [x]Cresterea colapsului cailor aeriene in expir \*\ Increased airway collapse on expiration
D) [x]Cresterea disproportionata a efortului respirator \*\ disproportionate increase of respiratory effort
E) [ ] Hipersecretia de mucus \*\ hypersecretion of mucus
---------------------------------------------------------------------
13. CM p5 [M2201125] Pneumoniile virale severe au rol in patogeneza bronsitei cronice (p1602)\*\Severe viral pneumonia has
role in the pathogenesis of severe chronic bronchitis
A) [ ]numai pe teren alergic \*\only on allergic field
B) [ ]doar la adolescenti \*\only in teenagers
C) [ ]se intrica la cei cu deficit imun \*\occur in those with immune deficiency
D) [x]la copii mici \*\in young children
E) [x]poate determina obstructie cronica pe caile aeriene respiratorii mici \*\may cause chronic obstruction in small resp. airway
---------------------------------------------------------------------
14. CM p5 [M2801254] Care dintre urmatoarele afirmatii privin pacientul cu BPOC le considerati corecte ? ()\*\Which of these
statements in respect to patient with COPD you consider correct?
A) [ ]pentru pacientul cu predominanta bronsitei dispneea este severa \*\ For the patient with predominant bronchitis dyspnea is
severe
B) [ ]pacientul emfizematos este supraponderal si cianotic\*\emphysematous patient is overweight and cyanotic
C) [ ]varsta aproximativa de diagnostic a emfizemului pulmonar este cuprinsa intre 65-75 ani\*\ Approximate age of diagnosis of
lung emphysema is between 65-75 years
D) [x]insomnia este o reactie adversa la administrarea de teofilina in doze terapeutice\*\ insomnia is a side effect from
administration of theophylline in therapeutic doses
E) [x]CT cuantifica si localizeaza emfizemul\*\ CT quantify and locate emphysema


3
15. CM p5 [M1601116] In BPOC examenul bacteriologic din sputa se indica in urmatoarele cazuri: (pag. 1606))
bacteriological examination of sputum in COPD is indicated in the following cases: ((p. 1606))
A) [ ]Hemoptizie \*\Haemoptysis
B) [x]Febra, frison \*\fever, chills
C) [x]Durere toracica \*\Chest pain
D) [x]Aspectul purulent al sputei nu se modifica la administrarea de antibiotice \*\appearance of purulent sputum does not change
the administration of antibiotics
E) [ ]Primul episod usor de bronsita \*\The first easy episode of bronchitis
---------------------------------------------------------------------
16. CM p5 [M2201138] Pacientul cu bronhopneumopatia cronica obstructiva cu predominanta bronsitei are urmatoarele
caracteristici ((pag. 1605))\*\Patient with chronic obstructive pulmonary disease with predominant bronchitis has the following
characteristics
A) [x]este fumator inveterat\*\Smoking is confirmed
B) [ ]are antecedente de pneumonii repetate\*\has a history of repeated pneumonia
C) [ ]frecvent are antecedente de tuberculoza pulmonara\*\often has a history of pulmonary tuberculosis
D) [ ]are trecut de dispnee progresiva\*\has passed progressive dyspnea
E) [x]antecedente de tuse cronica cu expectoratie purulenta\*\a history of chronic cough with purulent expectoration
---------------------------------------------------------------------
17. CM p5 [M2801253] Urmatoarele afirmatii sunt false , cu exceptia : ()\*\ The following statements are false except: ()
A) [x] indicele Reid reprezinta raportul dintre grosimea glandelor submucoase si cea a peretelui bronsic\*\Reid index is the ratio
of thickness submucoase glands and the bronchial wall
B) [ ] in regiunea periferica a acinului raportul dintre ventilatie si perfuzie este crescut\*\ in peripheral regions ratio of ventilation
and infusion is increased
C) [ ] fumatul scade rezistenta cailor aeriene\*\ Smoking reduces airway resistance
D) [ ] stimularea respiratiei si proprietatile diuretice apartin bromurii de ipatropiu\*\ respiration stimulation and diuretic properties
belong to ipatropium bromide
E) [x] Prednisonul este utilizat in doze de 30 mg pe zi\*\prednisone is used in doses of 30 mg daily
---------------------------------------------------------------------
18. CM p5 [M2801277] Referitor la fumat, un factor de agravare a bronsitei cronice, se poate afirma ca: (pag 1601) \*\Regarding
smoking, a factor worsening chronic bronchitis, it can be stated as: (page 1601)
A) [x]altereaza miscarile cililor epiteliului respirator \*\ alter movement of respiratory ciliated epithelium
B) [x]inhiba functia macrofagelor alveolare \*\inhibit alveolar macrophages function
C) [ ]imbunatateste considerabil functia respiratorie in general \*\ improves respiratory function in general
D) [x]contribuie la hiperplazia glandelor secretoare de mucus \*\ contribute to hyperplasia of mucus-secreting glands
E) [ ]stimuleaza antiproteazele \*\ stimulates antiprotease
---------------------------------------------------------------------
19. CM p5 [M2201135] Tomografia computerizata in diagnosticul bronhopneumopatiei cronice obstructive cu predominanta
emfizemului ((pag. 1605))
Computed tomography in the diagnosis of chronic obstructive pulmonary disease with predominant emphysema ((p. 1605))
A) [ ]se indica de rutina pentru diagnostic\*\Indicate the routine diagnostic
B) [x]cuantifica emfizemul\*\show emphysema
C) [ ]se indica in diagnosticul formei buloase\*\is indicated in the diagnosis of bullous form
D) [ ]are valoare prognostica\*\is a valuable prognostic
E) [x]are valoare practica limitata\*\has limited practical value
---------------------------------------------------------------------
20. CM p5 [M2801261] Precizati care dintre urmatoarele afirmatii le considerati a fi corecte : () \*\ Which of these statements
you consider to be correct:
A) [ ] examenul radiologic al pacientului cu predominanta emfizemului arata aspect de "sina de tren " \*\Radiological
examination of patients with predominant emphysema show aspect of "train track"
B) [x] convulsiile reprezinta un efect advers al teofilinei \*\seizures are a side effect of theophylline
C) [ ] oprirea fumatului nu determina o reducere a ratei de declin VEMS \*\ Stopping smoking does not cause a reduction in the
rate of decline FEV
D) [x] moraxella catarrhalis este o bacterie patogena ce este incriminata in BPOC \*\ Moraxella catarrhalis is a pathogenic
bacterium which is incriminated in COPD
E) [ ] doar streptoccocus pneumoniae si haemophillus influenzae sunt bacteriile incriminate \*\ only streptoccocus pneumoniae
and Haemophilus influenzae are the bacteria incriminated
---------------------------------------------------------------------
21. CM p5 [1201006] In bronsita cronica, abandonul fumatului ()\*\In chronic bronchitis, quiting smoking ()
A) [x]determinareducerea ratei de declin a VEMS\*\ determine the rate of decline of FEV
B) [x]este facilitat de folosirea inlocuitorilor de nicotina\*\ is facilitated by using nicotine substitutes
C) [ ]are efecte similare folosirii terapiei bronhodilatatoare\*\has similar effects using bronchodilator therapy
D) [ ]nu este eficient cand functia pulminara este sever alterata\*\is not effective when pulmonary function is severely impaired
E) [x] este mai facil la pacientii foarte motivati\*\is easier in highly motivated patients

4
22. CM p5 [mouseitl] In legatura cu BPCO cu predominanta bronsitei se pot afirma urmatoarele: \*\ In connection with COPD
with predominant bronchitis can be stated:
A) [ ]Debitele respiratorii maximale sunt invariabil crescute \*\ maximum respiratory flow rates are invariably higher
B) [x]CPT este de obicei normala \*\ CPT is usually normal
C) [ ]CV este crescuta \*\ CV is increased
D) [x]CV este moderat diminuata \*\CV is moderately diminished
E) [x]Exista o crestere moderata a VR \*\: There is a moderate increase in VR
---------------------------------------------------------------------
23. CM p5 [M2201128] Examenul obiectiv in bronhopneumopatia cronica obstructiva cu predominantna emfizemului evidentiaza
(p1604)\*\Objective exam in chronic obstructive pulmonary disease with predominant emphysema shows
A) [x]bolnav tahipneic\*\tachypneic patient
B) [x]expir prelungit\*\prolouged expiration
C) [ ]tuse seaca frecventa chinuitoare\*\ frequent excruciating dry cough
D) [ ]in pozitie sezanda bolnavii se reazema spre spate\*\patients resting in back sitting position
E) [x]au frecvent buzele protruzionate\*\ frequent protruded lips
---------------------------------------------------------------------
24. CM p5 [M2201132] Explorarea functionala respiratorie releva in bronhopneumopatia cronica obstructiva cu predominanta
emfizemului urmatoarele date (p1604)\*\ Functional respiratory exploration reveals chronic obstructive bronchopneumopathy
with predomiant emphysema following data
A) [ ]capacitatea pulmonara totala nemodificata\*\ total lung capacity unchanged
B) [x]volumul rezidual crescut\*\residual volume increased
C) [x]capacitatea vitala scazuta\*\low vital capacity
D) [ ]capacitatea de transfer a CO este nemodificata\*\CO transfer capacity is unchanged
E) [ ]permeabilitatea capilarului pulmonar este nemodificata\*\pulmonary capillary permeability is unchanged
---------------------------------------------------------------------
25. CM p5 [M1201087] In boala pulmonara cronica obstructiva se gasesc urmatoarele modificari fiziopatologice: (p1603)\*\In
chronic obstructive pulmonary disease are found these pathophysiological changes
A) [x]cresterea capacitatii functionale reziduale (CRF)\*\increase in functional residual capacity (CRF)
B) [ ]reducerea volumului rezidual (VR)\*\ residual volume reduction (VR)
C) [x]cresterea capacitatii pulmonare totale (CPT)\*\increase in total lung capacity
D) [ ]cresterea reculului elastic al plamanului\*\ increase of lung elastic rebound
E) [x]scaderea capacitatii vitale\*\ reduction of vital capacity
---------------------------------------------------------------------
26. CM p5 [M1201090] Semnele obiective la bolnavii cu boala pulmonara cronica obstructiva cu predominanta emfizemului
sunt: (p1604)\*\objective signs in patients with chronic obstructive pulmonary disease with predominant emphysema are:
A) [x] tahipneea \*\ tachypnea
B) [ ]bradipneea \*\ bradypnea
C) [ ]hiposonoritatea bazelor pulmonare \*\ hyporesonance in lung bases
D) [x]expirul relativ prelungit \*\ hyporesonance in lung bases
E) [x] galopul presistolic accentuat in timpul inspirului \*\ hyporesonance in lung bases
---------------------------------------------------------------------
27. CM p5 [M2201130] Auscultatia pulmonara in bronhopneumopatia cronica obstructiva cu predominanta emfizemului se
noteaza (p1604)\*\On auscultation of lung in chronic obstructive pulmonary disease with predominant emphysema can be noted
A) [ ]wheezing\*\wheezing
B) [ ]expir suierator\*\whistling expiration
C) [x]expir prelungit\*\expiration extended
D) [x]murmur vezicular diminuat\*\ decreased vesicular murmur
E) [x]raluri fine de tonalitate inalta la sfarsitul expirului\*\ fine rales of high tone at the end of expiration
---------------------------------------------------------------------
28. CM p5 Expunerea pasiva la fumul de tigara se coreleaza cu (p1601)\*\ Passive exposure to cigarette smoke is correlated with
A) [x] tuse\*\Cough
B) [x] wheezing\*\ wheezing
C) [ ] hemoptizie\*\haemoptysis
D) [x] productie de sputa\*\ Production of sputum
E) [ ] vomica \*\vomica
---------------------------------------------------------------------
29. CM p5 [M2801259] In general se poate afirma ca : ()\*\In general it can be stated that: ()
A) [x] emfizemul panacinar afecteaza atat zonele centrale cat si cele periferice ale acinului\*\panacinar emphysema affects both
central and peripheral areas of acinii
B) [x] bronsita cronica simpla se caracterizeaza printr-o sputa mucoasa \*\simple chronic bronchitis is characterized by mucous sputum
C) [ ] dioxidul de azot este incriminat clar in perioadele de exacerbare a bronsitei \*\nitrogen dioxide is clearly incriminated in
periods of exacerbation of bronchitis
D) [ ] la examenul radiologic aspectul de "sina de tren" apare la pacientul cu predominanta emfizemului\*\Radiological

5
examination aspect of "train track" appears in patient with predominant emphysema
E) [ ] slabiciunea si astenia sunt caracteristici alea pacientului cu predominanta bronsitei\*\ weakness and fatigue are
characteristic in patient with predominant bronchitis
---------------------------------------------------------------------
30. CM p5 [M1201086] La patogeneza bolii pulmonare cronice obstructive contribuie: ((pag. 1601/1602))\*\The following
contribute to the pathogenesis of chronic obstructive pulmonary disease
A) [x]infectia cu rinovirus \*\ infection with rinovirus
B) [ ]nivelul seric crescut al a1antitripsinei \*\ increased serum levels of a1antitripsine
C) [x]fumatul \*\smoking
D) [ ]dioxidul de azot (NO2) \*\ nitrogen dioxide (NO2)
E) [x]dioxidul de sulf (SO2) \*\ sulfur dioxide (SO2)
---------------------------------------------------------------------
31. CM p5 [M1502105] In comunitatile in care infectia cu virusul imunodeficientei umane de tip 1 (HIV-1) este endemica,
etiologia pneumoniei este determinata in primul rand de urmatorii agenti patogeni: (p1586-1587) \*\In communities where
infection with human immunodeficiency virus type 1 (HIV-1) is endemic, the etiology of pneumonia is caused primarily by the
following pathogens:
A) [ ]Chlamydia psittaci \*\Chlamydia psittaci
B) [x]Pneumocystis carinii \*\Pneumocystis carinii
C) [x]Mycobacterium tuberculosis \*\Mycobacterium tuberculosis
D) [ ] Staphylococcus aureus \*\Stafilococcus aureus
E) [ ]Mycoplasma pneumoniae \*\Mycoplasma pneumoniae
---------------------------------------------------------------------
32. CM p5 [M1302094] Selectati afirmatiile corecte legate de examenul sputei in pneumonie: (p1589) \*\ Select the correct
statements related to sputum examination in pneumonia:
A) [x] Contaminarea sputei cu anaerobi orali constituie cauza frecventa de diagnostic eronat a infectiei pulmonare cu anaerobi \*\
Contamination of sputum with oral anaerobes are common cause of wrong diagnosis of pulmonary infection with anaerobes
B) [x] In sindromul pneumonic tipic, specificitatea diagnostica a frotiului Gram din Sputa este de 85% \*\ In the typical lung
syndrome, specific diagnosis of sputum smear Gram is 85%
C) [x] Prezenta florei mixte pe frotiul necontaminat sugereaza o infectie cu anaerobi \*This mixed flora contaminated smear
suggests infection with anaerobic \
D) [ ] In pneumonia cu Blastomices, germenul se evidentiaza in sputa prin coloratia Giemsa \*\ In Pneumonia with Blastomices,
germ in sputum are confirmed by Giemsa staining
E) [ ] Evidentierea infectiei micobacteriene se realizeaza prin colorarea directa cu anticorpi fluorescenti \*\ Highlighting
mycobacterial infection is accomplished by direct staining with fluorescent antibodies
---------------------------------------------------------------------
33. CM p5 Pacientii cu Legionella au indicatie de tratament cu:(p1592) \*\Patients with Legionella have indication of treatment with:
A) [ ] Ceftazidin + Clindamicin Aminoglicozid \*\ Ceftazidin Clindamycin + aminoglycoside
B) [ ] Penicilina Aminoglicozid + Fluorochinolone \*\ Penicillin + aminoglycoside fluoroquinolones \*\
C) [ ] Metronidazol 500mg i v la 8 ore \*\ Metronidazole 500mg IV at 8:00
D) [x] Eritromicina 1g i v la 6 ore \*\ Erythromycin 1g IV at 6:00
E) [x] Rifampicina \*\rifampicin
---------------------------------------------------------------------
34. CM p5 [M2202148] Defectele imunitatii mediate celular se asociaza, in mod caracteristic, cu infectii cu: (p1587) \*\ Defects
in cell mediated immunity is associated, typically, with infections with:
A) [ ] bacterii incapsulate \*\ bacteria encapsulated
B) [ ] stafilococ aureu \*\ staphylococcus aureu
C) [x] pneumocystis carinii \*\Pneumocystis carinii
D) [x] cytomegalovirus \*\ cytomegalovirus
E) [x] histoplasma capsulatum \*\ Histoplasma capsulatum
---------------------------------------------------------------------
35. CM p5 [M1302086] Care din urmatoarele afirmatii referitoare la pneumonie sunt exacte? (p1585) \*\Which of the following
statements is correct about pneumonia?
A) [x]Identificarea microorganismului etiologic permite o terapie antimicrobiana adecvata \*\ Identification of the etiologic
microorganism allow appropriate antimicrobial therapy
B) [ ]Tratamentul antimicrobian de urgenta se incepe dupa confirmarea de laborator a agentului cauzal \*\Emergency
antimicrobial treatment is started after laboratory confirmation of causative agents
C) [x]Agentii cauzali sunt reprezentati de bacterii, mycoplasme, chlamidii, virusi \*\causative agents are represented by bacteria,
mycoplasmas, chlamidii, viruses
D) [ ]Etiologia specific microbiana ramane incerta in aproape 2/3 din cazuri \*\specific microbial etiology remains unclear in
almost 2 / 3 of cases
E) [x]Alegerea initiala a terapiei antimicrobiene este de obicei empirica \*\Choosing initial empirical antimicrobial therapy is
usually


6
36. CM p5 [M1502102] Principalele cai de patrundere in plaman a germenilor microbieni patogeni care determina producerea de
pneumonii sunt reprezentate de: (p1585-1586) \*\ The main way of insight into the lung pathogenic microbial germs that cause
pneumonia production are represented by:
A) [x]Aspirarea organismelor care colonizeaza orofaringele \*\Vacuum organisms colonize oropharyngeal
B) [x]Inhalarea aerosolilor infectiosi \*\ Inhalation of infectious aerosols
C) [x]Diseminarea hematogena a infectiei de la un focar extrapulmonar \*\ Dissemination marrow infection in an outbreak
extrapulmonary
D) [x]Inocularea directa ca rezultat al intubatiei traheale sau al plagilor injunghiate \*\ direct inoculation as a result of tracheal
intubation or stab wound
E) [ ]Diseminarea limfatica a infectiei de la un focar extrapulmonar*\The lymphatic dissemination of infection from an outbreak
extrapulmonary
---------------------------------------------------------------------
37. CM p5 [M1602112] La un pacient spitalizat pentru pneumonie cu Haemophilus influenzae se poate initia tratament cu:
(p1591) \*\In a patient hospitalized for pneumonia with Haemophilus influenzae treatment can be initiated by:
A) [x] Cefalosporine de generatia a IIIa \*\generation cephalosporin IIIa
B) [ ] Metronidazol \*\Metronidazole
C) [ ] Gentamicina \*\ Gentamicin
D) [x] Ampicillin-sulbactam \*\ Ampicilina-sulbactam \*\
E) [x] Trimetoprim-sulfametoxazol (cotrimoxazol) \*\ Trimethoprim-sulfamethoxazole (cotrimoxazole
---------------------------------------------------------------------
38. CM p5 [M2802255] Tabloul tipic al unei pneumonii cuprinde: \*\ A picture of pneumonia typically includes:
A) [x]debut brusc cu febra; \*\The sudden onset with fever;
B) [x]tuse productiva; \*\ productive cough;
C) [x]semne de condesare pulmnara (matitate, egofonie, raluri); \*\ signs of condesare pulmnara (Matita, egofonie, rales);
D) [ ]Rx normala; \*\ normal X-ray;
E) [x]durere toracica tip pleural. \*\pleuritic chest pain.
---------------------------------------------------------------------
39. CM p5 [M1202082] In care dintre tipurile etiologice de pneumonii se impune spitalizarea bolnavilor ? (pag. 1589) \*\in
which the etiologies of pneumonia, the patients require hospitalization?
A) [x] pneumonia cu Staphylococcus aureus \*\pneumonia with Staphylococcus aureus
B) [x] pneumonia cu Klebsiella pneumoniae \*\ pneumonia with Klebsiella pneumoniae
C) [ ] pneumonia cu Mycoplasma pneumoniae \*\pneumonia with Mycoplasma pneumoniae
D) [x] pneumonia cu anaerobi \*\ Pneumonia with anaerobes
E) [ ] pneumonia cu Haemophilus influenzae \*\ pneumonia with Haemophilus influenzae
---------------------------------------------------------------------
40. CM p5 [M2202174] Cauze de cavitatie: (pag. 1588) \*\ Causes of cavitation:
A) [x]fusobacterii \*\fusobacterii
B) [x]actinomyces \*\ actinomyces
C) [x] coci anaerobi \*\ anaerobic cocci
D) [ ]Chlamydia pneumoniae \*\Chlamydia pneumoniae
E) [x] coccidioides immitis \*\ coccidioides immitis
---------------------------------------------------------------------
41. CM p5 [M2202179] Agentii patogeni cel mai frecvent implicati la persoane cu deficite ale imunitatii celulare sunt: (p1587)
\*\ Pathogens most commonly involved in people with deficiencies of cellular immunity are:
A) [x]Pneumocystis carinii \*\Pneumocystis carinii
B) [ ]Haemophilus influenzae \*\ Haemophilus influenzae
C) [x]Histoplasma capsulatum \*\ Histoplasma capsulatum
D) [x]Cytomegalovirus \*\ Cytomegalovirus
E) [ ]Pseudomonas influenzae \*\ Pseudomonas influenzae
---------------------------------------------------------------------
42. CM p5 [M2802268] Pneumoniile cu tablou atipic pot avea urmatoarele manifestari: (p1587) \*\Pneumonia with atypical
manifestations may have the following events:
A) [x]Greata; \*\ Nausea;
B) [x]Tuse seaca, neproductiva; \* dry cough, nonproductive;\
C) [x]Varsaturi; \*\vomiting;
D) [x]Predominanta simptomelor extrapulmonare;\*\ The prevalence of extrapulmonary symptoms;
E) [ ]Sincope. \*\ syncope
---------------------------------------------------------------------
43. CM p5 [M2802257] Urmatoarele afirmatii referitoare la medicatia folosita in pneumonii, la pacientii internati, sunt adevarate:
(1591)\*\ The following statements relating to drugs used in pneumonia patients admitted are true:
A) [x] cefazolim 2g iv/8h\*\cefazolim 2g iv/8h
B) [ ] cefotaxima 2g/24h\*\cefotaxima 2g/24h
C) [x] ceftizoxima 2g/8-12 h\*\ceftizoxima 2g/8-12 h

7
D) [ ] ciprofloxacina 750 mg po/8h\*\ ciprofloxacin 750 mg po/8h
E) [x] eritromicina 500 mg/6h\*\ erythromycin 500 mg/6h
---------------------------------------------------------------------
44. CM p5 [M2202180] Urmatorii agenti infectiosi sunt foarte rar cauze de cavitatie: (pag. 1588) \*\The following infectious
agents rarely cause cavitation:
A) [x]H Influenzae \*\H influenzae
B) [ ]Bacili enterici aerobi gram-negativi \*\ Gram-negative enteric bacilli
C) [ ]Legionella \*\ Legionella
D) [x]Mycoplasma pneumoniae \*\ Mycoplasma pneumoniae
E) [ ]Histoplasma capsulatum \*\ Histoplasma capsulatum
---------------------------------------------------------------------
45. CM p5 [M2202124] Care dintre agentii patogeni enumerati mai jos determina pneumonii la pacientii cu neutropenie severa:
(pag. 1587) \*\Which pathogens listed below cause pneumonia in patients with severe neutropenia
A) [x]Pseudomonas aeruginosa \*\Pseudomonas aeruginosa
B) [ ]Pneumocystis carinii \*\ Pneumocystis carinii
C) [ ]M Tuberculosis \*\ \M. tuberculosis*\
D) [ ]Nocardia \*\Nocardia
E) [x]Aspergillus \*\ \Aspergillus*\
---------------------------------------------------------------------
46. CM p5 Procesul pneumonic poate interesa la inceput:(1586) \*\ The process can involve the lung at the beginning
A) [x] Interstitiul; \*\ interstitium;
B) [x] Alveolele; \*\ The alveoli
C) [ ] Bronhiile principale; \*\ main bronchi;
D) [ ] Bronhiolele; \*\ bronchioles;
E) [ ] Pneumocitele de tip II \*\ Type II Pneumocytes
---------------------------------------------------------------------
47. CM p5 Care dintre afirmatiile urmatoare despre nocardioza sunt adevarate: (1588)\*\ Which of the following statements are
true about nocardiosis:
A) [ ] Nu determinaleziuni cutanate\*\No skin determinaleziuni
B) [x] Se complicafrecvent cu leziuni ale sistemului nervos central\*\complicafrecvent central nervous system lesions
C) [x] Manifestarile majore se pot limita la febra, tahipnee, agitatie\*\major manifestations may be limited to fever, tachypnea, agitation
D) [ ] Poate determina necroza tesutului pulmonar cu aparitia de cavitati\*\ may cause necrosis of lung tissue with the appearance of cavities
E) [x] Simptomatologia poate lipsi la imunosupresati\*\ Symptoms may be missing in immunosuppressed
---------------------------------------------------------------------
48. CM p5 Cei mai frecventi agenti infectiosi intalniti in pneumoniile survenite la copiii cu varsta sub 6 luni sunt: (1587) \*\
The most frequent infectious agents encountered in pneumonia occurring in children under six months are:
A) [ ] Mycoplasma pneumoniae \*\Mycoplasma pneumoniae
B) [x] Chlamydia trachomatis \*\ Chlamydia trachomatis
C) [x] Virusul respirator sincitial \*\ respiratory syncytial virus
D) [ ] Moraxella catarrhalis \*\Moraxella catarrhalis
E) [ ] Staphylococcus aureus \*\Staphylococcus aureus
---------------------------------------------------------------------
49. CM p5 Care dintre urmatoarele afirmatii sunt corecte: (pag. 1585-1586)\*\ Which of the following statements is correct:
A) [ ] Colonizarea mucoasei orofaringiene la subiectii sanatosi depaseste 20 % \*\ The oropharyngeal mucosa colonization in
healthy subjects exceeds 20%
B) [x] Etilismul cronic,DZ,varsta inaintata cresc colonizarea orofaringelui cu flora gram negativa \*\ chronic alcoholism,
diabetes, age orofaringelui increase colonization with gram negative flora
C) [x] Distrugerea fibronectinei mucoasei orofaringiene favorizeaza colonizarea cu flora gram negativa \*\ Destruction
fibronectinei oropharyngeal mucosa favors colonization with gram negative flora
D) [ ] fibronectina reprezinta receptorul pentru flora gram negative \*\ fibronectina flora is Gram-negative receptor
E) [x] 50% dintre adultii normali aspira secretiile orofaringiene in tractul respirator in cursul somnului \*\ 50% of normal adults
aspire oropharyngeal secretions in the respiratory tract during sleep
---------------------------------------------------------------------
50. CM p5 [M2202176] Terapia antimicrobiana empirica in ''pneumoniile nozocomiale'' cauzate mai probabil de stafilococul
aureu se face cu: (pag. 1592) \*\Empirical antimicrobial therapy in "nosocomial pneumonia" caused by Staphylococcus aureus
can probably be done with:
A) [ ]Ceftazidim \*\ ceftazidime
B) [x]Nafcilina \*\nafcillin
C) [x]Vancomicina \*\Vancomycin
D) [ ]Aminoglicozide \*\ aminoglycosides
E) [ ]Amoxicilina \*\ Amoxicillin
---------------------------------------------------------------------


8
51. CM p5 [M2602239] In tratamentul ambulator al pneumoniilor cu Mycoplasma pneumoniae sunt eficiente: (pag. 1590) \*\In
outpatient treatment of pneumonia with Mycoplasma pneumoniae are effective:
A) [ ] Tetraciclina \*\ Tetracycline
B) [ ] Cefuroxim \*\ Cefuroxime
C) [x] Doxiciclina \*\ Doxycycline
D) [x] Eritromicina \*\Erythromycin
E) [x] Ciprofloxacina \*\ Ciprofloxacin
---------------------------------------------------------------------
52. CM p5 [M3204077] frotiul Gram din sputa, pentru identificarea S. pneumoniae (pag-1589) \*\Gram smears from sputum for
identifying S. pneumoniae (page-1589)
A) [ ]are un procent mare de rezultate fals negative \*\has a high percentage of false negative
B) [ ]sensibilitatea este de 72%v \*\ sensitivity is 72%
C) [x]specificitatea este de 85% \*\ the specificity is 85%
D) [x]este mai sensibil si mai specific decat cultura din sputa \*\ is more sensitive and specific than sputum culture
E) [ ]cand se suspicioneaza infectia cu S pneumoniae se foloseste coloratia Giemsa \*\on suspicion of S pneumoniae infection ,
Giemsa staining is used
---------------------------------------------------------------------
53. CS p4 [M2502054] Transmiterea pneumoniei prin aspirarea agentilor patogeni care colonizeaza orofaringele este specifica
pentru urmatoarele etiologii cu exceptia: (pag. 1585)\*\Transmission of pneumonia by aspiration of pathogenical agnets which
colonise the oropharynx is specific for the following etiologies except:
A) [ ]Streptococcus pneumoniae\*\The Streptococcus pneumoniae
B) [ ]Mycoplasma pneumoniae\*\Mycoplasma pneumoniae
C) [ ]Haemophilus influenzae\*\ Haemophilus influenzae
D) [x]Staphylococcus aureus\*\Staphylococcus aureus
E) [ ]Moraxella catarrhalis\*\Moraxella catarrhalis
---------------------------------------------------------------------
54. CS p4 [M2202039] Infectia cu C. trachomatis si virusul sincitial respirator sunt mai frecvente la: (pag. 1587) \*\Infection
with respiratory syncytial virus and C. trachomatis and are more frequent in :
A) [ ]adulti \*\ adult
B) [ ]copii sub 6 ani \*\ Children under 6 years
C) [ ]copii peste 6 ani \*\ Children over 6 years
D) [ ]batrani peste 60 de ani \*\ 60 years old
E) [x]copii sub 6 luni \*\Children under 6 months
---------------------------------------------------------------------
55. CS p4 [M1202008] Care este antibioticul de electie util in pneumonia cu Legionella pneumophila (pag. 1591) \*\What is the
antibiotic of choice in pneumonia with Legionella pneumophila (p. 1591)
A) [ ]penicilina \*\ Penicillin
B) [ ]ampicilina \*\ampicillin
C) [ ]amoxicilina \*\ amoxicillin
D) [ ]vancomicina \*\ vancomycin
E) [x]eritromicina \*\erythromycin
---------------------------------------------------------------------
56. CS p4 [M2202031] H. influenzae apare la: (pag. 1587) \*\H. influenzae occurs (p. 1587)
A) [ ]copii de 6 ani \*\ Children of 6 years
B) [ ]copii de 6 luni \*\ children 6 months
C) [x]copii de 6 luni-5 ani \*\ children 6 months-5 years
D) [ ]copii pana la 6 luni \*\Children up to 6 months
E) [ ]copii peste 5 ani \*\Children over 5 years
---------------------------------------------------------------------
57. CS p4 [M2202029] Pneumocitele de tipul I acopera: (pag. 1585) \*\ Pneumocytes type I covers: (p. 1585)
A) [ ]85% din suprafata alveolara \*\ 85% of alveolar surface
B) [ ]90% din suprafata alveolara \*\ 90% of alveolar surface
C) [ ]75% din suprafata alveolara \*\75% of alveolar surface
D) [x]95% din suprafata alveolara \*\ 95% of alveolar surface
E) [ ]70% din suprafata alveolara \*\70% in alveolar surface
---------------------------------------------------------------------
58. CS p4 [M2802269] Pneumonia este o infectie a: (pag.1585) \*\Pneumonia is an infection of: (pag.1585)
A) [ ]Interstitiului pulmonar; \*\pulmonary interstitium;
B) [x]Parenchimului pulmonar; \*\ lung parenchyma;
C) [ ]Pneumocitelor de tip I; \*\ Pneumocytes type I;
D) [ ]Tractului respirator superior; \*\ Upper respiratory tract;
E) [ ]Pneumocitelor de tip II; \*\ Pneumocytes type II;
---------------------------------------------------------------------

9
59. CS p4 [M2502052] Modalitatea de transmitere a pneumoniei prin inhalare de aerosoli infectiosi este specifica pentru: (pag.
1585 - 1586) \*\ The method of transmission of pneumonia by inhalation of infectious aerosols is specific for :
A) [x] Legionella pneumophila \*\Legionella pneumophila
B) [ ] Staphylococcus aureus \*\ Staphylococcus aureus
C) [ ] Streptococcus pneumoniae \*\Streptococcus pneumoniae
D) [ ] Haemophilus influenzae \*\ Haemophilus influenzae
E) [ ] Moraxella catarrhalis \*\ Moraxella catarrhalis
---------------------------------------------------------------------
60. CS p4 ''Nuclei in picatura'' sunt particule cu diametrul de: (1586) \*\ nuclei in droplets "are particles with diameter of:
A) [x]<5Im \*\ <5I m
B) [ ]intre 5Im si 7Im \*\ between 5i and 7i m m
C) [ ]>7Im \*\ > 7i m
D) [ ]intre 7Im si 9Im \*\ between 7i and 9i m m
E) [ ]>9Im \*\> 9i m
---------------------------------------------------------------------
61. CS p4 [M2203042] Urmatoarea posologie este recomandata pentru medicamentele antituberculoase in regimurile
intermitente (pg 1118) \*\The following dosage is recommended for tuberculosis drugs in intermittent regimes
A) [ ] streptomicina: 15 mg/kgc \*\ Streptomycin: 15 mg / kg
B) [x] izoniazida: 15mg/kgc \*\ isoniazid: 15mg/kg
C) [ ] rifampicina: 25-30 mg/kgc \*\ rifampicin: 25-30 mg / kg
D) [ ] pirazinamida: 10-15 mg/kgc \*\pirazinamide: 10-15 mg / kg
E) [ ] etambutol: 50-70mg/kgc \*\etambutol: 50-70mg/kg
---------------------------------------------------------------------
62. CS p4 Diagnosticul definitiv al tuberculozei este certificat prin: (1115-1116)\*\Definitive diagnosis of tuberculosis is certified by:
A) [x] Cultura, cu izolarea si identificarea M tuberculosis intr-o proba diagnostica, reprezentata, in majoritatea \*\ Culture,
isolating and identifying M. tuberculosis in a diagnostic test, represented in most
B) [ ] Radiografia toracica anormala, la un pacient cu simptome respiratorii \*\ Abnormal chest radiograph in a patient with
respiratory symptoms
C) [ ] Intradermoreactia la PPD pozitiva \*\ the positive intredermoreaction with PPD
D) [ ] Bronhoscopie \*\Bronchoscopy
E) [ ] Diagnostic serologic, bazat pe detectarea anticorpilor impotriva antigenelor micobacteriene \*\ serological diagnosis based
on detecting antibodies against mycobacterial antigens
---------------------------------------------------------------------
63. CS p4 [M1503020] Dozele zilnice de Izoniazida recomandate pentru tratamentul initial al tuberculozei pulmonare la adult
sunt: (pg 1117) \*\ Daily doses for izoniazid recommended for initial treatment of pulmonary tuberculosis in adults are:
A) [ ] 15 mg/Kg, maxim 1 g \*\ 15 mg / kg, maximum 1 g
B) [ ] 15-25 mg/Kg \*\ 15-25 mg / kg
C) [x] 5 mg/Kg, maxim 300 mg \*\ 5 mg / kg, maximum 300 mg
D) [ ] 10 mg/Kg, maxim 600 mg \*\ 10 mg / kg, maximum 600 mg
E) [ ] 15-30 mg/Kg, maxim 2 g \*\15-30 mg / kg, maximum 2 g
---------------------------------------------------------------------
64. CS p4 [M2303045] Despre tuberculoza pulmonara primara se pot afirma urmatoarele, cu exceptia (pg 1112) \*\ About
primary pulmonary tuberculosis the following can be affirmed, except
A) [x]in zonele cu prevalenta scazuta se intalneste mai frecvent la copii *\In low prevalence areas is seen more frequently in children
B) [ ]poate fi localizata in campurile pulmonare mijlocii \*\ can be located in the middle lung fields
C) [ ]leziunea se asociaza cu limfadenopatie paratraheala \*\ lesion is associated with paratracheal lymphadenopathy
D) [ ]poate determina aparitia de empiem \*\ \ can determine appearance of empyema *\
E) [ ]leziunea este de obicei periferica \*\The lesion is usually peripheral
---------------------------------------------------------------------
65. CS p4 Vindecare tuberculozei depinde in mod esential de: (pg 1117) \*\ Healing of tuberculosis depends essentially on
A) [x] complianta pacientului la tratament \*\ patient compliance to treatment
B) [ ] suportul social \*\social support
C) [ ] suportul material \*\ Material Support
D) [ ] igiena \*\ hygiene
E) [ ] alimentatia \*\ alimentation
---------------------------------------------------------------------
66. CS p4 [M2603060] TBC primara pulmonara este caracterizata prin: (1112) \*\Primary pulmonary TBC is characterised by
A) [ ]Se intilneste frecvent la adulti \*\frequently met in adults
B) [ ]Radiologic apare polimorfism lezional \*\ Radiologically appears polymorphic lesion
C) [ ]Este localizata in campurile pulmonare apicale \*\ It is localised in apical pulmonary field
D) [x]Leziunea se asociaza cu limfadenopatie hilara sau paratraheala \*\The lesion is associated with hilar lymphadenopathy or
paratracheal
E) [ ]In majoritatea cazurilor leziunea nu se vindeca spontan \*\ In most cases lesions do not heal spontaneously

10
67. CS p4 [M2503051] Global se apreciaza ca dintre persoanele infectate cu Mycobacterium tuberculosis vor dezvolta boala
aproximativ: (1110) \*\Global appreciation in people infected with Mycobacterium tuberculosis will develop the disease is about:
A) [ ] 50% \*\ 50%
B) [ ] 40% \*\ 40%
C) [ ] 20% \*\ 20%
D) [ ] 30% \*\ 30%
E) [x] 10% \*\ 10%
---------------------------------------------------------------------
68. CS p4 Cel mai important impediment in calea vindecarii bolnavilor cu tuberculoza pulmonara este reprezentat de: (1117)
\*\The most important impediment to healing patients with pulmonary tuberculosis consists of:
A) [ ]Chimiorezistenta dobandita \*\ Aquired chemoresistance
B) [x]Lipsa de aderenta a pacientilor la regimurile terapeutice \*\ Lack of adherence of patients to regimens
C) [ ]Costul ridicat al medicatiei \*\ \The high cost of medication*\
D) [ ]Toxicitatea crescuta a medicatiei \*\ increased toxicity of drugs
E) [ ]Deficiente ale personalului medical care supravegheaza administrarea medicatiei \*\Deficiencies from the medical staff who
supervise medication
---------------------------------------------------------------------
69. CM p5 [M2203164] Medicamentele din linia a doua in tratamentul tuberculozei pulmonare (1117) \*\ Drugs of second-line
treatment of pulmonary tuberculosis
A) [x]nu sunt indicate la bolnavii cu alergii medicamentoase \*\ not indicated in patients with drug allergies
B) [x]nu au activitate bactericida \*\does not have bactericidal activity
C) [ ]nu sunt indicate in cazul chimiorezistentei ca medicamente de prima linie \*\ not indicated in chemorezistent as first-line drugs
D) [x]au un grad de toxicitate ridicat \*\ have a high toxicity level
E) [ ]au un grad scazut de intoleranta \*\ have a low degree of intolerance
---------------------------------------------------------------------
70. CM p5 [M1303075] In legatura cu tuberculoza pulmonara se poate afirma, cu EXCEPTIA: (1112-1113) \*\ Concerning
pulmonary tuberculosis it can be said, except:
A) [x]se poate intalni hipernatremie datorita secretiei inadecvate de hormon antidiuretic \*\ hypernatremia due to inadequate
antidiuretic hormone secretion
B) [x]majoritatea pacientilor prezinta modificari patologice la examenul fizic toracic \*\most patients shows pathological changes
on chest physical examination
C) [ ]boala extensiva poate fi cauza de sindrom de detresa respiratorie a adultului \*\ Extensive disease may be due to adult
respiratory distress syndrome
D) [ ]in unele cazuri la examenul fizic se poate observa hipocratism digital \*\ in some cases the Digital hipocratism can be
observed on physical examination.
E) [ ]ralurile inspiratorii pot aparea mai frecvent dupa tuse \*\inspiratory rales may occur more frequently after coughing
---------------------------------------------------------------------
71. CM p5 [M1503092] Care dintre medicamentele urmatoare folosite in tratamentul tuberculozei pulmonare fac parte din
agentii terapeutici de prima linie utilizati in aceasta afectiune: (p1117) \*\Which of the following medicines used to treat
pulmonary tuberculosis as part of first-line therapeutic agents used in this disease
A) [ ] Kanamicina \*\Kanamycin
B) [x] Izoniazida \*\ isoniazid
C) [ ] PAS \*\ PAS
D) [x] Pirazinamida \*\Pyrazinamide
E) [ ] Etionamida \*\ Etionamide
---------------------------------------------------------------------
72. CM p5 La pacientii cu insuficienta renala cronica chimioterapia antituberculoasa trebuie sa respecte anumite reguli
suplimentare:(1119)\*\In patients with chronic renal failure antituberculous chemotherapy must meet certain additional rules
A) [x] Nu se recomanda utilizarea aminoglicozidelor \*\ is not recommended the use of aminoglycosides
B) [ ] Etambutolul este utilizat in toate schemele terapeutice fara restrictii \*\ Etambutol used without restrictions in all therapeutic
schemes
C) [x] Izoniazida, rifampicina si pirazinamida pot fi administrate in dozele uzuale in cazurile de insuficienta renala usoara pana la
moderata \*\ isoniazid, rifampicin and pyrazinamide usual doses may be administered in cases of mild to moderate renal insufficiency
D) [ ]Dozele de izoniazida si pirazinamida trebuie reduse la toti pacientii cu insuficienta renala cronica in program de hemodializa
\*\isoniazid and pyrazinamide doses should be reduced in all patients with chronic renal failure on hemodialysis program
E) [x]Pirazinamida se administreaza in doze reduse la toti pacientii cu insuficienta renala cronica severa, cu exceptia celor ce sunt
supusi hemodializei \*\Pyrazinamide is administered in low doses in all patients with severe chronic renal failure, except those
who are undergoing hemodialysis
---------------------------------------------------------------------
73. CM p5 In tuberculoza primara se intalnesc frecvent ca forme de manifestare: (1112) \*\ In primary tuberculosis the frequently
met manifestations
A) [x] Pleurezia \*\Pleurisy
B) [x] Limfadenopatia hilarasau mediastinala \*\hiliar or mediastinal lymphadenopathy

11
C) [ ] TB Peritonitis \*\ Peritonita TBC \*\
D) [ ] Tuberculoza miliara \*\ military tuberculosis
E) [ ] Meningita tuberculoasa \*\ Tuberculous meningitis
---------------------------------------------------------------------
74. CM p5 [M2803228] Dintre agentii de prima linie in tratamentul tuberculozei fac parte: (p1117) \*\ The first line agents in
the treatment of tuberculosis are:
A) [ ] kanamicina \*\ Kanamycin
B) [x] izoniazida \*\ isoniazid
C) [ ] amikacina \*\ amikacin
D) [x] rifampicina \*\ rifampin
E) [x] etambutolul \*\ etambutol
---------------------------------------------------------------------
75. CM p5 Monitorizarea raspunsului la tratamentul tuberculozei se bazeaza pe: (p1118) \*\ Monitoring response to tuberculosis
treatment is based on:
A) [ ] evaluarea radiologica este metoda preferata \*\ radiologic evaluation is the preferred method
B) [ ] in regimurile de 6 luni, 20% din pacienti vor avea culturi din sputa negative \*\in regimen of 6 months, 20% of patients will
have negative sputum cultures
C) [x] prezenta frotiurilor pozitive dupa 5 luni inseamna esec terapeutic \*\ positive smear 5 months after treatment means
therapeutic failure
D) [ ] evaluarea bacteriologica nu este recomandata \*\ bacteriological evaluation is not recommended
E) [x] urmarirea toxicitatii medicamentoase \*\ tracking drug toxicity
---------------------------------------------------------------------
76. CM p5 [M2503201] Agentii terapeutici de prima linie folositi in tratamentul tuberculozei pulmonare cuprind: (p1117) \*\
Therapeutic agents used in first line in treatment of pulmonary tuberculosis include:
A) [x]Izoniazida \*\ isoniazid
B) [ ]Kanamicina \*\ Kanamycin \*\
C) [ ]PAS \*\ PAS
D) [ ]Etionamida \*\ Etionamide
E) [x]Pirazinamida \*\ Pyrazinamide
---------------------------------------------------------------------
77. CM p5 [M2203141] Morbul Pott: (pag. 1115) \*\ Pott disease
A) [x] implica frecvent doi sau mai multi corpi vertebrali \*\ frequently involves two or more vertebral bodies
B) [ ] aparitia cifozei se observa din stadiile intermediare ale bolii \*\ appearance in kyphosis in intermediate stages of disease
C) [ ] procesul infectios nu difuzeaza niciodata la nivelul peretelui toracic \*\ progress of infection never diffuse on chest wall
D) [x] procesul infectios se poate manifesta si cau n abces de psoas\*\ infectious process can manifest and simply evolve to psoas
abscess
E) [x] leziunile mari produc sindrom de compresiune medulara \*\ large lesions produce medullar compression syndrome
---------------------------------------------------------------------
78. CM p5 [M1503094] Modalitatile de administrare ale tratamentului in tuberculoza pulmonara sunt: (p1117)\*\The methods of
administration in the treatment of pulmonary tuberculosis are:
A) [x] Zilnic pe toata durata curei \*\ Every day throughout the cure
B) [ ] O data pe luna \*\Once a month
C) [x] De trei ori pe saptamana \*\Three times a week
D) [x] De doua ori pe saptamana \*\ twice a week
E) [ ] Saptamanal \*\ Weekly
---------------------------------------------------------------------
79. CM p5 [M2303183] Despre diagnosticul tuberculozei pulmonare sunt adevarate urmatoarele, cu exceptia (p1115) \*\ About
the diagnosis of pulmonary tuberculosis following are true except
A) [ ]se pot utiliza frotiuri de sputa colorate auramina-rodamina \*\ You can use colored sputum smear-Rhodamine auramina
B) [ ]se poate utiliza examenul microscopic al probelor colorate Kinyoun \*\You can use microscopic examination of samples
stained Kinyoun
C) [x]coloratia cu fucsina bazica Ziehl-Neelsen este nesatisfacatoare \*\ staining with Ziehl-Neelsen alkaline is poor
D) [x]pentru detectarea cresterii micobacteriei pe cultura sunt necesare 2-3 saptamani \*\detection mycobacterial growth in
culture requires 2-3 weeks
E) [ ]detectarea cresterii se poate face si prin utilizarea mediilor lichide \*\ detection of increase may be done using liquid media
---------------------------------------------------------------------
80. CM p5 Care dintre urmatoarele afirmatii privind tuberculoza pulmonara primara la copii cu defecte imunitare sunt false:
(p1112)\*\Which of the following statements regarding primary pulmonary tuberculosis in children with immune defects are false
A) [x] paote evolua lent, insidios \*\ can evolve slowly, insidiously
B) [ ] poate progresa rapid cu manifestari clinice \*\ can progress rapidly with clinical manifestations
C) [x] adesea se poate complica cu rujeola \*\is often complicated by measles
D) [x] leziunea initiala ramane strict localizata \*\ initial lesion remains strictly localized
E) [ ] leziunea se extinde frecvent cu revarsat \*\ lesion frequently extends to effusion

12
81. CM p5 [M2503206] In tuberculoza pulmonara se pot folosi urmatoarele modalitati de administrare a tratamentului: (p1117)
\*\In pulmonary tuberculosis can be used these methods of administration for treatment
A) [ ]O data pe luna \*\Once a month
B) [x]Zilnic pe toata durata curei \*\ Daily throughout the duration of the cure
C) [x]De 3 ori pe saptamana \*\ three times a week
D) [ ]Saptamanal \*\ weekly
E) [x]De 2 ori pe saptamana \*\2 times per week
---------------------------------------------------------------------
82. CM p5 [gyanynac] macrofagele alveolare in TBC secreta : (1111) \*\ Alveolar macrophages in TB secrete
A) [x]IL1 -febra \*\ IL1-fever
B) [x]IL6 -hipergamaglobulinemie \*\IL6-hypergamaglobulinemia
C) [ ]IL2 -febra \*\ IL2-fever
D) [x]TNF alfa \*\TNF-alpha
E) [ ]IL8 \*\ IL8
---------------------------------------------------------------------
83. CM p5 [M2203120] Durerea toracica in tuberculoza secundara (p1113) \*\Chest pain secondary to tuberculosis
A) [ ]poate aparea in prezenta cavernelor mari \*\ can occur in this large cavities
B) [x]are caracter pleuritic \*\ pleuritic in nature
C) [ ]seamana cu durerea din angina pectorala \*\ similar to angina pectoralis
D) [ ]se insoteste de sughit rebel \*\ rebel hiccup accompanied
E) [x]apare in caz de leziuni subpleurale \*\ appears in case of subpleural lesions
---------------------------------------------------------------------
84. CM p5 [M1203072] Tuberculoza primara prezinta una sau mai multe dintre urmatoarele caracteristici: (p1112)\*\Primary
tuberculosis shows one or more of the following characteristics:
A) [x]Rezulta in urma unei infectii initiale cu bacilul tuberculos\*\results from an initial infection with tuberculosis bacillus
B) [ ]Rezulta din reactivarea endogena a unei infectii latente\*\results from endogenous reactivation of latent infection
C) [x]Este localizata, de obicei, in campurile pulmonare mijlocii si inferioare\*\It is located usually in the middle and lower lung fields
D) [ ]Este localizata, de obicei, in segmentele apicale si posterioare ale lobilor pulmonari superiori\*\ It is located usually in the
apical and posterior segments of upper lobe lung
E) [x]Este mai frecventa la copil\*\It is most common in children
---------------------------------------------------------------------
85. CM p5 [M2203162] Durata tratamentului in tuberculoza pulmonara nu poate fi redusa la 4 luni (p1117) \*\Duration of
treatment in pulmonary tuberculosis can not be reduced to four months
A) [x] la cei disciplinati \*\ in the disciplined
B) [x] la cei cu BK+ in culturi dar negativi la examenul direct al sputei \*\ those with BK + in culture but direct examination of
sputum negative
C) [ ] la cei BK-in culturi \*\ in those with BK- in culture
D) [x] la cei cu aspect radiologic necaracteristic \*\ those with uncharacteristic radiological appearance
E) [ ] la cei afebrili si asimptomatici \*\ at the afebrile and asymptomatic
---------------------------------------------------------------------
86. CM p5 [M2503198] Probele de sputa prelevate pentru izolarea si identificarea Mycobacterium tuberculosis trebuie: (p1116)
\*\Sputum samples taken for isolation and identification of Mycobacterium tuberculosis must:
C:
A) [x] Incubate la 37 grade C in atmosfera de CO2 5% \*\ be incubated at 37 degrees C in 5% CO2 atmosphere
B) [x] Inoculate pe un mediu pe bazade agar si ou \*\ medium inoculated on agar and egg base \*\
C) [ ] Incubate la 26 grade C in atmosfera de CO2 5% \*\ incubated at 26 degrees C in 5% CO2 atmosphere
D) [x] Inoculate pe mediul Lowenstein -Jensen \*\inoculated on Lowenstein-Jensen medium
E) [ ] Supravegheate 4 -8 saptamani \*\ 4 -8 weeks supervision
---------------------------------------------------------------------
87. CM p5 [M2203174] Care dintre urmatoarele afirmatii privind tuberculoza pulmonara primara sunt false (p1112) \*\Which of
these statements are false on primary pulmonary tuberculosis
A) [x]afecteaza regiunea pulmonara superioara \*\ affects the upper lung region
B) [x]evolueaza cu febra mare \*\evolving with high fever
C) [x]frecvent determina dispnee \*\ frequently cause dyspnea
D) [ ]leziunea este periferica \*\ The lesion is peripheral
E) [ ]leziunea se vindeca spontan \*\lesions heal spontaneously
---------------------------------------------------------------------
88. CM p5 [M2303187] Despre tuberculoza pulmonara se poate afirma (p1119) \*\ About pulmonary tuberculosis can be said
A) [ ] rezistenta dobandita se dezvolta in timpul curei cu un regim adecvat \*\acquired resistance develops during cure with
adequate treatment
B) [x] tratamentul tuberculostatic nu reprezinta contraindicatie pentru alaptare \*\ tuberculostatic treatment is not a
contraindication for breastfeeding
C) [x] pacientii pot fi tratati pana la 24 luni \*\ patients can be treated up to 24 months

13
D) [ ] tratamentul cu pirazinamida nu trebuie intrerupt daca apare artrita gutoasa \*\treatment with pyrazinamide should not be
discontinued if gouty arthritis appears
E) [ ] in cazul aparitiei tulburarilor gastro-intestinale tratamentul trebuie intrerupt \*\If gastrointestinal disorders appear, treatment
should be discontinued
---------------------------------------------------------------------
89. CM p5 [M2203155] In tratamentul tuberculozei, piridoxina este adaugata regmului terapeutic (p1118) \*\In the treatment of
tuberculosis, pyridoxine is added to therapeutic regimen
A) [ ] in dozele de 50-100 mg/zi \*\ In doses of 50-100 mg / day
B) [x] la pacientii cu IRC \*\ in patients with CRF
C) [x] la diabetici \*\ in diabetics
D) [x] la gravide \*\ pregnant women
E) [ ]in toate cazurile de anemie \*\in all cases of anemia
---------------------------------------------------------------------
90. CM p5 [M2203165] Care din urmatoarele afirmatii despre tuberculoza pulmonara secundara sunt false (p1112) \*\ Which of
the following statements about secondary pulmonary tuberculosis are false
A) [ ] evolueaza adesea cu infiltrate apicale \*\ often evolves with apical infiltrates
B) [x] frecvent se vindeca spontan \*\ often heal spontaneously
C) [ ] la pacientii netratati evolueaza letal in cca 33% din cazuri \*\untreated patients develop to lethal in about 33% of cases
D) [x] se manifesta prin determinari extrapulmonare \*\ manifested by extrapulmonary determination
E) [x] frecvent se complica cu cancer pulmonar \*\ often complicated with lung cancer
---------------------------------------------------------------------
91. CM p5 [M2204169] Proteinele eozinofilului importante in patogeneza astmului bronsic sunt: (p1567) \*\ Eosinophillic
proteins important in asthma pathogenesis are
A) [x] proteina bazica majora \*major base protein \
B) [x] proteina cationica eozinofilica \*\ eosinophilic cationic protein
C) [ ] proteina S \*\ protein S
D) [ ] amiloid \*\amyloid
E) [ ] catepsina \*\ cathepsin
---------------------------------------------------------------------
92. CM p5 [M1504103] Astmul alergic se asociaza adesea cu: (p1566, 1567) \*\ Allergic asthma is often associated with:
A) [x]Un istoric personal si/sau familial de rinite, urticarie si eczema \*\A personal and / or family history of rhinitis, hives and eczema
B) [x]Reactii cutanate de tip papula eritematoasa pozitiva la injectare intradermica de extracte din antigenele aerogene \*\ type
papulous erythematous skin reactions positive to intradermal injection of extracts of airborne antigens
C) [x]Niveluri crescute de IgE in ser \*\ Increased levels of IgE in serum
D) [x]Teste de provocare pozitive prin inhalarea unui antigen specific \*\positive challenge tests by inhalation of specific antigen
E) [ ]Rinoree purulenta \*\purulent rhinorrhrea
---------------------------------------------------------------------
93. CM p5 [M2504213] Crizele de bronhoconstrictie la astmatici pot fi declansate de efortul fizic in urmatoarele circumstante:
\*\Bronchoconstriction crises in asthma may be triggered by physical effort in the following circumstances: (p. 1569)
A) [x] Efort fizic intens (exemplu alergarea) \*\ intense physical effort (eg running)
B) [x] Temperatura aerului inhalat scazuta \*\ low temperature of inhaled air
C) [ ] Temperatura si umiditatea aerului inhalat crescuta \*\ increased temperature and humidity of inhaled air
D) [ ] Efortul fizic usor \*\light physical effort
E) [ ] Umiditatea aerului crescuta \*\ Increased Humidity of air
---------------------------------------------------------------------
94. CM p5 [CM04001] Urmatoarele afirmatii legate de IZOPROTERENOL sunt false: (p571) \*\ The following statements
related to IZOPROTERENOL are false:
A) [x] este un rezorcinol \*\ is a resorcinol
B) [ ] este o catecolamina \*\ is a catecholamines
C) [ ] este cel mai potent din grupul sau \*\ is the most potent of the its group
D) [x] are actiune alfa stimulanta \*\ has alpha stimulating action
E) [ ] nu are actiune alfa stimulanta \*\ does not have alpha stimulating action
---------------------------------------------------------------------
95. CM p5 Urmatoarele sunt adevarate privind patogenia astmului (p1568) \*\ The following are true regarding the pathogenesis
of asthma
A) [x] Mecanismele imunologice par a fi cauzale la 25-35% din pacienti \*\ immunological mechanisms appear to be causative in
25-35% of patients
B) [ ] Pentru forma sezoniera apar implicate mai frecvent alergene ca: praful, penele, fulgii \*\ The most common form of
seasonal allergens involved are: dust, feathers, flakes etc
C) [x] Expunerea la antigenele inhalante determina un raspuns imediat cu obstructia cailor aeriene ce se instaleaza in minute
\*\Exposure to inhalatory antigens induce an immediate response with airway obstruction that installs in minutes
D) [ ] Reactia intarziata este constanta si major implicata in aparitia bronhoconstrictiei instalate in urmatoarea ora dupa cea
provocata de raspunsul imediat \*\delayed reaction is constant and primarily involved in the appearance of bronchoconstriction

14
installed in the following hour after the one provoked by the immediate response
E) [x] Mecanismul prin care un antigen declanseaza astmul depinde de reactia antigen-anticorp pe care o declanseaza la nivelul
mastocitelor pulmonare \*\ The mechanism by which an antigen triggers asthma depends on antigen-antibody reaction that it
triggers in the lung mast cells
---------------------------------------------------------------------
96. CM p5 [M2604232] Cei mai multi astmatici au: (pag. 1569) \*\Most asthmatics have:
A) [ ] Hipercapnie \*\hypercapnia
B) [x] Alcalozarespiratorie \*\ respiratory alkalosis
C) [ ] Acidozarespiratorie \*respiratory acidosis \
D) [x] Hipocapnie \*Hypercapnea \
E) [ ] Acidozametabolica \*\ metabolic acidosis
---------------------------------------------------------------------
97. CM p5 [M2504212] Exacerbarea acuta a astmului bronsic la copii mari si la adulti este realizata cel mai frecvent de urmatorii
agenti infectiosi patogeni: (p1569) \*\Acute exacerbations of asthma in older children and adults are most commonly triggered by
the following infectious agents:
A) [x]Virusul gripal \*\Influenza virus
B) [ ]Virusul paragripal \*\Parainfluenza virus
C) [ ]Adenovirusurile \*\ Adenoviruses
D) [x]Rhinovirusurile \*\Rhinoviruses
E) [ ]Virusul sincitial respirator \*\ Respiratory syncytial virus
---------------------------------------------------------------------
98. CM p5 Terminarea unui episod de astm bronsic este frecvent marcata de: (p1570) \*\ The Ending of an episode of asthma is
often marked by:
A) [x] tuse cu expectoratie groasa, filanta \*\cough with thick expectoration
B) [x] spirale Curshman (sputa ia forma cailor aeriene distale) \*\ Curshman spirals (sputum in the form of distal airways)
C) [x] la examenul microscopic -eozinofile si cristale Charcot-Leyden \*\Microscopic examination, eosinophils and Charcot-
Leyden crystals
D) [ ] scadere TA \*\ decrease BP
E) [ ] bradicardie \*\bradycardia
---------------------------------------------------------------------
99. CM p5 Care afirmatii sunt adevarate despre IZOETARINA: (1571) \*\ Which statements are true about IZOETARINA:
A) [x] se gaseste sub forma de aerosol ,solutie 1% \*\ is in the form of aerosol, solution 1%
B) [ ] este un antiinflamator puternic \*\is a powerful anti-inflammatory
C) [ ] este un bronhodilatator puternic \*\ is a powerful bronchodilator
D) [x] este un bronhodilatator destul de slab \*\is a relatively weak bronchodilator
E) [ ] este cel mai neselectiv beta agonist \*\is the most non- selective beta agonist
---------------------------------------------------------------------
100. CM p5 Examenul microscopic al sputei la bolnavii cu astm bronsic prezinta urmatoarele aspecte specifice pentru
diagnosticul pozitiv: (pag. 1570) \*\ Microscopic examination of sputum in patients with asthma has the following specific aspects for a
positive diagnosis
A) [ ] Frecvente polimorfonucleare \*\ predominant polymorphonuclear cells
B) [x] Frecvente eozinofile \*\ predominant eosinophils
C) [x] Cristale Charcot -Leyden \*\Charcot-Leyden crystals
D) [ ] Frecventa floramicrobianaGram pozitiva \*\ predominant Gram positive microbial flora
E) [ ] Frecventa floramicrobianaGram negativa \*\ predominant Gram negative microbial flora
---------------------------------------------------------------------
101. CM p5 [M2304191] Simptomele astmului bronsic constau in: (pag. 1570) \*\Asthma symptoms are:
A) [x]dispnee \*\dyspnoea
B) [x]tuse \*\ Cough
C) [x]wheezing \*\ Wheezing
D) [ ]tahicardie \*\ tachycardia
E) [ ]TA crescuta \*\ high BP
---------------------------------------------------------------------
102. CM p5 Celulele care joaca un rol important in astmul bronsic sunt: (1567) \*\Cells that play an important role in asthma are:
A) [x] eozinofilele \*\ eosinophils
B) [x] mastocitele \*\ mastocytes
C) [ ] celulele spumoase \*\ foamy cells
D) [x] neutrofilele \*\ neutrophils
E) [ ] bazofilele \*\ basophils
---------------------------------------------------------------------
103. CM p5 [M2604234] Urmatoarele medicamente folosite in astma sunt stimulante adrenergice: (1571) \*\ The following
medicines used in asthma are adrenergic stimulating agents
A) [ ] Bromura de ipratropiu \*\ ipratropium bromide

15
B) [x] Saligeninele \*\Saliginines
C) [x] Rezorcinolii \*\ Resorcinol
D) [ ] Metilxantinele \*\ Methylxantines
E) [x] Izoproterenol \*\ Izoproterenol \*\
---------------------------------------------------------------------
104. CM p5 [M1504099] In tratamentul de durata al astmului bronsic sunt recomandati: (pag. 1572, 1573) \*\ Which of the
following are recommended in the long term treatment of Asthma:
A) [x] Beta-2-agonistii \*\ Beta-2 agonists
B) [x] Corticoterapia inhalatorie \*\inhaled corticotherapy
C) [x] Agentii stabilizatori ai mastocitelor \*\ mast cells stabilizers
D) [x] Corticoterapia orala \*\ Oral corticotherapy
E) [ ] Metotrexatul \*\Methotrexate
---------------------------------------------------------------------
105. CM p5 [M1604108] Diagnosticul diferential al astmului bronsic trebuie sa includa: (pag. 1570) \*\ .Which of the following
should be included in the differential diagnosis of asthma :
A) [ ] .TBC pulmonar miliar \*\ . pulmonary milliary TB \*\ .
B) [ ] .Septicemie cu Gram negativi \*\ Gram negative septicemia. \*\ .
C) [x] .tumori/edem laringian \*\ laryngeal tumor / edema . \*\ .
D) [x] .neoplasm/stenoza bronsica \*\ bronchial cancer / stenosis. \*\ .
E) [x] .tumori carcinoide \*\ .Carcinoid tumors \*\ .
---------------------------------------------------------------------
106. CM p5 [M2804254] Care medicamente utilizate in tratarea astmului pot avea ca efect advers tremorul: (pg 1571) \*\ What
medicines used to treat asthma can have as adverse effect "tremor"
A) [x] albuterol; \*\ albuterol;
B) [ ] izoproterenol; \*\izoproterenol;
C) [x] metaproterenol; \*\ methaproterenol;
D) [x] terbutalina; \*\ terbutaline;
E) [x] fenoterol. \*\ fenoterol.
---------------------------------------------------------------------
107. CM p5 Specifice pentru diagnosticul clinic pozitiv al astmului bronsic sunt: (p1570) \*\Specifics for positive clinical
diagnosis of asthma are:
A) [x] Dispneea \*\ Dyspnea
B) [x] Wheezing-ul \*\ wheezing
C) [x] Tusea cu expectoratie groasa filanta \*\ Cough with thick laminar expectoration
D) [ ] Tusea cu expectoratie mucopurulenta \*\ cough with mucopurulent expectoration
E) [ ] Durerile toracice \*\ Chest pain
---------------------------------------------------------------------
108. CM p5 [M2204179] Astmul alergic nesezonier se produce la: (p1568) \*\ Nonseasonal Allergic asthma occurs to:
A) [ ]polen de graminee \*grass pollen \
B) [ ]polen de ambrozie \*\ ambrosia pollen
C) [x]fanerele animalelor \*\ Animal fur
D) [ ]polen de buruieni \*\weed pollen
E) [x]fungi \*\ fungi
---------------------------------------------------------------------
109. CM p5 Astmul bronsic indus de effort este caracterizat prin: (1569) \*\Effort-induced asthma is characterized by:
A) [x]lipsa modificarii reactivitatatii cailor aeriene \*\ no change airway reactivity
B) [ ]aparitia unor contractii pasagere ale musculaturii netede \*\the transient appearance of smooth muscle contraction
C) [x]hiperemie termic indusa la nivelul mucoasei bronsice \*\heat-induced hyperemia in the bronchial mucosa
D) [x]congestia microvascularizatiei mucoasei bronsice \*\bronchial mucosal microvascular congestion
E) [x]lipsa producerii unor sechele in timp indelungat \*\no occurrence of sequels in long durations
---------------------------------------------------------------------
110. CM p5 Sindromul respirator tipic declansat de aspirina: (p1568)\*\Respiratory Syndrome typically triggered by aspirin
A) [x] Incepe prin rinitavasomotorie cronica\*\ begins with chronic vasomotor rhinitis
B) [x] Determina in timp o rinosinuzitahiperplazicacu polipi nazali\*\causes, in time, hyperplasic rhinosinusitis with nasal polyps
C) [ ] Este specific numai copiilor\*\ It is specific only to children
D) [x] Determina astm\*\ Causes Asthma
E) [x] Asociazacongestii nazale si oculare\*\ is associated with ocular and nasal congestion
---------------------------------------------------------------------
111. CM p5 [M1204077] Definitia astmului bronsic include una sau mai ulte dintre urmatoarele afirmatii: (p1566) \*\ The
definition of asthma includes one or more of the following statements:
A) [x] astmul bronsic este o afectiune a cailor respiratorii, caracterizata printr-o reactivitate crescuta a arborelui traheo-bronsic, la o
multitudine de stimuli \*\ asthma is a disease of the airways characterized by increased reactivity of the tracheo-bronchial tree to a variety of
stimuli

16
B) [x] astmul bronsic se caracterizeaza, din punct de vedere fiziopatologic, printr-o ingustare generalizata a conductelor aeriene,
care poate ceda spontan sau ca raspuns la tratament \*\Bronchial asthma is characterized, pathophysiologically, as a generalized
narrowing of air ducts, which can yield spontaneously or in response to treatment
C) [x] astmul bronsic se caracterizeaza, din punct de vedere clinic, prin accese de dispnee, tuse si wheezing \*\asthma is
characterized, clinically, through bouts of dyspnea, cough and wheezing
D) [x] astmul bronsic este o boala cu evolutie episodica, cu exacerbari acute, care alterneaza cu perioade asimptomatice \*asthma
is a disease with episodic evolution, with acute exacerbations, which alternate with asymptomatic periods\
E) [ ] astmul bronsic este o afectiune care evolueaza cu tuse cronica, productiva \*\ asthma is a condition results in chronic productive cough.
---------------------------------------------------------------------
112. CS p4 Cromoglicatul de sodiu este utilizat in tratamentul astmului bronsic datorita efectului (efectelor): (p1572) \*\Sodium
Cromoglicate is used to treat asthma because of the following effect (s):
A) [x] De inhibare a degranularii mastocitelor \*\ inhibition of mast cells degranulation
B) [ ] Bronhodilatator \*\ bronchodilator
C) [ ] Antiinfectios \*\ anti-infection
D) [ ] Expectorant \*\ expectorant
E) [ ] Mucolitic \*\ Mucolytic
---------------------------------------------------------------------
113. CS p4 [M2204030] Astmul bronsic apare: (pag. 1566) \*\Asthma appears
A) [x]la toate varstele \*\at all ages
B) [ ]predomina la varstele de peste 60 ani \*\ prevalent at ages above 60 years
C) [ ]numai la femei \*\ only women
D) [ ]only over 40 years \*\numai peste 40 ani
E) [ ]numai la copii \*\only in children
---------------------------------------------------------------------
114. CS p4 [M2204043] Limfocitele T sunt implicate in patogeneza astmului bronsic deoarece: (p1567) \*\T-lymphocytes are
involved in the pathogenesis of asthma because
A) [x] Sunt prezente in numar mare in caile aeriene \*\ They are present in great numbers in the airway
B) [ ] Produc citokine care stimuleaza raspunsul umoral de tip IgG \*\ they produce cytokines that stimulate IgG humoral response
C) [ ]Produc citokine care stimuleaza raspunsul umoral de tip IgM\*\they produce cytokines that stimulate the humoral response of IgM
D) [ ] Limfocitele TH1 stimuleaza cresterea celulelor B prin IL-6 \*\TH1 lymphocytes stimulates B cell growth through IL-6
E) [ ] Limfocitele TH1 produc IL-4 si IL-5 \*\ TH1 lymphocytes produce IL-4 and IL-5
---------------------------------------------------------------------
115. CS p4 [M2204038] Mecanismul reactivitatii bronsice este explicat prin ipoteza: (p1567) \*\The mechanism of bronchial
reactivity is explained by the following hypothesis
A) [ ] neurogena \*\ neurogenic
B) [x] inflamatiei cailor aeriene \*\airway inflammation
C) [ ] deficitului de receptori \*\receptor deficiency
D) [ ] deficitului enzimatic \*\enzyme deficiency
E) [ ] vdeficitului de stimulare neurogena \*\ the deficiency in neurogenic stimulation.
---------------------------------------------------------------------
116. CS p4 Reactia intarziata la bolnavii cu astm bronsic alergic apare: (1568) \*\ Delayed response in patients with allergic
asthma appears:
A) [ ] la toti barbati \*\ in all men
B) [ ] la o minoritate dintre bolnavi \*\ in a minority of patients
C) [x] la 30-50% dintre bolnavi \*\in 30-50% of patients
D) [ ] la femei \*\in women
E) [ ] la copii \*\ in children
---------------------------------------------------------------------
117. CS p4 In timpul unei crize de astm prezinta alterari: (pag. 1569) \*\ During an asthma attack there are deterioration in
A) [ ] exclusiv capacitatea vitala \*\ only vital capacity
B) [ ] rezistenta la flux si volumul rezidual \* resistance to flow and residual volume \
C) [ ] exclusiv FEV1 (VEMS) \*only FEV 1 \
D) [ ] FEV1, residual volume and flow resistance \*\ FEV1, volumul rezidual si rezistenta la flux \*\
E) [x] Toti parametrii spirometrici \*\ All spirometry parameters
---------------------------------------------------------------------
118. CS p4 La un pacient cu astm bronsic, hiperinflatia marcata a toracelui, folosirea muschilor respiratori accesori si prezenta
pulsului paradoxal semnifica: (1570) \*\ In a patient with asthma, marked hyperinflation, use of respiratory accessory muscles
and presence of pulsus paradoxus suggests:
A) [x]obstructia severa a cailor respiratorii \*\ severe airway obstruction
B) [ ]un tablou obisnuit intalnit in criza de astm bronsic \*\an usual picture seen in asthma crisis
C) [ ]pneumonia \*\Pneumonia
D) [ ]embolia pulmonara \*\pulmonary embolism
E) [ ]asocierea infectiei \*\The association of infection

17
119. CS p4 [M2504053] Tratamentul cel mai eficient al episoadelor acute de astm se realizeaza prin folosirea: (pag. 1572) \*\
The most effective treatment of acute episodes of asthma is achieved by using (p. 1572)
A) [x] Beta -2 -agonistilor sub formade aerosoli \*\Beta-2 agonists in the form of aerosol
B) [ ] Agentilor stabilizatori ai mastocitelor \*\ Mast cell stabilizers
C) [ ] Corticoterapiei inhalatorii \*\ Inhaled corticosteroids
D) [ ] Medicatiei anticolinergice \*\ Anticholinergic medications
E) [ ] Corticoterapiei orale \*\ oral corticosteroid
---------------------------------------------------------------------
120. CS p4 Corpii Creola din lumenul bronsic provin din: (p1567) \*\ Creole Bodies from the bronchial lumen originate from
A) [x]epiteliul cailor aeriene \*\ airway epithelium
B) [ ]distructie limfocitara \*\ lymphocytic destruction
C) [ ]proteine granulare ale polimorfonuclearelor neutrofile \*\ granular proteins of polymorphonuclear neutrophils
D) [ ]membrane macrofagice \*\ macrophage membranes
E) [ ]hipersecretie de mucus \*\mucus hypersecretion
---------------------------------------------------------------------
121. CS p4 Cancerele epidermoide si cu celule mari caviteaza in aproximativ: (p602) \*\ Epidermoid and large cell cancers forms
cavitation in about:
A) [ ] 5-10% \*\ 5-10%
B) [x] 10-20% \*\ 10-20%
C) [ ] 20-30% \*\20-30%
D) [ ] 30-50% \*\ 30-50%
E) [ ] 70% \*\ 70%
---------------------------------------------------------------------
122. CS p4 Care este procentul de reducere a riscului de moarte la 2 ani prin includerea chimioterapiei alaturi de radioterapia
radicala in tratamentul cancerelor pulmonare altele decat cele cu celule mici in stadiile avansate ale bolii localizate ? (p610)
\*\What is the percentage of reducing the risk of death in two years by including chemotherapy with radical radiotherapy in the
treatment of lung cancers other than small cell located in the advanced stages of disease?
A) [ ]Reducere cu 30% \*\Reduction by 30%
B) [ ]Reducere cu 40% \*\Reduction by 40%
C) [x]Reducere cu 13% \*\Reduction by 13%
D) [ ]Reducere cu 50% \*\Reduction by 50%
E) [ ]Reducere cu peste 50% \*\Reduction over 50%
---------------------------------------------------------------------
123. CS p4 Sindromul Pancoast-Tobias se trateaza cu: (pg 610) \*\Pancoast-Tobias syndrome is treated with:
A) [ ] Nu se trateaza \*\ Not treated
B) [ ] Chimioterapie \*\ Chemotherapy
C) [ ] Chimioterapie + Radioterapie \Chemotherapy + Radiotherapy*\
D) [ ] Tratament chirurgical + chimioterapie \*\ Surgery + chemotherapy
E) [x] Radioterapie + tratament chirurgical \*\Radiotherapy + surgery
---------------------------------------------------------------------
124. CS p4 [M1439017] De cate ori creste riscul relativ de a face cancer pulmonar la fumatorii activi: (pg 602) \*\ By how much
the relative risk of aqcuring lung cancer increases in an active smoker:
A) [ ] de 11 ori \*\ by 11 times
B) [ ] de 12 ori \*\by 12 times
C) [x] de 13 ori \*\ by 13 times
D) [ ] de 14 ori \*\ by 14 times
E) [ ] de 15 ori \*\ by 15 times
---------------------------------------------------------------------
125. CS p4 Boala metastatica extratoracica se intalneste la autopsie: (pg 605) \*\ Extrathoracic metastasis at autopsy is seen in:
A) [ ] La sub 50% din pacientii cu carcinom epidermoid \*\ In less than 50% of patients with epidermoid carcinoma
B) [x] La peste 95% din pacientii cu carcinom cu celule mici \*\ At over 95% of patients with small cell carcinoma
C) [ ] La sub 35% din pacientii cu adenocarcinom \*\In less than 35% of patients with adenocarcinoma
D) [ ] La sub 35 % din pacientii cu carcinom cu celule mici \*\ At less than 35% of patients with small cell carcinoma
E) [ ] La peste 95% din pacientii cu sindrom Pancoast \*\ At over 95% of patients with Pancoast syndrome
---------------------------------------------------------------------
126. CS p4 Care din urmatoarele tipuri histopatologice sunt tumori pulmonare benigne? (p602) \*\ Which of the following
histopathological types belong to benign pulmonary tumours:
A) [ ] carcinomul cu celule mici \*\Small cell cancer
B) [ ] adenocarcinomul \*\Adenocarinoma
C) [ ] carcinomul cu celule mari (anaplastic) \*Large cell cancer (anaplastic)\
D) [x] hamartom \*\ Hamartoma \*\
E) [ ] carcinom epidermoid \*\Epidermoid carcinoma


18
127. CS p4 [M1439018] Care sunt semnele si simptomele secundare cresterii periferice a cancerului pulmonar: (p605) \*\ What
are the secondary signs and symptoms of a growing peripheral lung cancer:
A) [ ]dispneea de tip obstructiv \*\Obstructive dyspnea
B) [ ]pneumonita de obstructie \*\ Obstructive pneumonitis
C) [x]tusea \*\ Cough
D) [ ]hemoptizia \*\Hemoptysis
E) [ ]wheezing \*Wheezing\
---------------------------------------------------------------------
128. CS p4 [M2639047] Urmatoarele afirmatii sunt false: (pg 602) \*\ The following statements are false:
A) [ ]Adenocarcinomul este cel mai frecvent la cei care nu au fumat niciodata \*\ Adenocarcinoma is most common in those who
never smoked
B) [ ]Riscul relativ de a face cancer pulmonar creste de 13 ori la fumatorii activi \*\ The relative risk of lung cancer increases by
13 times in active smokers
C) [ ]Carcinomul bronhiolo-alveolar este o foma speciala de adenocarcinom \*\ bronchiolo-alveolar carcinoma is a special form
of adenocarcinoma
D) [x]Cancerul cu celule mici formeaza de obicei o tumora periferica \*small cell cancer usually forms a peripheral tumor\
E) [ ]90% din pacienti cu cancer pulmonar au fost fumatori \*\ 90% of patients with lung cancer were smokers
---------------------------------------------------------------------
129. CM p5 Abordarea terapeutica la toti pacientii cu cancer pulmonar este: (608) \*\ Therapeutic approach in all patients with
lung cancer is:
A) [ ] Rezectie chirurgicala in caz de compresie a maduvei \*surgical resection in case of spinal compression\
B) [x] Radioterapie pe leziuni osoase litice pe oasele de sustinere \*\ Radiation therapy in lysis bone lesions on the supporting bones
C) [ ] Nu mai este necesar indemnul de a opri fumatul \*\ There is no urgent need to stop smoking
D) [ ] Rezectie chirurgicala in cancerul cu celule mici ce nu raspunde la chimioterapie \*\Surgical resections in small cell cancers
do not respond to chemotherapy
E) [x] Includerea in studii experimentale clinice pe criterii de eligibilitate \*\ Inclusion in experimental clinical trials based on
eligibility criteria
---------------------------------------------------------------------
130. CM p5 Care sunt examenele necesare pentru stabilirea unui diagnostic histologic de malignitate a cancerului pulmonar?
(606) \*\What are the exams necessary for establishing a histological diagnosis of malignancy in lung cancer?
A) [ ] Radiografia toracica, tomografia computerizata toracica, radiografia leziunilor osoase suspecte \*\thoracic radiograph,
thoracic CT, X-ray of suspected bone lesions
B) [x] Biopsie bronsica sau transbronsica cu bronhoscopul, biopsia leziunilor periferice accesibile, biopsia percutana a unui ganglion
limfatic\*\Bronchial or transbronchial biopsy with bronchoscope, biopsy of peripheral accessible lesions, percutaneous biopsy of a lymph node
C) [ ] Bronhoscopia cu fibre optice, probe ventilatorii pulmonare, teste de coagulare \*\ Bronchoscopy with optical fiber,
ventilatory pulmonary tests, coagulation tests
D) [x] Aspiratie sau biopsie a maduvei osoase, toracocenteza diagnostica, mediastinoscopia cu biopsia ganglionilor limfatici
\*\Aspiration or biopsy of bone marrow, diagnostic thoracentesis, mediastinoscopy with lymph node biopsy
E) [ ] Anamneza completa, hemograma completa, radiografia toracica, tomografia computerizata toracica \*\ Complete
anamnesis, complete blood count, thoracic radiography, thoracic CT
---------------------------------------------------------------------
131. CM p5 [M2839158] Carcinomul cu celule mici, in general este: \*\Small cell carcinoma generally is:
A) [ ] nu raspunde la chimioterapie, \*\ not responding to chemotherapy
B) [x] diseminat dincolo de limita de rezectie chirurgicala, la momentul prezentarii \*\spread beyond the surgical resection limit
at the time of presentation
C) [ ] supus initial tratamentului chirurgical, \*\ initial treatment is surgical
D) [x] este tratat mai intai prin chimioterapie cu sau fara radioterapie\*\ is treated first with chemotherapy with or without radiotherapy
E) [ ] localizat, la momentul prezentarii, \*\localized at the time of presentation
---------------------------------------------------------------------
132. CM p5 Cancerul pulmonar poate asocia sindroame paraneoplazice: (605)\*\Associated paraneoplastic syndromes in lung cancer
A) [x]Secretie inadecvata de ADH \*\Secretion of inappropriate ADH
B) [ ]Hipotiroidism \*\Hypothyroidism
C) [x]Polimiozita \*\Polymyositis
D) [x]Coagularea diseminata intravasculara \*\ disseminated intravascular coagulation
E) [ ]Hipozoospermie \*\Hypozoospermia
---------------------------------------------------------------------
133. CM p5 [M2639132] Criterii radiologice de baza pentru benignitatea unui nodul pulmonar solitar: (pg 609) \*\ The
radiological criteria for solitary pulmonary nodule to be benign is
A) [ ] Dinamica vie radiologica \*\dynamic radiology
B) [x] Lipsa de crestere pe o perioada de cel putin 2 ani \*\ Lack of growth over a period of at least 2 years
C) [x] Calcificari cu nucleu central dens, focare multiple punctiforme \*\ calcifications with dense central core, multiple focal points
D) [x] Calcificari in ''ochi de bou'' \*\ calcifications in the 'ox eye'
E) [ ] Ascensionarea hemidiafragmului prin pareza de nerv frenic \*\rising of hemidiafragm by phrenic nerve paresis

19
134. CM p5 [M2539125] Metodele de screening pentru cancerul pulmonar la persoanele cu risc ridicat include: (pg 605-606) \*\
The methods of screening for lung cancer in people at high risk include:
A) [ ] bronhoscopia cu fibre optice \*\ fiber optic bronchoscopy
B) [x] radiografia toracica \*\ chest radiograph
C) [x] citologia sputei \*\ sputum cytology
D) [x] bronhoscopia cu fluorescenta \*\fluorescence bronchoscopy
E) [ ] tomografia computerizata toracica \*\ torax CT
---------------------------------------------------------------------
135. CM p5 [M1539071] Care dintre urmatoarele reprezinta sindroame paraneoplazice intalnite la pacientii cu cancer pulmonar:
(pg 605) \*\ Which one of these paraneoplastic syndromes are encountered in patients with lung cancer:
A) [x] hiponatremia prin sindromul de secretie inadecvata de ADH \*\hyponatremia due to syndrome of inappropriate ADH secretion
B) [x] hipocratismul digital \*\ Digital hipocratismul (clubbing)
C) [x] osteoartropatia pulmonara hipertrofica \*\Hypertrophic pulmonary osteoartropatia
D) [ ] pielonefrita \*\ Pyelonephritis
E) [x] tromboflebitele venoase migratorii \*\ Vein migratory thrombophlebitis
---------------------------------------------------------------------
136. CM p5 [CM807267] Dintre sindroamele neurologice si miopatice se intilnesc in toate tipurile de cancere pulmonare:
(pg.605) \*\ The neurological and myopathic syndromes are found in all types of lung cancers
A) [x] neuropatiile peiferice \*\ peripheral neuropathy \*\
B) [x] polimiozita \*\ polymyositis \*\
C) [ ] sindromul Eaton-Lambert miastenic \*\ Eaton-Lambert myasthenic syndrome \*\
D) [x] degenerarea cerebeloasa \*\ cerebellar degeneration \*\
E) [ ] cecitate retiniana \*\ retinal blindness \*\
---------------------------------------------------------------------
137. CM p5 Extinderea regionala a cancerului pulmonar cu paralizia nervului simpatic determina sindromul Horner caracterizat
prin: (605) \*\ The extension of lung cancer with regional sympathetic nerve paralysis cause Horner syndrome characterized by:
A) [x] enoftalmie \*\ enophthalmie
B) [x] ptoza palpebrala \*\ ptosis of eye lid
C) [ ] midriaza \*\ mydriasis
D) [x] mioza \*\ miosis
E) [x] absenta ipsilaterala a transpiratiei \*\ lack of sweating on ipsilateral side
---------------------------------------------------------------------
138. CM p5 [M2539119] Care sunt metodele de convertire din stadiul nerezecabil in cel rezecabil a pacientilor cu cancer
pulmonar: (pg 609) \*\What are the methods of conversion of unresectable stage into the resectable stage in lung cancer patients:
A) [x]chimioterapia neoadjuvanta \*\ Neoadjuvant chemotherapy
B) [x]lobectomia pe planul de clivaj \*\ lobectomy on cleavage plane
C) [x]pneumectomia pe planul de clivaj traheal \*\pneumectomiy in the plane of tracheal cleavage
D) [ ]chirurgia toracica videoasistata \*\ video-assisted thoracic surgery
E) [x]rezectia peretelui toracic \*\chest wall resection
---------------------------------------------------------------------
139. CM p5 [M2639135] Urmatoarele tipuri histologice apartin neoplasmului pulmonar: (pg 603, 612) \*\ The following
histological types are lung cancer
A) [x]Carcinom cu celule mici \*\small cell carcinoma
B) [x]Carcinom epidermoid \*\ Epidermoid carcinoma
C) [x]Carcinom cu celule mari \*large cell carcinoma\
D) [x]Adenocarcinom \*\adenocarcinoma
E) [ ]Hamartom \*\Hamartoma
---------------------------------------------------------------------
140. CM p5 Semnificatia stadiului T2N0M0 in cancerul pulmonar este:(606)\*\The significance of stage T2N0M0 lung cancer is:
A) [x]tumora >3 cm, fara interesare ganglionara si fara metastaza cunoscuta la distanta \*\ tumor> 3 cm, without lymph node
involvement and no known distant metastasis
B) [ ]tumora cu extensie directa la peretele toracic, la mai putin de 2 cm de carina traheala \*\Tumor with direct extension to chest
wall, at least 2 cm of tracheal carina
C) [ ]tumora cu invazia esofagului, fara interesare ganglionara \*\esophagus tumor invasion without lymph node involvement
D) [x]tumora cu atelectazie distala extinsa pina la hil, fara interesare ganglionara si fara metastaza cunoscuta la distanta \*\ tumor
with distal atelectasis extended to hilum, without lymph node involvement and no known distant metastasis
E) [ ]tumora sub 3 cm cu revarsat pleural malign, fara interesare ganglionara si fara metastaza la distanta \*\ tumour less than 3
cm tumor with malignant pleural effusion without lymph node involvement and without distant metastases
---------------------------------------------------------------------
141. CM p5 Abordarea terapeutica in cancerul pulmonar cu celule mici: (608) \*\Therapeutic approach in small cell lung cancer
A) [ ]Rezectie chirurgicala la toti pacientii cu stare generala buna si cu ganglioni mediastinali \*\ surgical resection in all patients
with good general condition and mediastinal lymph node
B) [x]in stadiul limitat cu stare generala buna - chimioterapie combinata cu radioterapie toracica \*\in limited stage with good

20
general condition - chemotherapy combined with thoracic radiotherapy
C) [ ]Numai tratament simptomatic \*\ Symptomatic treatment only
D) [x]in toate stadiile la tumori complet responsive - radioterapia craniala profilactica \*\ at all stages of the tumors completely
responsive - Prophylactic cranial radiotherapy
E) [x]Stadiu avansat cu stare generala buna - chimioterapie combinata \*\ advanced stage with good general condition - combined
chemotherapy
---------------------------------------------------------------------
142. CM p5 Cancerul bronhopulmonar poate determina urmatoarele manifestari cutanate\*\Lung cancer can cause these skin manifestations
A) [ ] eritem facial \*\ flushing (facial erythema)
B) [x] manifestari cutanate de dermatomiozita \*\ cutaneous manifestations of dermatomyositis type
C) [ ] leziuni buloase \*\bullous lesions
D) [x] acantosis nigricans \*\acanthosis nigricans
E) [ ] manifestari de sclerodermie \*\ manifestations scleroderma
---------------------------------------------------------------------
143. CM p5 Care sunt tipurile histologice de cancere pulmonare care formaza de obicei tumori centrale cu expansiune
endobronsica?(602)\*\What are the histological types of lung cancer tumors that usually form central tumours with endobronchial expansion?
A) [ ] Carcinomul cu celule mici, adenocarcinomul, limfoamele \*\ small cell carcinoma, adenocarcinoma, lymphoma
B) [x] Carcinomele epidermoide, carcinoamele cu celule mici \*Carcinomele epidermoid, small cell carcinoma\
C) [ ] Adenocarcinomul, carcinoamele cu celule mari, tumorile stromale \*\adenocarcinoma, large cell carcinoma, stromal tumors
D) [ ] Carcinomul cu celule mari, tumorile carcinoide, mezoteliomul \*\ large cell carcinoma, carcinoid tumors, mesothelioma
E) [x] Carcinomul cu celule in bob de ovaz, carcinomul scuamos \*\ 'Oat cell' carcinoma, squamous cell carcinoma
---------------------------------------------------------------------
144. CM p5 [M2539106] Indicatia de radioterapie cu intentie curativa este rezervata pacientilor: (pg 609) \*\Indication for
radiotherapy with curative intent is reserved for patients:
A) [ ] cu revarsat pleural \*\ with pleural effusion
B) [x] in stadiul II care refuza interventia chirurgicala \*\ stage II who refuse surgery
C) [ ] cu invazia vaselor mari si cordului \*\ the invasion of large vessels and heart
D) [x] in stadiul III cu risc operator mare \*\ stage III with high risk
E) [ ] with solitary pulmonary nodule \*\ cu nodul pulmonar solitar \*\
---------------------------------------------------------------------
145. CM p5 [M2639131] Contraindicatiile majore de interventii chirurgicale in neoplasmul bronsic sunt: (pg 606, 608) \*\ Major
contraindications for surgery in bronchial neoplasms are: (pg 606, 608)
A) [x] Metastaze extratoracice la distanta \*\distant extrathoracic metastases
B) [x] Interesarea trunchiului principal al arterei pulmonare \*\ involvment of main trunk of pulmonary artery
C) [ ] Carcinom in situ \*\ carcinoma in situ
D) [ ] Cancer pulmonar cu celule mici \*\ small cell lung cancer
E) [ ] Fara evidentierea unei tumoriprimare \*\ Without evidence of a primary tumour
---------------------------------------------------------------------
146. CM p5 Contraindicatiile majore ale interventiei chirurgicale sau radioterapiei unice in cancerul pulmonar cu celule de alt tip
decit cele mici sunt: (610) \*\Major contraindications for surgery or radiotherapy unique in lung cancer other than small ones are:
A) [x]sindromul de vena cava superioara \*\ Superior vena cava syndrome
B) [ ]tumora endobronsica unilaterala \*\unilateral endobronchial tumor
C) [x]revarsatul pleural malign \*\ malignant pleural effusion
D) [x]metastaza in plaminul opus \*\lung metastasis in the opposite lung
E) [x]interesarea trunchiului principal al arterei pulmonare \*\ involving the main pulmonary artery trunk
---------------------------------------------------------------------
147. CM p5 [M1539073] Care sunt criteriile radiologice de baza pentru benignitate in cazul unui nodul pulmonar solitar: (609)
\*\ What are the basic radiological criteria for a benign solitary pulmonary nodule:
A) [x] lipsa de crestere pe o perioada de cel putin 2 ani \*\ lack of growth over a period of at least 2 years
B) [ ] diametrul sub 6cm\*\ 6cm in diameter
C) [x] calcificari in ''ochi de bou'' si ''bob de porumb'' \*\calcifications in the "ox-eye" and "grain corn"
D) [ ] localizarea la mai mult de 2cm de carina traheala \*\localization of more than 2cm of tracheal carina
E) [ ] lipsa atelectaziei \*\lack atelectasis
---------------------------------------------------------------------
148. CM p5 [M2839149] In cancerul pulmonar cu celule mici sunt false afirmatiile: (pg 604) \*\In small cell lung cancer the
following are false statements:
A) [ ]granulele dense sunt prezente \*\dense granules are present
B) [x]atg CD 46, CD 57 prezente \*\atg CD 46, CD 57 present
C) [ ]sinaptofizina si cromogranina sunt prezente \*synaptofizina and chromogranin are present\
D) [x]enolaza neuronala specifica crescuta si izoenzima CPK este scazuta \* enolaza neuronal specific is high and CPK
isoenzyme is low\
E) [x]activitatea L-Dopa decarboxilaza absenta \*\L-Dopa decarboxylase activity absent


21
149. CM p5 [M1539074] Aparitia pneumonitei de iradiere dupa radioterapie cu intentie curativa la pacientii cu cancer pulmonar
este direct proportionala cu: (pg 609) \*\ Appearance of radiation pneumonia after radiotherapy with curative intent in patients
with lung cancer is directly proportional to:
A) [ ] prezenta metastazelor \*\presence of metastases
B) [ ] tipul histologic al tumorii \*\ histological type of tumor
C) [x] doza de iradiere \*\dose of radiation
D) [x] volumul pulmonar inclus in campul de iradiere \*\ lung volume included in the radiation field
E) [ ] varsta pacientului \*\ The age of the patient
---------------------------------------------------------------------
150. CM p5 [M1239060] Care dintre urmatoarele afirmatii cu privire la cancerul pulmonar cu celule mici sunt adevarate? (pg
605) \*\ Which of the following statements about small cell lung cancer are true?
A) [ ] simptomul principal este tusea cu producerea de mari cantitati de sputa \*\ The main symptoms is cough with large amounts
of sputum production
B) [x] peste 95% din pacienti prezinta metastaze la autopsie \*\over 95% of patients at autopsy shows metastasis
C) [ ] are cea mai crescuta rata a supravietuirii la 5 ani \*\ has the highest 5 year survival rate
D) [ ] este cel mai frecvent tip histologic de cancer pulmonar \*\ is the most common histological type of lung cancer
E) [x] determina aparitia unei secretii inadecvate (ectopice) de ADH \*\ determine the apparition of inappropriate secretion (ectopic) of ADH
---------------------------------------------------------------------
151. CS p4 [M2205051] Pneumotoraxul spontan secundar apare: (pag. 1626)\*\Secondary spontaneous pneumothorax occurs
A) [ ]mai frecvent in traumantisme toracice\*\The more frequently in the thoracic traumantisme
B) [ ]mai frecevent in bolile mediastinale\*\more frecevent in mediastinal diseases
C) [ ]in bolile gastro-esofagiene\*\Gastro-oesophageal disease in
D) [x]mai frecvent in bolile obstructive pulmonare\*\more frequently obstructive pulmonary disease
E) [ ]in cancerul esofagian\*\esophageal cancer
---------------------------------------------------------------------
152. CS p4 [M1405015] Pneumotoraxul spontan primar apare la: (pag. 1626)\*\Primary spontaneous pneumothorax occurs in
A) [ ]bolnavi care au suferit un traumatism toracic\*\patients who suffered a chest injury
B) [ ]bolnavi cu boli pulmonare obstructive cronice\*\: patients with chronic obstructive pulmonary disease
C) [x]indivizi fara afectiuni pulmonare cunoscute\*\individuals without known lung
D) [ ]la nefumatori\*\the non-smoking
E) [ ]la pacienti care au fost supusi unei toracenteze\*\the patients who were undergoing toracenteze
---------------------------------------------------------------------
153. CS p4 [M2205038] Pneumotoraxul spontan primar apare: (pag. 1626)\*\Primary spontaneous pneumothorax occurs
A) [ ]Aproape exclusiv la lucratori din industria materialelor explozive\*\Almost exclusively to the explosives industry workers
B) [ ]Aproape exclusiv la alpinisti\*\: Almost exclusively climbers
C) [x]Aproape exclusiv la fumatori\*\almost exclusively in smokers
D) [ ]Aproape exclusiv la mineri\*\Almost exclusively miners
E) [ ]Aproape exclusiv la varstnici\*\Almost exclusively in the elderly
---------------------------------------------------------------------
154. CS p4 [M2205048] Toracoscopia cu abraziune pleurala are o rata de prevenire a recurentelor pneumotoraxului spontan
primar de: (1626)\*\Thoracoscopy with pleural abrasion has a prevention rate of recurrent primary spontaneous pneumothorax of
A) [ ]10%\*\10%
B) [ ]20%\*\20%
C) [ ]25%\*\25%
D) [ ]30%\*\30%
E) [x]aproape 100%\*\almost 100%
---------------------------------------------------------------------
155. CS p4 In pneumotoraxul spontan primar recurentele sunt: (p1626)\*\In recurrent primary spontaneous pneumothorax it is
A) [ ]rare\*\Rare
B) [ ]nu apare\*\Not applicable
C) [ ]extrem de frecvent\*\very common
D) [x] apar la aproape jumatate din indivizi care au mai avut un episod\*\occurring in almost half of individuals who have had an episode
E) [ ]legate totdeauna de traumatisme toracice penetrante\*\Penetrating chest trauma linked forever
---------------------------------------------------------------------
156. CS p4 [CS06022] Cauza cea mai frecventa a mediastinitei cronice? (pag.1627)\*\Which is the most common cause of
chronic mediastinitei? (Pag.1627)
A) [ ]Infectie fungica\*\fungal infection
B) [ ]sarcoidoza\*\sarcoidosis
C) [ ]Silicoza\*\Silicosis
D) [ ]Criptococoza\*\Criptococoza
E) [x]tbc\*\TB
---------------------------------------------------------------------


22
157. CS p4 [CS06001] Cea mai valoroasa metoda imagistica pentru diagnosticul tumorilor mediastinale este: (pag 1627)\*\Most
valuable imaging method for diagnosis of mediastinal tumors is:
A) [ ]Scintigrama cu iod 131\*\Iodine 131 Scintigram
B) [x]TC mediastinal\*\CT mediastinal
C) [ ]Examenul baritat al tractului gastrointestinal\*\: examination of the gastrointestinal tract Barite
D) [ ]Toracoscopia video-asistata\*\Video-assisted thoracoscopic
E) [ ]Mediastinoscopia\*\Mediastinoscopia
---------------------------------------------------------------------
158. CS p4 [M1605028] Agentii sclerozanti recomandati pentru tratamentul pneumotoraxului spontan secundar sunt: (pag.
1626)\*\Sclerosing agents recommended for treatment of secondary spontaneous pneumothorax are:
A) [ ]Cicloserina\*\: Cicloserine
B) [ ]Isoniazida\*\Isoniazide
C) [ ]Streptomicina\*\Streptomycin
D) [ ]Amiodarona\*\Amiodarone
E) [x]Doxiciclina\*\Doxycycline
---------------------------------------------------------------------
159. CM p5 [CM06034] Urmatoarele formatiuni se afla in mediastinul posterior: (pg.1627)\*\The following formations are
located in the posterior mediastinum
A) [ ]arterele si venele brahiocefalice\*\arteries and veins brahiocefalice
B) [x]esofagul\*\. esophagus
C) [ ]traheea\*\: trachea
D) [x]venele azygos\*\azygos veins
E) [ ]inima\*\Heart
---------------------------------------------------------------------
160. CM p5 [M2205144] Pneumotoraxul spontan secundar este mai periculos la: (pag. 1626)\*\Spontaneous secondary
pneumothorax is more dangerous in:
A) [ ]cei fara afectiuni pulmonare cunoscute
\*\those without known pulmonary disease
B) [ ]normali\*\normal people
C) [x]cei boli ale boala pulmonara obstructiva cronica\*\those with chronic obstructive pulmonary disease
D) [x]cei cu boli pulmonare preexistente\*\those with preexisting pulmonary disease
E) [ ]copii\*\children
---------------------------------------------------------------------
161. CM p5 Principalele cauze de paralizie ale diafragmului sunt: (pg 1628)\*\The main causes of paralysis of the diaphragm are:
A) [x] leziuni inalte ale maduvei spinarii\*\High spinal cord injuries
B) [x]distrofia musculara\*\muscular dystrophy
C) [x]traumele toracice, inclusiv chirurgia cardiaca\*\: thoracic injuries, including cardiac surgery
D) [x]scleroza multipla\*\: multiple sclerosis
E) [ ]sindromul cornului posterior\*\: posterior horn syndrome
---------------------------------------------------------------------
162. CM p5 [CM06031] Afectare severa in paraliziile diafragmatice este manifestata prin: ()\*\severe impairment in
diaphragmatic paralysis is manifested by:
A) [ ]insuficienta ventriculara stanga\*\left ventricular failure
B) [x]atelectazie\*\atelectasis
C) [x]pneumonie\*\: pneumonia
D) [x]insuficienta respiratorie\*\: respiratory failure
E) [x]hipercapnie\*\hypercapnia
---------------------------------------------------------------------
163. CM p5 [CM06082] Compartimentele mediastinului sunt: (1627) \*\Mediastinal compartments are:
A) [ ]mediastinul superior\*\superior mediastinum
B) [x]mediastinul anterior\*\anterior mediastinum
C) [ ]mediastinul inferior\*\inferior mediastinum
D) [ ]mediastinul drept\*\right mediastinum
E) [x]mediastinul posterior\*\posterior mediastinum
---------------------------------------------------------------------
164. CM p5 [M2205169] In pneumotoraxul in tensiune: (pag. 1627)\*\In tension pneumothorax:
A) [x]presiunea intrapleurala este amenintatoare de viata\*\intrapleural pressure is threatening to life
B) [ ]creste intoarcerea venoasa\*\venous return is increased
C) [ ]nu este influentata circulatia venoasa\*\the venous circulation is not influenced
D) [x]scade debitul cardiac\*\cardiac output decreases
E) [ ]presiunea intrapleurala este negativa\*\intrapleural pressure decreases
---------------------------------------------------------------------


23
165. CM p5 [CM06098] In mediastinita acuta: (pag 1627)\*\In acute mediastinitis:
A) [x]multe cazuri se datoreza perforatiei esofaului sau apar dupa sternotomia mediana din chirurgia cardiaca\*\Many cases are
due to oesophageal perforation or occur after median sternotomy in cardiac surgery
B) [x]pacientii cu ruptura esofagiana vin in stare acuta cu durere toracica si dispnee\*\patients with esophageal rupture come in
acute state with chest pain status and dyspnoea
C) [ ]tratamentul este in principal antibiotic\*\: main treatment is with antibiotics
D) [x]tratmentul consta in explorarea mediastinului, cura chirurgicala a plagii esofagiene si drenajul spatiului pleural si
mediastinal\*\treatment consists in mediastinal exploration, surgical cure of oesophageal wounds and drainage of pleural space and
mediastinum
E) [x]ruptura esofagului se poate produce spontan\*\esophageal rupture can occur spontaneously
---------------------------------------------------------------------
166. CM p5 Sunt adevarate urmatoarele afirmatii cu privire la revarsatul pleural: (1626)\*\following statements are true about the
when taking effusion from the pleural
A) [x]lichidul alb laptos si TGL>110mg/dl este sugestiv pentru chilotorax\*\Milky white liquid and TGL> 110mg/dl is suggestive chilotorax
B) [x]Ht>50% fata de sangele periferic este sugestiv pt hemotorax\*\Ht> 50% from peripheral blood is suggestive for hemotorax
C) [ ]pneumotoraxul este cauza frecventa de revarsat pleural\*\pneumothorax is common cause of pleural effusion
D) [x]in Sdr. Meigs revarsatul pleural se insoteste de ascita\*\SDR. Meigs break of pleural be accompanied by ascites
E) [ ]in pleurezia lupica creste nivelul AAM\*\to raise lupica pleurisy AAM
---------------------------------------------------------------------
167. CM p5 [CM06110] Paralizia bilaterala a diafragmului: (pg 1628)\*\Bilateral diaphragmatic paralysis
A) [ ]determina rar o patologie severa in cazul adultilor\*\rarely cause severe disease in adults
B) [x]se prezinta cu insuficienta hipercapnica, complicata frecvent cu cord pulmonar si insuficienta ventriculara
dreapta\*\presents with hypercapneic insufficiency, often complicated by right ventricular failure and heart failure
C) [x]poate da atelectazie si pneumonie\*\may give atelectasis and pneumonia
D) [ ]gradul paraliziei se poate aprecia cel mai bine prin masurarea presiunii mediastinale\*\the degree of paralysis can be
appreciated best by mediastinal pressure measurement
E) [ ]este mai frecventa decat cea unilaterala\*\: is more common than unilateral one
---------------------------------------------------------------------
168. CM p5 [CM06010] Principalele cauze ale pneumomediastinului sunt urmatoarele: (pag 1627)\*\main causes of
pneumomediastinum are:
A) [ ]ruptura bulelor apicale subpleurale\*\apical rupture of subpleural
B) [x]ruptura alveolara cu patrunderea aerului in mediastin\*\alveolar rupture with air penetration into the mediastinum
C) [x]perforarea traheei\*\tracheal perforation
D) [x]ruptura esofagului\*\esophageal rupture
E) [x]patrunderea aerului in mediastin dinspre abdomen\*\air penetration into the mediastinum from the abdomen
---------------------------------------------------------------------
169. CM p5 [M1205096] Cauzele cele mai frecvente ale pneumotoraxului traumatic iatrogen sunt: (pag. 1627)\*\The most
frequent causes of iatrogenic traumatic pneumothorax are:
A) [ ]cardioversia prin soc electric extern\*\cardioversion through external electrical shock
B) [ ]biopsia hepatica\*\liver biopsy
C) [x]biopsia transtoracica\*\transthoracic biopsy
D) [x]toracocenteza\*\thoracocentesis
E) [x]montarea unui cateter venos central\*\the setting up of a central venous catheter
---------------------------------------------------------------------
170. CM p5 Agenti sclerozanti utilizati in tratametul pneumotoraxului sunt: (1626)\*\Sclerosing agents used in the treatment of
pneumothorax are:
A) [ ]Nitredipina\*\Nitredipine
B) [x]Talc\*\Talc
C) [ ]Azitromicina\*\Azitromicine
D) [x]Doxiciclina\*\Doxycyclin
E) [ ]Nedocromilul\*\Nedocromil
---------------------------------------------------------------------
171. CM p5 [CM06027] Despre diagnosticul mediastinitei acute ca urmare a perforarii esofagului si sternotomiei mediane se
poate spune: \*\About mediastinitei diagnosis of acute esophageal perforation following medial and sternotomiei can say:
A) [x]perforatie esofagului poate duce la dispnee si durere toracica\*\esophageal perforation can lead to dyspnea and chest pain
B) [x]se poate evidentia secretia la nivelul plagii la cea determinata de o sternotomie mediana\*\secretion may reveal the plaque
in the determined by a median sternotomy
C) [x]perforatia esofagului poate fi spontana\*\can be spontaneous esophageal perforation
D) [ ]mediastinul poate aparea ingustat la cea determinata de sternotomia mediana\*\there might be narrowed in the mediastinum
caused by median sternotomy
E) [x]diagnosticul in sternotomia mediana se face cu punctie mediastinala\*\is mediastinitei diagnosed with mediastinal puncture
---------------------------------------------------------------------


24
172. CM p5 Tumorile frecvente in mediastinul mijlociu nu sunt: (p.1627)\*\Tumors which are common in middle mediastinum
A) [x]Timoame\*\Thymoma
B) [x]Limfoame\*\Lymphomas
C) [ ]Tu. metastatice ganglionare\*\metastatic tumour in lymph nodes
D) [x]meningocel\*\meningocele
E) [ ]Tu granulomatoase\*\granulomatous tumour
---------------------------------------------------------------------
173. CM p5 [CM06057] Elementele cheie frecvent intalnite la pacientii cu pneumomediastin sunt: (pg. 1627)\*\Main elements
commonly found in patients with pneumomediastinum are:
A) [ ]febra\*\fever
B) [x]durerea toracica severa substernala\*\severe substernal chest pain
C) [ ]tusea cu expectoratie mucopurulenta\*\cough with mucopurulent expectoration
D) [x]emfizemul subcutanat in incizura suprasternala\*\subcutaneous emphysema in suprasternal incision
E) [ ]murmurul vezicular absent\*\absent vesicular murmur
---------------------------------------------------------------------
174. CM p5 [CM06014] Mediastinul posterior contine: (pag. 1627)\*\posterior mediastinum contains
A) [x]Esofagul\*\The esophagus
B) [x]Canalul toracic\*\Channel chest
C) [ ] Traheea\*\: Trachea
D) [ ]Venele pulmonare\*\pulmonary veins
E) [x]Venele azygos\*\azygos veins
---------------------------------------------------------------------
175. CM p5 [M2705212] Pneumotoraxul spontan primar (pag. 1626)\*\Spontaneous primary pneumothorax
A) [x]Apare la un subiect fara boala pulmonara prexistenta\*\appears in a person without preexistent pulmonary disease
B) [x]Este secundar rupturii bulelor apicale subpleurale\*\is secondary to rupture of subpleural apical bulla
C) [x]Este asociat cu fumatul in majortatea cazurilor\*\is associated with smoking in majority of cases
D) [x]Tratamentul initial este aspiratia simpla\*\initial treatment is simple aspiration
E) [ ]Pleurodeza cu agent sclerozant introdus intrapleural este obligatorie dupa primul pneumotorax spontan ce a asociat
insuficienta respiratorie acuta\*\pleurodesy with sclerosing agent introduced intrapleurally is absolute after first spontaneous
pneumothorax which is associated with acute respiratory insufficiency
---------------------------------------------------------------------
176. CM p5 [CM06068] Cauze de mediastinita acuta pot fi: (1627)\*\Causes of acute mediastinitis can be the following:
A) [ ]Tuberculoza\*\Tuberculosis
B) [x]Perforatia esofagiana\*\esophageal perforation
C) [ ]Infectii fungice\*\Fungal Infections
D) [x]Toracotomia din chirurgia cardiaca\*\thoracotomy in cardiac surgery
E) [ ]Silicoza\*\Silicosis
---------------------------------------------------------------------
177. CM p5 [CM06118] Majoritatea cazurilor de mediastinita cr este data de: (1627)\*\Most cases of mediastinitis cr are due to
A) [x] TBC\*\TB
B) [x]histoplasmoza\*\: histoplasmosis
C) [ ]sarcoidoza\*\sarcoidosis
D) [ ]silicoza\*\silicosis
E) [ ]infectii fungice\*\Fungal infections
---------------------------------------------------------------------
178. CM p5 [CM06102] Pneumomediastinul se caracterizeaza prin: (1627)\*\Pneumomediastinum is characterized by:
A) [x] durere toracica substernala, cu sau fara iradiere in gat sau brat\*\substernal chest pain, with or without irradiation in the neck or arm
B) [x]de obicei, examenul fizic arata emfizem subcutanat in incizura suprasternala\*\usually physical examination shows
subcutaneous emphysema in suprasternal incision
C) [x]de obicei, examenul fizic arata semnul Hamman, care este un zgomot crepitant, sincron cu bataile cardice si care se aude cel
mai bine in decubit lateral stang\*\usually physical examination shows Hamman sign, which is a crepitant sound, synchronous
with the heartbeat and which is best heard in the left lateral decubitus
D) [x]de obicei, nu este necesar nici un tratament\*\usually no treatment is necessary
E) [ ]diagnosticul nu se confirma printr-o radiografie toracica\*\diagnosis is not confirmed by chest X-ray
---------------------------------------------------------------------
179. CM p5 Pneumotoraxul in tensiune este periculos pentru ca: (pag. 1627)\*\Tension pneumothorax is dangerous because:
A) [x]ventilatia este sever compromisa\*\ventilation is severely compromised
B) [x]scade intoarcerea venoasa la inima\*\it decreases venous return to the heart
C) [x]scade debitul cardiac\*\: it decreases cardiac output
D) [ ]poate produce embolie pulmonara\*\: can produce pulmonary embolism
E) [x]poate produce deces\*\can produce death
---------------------------------------------------------------------


25
180. CM p5 [CM06089] Tratamentul pneumomediastinului (pag 1627)\*\Pneumomediastinum treatment
A) [x]Nu este necesar in cele mai multe cazuri\*\It is not necessary in most cases
B) [x]Poate fi realizat prin aspirarea pe ac in caz de compresie a structurilor mediastinale\*\It can be done by needle aspiration in
case of compression of mediastinal structures
C) [ ]Compresia structurlor mediastinale necesita interventie chirurgicala\*\Compression of mediastinal structures requires
surgical intervention
D) [ ]Inspirarea unui aer bogat in oxigen poate agrava simptomatologia\*\Inhalation of an oxygen-rich air can aggravate symptoms
E) [ ]Este intotdeauna o urgenta medicala\*\It is always a medical emergency
---------------------------------------------------------------------
181. CS p4 Care din urmatoarele medicamente nu e indicat in angina instabila:(1516)\*\Which of these drugs is not indicated in unstable angina
A) [ ]nitroglicerina intravenos \*\ : intravenous nitroglycerin
B) [ ]aspirina\*\aspirin
C) [x]streptokinaza\*\streptokinase
D) [ ]heparina intravenos\*\\Intravenous heparin *\
E) [ ]betablocantele\*\beta blockers
---------------------------------------------------------------------
182. CS p4 Stenoza coronariana recurenta dupa angioplastia cu balon apare in primele 6 luni la: (1514)\*\Recurrent coronary
stenosis after balloon angioplasty occurs in the first six months on
A) [ ]50% din cazuri\*\50% of cases
B) [ ]10% din cazuri\*\10% of cases
C) [x]30-45% din cazuri\*\30-45% of cases
D) [ ]75% din cazuri\*\75% of cases
E) [ ]90% din cazuri\*\90% of cases
---------------------------------------------------------------------
183. CS p4 Ritmul jonctional accelerat se asociaza mai frecvent cu: (1189)\*\accelerated junctional rhythm is frequently associated with:
A) [ ]Infarctul miocardic anterior\*\prior myocardial
B) [x]Infarctul miocardic inferoposterior\*\inferoposterior myocardial infarction
C) [ ]Infarctul miocardic anteroseptal\*\anteroseptal Myocardial infarction
D) [ ]Infarctul miocardic de ventricul drept\*\Myocardial infarction of right ventricle
E) [ ]Infarctul miocardic anterolateral\*\anterolateral Myocardial infarction
---------------------------------------------------------------------
184. CS p4 [M1407017] Morfina administrata in controlul durerii din IMA se caracterizeaza prin urmatoarele cu EXCEPTIA
(1495)\*\administered morphine in controlling pain of MI is characterized by the following except
A) [ ]este un analgezic extrem de eficient pentru durerea asociata cu IMA\*\is a highly effective analgesic for pain associated with AMI
B) [ ]poate reduce constrictia arteriolara si venoasa mediata simpatic\*\arteriolar and venous constriction can reduce sympathetic mediated
C) [x]scaderea debitului cardiac si a tensiunii arteriale contraindica folosirea morfinei\*\decrease in cardiac output and blood
pressure contraindications morphine use
D) [ ]are efect vagotonic si poate cauza bradicardia\*\vagotonic effect and can cause bradycardia
E) [ ]staza venoasa rezultata poate scadea debitul cardiac si tensiunea arteriala\*\resulting venous stasis may decrease cardiac
output and blood pressure
---------------------------------------------------------------------
185. CS p4 [M2240047] Care dintre modificarile electrocardiografice atesta un test de efort pozitiv? (1509)\*\Which of
electrocardiographic changes evidenced by a positive exercise test
A) [ ]modificarile ascendente ale segmentului ST\*\upward ST-segment changes
B) [x]subdenivelarea orizontala cu mai mult de 0,1 mV sub linia izioelectrica, cu durata peste 0,08 secunde a segmentului
ST\*\horizontal depression of more than 0.1 mV below the izioelectrica, 0.08 seconds over the duration of ST segment
C) [ ]supradenivelarea orizontala cu mai mult de 0,1 mV peste linia izioelectrica, cu durata peste 0,08 secunde a segmentului
ST\*\horizontal elevation more than 0.1 mV over izioelectrica line, more than 0.08 seconds duration ST segment
D) [ ]aritmiile ventriculare\*\Ventricular arrhythmias
E) [ ]anomalii ale undei T\*\T wave abnormalities
---------------------------------------------------------------------
186. CS p4 Care clasa de medicamente este utilizata in terapia initiala a anginei Prinzmetal: (1514,1516-17) \*\What class of
drugs iare used in the initial therapy of Prinzmetal angina
A) [ ]blocantele beta-adrenergice\*\\beta-blockers
B) [x]antagonistii canalelor de calciu\*\calcium channel antagonists
C) [ ]inhibitorii enzimei de conversie\*\ACE inhibitors
D) [ ]tonicardiacele digitalice\*\tonicardiacele digitalis
E) [ ]diureticele de ansa\*\Loop diuretics
---------------------------------------------------------------------
187. CS p4 [M2240051] Regimul de administrare al diltiazemului cu eliberare lenta in angina pectorala stabila este: (pag.
1513)\*\management regime of slow-release diltiazem in stable angina pectoris is:
A) [ ]30mgde4oripezi\*\30mg 4 times per day
B) [ ]60mgde4oripezi\*\60mg 4 times per day

26
C) [ ]90mgde4oripezi\*\90mg 4 times per day
D) [x]60-120 mg de 2 ori pe zi\*\60-120 mg two times daily
E) [ ]240mgodatapezi\*\240mg once a day
---------------------------------------------------------------------
188. CS p4 [M2507066] Determinarea nivelului seric al mioglobinei in infactul miocardic acut este utila pentru ca: (1494)
\*\Determining the serum level of myoglobin in an infarction is useful for:
A) [ ]Are o specificitate superioaratroponinei T cardiac specifica(c TnT) si troponinei I cardiac specifica(c TnI)\*\He has a heart
specific T superioaratroponinei specificity (c TnT) and cardiac specific cardiac troponin I (TNI c)
B) [x]Este eliberatain sange doar in cateva ore de la debutul infarctului\*\It is released in blood in a few hours after onset of the infarct
C) [ ]Este utila pentru diagnosticul infarctului miocardic acut dupa24 - 48 ore de la debutul simptomelor\*\It is useful for
diagnosing myocardial infarction after 24 - 48 hours after onset of symptoms
D) [ ]Nivelurile ei serice pot ramane crescute timp de 7 - 10 zile dupadebutul infarctului miocardic\*\its serum levels may remain
elevated for 7 - 10 days after the beginning myocardial
E) [ ]Este foarte specifica pentru diagnostic\*\It is very specific for diagnostic
---------------------------------------------------------------------
189. CM p5 Procesul de vindecare, cicatrizare si remodelare al IMA poate fi influentat negativ de unele categorii de droguri care
trebuie evitate (1497)\*\The process of healing, scarring and remodeling of MI may be negatively influenced by certain categories
of drugs to be avoided
A) [ ]Betablocantele neselective\*\non-selective beta blockers
B) [ ]Blocantii receptorilor angiotensinei II\*\angiotensin II receptor Blockers
C) [x]Glucocorticoizii\*\: Glucocorticoids
D) [ ]Trimetazidina\*\Trimetazidine
E) [x]Antiinflamatoarele nesteroidiene\*\NSAIDs
---------------------------------------------------------------------
190. CM p5 [M2240148] Urmatoarele afirmatii privind procedeul de revascularizatie prin by-pass coronarian sunt adevarate:
(1515)\*\The following statements on the process of revascularization by coronary bypass surgery are true:
A) [x]mortalitatea intra si postoperatorie creste odata cu gradul disfunctiei ventriculare stangi\*\intra-and postoperative mortality
increases with the degree of left ventricular dysfunction
B) [ ]rata de mortalitate este de 20% cand procedeul se aplica corect, la pacienti fara boli severe asociate si cu functie ventriculara
stanga normala\*\The mortality rate is 20% when the process is correctly applied to patients without severe disease associated
with normal left ventricular function
C) [x]pe termen lung patenta este considerabil mai mare in cazul anastomozelor cu artera mamara interna\*\: long term patency
is significantly higher in cases with anastomosis in internal mammary artery
D) [ ]pe termen lung patenta e considerabil mai mare in cazul grefoanelor venoase\*\long-term patency is significantly higher in venous
bypass
E) [x]procedeul nu pare sa scada incidenta infarcului miocardic la pacientii cu cardiopatie ischemica cronica\*\: The process
seems to decrease the incidence of infarction in patients with chronic coronary heart
---------------------------------------------------------------------
191. CM p5 Controlul durerii din infarctul miocardic acut se realizeaza cu: (1496)\*\pain in myocardial infarction is controlled by
A) [x]morfina\*\morphine
B) [x]nitroglicerina\*\nitroglycerin
C) [x]betablocante\*\beta blockers
D) [ ]xilina\*\lidocaine
E) [ ]chinidina\*\quinidine
---------------------------------------------------------------------
192. CM p5 [M2207136] Indicati care din urmatoarele afirmatii legate de durerea din infarctul miocardic sunt adevarate:
(1493)\*\Indicate which of the following statements about the pain of myocardial infarction are true:
A) [x]Durerea se poate localiza in mandibula, spate, git\*\The pain is located in the lower jaw, back, neck
B) [x]Se insoteste adesea de anxietate si senzatia de moarte eminenta\*\Anxiety often accompanies the feeling of death and eminent
C) [ ]Poate iradia inferior de ombilic creind probleme de diagnostic diferential\*\Can radiate lower tummy creating problems of
differential diagnosis
D) [ ]Disconfortul poate debuta numai effort\*\The discomfort may begin only by effort
E) [ ]Atunci cind durerea incepe in timpul unui efort, ea se atenueaza progresiv la incetarea activitatii\*\When the pain begins
during an exercise, it gradually attenuates the demise of activity
---------------------------------------------------------------------
193. CM p5 Angina pectorala instabila cuprinde urmatoarele situatii: (1515-16)\*\unstable angina include the following situations:
A) [x]angina cu debut recent (<2 luni) care este severa si frecventa (mai mult de 3 episoade pe zi)\*\recent onset angina (<2
months) which is severe and frequent (more than three episodes per day)
B) [x]angina stabila cronica la care crizele anginoase devin mai frecvente, mai prelungite sau precipitate de eforturi mai mici
decat anterior\*\chronic stable angina that angina attacks become more frequent, prolonged or precipitated by less effort than before
C) [x]angina de repaus\*\rest angina
D) [ ]angina cu prag fix de aparitie a durerii dupa un anumit efort\*\fixed threshold for developing angina pain after an effort
E) [x]angina varianta Prinzmetal\*\"Prinzmetal" variant angina

27
194. CM p5 Antagonistii canalelor de calciu sunt indicati la pacientii cu: (1514)\*\calcium channel antagonists are indicated in
patients with
A) [x]angina si istoric de astm sau boala cronica obstructiva pulmonara\*\angina and a history of asthma or chronic obstructive
pulmonary disease
B) [x]sindromul sinusului bolnav sau afectare importanta a conducerii atrio-ventriculare\*\sick sinus syndrome or significant
impairment of atrio-ventricular management
C) [ ]edeme la membrele inferioare\*\swelling in the legs
D) [x]angina Prinzmetal\*\Prinzmetal angina
E) [x]boala vasculara periferica simptomatica\*\Symptomatic peripheral vascular disease
---------------------------------------------------------------------
195. CM p5 Urmatoarele afirmatii referitoare la PTCA sunt adevarate: (1514)\*\The following statements are true for PTCA
A) [ ]amelioreaza simptomele si imbunatateste supravietuirea\*\relieves symptoms and improves survival
B) [x]restenozarea apare la 30-45% din cazuri in primele 6 luin\*\restenozarea occurs in 30-45% of cases in the first six months
C) [x]este mai eficace in ameliorarea simptomelor decat tratamentul medicamentos\*\is more effective in relieving symptoms
than medical treatment
D) [ ]nu poate fi aplicata pentru dilatarea grefelor de by-pass stenozate\*\cannot be applied to dilate stenosed bypass grafts
E) [x]utilizarea unui stent metalic scade rata restenozarii\*\use of a metal stent reduced the restenosis rate
---------------------------------------------------------------------
196. CM p5 Care din afirmatiile privitoare la ECG si testul de efort in cardiopatia ischemica sunt adevarate: (1509)\*\Which of
the statements relating to the ECG and stress test in ischemic cardiomyopathy are true:
A) [ ]ECG de repaus este normal la aproximativ o treime din pacientii cu angina tipica\*\resting ECG is normal in about one third
of patients with typical angina
B) [ ]Modificarile ECG cele mai caracteristice pentru cardiopatia ischemica sunt undele T inalte si simetrice\*\ECG changes most
characteristic of ischemic cardiomyopathy are tall and symmetrical T waves
C) [ ]Sensibilitatea testului de efort este de 90%\*\: sensitivity to stress test is 90%
D) [x]Subdenivelarea ST > 0,1 mV si cu durata mai mare de 0,08 s la testul de efort este considerata de natura
ischemica\*\depression ST> 0.1 mV and duration was greater than 0.08 is considered effort to test the nature of the ischemia
E) [x]Testul de efort limitat de frecventa cardiaca poate fi practicat la 7 zile dupa un infarct miocardic\*\limited stress test heart
rate may be charged at 7 days after myocardial infarction
---------------------------------------------------------------------
197. CM p5 [M1440115] Mortalitatea intra si postoperatorie in cazul bypass-ului aortocoronarian este crescuta la: (1515)\*\ Intra-
and postoperative mortality in aorto coronarian bypass is increased in:
A) [x]pacientii cu asocieri morbide\*\patients with morbid associations
B) [x]pacientii peste 80 de ani\*\patients over 80 years
C) [ ]pacientii cu disfunctie ventriculara usoara\*\patients with mild ventricular dysfunction
D) [ ]pacientii de sex feminin\*\female patients
E) [ ]pacientii cu hipercolesterolemie\*\patients with hypercholesterolemia
---------------------------------------------------------------------
198. CM p5 Factorii de risc pentru aparitia socului cardiogen in IMA includ: (1501)\*\Risk factors for cardiogenic shock in AMI include:
A) [x]varsta inaintata\*\age
B) [x]fractia de ejectie ventriculara scazuta\*\lower ventricular ejection fraction
C) [x]infarct miocardic in antecedente\*\previous myocardial infarction
D) [x]diabet zaharat asociat\*\associated Diabetes mellitus
E) [ ]asocierea unei pericardite\*\association with pericarditis
---------------------------------------------------------------------
199. CM p5 Urmatoarele investigatii referitoare la testele de investigatie ale anginei pectorale sunt false: (1509/1510)\*\The
following investigations on the investigation of angina tests are false:
A) [x]ecocardiografia de stres este mai putin sensibila decat electrocardiograma de stres in diagnosticul cardiopatiei
ischemice\*\Stress echocardiography is less sensitive than stress electrocardiography in diagnosing coronary heart disease
B) [x]o electrocardiograma de efort negativa exclude boala coronariana trivasculara\*\a negative exercise electrocardiogram
exclude trivascular coronary artery disease
C) [x]testul cu dipiridamol se indica la pacientii cu test de efort negativ\*\dipyridamole test is indicated in patients with negative
exercise test
D) [ ]angiografia radioizotopica de stres poate vizualiza regiunile de a/diskinezie ale ventriculului stang care nu sunt prezente in
repaus\*\stress radioisotope angiography can visualize regions of dyskinesia of the left ventricle that are not present at rest
E) [ ]angiografia coronariana permite aprecierea severitatii leziunii obstructive coronariene\*\Coronary angiography allows
assessment of obstructive coronary lesion severity
---------------------------------------------------------------------
200. CM p5 Care afirmatii sunt adevarate legate se ischemia silentioasa (IS)? (1517)\*\Which statements are true about the silent
ischemia (SI)?
A) [x]aspirina administrata cronic in ischemia asimptomatica dupa infarct miocardic scade numarul evenimentelor
coronariene\*\Aspirin administered in chronic asymptomatic ischemia after myocardial infarction decreases the number of
coronary events

28
B) [x]tratamentul cu antagonisti ai canalelor de calciu scade incidenta IS\*\treatment with calcium channel antagonists decrease
the incidence of IS
C) [ ]betablocantele scad incidenta IS dupa infarctul miocardic, dar nu amelioreaza supravietuirea\*\beta blockers after
myocardial infarction decreases the incidence of IS, but does not improve survival rate
D) [x]nitratii cu actiune prelungita scad incidenta IS\*\nitrates with prolonged action lower the incidence of IS
E) [x]in IS si boala coronariana trivasculara este indicata revascularizatia chirurgicala\*\In IS and coronary heart disease surgical
revascularization is indicated trivasculara
---------------------------------------------------------------------
201. CM p5 [M1407109] La pacientii cu infarct de ventricul drept (1502)\*\In patients with right ventricular infarction
A) [x]clinic poate aparea semnul KUSSMAUL\*\Clinical signs of Kussmaul can appear
B) [ ]EKG arata frecvent in primele 12 ore subdenivelare ST in precordialele drepte\*\frequently shows ST depression in right
precordial lead in the first 12 hours
C) [x]Ecocardiografia bidimensionala este utila in stabilirea gradului de disfunctie ventriculara dreapta\*\two-dimensional
echocardiography is useful in determining the extent of right ventricular dysfunction
D) [ ]Expansiunea volemica cu mentinerea presarcinii VD este contraindicata\*\volemic expansion to maintain RV preload is
contraindicated
E) [x]Cateterismul VD evidentiaza un model hemodinamic asemanator cu pericardita constrictiva\*\VD catheterization reveals a
pattern similar to constrictive hemodynamic pericarditis
---------------------------------------------------------------------
202. CM p5 La ce categorii de bolnavi cu infarct miocardic acut ar trebui rezervat tratamentul profilactic de rutina cu antiaritmice
(1503-1504)\*\What categories of patients with acute myocardial infarction should be reserved for routine prophylaxis with antiarrhythmics
A) [x]Pentru bolnavii care nu pot ajunge la spital\*\For patients who can not reach hospital
B) [x]Pentru cei tratati in spitale in care nu se asigura prezenta constanta in unitatea de ingrijire a coronarienilor a unui medic sau
a unei asistente antrenate in recunosterea si tratamentul fibrilatiei ventriculare\*\For those treated in hospitals that do not ensure
constant presence in the coronary care unit of a doctor or a nurse trained in recognizing and treating ventricular fibrillation
C) [ ]La toti bolnavii cu infarct miocardic\*\In all patients with myocardial infarction
D) [x]Tahiaritmii ventriculare importante clinic\*\clinically significant ventricular tachyarrhythmias
E) [ ]La cei care au avut un ritm idioventricular accelerat pentru ca el este repetitiv si degenereaza frecvent intro aritmie mai
severa\*\Those who had accelerated idioventricular rhythm as it is repetitive and often degenerates more severe arrhythmia
---------------------------------------------------------------------
203. CM p5 Rar, infarctul miocardic se produce prin ocluzia arterei coronare secundar: (1493)\*\Rarely, myocardial infarction
occurs in secondary coronary artery occlusion
A) [x]emboliilor coronariene\*\coronary embolism
B) [x]spasmului coronarian\*\coronary spasm
C) [x]anomalii congenitale coronariene\*\congenital coronary abnormalities
D) [ ]ruptura si trombozarea placii de aterom\*\: rupture and thrombosed aterotic plaque buildup
E) [x]vasculitelor inflamatorii din boli sistemice\*\: vasculitis systemic inflammatory diseases
---------------------------------------------------------------------
204. CM p5 Diltiazemul si verapamilul ca si medicamente utilizate in tratamentul anginei pectorale pot avea urmatoarele reactii
adverse: (1512-13)\*\Diltiazem and verapamil as drugs used to treat angina may have the following side effects:
A) [ ]edem\*\edema
B) [ ]artimii supraventriculare\*\supraventricular arythmia
C) [x]blocuri atrio-ventriculare\*\atrioventricular block
D) [x]agravarea insuficientei cardiace\*\worsening heart insufficiency
E) [ ]bronhospasm\*\bronchospasm
---------------------------------------------------------------------
205. CM p5 [M2207145] Indicati care din urmatoarele afirmatii legate de izoenzima MB a creatinfosfokinazei sunt adevarate:
(1494)\*\Indicate which of the following statements related to the MB isoenzyme of creatine are true:
A) [x] Nu este prezenta in concentratii semnificative in tesutul extracardiac\*\It is not present in significant concentrations in
extracardiac tissue
B) [x]Un nivel CK-MB: activitate CK > sau = cu 2,5 % sugereaza mai de graba sursa miocardica a cresterii CKMB\*\A high
CK-MB: CK activity> or = 2.5% suggests rather the source of increased myocardial CKMB
C) [ ]Raportul CK-MB:activitate CK este mai ales util cind nivelul total al CK este crescut datorita unei injurii musculare
scheletice\*\Report of CK-MB: CK activity is especially useful when the total level of CK is increased due to skeletal muscle
injury
D) [ ] Raportul CK-MB:activitate CK este mai ales util cind nivelul total al CK este in limite normale dar CK-MB este
crescut\*\Ratio of CK-MB: CK activity is especially useful when the total CK level is normal but CK-MB ratio is increased
E) [ ]Eliberarea CK-MB in infarctul miocardic produce in mod tipic un model in ''platou''\*\CK release in myocardial infarction
typically produces a pattern in the "plateau"
---------------------------------------------------------------------
206. CM p5 [M1540119] Durerea anginoasa in absenta bolii coronariene poate aparea in urmatoarele situatii: (1509)\*\anginal
pain may occur in the absence of coronary disease in the following situations:
A) [ ]insuficienta mitrala\*\mitral insufficiency

29
B) [x]stenoza aortica\*\aortic stenosis
C) [x]insuficienta aortica\*\aortic insufficiency
D) [x]cardiomiopatia hipertrofica\*\: Hypertrophic cardiomyopathy
E) [ ]defectul septal interatrial\*\intratrial septal defect
---------------------------------------------------------------------
207. CM p5 [M2207179] Ce elemente pot fi gasite la un bolnav cu ruptura de perete liber ventricular: (pag. 1503)\*\what items
can be found in a patient with ventricular wall rupture:
A) [x]Disparitia brusca a pulsului\*\The sudden disappearance of the pulse
B) [ ]Puls paradoxal\*\Pulse paradoxical
C) [x]Disparitia presiunii sanghine\*\Disappearance of blood pressure
D) [x]Pierderea constientei\*\Loss of consciousness
E) [x]Disociatie electromecanica aparenta\*\electromechanical dissociation
---------------------------------------------------------------------
208. CM p5 La un bolnav cu infarct miocardic indicati care din urmatoarele efecte sub atribuite betablocantului intravenos
urmat de administrarea orala in era pretrombolitica: (1500)\*\A patient with myocardial infarction, indicate which of these effects
under beta blockers given intravenous followed by oral administration are attributed to pretrombolisis:
A) [x]Reducerea ischemiei recurente\*\Reduction of recurrent ischemia
B) [x]Reducerea reinfarctizarilor\*\Reduced rate of reinfarction
C) [ ]Reducerea relativa cu 25% a mortalitatii\*\25% relative reduction in mortality
D) [x]Reducerea reinfarctizarilor fatale\*\Reduction of fatal reinfarction
E) [x]Reducerea stopului cardiac nefatal\*\Reduced nonfetal cardiac arrest
---------------------------------------------------------------------
209. CM p5 [M2307217] Betablocantele sunt contraindicate in infarctul miocardic acut in urmatoarele situatii: (1188)
\*\betablockers are contraindicated in acute myocardial infarction in the following situations:
A) [x]bloc atrioventricular\*\AV block
B) [ ]hipertensiune arteriala\*\hypertension
C) [x]hipotensiune arteriala\*\hypotension
D) [x]bradicardie\*\bradycardia
E) [x]insuficienta cardiaca congestiva severa\*\severe congestive heart failure
---------------------------------------------------------------------
210. CM p5 Urmatoarele afirmatii referitoare la angina pectorala stabila nu sunt adevarate: (1508) \*\The following allegations
are not true about stable angina:
A) [ ]este tipic localizata retrosternal\*\It is typically located retrosternal
B) [x]poate aparea si in repaus sau noaptea\*\can occur at rest or at night
C) [x]cel mai frecvent are caracterul unei dureri toracice ascutite\*\most frequently has the character of a sharp chest pain
D) [ ]dureaza de regula 1-5 minute\*\usually lasts 1-5 minutes
E) [ ]poate iradia spre spate, gat, maxilar, dinti si epigastru\*\can radiate to the back, neck, jaw, teeth, and epigastrium
---------------------------------------------------------------------
211. CS p4 [M1109005] Diureticele tiazidice dau ca reactii secundare frecvente urmatoarele modificari biochimice cu o exceptie:
(pag. 1531)\*\thiazide diuretics give secondary reactions frequently in these biochemical changes with an exception:
A) [ ]Hipopotasemie\*\Hypokalaemia
B) [ ]Hiperuricemie\*\hyperuricemia
C) [ ]Hiperglicemie\*\Hyperglycemia
D) [ ]Hipercolesterolemie\*\hypercholesterolemia
E) [x]Hipocalcemie\*\Hypocalcemia
---------------------------------------------------------------------
212. CS p4 [M2209038] La care din urmatoarele diuretice se noteaza ca efect secundar ginecomastia: (1531)\*\which of the
following diuretics is observed as side effects in gynecomastia:
A) [ ]Tiazidice\*\Thiazide
B) [ ]Furosemid\*\Furosemide
C) [x]Spironolactona\*\Spironolactone
D) [ ]Triamteren\*\triamterene
E) [ ]Amilorid\*\amiloride
---------------------------------------------------------------------
213. CS p4 Care din urmatoarele antihipertensive reprezinta o alternativa la pacientele cu eclampsie care nu raspund la
hidralazina: (1537)\*\Which of the following antihypertensive presents an alternative to patients with eclampsia who do not
respond to hydralazine:
A) [x]Labetabolul\*\Labetabol
B) [ ]Losartan\*\Losartan
C) [ ]Captopril\*\captopril
D) [ ]Enalapril\*\Enalapril
E) [ ]Lisinopril\*\Lisinopril
---------------------------------------------------------------------

30
214. CS p4 [M1109004] Care dintre urmatorii factori de risc nu indica un prognostic nefavorabil al hipertensiunii:
(1526)\*\Which of the following risk factors does not indicate an unfavorable prognosis of hypertension.
A) [x]Sexul feminin\*\female
B) [ ]Fumatul\*\smoking
C) [ ]Diabetul zaharat\*\Diabetes mellitus
D) [ ]Consumul exagerat de alcool\*\excess alcohol intake
E) [ ]Varsta tanara\*\early age
---------------------------------------------------------------------
215. CS p4 [M1409021] Rezultatul final al defectului de membrana celulara responsabila de cresterea reactivitatii vasculare in
HTA este (1525)\*\The final result of cellular membrane defect responsible for increased vascular reactivity in hypertension is:
A) [ ]cresterea intracelulara a concentratiei ionului de sodiu\*\: increased intracellular sodium ion concentration
B) [ ]cresterea intracelulara a concentratiei ionului de potasiu\*\increased intracellular potassium ion concentration
C) [ ]cresterea intracelulara a concentratiei ionului de clor\*\increased intracellular chloride ion concentration
D) [x]cresterea intracelulara a concentratiei ionului de calciu\*\increased intracellular calcium ion concentration
E) [ ]cresterea intracelulara a concentratiei ionului de magneziu\*\increased intracellular magnesium ion concentration
---------------------------------------------------------------------
216. CS p4 [M2609074] Referitor la tratamentul crizei hipertensive din feocromocitom sunt reale afirmatiile:(1538)\*\Regarding
the treatment of hypertensive crisis in pheochromocytoma; which statements are true? :
A) [ ]medicamentul de electie este furosemidul\*\The drug of choice is furosemide
B) [ ]medicamentul de electie este metoprololul administrat intravenos\*\The drug of choice is intravenous metoprolol
C) [ ]medicamentul de electie este nitroglicerina\*\drug of choice is nitroglycerin
D) [x]medicamentul de electie este fentolamina (Regitina)\*\drug of choice is phentolamine (Regitina
E) [ ]medicamentul de electie este enalaprilul administrat intravenos\*\enalapril drug of choice is intravenous
---------------------------------------------------------------------
217. CS p4 [M2509065] Care reactie adversa este caracteristica administrarii de inhibitori ai enzimei de conversie a
angiotensinei: (pag. 1532)\*\What adverse reaction is characteristic to the administration of ACE inhibitors:
A) [ ]cefaleea\*\headache
B) [x]tusea\*\cough
C) [ ]tahicardia\*\tachycardia
D) [ ]insuficienta cardiaca\*\: heart failure
E) [ ]hiperglicemia\*\hyperglycaemia
---------------------------------------------------------------------
218. CS p4 [M1609033] Pentru hipertensiunea maligna sunt caracteristice urmatoarele cu EXCEPTIA: (pag. 1537)\*\for
malignant hypertension, the following characteristics are, with exception of:
A) [ ]edem papilar\*\papilloedema
B) [ ]cecitate tranzitorie\*\transient blindness
C) [x]disurie\*\dysuria
D) [ ]paralizii tranzitorii\*\transient paralysis
E) [ ]insuficienta cardiaca\*\heart failure
---------------------------------------------------------------------
219. CM p5 Despre antagonistii receptorilor de angiotensina II urmatoarele afirmatii sunt false, cu EXCEPTIA (1534)\*\About
the angiotensin II receptor antagonists, these statements are false except,
A) [ ]sunt mai eficienti decat IECA\*\ACE inhibitors are more effective than
B) [x]nu cauzeaza tuse\*\do not cause cough
C) [x]inhiba competitiv subtipul de receptor AT1 al angiotensinei II\*\angiotensin-1 inhibits competitively than angiotensin II
D) [ ]cauzeaza mai frecvent angioedem\*\more common causes of angioedema
E) [x]utilitatea este similara cu a IECA\*\The utility is similar to ACE-i
---------------------------------------------------------------------
220. CM p5 [M2209160] Indicati ce afirmatii legate de utilizarea diureticelor in hipertensiunea arterial sunt adevarate: (pag.
1530)\*\Indicate which statements are true relating to the use of diuretics in hypertension
A) [x]Diureticele tiazidice sunt deobicei eficiente in 3-4 zile \*\: thiazide diuretics are usually effective in 3-4 days
B) [x]S-a dovedit pe termen lung ca diureticele tiazice reduc mortalitatea si morbiditatea\*\: It is proved that diuretics reduce the
rates of mortality and morbidity
C) [ ]Diureticele de ansa sunt utilizate datorita duratei lor lungi de actiune\*\Loop diuretics are used because of their long action
D) [x]Spironolactona se dovedeste eficienta in hiperaldosteronismul primar sau secundar\*\Spironolactone is proving effective in
hyperaldosteronism in primary or secondary hypertension
E) [ ]Triamterenul are efect antihipertensiv intrinsec puternic\*\triamterene has intrinsically strong antihypertensive effect
---------------------------------------------------------------------
221. CM p5 [M2309204] Cele mai frecvente efecte secundare ale inhibitorilor enzimei de conversie a angiotensinei sunt: (pag.
1532)\*\The most frequent side effects of angiotensin converting enzyme inhibitors (ACE - i) are:
A) [x]hipotensiune\*\hypotension
B) [ ]tahicardie\*\Tachycardia
C) [x]tuse\*\Cough

31
D) [ ]bradicardie\*\bradycardia
E) [ ]diaree\*\diarrhea
---------------------------------------------------------------------
222. CM p5 [M2809253] Labetalolul este util in HTA maligna in (pag. 1537)\*\labetalolul is usefull in malign HTA in
A) [x]infarctul miocardic\*\miocardic infarct
B) [x]angina pectorala\*\chest pain
C) [x]eclampsia fara raspuns la hidralazina\*\ eclampsy without answer at hidralazina
D) [ ]cazurile tratate anterior cu beta-blocante\*\ cases that were treated previously with beta blockers
E) [ ]astmul bronsic\*\asthma
---------------------------------------------------------------------
223. CM p5 [M2609232] Referitor la diagnosticul hipertensiunii arteriale secundare sunt corecte urmatoarele afectiuni: (pag.
1528-1529)\*\for secondary hypertension, diagnosis is correct in the following conditions:
A) [ ]Metoda de diagnostic de electie a hipertensiunii renovasculare este dozarea metabolitilor catecolaminelor din urina de
24h\*\method of choice for diagnosis of renovascular hypertension is the determination of catecholamine metabolites in urine by 24 hours
B) [ ]Supresia nivelului cortizolului plasmatic sub 140nmol/l (5microg/dl) confirmasindromul Cushing\*\suppression in plasma
cortisol levels 140nmol / L (5microg/dl) confirming Cushing syndrome
C) [x]Aspect sugestive de ischemie renalala uiv: intarzierea unilateralaa aparitiei si excretiei substantei de contrast\*\Appearance
is suggestive of renal ischemia: delayed unilateral appearance and excretion of contrast substance
D) [x]In feocromocitom metodade diagnostic util este dozarea nivelului plasmatic de catecolamine\*\method pheochromocytoma
diagnosis is useful for determination of plasma catecholamines levels
E) [ ]Hiperkalemia este caracteristica hiperaldosteronismului primar\*\hyperkalaemia is characteristic of primary aldosteronism
---------------------------------------------------------------------
224. CM p5 [M2209185] Care sunt obiectivele tratamentului la pacient cu hipertensiune maligna: (pag. 1537)\*\What are the
objectives in patient treated for malignant hypertension:
A) [x]Corectarea complicatiilor medicale\*\Correction of medical complications
B) [ ]Scaderea presiunii diastolice cu o treime\*\diastolic pressure drop by third
C) [x]Scaderea presiunii diastolice cu o treime, dar nu sub 95mm Hg\*\diastolic blood pressure decreases by one third, but not
less than 95mmHg
D) [ ]Scaderea presiunii diastolice la 80 mm Hg\*\decrease to 80mmHg diastolic pressure
E) [ ]Scaderea presiunii diastolice la 90 mm Hg\*\decrease to 90mmHg diastolic pressure
---------------------------------------------------------------------
225. CM p5 [M2509222] Medicamentele din urmatoarele grupe pot fi utilizate ca prima linie terapeutica in tratamentul
hipertensiunii arteriale: (pag. 1535)\*\Agents of these groups can be used as first line therapy in hypertension treatment
A) [x]diureticele\*\diuretics
B) [ ]vasodilatatoarele periferice\*\peripheral vasodilatators
C) [x]beta-blocantele\*\Beta-blockers
D) [x]inhibitorii enzimei de conversie\*\ACE inhibitors
E) [x]antagonistii canalelor de calciu\*\Calcium channel antagonists
---------------------------------------------------------------------
226. CM p5 Indicati medicamentele ce incetinesc conducerea atrioventriculara (1534)\*\indicate medicines that slow drive
atrioventricular:
A) [ ]Nifedipina\*\Nifedipine
B) [ ]Amlodipina\*\Amlodipine
C) [ ]Felodipina\*\felodipine
D) [x]Verapamil\*\Verapamil
E) [x]Diltiazem\*\Diltiazem
---------------------------------------------------------------------
227. CM p5 [M2209166] Care din urmatoarele antihipertensive sunt indicate in feocromocitomul dovedit: (pag. 1531)\*\Which of
the following antihypertensive drugs are shown in proven pheochromocytoma :
A) [x]Fentolamina\*\phentolamine
B) [x]Fenoxibenzamina\*\Phenoxybenzamine
C) [ ]Rezerpina\*\Rezerpine
D) [ ]Guanetidina\*\: guanethidine
E) [ ]Metildopa\*\methyldopa
---------------------------------------------------------------------
228. CM p5 [M2709248] In urma efetuarii urografiei iv cu secventa rapida minutata urmatoarele aspecte pot fi sugestive pentru o
hipertensiune renovasculara: (pag. 1528)\*\ following the urografy IV with rapid secvention, the aspects could be sugestive for
renovascular hypertension
A) [x]Conturul neregulat al siluetei renale\*\irregular kidney form
B) [x]Intarzierea unilaterala a aparitiei si excretiei substantei de contrast\*\unilateral delay of apperence and excretion of the
substance of contrast
C) [x]Hiperconcentrarea substantei de contrast in sistemul colector al rinichiului mai mic\*\smaller hyperconcentartion of the
substance in the collector system of the kidney

32
D) [ ]Hiperconcentrarea substantei de contrast in sistemul colector al rinichiului mai mare\*\bigger hyperconcentration of the
substance in the collector system of the kidney
E) [ ]Hipoconcentrarea substantei de contrast in sistemul colector al rinichiului mai mic\*\smaller hypoconcentration of the
substance in the collector system of the kidney
---------------------------------------------------------------------
229. CM p5 [M1309102] Notati obiectivele initiale ale tratamentului in hipertensiunea arteriala maligna: (pag. 1537)\*\Note the
original goals in the treatment of malignant hypertension
A) [ ]reducerea aportului de sare\*\reducing salt intake
B) [x]corectarea complicatiilor medicale\*\correction of medical complications
C) [x]reducerea presiunii diastolice cu 1/3 dar nu sub 95mmHg\*\diastolic blood pressure reduction by one third but less than 95 mmHg
D) [ ]reducerea drastica a tensiunii arteriale\*\: a drastic reduction in blood pressure
E) [ ]aport suplimentar de K\*\additional contribution of K
---------------------------------------------------------------------
230. CM p5 [M2309203] Metoprololul este contraindicat in: (pag. 1532)\*\metoprolol is contraindicated in:
A) [ ]angina pectorala\*\: angina pectoris
B) [x]astmul bronsic\*\asthma
C) [x]sindrom de sinus bolnav\*\: sick sinus syndrome
D) [ ]hipertensiune usoara\*\mild hypertension
E) [ ]hiperuricemie\*\hyperuricemia
---------------------------------------------------------------------
231. CM p5 Pacienta gravida si hipertensiva va fi tratata cu: (1536)\*\A hypertensive pregnant patient can be treated with
A) [ ]Tiazide\*\Thiazides
B) [x]Metildopa\*\methyldopa
C) [ ]Betablocante\*\beta blockers
D) [x]Hidralazina\*\Hidralazina
E) [ ]blocante de receptori de angiotensina\*\angiotensin receptor blockers
---------------------------------------------------------------------
232. CM p5 Nitroglicerina este utila in tratamentul hipertensiunii arteriale: (1537)\*\ nitroglycerin is usefull in hypertension treatment
A) [ ]asociata cu accident vascular cerebral acut\*\associated with acute stroke
B) [x]dupa chirurgia de by-pass aortocoronarian\*\ after aortocoronarian bypass surgery
C) [x]asociata cu infarct miocardic\*\ associated with miocardic infarct
D) [x]cu angina pectorala instabila\*\ with unstable chest pain
E) [x]cu insuficienta ventriculara stanga\*\ with left ventricular defficency
---------------------------------------------------------------------
233. CM p5 Obiectivele initiale ale tratamentului hipertensiunii arteriale maligne sunt: (1537)\*\innitial onjectives of treatment in
malign hypertension are
A) [ ]Reducerea presiunii diastolice cu o treime,dar nu sub 75mm Hg\*\lowering the diastolic blood pressure with a third, but not
under 75 mmHg
B) [x]corectarea complicatiilor medicale\*\correction of medical complication*\
C) [ ]reducerea presiunii diastolice sub 95 mm Hg\*\ reducing the diastoli blood pressure under 95 mmHg
D) [x]reducerea presiunii diastolice cu o treime, dar nu sub 95mm Hg\*\reducing the diastolic blood pressure wit ha third. but not under
95 mmHg
E) [ ]reducerea presiunii diastolice sub 85 mm Hg\*\reducing diastolic blood pressure under 85 mmHg
---------------------------------------------------------------------
234. CM p5 Care din urmatoarele teste sunt utile pentru evaluarea HTA secundare din sindromul Cushing: (1528) \*\Which of
these tests are useful for secondary HTA evaluation from Cushing's syndrome:
A) [ ]Determinarea metanefrinelor urinare/24h\*\Determination metanefrinelor urinary/24h
B) [ ]Determinarea catecolaminelor urinare/24h\*\Determination of catecholamines urinare/24h
C) [x]Testul de supresie nocturna cu dexametazona (dozarea matinala a cortizolului plasmatic dupa administrarea a 1 mg
dexametazona seara precedenta)\*\Night suppression test of dexamethasone (determination of morning plasma cortisol after
administration of 1 mg dexamethasone in the previous evening)
D) [ ]Determinarea catecolaminelor plasmatice\*\Determination of plasma catecholamine
E) [x]Determinarea cortizolului in urina/24h\*\Determination of cortisol in urine/24h
---------------------------------------------------------------------
235. CM p5 [Caffee10] Metildopa: (pg.1531)\*\metildopa
A) [x]blocheaza nervii simpatici si centrul vaso-motor\*\blocks sympatetic nerves and vaso-motor center
B) [ ]se administreaza 1500 mg i.v.\*\administration 1500 mg IV
C) [ ]scade lent tensiunea arteriala moderata si severa\*\lowers progressively blood pressure that is moderate or severe
D) [ ]e contraindicata in feocromocitom si boala renala asociata cu hipertensiunea\*\its conterindicated in feocromocitom and
renal desease associated with hypertension
E) [x]determina hipotensiune posturala si sdr.''lupus-like''\*\it causes hypotension and lupus like sindrome
---------------------------------------------------------------------
236. CM p5 Care din urmatorii factori de risc indica un prognostic nefavorabil al hipertensiunii? (1526)\*\Which of the following

33
risk factors indicate an unfavorable prognosis of hypertension?
A) [ ]rasa alba\*\The white race
B) [x]sexul masculin\*\male sex
C) [ ]presiunea sistolica persistenta >160 mmhg\*\persistent systolic blood pressure >160 mmHg
D) [x]diabetul zaharat\*\diabetes
E) [ ]hiperuricemia\*\hyperuricemia
---------------------------------------------------------------------
237. CM p5 [M2209147] Care sunt complicatiile acromegaliei: (pag. 1527)\*\What are the complications of acromegaly
A) [x]Hipertensiunea\*\Hypertension
B) [x]Ateroscleroza coronariana\*\Coronary Atherosclerosis
C) [x]Hipertrofia cardiaca\*\: cardiac hypertrophy
D) [ ]Dilatatia cardiaca\*\cardiac dilatation
E) [ ]Tulburari de conducere\*\conduction disturbances
---------------------------------------------------------------------
238. CM p5 [M2209192] Indicati la ce categorie de bolnavi hipertensivi va fi evitatata hidralazina: (pag. 1537)\*\Indicate what
category of hypertensive patients will hydralazine be used:
A) [x]Cu ischemie miocardica\*\The myocardial ischemia
B) [x]Cu disectie de aorta\*\The dissection of the aorta
C) [ ]Cu preeclamsie\*\: with preeclampsia
D) [ ]Cu hipertensiune maligna\*\Malignant hypertension
E) [ ]Cu boala renala\*\The kidney disease
---------------------------------------------------------------------
239. CM p5 [M1509120] Care dintre urmatoarele clase de medicamente sunt folosite in tratamentul hipertensiunii arteriale: (pag.
1530-34)\*\Which of the following classes of drugs are used in treating hypertension,
A) [x]diureticele\*\diuretics
B) [ ]tonicardiacele digitalice\*\tonicardiac digitalis
C) [x]inhibitorii enzimei de conversie\*\ACE inhibitors
D) [x]antagonistii receptorilor angiotensinei\*\angiotensin receptor antagonists
E) [x]antagonistii canalelor de calciu\*\Calcium channel antagonists
---------------------------------------------------------------------
240. CM p5 [M1209093] Care din urmatoarele medicamente au o actiune imediata in tratamentul hipertensiunii maligne: (pag.
1534)\*\Which of these drugs have an immediate action in the treatment of malignant hypertension:
A) [ ]enalapril\*\Enalapril
B) [x]nitroprusiat\*\nitroprusside
C) [x]diazoxid\*\diazoxide
D) [x]trimetafan\*\trimetafan
E) [ ]labetalol\*\labetalol
---------------------------------------------------------------------
241. CS p4 [M2810280] Care dintre urmatoarele efecte este caracteristic administrarii dobutaminei: (1430) \*\ Which of these
effects is characteristic of dobutamine administration (1430)
A) [ ] stimuleaza receptorii dopaminergici \*\ stimulated dopamine
B) [ ] efect cardioaccelerator puternic \*\ effect of strong cardioaccelerator
C) [ ] este utila in tratamentul hipotensiunii arteriale cu ICcongestiva \*\ is useful in treating hypotension with IC congestive
D) [ ] efect inotrop pozitiv slab \*\ weak positive inotropic effect
E) [x] tensiunea arteriala constanta \*\ constant blood pressure
---------------------------------------------------------------------
242. CS p4 [M1510026] La pacientii cu insuficienta ventriculara stanga severa cu evolutie indelungata, ortopneea si congestia
pulmonara pot diminua intr-una din situatiile urmatoare: (pag. 1423) \*\ To patients with severe left ventricular failure with long
evolution, ortopneea and may reduce lung congestion in one of the following: (p. 1423)
A) [ ] producerea unui infarct miocardic acut al ventriculului stang \*\ The production of left ventricular myocardial infarction
B) [ ] instalarea fibrilatiei atriale \*\ atrial fibrillation installation
C) [ ] cresterea brusca a tensiunii arteriale \*\ increased blood pressure
D) [x] aparitia insuficientei ventriculului drept \*\ the emergence of right ventricular failure
E) [ ] ruptura unui cordaj al valvei mitrale \*\ rupture of the mitral valve cordage
---------------------------------------------------------------------
243. CS p4 Digoxinemia recunoaste ca valori terapeutice obisnuite concentratiile de: (1429) \*\ Recognized values of
Digoxinemia used in usual therapeutic concentrations :
A) [ ] 2-4ng/ml \*\ 2-4ng/ml
B) [x] 1 -1,5 ng/ml \*\ 1 -1.5 ng/ml
C) [ ] 1 -1,5 mg/ml \*\ 1 -1.5 mg/ml
D) [ ] 2-4 mg/ml \*\ 2-4 mg/ml
E) [ ] sub 1 ng/ml \*\ less than 1 ng/ml
---------------------------------------------------------------------

34
244. CS p4 Semnele clinice relevante pentru IC includ urmatoarele, cu exceptia: (1423) \*\ The relevant clinical signs for HF
include the following, except:
A) [ ] Galopul protodiastolic (zgomot IV) \*\ gallop protodiastolic (noise IV)
B) [ ] Pulsul alternant \*\ alternating pulse
C) [x] Pulsul paradoxal \*\ paradoxical pulse
D) [ ] Distensia venelor jugulare \*\ jugular vein distension
E) [ ] Reflux hepato - jugular \*\ hepatic reflux - jugularr
---------------------------------------------------------------------
245. CS p4 Administrarea vasodilatatoarelor arteriale sistemice nu se recomanda in tratamentul urmatoarei forme de insuficienta
cardiaca: (1428) \*\ Systemic arterial vasodilatator administration is not recommended in the treatment of the following heart failure forms:
A) [ ] Cu disfunctie sistolica izolata a ventriculului stang \*\ The isolated systolic left ventricular dysfunction
B) [ ] Cu edeme si ascita \*\ The swelling and ascites
C) [ ] Cu disfunctie sistolica si diastolica a ventriculului stang \*\ systolic and diastolic dysfunction of left ventricle
D) [x] Cu disfunctie diastolica izolata a ventriculului stang \*\ The isolated left ventricular diastolic dysfunction
E) [ ] Cu leziuni de regurgitare mitrala sau aortica \*\ The mitral regurgitation or aortic lesions
---------------------------------------------------------------------
246. CS p4 Diureza persista in cazul folosirii diureticelor tiaziddice aproximativ:\*\ Diuresis persists about when using diuretics tiaziddice:
A) [ ] 4h \*\ 4h
B) [ ] 8h \*\ 4h
C) [ ] 10h \*\ 10h
D) [x] 12h \*\ 12h
E) [ ] 24h \*\ 24h
---------------------------------------------------------------------
247. CS p4 In care din urmatoarele cauze de insuficienta cardiaca vasodilatatoarele NU sunt utile terapeutic ? (pag. 1428) \*\
Which of these causes of vasodilation heart failure therapy is not useful?
A) [ ] Insuficienta aortica \*\ aortic insufficiency
B) [ ] Hipertensiune arteriala sistemica \*\ Systemic Hypertension
C) [x] Cardiomiopatia restrictiva \*\ restrictive cardiomyopathy
D) [ ] Infarctul miocardic \*\ Myocardial infarction
E) [ ] Rezistenta vasculara sistemica crescuta \*\ Systemic vascular resistance increased
---------------------------------------------------------------------
248. CS p4 [M1210008] La pacientii cu insuficienta cardiaca medicamentul de electie pentru fibrilatia atriala este reprezentat de:
(pag. 1430) \*\ In patients with heart failure, drug of choice for atrial fibrillation is the:
A) [ ] chinidina \*\ quinidine
B) [ ] procainamida \*\ procainamide
C) [ ] flecainida \*\ flecainida
D) [x] amiodarona \*\ amiodarone
E) [ ] xilina \*\ lidocaine
---------------------------------------------------------------------
249. CM p5 [M2210141] Insuficienta cardiaca este frecvent expresia unei tulburari de contractilitate miocardica (insuficienta
miocardica) si se instaleaza in urmatoarele afectiuni (pag. 1419) \*\ Heart failure is frequently an expression of myocardial
contractility disorders (myocardial insufficiency) and installs in these conditions
A) [ ] embolia pulmonara masiva \*\ massive pulmonary embolism
B) [x] miocarditele virale \*\ viral miocarditele
C) [ ] crizele hipertensive acute \*\ Acute hypertensive crises
D) [x] cardiomiopatii \*\ cardiomyopathy
E) [ ] ruptura unei cuspe aortice \*\ a cuspe aortic rupture
---------------------------------------------------------------------
250. CM p5 [M2210156] Insufieienta cardiaca poate fi precipitata la bolnavi cu afectiune cardiaca anterior compensata de catre:
(pag. 1420) \*\ Heart failure may be precipitated in patients with previous heart disease is offset by:
A) [x] mediul exagerat de calduros \*\ The overly warm environment
B) [x] cresterea brusca a valorilor tensiunii arteriale \*\ The sudden increase in blood pressure
C) [ ] atacul acut de artrita gutoasa \*\ acute attack of gouty arthritis
D) [x] bradiaritmiile severe \*\ severe bradiaritmiile
E) [ ] colica biliara \*\ biliary colic
---------------------------------------------------------------------
251. CM p5 [M2510231] In care din urmatoarele afectiuni se poate instala o insuficienta cardiaca acuta: (pag. 1421) \*\ Which of
these diseases can install an acute heart failure:
A) [ ] defectul septal interatrial \*\ interatrial septal defect
B) [x] ruptura unei valve cardiace \*\ rupture of cardiac valves \*\
C) [ ] cardiomiopatia dilatativa \*\ dilated cardiomyopathy
D) [x] infarctul miocardic acut intins \*\ large acute myocardial infarction
E) [ ] pericardita cronica constrictiva \*\ pericarditis cronical constrictiva

35
---------------------------------------------------------------------
252. CM p5 Dispneea paroxistica (nocturna) se caracterizeaza prin: (1423) \*\ Paroxysmal Dyspnea (nocturnal) N is characterized by:
A) [x] crize severe de dispnee persistenta in pozitie sezanda \*\ The crisis of severe persistent dyspnea seating
B) [ ] dispnee legata de decubit care dispare in pozitie sezanda \*\ dyspnoea related to lying to disappear seating
C) [x] tuse si wheezing persistente in pozitie sezanda \*\ persistent cough and wheezing seating
D) [ ] tuse nocturna in clinostatism ameliorata de pozitia sezanda \*\ nocturnal cough in the supine position and relieved by sitting
E) [x] stare de anxietate \*\ state of anxiety
---------------------------------------------------------------------
253. CM p5 Care din urmatoarele diuretice nu trebuiesc administrate singure la pacientii cu hiperkaliemie, insuficienta renala sau
hiponatremie: (1427) \*\ Which of the following diuretics should not be alone in patients with hyperkalaemia, renal failure or hyponatraemia:
A) [x] spironolactona \*\ spironolactone
B) [x] triamterenul \*\ triamterene
C) [x] amiloridul \*\ amiloride
D) [ ] furoseminul \*\ furoseminul
E) [ ] bumetanida \*\ bumetanida
---------------------------------------------------------------------
254. CM p5 Reactiile adverse ale diureticelor tiazidice sunt: (pag. 1426) \*\ The side effects of thiazide diuretics are:
A) [ ] acidoza metabolica \*\ metabolic acidosis
B) [x] hiperuricemia si hiperglicemia \*\ hyperuricemia and hyperglycemia
C) [x] rash-ul cutanat \*\ skin rash
D) [x] trombocitopenii si granulocitopenii \*\ thrombocytopenia and granulocitopenii
E) [ ] tusea \*\ cough
---------------------------------------------------------------------
255. CM p5 Redistribuirea debitului cardiac scazut ca mecanism compensator in insuficienta cardiaca asigura un aport de oxigen
normal sau aproape normal la urmatoarele organe: (1422) \*\ Redistribution of decreased cardiac output, as a compensatory
mechanism in heart failure provides oxygen intake, is normal or nearly normal in these organs:
A) [x] creier \*\ brain
B) [ ] viscere abdominale \*\ abdominal viscera
C) [x] miocard \*\ myocardium
D) [ ] musculatura scheletica \*\ scheletical muscular
E) [ ] tegument \*\ skin
---------------------------------------------------------------------
256. CM p5 [M2210150] Insuficienta cardiaca NU se defineste prin: (pag. 1419) \*\ Heart failure is defined by:
A) [ ] incapacitatea cordului de a pompa sangele intr-un ritm satisfacator necesitatilor tisulare \*\ The inability of the heart to
pump blood at a rate satisfactory tissue needs
B) [x] retentia anormala de sare si apa (starea congestiva) in care nu sunt tulburari ale functiei cardiace \*\ abnormal salt and
water retention (congestive state) that are not disorders of cardiac function
C) [x] existenta unui debit cardiac inadecvat de cauza noncardiaca \*\ the existence of an inadequate cardiac output due noncardiaca
D) [ ] capacitatea cordului insuficient de a face fata necesitatilor cu pretul unui volum diastolic anormal crescut \*\ heart capacity
insufficient to meet the needs of the price of abnormal diastolic volume increased
E) [ ] tulburarea frecventa a contractilitatii miocardului \*\ Frequency of myocardial contractility disorder
---------------------------------------------------------------------
257. CM p5 [M1610138] Spironolactonele in terapia IC: (pag. 1427) \*\ Spironolactonele in HF therapy
A) [x] Actioneaza printr- un mecanism de inhibitie competitiva a aldosteronului \*\ They act through a competitive inhibition
mechanism of the aldosterone
B) [x] Induc o diureza bogata in sodiu \*\ induce a diuresis rich in sodium
C) [x] Produc retentie de potasiu \*\ Production of potassium retention
D) [ ] Actioneaza numai in prezenta concentratiilor serice crescute aldosteron \*\ It works only in the presence of elevated serum aldosterone
E) [ ] Efectul maxim apare la 24 h de la administrare \*\ The maximum occurs at 24 h from administration
---------------------------------------------------------------------
258. CM p5 Semnele radiologice din insuficienta cardiaca sunt: (1424) \*\ The radiological signs of heart failure are:
A) [x] distensia venelor pulmonare \*\ distension of pulmonary veins
B) [ ] distensia arterelor pulmonare \*\ pulmonary artery distension
C) [ ] redistributia spre baze a circulatiei venoase pulmonare \*\ redistribution of pulmonary venous flow to the base
D) [x] redistributia spre varfuri a circulatiei venoase pulmonare \*\ redistribution to the tops of pulmonary venous flow
E) [x] prezenta lichidului pleural \*\ Pleural fluid
---------------------------------------------------------------------
259. CM p5 Care sunt factorii ce reduc toleranta la digitala: (1429) \*\ What are the factors that reduce tolerance to digital
A) [x] varsta avansata \*\ Advanced age
B) [x] infarctul miocardic acut \*\ miocardic infarction
C) [x] cardioversia electrica \*\ electrical cardioversion
D) [ ] hipermagneziemia \*\ hipermagneziemia
E) [ ] hipertiroidismul \*\ Hyperthyroidism

36
---------------------------------------------------------------------
260. CM p5 [M1610134] IC cu debit crescut apare in (pag. 1421) \*\ HF with increased flow occurs
A) [x] Anemie \*\ Anemia
B) [x] Fistule arterio i venoase \*\ arterio venous fistulae
C) [x] Hipertiroidism \*\ Hyperthyroidism
D) [ ] Cardiomiopatii dilatative \*\ dilated cardiomyopathy
E) [x] Boala Paget \*\ Paget's Disease
---------------------------------------------------------------------
261. CM p5 [M1210100] La un bolnav cu edeme cardiace cronice usoare sau moderate, fara hiperglicemie, fara hiperuricemie sau
fara hipokaliemie, care sunt diureticele de electie in administrare orala: (pag. 1427) \*\ A patient with mild to moderate chronic
heart edema without hyperglycemia, hyperuricemia without or without hypokalemia, which are the oral diuretics of choice (p.
1427)
A) [ ] spironolactona administrata singura \*\ spironolactone alone
B) [ ] amiloridul administrat singur \*\ amiloride alone
C) [x] metolazona \*\ metolazona
D) [x] tiazidicele \*\ tiazidicele
E) [ ] acidul etacrinic \*\ etacrinic acid
---------------------------------------------------------------------
262. CM p5 In tratamentul insuficientei cardiace spironolactona: (pag. 1427) \*\ Spironolactone in heart failure treatment
A) [x] competitioneaza hiperaldosteronismul secundar \*\ competitioneaza secondary hyperaldosteronism
B) [x] actioneaza pe receptori aldosteronici al nivelul tubului contort distal si colector \*\ aldosterone acts on receptors of the
distal and collecting tube contort
C) [ ] are efect diuretic maxim din primele 24 ore \*\ maximum diuretic effect within 24 hours
D) [x] are efect diuretic amplificat de asocierea cu diureticele de ansa \*\ diuretic effect amplified by the combination of loop diuretics
E) [ ] poate avea ca efecte secundare hipoKemia si ginecomastia \*\ Side effects may hipoKemia and gynecomastia
---------------------------------------------------------------------
263. CM p5 [M2310229] Casexia din insuficienta cardiaca cronica severa se produce prin: (pag. 1424) \*\ Cachexia in severe
chronic heart failure occurs by (p. 1424)
A) [x] Cresterea ratei catabolismului \*\ Increased catabolism rate
B) [x] Tulburarea absorbtiei intestinale \*\ abnormal intestinal absorption \*\
C) [ ] Tulburari metabolice si hidroelectrolitice secundare administrarii cronice de diuretice \*\ metabolic and electrolyte
disturbances secondary to chronic administration of diuretics
D) [x] Cresterea nivelului plasmatic al factorului de necroza tumorala \*\ Increased plasma levels of tumor necrosis factor
E) [ ] Scaderea sintezei proteinelor si pierderea de proteine prin urina \*\ Decreased protein synthesis and protein loss through urine
---------------------------------------------------------------------
264. CM p5 In care dintre afectiunile enumerate insuficienta cardiaca NU este expresia unor modificari ale functiei miocardice
(1420) \*\ Which of the diseases listed in heart failure is NOT an expression of changes in myocardial function:
A) [ ] miocarditele virale \*\ Viral miocardiopathies
B) [ ] cardiomiopatiile \*\ cardiomyopathies
C) [ ] infarctul miocardic \*\ myocardial infarction
D) [x] embolia pulmonara masiva \*\ massive pulmonary embolism
E) [x] ruptura unei cuspe aortice \*\ rupture of aortic cuspe
---------------------------------------------------------------------
265. CM p5 Intre cauzele insuficientei cardiace cu debit crescut se numara: (1421) \*\ Among the causes of heart failure increased
flow include:
A) [x] Fistula arteriovenoasa \*\ arteriovenous fistula
B) [ ] Hipotiroidismul \*\ Hypothyroidism
C) [ ] Hipertensiunea arteriala \*\ High Blood Pressure
D) [x] Boala Paget \*\ Paget's Disease
E) [x] Anemia \*\ Anemia
---------------------------------------------------------------------
266. CM p5 Regimul alimentar hiposodat recomandat in insuficienta cardiaca presupune: (1426) \*\ The salt restriction diet
recommended for heart failure includes:
A) [x] excluderea alimentelor cu continut mare de sare \*\ exclusion of food with high salt content
B) [ ] adaugarea de sare in alimente in timpul meselor \*\ adding salt to meals
C) [x] evitarea adausului de sare in timpul prepararii alimentelor \*\ avoid the addition of salt during food preparation
D) [ ] reducerea aportului zilnic de sare din alimentatie la 6-10 grame clorura de sodiu \*\ reduction of daily intake of salt in the
diet to 6-10 grams of sodium chloride
E) [x] evitarea adaugarii de sare in alimente in timpul meselor \*\ avoid adding salt to meals
---------------------------------------------------------------------
267. CM p5 Hipertrofia ventriculara de tip concentric se produce in:(1420) \*\Concentric ventricular hypertrophy occurs in type:
A) [x] solicitarile cronice de presiune \*\ requesting chronic pressure
B) [ ] solicitarile cronice de volum \*\ chronic volume demands

37
C) [x] stenoza aortica valvulara \*\ aortic valve stenosis
D) [ ] insuficienta aortica \*\ aortic insufficiency
E) [x] hipertensiunea arteriala netratata \*\ untreated hypertension
---------------------------------------------------------------------
268. CM p5 [M1410117] Diuretice economisitoare de potasiu sunt: (pag. 1426) \*\ Potassium saving Diuretics are:
A) [ ] acidul etacrinic \*\ acid etacrinic
B) [x] spironolactona \*\ spironolactone
C) [ ] metolazona \*\ metolazona
D) [x] amiloridul \*\ amiloride
E) [ ] indapamida \*\ indapamida
---------------------------------------------------------------------
269. CM p5 Care sunt cele mai eficiente amine simpatomimetice folosite in tratamentul insuficientei cardiace: (1430) \*\ What
are the most effective sympathomimetic amines used to treat heart failure:
A) [ ] norepinefrina \*\ norepinephrine
B) [x] dopamina \*\ dopamine
C) [ ] epinefrina \*\ epinephrine
D) [ ] isoproterenolul \*\ isoproterenolul
E) [x] dobutamina \*\ Dobutamine
---------------------------------------------------------------------
270. CM p5 Care dintre urmatoarele masuri terapeutice se aplica in tratamentul edemului pulmonar acut secundar insuficientei
ventriculare stangi: (1431-32) \*\ Which of these therapeutic measures applied in the treatment of pulmonary edema secondary to
acute left ventricular failure:
A) [x] oxigenoterapie cu presiune pozitiva \*\ oxygen with positive pressure
B) [x] mentinerea pacientilor in pozitie sezanda, cu picioarele atarnand la marginea patului \*\ keeping patients in sitting position
with legs hanging from the bed
C) [x] administrarea de morfina intravenos, repetat la nevoie \*\ administration of intravenous morphine, repeated if necessary
D) [ ] administrarea de beta-blocante intravenos \*\ Intravenous administration of beta blockers
E) [x] administrarea de diuretice de ansa intravenos \*\ Intravenous administration of loop diuretics
---------------------------------------------------------------------
271. CS p4 Aplicarea cardioversiei electrice cu energie redusa - 25 - 50 W in flutteru atrial prezinta dezavantajul: (1396) \*\ The
application of low energy electrical cardioversion - 25-50 W flutteru atrial shows disadvantage:
A) [ ] Injurie miocardica \*\ myocardial injury
B) [ ] Cresterea blocajului AV \*\ Increasing AV blockage
C) [ ] Reducerea blocajului AV \*\ Reduction AV blockage
D) [x] Inducerea FA \*\ Induction of AF
E) [ ] Bloc sino - atrial \*\ Blocking of SAN
---------------------------------------------------------------------
272. CS p4 [M1508024] Blocul atrioventricular de grad II tip Mobitz I se caracterizeaza prin: (pag. 1387, 1388) \*\ Grade II
atrioventricular block Mobitz type I is characterized by:
A) [ ] Interval PR constant, mai mare de 0,20 secunde \*\ constant PR interval greater than 0.20 seconds
B) [x] Alungirea progresiva a intervalului PR, urmata de blocarea unui impuls atrial \*\ progressive lengthening of PR interval,
followed by blocking an atrial impulse
C) [ ] Blocarea brusca, neasteptata a unor unde P fara modificari ale intervalului PR \*\ sudden block, nonconduction of P without
changes in PR interval
D) [ ] Lipsa totala de transmitere a impulsurilor atriale spre ventriculi \*\ total lack of transmission of atrial impulses to the ventricles
E) [ ] Ritm jonctional de scapare in conditiile unei bradicardii sinusale severe \*\ junctional escape rhythm in conditions of severe
sinus bradycardia
---------------------------------------------------------------------
273. CS p4 [M1308011] Medicamentele care nu pot fi clasificate in schema antiaritmicelor pot avea in comun: (p1396 tabel,
p1398tabel) \*\ Drugs that can not be classified antiarrythmics scheme may have in common:
A) [ ] in boala nodulului sinusal pot provoca bloc sinusal de iesire sau oprire \*\ In sinus node disease can cause sinus exit block or stop
B) [ ] scderea vitezei de conducere la nivelul atriului si ventriculului \*\ conduction velocity decreasing tendency in the atrium
and ventricle
C) [ ] scaderea automatismului nodulului sinusal mai accentuata de catre digitala \*\ decrease sinus node automatism accentuated
by digital
D) [ ] cresterea automatismului nodulului sinusal mai accentuata de catre adenozina \*\ sinus node automatism sharpest increase
by adenosine
E) [x] nu apartin clasei de medicamente antiaritmice (I-IV) \*\ antiarrhythmic drugs do not belong to class (I-IV)
---------------------------------------------------------------------
274. CS p4 [CS10009] Blocul sino-atrial de iesire de grad II \*\ Sino-atrial exit block grade II:
A) [ ] Nu poate fi diagnosticat pe ECG de suprafata \*\ It can be diagnosed by surface ECG
B) [x] Se manifesta prin absenta intermitenta a undelor P \*\ It shows intermittent absence of P waves
C) [ ] Se caracterizeaza prin absenta activitatii atriale \*\ It is characterized by absence of atrial activity

38
D) [ ] Se caracterizeaza prin aparitia unui pace-maker atrial ectopic \*\ It is characterized by the appearance of an ectopic atrial
pace-maker
E) [ ] Inseamna alungirea timpului de conducere de la un nodul sinusal la tesutul atrial inconjurator pag 1385 \*\ prolongation of
condution time SAN to atrial tissue
---------------------------------------------------------------------
275. CS p4 [M2208035] In care din urmatoarele situatii tratamentul de electie pentru fibrilatia atriala este cardioversia electrica:
(pag. 1395) \*\ In which of these situations is the treatment of choice for atrial fibrillation is electrical cardioversion
A) [ ] Intoxicatia alcoolica \*\ Alcohol Poisoning
B) [ ] Tireotoxicoza \*\ thyrotoxicosis
C) [ ] Pericardita \*\ pericarditis
D) [x] Starea clinica a pacientului sever alterata \*\ severely impaired the patient's condition
E) [ ] Febra \*\ Fever
---------------------------------------------------------------------
276. CS p4 [M1208002] In fibrilatia atriala, pentru cardioversia electrica, este necesara in general o energie de: (pag. 1396) \*\
The following electrical charge is used for electrical cardioversion in atrial fibrillation
A) [x] 100-200 W s \*\ 100-200 W s
B) [ ] 50-30 W s \*\ 50-30 W s
C) [ ] 50-75 W s \*\ 50-75 W s
D) [ ] 300-400 W s \*\ 300-400 W s
E) [ ] 350-450 W s \*\ 350-450 W s
---------------------------------------------------------------------
277. CS p4 [CS10001] Proprietatea celulelor cardiace de a se depolariza spontan avand ca rezultat formarea unui impuls este:
(1383-1384) \*\ The property of cardiac cells to depolarize spontaneously resulting in the formation of a pulse is:
A) [ ] inotropism \*\ inotropism
B) [ ] contractilitate \*\ contractility
C) [x] automatism \*\ automatism
D) [ ] electricitate \*\ Electricity
E) [ ] conductibilitate \*\ conductivity
---------------------------------------------------------------------
278. CS p4 [M1608029] Tratamentul de electie la bolnavii cu WPW si FA instabili hemodinamic este: (pag. 1402) \*\ The
treatment of choice in patients with WPW and AF is haemodynamically unstable
A) [x] Cardioversie electrica \*\ Electrical cardioversion
B) [ ] Dopamina \*\ Dopamine
C) [ ] Electrostimulare endocavitara \*\ Electrostimulation endocavitara
D) [ ] Verapamil iv \*\ Verapamil iv
E) [ ] Xilina bolus iv \*\ lidocaine iv bolus
---------------------------------------------------------------------
279. CM p5 [CM10006] Urmatoarele medicamente pot conduce la disfunctia nodulului sinusal (p1385) \*\ The following drugs
can lead to sinus node dysfunction
A) [x] glicozide tonicardiace \*\ glycosides tonicardiace
B) [ ] alfa blocante \*\ alpha blockers
C) [x] beta blocante \*\ beta blockers
D) [x] chinidina \*\ quinidine
E) [x] verapamil \*\ verapamil
---------------------------------------------------------------------
280. CM p5 [M1208081] In tratamentul farmacologic de urgenta al tahicardiei ventriculare sustinute monomorfe se pot
administra: (1406) \*\ The emergency pharmacological treatment of sustained monomorphic ventricular tachycardia can be:
A) [x] procainamida \*\ procainamide
B) [x] lidocaina \*\ lidocaine
C) [ ] digoxin \*\ digoxin
D) [ ] furosemid \*\ furosemide
E) [ ] diltiazem \*\ diltiazem
---------------------------------------------------------------------
281. CM p5 Sindromul de preexcitatie WPW se caracterizeaza ECG prin:(1401)\*\Preexcitatie WPW syndrome ECG is characterized by:
A) [ ] interval PR scurt (<0,10 s) \*\ The short PR interval (<0.10 s)
B) [ ] QRS ingust \*\ narrow QRS
C) [x] prezenta undei delta \*\ this wave delta
D) [ ] fibrilatie atriala cu alura de regula joasa \*\ atrial fibrillation with the allure of low right
E) [x] flutter atrial sau fibrilatie atriala cu alura ventriculara neobisnuit de rapida \*\ atrial flutter or atrial fibrillation with
ventricular shape unusually fast
---------------------------------------------------------------------
282. CM p5 [M2208152] Care din urmatoarele afirmatii privind tahicardia prin reintrare AV sunt adevarate: (pag. 1400) \*\
Which of the following statements are true about AV reentry tachycardia by:

39
A) [x] Circuitul de reintrare include un fascicul atrioventricular accesor ascuns \*\ reentry circuit includes a hidden
atrioventricular accessory bundle
B) [ ] Fasciculul accesor poate conduce in sens anterograd in timpul ritmului sinusal sau in timpul altor tahiaritmii atriale \*\
during sinus rhythm or atrial tachyarrhythmias accessory fascicles can lead to anterograde effect
C) [x] Initierea tahicardiei paroxistice supraventriculare de catre o extrasistola ventriculara este virtual diagnostica pentru
reintrarea AV \*\ Initiation of paroxysmal supraventricular tachycardia by a ventricular extrasystole is virtually diagnostic for AV
reentry
D) [x] Undele P apar de obicei dupa complexele QRS \*\ P waves usually occur after the QRS complexes
E) [ ] Undele P apar de obicei inaintea complexelor QRS \*\ P waves usually occur before the QRS complexes
---------------------------------------------------------------------
283. CM p5 [CM10049] Sindromul bradicardie tahicardie din cadrul bolii nodului sinusal: (pag 1385) \*\ Bradycardia-
tachycardia syndrome the sinus node disease (p. 1385)
A) [x] Se refera la o aritmie atriala paroxistica urmata de pauze sinusale lungi \*\ It refers to a paroxysmal atrial arrhythmia
followed by long sinus pauses
B) [ ] Se manifesta in principal prin tahiaritmie cu perioade debradiaritmie neglijabile urmate de stop \*\ Its primary manifestation
is tachyarrhythmias along with negligible bradyarrhythmia followed by periods of pause
C) [ ] Pe ECG standard se manifesta sub forma de bradiaritmie \*\ The standard ECG is manifestion is in the form of brady-
arrhythmia
D) [x] Se manifesta ca o aritmie in care exista perioade alternative de tahiaritmie si bradiaritmie \*\ It shows up as an arrhythmia
in which there are alternating periods of tachyarrhythmias and bradyarrhythmia
E) [x] Se manifesta pe ECG standard sub forma tahiaritmiilor \*\ standard ECG manifestation is of tachyarrhythmias
---------------------------------------------------------------------
284. CM p5 [M2208124] Ritmul idioventricular accelerat poate apare: (1405) \*\ Accelerated idioventricular rhythm may occur:
A) [x] In infarctul miocardic acut \*\ acute myocardial infarction
B) [x] Dupa operatii pe cord \*\ After heart surgery
C) [x] In cardiomiopatii \*\ The cardiomyopathies
D) [x] In intoxicatia digitalica \*\ digitalis poisoning
E) [ ] Afectiuni intracraniene \*\ intracranial disorders
---------------------------------------------------------------------
285. CM p5 [M2208171] Care din urmatoarele pledeaza pentru localizarea blocului AV grad III la nivelul His sau distal: (1388)
\*\ Which of the following advocates for locating a grade III AV block or distal His:
A) [ ] Daca complexul QRS al ritmului de scapare este cu durata normala \*\ If the QRS complex escape rhythm is of normal duration
B) [x] Daca frecventa ritmului de scapare este < sau = cu 40 batati pe minut \*\ If the frequency rate of escape is <or = to 40 beats
per minute
C) [x] Ritmul de scapare este instabil \*\ escape rhythm is unstable
D) [x] La unii pacienti cu bloc infrahisian se poate intilni conducerea retrograda ventriculo-atriala \*\ In some patients with
infrahisian block a retrograde ventricular-atrial conduction may be met
E) [ ] Ritmul de scapare este influentat de atropina \*\ The escape rhythm is influenced by atropine
---------------------------------------------------------------------
286. CM p5 In fluterul atrial conversia la ritm sinusal dupa scaderea frecventei ventriculare se poate face cu: (1396) \*\ The
conversion of atrial flutter to sinus rhythm after decreasing ventricular frequency can be done by:
A) [x] procainamida \*\ procainamide
B) [ ] fenitoina \*\ phenytoin
C) [ ] mexiletina \*\ mexiletina
D) [x] flecainida \*\ flecainida
E) [x] amiodarona \*\ amiodarone
---------------------------------------------------------------------
287. CM p5 [M1308086] Tahicardia jonctionala neparoxistica prezinta urmatoarele particularitati, EXCEPTaND: (p1402-1403)
\*\ Non-paroxysmal junctional tachycardia shows these features, except:
A) [ ] Debut gradat (cu incalzire) \*\ Gradually starts (with rise in temperature)
B) [ ] Etiologie posibil iatrogena (intoxicatie digitalica), miocarditica sau ischemica \*\ Possible etiologies can be iatrogenic
(digitalis intoxication), myocarditis or ischemic
C) [x] Aspect QRS deformat (aberanta depolarizarii) \*\ Appearance of deformed QRS (aberrant depolarization)
D) [ ] Frecventa ventriculara influentata de modificarea tonusului vegetativ \*\ Ventricular frequency is affected by autonomic tone
E) [x] Electroconversia este terapia de electie \*\ The therapy of choice is Electrocardioversion
---------------------------------------------------------------------
288. CM p5 [M2208117] Torsada virfurilor poate aparea: (pag. 1405) \*\ Torsades de pointes can occur in: (p. 1405)
A) [x] In hipomagneziemie \*\ hypomagnesemia
B) [ ] In hiperkaliemie \*\ At hyperkalaemia
C) [x] Dupa tratament cu chinidina \*\ After treatment with quinidine
D) [ ] Dupa tratament cu blocante de calciu \*\ After treatment with calcium blockers
E) [x] Dupa tratament cu antidepresive triciclice \*\ After treatment with tricyclic antidepressants
---------------------------------------------------------------------

40
289. CM p5 [M2508193] Tratamentul chirurgical este indicat in cazurile de tahicardie ventriculara asociate cu: (pag. 1409) \*\
Surgery is indicated in cases of ventricular tachycardia associated with:
A) [x] Tetralogie Fallot \*\ tetralogy of Fallot
B) [x] Boala coronariana \*\ Dilated Cardiomyopathy
C) [ ] Cardiomiopatie dilatativa \*\ idiopathic aneurysm of the left ventricle
D) [x] Anevrism idiopatic al ventriculului stang \*\
E) [ ] Infarctul miocardic acut \*\ Myocardial infarction
---------------------------------------------------------------------
290. CM p5 [CM10008] Cauzele care pot produce disfunctii ale nodului sinusal sunt: () \*\ Causes that can result in sinus node
dysfunction are:
A) [x] degenerarea fibrelor nodului sinusal la varstnici \*\ fiber degeneration in the sinus node
B) [ ] stenoza mitrala reumatismala \*\ rheumatic mitral stenosis
C) [x] amiloidoza la varstnici \*\ amyloidosis
D) [x] infiltrarea miocardului atrial \*\ atrial myocardial infiltration
E) [x] ischemia arterei nodului sinusal \*\ sinus node artery ischemia
---------------------------------------------------------------------
291. CM p5 Undele F de pe ECG in flutterul atrial au urmatoarele caractere: (1396) \*\ F waves in atrial flutter on ECG following
characters:
A) [ ] sunt mai ample in derivatiile anterioare \*\ are broader in the previous derivations
B) [ ] frecventa atriala realizata este de circa 450/minut \*\ atrial frequency achieved is about 450/minut
C) [x] au aspect regulat \*\ they regularly issue
D) [x] sunt conduse la ventricul cu o frecventa uzuala de 150/minut \*\ is conducted at a usual frequency ventricle 150/minut
E) [ ] sunt complet neregulate \*\ completely irregular
---------------------------------------------------------------------
292. CM p5 Criteriile ECG ce sugereaza tahicardia ventriculara sunt: (1403) \*\ ECG criteria suggesting ventricular tachycardia are:
A) [x] disociatia atrioventriculara \*\ dissociating atrioventricular
B) [x] durata QRS>0.14 s cu aspect de BRD \*\ QRS duration> 0.14 s in the absence of antiarrhythmic therapy
C) [ ] neconcordanta complexelor QRS in derivatiile precordiale \*\ disparity QRS complexes in precordial derivations
D) [x] deviatie axiala stanga cu aspect de BRD \*\ left axial deviation looking BRD
E) [ ] tahicardie cu frecventa sub 100/min \*\ tachycardia frequency below 100/min
---------------------------------------------------------------------
293. CM p5 [M2308179] Care din urmatoarele afirmatii privind terapia tahicardiei paroxistice prin reintrare in nodulul AV sunt
false ? (1136-1137) \*\ Which of these statements on tahicardiei therapy in paroxysmal AV node reentry into false?
A) [x] cardioversia constituie terapia de prima intentie in toate cazurile \*\ cardioversion is first-line therapy in all cases
B) [ ] medicatia de prima alegere este reprezentata de adenozina si verapamil \*\ drugs of first choice is represented by adenosine
and verapamil
C) [ ] digitala constituie o medicatie de prima intentie in prevenirea recurentei \*\ Digital is a medication to prevent the recurrence
of first intention
D) [x] raportul beneficiu/ risc optim in prevenirea recurentei il au drogurile din clasa I A \*\ benefit / risk ratio in preventing
appellant we have the best of class IA drugs
E) [ ] in caz de accese recurente se recomanda electrostimulare temporara \*\ in case of recurrent bouts recommend temporary
electrostimulation
---------------------------------------------------------------------
294. CM p5 [CM10028] Fasciculul Hiss: (pag 1383) \*\ Bundle of Hiss
A) [x] ia nastere din nodulul AV \*\ take delivery of the AV node
B) [ ] ia nastere din reteaua Purkinje \*\ take delivery of the Purkinje network
C) [x] traverseaza scheletul fibros al inimii \*\ cross fibrous skeleton of heart
D) [ ] are o directie spre posterior traversand portiunea membranoasa \*\ It is directed towards the posterior-transverse portion of
the membrane
E) [ ] da nastere la un nr mic de fibre \*\ It divides into a number of smaller fibres
---------------------------------------------------------------------
295. CM p5 [M2308181] Care din pacientii cu BAV grII au indicatie de pacemaker ? (pag. 1129) \*\ Which of patients with
pacemaker indication of BAV grII have?
A) [ ] BAV gr II peranent, asimptomatic \*\ BAV peranent gr II, asymptomatic
B) [x] BAV gr II intermitent cu bradicardie simptomatica \*\ BAV gr II with intermittent symptomatic bradycardia
C) [x] BAV gr II asimptomatic cu blocaj infrahisian dovedit \*\ BAV gr II asymptomatic blockage proved infrahisian
D) [ ] BAV gr II tip Mobitz I asimptomatic cu blocaj infrahisian \*\ g II type BAV asymptomatic Mobitz I block infrahisian
E) [x] BAV gr II asociat cu insuficienta cardiaca \*\ g II BAV associated with heart failure
---------------------------------------------------------------------
296. CM p5 Flutterul atrial se caracterizeaza electrocardigrafi prin: (1396) \*\ Atrial flutter is characterized by the following ecg appearance:
A) [x] Frecventa atriala intre 250 - 350 / min \*\ Frequency of atria contractions between 250-350 / Min
B) [x] Unde atriale cu aspect de dinti de fierastrau \*\ When atrial depolarization has aspect of the saw teeth
C) [ ] Intervale izoelectrice intre undele de flutter atrial \*\ isoelectric intervals between flutter waves

41
D) [x] Conducere AV cu blocaj 2 / 1 - alura ventriculara 150 / min \*\ Management of AV block 2/1 - ventricular rate 150 / min
E) [ ] Modificarea blocajului AV la manevre vagale \*\ Change in AV blockage occurs due to vagal maneuvers
---------------------------------------------------------------------
297. CM p5 [M2208166] Care din urmatoarele afirmatii privind blocul AV grad I sunt adevarate: (pag. 1387,8) \*\ Which of the
following statements are true about grade I AV block:
A) [x] Blocul AV grad I se caracterizeaza printr-un PR > 0,20 s \*\ Grade I AV blcok is characterized by PR> 0.20 s
B) [ ] In prezenta unui complex QRS cu durata normala, prelungirea intervalului PR peste 0,24 s este invariabil produsa de
intirzierea impulsului la nivelul sistemului His-Purkinje \*\ In the presence of a QRS complex of normal duration, prolongation
of PR interval is invariably more than 0.24 s pulse delay caused by the His-Purkinje system
C) [ ] Prelungirea duratei QRS, alaturi de prelungirea intervalului PR este produsa de intirzierea impulsului la nivelul nodului AV
\*\ Prolongation of QRS, with PR interval prolongation is produced by AV node impulse delay
D) [x] Daca durata QRS este prelungita, intirzierea poate fi produsa la nivelul nodului AV sau a sistemului His-Pukinje \*\ If the
QRS duration is prolonged delay can be produced in the AV node or His-Pukinje system
E) [x] Locul precis la Intirzierii conducerii poate fi stabilit numai prin inregistrari intracardiace \*\ delayed conduction of specific
sites can only be determined by intracardiac recordings
---------------------------------------------------------------------
298. CM p5 Torsada varfurilor are urmatoarele particularitati: (1405) \*\ Torsades de pointes has the following features:
A) [x] Poate apare dupa administrarea de chinidina \*\ It can occur after administration of quinidine
B) [ ] Raspunde la tratamentul cu isoproterenol \*\ Responds to treatment with isoproterenol
C) [ ] Poate determina embolii periferice \*\ Can cause peripheral embolism
D) [x] Beneficiaza de tratament cu magneziu \*\ Treatment with magnesium beneficial
E) [x] Beta-blocantele reprezinta tratamentul principal \*\ Beta-blockers are the main treatment
---------------------------------------------------------------------
299. CM p5 [CM10030] Potentialul de actiune al sistemului Hiss purkinje sial miocardului ventricular are: (1383) \*\ Action
potential of ventricular myocardium and Hiss purkinje has:
A) [x] 5 faze \*\ The five phases
B) [x] o faza 0 reprezentand depolarizarea rapida \*\ stage 0 represents a rapid depolarization
C) [ ] 4 faze \*\ 4 stages
D) [x] fazele 1-3 ce reprezinta etapa de repolarizare \*\ 1-3 stages representing repolarization phase
E) [x] faza a 4a care este cea de potential membranar de repaus \*\ The fourth phase is the resting membrane potential
---------------------------------------------------------------------
300. CM p5 Vascularizatia fasciculului His se realizeaza prin: (1383) \*\ The blood supply to bundle of Hiss is accomplished by:
A) [x] Artera nodului atrioventricular \*\ The atrioventricular node artery
B) [x] Ramura din artera coronara descendenta anterioara \*\ branch of anterior descending coronary artery
C) [ ] Artera nodului sinusal \*\ sinus node artery
D) [ ] Artera coronara dreapta \*\ right coronary artery
E) [ ] Artera circumflexa stanga \*\ left circumflex artery
---------------------------------------------------------------------
301. CS p4 [M1144002] Ce procent dintre pacientii cu tromboza venoasa pelviana sau tromboza venoasa proximala a membrelor
inferioare netratate au T.E.P.: (p1620)\*\What percentage of patients with pelvic vein thrombosis or proximal leg vein thrombosis
were treated pulmonary thromboembolism
A) [ ]25%\*\25%
B) [ ]33%\*\33%
C) [x]50%\*\50%
D) [ ]75%\*\75%
E) [ ]90%\*\90%
---------------------------------------------------------------------
302. CS p4 [M2544052] Cel mai frecvent simptom intalnit in trombembolismul pulmonar este: (pg 1620)\*\the most common
symptom found in pulmonary thromboembolism is
A) [ ]durerea pleurala\*\The pleural pain
B) [ ]tusea\*\cough
C) [ ]hemoptizia\*\haemoptysis
D) [x]dispneea\*\dyspnea
E) [ ]subfebrilitatea\*\subfebrilitatea
---------------------------------------------------------------------
303. CS p4 [M2244035] Care din elementele de mai jos nu indica un TEP masiv? (pg 1620)\*\which of the following below DO
NOT indicate a massive PET
A) [ ]sincopa\*\syncope
B) [ ]hipotensiunea arteriala\*\hypotension
C) [ ]dispnee\*\dyspnoea
D) [x]tusea\*\cough
E) [ ]cianoza\*\cyanosis
---------------------------------------------------------------------

42
304. CS p4 [M1644020] In tromboembolismul pulmonar nivelul D-dimerului plasmatic este: (pg 1621)\*\in pulmonary
thromboembolism the level of D-dimer plasma is
A) [ ]Scazut\*\Low
B) [x]Crescut\*\Raised
C) [ ]Nemodificat\*\Not modified
D) [ ]Specifici\*\Specific
E) [ ]Fara valoare\*\No value
---------------------------------------------------------------------
305. CS p4 [M1244006] Diagnosticul diferential al trombembolismului pulmonar se face cu: (pg 1621)\*\differential diagnosis of
pulmonary embolism is made with
A) [ ]pancreatita acuta hemoragica\*\acute hemorrhagic pancreatitis
B) [ ]hipertensiunea arteriala esentiala\*\essential hypertension
C) [ ]cardiomiopatia obstructiva\*\Obstructive cardiomyopathy
D) [x]angina instabila\*\unstable angina
E) [ ]accidentul vascular cerebral\*\cerebrovascular accident : stroke
---------------------------------------------------------------------
306. CS p4 [M2644225] Care este cauza primordiala in decesul prin trombembolismul pulmonar (pagina 1620) ()\*\What is the
foremost cause of death by pulmonary embolism (page 1620) ()
A) [ ]edemul pulmonar\*\pulmonary edema
B) [x]insuficienta ventriculara dreapta\*\Right ventricular failure
C) [ ]insuficienta cardiaca stanga\*\Left heart failure
D) [ ]tensiunea parietala a ventriculului stang\*\Left ventricular tension parietal
E) [ ]bombarea septului\*\septum bulging
---------------------------------------------------------------------
307. CS p4 [M2344045] Urmatorii factori pot precipita tromboembolismul pulmonar cu exceptia: (pg 1620)\*\The following
factors may precipitate pulmonary thromboembolism except:
A) [ ]sarcina\*\pregnancy
B) [ ]interventiile chirurgicale\*\surgery
C) [ ]chimioterapia in cancer\*\chemotherapy in cancer
D) [x]mobilizarea precoce postoperatorie\*\Postoperative early mobilization
E) [ ]cateter venos central permanent\*\permanent central venous catheter
---------------------------------------------------------------------
308. CS p4 [M2244028] Care este cea mai frecventa predispozitie ereditara la hipercoagulabilitate (pg 1620)\*\What is the most
common inherited predisposition to hypercoagulability
A) [ ]varsta\*\age
B) [ ]sexul feminin\*\Female
C) [ ]sexul masculin\*\male
D) [x]rezistenta la proteina C activata\*\resistance to activated protein C
E) [ ]deficienta proteinei S\*\protein S deficiency
---------------------------------------------------------------------
309. CM p5 [M2544188] Cresterea rezistentei vasculare pulmonare consecutiva trombembolismului pulmonar este datorata: (pg
1620)\*\Increasing pulmonary vascular resistance, pulmonary embolism is consecutive of (pg 1620)
A) [ ]suntului pulmonar dreapta - stanga\*\Right- left pulmonary shunt
B) [x]obstructiei arteriale\*\obstruction take pressure
C) [ ]hipercapniei\*\hipercapnia
D) [x]vasoconstrictiei mediata de serotonina\*\vasoconstriction mediated by serotonin
E) [ ]bronhoconstrictiei\*\bronhoconstriction
---------------------------------------------------------------------
310. CM p5 [M2544194] Pacientii cu trombembolism pulmonar mic spre moderat prezinta: (pg 1620)\*\Patient with small to
moderate thromboembolism presents (pg 1620)
A) [x]functie normala a cordului drept\*\The function of the heart as normal
B) [ ]hipokinezie ventriculara la echografie\*\ventricular hypokinesia on ultrasound
C) [ ]colaps circulator\*\Circulatory collapse
D) [x]anticoagularea sau filtrul venos in vena cava inferioara reprezinta atitudini terapeutice adcvate\*\anticoagulation or inferior
venacava venous filter represents the therapeutic attitudes adcvate
E) [x]pronostic bun\*\good prognosis
---------------------------------------------------------------------
311. CM p5 [M2244166] Care din afirmatiile cu privire la tromboendarterectomia pulmonara sunt adevarate? (pg 1623)\*\Which
of the statements on pulmonary tromboendarterectomy are true? (pg 1623) (Pg 1623)
A) [x]indicatiile ii cuprind pe pacientii dispneici la eforturi mici\*\Indications II include patients with dyspnoea on little effort
B) [x]indicatiile ii cuprind pe pacientii dispneici in repaus\*\II indications include dyspnoea at rest in patients
C) [x]poate reduce mult hipertensiunea pulmonara\*\May reduce pulmonary hypertension than
D) [x]poate chiar vindeca hipertensiunea pulmonara\*\Maybe even cure pulmonary hypertension

43
E) [ ]au indicatie de tromboendarterectomie toti pacientii diagnosticati cu TEP\*\Tromboendarterectomy have indication of all
patients diagnosed with PET
---------------------------------------------------------------------
312. CM p5 [M2244136] Diagnosticul diferential al TEP se face cu: (pg 1621)\*\Differential Diagnosis of PET is made with:
A) [x]infarct miocardic acut\*\acute myocardial infarction
B) [x]angina instabila\*\unstable angina
C) [x]pneumonia\*\Pneumonia
D) [x]insuficienta cardiaca congestiva\*\Congestive heart failure
E) [ ]anevrism aortic\*\aortic aneurysm
---------------------------------------------------------------------
313. CM p5 [M2544206] Principalele complicatii ale tratamentului cu heparina in trombembolismul pulmonar sunt: (p1622)
\*\The main complication of treatment with heparin in pulmonary embolism are:
A) [x]hemoragia\*\hemorrhage
B) [ ]trombocitoza\*\thrombocytosis
C) [x]trombocitopenia\*\thrombocytopenia
D) [x]tromboze arteriale(sindromul cheagului alb) sau venoase \*\arterial thrombosis (white clot syndrome) or venous
E) [x]osteoporoza\*\Osteoporosis
---------------------------------------------------------------------
314. CM p5 [M2244162] Care din urmatoarele afirmatii privind tromboliza in TEP sunt adevarate? (pg 1623)\*\Which of the
following statements are true regarding thrombolysis in PET?
A) [ ]duce in toate cazurile la regresia rapida a insuficientei cardiace drepte\*\In all cases leads to rapid regression of right heart failure
B) [x]scade rata mortalitatii\*\reduced mortality rate
C) [x]scade recurenta TEP\*\decreases recurrent PET
D) [ ]nu are contraindicatii majore\*\no major contraindications
E) [x]se paote efectua in primele 14 zile\*\can be done in the first 14 days
---------------------------------------------------------------------
315. CM p5 [M1644113] Embolia pulmonara netrombotica poate avea urmatoarele etiologii: (pg 1620)\*\non thrombotic
pulmonary embolism may have the following etiologies:
A) [x]Embolia grasoasa\*\fat embolism
B) [x]Embolia tumorala\*\tumor embolism
C) [ ]Disectia de aorta\*\aortic dissection
D) [ ]Trombi situate in VS\*\LV thrombi located
E) [x]Folosirea de droguri intravenoase\*\IV drug use
---------------------------------------------------------------------
316. CM p5 [M2344182] Insertia unui filtru pe vena cava inferioara este recomandata in urmatoarele situatii: (pg
1623)\*\Insertion of inferior vena cava filter is recommended in these situations:
A) [x]cand anticoagularea nu se poate efectua\*\when anticoagulation can not be performed
B) [x]tromboza venoasa recurenta\*\recurrent venous thrombosis
C) [ ]ca terapie adjuvanta asociata trombolizei\*\as adjuvant therapy associated with thrombolysis
D) [x]profilaxia tromboembolismului pulmonar la pacientii cu risc extrem de crescut\*\pulmonary thromboembolism prophylaxis
in patients with extremely high risk
E) [ ]terapie primara in tromboembolismul pulmonar masiv\*\primary therapy in massive pulmonary thromboembolism
---------------------------------------------------------------------
317. CM p5 [M1344090] Contraindicatiile trombolizei in TEP sunt: (pg 1624)\*\contraindication of thrombolysis in PET are
A) [x]traumatisme recente\*\Recent injuries
B) [ ]hipertensiunea arteriala\*\Hypertension
C) [x]boala intracraniana\*\Intracranial disease
D) [x]interventii chirurgicale recente\*\recent surgery
E) [ ]insuficienta cardiaca\*\heart failure
---------------------------------------------------------------------
318. CM p5 [M2244149] Care din urmatoarele afirmatii privind angiografia pulmonara sunt adevarate? (pg 1621)\*\Which of the
following statements are true regarding pulmonary angiography?
A) [x]este cea mai specifica explorare disponibila pentru stabilirea diagnosticului definitiv de TEP\*\is the specific exploration
available for definitive diagnosis of PET
B) [x]poate detecta emboli de 1-2 mm\*\1-2 mm can detect emboli
C) [ ]poate detecta emboli doar cu dimensiuni mai mari de 3 mm\*\can only detect emboli larger than 3 mm
D) [ ]se efectueaza de rutina\*\is done routinely
E) [x]un diagnostic definitiv de TEP depinde de vizualizarea unui defect de umplere intraluminal in mai mult de o proiectie\*\A
definitive diagnosis depends PET viewing an intraluminal filling defect in more than a projection
---------------------------------------------------------------------
319. CM p5 [M2244122] Care din afirmatiile de mai jos nu fac parte din factorii care pot precipita TEP (pg 1620)\*\Which of the
statements below do not form part of the factors that may precipitate PET
A) [ ]interventiile chirurgicale\*\surgery

44
B) [x]emacierea\*\emacierea
C) [ ]traumatismele\*\trauma
D) [x]HTA\*\Hypertension
E) [ ]obezitatea\*\Obesity
---------------------------------------------------------------------
320. CM p5 Nivelele plasmatice crescute ale D-dimerilor indica:(1621)\*\Increased plasma levels of D-dimers is an indication of
A) [x]trombembolismul pulmonar\*\pulmonary embolism
B) [x]infarctul miocardic\*\myocardial infarction
C) [ ]pericardita\*\pericarditis
D) [x]septicemia\*\septicemia
E) [ ]hipertensiunea arteriala sistemica\*\systemic arterial hypertension
---------------------------------------------------------------------
321. CM p5 [M1644111] Triada de factori predispozanti pentru tromboza venoasa dupa Virchow este: (1620)\*\predisposing
factors to venous thrombosis after the triad of Virchow are
A) [x]Traumatismul local al peretelui vaselor (leziune endoteliala)\*\local trauma vessel wall (endothelial damage)
B) [ ]Hipertensiunea arteriala\*\High blood pressure
C) [x]Hipercoagulabilitate\*\hypercoagulability
D) [x]Staza venoasa\*\venous stasis
E) [ ]Fibrinogenemie scazuta\*\low Fibrinogenemie
---------------------------------------------------------------------
322. CM p5 [M2544209] Tromboliza cu activator de plasminogen tisular recombinat, administrat continuu, in perfuzie
endovenoasa, timp de 2 ore la pacientii cu trombembolism pulmonar, conduce la: (pg 1623)\*\thrombolysis with recombinant
tissue plasminogen activator, administered continuously, infusion for 2 hours in patients with pulmonary embolism, lead to:
A) [x]dizolvarea trombusului arterial pulmonar obstruant\*\pulmonary arterial thrombus dissolution blocked
B) [ ]fixarea si accelerarea activitatii antitrombinei III\*\fix, accelerate and activate antithrombin III
C) [x]dizolvarea trombusului din venele pelvine sau profunde ale membrelor inferioare\*\dissolution of thrombus in deep veins of
the legs or pelvic
D) [ ]scaderea hipertensiunii pulmonare prin stimularea descarcarii de serotonina\*\decrease pulmonary hypertension by
stimulating the serotonin release
E) [x]reducerea probabilitatii recurentei trombembolismului pulmonar\*\reduction probabilityof recurrent pulmonary embolism
---------------------------------------------------------------------
323. CM p5 [M1644115] Diagnosticul diferential in tromboembolismul pulmonar se face cu: (1620)\*\Differential Diagnosis in
Pulmonary thromboembolism is made with:
A) [x]IMA\*\acute MI
B) [x]Pneumonie\*\Pneumonia
C) [x]Pericardita\*\pericarditis
D) [ ]Boli de colagen\*\Collagen Diseases
E) [x]Astmul bronsic\*\asthma
---------------------------------------------------------------------
324. CM p5 [M2244031] Care dintre afirmatiile referitoare la efectele care pot fi produse de embolia pulmonara sunt false? (pg
1620)\*\Which of the statements on the effects that can be caused by pulmonary embolism are false?
A) [x]complianta pulmonara cerscuta\*\increased lung compliance
B) [ ]hiperventilatia alveolara\*\alveolar Hyperventilation
C) [ ]alterarea schimbului de gaze\*\impaired gas exchange
D) [x]rezistenta scazuta a cailor aeriene\*\low airway resistance
E) [ ]rezistenta vasculara pulmonara crescuta\*\Increased pulmonary vascular resistance
---------------------------------------------------------------------
325. CM p5 [M2244147] Care din urmatoarele afirmatii privind ecocardiografia in TEP sunt adevarate? (pg 1621)\*\Which of the
following statements are true about echocardiography in PET?
A) [x]este utila pentru trierea rapida a bolnavilor acuti\*\It is useful for rapid screening of acute patients
B) [ ]este esential a se efectua inaintea scintigrafiei pulmonare\*\is essential to perform before pulmonary scintigraphy
C) [ ]este o explorare neinvaziva obligatorie\*\is a non-invasive exploration mandatory
D) [x]poate face diagnosticul diferential\*\can be a tool for differential diagnosis
E) [x]ajuta la stabilirea riscului si prognosticului\*\help to determine the risk and prognosis
---------------------------------------------------------------------
326. CM p5 Complicatiile posibile in cazul terapiei cu warfarina sunt: (1623)\*\Possible complications of warfarin therapy are:
A) [x]sangerare\*\bleeding
B) [x]tromboza arteriala\*\administered only if a period of active thrombotic develop a potential throbogen
C) [x]necroza cutanata\*\skin necrosis
D) [x]embriopatia warfarinica\*\warfarin embriopathy
E) [ ]trombocitopenia mediata imun\*\Immune-mediated thrombocytopenia
---------------------------------------------------------------------


45
327. CM p5 [M2644221] Triada lui Virchov se caracterizeaza prin: ()\*\Virchov's triad is characterized by:
A) [ ]traumatismul local al peretelui arterial\*\local arterial wall trauma
B) [x]traumatismul local al peretelui vascular\*\local vascular wall trauma
C) [x]hipercoagulabilitatea\*\hipercoagulability
D) [ ]hipocoagulabilitatea\*\hipocoagulability
E) [x]staza\*\stasis
---------------------------------------------------------------------
328. CM p5 Care dintre afirmatiile referitoare la ultrasonografia venoasa efectuata la apcientii cu tromboembolism pulmonar este
adevarata? (1621)\*\Which of the statements about venous ultrasonography made on patients with pulmonary thromboembolism are true?
A) [ ]evidentiaza tromboza venoasa profunda la toti pacientii cu tromboembolism pulmonar\*\highlights deep vein thrombosis in
all patients with pulmonary thromboembolism
B) [ ]este extrem de utila pentru evidentierea trombusului cu localizare in venele pelvine\*\It is extremely useful for revealing the
location of thrombus in the pelvic veins
C) [x]are valoare certa la pacientii simptomatici in ambulator cu tromboza venoasa profunda proximala a membrelor
inferioare\*\has certain value in ambulatory patients with symptomatic proximal deep vein thrombosis of lower limbs
D) [ ]este o metoda sensibila pentru screeningul trombozei venoase profunde la pacientii asimptomatici internati\*\is a sensitive
method for screening asymptomatic deep vein thrombosis in hospitalized patients
E) [x]subestimeaza frecventa trombozei venoase proximale a membrulor inferioare la pacientii cu interventii ortopedice sau
neurochirurgicale\*\underestimate the frequency of proximal leg vein thrombosis in patients with orthopedic or neurosurgical intervention
---------------------------------------------------------------------
329. CM p5 [M2344178] Clasic, in tromboembolismul pulmonar, se descriu urmatoarel modificari electrocardiografice: (pg
1621)\*\the classical electrocardiographic changes in thomboembolism are:
A) [x]unda S in DI\*\S wave in DI
B) [x]flutter atrial recent instalat\*\atrial flutter recently installed
C) [ ]bradicardie sinusala\*\Sinus bradycardia
D) [x]axa QRS este la peste 90 grd\*\QRS axis is 90 degrees
E) [x]unda T negativa in V3\*\negative T wave in V3
---------------------------------------------------------------------
330. CM p5 Urmatoarele nu fac parte di triada Vircow (1620)\*\which of the following are not included in the Tirad of Vircow :
A) [ ]traumatism local al peretelui vascular\*\The local vascular wall injury
B) [x]hipercolesterolemia\*\hypercholesterolemia
C) [ ]staza\*\stasis
D) [ ]hipercoagulabilitatea\*\hipercoagulability
E) [x]hipertrigliceridemia\*\hypertriglyceridaemia
---------------------------------------------------------------------
331. CS p4 Cel mai obisnuit mecanism al stopului cardiac este: (247)\*\The most common mechanism of cardiac arrest is:
A) [x]Fibrilatia ventriculara\*\ventricular fibrillation
B) [ ]Bradiaritmii severe persistente\*\persistent severe bradyarrhythmia
C) [ ]Asistolia\*\asystole
D) [ ]Disociatia electromecanica\*\electromechanical dissociation
E) [ ]Tahicardia ventriculara sustinuta\*\sustained ventricular tachycardia
---------------------------------------------------------------------
332. CS p4 Cel mai frecvent mecanism electric al stopului cardiac este: (247)\*\Most common mechanism of cardiac arrest is:
A) [ ]bradiaritmia severa, persistenta\*\severe, persistent bradyarrythmia
B) [ ]asistolia\*\asystole
C) [ ]disociatia electromecanica\*\electromechanical dissociation
D) [ ]tahicardia ventriculara sustinuta\*\sustained ventricular tachycardia
E) [x]fibrilatia ventriculara\*\Ventricular fibrillation
---------------------------------------------------------------------
333. CS p4 [M2811235] Urmatoarele afirmatii cu privire la sincopele vasodepresoare sunt false, cu o exceptie: \*\These
statements on syncope vaso depressant are false, with one exception:
A) [ ]sunt consecinta directa a stopului cardiac\*\are the direct consequence of cardiac arrest
B) [ ]determina scaderea insidioassa a fluxului sangvin efectiv\*\insidious cause decreased blood flow actually
C) [x]multe dintre acestea sunt reversibile spontan\*\many of which are reversible spontaneously
D) [ ]sunt reversibile doar in urma interventiilor terapeutice\*\is reversible only after therapeutic interventions
E) [ ]sunt cauza frecventa de moarte subita cardiaca.\*\are common cause of sudden cardiac death
---------------------------------------------------------------------
334. CS p4 [M1111003] Urmatoarele conditii se asociaza cu stop cardiac prin scaderea acuta a debitului cardiac, cu EXCEPTIA:
(246)\*\The following cardiac conditions associated with cardiac arrest through an acute fall in cardiac output, except:
A) [ ]embolismul pulmonar acut masiv\*\acute massive pulmonary embolism
B) [ ]anafilaxia severa\*\severe anaphylaxis
C) [ ]anevrism de aorta rupt cu hemoragie interna\*\ruptured aortic aneurysm with internal bleeding
D) [x]tahicardie ventriculara nesustinuta, fara transformare in fibrilatie ventriculara\*\Unsupported ventricular tachycardia,

46
without ventricular fibrillation transformation
E) [ ]ruptura miocardica post infarct miocardic\*\myocardial rupture after myocardial infarction
---------------------------------------------------------------------
335. CS p4 [M1311017] Tratamentul stopului cardiac prin bradiaritmii sau asistolie nu include: (pag. 250)\*\Treatment of cardiac
arrest by bradyarrhythmia or asystole does not include:
A) [ ]dispozitive externe de electrostimulare\*\external devices for electrotherapy
B) [ ]intubatie orotraheala\*\orotracheal intubation
C) [x]defibrilare\*\defibrillation
D) [ ]adrenalina\*\adrenaline
E) [ ]atropina\*\atropine
---------------------------------------------------------------------
336. CS p4 [M2211033] Care este cea mai frecventa anomalie structurala generatoare de moarte subita cardiaca: (pag.
246)\*\What is the most common structural anomaly causing sudden cardiac death:
A) [ ]stenoza mitrala\*\mitral stenosis
B) [ ]stenoza aortica\*\aortic stenosis
C) [ ]insuficienta tricuspidiana\*\tricuspid faliure
D) [x]boala aterosclerotica coronariana\*\coronary atherosclerotic disease
E) [ ]sindromul Wolff-Parkinson-White\*\Wolff-Parkinson-White syndrome
---------------------------------------------------------------------
337. CS p4 Precizati factorii care NU sunt asociati mortii subite cardiace: (246)\*\Indicate factors witch are not related to sudden
cardiac death:
A) [ ]Intoxicatia cu cocaina\*\Cocaine poisoning
B) [ ]Intoxicatia cu digitala\*\Digital poisoning
C) [x]Sindromul LGL\*\LGL syndrome
D) [ ]Hipoxemia\*\hypoxemia
E) [ ]Acidoza\*\Lactic
---------------------------------------------------------------------
338. CS p4 [M2611080] Care din urmatoarele afectiuni cardiace NU reprezinta cauze structurale de stop cardiac si moarte subita
cardiaca: (246)\*\Which of the following heart diseases are NOT structural causes for cardiac arrest and sudden cardiac death
A) [ ]Boli valvulare cardiace\*\cardiac valvular disease
B) [ ]Cardiomiopatia dilatativa\*\Dilated cardiomyopathy
C) [ ]Infarctul miocardic vindecat\*\healed myocardial
D) [x]Hipopotasemia\*\Hypokalemia
E) [ ]Infarctul miocardic acut\*\Myocardial infarction
---------------------------------------------------------------------
339. CM p5 [M2211128] Mentionati factorii functionali asociati unor cauze cardiace structurale care contribuie la moartea subita
cardiaca: (246)\*\Mention the functional factors associated with structural cardiac causes that contribute to sudden cardiac death:
A) [x]reperfuzia dupa ischemie\*\reperfusion after ischemia
B) [ ]infarctul miocardic acut\*\acute myocardial infarction
C) [ ]cardiomiopatia hipertrofica obstructiva\*\hypertrophic obstructive cardiomyopathy
D) [x]ischemia tranzitorie\*\transient ischemia
E) [x]acidoza\*\acidosis
---------------------------------------------------------------------
340. CM p5 [M2211185] Prognosticul dupa stop cardiac intraspitalicesc resuscitat este mai bun la bolnavii cu: (pag.
250)\*\Prognosis after resuscitated hospital cardiac arrest is better in patients with:
A) [x]obstructia tranzitorie a cailor aeriene\*\transient airway obstruction
B) [x]dezechilibre electrolitice\*\electrolyte imbalances
C) [x]anomalii metabolice severe\*\severe metabolic abnormalities
D) [ ]instabilitate hemodinamica\*\hemodynamic instability
E) [ ]infectii severe, necontrolate terapeutic\*\severe infections, therapeutic uncontrolled
---------------------------------------------------------------------
341. CM p5 [M2811226] Instabilitatea electrofiziologica generatoare de stop cardiac fara IM acut este indicatie de: (250)
\*\electrophysiological instability generating cardiac arrest without acute MI is an indication of:
A) [x]tratament antiaritmic empiric cu amiodarona\*\empirical antiarrhythmic treatment with amiodarone
B) [x]tratament antiaritmic evaluat prin stimulare electrica programata\*\antiarrhythmic therapy evaluated by programmed
electrical stimulation
C) [x]chirurgie antiaritmica\*\antiarrhythmic surgery
D) [x]defibrilator-cardioverter implantabil\*\Implantable cardioverter-defibrillator
E) [ ]cardoistimulare permanenta\*\cardio constant stimulation
---------------------------------------------------------------------
342. CM p5 [M2211157] Care sunt tehnicile ventilatorii conventionale gresite in cadrul resuscitarii cardiorespiratorii atunci cand
resuscitarea este realizata de o singura persoana: (249)\*\Which are the conventional ventilatory techniques that are wrong in the
cardio-respiratory resuscitation when the resuscitation is performed by a person:

47
A) [x]15 insuflatii succesive dupa doua compresii toracice\*\15 chest compressions after two successive insufflations
B) [x]o insuflatie dupa cinci compresii toracice\*\one insufflation after five chest compressions
C) [x]cinci insuflatii la o compresie toracica\*\five insufflations to one chest compression
D) [ ]doua insuflatii succesive dupa 15 compresii toracice\*\two successive insufflations after 15 chest compressions
E) [x]patru insuflatii pulmonare la patru compresii toracice\*\four lung insufflations to four chest compressions
---------------------------------------------------------------------
343. CM p5 [M2211164] NU se incadreaza in etapa de asigurare a suportului vital avansat din cadrul resuscitarii
cardiorespiratorii urmatoarele manevre terapeutice: (pag. 249)\*\the following therapeutic maneuvers do not fit into the stage of
providing life support in advanced cardio-respiratory resuscitation:
A) [ ]intubatia cu sonsa endotraheala\*\endotracheal intubation with sons
B) [ ]asigurarea unei linii intravenoase\*\Ensure intravenous lines
C) [x]indepartarea corpilor straini din orofaringe\*\removal of foreign body from the oropharynx
D) [ ]defibrilarea/cardioversia\*\defibrillation / cardioversion
E) [x]curatirea cavitatii bucale de resturi alimentare\*\cleaning the mouth of food debris
---------------------------------------------------------------------
344. CM p5 Ingrijirea pacientului care face colaps cuprinde: (pag. 249)\*\Patient care which suffered a collapse includes:
A) [x]Interventia initiala si suportul vital de baza\*\The initial intervention and the life support
B) [x]Suportul vital avansat\*\advanced life support
C) [x]ingrijirea postresuscitare\*\post-resuscitation care
D) [ ]Anticoagulare pe termen lung\*\long-term anticoagulation
E) [x]ingrijire pe termen lung\*\Long-term care
---------------------------------------------------------------------
345. CM p5 In care situatii evolutia dupa resuscitarea stopului cardiac este favorabila la pacienti cu boli extracardiace (248)\*\In
which situations evolution after cardiac arrest resuscitation is favorable in patients with chronic Extra cardiac disease:
A) [x]obstructie tranzitorie a cailor aeriene\*\transient airway obstruction
B) [ ]infectii necontrolate\*\uncontrolled infection
C) [ ]cancer\*\Cancer
D) [x]medicatie ce induce aritmii\*\medications that induce arrhythmias
E) [x]dezechilibre electrolitice si metabolice severe tranzitorii\*\Transient severe electrolyte imbalances and metabolic
---------------------------------------------------------------------
346. CM p5 Compresia toracelui in timpul resuscitarii cardiorespiratorii NU presupune: (249)\*\Chest compression during cardio-
respiratory resuscitation does NOT involve:
A) [ ]ritmul de 80-100 compresii/minut\*\rate of 80-100 compressions per minute
B) [ ]o insuflare pulmonara la cinci compresii toracice\*\a lung insufflation to five chest compressions
C) [x]apasarea sternului cu antebratele flectate la 90 de grade\*\pressing the sternum with forearms bent at 90 degrees
D) [ ]comprimarea cordului cu 3-5 cm\*\3-5 cm cord compression
E) [x]ritmul de 50-70 compresii/minut\*\rate of 50-70 compressions / minute
---------------------------------------------------------------------
347. CM p5 Socul electric extern NU se administreaza bolnavilor cu: (250)\*\external electric shock is not administered to patients with:
A) [ ]tahicardie ventriculara sustinuta\*\sustained ventricular tachycardia
B) [ ]fibrilatie ventriculara\*\ventricular fibrillation
C) [x]asistola\*\asystole
D) [x]bradiaritmii\*\bradyarrythmias
E) [x]aritmie extrasistolica supraventriculara\*\extra-systolic supra-ventricular arrhythmia
---------------------------------------------------------------------
348. CM p5 Ritmul de perfuzare continua a procainamidei la bolnavii defibrilati repetat, la care persista instabilitatea electrica
NU este de: (250)\*\Continuous infusion rate of procainamide in patients repeatedly defibrillated, in which electrical instability persists is not:
A) [x]0,5 -2 mg/minut\*\0.5 -2 mg / minute
B) [x]5 -10 mg/minut\*\5 -10 mg / minute
C) [ ]2 -5 mg/minut\*\2 -5 mg / minute
D) [x]20 mg/minut\*\20 mg / minute
E) [x]100 mg/minut\*\100 mg / minute
---------------------------------------------------------------------
349. CM p5 [M2211148] Semnele de stop cardiac presupun: (pag. 249)\*\Signs of cardiac arrest assume:
A) [x]observarea miscarilor respiratorii\*\The observation of respiratory movements
B) [ ]observarea reflexului de deglutitie\*\observation of swallowing reflex
C) [x]observarea coloratiei tegumentului\*\observing skin colour
D) [x]precizarea absentei sau prezentei pulsului femural\*\Specification absence or presence of femoral pulse
E) [x]precizarea absentei sau prezentei pulsului carotidian\*\Specification absence or presence of carotid pulse
---------------------------------------------------------------------
350. CM p5 [M2611224] Care din urmatorii factori de risc ereditari sunt specifici pentru moartea subita cardiaca: (pag.
246)\*\Which of the following hereditary risk factors are specific for sudden cardiac death:
A) [ ]Hipertensiunea arteriala\*\High blood pressure

48
B) [x]Hiperlipoproteinemii genetice\*\Genetic Hyperlipoproteinemia
C) [x]Sindromul intervalului QT prelungit congenital\*\Congenital long QT syndrome
D) [x]Unele sindroame miopatice\*\Some myopathic syndromes
E) [x]Unele sindroame displazice\*\Some dysplastic syndromes
---------------------------------------------------------------------
351. CM p5 [M1211097] Dupa faza acuta a infarctului mioocardic, riscul pe termen lung de moarte subita cardiaca este prezis de:
(pag. 248)\*\After the acute phase of myocardial infarction, long-term risk of sudden cardiac death is predicted by:(p. 248)
A) [x]intinderea leziunii miocardului produsa in timpul evenimentului acut\*\The extent of myocardial injury produced during the acute event
B) [ ]prezenta complexelor ventriculare premature frecvente, pana la 5-10/ora\*\the presence of frequent premature ventricular
complexes, to 5-10/hour
C) [x]prezenta tahicardiei ventriculare nesustinute\*\the presence of unsupported ventricular tachycardia
D) [ ]prezenta fractiei de ejectie sub 50 %\*\the presence of ejection fraction below 50%
E) [x]prezenta insuficientei cardiace\*\presence of heart failure
---------------------------------------------------------------------
352. CM p5 In stopul cardiac secundar bradiaritmiilor NU sunt utile: (250)\*\In cardiac arrest secondary to bradyarrythmias is not useful:
A) [x]lidocaina\*\lidocaine
B) [x]procainamida\*\procainamide
C) [ ]electrostimularea\*\electrostimulation
D) [x]socul electric extern\*\external electric shock
E) [ ]atropina\*\atropine
---------------------------------------------------------------------
353. CM p5 [M2211123] Stopul cardiac NU este: (pag. 245)\*\Cardiac arrest is not:
A) [ ]oprirea brutala a functiei de pompa a inimii, reversibila prin interventie prompta\*\The brutal stop of the pump function of
the heart, reversible by prompt intervention
B) [x]pierderea subita a fluxului sanguin efectiv datorata factorilor cardiaci si/sau vasculari periferici, spontan reversibila sau doar
prin interventie\*\sudden loss of the effective blood flow due to cardiac and / or peripheral vascular factors. spontaneously
reversible or just through intervention
C) [x]oprirea ireversibila a tuturor functiilor biologice\*\irreversible cessation of all biological functions
D) [x]pierderea starii de constienta cu pastrarea functiilor vegetative\*\loss of consciousness with preserving autonomic function
E) [x]un eveniment absolut si ireversibil\*\an absolute and irreversible event
---------------------------------------------------------------------
354. CM p5 Drogurile utilizate in tratamentul fibrilatiei ventriculare sunt: (250)\*\Drugs used to treat ventricular fibrillation are:
A) [x]tosilatul de bretiliu\*\bretilium tosylate
B) [x]lidocaina\*\lidocaine
C) [x]procainamida\*\procainamide
D) [ ]digoxin\*\digoxine
E) [ ]atropina\*\atropine
---------------------------------------------------------------------
355. CM p5 [M1511115] Debutul stopului cardiac poate fi caracterizat prin simptome tipice unui eveniment cardiac acut precum:
(247)\*\The debut of cardiac arrest can be characterized by typical symptoms of an acute cardiac event such as:
A) [x]durerea de debut din infarctul miocardic\*\The debut pain of the myocardial infarction
B) [x]dispneea acuta sau ortopneea\*\acute dyspnea or ortopneea
C) [x]palpitatiile\*\palpitations
D) [x]ametelile instalate brusc\*\Dizziness suddenly installed
E) [ ]febra\*\Fever
---------------------------------------------------------------------
356. CM p5 [M2211161] Compresia toracelui in timpul resuscitarii cardiorespiratorii NU presupune: (pag. 249)\*\Chest
compression during cardio-respiratory resuscitation does NOT involve:
A) [x]cinci insuflatii pulmonare la cinci compresii toracice\*\five pulmonary insufflations to five chest compressions
B) [x]ritmul de 40-50 compresii/minut\*\rate of 40-50 compressions / minute
C) [x]comprimarea cordului cu 15 cm\*\15 cm cord compression
D) [ ]apasarea sternului cu bratele intinse\*\pressing the sternum with the arms stretched
E) [ ]ritmul de 80-100 compresii/minut\*\The rate of 80-100 compressions per minute
---------------------------------------------------------------------
357. CM p5 [M1211099] Care dintre afirmatiile referitoare la resuscitarea cardio-respiratorie sunt corecte: (249)\*\Which of the
allegations regarding cardio-respiratory resuscitation are correct:
A) [x]se indeparteaza corpii straini sau dantura falsa\*\Remove foreign objects or false teeth
B) [x]o insuflare a plamanului se realizeaza dupa fiecare 5 compresii toracice, daca resuscitarea este realizata de 2 persoane\*\a
lung insufflation is done after every five chest compressions, if resuscitation is performed by two persons
C) [ ]doua insuflari ale plamanului se realizeaza dupa 5 compresii toracice, daca resuscitarea este realizata de o singura
persoana\*\second insufflation of the lung is accomplished by five chest compressions, if resuscitation is performed by one person
D) [x]sternul este apasat cu o rata de aproximativ 80-100/min;\*\sternum is pressed with a rate of approximately 80-100/min
E) [x]compresia toracelui va comprima cordul cu 3-5 cm\*\chest compression will compress the heart with 3-5 cm

49
---------------------------------------------------------------------
358. CM p5 In stopul cardiac secundar bradiaritmiilor sau asistoliei: (250)\*\In cardiac arrest secondary to bradyarrythmia or asystole:
A) [x]Nu este necesar socul extern\*\You do not need external shock
B) [ ]Este necesar socul extern\*\The external shock
C) [x]Adrenalina se administreazaintravenos\*\Adrenaline is intravenously administerd
D) [x]Atropina se administreazaintravenos\*\atropine to intravenous administerd
E) [ ]Pacientul nu necesitaintubare\*\The patient does not require intubation
---------------------------------------------------------------------
359. CM p5 Care sunt disritmiile mai putin frecvente (20-30%) implicate in generarea stopului si mortii subite cardiace:
(247)\*\Which are the less common disrythmia (20-30%) involved in generating cardiac arrest and sudden death:
A) [ ]fibrilatia ventriculara\*\ventricular fibrillation
B) [x]asistolia\*\asystole
C) [x]disociatia electromecanica\*\dissociating electro
D) [x]bradiaritmiile severe, persistente\*\persistent sever bradyarrythmia
E) [ ]tahicardia ventriculara sustinuta\*\sustained ventricular tachycardia
---------------------------------------------------------------------
360. CM p5 [M2211127] In care dintre afectiunile enumerate factorul ereditar contribuie la riscul pentru moarte subita cardiaca:
(246)\*\In which of the diseases listed, heredity contributes to the risk for sudden cardiac death:
A) [ ]cardiopatia ischemica\*\ischemic cardiomyopathy
B) [ ]stenoza mitrala\*\mitral stenosis
C) [x]sindromul intervalului QT prelingit congenital\*\trickle congenital QT syndrome
D) [x]hiperlipoproteinemiile genetice\*\Genetic hiperlipoproteinemia
E) [ ]cardiomiopatia dilatativa\*\Dilated cardiomyopathy
---------------------------------------------------------------------
361. CS p4 Urmatoarele afirmatii sunt adevarate despre AgHBc cu exceptia:\*\ The following affirmations on AgHBc are correct, except:
A) [ ] este rezultatul traducerii proteinei C initiata in regiunea core \*\ is the result of the translation of C Proteins initiated in the core region
B) [ ] ramane in hepatocite unde este detectat cu usurinta prin coloratiiimunohistochinice \*\ remains in the hepatocytes where it
is easily detected by immunohistochemical staining
C) [ ] sunt exportate dupa incapsidare cu un invelis de AgHBs \*\ are exported after incapsualtion with an envelope of AgHBs
D) [ ] nu se gaseste in ser \*\ can not be found in serum
E) [x] are o peptida semnal cu care se ataseaza de reticulul endoplasmatic neted \*\ has a signal peptide with which it bindsto the
rough endoplasmatic reticulum
---------------------------------------------------------------------
362. CS p4 Rolul carui virus hepatitic nu a fost inca stabilit: (1847) \*\ The role of which hepatic virus has still not yet been stabilized:
A) [ ] Virusul hepatitei A \*\ Hepatic Virus A
B) [ ] Virusul hepatitei E \*\ Hepatic VirusE
C) [ ] Virusul hepatitei B \*\ Hepatic Virus B
D) [ ] Virusul hepatitei D \*\ Hepatic Virus D
E) [x] Virusul hepatitei G \*\ Hepatic Virus G
---------------------------------------------------------------------
363. CS p4 [CSN0002] Care virus hepatitic nu a fost inca vizualizat prin microscopie electronica: (p. 1847, fig. 295-1) \*\ Wich
hepatic virus has not yet been visualised by Eectric Microscope:
A) [ ] Virusul hepatitei A \*\ Hepatic Virus A
B) [ ] Virusul hepatitei B \*\ Hepatic Virus B
C) [x] Virusul hepatitei C \*\ Hepatic Virus C
D) [ ] Virusul hepatitei D \*\ Hepatic Virus D
E) [ ] Virusul hepatitei E \*\ Hepatic Virus E
---------------------------------------------------------------------
364. CM p5 Hepatitele acute virale cu transmitere fecal-orala sunt: (1855) \*\ Acute viral hepatitis with fecal oral transmissionis:
A) [x] HAV \*\ HVA
B) [ ] HBV \*\ HVB
C) [ ] HCV \*\ HVC
D) [ ] HDV \*\ HVD
E) [x] HEV \*\ HVE
---------------------------------------------------------------------
365. CM p5 Pentru diagnosticul hepatitelor acute virale se impune: (1860) \*\ For the diagnostics of acute viral hepatitis is required:
A) [x] Biopsia cand se suspecteaza o hepatita cronica \*\ Biopsy if chronic hepatitis is suspected
B) [x] Testarea serologica a pacientului \*\ Serologic testsing of the patient
C) [ ] Determinarea TCD4+ \*\ Determinatin of TCD4+
D) [x] Aminotransferazele serice (AST) si (ALT) \*\ Serum Aminotransferases (AST) and (ALT)
E) [ ] Dozarea de complexe imune circulante in ser \*\ The dosis of circulating immune complexes in Serum
---------------------------------------------------------------------


50
366. CM p5 In faza acuta a hepatitei A diagnosticul este sustinut de: (1847) \*\ In the acute phase of hepatitis A diagnosis is supported by:
A) [ ] Prezenta anticorpilor anti - HAV Ig G \*\ IgG anti-HAV
B) [x] Prezenta anticorpilor anti-HAV Ig M \*\ Ig M anti- HAV
C) [x] aminotransferaza serica cu valori crescute \*\ elevated serum aminotransferase
D) [ ] absenta virusului in materii fecale \*\ absence of virus in feces
E) [ ] hipocolesterolemie \*\ Hypocholesterolemia
---------------------------------------------------------------------
367. CM p5 [M1524078] Care din urmatoarele afirmatii sunt adevarate in legatura cu epidemiologia hepatitei virale acute tip A:
(pag. 1855, 1856) \*\Which of the following statements are true in connection with the epidemiology of Acute hepatitis virus A:
A) [ ] virusul se transmite predominant pe cale transfuzionala \*\ Predominately is transmitted via blood transfusions
B) [x] apar valuri epidemice la 5-20 de ani \*\ appears at 5-20yrs
C) [ ] numarul de cazuri este constant pe parcursul anului \*\ number of cases are constant by precursor years
D) [x] acest tip de hepatita apare mai ales la sfarsitul toamnei si inceputul iernii \*\ spears in mostly the end of autumn and
beginning of winter
E) [x] calea majora de transmitere este fecal-orala \*\ major transmission is fecal oral
---------------------------------------------------------------------
368. CM p5 [M2624123] Indicati afirmatiile corecte referitoare la diagnosticul de laborator al hepatitei acute virale C: (1853) \*\
Point out the correct statements on the laboratory diagnostics of acute viral hepatitis C:
A) [ ] Absenta Atc anti-HCV permite excluderea infectiei cu HCV \*\ Absence of antibodies anti HCV allows exclusion infection with HCV
B) [x] ARN-ul HCV este detectabil dupa cateva zile de la expunerea la HCV \*\ The RNA of HCV is detectable within some days
after exposure to HCV
C) [x] Cea mai sensibila metoda de evidetiere a ARN-HCV este PCR \*\ The most sensitive method to evidence RNA of HCV is by PCR
D) [x] Cresterea alaninaminotransferazei (ALT) este precedata de aparitia ARN-HCV \*\ The increase of Alaninaminotransferase
(ALT) is preceeded by the appearnace of RNA of HCV
E) [ ] ARN-ul HCV nu este detectabil in limfocitele din sange la persoanele infectate \*\ The RNA of HCV is not detectable in
lymphocytes in blood from infected persons
---------------------------------------------------------------------
369. CM p5 [M1324070] Complicatiile rare ale hepatitei virale includ: (1861) \*\ Rare complications of viral hepatitis include
A) [x] pancreatita \*\ pancreatitis
B) [x] miocardita \*\ myocarditis
C) [ ] osteomielita \*\ osteomyelitis
D) [ ] meningita \*\ meningitis
E) [x] anemia aplastica \*\ aplastic anemia
---------------------------------------------------------------------
370. CM p5 [M1524077] Care dintre hepatitele virale acute pot fi prevenite prin vaccinare: (1855) \*\ Which of the following
acute hepatitis viruses can be prevented by vaccine?
A) [x] HAV \*\ HVA
B) [x] HBV \*\ HVB
C) [ ] HCV \*\ HVC
D) [ ] HGV \*\ HVG
E) [ ] HEV \*\ HVE
---------------------------------------------------------------------
371. CM p5 [M2624139] Despre HBV putem afirma (pg. 1848) \*\ About HVB following affirmatins can be made:
A) [x] este o particula de dimensiuni mici \*\ It is a particle of smal dimensions
B) [x] are un genom partial monocatenar, partial dublucatenar \*\ It has a genom partially monocatenary, partial doubblecatenary
C) [x] se bazeaza pe o stradegie replicativa tipica retrovirusilor \*\ it is based on a retrovirus replication strategy
D) [ ] are doua forme morfologice distincte \*\ Has two morphologic distinct forms
E) [x] se poste cultiva prin combinarea anumitor celule cu ADN-HBV \*\ It can be cutivated by combination of several cells with HBV-DNA
---------------------------------------------------------------------
372. CM p5 Urmatoarele afirmatii cu privire la hepatita virala acuta B sunt corecte cu exceptia: (1850) \*\ The following
affirmations regarding acute viral hepatitis B are correct except:
A) [x] In infectia acuta HBV, AgHBe se dezvolta tardiv in decursul bolii \*\ During acute infection withHBV, the AgHBe
developes late in the course of the disease
B) [ ] Serul AgHBs pozitiv continand AgHBe prewzinta infectivitate ridicata \*\ Serum positiv AgHBs containing AgHBe
represents an increased infectivity
C) [x] Gravidele purtatoare de AgHBs si Atc Anti-Hbe transmit frecvent infectia produsului de conceptie \*\ Pregnants with
AgHBs and Antibodies AntiHBe often transmit the infection during conception
D) [ ] Persistenta in ser a AgHBe peste durata de 3 luni semnaleaza dezvoltarea infectiei cronice \*\ Persistence of AgHBe in
Serum for 3 months signalizes development of chronic infection
E) [ ] Persistenta AgHBe dupa hepatita acuta virala B se asociaza cu continuarea replicarii virale \*\ Persistence of AgHBe after
an acute viral hepatitis B is associated with continuous viral replication
---------------------------------------------------------------------


51
373. CM p5 [M2524119] Urmatoarele produse biologice sunt mai frecvent implicate in transmiterea virusului hepatitic C? () \*\
The following biologic products are frequently involved in transmission of hepatic virus C?
A) [x] singe integral \*\ Whole Blood
B) [x] plasma \*\ Plasma
C) [x] concentratele de factori de coagulare \*\ Concentrates of coagulation factors
D) [ ] albumina \*\ Albumines
E) [ ] imunoglobuline (administrabile intramuscular) \*\ Immunoglobulines (intramuscular administration)
---------------------------------------------------------------------
374. CM p5 Biopsia hepatica este indicata in hepatiele acute virale cand: (1860) \*\ Liver biopsy is indicated in acute viral hepatiele when
A) [x] Se suspicioneaza o hepatita cronica. \*\ chronic hepatitis thinks.
B) [x] Diagnosticul este incert. \*\ The diagnosis is uncertain
C) [ ] Se suspicioneaza evolutia spre o forma fulminanta si in acest fel se pune un diagnostic precoce. \*\ thinks evolution to a
fulminating form and so put an early diagnosis
D) [ ] in formele colestatice. \*cholestatic forms\
E) [ ] in formele anicterice. \*in the ways anicterice\
---------------------------------------------------------------------
375. CM p5 [M2624121] Indicati afirmatiile corecte referitoare la hepatita acuta virala B: (1850) \*\ Mark the correct affirmations
that refers to acute viral hepatitis B:
A) [x] Primul marker detectabil in ser este AgHBs \*\ The first detectable serum- marker is AgHBs
B) [x] Anticorpii anti-HBs sunt detectabili in ser nedefinit dupa boala acuta \*\ Antibodies anti-HBs are detectable in serum for
indefinet time after an acute disease
C) [ ] Anticorpii anti-HBc pot fi evidentiasi in ser incepand cu perioada de declin a bolii \*\ Antibody anti-HBc can be evident in
serum at the beginning of the period when the disease declines
D) [ ] AG HBs este detectabil in ser de reguli peste 6 luni de la debut \*\ AG HBs is usually detectable in serum for 6 months
from the onset
E) [x] Atc Anti-HBc din ser preced cu cateva saptamani anticorpii anti-HBs \*\ Antibdies anti HB c of the serum preceeds the
antibodies anti HB s with some weeks
---------------------------------------------------------------------
376. CM p5 In afara implicarii virusurilor hepatitice umane, instalarea afectarii hepatice poate fi cauzata de: (1862.) \*\ Besides
human hepatitis virus what else can affect the liver
A) [x] Leptospira spp \*\ Leptospira
B) [x] Brucella spp \*\ Brucella
C) [x] Pneumocystis carinii \*\ Pneumocystis carinii
D) [x] Mycobacteria spp \*\ Myobacteria
E) [ ] Trichomonas \*\ Trichonomas
---------------------------------------------------------------------
377. CM p5 [M2624127] Pricipalele leziuni morfologice ale hepatitelor virale acute sunt: (pag. 1854) \*\ The principal
morphologic lesions of acute viral hepatitis are:
A) [ ] Celulele Kupffer nemodificate \*\ Unmodificated Kupffer cells
B) [x] Infiltrarea panlobulara cu celule mononucleare \*\ Panlobular infiltration with mononuclear cells
C) [ ] Absenta colestezei \*\ Absence of cholestasis
D) [x] Necroza celulelor hepatice \*\ Hepatic cell necrosis
E) [x] Mitoza celuleor hepatice \*\ Mitosis of hepatic cells
---------------------------------------------------------------------
378. CM p5 [M1324067] In hepatita acuta B pot fi evidentiati urmatorii markeri virali: (pag. 1859) \*\ The following markers
provide evidence of acute hepatitis B Virus
A) [x] antigeni HBs \*\ HBs antigen
B) [ ] anticorpi anti -HBs \*\ anti-HBs
C) [x] Ig M anti -HBc \*\ Ig M anti-HBc
D) [ ] Ig G anti-HBc \*\ Ig G ant-HBc
E) [x] antigen Hbe \*\ HBe antigen
---------------------------------------------------------------------
379. CM p5 [M1424071] Diagnosticul de infectie cu VHB este pus in baza urmatorilor markeri serologici: (1860) \*\ The
following serologic markers are diagnostic of infection with HBV:
A) [x] AgHBs pozitiv \*\ AgHBV positive
B) [x] AgHBs pozitiv+ IgM-HBc poz + AgHBe pozitiv \*\ AgHBs positive ,IgM-HBc positive, AgHBe positive
C) [x] AgHBs poz + IgG-HBc poz + AgHBe poz \*\ AgHBs positive .IgG positive ,antibody antigen Hbe positive
D) [x] AgHBs poz + IgG - HBc poz + anticorpi anti HBe poz \*\ AgHBs positive, IgG-HBc positive,antibody HBe positive
E) [ ] AgHBs neg + IgG - HBc poz + anticorpi anti HBe poz + anticorpi anti HBs poz \*\ AgHBs negative, IgG-HBc positive,
antibodyHBe positive, antibody anti HBs positive
---------------------------------------------------------------------
380. CM p5 [M1524075] Urmatoarele afirmatii sunt adevarate in ceea ce priveste atg HBs, cu EXCEPTIA: (pag. 1850) \*\ The
following statements are true in sight of antigen HBs with EXCEPTION:

52
A) [ ] este constituient al anvelopei HBV \*\ is a compound of a nuclear capsule
B) [ ] poate exista in ser sub forma filamentoasa sau sferica \*\ may exist in sub serum form filament or sferica
C) [x] este constituient al nucleocapsidei \*\ consists of a nuclear capsule
D) [x] nu induce aparitia de anticorpi specifici \*\ doesn't induce the specific antibody
E) [ ] persistenta peste 6 luni sugereaza cronicizarea infectiei \*\ persistence over 6 months suggests chronic infection
---------------------------------------------------------------------
381. CM p5 [M2625150] Proteina mare al HBV: (pg. 1848) \*\ The big protein of HVB:
A) [x] este produsa de gena pre S1 \*\ is produced of type pre S1
B) [x] este produsa de gena pre S2 \*\ is produced of type pre S2
C) [x] este produsa de gena S \*\ is produced of type S
D) [x] specifica virionului complet \*\ The specific complete virion
E) [ ] specific tuturor celor 3 forme morfologice \*\ Speficic for all three morphologic forms
---------------------------------------------------------------------
382. CM p5 [M2524116] Care dintre caracteristicile de laborator enumerate mai jos se coreleaza cu formele severe ale hepatitelor
virale acute (cu lezare importanta hepatocelulara)? (pag. 1858) \*\ Which of the below mentioned laboratory characteristics are
correlated with severe forms of acute viral heptitis (with remarkable hepatoceluar injury)
A) [ ] aminotransferaze serice crescute \*\ Increased serum aminotransferase
B) [x] bilirubinemie > 20 mg/dl, persistenta \*\ Persistent bilirunbinemia > 20mg/dl
C) [x] prelungire importanta a timpului de protrombina (TP) \*\ Remarkable prolongation of prothrombin time (TP)
D) [x] hipoglicemie \*\ Hypoglycemia
E) [ ] nivel normal al albuminei serice \*\ Normal levels of serum albumin
---------------------------------------------------------------------
383. CM p5 [M2625152] Care sunt virusurile hepatice flavivirus-like (pg.1849) \*\ Which are the flavivirus-like virus?
A) [ ] HAV \*\ HVA
B) [ ] HBV \*\ HVB
C) [x] HCV \*\ HVC
D) [ ] HDV \*\ HVD
E) [x] HGV \*\ HVG
---------------------------------------------------------------------
384. CM p5 [M2624133] Semnificatia timnpului de protombina in hepatitele acute virale sunt urmatoarele, cu exceptia: (pag.
1858) \*\ The significance of the prothombin time in acute viral hepatitis are the following, except:
A) [x] Indica un prognostic favorabil \*\ Indicates a favourable prognosis
B) [ ] Prelungirea acestuia reflecta deficitul de sinteza \*\ It's elongation reflects a defecit of synthesis
C) [x] Conduce la cronicizare \*\ Leads to chronic state
D) [ ] Necroza hepatocelulara extinsa \*\ Extensive hepatocelular necrosis
E) [ ] Contribuie la un prognostic nefavorabil \*\ Contribute to an unfavourable prognosis
---------------------------------------------------------------------
385. CM p5 Calea de transmitere a infectiei cu virusul hepatitei B poate fi: (1856) \*\ Viral Hepatitis B can be transmitted by:
A) [x] sexuala \*\ sex
B) [x] prin transfuzie de sange sau derivate \*\ blood transfusion or derivatives
C) [ ] aerogena \*\ airbourne
D) [x] perinatala \*\ Perinatal
E) [x] percutana \*\ Percutaneous
---------------------------------------------------------------------
386. CM p5 Calea de transmitere a infectiei cu virusul hepatitei C nu e: (1857)\*\The path of transmission of infection with hepatitis C is not
A) [x] Fecal-orala \*\ fecal-oral
B) [ ] Prin transfuzii de sange \*\ The blood transfusion
C) [ ] Prin sistemele de hemodializa \*\The hemodialysis system
D) [x] Hidrica \*\ fluid
E) [ ] Transplant de organe \*\ Organ Transplantation
---------------------------------------------------------------------
387. CM p5 [M1324066] Debutul unei hepatite virale include frecvent urmatoarele simptome: (1857) \*\ The following
symptoms can be present at the onset of viral hepatitis
A) [x] digestive \*\ Digestive
B) [x] pseudogripale \*\ Flu like
C) [x] mio-osteo-articulare \*\ myo-osteo-articular
D) [ ] tulburari oculare si auditive \*\ ocular and auditory disturbances
E) [ ] oligurie/anurie \*\ oliguria/anuria
---------------------------------------------------------------------
388. CM p5 [M1524076] In legatura cu virusul hepatitic E afirmatiile de mai jos sunt adevarate, cu EXCEPTIA: (pag. 1853,
1847) \*\ The following statements in connection with HVE is true with EXCEPTION:
A) [ ] realizeaza un tip distinct de hepatita nonA nonB, cu modalitate de transmitere digestiva \*\ realized a type of distinct
Heptatis nonA nonB with modality of digestive transmission

53
B) [x] este incadrat in clasa flavivirusurilor \*\ is included in class flavivirus
C) [ ] izolatele HEV par sa apartina unui singur serotip \*\ isolation HVE appears a single serotype
D) [x] poate duce la aparitia de hepatita cronica, ciroza hepatica, carcinom hepatocelular \*\ may lead to appearance of chronic
hepatitis ,cirrhosis,hepatocellular carcinoma
E) [x] este inrudit cu HAV \*\ related to HVA
---------------------------------------------------------------------
389. CM p5 [M1224061] Hepatita virala aacuta cu virus A se considera a prezenta recadere daca se constata: (pag. 1860) \*\
Relapse of acute hepatitis A virus is considered to be present if you find
A) [ ] ameliorarea icterului \*\ improvement of jaundice
B) [x] recurenta simptomelor initiale \*\ recurrent initial symptoms
C) [x] excretia fecala a HAV \*\ fecal excretion of HAV
D) [x] cresterea aminotransferazelor \*\ increased aminotransferase
E) [ ] evolutie clinica spre cronicizare \*\ The clinical evolution to be chronic
---------------------------------------------------------------------
390. CM p5 [M2625151] Despre AgHBe putem afirma (pg.1848) \*\ About AgHBe following affirmations can be made:
A) [x] este produsa de regiunea precore al genei C \*\ it is produced by the precore region of the C type
B) [x] are o peptida semnal \*\ they have a signal peptide
C) [x] se secreta in circulatie \*\ it is secreteing in circulation
D) [ ] e insolubila \*\ it is unsoluble
E) [ ] are structura particulata \*\ it has a specific structure
---------------------------------------------------------------------
391. CS p4 [M1416021] Masuri eficiente dovedite in terapia cirozei biliare primitive sunt urmatoarele: (pg 1883) \*\ Proven
effective measures in the treatment of primary biliary cirrhosis are:
A) [ ] glucocorticoizii \*\ Glucocorticoids
B) [ ] D-penicilamina \*\ D-penicillamine
C) [ ] metotrexat \*\ methotrexate
D) [x] acid ursodezoxicolic \*\ Acid ursodezoxicolic
E) [ ] ciclosporina \*\ cyclosporine
---------------------------------------------------------------------
392. CS p4 [M2616089] Care din ummatoarele afirmatii cu privire la tratamentul hipertensiunii portale sunt false? (pg 1886) \*\
Which of the following statements on the treatment of portal hypertension are false?
A) [ ] Betablocantele se folosesc in doze care reduc frecventa cardiaca cu 25%. \*\beta-blockers are used in doses that reduce
cardiac frequency by 25%
B) [x] Betablocantele nu mai sunt indicate la pacientii care au avut sangerare variceala \*\ beta-blockers are not indicated in
patients who have had to variceal bleeding
C) [ ] Se poate folosi propranololul sau nadololul. \*\ You can use propranolol or nadololul
D) [ ] Sunturile portosistemice chirugicale nu cresc supravietuirea bolnavilor cirotici. \*\ surgical portosistemice shunts does not
increase the survival of cirrhotic patients
E) [ ] Exista posibilitatea realizarii unor sunturi portosistemice nechirugical \*\ there are possibility to achieve non surgical
portosystemic shunt
---------------------------------------------------------------------
393. CS p4 Suntul porto-cav in urgenta este insotit de o mortalitate de: (1877) \*\ Are Porto-cavity sound in emergency is accompanied by a
mortality rate
A) [ ] 25% \*\ 25%
B) [x] 30% \*\ 30%
C) [ ] 60% \*\ 60%
D) [ ] 15% \*\ 15%
E) [ ] 40% \*\ 40%
---------------------------------------------------------------------
394. CS p4 Care este boala ce determina hipertensiune portala la nivel sinusoidal? (pg 1885) \*\ What is the disease that cause
portal hypertension at the sinus?
A) [ ] sindromul Budd-Chiari \*\ Budd-Chiari syndrome
B) [ ] tromboza venei cave inferioare \*\ inferior vena cava thrombosis
C) [ ] boala venoocluziva \*\ venoocluziva disease
D) [ ] schistosomiaza \*\ schistosomiaza
E) [x] ciroza hepatica \*\ liver cirrhosis
---------------------------------------------------------------------
395. CS p4 [M2516069] Tratamentul cu colchicina este indicat in: (1880) \*\ Treatment with colchicine is indicated with
A) [ ] ciroza postvirala \*\ postviral cirrhosis
B) [ ] hepatita autoimuna \*\ autoimmune hepatitis
C) [ ] hepatita cronica virala \*\ chronic viral hepatitis
D) [x] hepatopatiile alcoolice \*\ Alcoholic liver disease
E) [ ] ciroza biliara secundara \*\ secondary biliary cirrhosis

54
---------------------------------------------------------------------
396. CS p4 [M1316017] Urmatoarele afirmatii despre ciroza biliara secundara sunt adevarate, cu exceptia: (pg 1883) \*\ The
following statements are true about secondary biliary cirrhosis, except:
A) [ ] febra si durerile colicative de tip biliar sunt tipice pentru tabloul clinic\*\ The fever and biliary colic pain are typical clinical
picture
B) [ ] in ser exista lipoproteina X. \*\ in serum exist lipoprotein X
C) [ ] colangita este o complicatie frecventa. \*\ cholangitis is a frequent complication
D) [ ] ruperea ductelor biliare duce la formarea de lacuri biliare. \*\ breaking the bile duct leading to the formation of bile lakes
E) [x] pentru ca obstructia biliara se produca ciroza sunt suficiente 3 luni. \*\ for biliary obstruction is sufficient to produce
cirrhosis less than three months
---------------------------------------------------------------------
397. CS p4 [M2516083] Un regim adecvat pentru a induce o balanta negativa a sodiului si a permite diureza la un pacient cu
ciroza hepatice si ascita contine NaCl in cantitate de: (pg 1889) \*\ A proper diet to induce a balance of negative sodium and
allow diuresis to a patient with liver cirhosis, contain NaCL in quantity of:
A) [ ] 10 g \*\ 10 g
B) [ ] 0,2 g \*\ 0,2 g
C) [ ] 2 mg \*\ 2 mg
D) [ ] 20 g \*\ 20 g
E) [x] 2 g \*\ 2 g
---------------------------------------------------------------------
398. CS p4 [M1416022] Stadiul II al leziunilor histopatologice din ciroza biliara primitiva este caracterizat de: (pg 1882) \*\
Stage II of the histopathological lesions of primary biliary cirrhosis is characterized by:
A) [ ] corpi Mallory si scleroza hialina centrala \*\ Mallory bodies and central hyaline sclerosis
B) [ ] noduli de regenerare mari separati de benzi fibroase \*\ large regenerative nodules separated by fibrous bands
C) [x] infiltrat inflamator redus, ductopenie si proliferarea canaliculelor biliare mici \*\ reduced inflammatory infiltrate,
ductopenie and small biliary canalicular proliferation
D) [ ] congestie pasiva, fibroza si necroza pericentrolobulara \*\ passive congestion, fibrosis and necrosis pericentrolobulara
E) [ ] hepatocite incarcate lipidic \*\ lipid loaded hepatocytes
---------------------------------------------------------------------
399. CM p5 Factorii precipitanti ai encefalopatiei hepatice sunt: (1891) \*\ Precipitant factors of hepatic encephalopathy are
A) [x] diuretice tiazidice \*\ thiazide diuretics
B) [x] sangerari digestive \*\ gastric bleeding
C) [x] infectii \*\ infections
D) [ ] antibiotice din clasa penicilinelor \*\ penicillin antibiotic
E) [x] interventii chirurgicale \*\ surgical intervention
---------------------------------------------------------------------
400. CM p5 Alegeti situatiile in care o biopsie hepatica percutana poate fi utila pentru diagnosticul bolii hepatice alcoolice sau cirozei: (1880)
\*\ Select situations in which a percutaneous liver biopsy may be useful for the diagnosis of alcoholic liver disease and cirrhosis
A) [x] in deosebirea pacientilor cu afectare hepatica mai putin avansata de cei cu ciroza \*\ to distinguish patients with less
advanced liver damage from those with cirrhosis
B) [x] excluderea hepatitei virale \*\ the exclusion of viral hepatitis
C) [x] evaluarea pacientilor care neaga consumul de alcool \*\ evaluation of patients who deny alcohol
D) [ ] pentru a confirma constatarile tipice pentru hepatita alcoolica sau ciroza \*\ To confirm the findings typical of alcoholic
hepatitis or cirrhosis
E) [ ] pentru excluderea prezentei obstructiei biliare extrahepatice \*\ to exclude extrahepatic biliary obstruction
---------------------------------------------------------------------
401. CM p5 [M2216198] Alegeti afirmatiile corecte despre testul anticorpilor antimitocondriali in ciroza biliara primitiva: (pg
1882) \*\ Choose the correct statements about the test antimitochondrial antibody in primary biliary cirrhosis (pg 1882)
A) [ ] testul este absolut specific pentru boala \*\ The test is absolutely specific for the disease
B) [x] testul este sensibil pentru boala \*\ the test is sensitive to disease
C) [x] testul pozitiv se intalneste la peste 90% dintre pacientii simptomatici \*\ positively test encounters above 90% symptomatic patients
D) [x] diagnosticul bolii, cand bilirubina si aminotransferazele serice sunt normale, este sprijinit de pozitivitatea testului \*\
diagnosis when serum bilirubin and aminotransferases are normal, is supported by test positivity
E) [ ] titrul este mai mic de 1:40 cand testul este pozitiv \*\ less than 1:40 titer test is positive when
---------------------------------------------------------------------
402. CM p5 [M2216192] Care din urmatoarele alterari sunt cel mai frecvent intalnite in ciroza biliara primitiva ? (pg 1881-1882)
\*\ Which of these alterations are most commonly seen in primary biliary cirrhosis?
A) [x] anticorpi antimitocondriali circulanti de tip IgG \*\ circulating IgG antibodies antimitocondriali
B) [x] niveluri serice crescute de IgM si crioproteine \*\ Increased serum levels of IgM and cryoprotein
C) [ ] anticorpi antinucleari circulanti \*\ circulating antinuclear antibodies
D) [ ] IgA serica crescuta \*\ serum IgA increased
E) [ ] limfocitoza \*\ lymphocytosis
---------------------------------------------------------------------

55
403. CM p5 [M1316122] Urmatoarele afirmatii despre hemoragia digestiva superioara prin ruptura varicelor esofagiene sunt
adevarate: (pg 1886) \*\ The following statements about upper GI bleeding by rupture of esophageal varices are true:
A) [ ] 80% din cazuri se opresc spontan. \*\ 80% of cases stop spontaneously
B) [ ] controlul terapeutic al sangerarii se obtine la 50% din cazuri. \*\ treatment of bleeding control is achieved in 50% of cases
C) [ ] resangerea apare la mai putin de 50% din cazuri. \*\ rebleeding occurs in less than 50% of cases
D) [x] 50% se opresc spontan \*\ 50% stop spontaneously
E) [x] tratamentul medicamentos consta in folosirea vasopresinei si stomatostatinei. \*\ drug therapy lies in the use of vasopressin
and stomatostatin
---------------------------------------------------------------------
404. CM p5 [M1516138] In patogeneza ascitei din ciroza hepatica sunt implicati urmatorii factori: (pg 1888) \*\ The pathogenesis
of ascites in liver cirrhosis are involved the following factors: (pg 1888)
A) [x] hipoalbuminemia \*\ hypoalbuminemia
B) [ ] scaderea rezistentei vasculare intrahepatice \*\ decreased intra hepatic vascular resistance
C) [ ] cresterea volumului intravascular efectiv \*\ increased effective intravascular volume
D) [x] reducerea presiunii oncotice plasmatice \*\ reduction of plasma oncotic pressure
E) [x] scaderea perfuziei renale \*\ decrease in renal perfusion
---------------------------------------------------------------------
405. CM p5 In peritonita bacteriana spontana, complicatia cirozei: (1888) \*\ The spontaneous bacterial peritonitis, complication of cirrhosis
A) [x] debutul este abrupt cu febra, frisoane, dureri abdominale generalizate \*\ onset is abrupt with fever, chills, generalized
abdominal pain
B) [x] exista un numar mai mare de 500 leucocite/ml sau mai mult de 250 leucocite/PMN \*\ There are a total of more than 500
leukocytes / ml or more than 250 WBC/PMN
C) [ ] determinarea pH este intotdeauna necesara \*\ pH determination is always required
D) [x] lipsa ameliorarii dupa terapia standard de 48 ore sugereaza ca peritonita poate fi secundara unei infectii \*\ no improvement
following standard therapy for 48 hours suggested that peritonitis may be secondary to infection
E) [ ] toate raspunsurile sunt corecte \*\ All answers are correct
---------------------------------------------------------------------
406. CM p5 [M2216167] Terapia cu agenti blocanti beta-adrenergici are urmatoarele indicatii in hipertensiunea portala: (1886)
\*\ Treatment with beta-adrenergic blocking agents has the following indications in portal hypertension:
A) [ ] in tratamentul sangerarilor acute la nivelul varicelor esogastrice cu hipertensiune si hipovolemie \*\ the treatment of acute
esophago-gastric variceal bleeding with hypertension and hypovolemia
B) [x] reducerea riscului hemoragiilor digestive superioare recurente \*\ reducing the risk of recurrent upper gastrointestinal bleeding
C) [x] tratamentul profilactic cu blocanti neselectivi la pacientii cu varice mari care nu au sangerat niciodata \*\ Prophylactic
treatment with nonselective blockers in patients with large varices who have never bled
D) [x] tratamentul cu propranolol in prevenirea sangerarilor recurente la cirotici cu gastropatie hipertensiva portala severa \*\
treatment with propranolol in preventing recurrent bleeding in cirrhosis with severe gastropathy portal hypertension
E) [x] pentru prelungirea supravietuirii la ciroticii fara sangerare variceala \*\ to extend survival of cirrhotic patients without variceal bleeding
---------------------------------------------------------------------
407. CM p5 [M2516242] Anemia in ciroza alcoolica se datoreaza: (1879) \*\ Anemia in alcoholic cirrhosis due to:
A) [x] hipersplenismului \*\ hypersplenism
B) [x] deficientei de acid folic \*\ folic acid deficiency
C) [x] sangerarilor gastro-intestinale \*\ gastrointestinal bleeding
D) [x] hemolizei \*\ haemolysis
E) [ ] infiltratiei limfocitare hepatice \*\ liver lymphocyte infiltration
---------------------------------------------------------------------
408. CM p5 [M2216180] Ciroza reprezinta o entitate (pg 1878) \*\ Cirrhosis is an entity :
A) [x] definita morfopatologic \*\ defined morphopathological
B) [x] ce se asociaza cu un spectru de manifestari clinice caracteristice \*\ Why is associated with a characteristic spectrum of
clinical manifestations
C) [x] reflecta lezarea cronica ireversibila a parenchimului hepatic \*\ reflects chronic irreversible damage to liver parenchyma
D) [ ] entitate exclusiv morfopatologica \*\ only Morphological entity
E) [ ] entitate exclusiv clinica \*\ only clinical entity
---------------------------------------------------------------------
409. CM p5 Encefalopatia hepatica este un sindrom neuropsihiatric complex caracterizat prin: (1890) \*\ Hepatic encephalopathy
is a complex neuropsychiatric syndrome characterized by:
A) [x] modificari ale starii de constienta \*\ changes in consciousness
B) [ ] nevroza obsesivo-fobica \*\ obsessive-phobic neurosis
C) [ ] areflexie osteotendinoasa in stadiile incipiente \*\ tendon areflexia in the early stages
D) [x] asterixis \*\ asterixis
E) [x] modificari electroencefalografice distincte \*\ different electroencephalographic changes
---------------------------------------------------------------------
410. CM p5 [M1216114] Care din urmatoarele semne sugereaza ciroza hepatica de etiologie alcoolica? (pg 1879) \*\ Which of
these signs suggest alcoholic cirrhosis etiology?

56
A) [x] marirea de volum a glandelor parotide \*\ enlargement of the parotid glands
B) [ ] ascita sub tensiune \*\ ascites under tension
C) [x] hipertrofia falangelor distale \*\ hypertrophy of the distal phalanges
D) [ ] sindromul hemoragipar \*\ bleeding syndrome
E) [ ] flapping tremor \*\ flapping tremor
---------------------------------------------------------------------
411. CM p5 [M2216168] Care din urmatorii parametri de laborator sunt specifici cirozei biliare primitive? (pg 1882) \*\ Which of
the following laboratory parameters are specific to primary biliary cirrhosis?
A) [x] anticorpii antimitocondriali, titrul > 1:40 \*\ antimitocondrial antibodies, titer> 1:40
B) [x] fosfataza alcalina crescuta \*\ increased alkaline phosphatase
C) [ ] cresterea aminotransferazelor serice \*\ increased serum aminotransferase
D) [ ] VSH crescuta \*\ increased ESR
E) [ ] nivelul crescut de IgM serica \*\ increased level of serum IgM
---------------------------------------------------------------------
412. CM p5 [M2516241] Aspectul de corpi Mallory este dewscris la nivelul hepatocitului in: (pg 1878) \*\ The appearance of
Mallory bodies in the hepatocyte suggest
A) [ ] hepatita autoimuna \*\ autoimmune Hepatitis
B) [x] boala Wilson \*\ Wilson's disease
C) [x] diabetul zaharat slab controlat \*\ poorly controlled diabetes
D) [x] by-pass-ul jejuno-ileal \*\ jejuno-ileal bypass
E) [x] hepatita alcoolica \*\ alcoholic Hepatitis
---------------------------------------------------------------------
413. CM p5 [M2516247] Sindromul Budd-Chiari este favorizat de: (pg 1884) \*\ Budd-Chiari syndrome is favored by:
A) [x] folosirea contraceptivelor orale \*\ The use of oral contraceptives
B) [x] policitemia rubra vera \*\ polycythemia rubra vera
C) [ ] hipertensiunea portala \*\ portal hypertension
D) [ ] ascita \*\ ascites
E) [x] sindroame mieloproliferative \*\ myeloproliferative syndromes
---------------------------------------------------------------------
414. CM p5 [M2216165] Alegeti caracteristicile clinice corecte ale sangerarilor variceale esogastrice: (pg 1886) \*\ Choose the
correct clinical characteristics esophago-gastrice variceal bleeding
A) [ ] au loc adesea datorita unor factori precipitanti \*\ They often occur due to precipitating factors
B) [x] de obicei se prezinta ca o hematemeza nedureroasa, masiva \*\ usually presents as a painless ,massive haematemesis
C) [x] semnele asociate merg de la tahicardie postural usoara pana la soc profund \*\ signs associated with postural tachycardia
ranging from mild to profound shock
D) [x] pacientii cu varice pot sangera si datorita existentei altor leziuni gastro-intestinale \*\ patients with varicose veins may
bleed and the existence of other gastrointestinal lesions
E) [ ] la pacientii cu hemoragii anterioare nu e necesara excluderea altor surse de sangerare \*\ patients with previous bleeding is
not necessary to exclude other sources of bleeding
---------------------------------------------------------------------
415. CM p5 [M1216116] Care sunt semnele si simptomele in ciroza biliara primitiva? (pg 1882) \*\ What are the signs and
symptoms in primary biliary cirrhosis?
A) [x] pruritul \*\ itching
B) [x] fatigabilitatea \*\ fatigue
C) [x] icterul \*\ jaundice
D) [x] dureri osoase \*\ pain bone
E) [ ] dispneea \*\ dyspnoea
---------------------------------------------------------------------
416. CM p5 Care sunt factorii precipitanti ai encefalopatiei hepatice? (1891) \*\ What are precipitating factors of hepatic encephalopathy?
A) [x] hemoragiile gastrointestinale \*\ Gastrointestinal bleeding
B) [ ] excesul de glucide din alimentatie \*\ excess carbohydrates in the diet
C) [x] constipatia \*\ constipation
D) [ ] consumul exagerat de legume \*\ excessive consumption of vegetables
E) [x] hipopotasemia \*\ hypokalemia
---------------------------------------------------------------------
417. CM p5 Profilaxia recurentelor peritonitei bacteriene spontane se face cu: (1890) \*\ Spontaneous bacterial peritonitis
prophylaxis done with:
A) [x] Norfloxacin. \*\ Norfloxacin
B) [x] Ciprofloxacin. \*\ Ciprofloxacin
C) [ ] Cefotaxim. \*\ cefotaxime
D) [x] Trimetoprim-sulfametoxazol. \*\ Trimethoprim-sulfamethoxazole \*\
E) [ ] Ampicilina. \*\ Ampicillin
---------------------------------------------------------------------

57
418. CM p5 [M1316124] Urmatoarele afirmatii privind tratamentul cirozei biliare primitive sunt adevarate, cu exceptia: (pg
1883) \*\ The following statements on the treatment of primary biliary cirrhosis are true, except: (pg 1883)
A) [x] exista terapie specifica, eficienta. \*\ there are efficient and specific therapy
B) [x] glucocorticoizii sunt intotdeauna eficienti. \*\ Glucocorticoids are always effective
C) [ ] D-penicilamina nu pare a fi eficienta si prezinta multiple efecte secundare. \*\ D-penicillamine appears to be effective and
presents many side effects
D) [ ] tratamentul cu Ursodiol determina ameliorarea simptomatica. \*\ Treatment with Ursodiol determine symptom
improvement
E) [ ] colestiramina poate fi utila pentru tratamentul pruritului. \*\ cholestyramine may be useful for the treatment of pruritus
---------------------------------------------------------------------
419. CM p5 [M1416130] In patogeneza cirozei biliare primitive intervin urmatorii factori: (pg 1882) \*\ The following factors
involved in the pathogenesis of primary biliary cirrhosis following factors:
A) [ ] anticorpi anti LKM1 \*\ anti LKM1
B) [x] anticorpi antimitocondriali \*\ antibodies antimitocondriali
C) [ ] anticorpi anti-SLA \*\ anti-SLA
D) [ ] expresia aberanta a moleculelor de histocompatibilitate clasa I la nivelul epiteliului biliar \*\ aberrant expression of class I
molecules histocompatibilitate biliary epithelium
E) [x] defectul limfocitelor T supresoare \*\ T cell suppressor defect
---------------------------------------------------------------------
420. CM p5 [M1316125] Metodele de profilaxie a recidivelor hemoragice la bolnavii cu varice esofagiene sunt: (pg 1887) \*\ The
methods of prevention of relapses in patients with variceal bleeding are:
A) [x] tratamentul cu doze de propranolol care sa scada cu un sfert frecventa cardiaca de repaus \*\ treatment with doses of
propranolol to decrease heart rate by a quarter rest
B) [ ] inhibitorii de H2 receptori in doze mari. \*\ H2 receptor inhibitors in high doses
C) [x] suntul porto sistemic transjugular intrahepatic. \*\ transjugular intrahepatic porto systemic shunt
D) [x] sunturile chirurgicale porto sistemice \*\ porto systemic Surgical shunts
E) [ ] omeprazolul in administrare cronica. \*\ omeprazole in chronic administration
---------------------------------------------------------------------
421. CS p4 [C1211005] Germenii responsabili de infectia necrozelor pancreatice sunt reprezentati cel mai frecvent de: (2001) \*\
Germs responsible for infection of pancreatic necrosis is most frequently represented
A) [ ] bacterii Gram-pozitive \*\ Gram-positive bacteria
B) [x] bacterii Gram-negative \*\ Gram-negative bacteria
C) [ ] bacterii anaerobe \*\ anaerobic bacteria
D) [ ] virusuri \*\ viruses
E) [ ] fungi \*\ fungi
---------------------------------------------------------------------
422. CS p4 [C1211003] Simptomul major prezent in cadrul tabloului clinic al pancreatitei acute este reprezentat de: (pag. 1994)
\*\ Present major symptom in the clinical picture of acute pancreatitis consists of:
A) [x] durere \*\ Pain
B) [ ] greturi \*\ Nausea
C) [ ] febra \*\ Fever
D) [ ] varsaturi bilioase \*\ bilious vomiting
E) [ ] tahicardie \*\ tachycardia
---------------------------------------------------------------------
423. CS p4 [C1211002] Stadiul 'C' al clasificarii tomodensitometrice Ranson si Baltazar este reprezentat de: (1998) \*\ Stage 'C'
tomodensitometrice Ranson and Balthazar's classification is represented by:
A) [ ] pancreas normal \*\ normal pancreas
B) [ ] cresterea in volum a pancreasului cu conservarea conturului glandei \*\ increase in volume of the pancreas gland with
preservation of contour
C) [x] inflamarea pancreasului si a grasimii peripancreatice cu pierderea conturului \*\ inflammation of the pancreas and peri
pancreatic fat with loss of contour
D) [ ] prezenta unei colectii peripancreatice \*\ presence of peri pancreatic collections
E) [ ] prezenta mai multor colectii lichidiene peripancreatice si la distanta de pancreas \*\ The presence of several peri pancreatic
fluid collections and pancreatic distance
---------------------------------------------------------------------
424. CS p4 [C1611016] Infectia pancreatica care apare ca o complicatie a pancreatitei acute este cauza de deces intr-o proportie
de: (pag. 2001) \*\ Pancreatic infection that occurs as a complication of acute pancreatitis is the cause of death in a proportion of
A) [ ] 30% \*\ 30%
B) [x] 80% \*\ 80%
C) [ ] 50% \*\ 50%
D) [ ] 15% \*\ 15%
E) [ ] 60% \*\ 60%
---------------------------------------------------------------------

58
425. CS p4 Care tip de germeni predomina in infectia pancreatica: (2001) \*\ What kind of germs predominate in pancreatic infection
A) [ ] stafilococul aureu \*\ Staphylococcus aureu
B) [ ] anaerobi \*\ anaerobic
C) [x] gram negativi; \*\ gram negative
D) [ ] Clostridium; \*\ Clostridium
E) [ ] pneumococul.\*\ pneumococcal
---------------------------------------------------------------------
426. CS p4 Sunt sisteme de scor aplicate in PA urmatoarele, cu exceptia:\*\ Scoring systems are applied in IP following, except:
A) [ ] Ranson \*\ Ranson
B) [ ] APACHE \*\ APACHE
C) [ ] Glasgow \*\ Glasgow
D) [ ] SAPS \*\ SAPS
E) [x] Pickford \*\ Pickford
---------------------------------------------------------------------
427. CS p4 Urmatorul aspect ecografic il intalnim in pancreatita acuta forma usoara: (1995) \*\ Ultrasound next issue we
encounter in mild acute pancreatitis
A) [ ] calcificari pancreatice difuze la nivelul glandei pancreatice \*\ diffuse pancreatic calcifications in the pancreatic gland
B) [x] glanda pancreatica marita de volum cu ecogenitate diminuata \*\ pancreatic gland volume increased with diminished echogenic
C) [ ] reducerea dimensiunilor glandei pancreatice cu dilatarea canalului pancreatic principal \*\ Pancreatic gland size reduction
with dilated main pancreatic duct
D) [ ] cresterea ecogenicitatii parenchimului glandular \*\ increasing ecogenicitatii glandular parenchyma
E) [ ] aspect heterogen al grasimii peripancreatice, colectii peripancreatice \*\ heterogeneous appearance of peripancreatic fat,
peripancreatic collections
---------------------------------------------------------------------
428. CS p4 Pentru a exclude sursele extrapancreatice ale hiperamilazemiei totale se indica: \*\ To exclude sources of
hiperamilazemiei extrapancreatice total indicate:
A) [ ] metode colorimetrice de dozare a lipazelor \*\ The colorimetric method of determination of lipases
B) [x] metode cromatografica a izoamilazelor \*\ chromatographic methods of izoamilazelor
C) [ ] determinarea elastazei pancreatice \*\ Determination of pancreatic elastase
D) [ ] ERCP \*\ ERCP
E) [ ] laparoscopie \*\ Laparoscopy
---------------------------------------------------------------------
429. CM p5 In pancreatitele acute examenul clinic poate decela:(1994)\*\ The clinical examination can detect acute pancreatitis
A) [ ] contractura musculara generalizata \*\ generalized muscle contracture
B) [x] formatiune inflamatorie epigastrica ca o impastare difuz conturata\*\inflammatory epigastric formation shaped like a diffuse impastare
C) [x] echimoze in jurul ombilicului sau pe flancuri \*\ bruising around the umbilicus or flanks
D) [ ] semne de soc hipovolemic \*\ signs of hypovolemic shock
E) [ ] disparitia matitatii hepatice. \*\ extinction matitatii liver
---------------------------------------------------------------------
430. CM p5 Elementele caracteristice ale examenului ecografic in pancreatita acuta edematoasa sunt reprezentate de: (1995) \*\
Elements characteristic of ultrasound in acute edematous pancreatitis are: \*\
A) [ ] evidentierea unei litiaze biliare \*\ The highlight of gallstone
B) [x] marirea volumului pancreasului \*\ increasing the volume of the pancreas
C) [x] reducerea ecogenitatii parenchimului pancreatic \*\ reduction of pancreatic parenchyma ecogenitatii
D) [ ] cresterea ecogenitatii pancreatice \*\ increase pancreatic ecogenitatii
E) [ ] prezenta unei colectii lichidiene intrapancreatice, neomogena \*\ presence of fluid collections intrapancreatice, heterogeneous ultra
---------------------------------------------------------------------
431. CM p5 [C2911223] Efectele dopaminei si dobutaminei: \*\ Dopamine and dobutamine effects are:
A) [x] efecte mai benefice asupra inimii \*\
B) [x] efecte benefice asupra distributiei fluxului sangvin \*\
C) [ ] rezistenta sistemica scazuta \*\
D) [x] vasodilatatie si cresterea debitului cardiac \*\
E) [ ] creste consumul miocardic de O2 \*\
---------------------------------------------------------------------
432. CM p5 Urmatoarele afirmatii privind atitudinea terapeutica in cazul pseudochistului pancreatic sunt corecte: (2006) \*\ The
following statements concerning the therapeutic approach when Pancreatic pseudocyst is correct \*\
A) [ ] pseudochisturile cu diametrul mai mic de 6 cm au indicatie de punctie ghidata; \*\ pseudocysts with diameter less than 6 cm
have guided puncture indication
B) [ ] pseudochistele pancreatice cu diametru peste 6 cm si complicatii hemoragice au indicatie de drenaj percutan si instilare de
hemostatice pe tubul de dren; \*\ pancreatic pseudochistele than 6 cm in diameter and hemorrhagic complications have indication
of percutaneous drainage and instillation of hemostatic the drain tube
C) [x] practicarea unei derivatii chistodigestive evita riscul producerii unei fistule pancreatice externe \*\ the practice of
derivatives chistodigestive avoid risk of external pancreatic fistulas

59
D) [x] drenajul extern al pseudochistelor pancreatice expune mai frecvent la recidiva fata de derivatia chistodigestiva; \*\ external
drainage of pancreatic pseudochistelor exhibit more frequent recurrence over chistodigestiva derivation
E) [ ] hemoragia intrachistica necesita tratament endoscopic. \*\ intrachistica bleeding requiring endoscopic treatment
---------------------------------------------------------------------
433. CM p5 [SI000026] Valorile ''supranormale '' la care cresc DC si oferta de O2 sub trat. cu dobutamina si dopamina sunt: \*\
Values "supernormal" in DC and growing supply of O2 in the square. with dobutamine and dopamine are
A) [x] CI(index cardiac)>4,5 ml/min/m2 \*\ CI (cardiac index)> 4.5 ml/min/m2
B) [x] DO>600 ml/min/m2 \*\ D> 600 ml/min/m2
C) [ ] DO>900ML/MIN \*\ OD> 900ML/MIN
D) [ ] CI>5ML/MIN/M2 \*\ IC> 5ML/MIN/M2
E) [ ] DO>600ml/min/kgc \*\ D> 600ml/min/kgc
---------------------------------------------------------------------
434. CM p5 [C2211108] Clasificarea histopatologica a pancreatitei acute cuprinde urmatoarele forme: (pag. 1989) \*\
Histopathological classification of acute pancreatitis include the following forms:
A) [x] pancreatita edematoasa \*\ edematous pancreatitis
B) [ ] pancreatita acuta usoara \*\ mild acute pancreatitis
C) [x] pancreatita necrotico-hemoragica \*\ necrotic hemorrhagic pancreatitis
D) [ ] pancreatita acuta severa \*\ severe acute pancreatitis
E) [x] pancreatita supurata \*\ effusion pancreatitis
---------------------------------------------------------------------
435. CM p5 Drogurile cu efect inotrop poz . folosite in tratamentul PA sunt:\*\Drugs with inotropic effect pos. used in the treatment of IP are:
A) [x] Dopexamina \*\ Dopexamina
B) [ ] Digitalina \*\ Digitalina
C) [ ] Digoxinul \*\ Digoxin
D) [x] Dobutamina \*\ dobutamine
E) [x] Dopamina \*\ Dopamine
---------------------------------------------------------------------
436. CM p5 Cele doua ipoteze cu privire la mecanismul autodigestiei pancreatice sunt: (1992)\*\ The two hypotheses on the
mechanism of pancreatic autodigestiei are:
A) [x] autoactivarea tripsinogenului \*\ autoactivarea tripsinogenului
B) [ ] disturbarea reactiilor de fuziune-fisiune \*\ fusion-fission reactions disturbance
C) [x] actiunea enzimelor lizozomale duce la transformarea tripsinogenului in tripsina \*\ action of lysosomal enzymes leads to
conversion to trypsin tripsinogenului
D) [ ] exocitoza \*\ exocytosis
E) [ ] modificarile transportului intracelular \*\ changes in intracellular transport
---------------------------------------------------------------------
437. CM p5 Formele morfopatologice ale pancreatitei acute sunt reprezentate de (1993) \*\ Morphological forms of acute
pancreatitis are represented by
A) [x] forma edematoasa \*\ The form edematous
B) [ ] forma ulcerativa \*\ ulcerative form
C) [x] forma necrotico-hemoragica \*\ necrotic hemorrhagic form
D) [ ] forma emfizematoasa \*\ form emfizematoasa
E) [x] forma supurata \*\ effusion form
---------------------------------------------------------------------
438. CM p5 Diagnosticul diferential al pancreatitei acute se face cu: (1996) \*\ Differential diagnosis of acute pancreatitis is made by:
A) [x] ulcerul perforat \*\ perforated ulcer
B) [ ] diabetul zaharat \*\ diabetes
C) [x] infarctul enteromezenteric \*\ Myocardial enteromezenteric
D) [ ] colica ureterala stanga \*\ left ureteral colic
E) [x] infarctul miocardic \*\ myocardial infarction
---------------------------------------------------------------------
439. CM p5 Cauzele cele mai frecvente ale pancreatitei acute sunt:(1989-1990) \*\ The most frequent causes of acute pancreatitis are:
A) [ ] parazitozele \*\ parasitoses
B) [x] litiaza \*\ stones
C) [ ] idiopatice \*\ idiopathic
D) [x] consumul de alcool \*\ alcohol
E) [ ] pancreatitele cronice \*\ Chronic pancreatitis
---------------------------------------------------------------------
440. CM p5 [C1211067] Complicatiile evolutive ale pancreatitei acute necrotico-hemoragice sunt reprezentate de: (1999) \*\
Progressive complications of acute pancreatitis haemorrhagic necrotic are:
A) [x] sechestrul pancreatic \*\ Pancreatic seizure
B) [ ] infarctul splenic \*\ splenic infarction
C) [x] pseudochistul pancreatic \*\ Pancreatic pseudocyst

60
D) [x] abcesul pancreatic \*\ Pancreatic abscess
E) [ ] cancerul pancreatic \*\ Pancreatic cancer
---------------------------------------------------------------------
441. CM p5 Indicatiile sfincterotomiei endoscopice in tratamentul pancreatitei acute de cauza biliara sunt : (2004) \*\
Sincterotomiei Indications for endoscopic treatment of biliary cause of acute pancreatitis are \*\
A) [ ] de rutina \*\ Routine
B) [x] vin caz de calcul impactat in ampula lui Vater \*\ in case of calculating impact in ampoule of Vater
C) [ ] litiaza veziculara \*\ vesicular lithiasis
D) [ ] dilatatii ale canalului Wirsung; \*\ dilated duct of Wirsung
E) [x] litiaza de cale biliara principala. \*\ main bile stones
---------------------------------------------------------------------
442. CM p5 [SI000039] Abordul laparoscopic in pancreatita acuta : (2004) \*\ We approach laparoscopy in acute pancreatitis
A) [x] este permis in formele benigne \*\ It is allowed in benign forms
B) [x] este permis in formele in care inflamatia nu constituie un obstacol in realizarea gestului chirurgical \*\ is allowed in the
form in which inflammation is not an obstacle in achieving surgical gesture
C) [x] este mai usor de realizat intre ziua a &-a si a 10 -a \*\ it is easier to enter and day & 10th
D) [ ] este mai udor de realizat la debut \*\ is performed at onset udor
E) [ ] conversia la debut poate fi de 10% \*\ Conversion of onset may be 10%
---------------------------------------------------------------------
443. CM p5 Cele mai frecvente cauze ale pancreatitei acute sunt: (1989) \*\ The most common causes of acute pancreatitis are:
A) [x] consumul de alcool, frecvent la tineri \*\ alcohol, often in young
B) [x] litiaza biliara, frecvent la varstnici \*\ gallstones, common in elderly
C) [ ] obezitatea \*\ obesity
D) [ ] tabagismul \*\ smoking
E) [ ] traumatismele \*\ trauma
---------------------------------------------------------------------
444. CM p5 Care dintre cauzele de mai jos sunt cel mai frecvent intalnite in etiologia pancreatitei acute (1989-1990)\*\ Which of
the following causes are most often encountered in the etiology of acute pancreatitis
A) [x] litiaza biliara \*\ gallstones
B) [x] consumul de alcool \*\ alcohol
C) [ ] hiperparatiroidia \*\ hyperparathyroidism
D) [ ] anumite medicamente \*\ certain drugs
E) [ ] dislipidemia \*\ dyslipidemia \*\
---------------------------------------------------------------------
445. CM p5 Cele mai frecvente cauze etiologice ale pancreatitei acute sunt: (1989) \*\ The most common etiological causes of
acute pancreatitis are:
A) [x] consumul de alcool \*\alcohol
B) [x] litiaza biliara \*\ gallstones
C) [ ] cauzele iatrogene \*\ Iatrogenic causes
D) [ ] fumatul \*\ Smoking
E) [ ] medicamente antiinflamatorii nesteroidiene \*\ NSAIDs
---------------------------------------------------------------------
446. CM p5 Care dintre cauzele de mai jos sunt cel mai frecvent intalnite in etiologia pancreatitei acute: (1989-1990) \*\ Which
of the following causes are most often encountered in the etiology of acute pancreatitis
A) [ ] colangiopancreatografia retrograda endoscopica; \*\ Endoscopic retrograde colangiopancreatografia
B) [x] litiaza biliara; \*\ gallstones
C) [ ] hiperparatiroidia; \*\ hyperparathyroidism
D) [x] consumul de alcool; \*\ alcohol
E) [ ] traumatismele intraoperatorii. \*\ intraoperative trauma
---------------------------------------------------------------------
447. CM p5 Care sunt caracterele durerii in pancreatita acuta? (1993-1994) \*\ What are the characters pain in acute pancreatitis
A) [x] Debut brusc \*\ The sudden onset \*\
B) [x] Persista cel putin 1-2 zile \*\ persisted at least 1-2 days \*\
C) [x] Localizata in epigastru cu iradiere in hipocondrul drept si sting si in regiunea dorso lombara \*\ Located in the epigastrium
with radiation into left and right hypochondrium and lumbar region dorso \*\
D) [ ] Caracter pulsatil \*\ Character pulsed \*\
E) [ ] Cedeaza la ingestia de alimente \*\ Yield on food intake \*\
---------------------------------------------------------------------
448. CM p5 [SI000033] Urmatoarele sunt adevarate despre tratamentul PA: \*\ The following is true about IP treatment:
A) [x] Analgezia este necesara in trat. PA \*\ analgesia is required in the treaty. PA
B) [x] Alte masuri suportive includ profilaxia ulcerului de stres \*\ Other supportive measures include stress ulcer prophylaxis
C) [x] In cazul insuficientei renale se instituie hemofiltrarea arteriovenoasa \*\ in case of renal arteriovenous haemofiltration establish
D) [ ] Antibioticoprofilaxia nu poate fi realizata prin decontaminare digestiva selectiva \*\ Antibioticoprofilaxia can not be

61
achieved by selective digestive decontamination
E) [ ] Nu se utilizeaza inhibitori de enzime pancreatice \*\ Do not use inhibitors of pancreatic enzymes
---------------------------------------------------------------------
449. CM p5 Despre scorul APACHE sunt adevarate urmatoarele:\*\ About APACHE score following are true
A) [x] Ia in calcul 34 de parametrii \*\ Take into account 34 parameters
B) [x] Reflecta gradul anormalitatii a 7 sisteme fiziologice majore \*\ reflect abnormality of seven major physiological systems
C) [x] Fiecarui rezultat ii este atribuit un coef. de la 0 la 4 in functie de gradul anormalitatii \*\ Each product is given a coef. from
0-4 depending on the degree of abnormality
D) [ ] Cu cit suma punctelor este mai crescuta cu atit stadiul bolii este mai putin sever \*\ The more the amount of points is higher
with both stage of disease is less severe
E) [ ] Ia in calcul 36 de parametrii \*\ Take into account 36 parameters
---------------------------------------------------------------------
450. CM p5 [C2511152] Care dintre urmatoarele variante reprezinta forme clinice de pancreatita acuta dupa clasificarea de la
Atlanta (1992) : (1989) \*\ Which of the following are clinical forms of acute pancreatitis by the Atlanta classification
A) [x] pancreatita acuta usoara \*\ mild acute pancreatitis
B) [ ] pancreatita acuta edematoasa; \*\ acute edematous pancreatitis
C) [x] pancreatita acuta severa; \*\ severe acute pancreatitis
D) [ ] pancreatita acuta necrotico-hemoragica; \*\ acute necrotic hemorrhagic pancreatitis
E) [ ] pancreatita acuta supurata \*\ effusion acute pancreatitis
---------------------------------------------------------------------
451. CS p4 Rata recidivelor ulcerului peptic in primul an dupa terapia de eradicare, cu succes, a Helicobacter pylori este:
(1760)\*\peptic ulcer recurrence rate in the first year after successful eradication therapy of Helicobacter pylori is:
A) [x]Mai mica de 15%\*\Less than 15%
B) [ ]Mai mare de 15%\*\More than 15%
C) [ ]Mai mica de 10%\*\less than 10%
D) [ ]Mai mare de 20%\*\More than 20%
E) [ ]25%\*\25%
---------------------------------------------------------------------
452. CS p4 Care dintre urmatoarele medicamente utilizarea in eradicarea cu Helicobacter Pylori poate determina ca reactie
adversa colita pseudomembranoasa: (1763)\*\Which of these drugs used in eradicating Helicobacter pylori may cause side effects
like pseudomembranous colitis:
A) [x]amoxicilina\*\amoxicillin
B) [ ]inhibitori de pompa de protoni\*\proton pump inhibitors
C) [ ]tetraciclina\*\tetracycline
D) [ ]antiacide\*\antacids
E) [ ]famotidina\*\ famotidine
---------------------------------------------------------------------
453. CS p4 Urmatoarele afirmatii cu privire la infectia cu Helicobacter pylori sunt corecte cu EXCEPTIA: (1759)\*\The
following statements on Helicobacter pylori infection are correct except :
A) [x] H. pylori este prezent la 75-90% dintre pacientii cu ulcer duodenal\*\ H. pylori is present in 75-90% of patients with duodenal ulcer
B) [ ]H. pylori este prezent la 75-85% dintre pacientii cu ulcer gastric\*\H. pylori is present in 75-85 % of patients with gastric ulcer
C) [ ]15-20% dintre persoanele infectate cu H. pylori vor dezvolta un ulcer in timpul vietii\*\15-20% of people infected with H.
pylori develop an ulcer in life
D) [ ]Infectia preexistenta cu H. pylori creste riscul dezvoltarii ulterioare atat de ulcer duodenal cat si de ulcer gastric\*\pre-
existing infection with H. pylori increases the risk of subsequent development of both duodenal ulcer and gastric ulcer
E) [ ]Nivelul de anticorpi tip IgG impotriva H. pylori se coreleaza direct cu riscul de ulcer duodenal si ulcer gastric\*\Level IgG
antibodies against H. pylori infection directly correlates with the risk of duodenal ulcer and gastric ulcer
---------------------------------------------------------------------
454. CS p4 Cel mai precis mijloc de diagnostic al Ulcerului duodenal este:\*\The most accurate means of diagnosis of duodenal ulcer is:
A) [ ]Examenul radiologic baritat\*\Barium radiologic exam
B) [ ]Testul HP\*\HP Test
C) [x]Examenul endoscopic al tractului digestiv superior\*\Endoscopic examination of upper digestive tract
D) [ ]RMN\*\MRI
E) [ ]Ecografia abdominal?\*\Abdominal ultrasound
---------------------------------------------------------------------
455. CS p4 [M2215031] Secretia acida gastrica poate fi inhibata de: (1757, 1758)\*\gastric acid secretion can be inhibited by:
A) [ ]ingestia de alimente\*\food intake
B) [ ]consumul de cofeina\*\caffeine consumption
C) [ ]consumul de bere si vin\*\consumption of beer and wine
D) [x]hiperglicemie\*\hyperglycemia
E) [ ]calciu administrat intravenos\*\calcium given intravenously
---------------------------------------------------------------------


62
456. CS p4 [M1615028] Referitor la ulcerul gastric, urmatoarea afirmatie este adevarata: (1767)\*\Referring to gastric ulcer, the
following statement which is true is:
A) [x]mortalitatea prin perforatia unui ulcer gastric este de aproximativ 3 ori mai mare fata de cea prin perforatia unui ulcer
duodenal\*\ death by a gastric ulcer perforation is approximately 3 times higher than that by a duodenal ulcer perforation
B) [ ]hemoragia apare in 55 % din cazuri\*\bleeding occurs in 55% of cases
C) [ ]perforatia gastrica se intalneste mai frecvent decat hemoragia gastrica\*\gastric perforation is seen more frequently than gastric bleeding
D) [ ]ulcerul gastric cu aclorhidrie la pentagastrina este frecvent\*\gastric ulcer with achlorhydria is frequently the pentagastrina
E) [ ]atat ulcerele gastrice benigne cat si cele maligne sunt mai frecvent localizate la nivelul marii curburi\*\both stomach ulcers
and malignant tumors are frequently located at the level of greater curvature
---------------------------------------------------------------------
457. CS p4 [M2215045] Vagotomia tronculara cu antrectomie reprezinta procedeul chirurgical prin care: (1769)\*\Vagotomy of
the trunk with antrectomy is the surgical procedure represented by:
A) [ ]se realizeaza vagotomie supraselectiva\*\performing supraselective vagotomy
B) [ ]se sectioneaza trunchiul vagal si se efectueaza piloroplastie\*\sectioning vagal trunk and performing pyloroplasty
C) [ ]se efectueaza vagotomie proximala gastrica si se extirpa antrul\*\proximal gastric vagotomy and antral removal
D) [x]se sectioneaza trunchiul vagal, se extirpa antrul cu anastomoza Billroth I sau Billroth II\*\cutting through the trunk vagal,
antral removal with Billroth I or Billroth II anastomosis
E) [ ]se sectioneaza trunchiul nervului vag\*\cutting the vagus nerve trunk
---------------------------------------------------------------------
458. CS p4 [M1315012] Care dintre urmatoarele afirmatii cu referire la mecanismele secretiei gastrice nu este adevarata?
(1757)\*\Which of the following statements referring to the mechanisms of gastric secretion is not true?
A) [x]Histamina stimuleaza secretia acida gastrica prin cresterea calciului citosolic in celulele parietale.\*\Histamine stimulates
gastric acid secretion by increasing cytosolic calcium in parietal cells.
B) [ ]Gastrina stimuleaza secretia acida gastrica prin stimularea directa a celulelor parietale.\*\gastrin stimulates gastric acid
secretion by direct stimulation of parietal cells.
C) [ ]Gastrina stimuleaza secretia acida gastrica prin stimularea eliberarii de histamina din celulele ECL.\*\gastrin stimulates
gastric acid secretion by stimulating release of histamine from ECL cells.
D) [ ]Somatostatina inhiba eliberarea de histamina din celulele ECL.\*\somatostatin inhibits histamine release from ECL cells.
E) [ ]Stimularea vagala creste secretia acida gastrica si prin eliberarea de gastrina din celulele G antrale.\*\vagal stimulation
increases gastric acid secretion and release of gastrin from antral G cells.
---------------------------------------------------------------------
459. CM p5 Despre gastrina si secretia ei se pot afirma urmatoarele: (1757)\*\The following can be said about gastrin secretion:
A) [ ]secretia este stimulata de somatostatina produsa de celulele D din antru\*\it is stimulated by somatostatin which is produced
by cells D from the antrum
B) [x]este cel mai puternic stimulant cunoscut al secretiei gastrice\*\is the most powerful known stimulant of gastric secretion
C) [x]forma heptadecapeptidica este forma principala a gastrinei in mucoasa antrala\*\heptadecapeptide form is the main form of
gastrin in antral mucosa
D) [x]este prezenta si in mucoasa duodenala in zonele proximale\*\is present in duodenal mucosa in the proximal areas
E) [ ]neuropeptidul inhibitor al secretiei de gastrina este secretat de celulele D antrale\*\neuropeptide inhibitor of secretion of
gastrin is secreted by antral D cells
---------------------------------------------------------------------
460. CM p5 Simptomatologia obstructiei caii de evacuare gastrica include: (1768)\*\Obstructive Symptoms from gastric evacuation include:
A) [x]greturi\*\nausea
B) [ ]diaree\*\diarrhea
C) [x]distensie abdominala\*\abdominal distension
D) [x]scadere din greutate\*\weight loss
E) [x]varsaturi\*\vomiting
---------------------------------------------------------------------
461. CM p5 Urmatoarele afirmatii cu referire la mecanismele secretiei gastrice nu sunt adevarate: (p1757)\*\The following
statements referring to the mechanisms of gastric secretion are not true:
A) [x]gastrina stimuleaza secretia gastrica acida prin influentarea productiei de AMPc\*\gastrin stimulates gastric acid secretion
from influence of cAMP production
B) [x]acetilcolina stimuleaza producerea de AMPc\*\acetylcholine stimulates production of cAMP
C) [ ]distensia mecanica gastrica stimuleaza secretia acida\*\mechanical gastric distension stimulates acid secretion
D) [ ]histamina reprezinta factorul principal de stimulare a secretiei gastrice acide\*\histamine represents the main factor
stimulating secretion of gastric acid
E) [ ]stimularea vagala creste secretia acida gastrica prin eliberarea de gastrina din celulele G antrale\*\vagal stimulation increases
secretion of gastric acid by release of gastrin from antral G cells
---------------------------------------------------------------------
462. CM p5 Ulcerul gastric (UG) are urmatoarele caracteristici etiopatogenice, cu exceptia ( 1767)\*\gastric ulcer (UG) has the
following characteristics etiopathogenic, except:
A) [x]aproximativ un sfert din pacienti asociaza ulcer duodenal\*\Approximately one quarter of patients associated with duodenal ulcer
B) [ ]nu se asociaza cu hipersecretie acida gastrica\*\not associated with gastric acid hypersecretion

63
C) [ ]majoritatea pacientilor prezinta nivele crescute ale gastrinei serice\*\most patients shows high levels of serum gastrin
D) [ ]aproximativ un sfert din UG sunt cauzate de consumul de antiinflamatoare nonsteroidiene\*\Approximately one quarter of
UG are caused by the use of NSAIDs
E) [x]evacuarea stomacului este accelerata la pacientii cu UG\*\stomach evacuation is accelerated in patients with UG
---------------------------------------------------------------------
463. CM p5 [M1315102] Care dintre urmatoarele afirmatii referitoare la mecanismele implicate in apararea mucoasei gastrice si
duodenale la agresiunea clorhidro-peptica sunt neadevarate ? (1759)\*\Which of the following statements concerning the
mechanisms involved in defending the gastric and duodenal mucosa from peptic hydrochloride aggression is untrue?
A) [ ]Mucusul gastric are rol protectiv.\*\Gastric mucosa have protective role
B) [x]Concentratia crescuta a sarurilor biliare prin refluxul biliar cu pH alcalin are rol protectiv.\*\elevated bile salts concentration
from biliary reflux with alkaline pH has a protective role.
C) [ ]Ionii de bicarbonat secretati de celulele gastrice epiteliale neparietale au rol protectiv.\*\bicarbonate ions secreted by non
parietal gastric epithelial cells are protective
D) [x]Fluxul sagvin al mucoasei nu constituie un element esential in aparare.\*\Flow of sagvin in mucosa is not an essential
element in defense
E) [ ]Prostaglandinele din clasa E impiedica lezarea mucoasi gastrice.\*\Prostaglandins Class E Prevents damage to gastric mucosa.
---------------------------------------------------------------------
464. CM p5 [M2615258] Care din urmatoarele afirmatii referitoare la ulcerul duodenal sunt adevarate: (1759)\*\Which of the
following statements related to duodenal ulcer are true:
A) [ ]Intre 75-85% dintre pacientii cu UD au infectia cu H.pylori\*\Between 75-85% of patients with duodenal ulcer have
infection with H.pylori
B) [x]Nivelul de anticorpi tip IgG impotriva H.pylori se coreleaza direct cu riscul de UD\*\The level of IgG antibodies against H.
pylori is correlated directly with the risk of duodenal ulcer
C) [x]Doar 15-20% dintre persoaele infectate cu H.pylori vor dezvolta un ulcer in timpul vietii\*\Only 15-20% of persons
infected with H. pylori will develop an ulcer during their lifetime
D) [ ]In ultimii 40 de ani frecventa UD a cres cut in Statele Unit\*\In the last 40 years, the frequency of duodenal ulcer has
increased in the United States
E) [x]evolutia naturala a ulcerului netratat consta in vindecare spontana si recurenta\*\the natural evolution of untreated ulcer
consists in spontaneous healing and recurrence
---------------------------------------------------------------------
465. CM p5 [M1615127] Prostaglandinele exogene exercita urmatoarele actiuni care au ca rezultat cresterea apararii mucoasei
(pg 1766)\*\Exogenous Prostaglandins exert the following actions that result in increased mucosal defense (pg 1766)
A) [x]stimuleaza secretia de mucus gastric\*\stimulates secretion of gastric mucus
B) [x]stimuleaza secretia gastrica si duodenala de bicarbonat\*\stimulates secretion of gastric and duodenal bicarbonate
C) [ ]scad fluxul sanguin gastric\*\reduced gastric blood flow
D) [x]mentin bariera gastrica impotriva retrodifuziunii ionilor de H+\*\keep the gastric barrier against H+ ions rediffusion
E) [ ]inhiba regenerarea celulelor mucoasei\*\inhibit mucosal cell regeneration
---------------------------------------------------------------------
466. CM p5 ''Noua tripla terapie'' pentru eradicarea H.Pylori cuprinde urmatoarele medicamente: (1764)\*\ "New triple therapy
for eradication of H. pylori consists of the following drugs:
A) [x]omeprazol\*\omeprazole
B) [ ]subsalicilat de bismut\*\bismuth subsalycilate
C) [x]metronidazol\*\metronidazole
D) [ ]tetraciclina\*\Tetracycline
E) [x]claritromicina\*\clarithromycin
---------------------------------------------------------------------
467. CM p5 Secretia gastrica de bicarbonat este stimulata de: (pg 1759)\*\Gastric secretion of bicarbonate is stimulated by:
A) [x]ionii de calciu\*\calcium ions
B) [x]prostaglandinele E si F\*\prostaglandin E and F
C) [ ]alcool\*\alcohol
D) [ ]antiinflamatoarele nesteroidiene\*\NSAIDs
E) [ ]acetazolamida\*\acetazolamide
---------------------------------------------------------------------
468. CM p5 Reglarea secretiei gastrice cuprinde 3 faze: (1757)\*\Regulation of gastric secretion comprises 3 phases:
A) [x]faza cefalica, gastrica si intestinala\*\cephalic phase, gastric and intestinal
B) [x]faza cefalica cuprinde componentele corticala si hipotalamica\*\cephalic phase includes cortical and hypothalamic
components
C) [ ]faza cefalica este mediata prin activare simpatica\*\cephalic phase is mediated by sympathetic activation
D) [x]faza gastrica rezulta din stimularea receptorilor chimici si mecanici din peretele gastric\*\phase gastric results from
chemical receptor stimulation and mechanism of gastric wall
E) [x]faza intestinala este determinata de prezenta alimentelor din intestinul subtire\*\intestinal phase is determined by the
presence of food in the small intestine
---------------------------------------------------------------------

64
469. CM p5 [M1515115] La pacientii cu sindrom ulceros, endoscopia digestiva superioara este indicata pentru: (pg 1762)\*\In
patients with ulcer syndrome, upper GI endoscopy is indicated for:
A) [ ]confirmarea imaginii de nisa duodenala evidentiata printr-un examen baritat anterior\*\confirmation of ulcer niche image
highlighted by an anterior baritat examination
B) [ ]aprecierea gradului de deformare a bulbului duodenal\*\assessment of the degree of deformity of duodenal bulb
C) [x]diagnosticarea ulcerelor care determina hemoragie digestiva superioara\*\diagnosing the cause of ulcers from upper digestive bleeding
D) [x]depistarea ulcerelor la pacienti simptomatici dar fara imagine radiologica caracteristica\*\detection of symptomatic ulcers in
patients without radiological feature
E) [x]la pacienti cu modificari radiologice nesigure in ceea ce priveste activitatea ulcerului\*\in patients with radiological
changes, not sure of the ulcer activity
---------------------------------------------------------------------
470. CM p5 Urmatoarele afirmatii cu privire la epidemiologia infectiei cu Helicobacter pylori sunt corecte: (1760)\*\The
following affirmations related to the epidemiology of infection with helicobacter pylori are correct:
A) [x]Prevalenta colonizarii gastrice cu H. pylori creste cu varsta\*\prevalence of gastric colonization with H.pylori increases with age
B) [x]Ratele de infectie cu H. pylori cresc in conditii socioeconomice precare\*\rates of H. pylori infection increases in poor
socioeconomic conditions
C) [ ]In tarile in curs de dezvoltare H. pylori apare in general la persoanele de pste 60 de ani\*\in course of development, H. pylori
appears generally in persons over 60 years
D) [x]Majoritatea pacientilor colonizati cu H. pylori nu dezvolta niciodata o ulceratie\*\the majority of patients colonized with
H.pylori never develop ulcer
E) [ ]Rata de infectie cu H. pylori este mai crescuta la asiatici\*\the rate of infection with H.pylori increases in Asians
---------------------------------------------------------------------
471. CM p5 Despre implicatiile fumatului in ulcerul duodenal este adevarat ca (1761)\*\About the implications of smoking in
duodenal ulcer, it is true that:
A) [x]se asociaza cu raspuns mai slab la tratament\*\it is associated with worse response to treatment
B) [ ]creste secretia acida gastrica\*\it increases the gastric acid secretion
C) [x]poate precipita golirea accelerata a acidului gastric in duoden\*\it may precipitate accelerated emptying of gastric acid in duodenum
D) [x]creste mortalitatea prin ulcer\*\it increases mortality from ulcer
E) [ ]favorizeaza metaplazia gastrica\*\it promotes gastric metaplasia
---------------------------------------------------------------------
472. CM p5 Helicobacter Pylori se localizeaza in: (pg 1759)\*\Helicobacter pylori is localized in:
A) [ ]submucoasa\*\submucosa
B) [ ]stratul superficial al mucusului gastrice\*\superficial layer of gastric mucus
C) [x]stratul profound al mucusului gastrice\*\Deep layer of gastric mucus
D) [ ]epiteliul mucoasei gastrice\*\gastric mucosal epithelium
E) [x]intre stratul de mucus si suprafata apicala a celulelor epiteliale ale mucoasei gastrice\*\between the layer of mucus and
apical surface of gastric mucosal epithelial cells
---------------------------------------------------------------------
473. CM p5 Precizati care dintre urmatorii factori intervin in patogeneza ulcerului duodenal: (1760-1761)\*\Indicate which of the
following factors intervene in the pathogenesis of duodenal ulcer:
A) [x]Helicobacter pylori\*\Helicobacter pylori
B) [x]Factorii genetici\*\Genetic factors
C) [x]Fumatul\*\Smoking
D) [ ]Prostaglandinele din clasa E\*\Prostaglandins E Class
E) [ ]Dibutiril-guanozinmonofosfatul ciclic\*\Dibutiril-cyclic guanosine monophosphate
---------------------------------------------------------------------
474. CM p5 Dupa interventia chirurgicala pentru ulcer peptic diareea care apare: (1770)\*\Following surgery for peptic ulcer,
diarrhea which occurs:
A) [ ]este secundara vagotomiei supraselective\*\is secondary to supraselective vagotomy
B) [x]este secundara vagotomiei tronculare\*\is secondary to trunkal vagotomy
C) [ ]apare la 8 ore postprandial\*\appear 8 hours postprandial
D) [x]apare la 2 ore postprandial\*\appear 2-hours postprandial
E) [ ]apare la 6 ore postprandial\*\appears 6-hours postprandial
---------------------------------------------------------------------
475. CM p5 Cauzele maldigestiei si malabsorbtiei globale care este o complicatie postoperatorie a ulcerului peptic sunt:
(1771)\*\causes of global malabsorbtion and maldigestion which is a postoperative complication in peptic ulcer are:
A) [x]concentratia mica de bila de la nivelul lumenului intestinal\*\low concentration of bile from the intestinal lumen
B) [x]evacuarea gastrica rapida\*\rapid gastric emptying
C) [x]raspunsul pancreatic redus la ingestia de alimente\*\Pancreatic response decrease by food intake
D) [ ]dispersia crescuta a alimentelor in stomac\*\dispersion increases by food in the stomach
E) [x]tranzitul accelerat al bolului alimentar prin intestinul subtire\*\the rapid transit of food through the small intestine
---------------------------------------------------------------------
476. CM p5 Ostemalacia si osteoporoza sunt complicatii postoperatorii pentru ulcerul peptic operat. Care dintre afirmatii sunt

65
corecte? (1771)\*\Ostemalacia and osteoporosis are postoperative complications for peptic ulcer. Which statements are correct?
A) [ ]Apar secundar sindromului Dumping\*\appear secondarily Dumping syndrome
B) [x]Apar secundar malabsorbtiei calciului si vitaminei D\*\appears secondary calcium and vitamin D malabsorption
C) [x]Incidenta fracturilor la barbatii cu rezectie gastrica este de 2 ori mai mare comparativ cu barbatii fara\*\Incidence of
fractures in men with gastric resection is 2 times higher than men without
D) [ ]Incidenta fracturilor la barbatii cu rezectie gastrica este de 4 ori mai mare comparitiv cu barbatii fara\*\Incidence of
fractures in men with gastric resection is 4 times higher than men without
E) [x]Postoperator se recomanda tratament profilactic cu vitamina D si calciu\*\Postoperative recommend prophylactic treatment
with vitamin D and calcium
---------------------------------------------------------------------
477. CM p5 Metodele majore de diagnostic ale ulcerului duodenal sunt: (1767)\*\The major methods of diagnosis of duodenal ulcer are:
A) [ ]Radiografia abdominala simpla\*\simple abdominal radiograph
B) [ ]Ecografia abdominala\*\abdominal ultrasound
C) [x]Examenul radiologic baritat\*\radiological barium examination
D) [ ]Tomografia computerizata abdominala\*\abdominal CT
E) [x]Endoscopia digestiva superioara\*\superior digestive endoscopy
---------------------------------------------------------------------
478. CM p5 Mecanismele de actiune a sucralfatului in ulcerul duodenal sunt: (1766)\*\The mechanisms of action of sucralfate in
duodenal ulcer are:
A) [ ]Blocarea refluxului gastroesofagian\*\Blocking gastroesophageal reflux
B) [x]Blocarea retrodifuziunii ionilor de H+\*\Block retrodiffusion of ions H +
C) [x]Diminuarea efectelor nocive ale pepsinei si acizilor biliari\*\Reducing the harmful effects of pepsin and bile acid
D) [ ]Reducerea secretiei de gastrina\*\Reducing the secretion of gastrin
E) [x]Stimularea prostaglandinelor tisulare endogene\*\Stimulation of endogenous tissue prostaglandin
---------------------------------------------------------------------
479. CM p5 Complicatiile ulcerului peptic sunt: (1768)\*\peptic ulcer complications are:
A) [x]hemoragia\*\ bleeding
B) [ ]sindromul Zollinger-Ellison\*\Zollinger-Ellison syndrome
C) [x]obstructia\*\obstruction
D) [x]perforatia\*\perforation
E) [ ]malignizarea\*\ malignancy
---------------------------------------------------------------------
480. CM p5 Precizati care din urmatoarele enuntari legate de diagnosticul ulcerului gastric sunt adevarate (pg 1767)\*\indicate
which of the following statement related to the diagnosis of stomach ulcers are true:
A) [ ]prezenta plicilor gastrice radiante la marginea ulcerului sugereaza malignitatea\*\This gastric fold radiating from the
ulcerated margin suggests malignancy
B) [x]ulcerele gastrice mari peste 3cm sunt mai frecvent maligne decat cele mici\*\stomach ulcers greater than 3 cm are
frequently malignant than smaller ones
C) [ ]pentru excluderea malignitatii sunt suficiente 2 biopsii de la marginea craterului ulceros\*\for exclusion of malignancy 2
biopsies from ulcerous crater edge are sufficient
D) [x]vizualizarea endoscopica permite aprecierea dimensiunilor ulcerului\*\Endoscopic view allows assessment of ulcer size
E) [ ]ulcerele generate de AINS sunt de regula mai mari si pot fi diagnosticate radiologic\*\ulcers caused by NSAIDs are usually
larger and can be diagnosed radiologically
---------------------------------------------------------------------
481. CS p4 Carcinomul rectal cu celule mici: (1711-1712)\*\ rectal small cell carcinoma:
A) [ ] este alcatuit din celule scuamoase cu punti intercelulare\*\ is composed of squamous cells with intercellular bridges
B) [ ] are o arhitectura tisulara cu structuri tubulare sau viloase\*\have a tissue architecture with tubular structures or viloase
C) [ ] este un adenocarcinom cu importanta componenta mucinoasa (peste 50%)\*\is an adenocarcinoma with important mucinous
component (over 50%)
D) [x] are comportament si histochimie asemanatoare cu tumora similara a plamanului\*\histochemistry has similar behavior as a
similar lung tumor
E) [ ] are celule ce contin mucina intracelular\*\has cells containing intracellular mucinous
---------------------------------------------------------------------
482. CS p4 Cea mai mare parte a rectului dreneaza limfatic: (1712)\*\Most of rectal lymphatic draining:
A) [ ]Descendent\*\Descending
B) [ ]Lateral, spre aripioarele rectale\*\Side, for rectal fins
C) [ ]Lateral spre ganglionii iliaci comuni si iliaci interni\*\Lateral to common iliac lymph nodes and internal iliac
D) [x]Spre ganglionii de la originea arterei mezenterice inferioare\*\to ganglia of the lower mesenteric artery origin
E) [ ]Spre ganglionii inghinali\*\to ingunal lymphs
---------------------------------------------------------------------
483. CS p4 Rezectia de colon transvers implica ligatura: (1679)\*\ transverse colon resection involves ligation of:
A) [ ] arterei colice drepte\*\The right colic artery
B) [ ] arterei colice stangi\*\ left colic artery

66
C) [x] arterei colice medii\*\middle colic artery
D) [ ] arterei mezenterice superioare\*\superior mesenteric artery
E) [ ] arterei mezenterice inferioare\*\inferior mesenteric artery
---------------------------------------------------------------------
484. CS p4 Care din localizari au cel mai prost prognostic in cancerul de colon ? (1683)\*\Which locations have the worst
prognosis in colon cancer?
A) [ ]tumorile de unghi hepatic;\*\tumors on liver angle;
B) [x]tumorile de unghi splenic;\*\spleen angle tumors;
C) [ ]cele de colon drept;\*\those on right colons;
D) [ ]cele pe sigma;\*\those on sigmoid;
E) [ ]cele de la nivelul cecului.\*\those on Cecum
---------------------------------------------------------------------
485. CS p4 Conform clasificarii pTNM in cancerul de colon, stadiul Ib, are urmatoarele caracteristici: (1670)\*\According to
pTNM classification in colon cancer, stage Ib has the following characteristics:
A) [x]T2N0 M0\*\T2N0 M0
B) [ ]T2N1 M0\*\T2N1 M0
C) [ ]T1N1 M0\*\T1N1 M0
D) [ ]T1N0 M0\*\T1N0 M0
E) [ ]Tis N0M0\*\Tis N0M0
---------------------------------------------------------------------
486. CS p4 Deceniul de varsta cel mai frecvent afectat de cancerul de colon este: (1665)\*\group of age most frequently affected
by colon cancer is:
A) [ ] 20-29 ani\*\20-29 years
B) [ ] 30-39 ani\*\ 30-39 years
C) [ ] 40-49 ani\*\40-49 years
D) [ ] 50-59 ani\*\50-59 years
E) [x] 60-69 ani\*\60-69 years
---------------------------------------------------------------------
487. CS p4 Care dintre cele enumerate nu sunt considerate a avea rol in diminuarea riscului de aparitie a cancerului rectal?
(1710)\*\ Which of those listed are considered to have a role in reducing the risk of developing rectal cancer?
A) [ ] fibrele alimentare\*\dietary fiber
B) [ ] legumele crucifere\*\cruciferous vegetables
C) [ ] anti-inflamatoriile nonsteroidiene\*\NSAIDS
D) [x] carnea rosie\*\ red meat
E) [ ] antioxidantii\*\ antioxidant
---------------------------------------------------------------------
488. CS p4 Care este deceniul de varsta cel mai frecvent afectat de cancerul de colon ? (1665)\*\what is the group of age most
frequently affected by colon cancer?
A) [ ] 30-39\*\30-39
B) [ ] 40-49\*\40-49
C) [ ] 50-59\*\ 50-59
D) [x] 60-69\*\60-69
E) [ ] 70-79\*\70-79
---------------------------------------------------------------------
489. CM p5 Ablatia rectului in orice procedeu chirurgical trebuie sa respecte 4 ''chei'' anatomice si anume: (1719)\*\Removal of
rectum in any surgical procedure must meet 4 anatomical "keys", namely:
A) [x]indepartarea mezorectului,\*\mesorectum separation
B) [x]dilacerarea lamelor constitutive ale faciei Denonvilliers,\*\Blades expanding of constitutive Denonvilliers facia
C) [x]sectiunea ligamentelor laterale si a arterelor rectale medii,\*\sectioning oflateral ligament and of middle rectal arteries
D) [ ]pastrarea mezorectului superior pentru a evita leziunile plexurilor nervoase pelvine,\*\preserving superior mesorectum to
avoid pelvic nerve plexus lesions,
E) [x]respectarea plexurilor nervoase pelvine\*\Compliance pelvic nerve plexus
---------------------------------------------------------------------
490. CM p5 In functie de localizarea tumorii colonice, cel mai bun prognostic postoperator il au cancerele: (1683)\*\Depending
on solon tumor location, the best postoperative prognosis have the cancers:
A) [x]colonului drept\*\right colon
B) [ ]transversului\*\transverse colon
C) [x]sigmei\*\sigma
D) [ ]unghiului splenic\*\splenetic angle
E) [ ]unghiului hepatic\*\hepatic angle
---------------------------------------------------------------------
491. CM p5 [C2631161] Referitoe la epidemiologia cancerului rectal sunt adevarate urmatoarele afirmatii: (pag. 1709)\*\About
the epidemiology of rectal cancer following next statements are true:

67
A) [x]deceniul cel mai afectat este al 7-lea\*\the most affected is the 7
th
decade
B) [ ]frecventa mai mare in mediul rural decat in cel urban\*\more frequent in rural than in urban areas
C) [x]evolutie mai nefavorabila la tineri fata de varstnici\*\less favorable evolution in younger than in older
D) [x]mai frecvent la barbati decat la femei\*\more frequent in men than in women
E) [x]cancerul anal este mai putin frecvent decat cel rectal propriu-zis\*\anal cancer is less common than rectal itself
---------------------------------------------------------------------
492. CM p5 Formele rare de tumori maligne ale intestinului gros sunt: ()\*\Rare forms of malignant tumors of large intestine are:
A) [x]leiomiosarcomul\*\leiomiosarcoma
B) [x]tumorile carcinoide\*\carcinoid tumors
C) [x]carcinomul cu celule scuamoase\*\squamous cell carcinoma
D) [x]limfomul malign\*\malignant lymphoma
E) [ ]forma ulcerativa\*\ulcerative form
---------------------------------------------------------------------
493. CM p5 Riscul crescut al cancerului de colon este pus in legatura cu urmatorii factori alimentari : (1666)\*\increased risk of
colon cancer is related with following food factors:
A) [x]regimul alimentar occidental sarac in fibre celulozice\*\Western diet poor in cellulose fibers
B) [ ]regim alimentar hidrolactozaharat\*\diet hidro-lacto-zaharat
C) [ ]crestera secretiei de acizi biliari postcolecistectomie\*\increased bile acid secretion postcholecystectomy
D) [x]dieta bogata in grasimi animale\*\diet rich in animal fat
E) [x]lipsa vegetalelor, in special a celor din familia cruciferelor (varza)\*\lack of vegetables, especially those in the cruciferous (cabbage)
---------------------------------------------------------------------
494. CM p5 Care sunt manifestarile generale la un bolnav cu cancer de colon? (1670)\*\What are general manifestations in a
patient with colon cancer?
A) [x]slabire\*\Weight Loss
B) [x]scaderea capacitatii de efort fizic si intelectual\*\loss of physical and intellectual capacity
C) [x]astenie\*\asthenia
D) [ ]cefalee\*\headache
E) [ ]anemie\*\anemia
---------------------------------------------------------------------
495. CM p5 Pregatirea preoperatorie a bolnavului cu neoplasm al colonului impune intotdeauna (1677)\*\Preoperative
preparation of patients with cancer of the colon assumes:
A) [x]corectarea dezechilibrelor hidroelectrolitice si a anemiei\*\correction of electrolyte imbalances and anemia
B) [x]profilaxia antimicrobiana\*\antimicrobial prophylaxis
C) [ ]explorarea tractului urologic\*\exploring the urological tract
D) [x]\*\local mechanical bowel preparation
E) [ ]profilaxia trombozei venoase profunde si a emboliei pulmonare\*\prophylaxis of deep vein thrombosis and pulmonary embolism
---------------------------------------------------------------------
496. CM p5 In cazul aplicarii radioterapiei radicale in cancerul de rect (1721)\*\When is applied the radical radiotherapy in rectal cancer:
A) [ ]la o tumora mai mica de 5 cm diametru se obtine sterilizare completa numai la 20% din cazuri\*\in a tumor less than 5 cm in
diameter is achieved a complete sterilization in only 20% of cases
B) [ ]se folosesc de obicei 10 campuri de iradiere\*\10 fields are usually used for radiation
C) [x]doza folosita este de 55 Gy in 20 fractiuni\*\dose used is 55 Gy in 20 fractions
D) [ ]prezenta metastazelor hepatice reprezinta clar o contraindicatie\*\the presence of liver metastases is clearly a contraindication
E) [x]regresia cancerului este completa dupa mai multe luni de la terminarea tratamentului iradiant\*\cancer regression is
complete after several months after the end of irradiation treatment
---------------------------------------------------------------------
497. CM p5 Factorii care diminua riscul cancerului rectal: (1710)\*\Factors which reduce the risk of rectal cancer:
A) [x]Regim alimentar bogat in fibre alimentare;\*\Diet rich in dietary fiber
B) [x]Ca si vit\*\Ca and Vitamins
C) [ ]Tutunul;\*\Tobacco
D) [ ]Colecistectomia efectuata in antecedente;\*\cholecystectomy performed in history
E) [x]Vitaminele (A, C, E) si antioxidantii\*\vitamins (A, C, E) and antioxidants
---------------------------------------------------------------------
498. CM p5 Tratamentul local al cancerului rectal include: (1719)\*\Local treatment of rectal cancer include:
A) [x]electrocoagularea tumorii;\*\tumor electrocoagulation;
B) [ ]operatia Parks -Percy;\*\Parks -Percy surgery
C) [x]iradierea de contact;\*\contact irradiation
D) [x]laserterapia Nd -Yag;\*\Nd -Yag lasertherapy
E) [x]operatia Lockhart -Mummery\*\Lockhart -Mummery surgery
---------------------------------------------------------------------
499. CM p5 In vederea tratamentului chirurgical al cancerului de colon, preoperator trebuie evaluati urmatorii parametrii:
(1676)\*\for the surgical treatment of colon cancer, preoperatively the following parameters should be evaluated:
A) [x]Explorarea campurilor pulmonare\*\Exploration of lung fields

68
B) [ ]Fixitatea tumorii\*\tumor fixity
C) [x]Detectarea metastazelor hepatice\*\Detection of liver metastases
D) [ ]Prezenta metastazelor peritoneale\*\The peritoneal metastasis
E) [x]Nivelul antigenului carcinoembrionar\*\carcinoembrionar antigen level
---------------------------------------------------------------------
500. CM p5 Urmatoarele afirmatii referitoare la determinarile singerarilor oculte in materiile fecale, sunt adevarate: (1673)\*\The
following statements concerning the determination of occult bleeding in faeces, are true:
A) [ ]Acest test poate fi considerat ca un mijloc de diagnostic deoarece reactia negativa exclude intotdeauna cancerul\*\This test
can be considered as means of diagnosis because negative reaction always exlude cancer
B) [x]Acest test nu poate fi considerat ca un mijloc de diagnostic, deoarece reactia negativa nu exclude cancerul\*\This test can
not be considered as a diagnostic tool, since negative reaction does not exclude cancer
C) [x]Reactia pozitiva poate fi influentata de numerosi factori de eroare ( alte tumori sau leziuni care pot prezenta singerari
oculte)\*\The positive reaction may be influenced by numerous factors of error (other tumors or bleeding lesions may be occult)
D) [x]Aceasta investigatie isi pastreaza valoarea ca test screening pentru depistarea in masa a pacientilor cu risc crescut de cancer
digestiv\*\This investigation retain their value as screening test for mass screening of patients with digestive cancer risk
E) [ ]Aceasta investigatie nu are valoare de test screening pentru depistarea in masa a pacientilor cu risc crescut de cancer
digestiv\*\This investigation is not viable screening test for mass screening of patients with digestive cancer risk
---------------------------------------------------------------------
501. CM p5 Stadiul Astler & Coller B2 corespunde: (1714)\*\Astler & Coller stage B2 corresponds to:
A) [x]T4N0M0\*\T4N0M0
B) [x]Dukes B\*\Dukes B
C) [ ]T3N0M0\*\T3N0M0
D) [ ]T3N1M0\*\T3N1M0
E) [ ]T4N1M0\*\T4N1M0
---------------------------------------------------------------------
502. CM p5 Tuseul rectal poate decela la un pacient cu cancer de rect: (1715)\*\Digital rectal exam can detect a patient with
rectal cancer:
A) [ ]tumori ampulare superioare stenozante;\*\stenosed superior ampullary tumors;
B) [x]tumori situate in 1/2 distala a rectului;\*\tumors located in the distal rectum half;
C) [x]apreciaza consistenta si modificarea tumorii;\*\appreciate consistency and changes in the tumor;
D) [x]permite identificarea adenopatiei perirectale voluminoase;\*\permits the identification of perirectal bulky adenopathy;
E) [x]apreciaza intinderea in sens axial si circumferential\*\appreciate the axial and circumferential senses
---------------------------------------------------------------------
503. CM p5 Urmatoarele sunt simptome si semne particulare ale cancerului colonului drept: (1672)\*\The followings are specific
signs and symptoms of right colon cancer:
A) [x] a\*\nemia secundara hemoragiilor oculte\*\anemia secondary to occult bleeding
B) [x]dureri surde profunde localizate in fosa iliaca dreapta si flancul drept\*\deep dull pain located in right iliac fossa and right
flank
C) [ ]greturi, varsaturi si oprirea tranzitului intestinal\*\nausea, vomiting and intestinal transit stop
D) [x]accelerarea tranzitului intestinal\*\accelerating intestinal transit
E) [x]tabloul clinic al unui plastron apendicular\*\clinical picture of an appendicular shirt
---------------------------------------------------------------------
504. CM p5 Factorii care maresc riscul cancerului de rect sunt: (1710)\*\Factors that increase the risk of rectal cancer are:
A) [x]alcoolul ingerat, care reprezinta un factor de risc moderat\*\alcohol intake, which represents a moderate risk factor
B) [ ]regimul sarac in proteine\*\low protein regime
C) [x]grasimile, mai ales cele saturate sunt incriminate ca factori favorizanti\*\fat, especially saturated ones are incriminated as risk factor
D) [x]tutunul este considerat factor favorizant mai ales la barbat in jurul virstei de 35 de ani\*\Tobacco is considered risk factor
especially in men around age 35 years
E) [ ]cafeaua\*\coffee
---------------------------------------------------------------------
505. CM p5 Urmatoarele afirmatii sunt adevarate referitoare la radioterapia paliativa in cancerele rectale: (1721)\*\following
statements are true regarding palliative radiotherapy in rectal cancers:
A) [x]In cancerele rectale cu evolutie locala avansata poate controla singerarea, durerea si diareea mucoasa\*\In rectal cancer with
locally advanced evolution can control bleeding, pain and mucous diarrhea
B) [x]In cancerele rectale local avansate sau cu metastaze extensive poate oferi un bun control al simptomelor la peste 70% din
bolnavi\*\In locally advanced rectal cancer or with extensive metastases may provide a better control of symptoms in 70% of patients
C) [ ]In cancerele rectale cu evolutie locala avansata poate controla singerarea, durerea, diareea mucoasa sau fenomenele
obstructive\*\In rectal cancer with locally advanced evolution, can control bleeding, pain, mucous diarrhea or obstructive phenomena
D) [x]Dozele uzuale, de ordinul a 20 Gy in 5 fractiuni zilnice de-a lungul unei saptamini s-au dovedit eficiente\*\usual doses of
the order of 20 Gy in five daily fractions over a week have proved effective
E) [x]Dozele uzuale, de ordinul a 30-35 Gy in 10 fractiuni zilnice de-a lungul a 2 saptamini, s-au dovedit eficiente\*\usual doses
of the order of 30-35 Gy in 10 daily fractions over 2 weeks, have proved effective
---------------------------------------------------------------------

69
506. CM p5 Ingrijirile postoperatorii dupa o interventie chirurgicala pentru cancer de colon sunt: (1682)\*\Postoperative care
following surgery for colon cancer are:
A) [x]combaterea durerii\*\pain relief
B) [ ]clisma\*\enema
C) [x]mobilizarea precoce\*\early mobilization
D) [x]examinarea zilnica a bolnavului\*\daily review of patient
E) [x]aportul caloric necesar\*\necessary energy intake
---------------------------------------------------------------------
507. CM p5 Formele macroscopice ale cancerului colic sunt: (vol.II. pag. 1667 -1668)\*\Macroscopic forms of colon cancer are:
A) [x]tumori exofitice si vegetante\*\exophytic und vegetant tumors
B) [x]linita colonica\*\colonic linitis
C) [ ]adenocarcinoame\*\adenocarcinoama
D) [x]tumori ulcerate\*\ulcerated tumors
E) [ ]forme subdenivelate\*\underdenivelations
---------------------------------------------------------------------
508. CM p5 Care sunt caracteristicile radiologice ale unei stenoze maligne dezvoltata la nivelul colonului (1673)\*\Which are the
radiological characteristics of a malignant stenoses developed in the colon:
A) [ ]corespunde unui proces proliferativ care nu intereseaza toata conturul colonului\*\corresponds to a proliferative process not
interested in the entire colonic contour
B) [x]corespunde unui proces tumoral care intereseaza in intregime conturul colonului\*\corresponds to a tumoral process that
interested in the entire colonic contour
C) [x]poate avea aspect inelar sau de cordon pe o distanta de 2-8 cm\*\may look like a ring or cord over a distance of 2-8 cm
D) [x]lumenul colonului este frecvent excentric neregulat, asemanator unui cotor de mar\*\colon lumen is frequently eccentric
irregular, like an apple core
E) [x]in ansamblu, colonul sugereaza aspectul pantalonului de golf\*\the overall appearance of colo suggests golf trousers look
---------------------------------------------------------------------
509. CM p5 Care sunt factorii care influenteaza nefavorabil procesul cicatrizarii suturilor colonice la bolnavii cu cancer de colon?
(1678)\*\What are the factors that adversely affect healing process of the sutures in patients with colon cancer?
A) [x]riscul vascular\*\vascular risk
B) [ ]folosirea suturilor mecanice\*\using mechanical sutures
C) [x]riscul structural (perete colonic subtire)\*\structural risk (thin colonic wall)
D) [x]riscul septic (continut colonic bogat in flora microbiana)\*\septic risk (colon content rich microbial flora)
E) [x]riscul biologic (cancerosi, tarati)\*\biological risk (cancer, bran)
---------------------------------------------------------------------
510. CM p5 Antigenele normale ce pot fi depistate in tumora rectala prin tehnici de imunohistochimie sunt: (1712)\*\Antigens
that can be detected in the normal rectal tumor by immunohistochemistry techniques are:
A) [ ]factorul de necroza tumorala\*\tumor necrosis factor
B) [x]antigenul carcino-embrionic\*\Carcinoembryonic antigen (CEA)
C) [ ]CA-19-9\*\CA 19-9
D) [x]alfa fetoproteina\*\alpha fetoprotein
E) [x]fosfataza alcalina placentara umana\*\Human placental alkaline phosphatase
---------------------------------------------------------------------
511. CS p4 Care dintre urmatoarele afirmatii privitoare la bilirubina delta (biliproteina) sunt adevarate: (275)\*\Which of the
following information regarding delta bilirubin (biliprotein) is true:
A) [ ]reprezinta o forma de bilirubina neconjugata\*\it represents a form of unconjugated bilirubin
B) [ ]este legata reversibil, necovalent de albumina\*\it is reversibly noncovalently bound to albumin
C) [ ]este excretata prin rinichi\*\it is excreted by the kidneys
D) [x]reprezinta bilirubina conjugata legata covalent, ireversibil de albumina\*\it represents conjugated bilirubin irreversibly
covalently bound to albumin
E) [ ]are un timp de injumatatire scurt si dispare rapid din ser\*\it has a short half-time & disappears rapidly from the serum
---------------------------------------------------------------------
512. CS p4 Precizati in care dintre urmatoarele tulburari hepatocelulare icterul asociat nu este obstructiv sau colestatic:
(279)\*\Define, in which of the following hepatocellular disturbances the associated jaundice is neither obstructive nor
cholestatic:
A) [ ]Hepatita alcoolica si infiltrarea grasa a ficatului indusa de alcool\*\alcohol hepatitis with fatty infiltration of the liver by alcohol
B) [x]Sindromul Gilbert\*\Gilbert's syndrome
C) [ ]Sindromul Dubin-Johnson\*\Dubin-Johnson's syndrome
D) [ ]Sindromul Rotor\*\Rotor'S syndrome
E) [ ]Colestaza intrahepatica benigna recurenta\*\recurrent benign intrahepatic cholestasis
---------------------------------------------------------------------
513. CS p4 In conditii normale, excretia zilnica a urobilinogenului este de maxim: (276)\*\in normal conditions, daily excretion
of urobilinogen is maximal:
A) [ ]1 mg\*\1 mg

70
B) [ ]2 mg\*\2 mg
C) [x]4 mg\*\4 mg
D) [ ]10 mg\*\10 mg
E) [ ]2 g\*\2 g
---------------------------------------------------------------------
514. CS p4 Icterul Criegler-Najjar tip II apare datorita: (278)\*\Jaundice in Crigler-Najjar type II appears because of:
A) [ ]supraproductiei de bilirubina\*\superproduction of bilirubin
B) [ ]captarii hepatice scazute a bilirubinei\*\decreased hepatic bilirubin uptake
C) [ ]afectarea excretiei bilirubinei\*\affections of biliary excretion
D) [ ]leziuni hepatocelulare severe\*\severe hepatocellular lesions
E) [x]deficit moderat de transferaza hepatica\*\moderat defiency of hepatic transferase
---------------------------------------------------------------------
515. CS p4 [M1117003] Care este cea mai frecventa cauza de crestere usoara a bilirubinei neconjugate (pg 280)\*\Which is the
most frequent cause of a mild rise in unconjugated bilirubin
A) [ ]anemia hemolitica autoimuna\*\autoimmune haemolytic anaemia
B) [ ]resorbtia unui hematom voluminos\*\resorption of a voluminous haematoma
C) [ ]anemia hemolitica microangiopatica\*\microangiopathic haemolytic anaemia
D) [x]sindromul Gilbert\*\Gilbert's syndrome
E) [ ]hepatita acuta\*\acute hepatitis
---------------------------------------------------------------------
516. CS p4 [M1417016] Un pacient cu o nuanta verzuie a icterului ce asociaza scadere ponderala,adenopatii si splenomegalie
spre ce afectiune ne poate orienta: (pg 280)\*\In a patient with a green nuance of jaundice associated with slight weight loss,
adenopathy & splenomegaly we can orientate towards:
A) [ ]colangiocarcinom\*\cholangiocarcinoma
B) [ ]carcinom ampular\*\ampullar carcinoma
C) [ ]carcinom periampular\*\periampullar carcinoma
D) [ ]hepatita cronica grava\*\chronic severe hepatitis
E) [x]cancer pancreatic\*\pancreatic cancer
---------------------------------------------------------------------
517. CS p4 [M2717071] In legatura cu excretia renala a bilirubinei sunt adevarate urmatoare afirmatii: (pg 276)\*\According the
urinary excretion of bilirubin the following information is true:
A) [x]urina contine bilirubina detectabila doar prin procedee spectro-fotometrice sensibile\*\urine contains bilirubin, which is just
detectable by sensitive spectro-fotometric procedures
B) [ ]exista un proces de secretie tubulara pentru bilirubina neconjugata\*\a process for tubular secretion of unconjugated bilirubin exists
C) [ ]sarurile biliare scad filtrarea glomerulara a bilirubinei conjugate\*\bile salts fall by glomerular filtration of conjugated bilirubin
D) [ ]prezenta bilirubinei in urina apare doar in hiperbilirubinemiile neconjugate\*\presence of urinary bilirubin appears only in
unconjugated bilirubinaemia
E) [ ]bilirubina neconjugata este filtrata la nivelul glomerulilor renali\*\unconjugated bilirubin is filtrated at the level of the renal glomeruli
---------------------------------------------------------------------
518. CS p4 SDBS-sindromul ductului biliar disparut nu apare in (281)\*\VBDS-vanishing bile duct syndrome does not appear in:
A) [ ]SIDA\*\AIDS
B) [ ]dupa iradiere\*\after radiation
C) [ ]dupa tratament anticonvulsivant\*\after anticonvulsive treatment
D) [x]in colangita sclerozanta primara\*\in primary sclerosing cholangitis
E) [ ]in invectia cu VCM\*\in CMV infection
---------------------------------------------------------------------
519. CM p5 [M2217209] In bolile hepatocelulare (hepatite si ciroze) icterul poate fi determinat de : (pg 278)\*\In hepatocellular
disease (hepatitis & cirrhosis) jaundice can be caused by:
A) [x]afectarea excretiei biliare\*\affections of biliary excretion
B) [x]reducerea conjugarii bilirubinei\*\decreased bilirubin conjugation
C) [ ]cresterea conjugarii bilirubinei\*\increased bilirubin conjugation
D) [x]reducerea captarii bilirubinei\*\decreased bilirubin uptake
E) [ ]obstructie biliara extrahepatica\*\extrahepatic biliary obstruction
---------------------------------------------------------------------
520. CM p5 [M2217200] Tulburarile hepatocelulare in care icterul poate fi asociat ca faza obstructiva sau colestatica sunt: (pg
279)\*\Hepatocellular disorders in which jaundice can be associated with obstructive or cholestatic phases are:
A) [x]hepatita alcoolica\*\alcohol-induced hepatitis
B) [x]colestaza intrahepatica benigna recurenta\*\recurrent benign intrahepatic cholestasis
C) [ ]sindromul Gilbert\*\Gilbert's syndrome
D) [x]reactii medicamentoase (Clorpromazina)\*\medication reaction (chlorpromazine)
E) [ ]sindrom Crigler- Najjar tip II\*\Crigler- Najjar syndrome type II
---------------------------------------------------------------------


71
521. CM p5 [M2217204] Icterul din bolile hepatocelulare se caracterizeaza prin: (pg 278)\*\Jaundice by heparocellular disease is
characterized by: (s 278)
A) [x]sunt afectate toate cele trei etape ale metabolismului bilirubinei\*\each of the three steps in bilirubin metabolism is affected
B) [ ]in cea mai mare masura este afectata captarea bilirubinei\*\most importantely bilirubin uptake is affected
C) [ ]predomina bilirubina neconjugata in ser\*\there is predominately unconjugated bilirubin in serum
D) [x]in cea mai mare masura este afectata excretia bilirubinei\*\most importantely bilirubin excretion is affected
E) [x]predomina bilirubina conjugata in ser\*\there is predominantely conjugated bilirubin in serum
---------------------------------------------------------------------
522. CM p5 [M2217170] Constatarea la examenul de laborator a unei hiperbilirubinemii predominant neconjugata, ne orienteaza
spre: (pg 280)\*\On laboratory examination the manifestation of preominantely unconjugated hyperbilirubinaemia suggests:
A) [x]anemie hemolitica autoimuna\*\autoimmune haemolytic anaemia
B) [x]eritropoieza ineficienta\*\inefficient erythropoiesis
C) [x]resorbtia unui hematom voluminos\*\reabsorption of a voluminous haematoma
D) [ ]hepatita colestatica\*\cholestatic hepatitis
E) [ ]obstructie biliara intrahepatica\*\intrahepatic biliary obstruction
---------------------------------------------------------------------
523. CM p5 Care dintre urmatoarele medicamente pot produce colestaza: (278)\*\Which of the following drugs can cause cholestasis:
A) [x]androgeni\*\androgens
B) [x]contraceptive orale\*\oral contraceptives
C) [ ]acid ursodezoxicolic\*\ursodeeoxycholic acid
D) [x]clorpromazina\*\clorpromazine
E) [ ]izoniazida\*\izoniazide
---------------------------------------------------------------------
524. CM p5 [M1117088] Precizati care din urmatoarele cauze de colestaza intrahepatica asociaza frecvent semne clinice de
colestaza cu ducte de calibru normal (pg 281)\*\Define, which of the following causes of intrahepatic cholestasis is frequently
associated with clinical sign of cholestasis & normal caliber ducts
A) [x]ciroza biliara primitiva\*\primary biliary cirrhosis
B) [ ]chimioterapia intraarteriala hepatica\*\intrahepatic arterial chemotherapy
C) [ ]colangita sclerozanta primara\*\primary sclerosing cholangitis
D) [x]unele medicamente\*\certain drugs
E) [x]alcoolism\*\alcoholism
---------------------------------------------------------------------
525. CM p5 Precizati care din urmatoarele afirmatii sunt adevarate: (275-276)\*\Define, which of the following information is true:
A) [x]icterul scleral apare in general mai precoce decat icterul generalizat\*\sclera jaundice generally appears before gerneralisation
B) [ ]consemnarea icterului scleral nu este utila pentru diagnosticul diferential al icterului cu carotenemia\*\the sign of sclera
jaundice is not used for the differential diagnosis of jaundice with carotenemia
C) [x]la pacientii anemici icterul este mai pronuntat\*\in anaemic patients jaundice is more pronounced
D) [ ]in zonele edematoase icterul este mai pronuntat\*\in oedemic regions jaundice is more pronounced
E) [x]zonele cu deficit motor au tendinta de a ramane necolorate in cazul icterului\*\regions with motor deficit tend to remain
noncolourised in the case of jaundice
---------------------------------------------------------------------
526. CM p5 [M1117081] In care din urmatoarele sitatii vom avea urobilinogenul crescut in urina (276)\*\In which of the
following situation urinary urobilinogen will be increased:
A) [ ]colestaze\*\cholestasis
B) [x]hemolize\*\haemolysis
C) [x]boli hepatocelulare\*\hepatocellular diseases
D) [ ]obstructii biliare extrahepatice\*\extrahepatic biliary obstructions
E) [ ]consum medicamentos\*\drug consumation
---------------------------------------------------------------------
527. CM p5 [gabitza] Mecanismele de excretie scazuta a bilirubinei in boala hepatocelulara sau boala colestatica sunt:
\*\Mechanisms of decreased bilirubin excretion in hepatocellular or cholestatic diseases are:
A) [x]ocluzia canaliculelor de catre bila ingrosata\*\occlusion of ducts by thickened bile
B) [ ]ocluzia canaliculelor de catre bila neingrosata\*\occlusion of ducts by non-thickened bile
C) [x]ocluzia canaliculelor de catre hepatocitele inflamate\*\occlusion of ducts by inflamed hepatocytes
D) [x]obstructia ductelor biliare intrahepatice terminale prin celulele inflamatorii\*\obstruction of intrahepatic terminal bile ducts
by inflammatory cells
E) [x]permeabilitate hepatocelulara modificata\*\modified hepatocellular permeability
---------------------------------------------------------------------
528. CM p5 [M1217092] Care dintre urmatoarele afirmatii privitoare la conjugarea bilirubinei sunt adevarate: (pg 276)\*\Which
of the following information regarding the conjugation of bilirubin is true: (s 276)
A) [ ]bilirubina neconjugata preluata in hepatocit este hidrosolubila\*\unconjugated bilirubin taken up by hepatocytes is hydrosoluble
B) [x]conjugarea bilirubinei cu acidul glucuronic ii creste hidrosolubilitatea\*\the conjugation of bilirubin with glucuronic acid
creates hydrosolubility

72
C) [x]reactia de conjugare are loc in microzomii hepatici (reticul endoplasmic)\*\the reaction of conjugation takes place in hepatic
microsomes (endoplasmatic reticulum)
D) [x]reactia de conjugare este catalizata de bilirubin-glucuronil-transferaza\*\the reaction of conjugation is catalyzed by bilirubin
glucoronyl transferase
E) [ ]bilirubin-monoglucuronidul reprezinta forma principala de bilirubina excretata in bila\*\bilirubin monoglucoronyl represents
the principle form of bilirubin excreted into bile
---------------------------------------------------------------------
529. CM p5 Colangiopancreatografia endoscopica retrograda, pe langa colangiografie, ofera urmatoarele avantaje: (280, 281)
\*\Endoscopic retrograde cholangiopancreatiography offers the following advantages besides cholangiography:
A) [x]este preferata pentru diagnostic si tratamentul obstructiilor biliare distale\*\it is preferred for diagnosis & treatment of distal
biliary obstructions
B) [x]permite biopsierea ampulei Vater\*\it allows biopsy of the ampulla Vater
C) [x]vizualizeaza ductele pancreatice\*\it visualizes the pancreatic ducts
D) [x]poate detecta semne de litiaza a canalelor pancreatice\*\it can detect signs of lithiasis in pancreatic canaliculi
E) [ ]nu permite biopsierea directa a epiteliului ductal biliar\*\it does not allow direct biopsy of the biliary ductal epithelium
---------------------------------------------------------------------
530. CM p5 Hiperbilirubinemia conjugata izolata apare in: (280)\*\Isolated conjugated hyperbilirubinaemia appears in:
A) [x]sindromul Rotor\*\Rotor's syndrome
B) [x]sidrom Dubin-Johnson\*\Dubin-Johnson's syndrome
C) [ ]sindrom Gilbert\*\Gilbert's syndrome
D) [x]sindromul colestazei intrahepatice recurente benigne\*\benign recurrent intrahepatic syndrome of cholestasis
E) [ ]sindrom Crigler-Najjar tip I\*\Crigler-Najjar syndrome type I
---------------------------------------------------------------------
531. CM p5 [M2217211] Bilirubina neconjugata se caracterizeaza prin: (275)\*\Unconjugated bilirubin is characterized by:
A) [x]circula in plasma stans legata de albumina\*\in circulates in plasma tightly bound to albumin
B) [x]celulele creierului au o mare afinitate fata de ea\*\there is an increased affinity for cerebral cells
C) [ ]formeaza cu albumina un complex ireversibil\*\it forms an irreversible complex with albumin
D) [ ]se excreta renal\*\it is excreted renally
E) [x]are afinitate pentru lipide\*\it has an affinity for lipids
---------------------------------------------------------------------
532. CM p5 Care sunt caracteristicile bilirubinei neconjugate: (275)\*\Which are the characteristics of unconjugated bilirubin:
A) [x]reprezinta majoritatea bilirubinei serice la indivizii normali\*\it represents the biggest amount of serum bilirubin in normal individuals
B) [x]deriva in cea mai mare parte din distrugerea eritocitelor imbatranite\*\it derives mostly from destruction of aged erythrocytes
C) [ ]este legata covalent de albumina\*\it is covalently bound to albumin
D) [x]in perioada neonatala are afinitate crescuta pentru celulele din ganglionii bazali ai creierului\*\it has an increased affinity
for cells of the cerebral basal ganglia in the neonatal period
E) [ ]in hiperbilirubinemii persistente formeaza cu albumina un complex covalent numit bilirubina delta\*\in persisting
hyperbilirubinaemia it forms a covalent complex called bilirubin delta together with albuminin
---------------------------------------------------------------------
533. CM p5 In evaluarea pacientului icteric, scaunele acholice sugereaza: (279)\*\In evalutation of an icteric patient, acholic stools suggest:
A) [x]chist coledocian inflamat\*\inflamed choledochal cyst
B) [x]litiaza coledociana\*\choledochal lithiasis
C) [ ]ciroza biliara primitiva\*\primary biliary cirrhosis
D) [ ]colangita sclerozanta\*\sclerosing cholangitis
E) [ ]colita ulceroasa\*\ulcerative colitis
---------------------------------------------------------------------
534. CM p5 [M2217180] Sindromul ductului biliar disparut apare in: (281)\*\Vanishing bile duct syndrome ocurs in:
A) [x]rejectia postransplant hepatic\*\post-transplant hepatic rejection
B) [x]SIDA\*\AIDS
C) [x]infectia cu virus citomegalic\*\infection with cytomegalovirus
D) [x]boala de iradiere\*\irradiation disease
E) [ ]limfom non Hodgkin\*\non-Hodgkin lymphoma
---------------------------------------------------------------------
535. CM p5 [M2217186] Care din urmatoarele mecanisme sunt implicate in cresterea bilirubinei din starile septice: (pg
278)\*\Which of the following mechanisms are involved in bilirubin increase by septic states:
A) [ ]supraproductie de bilirubina\*\bilirubin hyperproduction
B) [x]conjugare scazuta a bilirubinei\*\decreased bilirubin conjugation
C) [ ]obstructie intraductala\*\intraductal obstruction
D) [x]afectarea excretiei hepatice\*\affections of hepatic excretion
E) [x]captare scazuta\*\decreased uptake
---------------------------------------------------------------------
536. CM p5 [M2217169] Nuanta verzuie a icterului sugereaza: (pg 279, 280)\*\Green nuance of jaundice suggests:
A) [x]ciroza biliara primitiva\*\primary biliary cirrhosis

73
B) [x]colangita sclerozanta\*\sclerosing cholangitis
C) [x]hepatita cronica grava\*\severe chronic hepatitis
D) [x]obstructie maligna cu evolutie indelungata\*\malignant obstruction with prolonged evolution
E) [ ]litiaza coledociana\*\choledochal lithiasis
---------------------------------------------------------------------
537. CM p5 [M1217096] Icterul asociat hiperbilirubinemiei predominant conjugate se poate datora: (pg 279)\*\Jaundice
associated with predominately conjugated hyperbilirubinaemia is possibly caused by:
A) [ ]hemolizei\*\ haemolysis
B) [x]unei boli hepatocelulare\*\certain hepatocellular diseases
C) [ ]resorbtiei unui hematom voluminos\*\reabsorption of a high volume haematoma
D) [x]unei obstructii biliare intrahepatice\*\certain intrahepatic biliary obstructions
E) [x]unei obstructii biliare extrahepatice\*\certain extrahepatic biliary obstructions
---------------------------------------------------------------------
538. CM p5 [M2217206] Care dintre urmatoarele afectiuni se asociaza cu hiperbilirubinemia predominant conjugata? (pg
278)\*\Which of the following affections is associated with predominantely conjugated hyperbilirubinaemia?
A) [x]nutritie parenterala\*\parenteral nutrition
B) [x]ciroza biliara primitiva\*\primary biliary cirrhosis
C) [x]colangiohepatita orientala\*\oriental cholangiohepatitis
D) [ ]post prelungit\*\prolonged fasting
E) [ ]icterul laptelui de san\*\mother's milk jaundice
---------------------------------------------------------------------
539. CM p5 [M1117087] In care din urmatoarele circumstante clinice poate sa apara ''sindromul ductului biliar disparut'' (pg
281)\*\In which of the following clinical circumstances vanishing bile duct syndrome can appear
A) [ ]ciroza biliara primitiva\*\primary biliary cirrhosis
B) [x]boala de iradiere\*\radiation sickness
C) [ ]colangiocarcinom\*\cholangiocarcinoma
D) [x]infectia cu citomegalovirus\*\cytomegaloveirus infection
E) [x]SIDA\*\AIDS
---------------------------------------------------------------------
540. CM p5 Care din situatii sunt favorizate de existenta unei sarcini (279)\*\Which of the following situations are favourised by pregnancy
A) [x]colestaza\*\cholestasis
B) [x]steatoza\*\steatosis
C) [ ]congestia hepatica\*\hepatic congestion
D) [x]insuficienta hepatica acuta\*\acute hepatic insuffiency
E) [ ]intreruperea selectiva a transportului bilirubinei\*\selective interruption of bilirubin transport
---------------------------------------------------------------------
541. CS p4 Care dintre formala clinice de litiaza veziculara debuteaza cu icter: (1916) \*\Which of the clinical forms of vesicular
lithiasis starts with an Icterus:
A) [ ] pseudoulceroasa \*\Pseudoulcerosis
B) [ ] latenta \*\ Latent
C) [ ] dureroasa \*\ Painful
D) [x] pseudoneoplazica \*\Pseudoneoplastic
E) [ ] dispeptica \*\Dispeptic
---------------------------------------------------------------------
542. CS p4 [C1518014] Elementul decisiv in diagnosticul pozitiv al litiazei veziculare este reprezentat de: (pg 1918)\*\The
decisive element in the positive diagnosis of vesicualr lithiasis is represented by:
A) [ ] prezenta leucocitozei; \*\Presence of Leucocytosis
B) [ ] prezenta subicterului; \*\Presence of subicterus
C) [ ] prezenta durerii la nivelul hipocondrului drept; \*\ presence of pain at level of right Hypochondrium
D) [x] vizualizarea ecografica a calculilor; \*\ Ecographic visualization of claiculi
E) [ ] prezenta suferintei de tip ''non-ulcer dispepsia''. \*\Presence of suffering of non-ace dyspeptic ulcer
---------------------------------------------------------------------
543. CS p4 [CS19004] Urmatoarele afectiuni sunt contraindicatii ale ERCP,cu exceptia: (Pag. 1936) \*\The following affections
are contraindications for ERCP, except:
A) [ ] Discraziile sangvine \*\ Blood dyscrasia
B) [ ] Stenozele esofagiene \*\ Esophageal stenotele
C) [x] Intoleranta la iod \*\ Iodine intolerance
D) [ ] Ascita \*\ Ascites
E) [ ] Derivatia bilio-jejunala \*\Bilio-jejeunal derivation
---------------------------------------------------------------------
544. CS p4 [CS19039] Care din urmatoarele nu reprezinta forma icterigena a litiazei CBP? (1929 - 1932) \*\Which of the
following doesn't represent the ictergenic form of CBP lithiasis?
A) [ ]clasica \*\ classic

74
B) [ ]asociata cu pancreatita acuta \*\associated with acute pancreatitis
C) [ ]asociata cu colecistita acuta \*\ associated with acute Cholecystits
D) [x]dispeptica \*\Dyspeptic
E) [ ]cu inclavare in papila \*\With inclavation in papilla
---------------------------------------------------------------------
545. CS p4 Peste ce valoare, grosimea peretilor veziculari, evidentiata ecografic, are semnificatia unui proces acut? (pg 1917) \*\
From which value onwards does the thickness of the vesicular walls does the echographic evidence show an acute process?
A) [ ] 2 mm \*\ 2 mm
B) [x] 3 mm \*\ 3 mm
C) [ ] 4 mm \*\ 4 mm
D) [ ] 5 mm \*\ 5 mm
E) [ ] 6 mm \*\6 mm
---------------------------------------------------------------------
546. CS p4 Diametrul calculilor care traverseaza cel mai frecvent ecluza cervico-istmica este: (1921) \*\ The diameter of caliculi
that transverse most frequently the cervico-isthmic barrier is:
A) [ ]2 cm; \*\2cm
B) [ ] more then 5mm \*\peste 5 mm; \*\
C) [ ]peste 1 cm; \*more then 1cm\
D) [x]sub 5 mm; \*\ below 5mm
E) [ ]intre 5 - 10 mm. \*\Between 5-10 mm
---------------------------------------------------------------------
547. CS p4 [C1518019] Ileusul biliar este consecinta: (pg 1921) \*\ Choleangiography is not contraindicated in:
A) [ ] migrarii calculului in calea biliara principala; \*\ Acute cholecystitis \*\
B) [ ] prezentei unei fistule colecisto-coledociene; \*\ Acute pancreatitis\*\
C) [ ] aparitiei peritonitei biliare; \*\ Non-complicated biliry lithiasis \*\
D) [x] trecerii unui calcul din colecist in duoden printr-o fistula bilio-digestiva; \*\ Hepatic insufficiency \*\
E) [ ] prezentei unei fistule biliare externe. \*\ Intolerance towards iodated compounds \*\
---------------------------------------------------------------------
548. CS p4 Diagnosticul de certitudine al litiazei veziculare poate fi pus prin: (1917) \*\The certain diagnosis of vesicular lithiasis
can be made by:
A) [ ]examen radiologic \*\ Radiologic examination
B) [ ]angiografie \*\ Angiography
C) [x]ecografie \*\Ecography
D) [ ]scintigrama hepato-biliara \*\Hepato-biliary scintigram
E) [ ]Ba pasaj \*\True Passage
---------------------------------------------------------------------
549. CM p5 Calculul unic coledocian NU se caracterizeaza prin: (pg 1926) \*\ Single CBD calculi is NOT characterized by:
A) [x] este exclusiv de provenienta coledociana \*\ Origin is exclusively choledochal
B) [ ] are un nucleu central pigmentar in jurul caruia precipita colesterina sau sarurile de calciu \*\ has a central nucleus,
pigmented around, which precipitated cholesterol or calcium salts
C) [ ] este friabil, sfarimicios \*\ is brittle, sfarimicios
D) [x] este fecvent \*\ is frequent
E) [x] are forma poliedrica \*\has polyhedra form
---------------------------------------------------------------------
550. CM p5 Tulburarile dispeptice din tabloul clinic al litiazei veziculare cuprind: (1916) \*\ Dyspeptic disorders at he clinical
presentation of a vesicualr lithiasis contains:
A) [x] balonari \*\ bloating
B) [x] astenie psiho-fizica \*\ Psycho-physic asthenia
C) [x] tulburari de tranzit \*\ Transitory disorders
D) [ ] sialoree \*\ Sialorrhea
E) [x]sindrom migrenos \*\ Migernous syndrome.
---------------------------------------------------------------------
551. CM p5 Litotritia extracorporeala este contraindicata in: (pg 1922) \*\ Extracorporal Lithotripsy is contraindocated in:
A) [x] sarcina \*\ Pregnancy
B) [ ] absenta complicatiilor biliare \*\Absence of biliary complications
C) [x] ulcer gastroduodenal \*\gastroduodenal ucer
D) [ ] cazul calculior urici < 3 cm \*\ in caseof uric calculi < 3cm
E) [x] anevrisme regionale \*\ regional aneurisms.
---------------------------------------------------------------------
552. CM p5 [C2218116] In care dintre urmatoarele situatii examinarea ecografica la un pacient cu colecistita acuta poate sa nu
evidentieze semiologia tipica pentru un proces acut? (pg 1921-1922) \*\ In which of the following situations at the echographic
examination at a patient with acute cholecystitis, the typical semiological evidence for an acute process can be missing?
A) [x] Colagenoze \*\ cholangenosis

75
B) [x] SIDA \*\AIDS
C) [ ] Gravide \*\ Pregnancy
D) [x] Postpartum \*\ Postpartum
E) [x] Politraumatizati \*\ Polytrauma
---------------------------------------------------------------------
553. CM p5 [CM19099] Calculii autohtoni ai CBP se caracterizeaza prin (pg1926) \*\Local CBP stones are characterized by
A) [ ] are faceted \*\ sunt fatetati \*\
B) [x] pot fi cilindrici \*\ can be cylindrical
C) [ ] au continut bogat de colesterina \*\ are rich in cholesterol
D) [x] sunt friabili \*\ is friable
E) [x] in general se insotesc de dilatarea CBP (20-25mm) \*\ is usually accompanied by dilated CBD (20-25mm)
---------------------------------------------------------------------
554. CM p5 Dintre formele de litiaza coledociana icterigene fac parte: (p.1932) \*\Some forms of bile duct stones areicterigenic
A) [x] forma clasica caracterizata prin prezenta sindromului coledocian \*\ The classic form is characterized by choledochal
syndrome presentation
B) [x] inclavarea calculului in papila \*\calculi inclavarea in papilla
C) [ ] colecistita acuta asociata litiazei intrahepatice \*\ acute cholecystitis associated with intra hepatic lithiasis
D) [x] severe forms associated with acute pancreatitis and acute cholangitis \*\ forme grave asociate cu pancreatita acuta si
angiocolita acuta \*\
E) [ ] forma dureroasa pura \*\ pure painful form
---------------------------------------------------------------------
555. CM p5 [CM19115] Lipsa de opacifiere a hepatocoledocului in cadrul colangiografiei intravenoase se poate datora: (pag.
1933) \*\ Lack of opacification of hepatocholedochus during intravenous cholangiography may be due to:
A) [x] insuficientei hepatocitare \*\ The failure hepatocite
B) [x] hipotoniei oddiene \*\ oddiene hypotonia
C) [x] inflamatiei coledocului \*\ choledochal inflammation
D) [ ] unui calcul oddian \*\ oddian calculi
E) [ ] unei obstructii oddiene incomplete prin compresiune externa \*\an incomplete oddiene obstruction by external compression
---------------------------------------------------------------------
556. CM p5 Care sunt particularitatile colecistectomiei anterograde? (1924)\*\Which are the particularities of an anterograde cholecystectomy
A) [x] Este preferata in conditiile unui pedicul hepatic dificil \*\ It is preferred in conditions of an difficult hepatic pedicule
B) [ ] Creste riscul lezarii CBP \*\Increases risk of lesions of CBD
C) [x] Reduce riscul lezarii CBP \*\ Reduces risk of lesions of CBD
D) [x] Faciliteaza migrarea unor calculi in CBP \*\ Facilitates the migration of an calculi in the CBD
E) [ ] Evita riscul migrarii unor calculi in CBP \*\ Avoids risk of migration of an CBD calculi
---------------------------------------------------------------------
557. CM p5 [C2218135] Prin ce elemente se diferentiaza clinic icterul neoplazic de icterul aparut la un pacient cu complicatii ale
litiazei veziculare? (pg 1919) \*\ By which elements differentiates clinical the neoplastic icterus from the icterus that appears at a
patient with complications of an vesicualr lithiasis?
A) [x] Icter afebril \*\Nonfebrile icterus
B) [ ] Icter febril \*\ Febrile icterus
C) [x] Icter indolor \*\Painless icterus
D) [ ] Icter asociat cu colica \*\ Icterus associated with cholic.
E) [ ] Icter care se intensifica cu perioade de remisiune \*\ Icterus that intensifies with periods of remission
---------------------------------------------------------------------
558. CM p5 [C2618190] Complicatiile litiazei biliare cuprind (pg 1920) \*\ Complications of gallstones include
A) [x] colecistita acuta \*\ acute cholecystitis
B) [x] fistula biliara \*\biliary fistula
C) [x] ileusul biliar \*\biliary ileus
D) [ ] agenezia biliara \*\ biliary agenesis
E) [x] malignizarea \*\ malignant
---------------------------------------------------------------------
559. CM p5 [C2518178] Tehnicile neablative aflate in arsenalul terapeutic destinat litiazei veziculare sunt reprezentate de: (pg
1922) \*\ Neablative techniques available in the therapeutic arsenal for vesicular lithiasis are:
A) [ ] chirurgia laparoscopica; \*\ laparoscopic surgery
B) [x] disolutia chimica; \*\ chemical dissolution
C) [x] litotritia extracorporeala; \*\ extracorporeal lithotripsy
D) [x] litotritia percutana; \*\ Percutaneous lithotripsy
E) [ ] vendoscopia digestiva superioara. \*\ upper GI endoscopy
---------------------------------------------------------------------

76
560. CM p5 [C1418080] Colecistectomia laparoscopica este contraindicata la bolnavii: (pg 1924) \*\Laprascopic
cholecystectomy is contraindicated at patients:
A) [ ]peste 50 de ani \*\older then 50 years
B) [x]cu interventii chirurgicale supramezocolice \*\with surgical supramezocholic interventions
C) [ ]cu evisceratie \*\ with evisceration
D) [x]cu plastron vezicular \*\ with vesicular plastron
E) [ ]cu eventratie \*\ with eventration
---------------------------------------------------------------------
561. CM p5 [C2818196] Ileusul biliar: (pg 1921) \*\Bile ileus: (pg 1921)
A) [x] este o ocluzie intestinala mecanica \*\ is a mechanical bowel obstruction
B) [ ] este o ocluzie intestinala dinamica \*\ intestinal obstruction is a dynamic
C) [ ] calculul are maxim 3-4 cm \*\ calculation is within 3-4 cm
D) [ ] cel mai frecvent se localizeaza la nivelul colonului \*\most frequent in the colon show
E) [x] cel mai frecvent se localizeaza la nivelul duodenului, la unghiul lui Treitz \*\ show most frequent at the level of the
duodenum, at the angle of Treitz
---------------------------------------------------------------------
562. CM p5 [CM19079] Posibilitatea existentei litogenezi la nivelul CBP este sustinuta de urmatoarele observatii: (p1926) \*\
The possibility of the CBD lithogenesis is supported by the following observations:
A) [x] Litogeneza CBP apare la 24-43% din pacientii cu absenta congenitala a colecistului \*\ CBD lithogenesis appears to 24-
43% of patients with congenital absence of gallbladder
B) [x] 20% din pacienti cu CBP au colecistul nelocuit si de aspect normal \*\ 20% of patients with CBD have gallbladder empty
and normal aspect
C) [x] structura calculilor dovedeste originea lor coledociana \*\ stones structure proves their choledochal origin
D) [ ] litiaza veziculara exclude litiaza CBP concomitenta \*\vesicular lithiasis excludes simultaneous CBD lithiasis
E) [x] recidiva post colecistectomie \*\ Relapse after cholecystectomy
---------------------------------------------------------------------
563. CM p5 [CM19098] Sunt forme grave ale litiazei coledociene (pg1930) \*\ Are serious forms of lithiasis coledociene . \*\ .
A) [x] .litiaza cu pancreatita \*\ stones with pancreatitis . \*\ .
B) [x] .litiaza cu angiocolita \*\ .stones with cholangitis \*\ .
C) [ ] .litiaza cu calcul inclavat \*\ stones with inclavat calculi . \*\ .
D) [ ] .litiaza cu icter izolat \*\ .lithiasis with isolated jaundice \*\ .
E) [ ] .litiaza cu colecistita \*\stones with cholecystitis . \*\ .
---------------------------------------------------------------------
564. CM p5 [CM19110] Sdr. coledocian este intalnit in: (pag. 1929) \*\Choledochal syndrome is seen in:
A) [x]litiaza CBP \*\CBD stones
B) [x]stenoze oddiene benigne \*\ benign oddiene stenosis
C) [x]chist hidatic hepatic rupt in caile biliare \*\liver hydatid cyst ruptured in the biliary
D) [x]ascaridioza coledociana \*\ choledochal ascariasis
E) [ ]diskinezia biliara \*\ biliary dyskinesia
---------------------------------------------------------------------
565. CM p5 [CM19048] ERCP: (Pag:1934) \*\ERCP
A) [ ]utilizeaza un duodenoscop cu optica verticala, \*\ uses a vertical optic Duodenoscopy
B) [ ]intreaga examinare nu depaseste 15 minute, \*\ whole examination shall not exceed 15 minutes,
C) [x]rata diagnostica atinge procentul de 88-90%, \*\ Diagnostic percentage rate reaches 88-90%,
D) [x]principiile metodei au fost stabilite de McCune in 1968, \*\ Principles of the method were established by McCune in 1968
E) [x]timpul mediu al canularii este 15 minute \*\Canulating average time is 15 minutes
---------------------------------------------------------------------
566. CM p5 [C2618183] Lititritia extracorporeala a calculilor biliari poate fi utilizata in caz de (pg 1922) \*\Extracorporeal
Lititritia of gallstones can be used in case (PG 1922)
A) [x]calcul unic, cu diametru sub 3 cm \*\Single stone, less than 3 cm in diameter
B) [ ]cistic stenozat \*\ stenosed cystic
C) [x]bila neinfectata \*\ uninfected bile
D) [ ]colecistita acuta \*\Acute cholecystitis
E) [x]motricitate parietala pastrata \*\ preserved parietal motricity
---------------------------------------------------------------------
567. CM p5 [CM19080] Sediul calculilor CBP poate fi: (p1927) \*\ CBD Headquarters stones may be:
A) [x] portiunea supraduodenala a coledocului \*\ portion of supraduodenal CBD
B) [x] frecvent calculii se opresc in portiunea retroduodenopancreatica \*\ Calculi frequently stop in the retroduodenopancreatic portion
C) [x] rareori ajung in calea biliara intrahepatica \*\ rarely reach the intrahepatic bile duct
D) [ ] frecvent se situeaza in diverticulul Mekel \*\ frequently located in Mekel diverticulum
E) [x] coledocul terminal \*\ terminal common bile duct
---------------------------------------------------------------------

77
568. CM p5 Icterul din sindromul coledocian se caracterizeaza prin:(1929)\*\Jaundice from bile duct syndrome is characterized by:
A) [x] apare in 12-24 ore de la colica \*\occurs in 12 - 24 hours of colic
B) [x] este variabil,fluctuent,si prezinta remisiuni legate de mobilizarea calculilor \*\ is variable fluctuent, and shows remission
related to mobilization calculus
C) [x] urini colurice,scaune hipocolice \*\ colored urine, hypocolic stool
D) [ ] absenta pruritului \*\absence of pruritus
E) [ ] jaundice reduces if there are other colic \*\ icterul diminua daca apar alte colici \*\
---------------------------------------------------------------------
569. CM p5 [CM19113] Complicatii la distanta determinate de flora microbiana din bila sunt: (pag. 1931) \*\ .Remote
complications caused by microbial flora of the ball are:
A) [ ] .abcese hepatice \*\ liver abscess . \*\ .
B) [x] .abcese cerebrale \*\ . Brain abscess \*\ .
C) [x] .leziuni renale \*\ .kidney damage \*\ .
D) [x] .bronhopneumonii \*\ .bronhopneumonii \*\ .
E) [x] .endocardita vegetanta \*\ .endocarditis vegetant \*\ .
---------------------------------------------------------------------
570. CM p5 Formele grave ale litiazei coledociene sunt cele asociate cu: (1930) \*\Severe forms of choledochal lithiasis are associated with:
A) [ ]calcul inclavat in papila \*\ inclavat calculi in the papilla
B) [ ]litiaza intrahepatica \*\ intrahepatic lithiasis
C) [x]angiocolita acuta \*\ Acute cholangitis
D) [x]pancreatita acuta \*\ Acute pancreatitis
E) [ ]colecistita acuta \*\ Acute cholecystitis
---------------------------------------------------------------------
571. CS p4 Cauzele formei secundare de diabet pot fi, cu EXCEPTIA: (2266)\*\Causes of secondary form of diabetes may be, except:
A) [ ] Pancreatita cronica la alcoolici \*\ Chronic pancreatitis in alcoholics
B) [ ] Sindromul Cushing \*\ Cushings syndrome
C) [x] Hipertiroidismul \*\ Hyperthyroidism
D) [ ] Acromegalia \*\ Acromegaly
E) [ ] Medicamente \*\ Medicines
---------------------------------------------------------------------
572. CS p4 Care este momentul optim de administrare a insulinei la un bolnav cu cetoacidoza diabetica si potasiul seric foarte
scazut? (2279)\*\What is the best time for the administration of insulin in a patient with diabetic ketoacidosis and very low serum potassium?
A) [ ] Imediat ce bolnavul s-a prezentat la medic \*\as soon as the patient was presented to physician
B) [ ] Se administreaza concomitent insulina + potasiu \*\ concomitant insulin + potassium
C) [x] Dupa 60-90 min pana se administreaza 40-50 mmoli potasiu \*\ at 60-90 minutes after administration of 40-50 mmoli potassium
D) [ ] La 10-15 min dupa administrarea solutiei Ringer \*\ at 10-15 min after administration of Ringer solution
E) [ ] La 2-3 ore dupa administrarea a 40-50 mmoli potasiu \*\ at 2-3 hours after administration of 40-50 mmoli potassium
---------------------------------------------------------------------
573. CS p4 Paraclinic, cetoacidoza diabetica se caracterizeaza prin: (2278)\*\Paraclinical, diabetic ketoacidosis is characterized by:
A) [ ] Concentratii plasmatice initiale ale potasiului scazute \*\lower initial serum potassium concentrations \*\
B) [ ] Prezenta gaurii cationice \*\ presence of cationic hole \*\
C) [ ] Niveluri plasmatice crescute ale peptidului C \*\ elevated plasma levels of C peptide \*\
D) [x] lower serum sodium concentrations \*\ Concentratiile plasmatice ale sodiului scazute \*\ \*\
E) [ ] pH > 7,45 \*\ pH > 7,45 \*\
---------------------------------------------------------------------
574. CS p4 Necesarul de proteine la o persoana adulta pentru o buna nutritie este de aproximativ: (2271) \*\The protein needs in
an adult for good nutrition is approximately:
A) [ ]0,5-0,6 g/kg/zi \*\ 0,5-0,6 g/kg/day
B) [x]0,9-1,5 g/kg/zi \*\0,9-1,5 g/kg/day
C) [ ]3,5-4 g/kg/zi \*\3,5-4 g/kg/day
D) [ ]6-7 g/kg/zi \*\ 6-7 g/kg/day
E) [ ]8-10 g/kg/zi \*\ 8-10 g/kg/day
---------------------------------------------------------------------
575. CS p4 Intr-o perioada de 10 ani care este procentul de bolnavi cu retinopatie diabetica simpla ce progreseaza spre boala
proliferativa? (2282) \*\In a period of 10 years, what is the percentage of patients with simple diabetic retinopathy which
progresses to proliferative disease?
A) [ ] 5% \*\ 5%
B) [ ] 8% \*\8%
C) [ ] 2-3% \*\ 2-3%
D) [x] 10-18% \*\10-18%
E) [ ] 20-25% \*\20-25%
---------------------------------------------------------------------

78
576. CS p4 [M2214046] Prin microalbuminurie se intelege excretia renala de albumina pana la nivelul de: (pag. 2283) \*\By
microalbuminuria it is understood renal excretion albumin levels of:
A) [ ]400-450 mg/zi \*\ 400-450 mg/day
B) [ ]500-550 mg/zi \*\500-550 mg/day
C) [x]30-300 mg/zi \*\30-300 mg/day
D) [ ]600 mg/zi \*\ 600 mg/day
E) [ ]peste 800 mg/zi \*\over 800 mg/day
---------------------------------------------------------------------
577. CS p4 Care este necesarul zilnic de proteine la un bolnav cu diabet zaharat si nefropatie diabetica? (2272) \*\ What is the
daily requirement of proteins for a patient with diabetes mellitus and diabetic nephropathy?
A) [x]0,8 g/kg/zi \*\0,8 g/kg/day
B) [ ]1,5 g/kg/zi \*\1,5 g/kg/day
C) [ ]0,9 g/kg/zi \*\ 0,9 g/kg/day
D) [ ]2 g/kg/zi \*\ 2 g/kg/day
E) [ ]0,3 g/kg/zi \*\ 0,3 g/kg/day
---------------------------------------------------------------------
578. CS p4 [M2514061] Initierea terapiei cu insulina in diabetul zaharat prin tehnica cu mai multe injectii se face cu o doza
raportata la kilogram greutate corporala de: (2273) \*\Insulin therapy in diabetes mellitus with multiple injection technique is
reported with a dose per kilogram body weight:
A) [ ]0,1-0,2 unitati \*\0,1-0,2 units
B) [x]0,6-0,7 unitati \*\ 0,6-0,7 units
C) [ ]1,5-2 unitati \*\1,5-2 units
D) [ ]2-3 unitati \*\ 2-3 units
E) [ ]5-10 unitati \*\5-10 units
---------------------------------------------------------------------
579. CM p5 Care dintre urmatoarele afirmatii referitoare la neuropatia diabetica sunt adevarate? (2283) \*\ Which of the
following statements are true regarding diabetic neuropathy?
A) [ ] Mononeuropatia diabetica este un sindrom senzitiv in care durerea apare urmind distributia unuia sau a mai multor nervi
spinali \*\diabetic mononeuropathy is a sensitive syndrome in which the pain follows the distribution of one or more spinal nerves
B) [x] Mononeuropatia diabetica este, de obicei, autolimitata \*\ diabetic mononeuropathy is usually self-limiting
C) [ ] Polineuropatia periferica diabetica se caracteriseaza prin durere care se accentueaza la mers \*\ peripheral diabetic
polyneuropathy is characterized by pain which is getting worse by walking
D) [x] Reflexele osteo-tendinoase in polineuropatia periferica diabetica sunt absente \*\ osteo-tendon reflexes in peripheral
diabetic polyneuropathy are absent
E) [x] Pierderea curburii cu fracturi multiple ale oaselor tarsiene este un aspect obisnuit la radiografie \*\ loss of curvature with
multiple fractures of tarsus bone is a common issue on the radiography
---------------------------------------------------------------------
580. CM p5 Dieta in diabetul zaharat: (2271 - 2272) \*\Diet in diabetes mellitus:
A) [ ]La pacientii non-obezi se recomanda, in mod obisnuit, o cantitate de proteine de aproximativ 30% din numarul total de
calorii \*\in non-obese patients it is recommended, usually, a protein quantity of approximately 30% from total calories
B) [ ]Restrictia de proteine este prudenta daca se doreste scaderea ponderala, deoarece proteinele contin o cantitate mai mare de
energie fata de lipide si carbohidrati \*\ protein restriction is prudent when weight loss is desired, since proteins contain a higher
amount of energy than fat and carbohydrates
C) [ ]Aportul de colesterol trebuie sa reprezinte 7% din calorii \*\Cholesterol intake should represent 7% of calories
D) [x]Se recomanda suplimentarea dietei cu ulei de peste, care contine acizi grasi 3-omega \*\it is recommended supplementing
the diet with fish oil that contains omega 3 fatty acids
E) [x]Necesarul minim proteic pentru o buna nutritie este in jur de 0.9g/kg greutate corporala pe zi \*\minimum protein
requirement for good nutrition is about 0,9g/kg body weight per day
---------------------------------------------------------------------
581. CM p5 Coma hiperosmolara noncetoacidotica: (2281)\*\Non-ketoacidosis hyperosmolar coma:
A) [ ]este cauzata de cresterea aportului de insulina \*\it is caused by growth of insulin dose
B) [x]apare mai frecvent la persoane in varsta, cu un grad avansat de ateroscleroza cerebrala \*\ is more common in older people
with a high level of cerebral atherosclerosis
C) [ ]se dezvolta datorita blocarii procesului cetogenetic \*\ it is develop due to the blocking of ketogenic process
D) [x]se asociaza cu cresterea azotului ureic sanguin si a creatininei \*\it is associated with increased blood urea nitrogen and creatinine
E) [x]se poate asocia cu semne neurologice (ex hemiplegie tranzitorie) \*\may be associated with neurological signs (e.g. transient hemipegia)
---------------------------------------------------------------------
582. CM p5 Cetoacidoza diabetica: (pag. 2277) \*\Diabetic ketoacidosis:
A) [ ] Apare frecvent in diabet zaharat non-insulino-dependent \*\occurs frequently in non-insulin-dependent diabetes
B) [x] Este cauzata de intreruperea aportului de insulina \*\it is caused by interruption of insulin injection
C) [ ] Necesita deficit de insulina cuplat cu scaderea concentratiei de glucagon\*\requires insulin deficiency combined with decreased
glucagons concentrations
D) [x] Poate fi determinata de o interventie chirurgicala \*\ can be caused by surgery

79
E) [ ] Poate fi determinata de administrarea unei doze crescute de insulina \*\ can be caused by high dose insulin
---------------------------------------------------------------------
583. CM p5 La un bolnav cu diabet zaharat tratat cu insulina, pentru a evita hipoglicemia, distributia caloriilor in cursul zilei este
urmatoarea:(2272)\*\In a patient with diabetes treated with insulin, to avoid hypoglycemia, the distribution of calories during the day is:
A) [x] 20% la micul dejun \*\ 20% at breakfast \*\
B) [ ] 45% la pranz \*\ 45% at lunch \*\
C) [x] 30% pentru cina \*\ 30% for dinner \*\
D) [x] 35% pentru pranz \*\ 35% for lunch \*\
E) [x] 15% pentru seara tarziu \*\ 15% for late night \*\
---------------------------------------------------------------------
584. CM p5 Cetoacidoza diabetica: (2277) \*\Diabetic ketoacidosis:
A) [x]Acidoza metabolica se explica prin nivelurile plasmatice crescute ale acetoacetatului si beta-hidroxibutiratului \*\metabolic
acidosis can be explained by increased plasma levels of acetate and beta-hydroxybutyrate
B) [x]Poate fi determinata de o interventie chirurgicala \*\ could be caused by surgery
C) [ ]Apare frecvent in diabetul zaharat non-insulino-dependent \*\occurs frequently in diabetes non-insulin-dependent
D) [x]Este cauzata de intreruperea aportului de insulina \*\ it is caused by interruption of insulin injection
E) [ ]Leucopenia, frecvent foarte marcata, este o trasatura a acidozei metabolice in sine \*\Leukopenia, often very marked, is a
feature of metabolic acidosis itself
---------------------------------------------------------------------
585. CM p5 Cetoacidoza diabetica se poate complica cu: (2280) \*\ Diabetic ketoacidosis may be complicated with:
A) [x] Mucormicoza \*\ Mucormycosis
B) [x] Edem cerebral \*\cerebral edema
C) [ ] Hipercheratoza \*\hyperkeratosis
D) [x] Dilatatie gastrica acuta \*\ acute gastric dilatation
E) [x] Hipopotasemie \*\Hypokalaemia
---------------------------------------------------------------------
586. CM p5 Referitor la tratamentul cu insulina al pacientilor diabetici: (p2272-2273, 2276) \*\About the insulin treatment on
diabetic patients:
A) [ ]Toti pacientii vor fi sfatuiti sa-si creasca doza de insulina cand se anticipeaza o activitate sustinuta sau un efort semnificativ
\*\ all patients will be advised to increase the dose of insulin when they anticipate a sustained activity or a significant effort
B) [x]Hipoglicemia este mai frecventa dupa insulina decat dupa antidiabetice orale \*\hypoglycemia is more common after insulin
than after oral agents
C) [ ]In administrarea continua s.c. a insulinei sunt folosite preparatele cu actiune intermediara \*\ for the continues s.c.
administration of insulin are used the intermediate-acting preparations
D) [ ]Terapia conventionala cu insulina implica administrarea de insulina cu actiune intermediara sau lunga seara, o doza unica,
impreuna cu insulina rapida inaintea fiecarei mese \*\conventional insulin therapy involves administration of intermediate or long
acting insulin in the evening, a single dose, with fast insulin before each meal
E) [x]In administrarea continua s.c. de insulina cu ajutorul pompei, insulina este eliberata intr-un ritm bazal continuu pe parcursul
zilei, cu ritmuri crescute programate inainte de mese \*\the continues s.c. administration with the insulin pump, insulin is released
into a basal rate continuously throughout the day, with increased rates programmed prior to meals
---------------------------------------------------------------------
587. CM p5 Coma diabetica hiperosmolara se caracterizeaza prin: (2280-2281)\*\Hyperosmolar diabetic coma is characterized by:
A) [x]deshidratare extrema \*\extreme dehydration
B) [ ]valori moderat crescute ale glicemiei \*\ moderately elevated blood glucose values
C) [ ]valori scazute ale bicarbonatului seric \*\ low values of serum bicarbonate
D) [x]rata de mortalitate peste 50 % \*\rate mortality > 50 %
E) [x]hipervascozitatea sanguina \*\ blood hyperviscosity
---------------------------------------------------------------------
588. CM p5 Cetoacidoza diabetica apare ca urmare a: (2277) \*\ Diabetic ketoacidosis occurs due to:
A) [ ] aportului crescut de lipide \*\ increased intake of lipids
B) [ ] supradozarii insulinei \*\ insulin overdose
C) [x] infectiilor intercurente \*\ intercurrent infections
D) [x] interventiilor chirurgicale \*\ surgery
E) [x] intreruperii aportului de insulina \*\ disruption of insulin injection
---------------------------------------------------------------------
589. CM p5 Hipoglicemia din diabetul zaharat poate fi determinata de: (2276) \*\ What are the signs of poor prognosis in a
patient presenting with diabetic ketoacidosis?
A) [x] boala renala diabetica \*\Hyperglycemia
B) [ ] hipertiroidismul \*\ Hypotension
C) [x] insuficienta suprarenala autoimuna \*\Azotemia
D) [x] anticorpii circulanti antiinsulinici \*\ urine ketone bodies
E) [ ] excesul alimentar de hidrati de carbon \*\ deep coma
---------------------------------------------------------------------

80
590. CM p5 Leziunile simple din retinopatia diabetica sunt, exceptand (2282) \*\ The simple lesions in diabetic retinopathy are, except:
A) [ ] Pete vatuite \*\ wadded spots \*\
B) [ ] Microanevrisme \*\ Microaneurysma \*\
C) [x] Cicatrice \*\ scars\*\
D) [x] Hemoragii in vitros \*\ bleeding in the vitreous \*\
E) [ ] Hemoragii(puncte sau pete) \*\ bleeding (dots or spots) \*\
---------------------------------------------------------------------
591. CM p5 Cetoacidoza diabetica se poate complica cu: (pag. 2280) \*\Diabetic ketoacidosis may be complicated with:
A) [x] Infarct miocardic \*\ myocardial infarction
B) [x] Sindrom de detresa respiratorie \*\ respiratory distress syndrome
C) [x] Edem cerebral \*\ cerebral edema
D) [x] Tromboza vasculara \*\vascular thrombosis
E) [ ] Hipercheratoza \*\Hyperkeratosis
---------------------------------------------------------------------
592. CM p5 Clinic, cetoacidoza diabetica se caracterizeaza prin: (2278) \*\ Clinically, diabetic ketoacidosis is characterized by:
A) [x] Greata si varsaturi \*\Nausea and vomiting
B) [ ] Polifagie \*\ excessive hunger
C) [x] Dureri abdominale \*\ abdominal pain
D) [x] Deshidratare \*\Dehydration
E) [x] Respiratie Kussmaul \*\ Kussmaul breathing
---------------------------------------------------------------------
593. CM p5 Caracteristicile clinico-biologice ale comei hiperosmolare noncetozice sunt: (2281) \*\ Clinical and biological
characteristics of non-ketotic hyperosmolar coma are:
A) [x] Semne neurologice (comitialitate, hemiplegie tranzitorie, coma superficiala) \*\ neurological signs (epilepsy, transient
hemiplegia, superficial coma)
B) [x] Hiperglicemie extrema \*\ extreme hyperglycaemia
C) [ ] Scaderea azotului ureic sanguin si a creatininei \*\ decreased of blood urea nitrogen and creatinine
D) [x] Cresterea osmolaritatii sangvine \*\ increased blood osmolarity
E) [ ] Scaderea vascozitatii plasmatice \*\ decreased plasma viscosity
---------------------------------------------------------------------
594. CM p5 [M2214165] Prin mentinerea la o femeie cu diabet zaharat a unei glicemii normale pe timpul sarcinii se previne:
(pag. 2274) \*\ What category of patients with diabetes will be excluded from intensive insulin therapy?
A) [x] macrosomia fetala \*\ Elderly
B) [ ] aparitia edemelor \*\people with coronary heart disease
C) [x] mortalitatea perinatala \*\patients with stroke
D) [x] sindromul de detresa respiratorie \*\ patients with gastric ulcer
E) [ ] aparitia HTA \*\ patients with chronic hepatitis
---------------------------------------------------------------------
595. CM p5 Hipoglicemia la pacientii diabetici insulino-dependenti poate fi cauzata de: (2275-76) \*\Hypoglycaemia in insulin-
dependent diabetic patients may be caused:
A) [x] lipsa unei mese \*\ the lach of a meal
B) [x] efort fizic neasteptat \*\unexpected exercise
C) [ ] scaderea dozei de insulina \*\ reduction of insulin dose
D) [ ] eliberarea catecolaminelor ca hormoni de contrareglare \*\ release of catecholamines as counterregulation hormones
E) [x] instalarea complicatiilor renale ale diabetului \*\ renal complications of diabetes
---------------------------------------------------------------------
596. CM p5 [M2214169] Simptomele vegetative si modificarile functiei cerebrale declansate de hipoglicemie in evolutia
diabetului zaharat apar la o glicemie de: (pag. 2275) \*\Hypoglycemia in diabetes may be due to:
A) [x]50-55 mg/dl \*\ diabetic renal disease
B) [x]70-72 mg/dl \*\ hyperthyroidism
C) [ ]90 mg/dl \*\autoimmune adrenal insufficiency
D) [ ]75-85 mg/dl \*\circulating antibodies against insulin
E) [ ]95 mg/dl \*\ excess dietary carbohydrates
---------------------------------------------------------------------
597. CM p5 Care sunt primele teste de laborator ce se efectueaza pentru diagnosticul de cetoacidoza diabetica? (2279) \*\What
are the first laboratory tests to be performed for diagnosis of diabetic ketoacidosis?
A) [ ] hemoglobina glicozilata (A1C) \*\ glycosylated hemoglobin (A1C) \*\
B) [ ] leucocitele din sangele periferic \*\ peripheral blood leukocytes \*\
C) [x] corpii cetonici din urina \*\ urine ketones bodies \*\
D) [x] glucoza urinara \*\ urinary glucose \*\
E) [ ] glucagonul seric \*\ serum glucagon \*\
---------------------------------------------------------------------
598. CM p5 Diagnosticul diferential al cetoacidozei la un bolnav cu diabet zaharat nediagnosticat anterior se face cu: ( 2279)

81
\*\Differential diagnosis of ketoacidosis in a patient with previously undiagnosed diabetes is done:
A) [x] uremia \*\uremia
B) [x] cetoacidoza alcoolica \*\ alcoholic ketoacidosis
C) [x] intoxicatii \*\ poisoning
D) [ ] diabetul insipid \*\ diabetes insipidus
E) [ ] pancreatita acuta \*\acute pancreatitis
---------------------------------------------------------------------
599. CM p5Dupa testul standard de toleranta orala la glucoza, diagnosticul de toleranta alterata la glucoza este sugerat de: (pag.
2266) \*\After the standard oral glucose tolerance test, impaired glucose tolerance diagnosis is suggested by:
A) [ ] glicemia la 2 ore 130 mg/dl \*\blood glucose at 2 hours 130 mg/dl
B) [x] glicemia la 2 ore 140-200 mg/dl \*\ blood glucose at 2 hours 140-200 mg/dl
C) [ ] glicemia la 2 ore 120 mg/dl \*\ blood glucose at 2 hours 120 mg/dl
D) [x] o alta valoare a glicemiei in cele 2 ore mai mare sau egala cu 200 mg/dl \*\ a new value of the blood glucose in 2 hours
greater or equal to 200 mg/dl
E) [ ] glicemia la 2 ore 115 mg/dl \*\ blood glucose at 2 hours 115 mg/dl
---------------------------------------------------------------------
600. CM p5 [M2814251] Cetoacidoza diabetica apare in: (pag. 2277) \*\ Diabetic ketoacidosis occurs:
A) [ ] efort fizic \*\physical exercise
B) [x] intreruperea aportului de insulina \*\ interruption of insulin injection
C) [ ] preponderent in diabetul zaharat noninsulino dependent \*\ mainly in non insulin-dependent diabetes
D) [x] infectii \*\ infections
E) [x] interventii chirurgicale \*\ surgery
---------------------------------------------------------------------
601. CS p4 Care din afirmatiile de mai jos defineste socul septic?(853)\*\Which of the following statements defines septic shock?
A) [x]sepsis cu hipotensiune neresponsiva la resuscitarea lichidiana, asociate cu disfunctie de organ sau anomalii de
perfuzie\*\sepsis with hypotension neresponsiva to fluid resuscitation, associated with an organ dysfunction or perfusion abnormalities
B) [ ]sepsis asociat cu tensiune< 90mmHg corectabila prin aport lichidian\*\sepsis associated with tension <90mmHg corrected by fluid intake
C) [ ]extremitati reci la un pacient cu sepsis\*\cold extremities in a patient with sepsis
D) [ ]puls filiform decelabil la un pacient cu sepsis\*\ Detectable filiform pulse in a patient with sepsis
E) [ ]cianoza extremitatilor la un pacient cu sepsis\*\cyanosis of the extremities in a patient with sepsis
---------------------------------------------------------------------
602. CS p4 Care dintre germenii de mai jos, izolati de la un pacient cu sepsis, pot genera petesii sau purpura cutanata?
(854)\*\Which of the following germs, isolated from a patient with sepsis, may cause petechiae or purple skin?
A) [ ]Neisseria gonorrhoeae\*\Neisseria gonorrhoeae
B) [x]Neiserria meningitidis\*\Neiserria meningitidis
C) [ ]Pseudomonas aeruginosa\*\Pseudomonas aeruginosa
D) [ ]Staphylococcus aureus\*\Staphylococcus aureus
E) [ ]Candida albicans\*\Candida albicans
---------------------------------------------------------------------
603. CS p4 Diferentierea dintre socul septic si cel cardiogen sau cel prin obstructie sau cel hipovolemic es face prin: (pg 855)\*\
the differentiation of cardiogenic or septic shock at the obstruction or the hypovolemia es made by:
A) [x]debit cardiac initial normal/crescut si rezistenta vasculara sistemica scazuta \*\initially normal cardiac output / high and low
systemic vascular resistance
B) [ ]debit cardiac scazut si rezistenta vasculara sistemica scazuta \*\low cardiac output and low systemic vascular resistance
C) [ ]debit cardiac crescut si rezistenta vasculara sistemica crescuta \*\increased cardiac output and systemic vascular resistance increased
D) [ ]debit cardiac normal si rezistenta vasculara sistemica normala \*\ Normal cardiac output and systemic vascular resistance normal
E) [ ]debit cardiac scazut si rezistenta vasculara sistemica crescuta \*\decreased cardiac output and systemic vascular resistance increased
---------------------------------------------------------------------
604. CS p4 Specificati care din urmatoarele mecanisme nu intervin in declansarea socului septic: (855)\*\in does not specify
which of the following mechanisms involved in triggering the septic shock
A) [ ]Scaderea severa a rezistentei vasculare sistemice\*\severe decrease in systemic vascular resistance
B) [ ]Maldistributia fluxului sanguin\*\blood flow Maldistributia
C) [ ]Hipovolemia functionala\*\functional hypovolaemia
D) [x]Presiunea crescuta in capilarele pulmonare peste 18mmHg\*\pulmonary capillary pressure increased in more than 18mmHg
E) [ ]Poliuria\*\Polyurea
---------------------------------------------------------------------
605. CS p4 Urmat.afirmatii privitoare la TNFalfa sunt adevarate cu exceptia:\*\The following statements are true regarding TNF-alpha, except
A) [ ]stimuleaza leucocitele\*\stimulated leukocytes
B) [ ]stimuleaza endoteliul vascular\*\stimulates vascular endothelial
C) [ ]nivelul TNF alfa este crescut la majoritatea pacientilor cu sepsis sever\*\TNF-alpha levels increased in most patients with severe sepsis
D) [ ]la animale, dozele mari de TNF alfa induc soc si coagulare intrevasculara diseminata\*\animals, high doses of TNF-alpha
induce shock and disseminated coagulation intrevasculara
E) [x]are rol minor in declansarea sepsisului\*\ has minor role in causing sepsis

82
606. CS p4 [C1420007] Care este durata minima de tratament antimicrobian pe care o necesita cei mai multi pacienti in cazul
sepsiului: (856)\*\What is the minimum duration of antimicrobial therapy that most patients require if sepsiului
A) [ ]o zi\*\one day
B) [ ]doua luni\*\two months
C) [x]o saptamana\*\one week
D) [ ]o luna\*\one month
E) [ ]21 de zile\*\21 days
---------------------------------------------------------------------
607. CS p4 Ce este folosit pt efectuarea testului de stimulare ce poate sugera insuf. corticosuprarenala absenta/partiala:\*\ What
is used for testing may suggest incentives to inspire. corticosuprarenala absenta/partiala: cortical absent / partial
A) [x]cosyntropin\*\cosyntropin
B) [ ]corticoizi\*\steroids
C) [ ]ADH\*\ADH
D) [ ]HHC\*\HHC
E) [ ]cantastin\*\cantastin
---------------------------------------------------------------------
608. CS p4 Lipidul A este caracteristic urmatoarelor microorganisme: (857)\*\Lipid A is characteristic of the following microorganisms:
A) [ ]Coci gram-pozitiv\*\Gram-positive cocci
B) [ ]Fungi\*\Fungi
C) [ ]Virusuri\*\Viruses
D) [ ]Bacili gram-pozitivi\*\Gram-positive bacilli
E) [x]Bacili gram-negativi\*\gram-negative bacilli
---------------------------------------------------------------------
609. CS p4 [M1225008] In cazului sepsisului sever hemocultura permite identificarea agentului infectios (bacterie sau fung) in
procent de: (pag. 852)\*\case of severe sepsis blood cultures to identify infectious agent (bacteria or fungi) in percentage:
A) [x]20-40% din cazuri\*\20-40% of cases
B) [ ]70-85% din cazuri\*\70-85% of cases
C) [ ]10-15 % din cazuri\*\10-15% of cases
D) [ ]60-65% din cazuri\*\ 60-65% of cases
E) [ ]mai putin de 10% din cazuri\*\less than 10% of cases
---------------------------------------------------------------------
610. CS p4 [M1125005] Tratamentul initial al hipotensiunii din socul septic consta in una din urmatoarele atitudini terapeutice:
(856)\*\ Initial treatment of hypotension in septic shock lies in one of these therapeutic attitudes
A) [ ]transfuzia de sange izogrup\*\ Blood transfusion izogrup
B) [ ]transfuzii de masa trombocitara\*\platelet transfusion
C) [x]perfuzii cu solutie salina izotona\*\platelet transfusion
D) [ ]administrarea de substante vasopresoare intravenoase\*\intravenous administration of pressor substances
E) [ ]administrarea de glucocorticosteroizi intravenos\*\ Intravenous administration of glucocorticosteroids
---------------------------------------------------------------------
611. CS p4 Eritrodermia generalizata la un pacient septic sugereaza: (854)\*\generalized erythroderma in a septic patient suggests
A) [ ]Bacteriemie cu Vibriovulnificus\*\bacteraemia Vibriovulnificus
B) [ ]Infectia cu Haemophylus influenzae\*\Haemophylus influenzae infection
C) [ ]Febra patata a Muntilor stancosi\*\Spotted Fever Rocky Mountains
D) [x]Sindromul de soc toxic cauzat de Staphylococcus aureus sau Streptococcus pyogenes\*\TSS caused by Staphylococcus
aureus or Streptococcus pyogenes
E) [ ]Bacteriemia cu Pseudomonas aeruginosa\*\ Pseudomonas aeruginosa bacteraemia
---------------------------------------------------------------------
612. CS p4 In cazul complicatiilor renale, majoritatea insuficientelor renale sunt determinate de: (pg. 855)\*\In case of renal
complications, most of the renal failures are caused by:
A) [ ]Administrarea de antibiotice aminoglicozidice\*\The administration of aminoglycoside antibiotics
B) [ ]Necroza tubulara acuta indusa de hipertensiune sau alterari capilare\*\acute tubular necrosis induced by hypertension or
alterations of capillary
C) [ ]Necroza corticala renala)\*\renal cortical necrosis
D) [x]Necroza tubulara acuta indusa de hipotensiune/alterari capilare\*\acute tubular necrosis induced by hypotension or capillary alterations
E) [ ]Nefrita interstitiala\*\interstitial nephritis
---------------------------------------------------------------------
613. CS p4 In tratamentul sepsisului terapia ventilatorie este indicata in urmatoarele situatii cu EXCEPTIA: (pag. 857)\*\
ventilatory therapy in sepsis treatment is indicated in these situations EXCEPT
A) [ ]Hipoxemia progresiva\*\progressive hypoxemia
B) [ ]Hipercapnia\*\ hypercapnia
C) [ ]Deteriorare neurologica\*\Neurological Damage
D) [ ]Insuficienta muschilor respiratori\*\respiratory muscle failure
E) [x]Presiune arteriala medie peste 60mmHg\*\average blood pressure over 60mmHg

83
614. CS p4 In majoritatea cazurilor (peste 75%), sepsisul este produs de: (852)\*\Most cases (over 75%), sepsis is the product of:
A) [x]bacterii gram-negative si gram-pozitive\*\Gram-negative and gram-positive
B) [ ]fungi\*\fungi
C) [ ]virusuri\*\viruses
D) [ ]paraziti\*\parasites
E) [ ]cauze non-infectioase\*\Non-infectious causes
---------------------------------------------------------------------
615. CS p4 [M1525021] La un bolnav cu sepsis, hemoliza activa sugereaza una dintre urmatoarele conditii, cu EXCEPTIA:
(855)\*\A patient with sepsis, suggesting an active hemolysis of these conditions, except:
A) [ ]bacteriemie cu clostridii\*\bacteremia with clostridii
B) [ ]malarie\*\Malaria
C) [x]pneumonie cu Pneumocistis carinii\*\Pneumocistis carinii pneumonia with
D) [ ]reactie adversa la medicamente\*\adverse reaction to medicines
E) [ ]coagulare intravasculara diseminata\*\disseminated intravascular coagulation
---------------------------------------------------------------------
616. CM p5 [C1220031] Hemocultura este o examinare paraclinica prin care se evidentiaza prezenta in torentul sanguin (sange)
a: (pag. 852)\*\blood cultures is a paraclinical examination, pointing out this in torrents of blood (blood) to:
A) [ ]Virusurilor\*\Viruses
B) [x]Bacteriilor\*\bacteria
C) [x]Fungilor\*\ fungi
D) [ ]Protozoarelor\*\protozoa
E) [ ]Toxinelor eliberate de bacterii\*\The toxins released by bacteria
---------------------------------------------------------------------
617. CM p5 Complementul C5a si alti produsi ai activitatii complementului pot initia in cadrul sepsisului rectii ale neutrofilelor
cum ar fi: (854)\*\ complement C5a and other items you can initiate complement activity within the neutrophils rectii sepsis such as
A) [ ] granularea\*\granulation
B) [x] chemotaxia\*\chemotaxia
C) [x] agregare \*\ achemotaxia
D) [x] productia de radicali de oxigen\*\The production of oxygen radicals
E) [x] degranularea\*\degranularea
---------------------------------------------------------------------
618. CM p5 [C1420040] Complicatiile majore ale sepsisului si a socului septic sunt reprezentate de catre: (pag. 855)\*\major
complications of sepsis and septic shock are represented by:
A) [ ] complicatiile tardive\*\late complications
B) [x] complicatiile cardio-pulmonare\*\The cardio-pulmonary complications
C) [x] tulburarile de coagulare\*\coagulation disorders
D) [x] complicatiile renale\*\Renal complications
E) [x] complicatiile neurologice\*\Neurological complications
---------------------------------------------------------------------
619. CM p5 Tratamentul antimicrobian de prima intentie la un pacient cu sepsis, neutropenic, apeleaza la urmatoarele antibiotice
A) [x] ticarcilina
B) [x] mezlocilina
C) [x] piperacilina
D) [x] ceftazidim+tobramicina
E) [ ] vancomicina
---------------------------------------------------------------------
620. CM p5 [C1420036] Care dintre urmatoarele afirmatii in legatura cu prognosticul sepsisului si al socului septic sunt
adevarate: (pag. 857)\*\Which of the following statements about the prognosis of sepsis and septic shock are true
A) [x]25-35% din pacientii cu sepsis sever decedeaza in decurs de 30 de zile\*\25-35% of patients with severe sepsis die within 30 days
B) [ ] 25-35% din pacientii cu soc septic decedeaza in decurs de 30 de zile\*\25-35% of patients with septic shock die within 30 days
C) [x]ratele de fatalitate sunt similare sepsisului sever si socului septic cu culturi pozitive si negative\*\fatality rates are similar to
severe sepsis and septic shock with positive and negative cultures
D) [ ]ratele de fatalitate sunt net diferentiate sepsisului sever si socului septic cu culturi pozitive si negative\*\ fatality rates are
significantly differentiated severe sepsis and septic shock with positive and negative cultures
E) [ ]toate afirmatiile de mai sus sunt corecte\*\all the above statements are correct
---------------------------------------------------------------------
621. CM p5 La pacientii cu sepsis sever provenind din tractul urinar trebuie excluse: (856)\*\ In patients with severe sepsis from
urinary tract should be excluded
A) [ ] calculii vezicali\*\bladder stones
B) [x] obstructia ureterala\*\ureteral obstruction
C) [x] abcesul perinefritic\*\abscess perinefritic
D) [x] abcesul renal\*\ Renal abscess
E) [ ] calculii renali\*\kidney stones

84
622. CM p5 [C1420041] Care dintre urmatoarele afirmatii sunt corecte in legatura cu sepsisul si socul septic: (pag. 852-
853)\*\Which of the following statements is correct about sepsis and septic shock:
A) [x] hemoculturile evidentaiaza bacterii sau fungii la aproximativ 20-40% din pacientii cu sepsis sever\*\blood cultures
evidentaiaza bacteria or fungi in approximately 20-40% of patients with severe sepsis
B) [ ] hemoculturile evidentiaza bacterii sau fungii la aproximativ 20-40% din pacientii cu soc septic\*\blood cultures reveals
bacteria or fungi in approximately 20-40% of patients with septic shock
C) [ ] nivelul sanguin de TNFalfa este scazut la majoritatea pacientilor cu sepsis sever\*\TNFalfa is low blood levels of most
patients with severe sepsis
D) [x] depozitarea intravasculara a fibrinei , tromboza si CID sunt caracteristici importante ale raspunsului septic\*\storage
intravascular fibrin, thrombosis and DIC are important features of septic response
E) [ ] diferite specii de fungii sunt raspunzatoare pentru aproximativ 75-85 din izolarile evidentiate prin hemoculturi\*\different
species of fungi are responsible for about 75-85 from isolation evidenced by blood cultures
---------------------------------------------------------------------
623. CM p5 [C1420037] Gastro-enterita acuta poate fi sugerata de catre urmatoarele manifestari gastro-intestinale: (pag.
854)\*\Acute Gastro-enteritis can be implied by these gastrointestinal events
A) [x]diareea\*\diarrhea
B) [x]ileusul\*\ ileus
C) [x]greata\*\nausea
D) [ ]constiparea\*\constipation
E) [x]voma\*\vomiting
---------------------------------------------------------------------
624. CM p5 [C1420038] In cadrul sepsislui si a socului septic raspunsul de faza acuta mediat de citokine inhiba productia de
(pag. 855)\*\In sepsislui septic shock and acute phase response mediated by inhibiting cytokine production
A) [ ]proteina C rectiva\*\Protein C rectal
B) [x]albumina\*\ albumin
C) [ ]fibrina\*\fibrin
D) [ ]componenti ai complementului\*\The components of complement
E) [x]transtiretina\*\transtiretina
---------------------------------------------------------------------
625. CS p4 [M2625131] Manifestarile clinice in sepsis includ febra.Absenta ei nu se intalneste la pacientii: ()\*\including febra.
Absenta clinical manifestations in sepsis patients would not be met: ()
A) [ ]Alcoolici\*\Alcoholics
B) [ ]Nou nascuti\*\Infants
C) [ ]Uremici\*\uremia
D) [x]Imunodeprimati\*\immune
E) [ ]Varstnici\*\Elderly
---------------------------------------------------------------------
626. CS p4 [M1125007] In septicemie se constata urmatoarele modificari de laborator, cu exceptia: ()\*\septicemia is found in
these laboratory changes, except: ()
A) [ ]leucopenie\*\leukopenia
B) [x]trombocitoza\*\thrombocytosis
C) [ ]neutrofilie cu corpi Dohre\*\neutrophilia bodied Dohr
D) [ ]fibrinogen plasmatic scazut\*\lower plasma fibrinogen
E) [ ]retentie azotata\*\nitrogen retention
---------------------------------------------------------------------
627. CS p4 [M2525033] Urmatorii mediatori sunt derivati din fosfolipide, cu exceptia: (pag. 853)\*\The following mediators are
derived from phospholipids, except:
A) [ ]prostaglandina E2\*\prostaglandin E2
B) [ ]prostaciclina\*\prostacyclin
C) [x]IL-2\*\IL-2
D) [ ]tromboxanul\*\thromboxane
E) [ ]factorul de activare plachetara (PAF)\*\platelet activating factor (PAF)
---------------------------------------------------------------------
628. CS p4 [M1225012] Prezenta unui sindrom hemoragipar, exteriorizat prin petesii sau purpura cutanata, la un pacient
confirmat cu sepsis sever si soc septic, orienteza diagnosticul spre implicarea: (pag. 854)\*\This syndrome bleeding, petechiae or
purpura externalized through the skin, confirmed in a patient with severe sepsis and septic shock, diagnosis orienteza to involve:
A) [x]Neisseriei meningitidis\*\meningitidis Neisseriei
B) [ ]Staphylococcus aureus\*\Staphylococcus aureus
C) [ ]Streptococcus pyogenes\*\Streptococcus pyogenes
D) [ ]Enterococcus\*\Enterococcus
E) [ ]Clostridium perfringens\*\Clostridium perfringens
---------------------------------------------------------------------


85
629. CS p4 [M1225010] Sepsisul este definit ca: (pag. 853)\*\Sepsis is defined as
A) [x]SRIS cauzat de un agent bacterian dovedit sau suspectat\*\SRIS caused by proven or suspected bacterial agent
B) [ ]SRIS declansat de instalarea unei infectii virale\*\SRIS started installing a viral infection
C) [ ]SRIS declansat de instalarea unui anevrism disecant de aorta\*\SRIS started the installation of a dissecting aneurysm of the aorta
D) [ ]SRIS declansat de administrarea unei medicatii imunosupresive
E) [ ]SRIS declansat urmare aplicarii unei chimioterapii\*\Following application of chemotherapy started SRIS
---------------------------------------------------------------------
630. CS p4 O examinare paraclinica cu valoare diagnostica (sepsis) si prognostica (sepsis sever cu soc septic) este cresterea
precoce a: (854)\*\An examination paraclinical diagnostic value (sepsis) and prognosis (severe sepsis with septic shock) is increased early
A) [x]nivelului sangvin de lactat\*\blood lactate level
B) [ ]transaminazelor (TGP/TGO)\*\transaminases ( TGP / TGO )
C) [ ]creatininei serice\*\serum creatinine
D) [ ]fosfatazei alcaline\*\alkaline phosphatase
E) [ ]proteinei C reactive\*\C-reactive protein
---------------------------------------------------------------------
631. CS p4 [M2822072] Urmatoarele afirmatii referitoare la echilibrul fierului alimentar sunt adevarate, cu exceptia (pag. 699)
A) [ ] fosfatii inhiba absorbtia fierului
B) [ ] acidul ascorbic faciliteaza absorbtia fierului
C) [x] fitatii faciliteaza absorbtia fierului
D) [ ] fierul anorganic este toxic
E) [ ] fierul heminic se absoarbe usor
---------------------------------------------------------------------
632. CS p4 [M2622065] Principala sursa de acid folic din alimentatie este reprezentata de: (pag. 714)
A) [ ] Ficat
B) [ ] Carne
C) [ ] Lactate
D) [x] Fructe si legume
E) [ ] Altele
---------------------------------------------------------------------
633. CS p4 [MC100004] Despre anemia megaloblastica refractara putem afirma: (pg.719)
A) [ ] nu se asociaza cu incidenta crescuta al leucemiei acute
B) [x] este o forma de mielodisplazie
C) [ ] prezinta metamielocite gigante la examenul maduvei
D) [ ] se pot identifica precursori granulocitari de dimensiuni mari
E) [ ] raspunde favorabil la tratamentul etiologic
---------------------------------------------------------------------
634. CS p4 [[CS][01]] La bolnavii cu anemii inflamatorii: ()
A) [ ] fierul seric este normal
B) [ ] nivelul transferinei este normal
C) [x] feritina serica este normala sau crescuta
D) [ ] rezervele de fier sunt scazute
E) [ ] nivelul receptorilor pentru transferina creste
---------------------------------------------------------------------
635. CS p4 [M1222010] Depozitele de fier din celulele sistemului reticuloendotelial pot fi estimate cu ajutorul: (pag. 701)
A) [x] coloratiei cu albastru de Prusia
B) [ ] albastru de metil
C) [ ] Ziehl-Nielsen
D) [ ] rosu bengal
E) [ ] acetona
---------------------------------------------------------------------
636. CS p4[M1122004] Sunt afirmatii adevarate privind anemia pernicioasa, cu exceptia: (pag. 718)
A) [ ] Asocierea cu alte boli imunologice are o incidenta crescuta
B) [x] Apare la cei cu atrofie gastrica cu localizare antrala
C) [ ] Cancerul gastric este de doua ori mai frecvent la cei cu aceasta anemie
D) [ ] Deficitul de fier, asociat, reduce intensitatea macrocitozei
E) [ ] Terapia cu ciancobalamina nu corecteaza totdeauna si complet manifestarile neurologice
---------------------------------------------------------------------
637. CS p4 [M1522031] In anemia megaloblastica prin deficit de acid folic este caracteristica (pag. 715, 720)
A) [x] Cresterea homocisteinei in ser
B) [ ] Scaderea transcobalaminei II serice
C) [ ] Cresterea numarului receptorilor R gastrici
D) [ ] Cresterea acidului metilmalonic in ser
E) [ ] Cresterea izoenzimei 1 a lactic-dehidrogenazei in plasma

86
---------------------------------------------------------------------
638. CS p4 [M2622061] Simptomele si semnele deficitului grav de fier includ urmatoarele, cu exceptia: (pag. 700)
A) [ ] Paloare
B) [x] Icter
C) [ ] Oboseala
D) [ ] Coilonichie
E) [ ] Disfagie
---------------------------------------------------------------------
639. CM p5 [M1322091] Anemia ''inflamatorie'' din bolile cronice cu blocarea eliberarii fierului din sistemul reticuloendotelial se
diferentiaza de anemia feripriva prin: (pag. 702)
A) [ ] nivelul crescut al fierului seric
B) [ ] -cresterea capacitatii de legare a fierului de catre siderofilina (transferina)
C) [x] scaderea capacitatii de legare a fierului de catre siderofilina (transferina
D) [ ] scaderea nivelului calciului seric
E) [x] nivelul normal al receptorului pentru transferina
---------------------------------------------------------------------
640. CM p5. [M2522182] Inhibitorii dihidrofolat reductazei implicati in anemia megaloblastica prin deficit de acid folic sunt:
(pag. 715, 719)
A) [x] Metotrexat
B) [ ] Metadona
C) [x] Triamteren
D) [x] Trimetoprim
E) [ ] Metoclopramid
---------------------------------------------------------------------
641. CM p5 . [M1522113] Diagnosticul diferential al anemiei feriprive se face cu: (pag. 702)
A) [ ] Anemia megaloblastica
B) [x] Talasemia
C) [x] Anemia din bolile cronice
D) [x] Anemia sideroblastica
E) [ ] Eritroleucemia
---------------------------------------------------------------------
642. CM p5. [MC100005] Modificarile de laborator al anemiei megaloblastice includ (pg.720)
A) [x] maduva este hipercelulara si bogata in fier
B) [ ] se pot identifica anomalii Pellger-Heute
C) [x] asincronism nucleo-citoplasmatic al precursorilor eritroizi
D) [x] uneori se pot observa eritrocite cu punctatii bazofile si eritrocite nucleate
E) [ ] cresterea bilirubinei conjugate si al LDH1
---------------------------------------------------------------------
643. CM p5 [M1422097] Entitati clinice asociate cu deficit de acid folic (pag. 715/)
A) [x] Sarcina
B) [x] Anemii hemolitice cronice
C) [x] Sprue tropical
D) [x] Afectiuni exfoliative cronice ale tegumentelor
E) [ ] Anemia Fanconi
---------------------------------------------------------------------
644. CM p5 [M1422096] Lipsa raspunsului la terapia cu fier semnifica (pag. 703)
A) [x] Non-complianta pacientului
B) [x] Absorbtie anormala a fierului
C) [x] Pierderea persistenta de sange
D) [x] Diagnostic incorect
E) [ ] Hemoglobina instabila
---------------------------------------------------------------------
645. CM p5. [M2822219] Diagnosticul diferential al unei anemii feriprive se face in principal cu: (pag. 702)
A) [ ] Anemiile aplastice
B) [x] Anemia sideroblastica ereditara
C) [x] Beta-talasemia
D) [x] Anemiile inflamatorii
E) [ ] Anemiile hemolitice
---------------------------------------------------------------------
646. CM p5 [M1222086] Care din urmatoarele simptome si semne la intalnim in anemia feripriva: (pag. 700)
A) [x] coilonichia
B) [x] disfagia
C) [ ] degete hipocratice

87
D) [x] usturimi ale mucoasei bucale
E) [ ] icter
---------------------------------------------------------------------
647. CM p5. [m2822225] Citokinele inflamatorii determina: (pag. 702)
A) [ ] stimuleaza secretia de eritropoietina
B) [x] suprima secretia de eritropoietina
C) [x] suprima proliferarea celulelor eritroide
D) [x] suprima aprovizionarea cu fier a maduvei osoase
E) [ ] creste rezervele de fier
---------------------------------------------------------------------
648. CM p5 [M1222085] Cauzele lipsei de fier sunt: (pag. 700)
A) [x] menstruatii abundente
B) [x] sarcina
C) [ ] dieta bogata in carne
D) [x] cresterea din perioada adolescentei
E) [ ] lipsa absorbtiei vitaminei B12
---------------------------------------------------------------------
649. CM p5. [M2522188] Anemia megaloblastica este intalnita in urmatoarele afectiuni: (pag. 718, 719)
A) [x] Acidurie orotica
B) [x] Acidurie metilmalonica
C) [ ] Acidurie mevalonica
D) [ ] Acidoza tubulara renala
E) [x] Sindrom Zollinger Ellison
---------------------------------------------------------------------
650. CM p5 [M1122081] Sunt afirmatii adevarate privind tratamentul deficitului de cobalamina: (pag. 720, 721)
A) [x] Obisnuit, ciancobalamina se administreaza intramuscular
B) [ ] Revenirea la normal a morfologiei medulare apare la cateva zile de la debutul tratamentului
C) [x] Coexistenta deficitului de folat intarzie sau impiedica aparitia reticulocitozei
D) [ ] Hiperkaliemia apare precoce dupa initierea tratamentului
E) [ ] Corectarea anemiei megaloblastice cu doze mari de folat exclude deficitul de cobalamina
---------------------------------------------------------------------
651. CM p5. [M2822209] Anemia din bolile inflamatorii cronice se diferentiaza de anemia feripriva prin: (pag. 702)
A) [x] scaderea capacitatii de legare a fierului de catre transferina
B) [ ] cresterea capacitatii de legare a fierului de catre transferina
C) [x] nivelul normal al receptorilor pentru transferina
D) [x] nivelul normal sau crescut de feritina serica
E) [ ] scaderea nivelului calciului seric
---------------------------------------------------------------------
652. CM p5 . [M2322127] Aspectul hipocrom microcitar este caracteristic: (pag. 702)
A) [x] anemiei feriprive
B) [ ] anemiei prin deficit de acid folic
C) [x] talasemiei
D) [ ] anemiei hemolitice autoimune
E) [ ] anemiei prin deficit de vitamina B12
---------------------------------------------------------------------
653. CM p5 . [M1622122] Alte cauze de macrocitoza, in afara anemiei megaloblastice, sunt: (pag. 719)
A) [x] alcoolismul
B) [ ] deficitul de fier
C) [x] hipotiroidismul
D) [ ] talasemia
E) [x] afectiunile hepatice
---------------------------------------------------------------------
654. CM p5. [M2822228] Citokinele inflamatorii produc anemie prin urmatoarele mecanisme: ()
A) [x] inhiba secretia de eritropetina;
B) [x] inhiba proliferea de eritroide;
C) [x] inhiba aprovizionarea cu Fe a maduvei osoase;
D) [ ] cresterea eliminarii Fe din organism;
E) [ ] prin inglobarea Fe in compusi de atac impotriva microbilor.
---------------------------------------------------------------------
655. CM p5. [M2822224] Manifestarile gastrointestinale specifice deficitului de cobalamina includ: (pag. 717)
A) [ ] Polifagie
B) [x] Arsuri ale limbii
C) [ ] Crestere ponderala

88
D) [x] Diaree
E) [ ] Limba este palida si aspra
---------------------------------------------------------------------
656. CM p5 [M1322093] Administrarea parenterala de fier este indicata in: (pag. 703)
A) [x] -intoleranta orala
B) [x] -sindrom de malabsorbtie
C) [x] asocierea cu tratamentul cu eritropoietina
D) [ ] -asocierea cu tratamentul cu vitamina B12
E) [ ] asocierea cu medicatia blocanta a acidului folic
---------------------------------------------------------------------
657. CM p5 . [M1522112] Anemia pernicoasa se asociaza cu frecventa crescuta in urmatoarele boli: (pag. 718, 719)
A) [ ] Sindromul nefrotic
B) [x] Boala Graves
C) [ ] Endocardita Liebmann-Sachs
D) [ ] Eritroleucemia acuta Di Guglielmo
E) [x] Tiroidita
---------------------------------------------------------------------
658. CM p5. [M2622198] Pentru diagnosticul de anemie megaloblastica pledeaza: (pag. 719, 720)
A) [ ] Sideremia scazuta
B) [x] Macrocitoza semnificativa
C) [ ] Reticulocitoza
D) [ ] Hipocromia
E) [x] Leucopenie si trombocitopenie
---------------------------------------------------------------------
659. CM p5 [M1322092] Absenta raspunsului terapeutic la administrarea de fier in anemia feripriva inseamna: (pag. 703)
A) [x] absenta absorbtiei fierului administrat pe cale orala
B) [x] lipsa de complianta a pacientului
C) [x] diagnostic eronat
D) [ ] -hipogammaglobulinemia asociata
E) [ ] -anemie hemolitica asociata
---------------------------------------------------------------------
660. CM p5 . [M2322128] Esecul tratamentului cu fier la pacientii cu anemie feripriva poate apare in cazul: (pag. 703)
A) [x] lipsei de complianta la tratament
B) [x] absorbtie anormala a fierulu
C) [x] pierdere persistenta de sange ce depaseste aportul
D) [x] diagnostic incorect
E) [ ] tratament cu preparate de fier timp de 6 luni
---------------------------------------------------------------------
661. CS p4 In leucemia mieloida acuta, care din urmatoarele anomalii cromozomiale nu se asociaza cu remisiune completa la
chimioterapie standard de inductie? (pag. 753)\*\In acute myeloid leukemia, which of these chromosomal abnormalities are not
associated with complete remission from standard induction chemotherapy?
A) [ ]t(8;21)\*\ t (8; 21)
B) [ ]t(15;17)\*\ t (15; 17)
C) [x]inv(3)\*\inv (3)
D) [ ]inv(16)\*\inv (16)
E) [ ]del(5q)\*\del (5q)
---------------------------------------------------------------------
662. CS p4 Produsul genei de fuziune rezultanta a translocatiei caracteristice bolii este, in leucemia mieloida cronica: (p758) \*\
the product of the fusion gene resulting from the translocation characteristic for the disease in chronic myelogenous leukemia is:
A) [ ]p53\*\p53
B) [ ]Cmyc\*\ Cmyc
C) [ ]RAS\*\RAS
D) [ ]p 120 BCR-ABL\*\ p 120 BCR-ABL
E) [x]p 210 BCR-ABL\*\p 210 BCR-ABL
---------------------------------------------------------------------
663. CS p4 Limfadenopatia din leucemia mieloida acuta este asociata cu: (pag. 751)\*\Lymphadenopathy in acute myeloid
leukemia is associated with:
A) [ ]diabetul zaharat\*\diabetes mellitus
B) [ ]t (8;21)\*\ t (8; 21)
C) [ ]hemofilia\*\haemophilia
D) [ ]inv (7)\*\ inv (7)
E) [x]inv (16)\*\inv (16)
---------------------------------------------------------------------

89
664. CS p4 Numarul de trombocite in momentul diagnosticului in leucemia acuta mieloblastica este de obicei: (pag.
752)\*\Platelet count at diagnosis in acute myeloid leukemia is usually:
A) [x]sub 100.000\*\ under 100,000
B) [ ]normal\*\normal
C) [ ]crescut\*\increased
D) [ ]sub 20.000\*\under 20,000
E) [ ]sub 15.000\*\below 15 000
---------------------------------------------------------------------
665. CS p4 Prezenta eritroblastilor > 50% din celulele nucleate medulare si a mieloblastilor > 30% din elementele noneritrocitare
medulare permite diagnosticul urmatorului subtip de leucemie mieloida acuta in clasificarea FAB: (pg.751)\*\ The presence of
erythroblasts > 50% from medullary/marrow nucleated cells and myeloblasts > 30% from medullary nonerythrocytar elements
permits the diagnosis of the following subtypes of acute myeloid leukemia in FAB classification:
A) [ ]M0\*\M0
B) [ ]M2\*\M2
C) [ ]M3\*\M3
D) [x]M6\*\M6
E) [ ]M7\*\M7
---------------------------------------------------------------------
666. CS p4\*\2246031] Pentru detectarea anomaliilor moleculare asociate cu leucemia mieloida acuta la pacientii aflati in
remisiune completa se foloseste in mod curent: (pag. 753)\*\For detection of molecular abnormalities associated with acute
myeloid leukemia patients in complete remission, it is currently used: (p. 753)
A) [x]reactie de polimerizare in lant a transcriptazei inverse (RT-PCR)\*\The reaction of reverse transcriptase polymerase chain (RT-PCR)
B) [ ]hibridizare fluorescenta in situ (FISH)\*\ fluorescence in situ hybridization (FISH)
C) [ ]citometria de flux\*\ flux cytometry
D) [ ]amplificarea genomica\*\ Genomic amplification
E) [ ]nici una dintre variante\*\none of the variants
---------------------------------------------------------------------
667. CS p4 Diagnosticul de leucemie mieloida cronica se stabileste identificand prin metode citogenetice sau moleculare
expansiunea clonala a unei celule-susa hematopoietice care poseda o translocatie reciproca intre (pag. 757)\*\The diagnosis of
chronic myelogenous leukemia is determined by identifying cytogenetic methods or molecular clonal expansion of hematopoietic
stem cells possessing a reciprocal translocation between
A) [ ]Cromozomii 9 si 23\*\Chromosomes 9 and 23
B) [ ]Cromozomii 8 si 22\*\chromosomes 8 and 22
C) [ ]Cromozomii 8 si 16\*\chromosomes 8 and 16
D) [ ]Cromozomii 6 si 21\*Chromosomes 6 and 21
E) [x]Cromozomii 9 si 22\*\Chromosomes 9 and 22
---------------------------------------------------------------------
668. CS p4 In prezent, informatia citogenetica este utila sub aspect terapeutic in LMA in: (752)\*\Currently, cytogenetic
information is useful in the therapeutic aspect of AML in:
A) [x]forma M3\*\ M3 form
B) [ ]forma M4\*\M4 form
C) [ ]forma M0\*\M0 form
D) [ ]in LAL\*\ ALL
E) [ ]in formele mixte\*\ in mixed forms
---------------------------------------------------------------------
669. CM p5 Expunerea la urmatoarele substante chimice se asociaza cu un risc crescut de leucemie mieloida acuta:
(p750)\*\Exposure to the following chemicals is associated with an increased risk of acute myeloid leukemia:
A) [x]fumatul\*\Smoking
B) [x]vopselele\*\ dyes
C) [x]benzen\*\benzene
D) [x]ierbicide\*\herbicides
E) [ ]niciuna dintre variante nu este corecta\*\none of the variants are correct
---------------------------------------------------------------------
670. CM p5 Criteriile de remisiune completa in leucemia acuta mieloblastica includ: (753)\*\The criteria for complete remission
in acute myeloid leukemia include:
A) [x]numar de neutrofile egal sau peste 1500/?L\*\neutrophil count equal to or over 1,500/ L
B) [ ]hemoglobina peste 10g/dL\*\hemoglobin over 10g/dL
C) [x]corpi Auer absenti\*\Auer rods absent
D) [ ]numar de trombocite egal sau peste 150.000/?L\*\platelet count equal to or over 150,000 / L
E) [x]absenta focarelor leucemice extramedulare\*\lack of extramedullary leukemia
---------------------------------------------------------------------

90
671. CM p5 [M2547218] Urmatoarele semne sunt identificate in momentul diagnosticului leucemiei mieloide cronice,
(758)\*\The following findings are identified at diagnosis of chronic myeloid leukemia:
A) [x]sub 10% celule blastice si promielocite\*\ less than 10% blast cells and promyelocytes
B) [x]sub 5% celule blastice circulante\*\less than 5% circulating blast cells
C) [ ]fosfataza alcalina caracteristic crescuta\*\alkaline phosphatase characteristically increased
D) [x]nivel seric de vitamina B12 crescut\*\increased serum levels of B12 vitamin
E) [x]numarul trombocitelor crescut\*\increased platelet count
---------------------------------------------------------------------
672. CM p5 La momentul diagnosticului leucemiei mieloide acute, seria plachetara prezinta urmatoarele caracteristici: (752)\*\At
AML diagnosis, platelets count has the following characteristics:
A) [x]nr.de plachete mai mic de 100.000/microL la cca 75% dintre pacienti\*\platelets count less than 100000/microL in about 75% of patients
B) [x]numar de plachete mai mic de 25000/microL la 25% dintre pacienti\*\platelets count less than 25000/microL in about 25% of patients
C) [x]plachetele prezinta anomalii morfologice\*\platelets show morphological abnormalities
D) [x]sunt prezente si anomalii functionale (incapacitate de agregare sau aderare)\*\are also present functional abnormalities
(incapacity of aggregation or adherence)
E) [ ]rareori numarul de plachete este scazut sub 100.000/microL\*\number of platelets is rarely below 100.000/microL
---------------------------------------------------------------------
673. CM p5 Anemia din leucemia mieloida acuta are urmatoarele caractere (752)\*\Anemia in acute myeloid leukemia has the
following characters:
A) [x]este normocroma si normocitara\*\is normochromic and normocytic
B) [x]se asociaza cu scaderea numarului de reticulocite\*\is associated with decreased number of reticulocytes
C) [x]este produsa si de pierderile active de sange\*\Is also produced by active blood loss
D) [x]este prezenta la momentul diagnosticului\*\is present at diagnosis
E) [ ]valorile anemiei sunt usoare/moderate\*\levels of anemia are mild / moderate
---------------------------------------------------------------------
674. CM p5 Nu pot fi simptome initiale in leucemia mieloblastica acuta:(753)\*\These cannot be the initial symptoms in acute
myeloblastic leukemia:
A) [x]hemoptizia\*\haemoptysis
B) [ ]tusea\*\cough
C) [x]dispneea\*\dyspnea
D) [x]junghiul toracic\*\Intense thoracic pain
E) [ ]febra\*\ Fever
---------------------------------------------------------------------
675. CM p5 Factorii de pronostic negativ in leucemia mieloida cronica sunt, cu EXCEPTIA: (p760)\*\ Negative prognostic
factors in chronic myelogenous leukemia are, WITH EXCEPTION:
A) [x]varsta sub 30 de ani\*\Age under 30 years
B) [ ]splina la peste 10 cm sub rebordul costal\*\spleen over 10 cm below the rib border
C) [ ]700.000 plachete/ml\*\700 000 platelets / ml
D) [ ]celule blastice peste 3%\*\ more than 3% blast cells
E) [x]bazofile sub 7%\*\less than 7% basophils
---------------------------------------------------------------------
676. CM p5 [M2247192] Printre manifestarile leucostatice ale leucemiei mieloide cronice se numara: (pag. 758))\*\The
leukostatic manifestations of chronic myeloid leukemia include:
A) [x]boala vasculara ocluziva\*\vascular occlusive disease vascular occlusive disease
B) [x]accidente cerebro-vasculare\*\cerebro-vascular accident
C) [x]infarctul miocardic\*\Myocardial infarction
D) [x]priapismul\*\ priapism
E) [ ]fractura sternala\*\sternal fracture
---------------------------------------------------------------------
677. CM p5 [M1547132] Prognosticul nefavorabil in leucemia granulocitara cronica se asociaza cu: (pag. 759)\*\Unfavorable
prognosis in chronic granulocytic leukemia is associated with:
A) [ ]Varsta egala sau mai mica de 50 ani\*\Age equal to or less than 50 years
B) [x]Splina la 10 cm sau mai mult sub rebordul costal\*\spleen 10 cm or more below the rib border
C) [ ]Plachete sub 400.000/mL\*\platelets below 400.000/mL
D) [x]Celule blastice 3% sau peste in sange si 5% sau peste in maduva\*\3% or more blast cells in blood and marrow 5% or more
E) [x]Bazofile 7% sau peste in sange si 3% sau peste in maduva\*\basophils 7% or more in blood and 3% or more in the marrow
---------------------------------------------------------------------
678. CM p5 [M2847268] Simptomatologia la un pacient cu leucemie mieloida cronica cuprinde urmatoarele variante (pag.
758)\*\Symptomatology in a patient with chronic myelogenous leukemia include the following variations:
A) [x]satietate precoce\*\early satiety
B) [x]accidente cerebro-vasculare\*\cerebro-vascular accident
C) [ ]trombocitopenie severa\*\severe thrombocytopenia
D) [x]infarct miocardic\*\myocardial infarction

91
E) [ ]majoritatea cazurilor nou diagnosticate se prezinta in faza blastica a boli\*\ Most newly diagnosed cases are presented in
blastic phase of disease
---------------------------------------------------------------------
679. CM p5 [M2647259] Fixarea secventelor BCR la ABL are, in leucemia mieloida cronica, drept rezultat: (pag. 758)\*\The
attachment of BCR sequences to ABL in chronic myelogenous leukemia results in:
A) [ ]Achizitia unei translocatii t(9;22) suplimentare\*\The acquisition of a supplementary translocation t (9, 22)
B) [x]Activarea constitutiva a proteinei Abl ca si enzima tirozin-kinazica\*\constitutive activation of ABL protein, as a tyrosine kinase enzyme
C) [ ]Alterarea genei p53\*\Alteration of p53 gene
D) [x]Atenuarea activitatii AND de legare a proteinei Abl\*\The DNA protein binding activity of ABL is attenuated
E) [x]Amplificarea legarii Abl de filamentele citoscheletice de actina\*\The binding of ABL to cytoskeletal actin filaments is amplified
---------------------------------------------------------------------
680. CM p5 [M2247191] Caracteristicile fundamentale ale leucemiei mieloide cronice din punct de vedere al instabilitatii
cromozomiale a clonei maligne implica: (pag. 758)\*\The fundamental characteristics of chronic myeloid leukemia in terms of
chromosomal instability of the malignant clone involves:
A) [x]achizitia unei translocatii t(9;22) suplimentare\*\acquisition of an additional t (9, 22) translocation
B) [ ]achizitia unei translocatii t(8;21)\*\Acquisition of a translocation t (8; 21)
C) [x]achizitia unei trisomii 8\*\ acquisition of trisomy 8
D) [ ]achizitia unei trisomii 9\*\Acquisition of trisomy 9
E) [x]achizitia unei trisomii 17p-\*\acquisition of a 17p trisomy
---------------------------------------------------------------------
681. CM p5 Leucemiile asociate cu administrarea de agenti alchilanti se caracterizeaza prin: (750)\*\Leukemia associated with
the use of alkylating agents is characterized by:
A) [ ]apar la 10-30 ani dupa expunere\*\occurs in 10 to 30 years after exposure
B) [x]apar la 4-6 ani de la expunere\*\ occurs in 4-6 years after exposure
C) [ ]sunt de obicei leucemii limfoide acute\*\Is usually acute lymphocytic/lymphoid leukemia
D) [ ]aberatii la nivelul bandei cromozomiale 11 q 23\*\aberrations at the level of chromosome band 11 q 23
E) [x]aberatii la nivelul cromozomilor 5 si 7\*\aberrations at the level of chromosomes 5 and 7
---------------------------------------------------------------------
682. CM p5 Examenul maduvei nu evidentiaza, la un pacient cu leucemie mieloida cronic, aflat in faza cronica de boala:
(758)\*\Bone marrow examination does not show, in a patient with chronic myelogenous leukemia, found in chronic phase of the disease:
A) [x]fibroza colagenica\*\collagen fibrosis
B) [ ]bazofilie\*\basophilia
C) [x]celularitate scazuta\*\decreased cellularity
D) [ ]raport mieloid/eritroid alterat\*\altered myeloid / erythroid ratio
E) [ ]eozinofilie\*\eosinophilia
---------------------------------------------------------------------
683. CM p5 Boli as. cu o fragilitate cromatiniana excesiva (750)\*\Diseases associated with excessive chromatin fragility are:
A) [x]an.Fanconi\*\Fanconi anemia
B) [x]sdr.Bloom\*\sdr.Bloom
C) [x]ataxia-telangiectazia\*\ataxia-telangiectazia
D) [x]sdr.Kostmann\*\sdr.Kostmann
E) [ ]an.feripriva\*\iron deficiency anemia
---------------------------------------------------------------------
684. CM p5 Semnele hematologice ale leucemiei mieloide cronice constau in: (758)\*\Haematological signs of chronic myeloid
leukemia are:
A) [x]leucocitoza cu grade variate de imaturitate a elementelor granulocitare\*\leukocytosis with varying degrees of immaturity of
granulocytic series
B) [x]numarul de celule blastice circulante este mai mic de 5%\*\number of circulating blast cells less than 5%
C) [x]fosfataza alcalina din celulele LMC este scazuta\*\alkaline phosphatase in CML cells is decreased
D) [x]nivelul seric al vitaminei B12 este crescut\*\serum level of vitamin B12 is increased
E) [ ]in momentul diagnosticului functiile fagocitare sunt scazute, urmind sa creasca in perioada cronica a bolii\*\The phagocytic
function at diagnosis is low, later increasing in the chronic phase of disease.
---------------------------------------------------------------------
685. CM p5 [M2246178] Urmatoarele afirmatii despre leucemia mieloida acuta sunt adevarate (pag. 752)\*\The following
statements are true about acute myeloid leukemia: (p. 752)
A) [x]debutul bolii este cel mai adesea cu simptome nespecifice\*\The onset is most often with nonspecific symptoms
B) [x]la cca jumatate din pacienti primul simptom este oboseala\*\In about half of patients the first symptom is fatigue
C) [x]semnele clinice cele mai frecvente sunt: febra, hepatosplenomegalia, limfadenopatia\*\The most common clinical signs are
fever, hepatosplenomegaly, lymphadenopathy
D) [ ]sangerari semnificative se observa mai frecvent in leucemia M5\*\significant bleeding is observed more frequently in leukemia M5
E) [x]hemoragiile retiniene sunt observate la 15% dintre pacienti\*\retinal hemorrhages are seen in 15% of patients
---------------------------------------------------------------------

92
686. CM p5 Incidenta crescuta aLAM se as. cu fol. urmatoarelor medicamente: (750-751)\*\A high incidence of AML is
associated with the use of the following drugs:
A) [ ]AINS\*\NSAIDs
B) [x]inhib.topoizomeraza II\*\topoisomerase II inhibitors
C) [x]medicam. antineoplazice\*\antineoplastic medication
D) [x]cloramfenicol\*\chloramphenicol
E) [x]fenilbutazona\*\phenylbutazone
---------------------------------------------------------------------
687. CM p5 Care din afirmatiile de mai jos sunt adevarate pentru leucemia mieloida cronica (757,758)\*\Which of the statements
below are true for chronic myelogenous leukemia:
A) [x]Incidenta leucemiei mieloide cronice creste rapid dupa decada a 4-a\*\Incidence of chronic myeloid leukemia increases
rapidly after the 4th decade
B) [x]Leucemia mieloida cronica se defineste printr-o expansiune clonala a unei celule susa hematopoietice care poseda o
translocatie reciproca intre cromozomii 9 si 22:\*\chronic myelogenous leukemia is defined by a clonal expansion of
hematopoietic stem cells possessing a reciprocal translocation between chromosomes 9 and 22
C) [ ]Prolifereaza medular celule mici cerebriforme\*\bone marrow proliferation of small cerebriform cells
D) [x]Are o tranzitie inevitabila de la o faza cronica la o faza accelerata si la criza blastica\*\Does an inevitable transition from
chronic phase to accelerated phase and blast crisis
E) [ ]Prezinta cresterea rapida a ganglionilor si determinari extraganglionare\*\It presents with the rapid growth of nodes and
extranodal manifestation
---------------------------------------------------------------------
688. CM p5 La stabilirea diagnosticului de leucemie mieloida cronica se constata la aproape toti pacientii urmatoarele (758) \*\
In establishing the diagnosis of chronic myelogenous leukemia, it is found in almost all patients the following:
A) [x]cresterea celularitatii medulare, mai ales liniile mieloida si megacariocitara\*\ increased bone marrow cellularity, especially
myeloid and megakaryocytic lines
B) [ ]raportul mieloid/eritroid normal sau usor modificat in maduva osoasa\*\ratio of myeloid / erythroid normal or slightly
modified in bone marrow
C) [ ]procentul de blasti medulari mult crescut\*\percentage of marrow blasts highly increased
D) [x]in maduva osoasa sau singele periferic se observa bazofilie, eozinofilie si monocitoza\*\in bone marrow or peripheral blood
basophilia, eosinophilia and monocytosis are observed
E) [x]fibroza colagenica a maduvei este neobisnuita la prezentare\*\collagen fibrosis of marrow is unusual on presentation
---------------------------------------------------------------------
689. CM p5 [M2246142] Factorii care influenteaza probabilitatea remisiunii complete a leucemiei mieloide acute sunt: (pag.
753)\*\Factors that influence the likelihood of complete remission of acute myeloid leukemia are:
A) [x]varsta pacientului\*\The age of the patient
B) [x]alterarile cromozomiale detectate la momentul diagnosticului\*\chromosomal alterations detected at diagnosis
C) [x]interval simptomatic prelungit\*\prolonged symptomatic period
D) [ ]prezenta receptorului alfa al acidului retinoic pe cromozomul 17\*\presence of alpha receptor of retinoic acid on
chromosome 17
E) [ ]valori scazute ale acidului uric la momentul diagnosticului\*\low uric acid levels at diagnosis
---------------------------------------------------------------------
690. CM p5 [M2246177] Din punct de vedere molecular, leucemia mieloida acuta varianta M3 se caracterizeaza prin: (pag.
752)\*\From a molecular point of view, acute myeloid leukemia of M3 variant is characterized by:
A) [x]translocatie (15;17)\*\translocation (15, 17)
B) [ ]anomalie inv(16)\*\inv (16) abnormality
C) [ ]translocatie 11q23\*\translocation 11q23
D) [x]translocatie (11;17)(q23;q21) rar intilnita\*\translocation (11, 17) (q23; q21) rarely encountered
E) [ ]toate variantele\*\All of the above
---------------------------------------------------------------------
691. CS p4 [M2923150] Tratamentul cu fluorochinolone in prostatita cronica trebuie administrat cel putin: (pg 905)\*\Treatment
with fluoroquinolones in chronic prostatitis should be administered at least:
A) [ ]7 zile\*: 7 days
B) [ ]2 saptamani\*\2 weeks
C) [ ]6 saptamani\*\6 weeks
D) [x]12 saptamani\*\12 weeks
E) [ ]3 luni\*\3 months
---------------------------------------------------------------------
692. CS p4 [M1623019] Recaderea, tipul cel mai frecvent de recurenta a infectiei urinare se defineste prin una din variantele de
mai jos: (pag. 899)\*\ the most common type of relapsing urinary infection is defined by one of the options below: (p. 899)
A) [ ]bacteriurie semnificativa cu un germen diferit, constatata dupa 7-10 zile de la eradicarea episodului precedent\*\significant
bacteriuria with a different traits , found after 7-10 days after eradication of the previous episode
B) [ ]reaparitia bacteriuriei semnificative cu acelasi agent infectios intr-o perioada de peste 3 saptamani de la terminarea unui
tratament de sterilizare a urinei\*\ significant bacteriuriei returning with the same infectious agent after a period of three weeks after

93
C) [ ]repetarea la intervale mari de timp a unor episoade de infectie urinara\* repeated at intervals of time of episodes of urinary infection
D) [ ]bacteriurie semnificativa cu un germen diferit, aparuta dupa 3 saptamani de la terminarea tratamentului de sterilizare a
urinei\*\significant bacteriuria with a different trait, which appeared three weeks after the end of treatment for sterilization of the urine
E) [x]infectie recurenta cu aceeasi tulpina care survine in decurs de 2 saptamani de la oprirea terapiei\*\infection with the same
strain that occurs within 2 weeks after stopping therapy
---------------------------------------------------------------------
693. CS p4 Care dintre urmatoarele virusuri determina cistita hemoragica la copil: (900)\*\Which of these viruses cause
haemorrhagic cystitis in children:
A) [ ]Mixovirusuri\*\Mixovirusuri
B) [ ]Rinovirusuri\*\ Rinovirusuri
C) [ ]Togavirusuri\*\Togavirusuri
D) [ ]Citomegalovirusuri\*\Citomegalovirusuri
E) [x]Adenovirusuri\*\adenoviruses
---------------------------------------------------------------------
694. CS p4 Care din urmatoarele patologii reprezinta factori predispozanti extraurinari ai infectiei de tract urinar (ITU):
(900)\*\Which of these diseases are predisposing factors of urinary tract infection extraurinari (ITU):
A) [ ]Litiaza renala si urinara\*\kidney stones and urinary
B) [ ]Refluxul vezico-ureteral\*\vesico-ureteral reflux
C) [ ]Anomalii intrarenale congenitale\*\ Congenital anomalies intrarenale
D) [x]Diabetul zaharat\*\ Diabetes mellitus
E) [ ]Golirea incompleta a vezicii urinare\*\Empty incomplete bladder
---------------------------------------------------------------------
695. CS p4 [M1623022] In infectia chlamidiana la femeile cu uretrita acuta cel mai frecvent antibiotic utilizat este: (904)\*\The
chlamidiana infection in women with acute urethritis is most commonly used antibiotic:
A) [ ]Ampicilina\*\Ampicillin
B) [ ]Nolicinul\* \Nolicinul
C) [ ]Gentamicina\*\Gentamicin
D) [x]Doxiciclina\*\ Doxycycline
E) [ ]Amoxicilina\*\Amoxicillin
---------------------------------------------------------------------
696. CS p4 [M2623045] Debutul unei PNA se caracterizeaza prin: (pag. 902)\*\beginning of a NAP is characterized by:
A) [ ]Febra\*\Fever
B) [ ]Frisoane\*\ Chills
C) [ ]Dureri lombare\*\ Low Back Pain
D) [ ]Manifestari digestive\*\digestive Events
E) [x]Toate acestea\*\All of them
---------------------------------------------------------------------
697. CS p4 [M1523016] Cercetarea bacteriuriei la toate femeile gravide este obligatorie: (pag. 905)\*\Bacterial Lab work is
mandatory for all pregnant women:
A) [x]in primul trimestru\*\First quarter
B) [ ]in al doilea trimestru\*\ in the second quarter
C) [ ]in al treilea trimestru\*\ in the third quarter
D) [ ]in primele 6 luni de gestatie\*\in the first six months of pregnancy
E) [ ]intreaga perioada gestationala\*\ whole gestational period
---------------------------------------------------------------------
698. CS p4 Uretrita acuta cu Chlamydia la femei se trateaza cu: (pag. 904)\*\acute urethritis Chlamydia in women is treated with:
A) [ ]Penicilina\*\Penicillin
B) [ ]Ofloxacina\*\ofloxacin
C) [ ]Amoxicilina\*\Amoxicillin
D) [ ]Trimetoprim\*\Trimethoprim
E) [x]Doxiciclina\*\Doxycycline
---------------------------------------------------------------------
699. CM p5 Care dintre antibioticele de mai jos sunt recomandate ca terapie de prima intentie la un pacient cu infectie urinara
cateterizat cu o sonda Dormia pentru extragerea unui calcul ureteral? (pag. 904)\*\ Which of the following antibiotics are
recommended as first-line therapy in a patient with urinary infection with a probe cateterizat for calculi removal?
A) [x]fluorochinolone\*\ fluoroquinolones
B) [x]imipenem-cilastatin\*\ imipenem-cilastatin
C) [x]ceftriaxona+amikacina\*\ceftriaxone + amikacin
D) [ ]tetracicline\*\tetracycline
E) [ ]nitrofurantoin\*\nitrofurantoin
---------------------------------------------------------------------

94
700. CM p5 [M1223060] Predispozitia pentru infeciile tractului urinar superior in timpul sarcinii rezulta din:
(900)\*\Predisposition for upper urinary tract infections during pregnancy result from:
A) [x]reducerea tonusului ureteral\*\reduce ureteral tone
B) [ ]cresterea tonusului ureteral\*\increase in ureteral tone
C) [x]scaderea peristaltismului ureteral\*\lower ureteral peristalsis
D) [x]disfunctia valvelor vezico-ureterale\*\vesico-ureteral valve dysfunction
E) [ ]toxemia gravidica\*\pregnant toxemia
---------------------------------------------------------------------
701. CM p5 Recoltarea corecta a urinei se face de obicei: (p902)\*\accurate urine collection is usually:
A) [x]Din mijlocul jetului urinar\*\ From mid-stream urine
B) [ ]Prin punctie suprapubiana la adulti\*\The suprapubic puncture in adults
C) [ ]Prin cateterizare uretrovezicala\*\The catheterization uretrovezicala
D) [x]din prima urina de dimineata\*\the first morning urine
E) [ ]Din intregul jet urinar\*\ The entire urinary stream
---------------------------------------------------------------------
702. CM p5 Prostatita nebacteriana se caracterizeaza prin: (pg 906)\*\uninfected prostatitis is characterized by:
A) [x] leucocitoza in secretiile prostatice exprimate si in urina postmasaj prostatic\*\ leukocytosis in expressed prostatic
secretions and urine of prostate postmasaj
B) [x]fara crestere bacteriana in culturi\*\no increase in bacterial cultures
C) [x]semne si simptome de prostatita\*\signs and symptoms of prostatitis
D) [ ]fara semne si simptome de prostatita\*\ no signs and symptoms of prostatitis
E) [ ]istoric de episoade recurente de prostita\*\History of recurrent episodes of prostate
---------------------------------------------------------------------
703. CM p5 Prostatita cronica se manifesta prin: (pg906)\*\Chronic prostatitis is manifested by:
A) [x]mictiuni frecvente, disurie cand infectia disemineaza la vezica urinara\*\frequent urination, dysuria when the bladder infection
disseminates
B) [ ]prostata moale, dureroasa\*\Prostate soft, painful
C) [x]simptome de obicei absente\*\symptoms usually absent
D) [x]prostata normala la palpare\*\ normal prostate on palpation
E) [ ]hematurie\*\haematuria
---------------------------------------------------------------------
704. CM p5 [M2523115] Care dintre urmatorii germeni pot fi izolati mai frecvent la un pacient sondat urinar? (pag. 902)\*\
Which of the following pathogens can be isolated more frequently in a patient urine surveyed?
A) [x]Escherichia coli\*\ Escherichia coli
B) [x]Proteus spp\*\Proteus spp
C) [x]Klebsiella spp\*\Klebsiella spp
D) [ ]adenovirus\*\adenovirus
E) [ ]Chlamydia trachomatis\*\Chlamydia trachomatis
---------------------------------------------------------------------
705. CM p5 [M2623122] ITU la gravide sunt favorizate de: (pag. 900)\*\UTI in pregnant women are favored by:
A) [x]Alterarea motilitatii tractului urinar\*\ Altered urinary tract motility
B) [ ]Modificarile hormonale\*\Hormonal changes
C) [ ]Modificarile compozitiei urinei\*\ Changes in urine composition
D) [x]Refluxul vezico ureteral\*\ vesico ureteral reflux
E) [ ]Toate cele de mai sus\*\All the above
---------------------------------------------------------------------
706. CM p5 In sarcina, cistita acuta poate fi tratata in 3-7 zile cu: (904)\*\In pregnancy, acute cystitis can be treated in 3-7 days
A) [x]amoxicilina\*\amoxicillin
B) [ ]ciprofloxacina\*\ciprofloxacin
C) [x]nitrofurantoin\*\nitrofurantoin
D) [x]o cefalosporina\*\a cephalosporin
E) [ ]norfloxacina\*\norfloxacin
---------------------------------------------------------------------
707. CM p5 In tratarea episoadelor acute, necomplicate, de cistita se pot folosi doze unice de: (pag. 904)\*\In treating episodes of
acute uncomplicated cystitis may be used for single doses
A) [x]trimetoprim-sulfametoxazol (4 tablete o data)\*\ trimethoprim-sulfamethoxazole (4 tablets a day)
B) [x]trimetoprim (400 mg)\*\trimethoprim (400 mg)
C) [x]sulfametoxazol (2g)\*\sulfamethoxazole (2g)
D) [x]norfloxacina\*\ norfloxacin
E) [ ]oxacilina\*\oxacillin
---------------------------------------------------------------------

95
708. CM p5 [M2923151] Prostatita acuta se manifesta prin: (pg 905)\*\Acute prostatitis is manifested by:
A) [x]febra\*\fever
B) [x]frisoane\*\chills
C) [ ]poliurie\*\ urination
D) [x]disurie\*\ dysuria
E) [x]prostata moale si sensibila\*\Prostate soft and sensitive
---------------------------------------------------------------------
709. CM p5 [M2523120] Care dintre urmatoarele antibiotice pot fi utilizate la o gravida ce sufera de cistita acuta? (pag.
904)\*\Which of these antibiotics can be used on a pregnant woman suffering from acute cystitis?
A) [x]amoxicilina\*\amoxicillin
B) [x]nitrofurantoin\*\nitrofurantoin
C) [x]cefalosporine\*cephalosporins \
D) [ ]fluorochinolone\*\fluoroquinolones
E) [ ]tetraciclina\*\ tetracycline
---------------------------------------------------------------------
710. CM p5 [M2523106] Urmatoarele afirmatii sunt adevarate cu privire la infectiile urinare acute: (pag. 899)\*\The following
statements are true about acute urinary infection
A) [x]sunt mai frecvente la pacientii necateterizati\*\ are more common in patients necateterizati
B) [x]apar la 1-3% din fetele de varsta scolara\*\occurring in 1-3% of school age girls
C) [x]marea majoritate a infectiilor urinare acute simptomatice apar la femeile tinere\*\the vast majority of acute symptomatic
urinary infections occur in young women
D) [x]I.U simptomatice sunt rare la barbatii sub 50 ani\*\DH symptomatic are rare in men under 50 years
E) [ ]la femei, IU acute nu sunt mai frecvente dupa inceperea vietii sexuale\*\ women, are more frequent acute DH after starting sex
---------------------------------------------------------------------
711. CM p5 [M1223050] Urmatoarele afirmatii privind refluxul vezico-ureteral sunt adevarate: (pag. 901)\*\The following
statements vesico-ureteric reflux are true:
A) [x]este frecvent la copii cu tract urinar normal dar cu infectie\*\It is common in children with normal urinary tract but with infection
B) [x]este frecvent la copii cu anomalii anatomice ale tractului urinar\*\is common in children with urinary tract anatomical abnormalities
C) [x]lezarea renala se coreleaza cu refluxul\*\renal damage correlates with reflux
D) [ ]lezarea renala se coreleaza cu infectia\*\renal damage correlates with infection
E) [x]refluxul dispare cu inaintarea in varsta la cei cu tract urinar normal anatomic\*\reflux disappears with increase in age of
patients with anatomically normal urinary tract
---------------------------------------------------------------------
712. CM p5 [M2823137] Pacientii susceptibili sa dezvolte necroza papilara ca si complicatie sint; (pag. 905)\*\Patients likely to
develop complications that are papillary necrosis:
A) [ ]cei cu insuficienta renala acuta\*\ those with acute renal failure
B) [x]diabeticii\*\diabetic
C) [ ]cei cu hipertensiune pulmonara\*\those with pulmonary hypertension
D) [x]cei cu siclemie\*\those with sickle cell
E) [x]alcoolismul cronic\*\chronic alcoholism
---------------------------------------------------------------------
713. CM p5 [M2323087] Factorii de virulenta bacteriana care influenteaza infectia tractului urinar sunt (pag. 900)\*\bacterial
virulence factors that are influencing urinary tract infections are
A) [x]fimbriile\*\fimbriaea
B) [x]pilii P\*\P pilii
C) [x]productia de hemolizine\*\production hemolizine
D) [ ]kinaze\*\ kinases
E) [x]rezistenta la actiunea bactericida a serului uman\*\resistance to human serum bactericidal action
---------------------------------------------------------------------
714. CM p5 [M1223051] Piuria sterila poate indica: (pag. 902)\*\Pyuria sterile may indicate:
A) [x]infectii cu agenti bacterieni neobisnuiti\*\unusual bacterial infections agents
B) [ ]nefropatie diabetica\*\diabetic nephropathy
C) [x]infectia cu Mycobacterium tuberculosis\*\Mycobacterium tuberculosis infection
D) [x]infectii cu fungi\*\fungal infections
E) [x]boala polichistica renala\*\polycystic kidney disease
---------------------------------------------------------------------
715. CM p5 [M2923149] Prostatodinia se caracterizeaza prin: (pg 906)\*\Prostatodinia characterized by:
A) [ ]numar mare de leucocite in secretia prostatica\*\number of leukocytes in prostatic secretion
B) [x]culturi urinare negative\*\negative urine culture
C) [x]semne si simptome de prostatita\*\signs and symptoms of prostatitis
D) [x]numar de leucocite normal in secretiile prostatice\*\number of normal white blood cells in prostatic secretions
E) [ ]culturi urinare pozitive pt E. Coli, Proteus, Klebsiella\*\ positive urine cultures for E. coli, Proteus, Klebsiella
---------------------------------------------------------------------

96
716. CM p5 [M2923138] Agentii etiologici cel mai frecventi implicati in infectiile acute ale tractului urinar sunt: (pag. 899)\*\
etiological agents most frequently involved in acute urinary tract infections are:
A) [ ]Staphilococcus saprophiticus\*\Staphylococcus saprophiticus
B) [x]Proteus\*\ proteus
C) [x]E.coli\*\E. coli
D) [ ]Serratia\*\Serratia
E) [x]Klebsiella\*\ Klebsiella
---------------------------------------------------------------------
717. CM p5 [M2323094] La baza tratamentului infectiilor tractului renal, stau urmatoarele principii: (pag. 903)\*\In urinary tract
infection the principles of treatment are :
A) [x]in majoritatea circumstantelor trebuie obtinuta o cultura urinara cantitativa pentru confirmarea infectiei inainte de inceperea
terapiei\*\ In most circumstances must be obtained for quantitative urine culture to confirm infection before starting therapy
B) [x]trebuie identificati si corectati, daca este posibil factorii ce predispun la infectie cum sunt obstructia si calculii\*\to be
identified and corrected, if possible factors predisposing to infection such as obstruction and stones
C) [x]reducerea simptomelor clinice nu indica intotdeauna vindecarea bacteriologica\*\reduction of clinical symptoms does not
always indicate decrease of infection
D) [x]infectiile necomplicate limitate la tractul urinar inferior raspund la cure scurte de terapie\*\ limited to uncomplicated lower
urinary tract respond to short courses of therapy
E) [ ]infectiile urinare dobandite in comunitatea sunt datorate de obicei tulpinilor rezistente la antibiotice\*\community acquired
urinary tract infections are usually due to antibiotic resistant strains
---------------------------------------------------------------------
718. CM p5 Care dintre antibioticele de mai jos se utilizeaza ca prima intentie in tratamentul unei pielonefrite acute
necomplicate? (904)\*\Which of the following antibiotics are used as first intention in the treatment of acute uncomplicated pyelonephritis?
A) [x]trimetoprim-sulfametoxazol\*\trimethoprim-sulfamethoxazole
B) [x]fluorochinolone\*\fluoroquinolones
C) [x]aminoglicozide\*\ aminoglycosides
D) [x]cefalosporine gen a III-a\*\cephalosporins 3
rd
gen
E) [ ]tetraciclina\*\tetracycline
---------------------------------------------------------------------
719. CM p5 [M2523121] Ce antibiotice veti alege in cazul unei gravide care se prezinta cu simptomatologie sugestiva pentru o
pielonefrita acuta? (904)\*\What you choose antibiotics in case of pregnant women who present with symptoms suggestive of an
acute pyelonephritis (first episode)?
A) [x]cefalosporine\*\cephalosporins
B) [x]peniciline cu spectru larg\*\broad spectrum penicillins
C) [ ]fluorochinolone\*\fluoroquinolones
D) [ ]tetraciclina\*\tetracycline
E) [ ]nitrofurantoin\*\ nitrofurantoin
---------------------------------------------------------------------
720. CM p5 [M1223052] La bolnavii cateterizati vezical bacteriile ajung in vezica urinara: (pag. 902)\*\When bacteria from the
urinary catheter get into the bladder by
A) [ ]pe cale hematogena\*\ by marrow
B) [ ]pe cale limfatica\*\ via lymphatics
C) [x]pe cale intraluminala\*\by intraluminal
D) [x]pe cale periuretrala\*\ by periuretrala
E) [ ]in decurs de 2-3 saptamani\*\within 2-3 weeks
---------------------------------------------------------------------
721. CS p4 Alegeti afirmatiile corecte referitoare la pericardita uremica: (1671)\*\Choose the correct statements related to uremic pericarditis
A) [ ]revarsatul pericardic este de obicei serocitrin, rareori hemoragic\*\ the break is usually pericardial serocitrin rarely hemorrhagic
B) [ ]anticoagulantele sistemice sunt recomandate in toate cazurile\*\ systemic anticoagulants are recommended in all cases
C) [ ]aparitia pericarditei nu este evitata prin dializa timpurie\*\pericarditei occurrence is avoided by early dialysis
D) [x]pericardiocenteza si instilarea de glucocorticoizi pot fi eficiente in tamponada pericardica\*\pericardiocentesis and
instillation of corticosteroids can be effective in pericardial tamponade
E) [ ]pericardita uremica continua sa fie o complicatie obisnuita (comuna, frecventa) datorita initierii precoce a dializei\*\ uremic
pericarditis continues to be a common complication (shared frequency) due to early initiation dialysis
---------------------------------------------------------------------
722. CS p4 Care din urmatorii hormoni se comporta ca o ''toxina uremica'': (1668)\*\Which of the following hormone act as a
"uremic toxin"
A) [ ]Prolactina\*\Prolactin
B) [ ]Glucagonul\*\ Glucagon
C) [ ]Insulina\*\Insulin
D) [x]Hormonul paratiroidian\*\ Parathyroid hormone
E) [ ]Hormonul luteinizant\*\luteinizing hormone
---------------------------------------------------------------------

97
723. CS p4 Care din urmatoarela substante folosite in tratamentul IRA nefrotoxice sunt agenti chelatori (p1664, 1665)\*\Which
uof the following nephrotoxic substances used to treat the ARF are chelating agents
A) [ ]Allopurinolul\*\Allopurinol
B) [x]Dimercaprolul\*\Dimercaprolul
C) [ ]Etanolul\*\Ethanol
D) [ ]N-acetil-cisteina\*\ N-acetyl-cysteine
E) [ ]Bicarbonatul de sodiu\*\Baking soda
---------------------------------------------------------------------
724. CS p4 La pacientii cu insuficienta renala cronica, hipotermia poate fi data de toxinele uremice prin: (1668)\*\In patients with
chronic renal failure, hypothermia can be given by uremic toxins by
A) [ ]cresterea enzimei de conversie a angiotensinei\*\increased angiotensin converting enzyme
B) [ ]scaderea lipoprotein-lipazei\*\reduction of lipoprotein-lipase
C) [ ]acumularea tetrahidrofolatului\*\accumulation tetrahidropholate
D) [x]inhibitia pompei de sodiu\*\sodium pump inhibition
E) [ ]cresterea fosfolipazei A2\*\ increased phospholipase A2
---------------------------------------------------------------------
725. CS p4 [M2352061] Tratamentul hiperparatiroidismului secundar din IRC se poate face prin: (1671)\*\the treatment of
secondary hyperparathyroidism due to CRF may be made by:
A) [ ]dieta cu restrictie de fosfati\*\restriction of phosphate in diet
B) [ ]carbonat de calciu\*\calcium carbonate
C) [ ]calcitriol\*\calcitriol
D) [x]toate\*\all
E) [ ]nici unul\*\none
---------------------------------------------------------------------
726. CS p4 [M2251030] In insuficienta renala acuta prin nefrita interstitiala alergica nu se intalnesc frecvent: (pag. 1662)\*\In
acute renal failure with allergic interstitial nephritis we do not frequently meet
A) [ ]cilindrii leucocitari\*\leukocytes
B) [ ]eozinofiliurie\*\eosinophils in urine
C) [x]proteinurie nefrotica\*\nephrotic proteinuria
D) [ ]vasculita leucocitoclastica\*\Leukocytoclastic vasculitis
E) [ ]eozinofilie sistemica\*\Systemic eosinophilia
---------------------------------------------------------------------
727. CS p4 [M2551045] Alegeti metoda alternativa hemodializei in tratamentul IRA dintre urmatoarele: (pag. 1666)\*\Choose
alternative method of hemodialysis to treat the ARF of the following:
A) [ ]Plasmafereza\*\ plasmaphoresis
B) [ ]Suntul portosistemic transjugular\*\ portosystemic transjugular shunt
C) [ ]Transplantul renal\*\Kidney Transplantation
D) [x]Hemodiafiltrarea venovenoasa continua\*\continuous veno-venous filtration
E) [ ]Circulatia extracorporeala\*\extracorporal circulation
---------------------------------------------------------------------
728. CS p4 [M2252026] Termenul de ''uremie'' este folosit pentru a desemna: (1667)\*\The term "uremia" is used to describe
A) [ ]Nivelul normal de uree din sange\*\ The normal level of blood urea
B) [ ]Nivelul normal de azot din sange\*\The normal blood nitrogen
C) [ ]Nivelul de uree din sange, indiferent de valoare\*\blood urea level, regardless of value
D) [x]Un sindrom clinic si biologic intalnit in insuficienta renala severa, in care se intalnesc atat cresterea nivelului de cataboliti azotati in
sange, cat si simptome si semne clinice datorate insuficientei renale\*\A clinical and biological syndrome seen in severe renal insufficiency,
which comprises of both the increasing levels of nitrogen catabolic blood, as well as symptoms and clinical signs of renal failure due
E) [ ]Cantitatea crescuta de uree eliminata in urina\*\The increased quantity of urea excreted in urine
---------------------------------------------------------------------
729. CM p5 Hipertensiunea arteriala la pacientii cu insuficienta lipseste in: (1671)\*\patients with severe hypertension is lacking
A) [ ]cardiomiopatia dilatativa\*\Dilated cardiomyopathy
B) [x]boala polichistica renala\*\polycystic kidney disease
C) [x]deshidratare\*\dehydration
D) [ ]bolile de colagen\*\collagen diseases
E) [x]afectiunile tubulointerstitiale\*\ tubulointerstitiale disease
---------------------------------------------------------------------
730. CM p5 Care dintre urmatoarele afirmatii este corecta privind faza de recuperare a insuficientei renale acute intrinseci:
(1659)\*\Which of the following statements is correct regarding the recovery phase of intrinsic acute renal failure
A) [x]se caracterizeaza prin regenerarea celulelor tubulare\*\ is characterized by tubular cell regeneration
B) [ ]rata de filtare glomerulara revine brusc\*\glomerular filtration rate falls sharply
C) [x]se poate complica cu diureza marcata\*\ may be complicated by marked diuresis
D) [ ]diureza marcata apare dat.reducerii excretiei apei si sarii retinute\*\marked diuresis is due to the reduction of water and salt excretion
E) [x]diureza marcata apare ca urmare a utilizarii diureticelor\*\is marked diuresis resulting from use of diuretics

98
731. CM p5 Insuficienta renala acuta ischemica apare cel mai frecvent dupa:(1658)\*\ischemic acute renal failure occurs most frequently after
A) [x]interventiile chirurgicale\*\surgery
B) [x]traumatisme severe\*\severe trauma
C) [x]hemoragii\*\ bleeding
D) [x]septicemii\*\septicemia
E) [ ]stari de hiperhidratare\*\state of Hyperhydration
---------------------------------------------------------------------
732. CM p5 Prognosticul sever in insuficienta renala acuta este legat de:(1666)\*\severe prognosis in acute renal failure is related to:
A) [x]Creatinina mai mare de 3 mg/dl\*\ Creatinine greater than 3 mg / dL
B) [ ]pH arterial mai mare de 7,2\*\arterial pH greater than 7.2
C) [ ]Acid uric mai mare de 15 mg/dl\*higher uric acid 15 mg / dL \
D) [ ]Uree peste 100 mg/dl\*\urea 100 mg / dL
E) [x]Oligurie sub 400 ml/zi la prezentare\*\oliguria less than 400 ml / day at presentation
---------------------------------------------------------------------
733. CM p5 Indicatiile absolute ale dializei in IRA include: (pag. 1666)\*\absolute indications of dialysis in the IRA include:
A) [x]simptome /semne ale sindromului uremic\*\The symptoms / signs of uremic syndrome
B) [x]tratamentul hipervolemiei refractare\*\treatment of refractory hipervolemiei
C) [x]tratamentiul acidozei metabolice refractare la tratament\*\tratamentiul metabolic acidosis resistant to treatment
D) [x]tratamentul hiperpotasemiei\*\treatment of hyperkalaemia
E) [ ]tratamentul anemiei\*\treatment of hyperkalaemia
---------------------------------------------------------------------
734. CM p5 Leziunea ischemica din insuficienta renala acuta ischemica este mai importanta in: (1659)\*\ischemic lesions in
ischemic acute renal failure is more important
A) [x]portiunea tubulara medulara a tubului proximal\*\medullary portion of the tube proximal tubular
B) [x]portiunea medulara a ramurei ascendente groase a ansei lui Henle\*\medullary portion of the tube proximal tubular
C) [ ]portiunea medulara a ramurei descendente groase a ansei Henle\*\medullary portion of thick descending branch of the loop Henle
D) [ ]corticala\*\cortical
E) [ ]glomerul\*\ glomerulus
---------------------------------------------------------------------
735. CM p5 Care dintre urmatoarele afirmatii este corecta: (pag. 1663)\*\ Which of the following statements is correct:
A) [x]in azotemia prerenala raportul dintre creatinina urinara si cea plasmatica >40\*\azotemia prerenala urinary creatinine and the ratio of
plasma> 40
B) [ ]raportul dintre ureea urinara si cea plasmatica >3 in azotemia renala intrinseca\*\ratio of urinary urea and the plasma> 3 in the intrinsic
renal azotemia
C) [x]osmolaritatea urinara <300 mmol/kg HO in azotemia renala intrinseca\*\urine osmolality <300 mmol / kg HO on intrinsic renal azotemia
D) [x]raportul uree/creatinina plasmatica >20 in azotemia prerenala\*\ratio urea / plasma creatinine> 20 in azotemia prerenala
E) [x]indexul insuficientei renala <1 in azotemia prerenala\*\renal index <1 in azotemia prerenala
---------------------------------------------------------------------
736. CM p5 Urmatoarele afirmatii caracterizeaza complicatiile insuficientei renale acute: (p1663, 1664)\*\The following
statements characterize complications of acute renal failure
A) [ ]alcaloza metabolica poate exacerba hiperkalemia\*\The metabolic alkalosis may exacerbate hyperkalaemia
B) [x]acidoza metabolica este severa in intoxicatia cu etilenglicol\*\metabolic acidosis is severe in ethylene glycol poisoning
C) [x]anemie severa in absenta hemoragiei poate sugera microangiopatie trombotica\*\severe anemia in the absence of bleeding
may suggest thrombotic microangiopathy
D) [x]infectia poate complica 50-90% dintre cazurile de insuficienta renala acuta\*\50-90% of infections may complicate cases of acute renal
failure
E) [ ]potasiul seric creste cu 2 mmol/l/zi in insuficienta renala acuta oligoanurica\*\serum potassium increased by 2 mmol / l / day
in acute oligoanuric renal failure
---------------------------------------------------------------------
737. CM p5 Sindromul hepatorenal complica frecvent: (pag. 1658)\*\hepatorenal syndrome frequently complicates
A) [x]ciroza hepatica\*\liver cirrhosis
B) [x]tumorile hepatice\*\liver tumors
C) [x]rezectia hepatica\*\ liver resection
D) [x]obstructia biliara\*\biliary obstruction
E) [ ]pancreatita acuta\*\Acute pancreatitis
---------------------------------------------------------------------
738. CM p5 [M2552215] Care dintre urmatoarele tulburari gastrointestinale din insuficienta renala cronica se amelioreaza dupa
un program optim de dializasi tratamentul asociat (pag. 1669)\*\What of these gastrointestinal disorders of chronic renal failure
get better after a program dializasi optimal therapy (p. 1669)
A) [ ]Ascita idiopatica\*\ Idiopathic ascites
B) [ ]Hepatita\*\Hepatitis
C) [x]Anorexia\*\Anorexia
D) [x]Greata sivrsaturile\*\Great sivrsaturile
E) [x]Halena uremica\*\Halen uremic

99
739. CM p5 Tratamentul hiperkalemiei la pacientii cu insuficienta renala cronica cuprinde administrarea de: (1670) \*\ treatment
of hiperkalemia in patients with chronic renal failure include administration of:
A) [ ]spironolactona\*\spironolactone
B) [x]bicarbonat de sodiu\*\sodium bicarbonate
C) [ ]sare fara sodiu\*\salt without sodium
D) [x]diuretice (furosemid)\*\diuretic (furosemide)
E) [x]glucoza si insulina administrate intravenos\*\glucose and intravenous insulin
---------------------------------------------------------------------
740. CM p5 Tratamentul anemiei din insuficienta renala cronica: (1672)\*\Treatment of anemia in chronic renal failure
A) [ ]se efectueaza, de preferinta ,cu transuzie de masa eritrocitara\*\is made, preferably with tranfusion of packed red blood cells
B) [x]se efectueaza, de preferinta, prin administrarea de eritropoetina\*\ is done, preferably by administration of erythropoietin
C) [ ]trebuie instituit la toti pacientii cu IRC\*\needs be established in all patients with CRF
D) [x]se instituie daca hematocritul este mai mic de 30%\*\is needed if hematocrit is less than 30%
E) [x]imbunatateste functia cardiaca\*\improves heart function
---------------------------------------------------------------------
741. CM p5 In insuficienta renala acuta sunt indicate urmat.mijloace dietetice:(1665)\*\In acute renal failure are given these dietary means
A) [ ]aport1g/kg/zi proteine\*\aport1g/kg/zi protein
B) [x]hidrati de carbon 100g/zi\*\carbohydrates 100g/zi
C) [x]aport 0,6g/kg/zi proteine\*\intake 0.6 g / kg / day protein
D) [ ]hidrati de carbon 50g/zi\*\carbohydrates 50g/zi
E) [ ]aport de alimente bogate in fosfor\*\intake of foods rich in phosphorus
---------------------------------------------------------------------
742. CM p5 Azotemia prerenala se poate datora: (1658)\*\prerenala azotemia may be due to
A) [x]pancreatitei acute\*\acute pancreatitis
B) [x]ventilatiei mecanice cu presiune pozitiva\*\mechanical ventilation with positive pressure
C) [x]cirozei hepatice cu ascita\*\liver cirrhosis with ascites
D) [x]sindromului de hipervascozitate\*\ hyperviscosity syndrome
E) [ ]obstructiei arterei renale\*\Renal artery obstruction
---------------------------------------------------------------------
743. CM p5 In uremie apar urmat. tulburari ale fluidelor si electrolitilor:(1669)\*\In uremia occur following fluid and electrolyte disorders
A) [ ]alcaloza metabolica\*\metabolic alkalosis
B) [x]acidoza metabolica\*\metabolic acidosis
C) [x]expansiunea si contractarea volemica\*\expansion and contraction volemica
D) [x]hipernatremia si hiponatremia\*\ hipernatremia and hyponatremia
E) [x]hiperkaliemia si hipokaliemia\*\hyperkalemia and hypokalemia
---------------------------------------------------------------------
744. CM p5 [M2951224] Biopsia renala poate fi indicata in (pag. 1663)\*\Renal biopsy may be indicated
A) [x]glomerulonefrite\*\glomerulonephritis
B) [ ]litiaza ureterala\*\ureteral stones
C) [x]nefrite interstitiale alergice\*\Allergic interstitial nephritis
D) [ ]sdr. de deshidratare severa\*\SDR. severe dehydration
E) [x]sdr. hemolitic uremic\*\SDR. hemolytic uremic
---------------------------------------------------------------------
745. CM p5 [M2851215] Azotemia postrenala se poate datora: (pag. 1658)\*\postrenala azotemia may be due to:
A) [x]necrozei papilare\*\papillary necrosis
B) [ ]depozitelor intratubulare obstructive\*\ Deposit intratubulare obstructive
C) [x]fibrozei retroperitoneale\*\retroperitoneal fibrosis
D) [x]vezicii neurogene\*\ neurogenic bladder
E) [x]fimozei\*\ phimosis
---------------------------------------------------------------------
746. CM p5 [M2251135] Printre cauzele de rabdomioliza se numara (pag. 1660)\*\The causes of rhabdomyolysis include
A) [x]leziuni le de strivire\*\ crushing injuries to
B) [x]convulsiile\*\seizures
C) [x]efortul excesiv\*\excessive effort
D) [x]alcoolismul\*\Alcoholism
E) [ ]hipovolemia\*\hypovolaemia
---------------------------------------------------------------------
747. CM p5 [M2251145] Insuficienta renala acuta deterioreaza: (pag. 1663)\*\worsens acute renal failure (p. 1663)
A) [x]excretia renala de sodiu\*\ renal sodium excretion
B) [ ]reabsorbtia apei\*\water reabsorption
C) [ ]reabsorbtia potasiului\*\ potassium reabsorption
D) [x]homeostazia cationilor divalenti\*\cation homeostasis divalenti
E) [x]mecanismele acidifierii urinare\*\mechanisms of urinary acidification

100
748. CM p5 [M2252131] Care dintre urmatorii hormoni au niveluri serice crescute in insuficienta renala cronica: (1667)\*\Which
of the following hormones were elevated serum levels in chronic renal failure
A) [x]Insulina\*\Insulin
B) [x]Parathormonul\*\ Parathyroid hormone
C) [x]Glucagonul\*\Glucagon
D) [x]Prolactina\*\Prolactin
E) [ ]Adrenalina\*\ Adrenalin
---------------------------------------------------------------------
749. CM p5 Acidoza metabolica din insuficienta renala acuta se trateaza cu: (1665)\*\Metabolic acidosis in acute renal failure are treated with:
A) [ ]restrictia aportului de apa\*\The restriction of water intake
B) [x]restrictie de proteine in dieta\*\ Restriction of dietary protein
C) [x]bicarbonat de sodiu\*\ sodium bicarbonate
D) [x]dializa\*\dialysis
E) [ ]evitarea solutiilor intravenoase hipotone\*\avoid hypotonic intravenous solutions
---------------------------------------------------------------------
750. CM p5 Sindromul de liza tumorala se caracterizeaza prin: (1662)\*\tumor lysis syndrome is characterized by:
A) [x]hiperuricemie >15 mg%\*\ hyperuricemia> 15 mg%
B) [ ]hipokaliemie\*\ hypokalemia
C) [ ]hipofosfatemie\*\hypophosphataemia
D) [x]posibilitatea aparitiei IRA prin necroza tubulara acuta toxica\*\the chances of the IRA by toxic acute tubular necrosis
E) [x]complica tratamentul bolilor limfo-sau mieloproliferative\*\complicating lymph-or myeloproliferative diseases
---------------------------------------------------------------------
751. CS p4 Trasaturile angiografice la pacientii cu AVC indus de cocaina pot fi: \*\ Angiographic traces in patients with stroke
induced by cocaine may be.
A) [x]A. Artere normale. \*\ normal artery
B) [ ]B. Ocluzia sau stenoza vaselor mari. \*\ occlusion or stenosis of large vessels
C) [ ]C. Vasospasm\*\ vasospasm
D) [ ]D. Leziuni de tip vasculitic\*\ vasculitis like lesions
E) [ ]E. Amiloid\*\ amyloid
---------------------------------------------------------------------
752. CS p4 In conformitate cu studiile NASCET si ECST pacientii simptomatici cu stenoza carotidiana beneficiaza in mod clar
de endarterectomie carotidiana daca stenoza carotidiana este de: (2573)\*\ According to NASCET and ECST trials in
symptomatic patients with carotid stenosis benefit without doubt from carotid endarterectomy if carotid stenosis is:
A) [ ]30-39%\*\ 30-39%
B) [ ]40-49%\*\ 40-49%
C) [ ]50-59%\*\ 50-59%
D) [ ]60-69%\*\ 6-0-69%
E) [x]70-99%\*\ 70-99%
---------------------------------------------------------------------
753. CS p4 Deficitul neurologic major al hemoragiei occipitale lobare este: (2580)\*\ major neurological deficit of the occipital
lobar hemorrhage is:
A) [x]hemianopsia\*\ hemianopia
B) [ ]afazia\*\ aphasia
C) [ ]delirul\*\ delirium
D) [ ]pareza bratelor\*\ arm paresis
E) [ ]deficit senzitiv pe un hemicorp\*\ sensory deficit in half of body
---------------------------------------------------------------------
754. CS p4 Mentionati cea mai frecventa cauza de ischemie si infarct cerebral: (2558)\*\ Mention the most common cause of
ischemia and cerebral infarction
A) [ ]boala Moyamoya\*\ Moyamoya disease
B) [ ]meningita TBC\*\ TB meningitis
C) [ ]arterita Takayasu\*\ Takayasu arteritis
D) [x]embolismul cardiogen\*\ cardiogenic embolism
E) [ ]cancerul sistemic\*\ Systemic cancer
---------------------------------------------------------------------
755. CS p4 Cea mai frecventa cauza de embolism cerebral o reprezinta: (2575)\*\ The most common cause of cerebral embolism is the:
A) [x]fibrilatia atriala nereumatica\*\ atrial fibrillation non rheumatic
B) [ ]bolile cardiace congenitale\*\ congenital heart disease
C) [ ]mixomul atrial\*\ mixoma atrial
D) [ ]prolapsul de valva mitrala\*\ mitral valve prolapse
E) [ ]contraceptivele orale\*\ oral contraceptives
---------------------------------------------------------------------

101
756. CS p4 Interesarea nucleului rosu si/sau a tractului dentorubrotalamic poate produce: (2566)\*\ involvement of the red
nucleus and / or dentorubrotalamic tract may produce:
A) [ ]hemiplegie\*\ hemiplegia
B) [ ]hemianopsie\*\ hemianopia
C) [x]ataxie controlaterala\*\ controlateral ataxia
D) [ ]cecitate\*\ blindness
E) [ ]afazie\*\ aphasia
---------------------------------------------------------------------
757. CS p4 In cazul unui accident vascular cerebral, decelarea unei infarctizari hemoragice pledeaza pentru: (p2560, 2575,
2576)\*\ In the case of stroke, detection of a hemorrhagic infarction advocates)
A) [ ]mecanism trombotic de ocluzie a vasului cerebral\*\ thrombotic mechanism of vessel occlusion
B) [x]mecanism embolic de ocluzie a vasului cerebral\*\ embolic mechanism of vessel occlusion
C) [ ]hemoragie lobara la debut\*\ beginning of lobar hemorrhage
D) [ ]hemoragie pontina la debut\*\onset of pontine bleeding
E) [ ]hemoragie subarahnoidiana\*\ subarachnoid hemorrhage
---------------------------------------------------------------------
758. CS p4 [M1126001] Endocardita bacteriana poate determina hemoragii subarahnoidiene prin: (pag. 2583)\*\ Bacterial
endocarditis can cause subarachnoidian bleeding by
A) [ ]trombocitoza\*\ thrombocytosis
B) [ ]cresterea tensiunii arteriale\*\ high blood pressure
C) [x]anevrisme micotice\*\ mycotic aneurysms
D) [ ]complexe imune circulante\*\ circulating immune complexes
E) [ ]bacteriemie\*\ bacteraemia
---------------------------------------------------------------------
759. CM p5 Care din urmatoarele afirmatii sunt adevarate: (p2579)\*\ Which of the following are true:
A) [x]A. In hemoragia din putamen ochii sunt deviati de partea opusa paraliziei. \*\ In putamen hemorrhage the eyes are deviated
to the opposite side of the paralysis
B) [ ]B. In hemoragia talamica ochii sunt deviati in sus\*\ In thalamic hemorrhage eyes are deviated upwards
C) [x]C. In hemoragia pontina miscrrile laterale reflexe ale ochilor sunt diminuate . \*\ In pontine hemorrhage micrile
lateral eye reflexes are diminished.
D) [x]D. In hemoragia cerebeloasa ochii pot fi deviati lateral spre partea opusa leziunii. \*\ In cerebellar hemorrhage eyes may be
deviated laterally towards the opposite side of the lesion
E) [ ]E. In hemoragia cerebeloasa ochii pot fi deviati lateral de aceeas parte cu leziunea\*\ In cerebellar hemorrhage eyes may be
deviated laterally on the same side as the lesion
---------------------------------------------------------------------
760. CM p5 In tratamentul AVC prima linie este reprezentata de: (2572)\*\ The first line treatment of stroke is represented by:
A) [x]modificarile dietetice\*\ Dietary changes
B) [x]modificarile stilului de viata\*\ changes in lifestyle
C) [ ]abandonarea fumatului\*\ smoking cessation
D) [ ]reducerea sarii din alimentatie\*\ reducing salt in food
E) [ ]gimnastica medicala\*\ medical gymnastics
---------------------------------------------------------------------
761. CM p5 [M2626203] Traumatismul cranian produce deobicei (pg.2557)\*\ Cranial trauma usually causes
A) [x]hematom subdural\*\ subdural hematoma
B) [x]hematom epidural\*\ epidural hematoma
C) [ ]hemoragie intracerebrala\*\ intracerebral hemorrhage
D) [ ]hemoragie subarahnoidiana\*\ subarachnoidian hemorrhage
E) [ ]apoplexie\*\ apoplexia
---------------------------------------------------------------------
762. CM p5 Sindromul Wallenberg, de afectare a portiunii laterale a bulbului, include ca manifestari clinice: (pag. 2566 -
2567)\*\ Wallenberg syndrome from the damage to the lateral portion of the bulb, had the clinical manifestations of:
A) [ ]hemianopsie homonima\*\ homonymous hemianopia
B) [x]ataxia membrelor\*\ limb ataxia
C) [ ]deficit de sensibilitate pe jumatatea contralaterala a fetei\*\ lack of sensitivity on the contralateral half of face
D) [x]diminuarea sensibilitatii dureroase si termice pe jumatatea contralaterala a corpului\*\ reduction of pain and thermal
sensitivity of the contralateral half body
E) [x]nistagmus\*\ nystagmus
---------------------------------------------------------------------
763. CM p5 Printre bolile care pot produce accidente vasculare cerebrale ischemice printr-un mecanism de hipercoagulabilitate,
se numara: (2577)\*\ Among the diseases that can cause ischemic stroke by a mechanism of hypercoagulability, are:
A) [x]purpura trombotica trombocitopenica\*\ thrombotic thrombocytopenic purpura
B) [x]deficitul de proteina C\*\ Protein C deficiency
C) [ ]deficitul de proteina bazica a mielinei\*\ deficiency of basic protein of myelin

102
D) [x]policitemia vera\*\ polycythemia vera
E) [ ]hemofilia\*\ haemophilia
---------------------------------------------------------------------
764. CM p5 Ischemia cerebrala este produsa de o reducere a fluxului cerebral cu durata de: (2557)\*\ cerebral ischemia is caused
by a reduction in cerebral flow with a duration of
A) [x]citeva secunde\*\ few seconds
B) [x]citeva minute\*\ few minutes
C) [ ]citeva ore\*\ several hours
D) [ ]citeva zile\*\ several days
E) [ ]citeva saptamini\*\ several weeks
---------------------------------------------------------------------
765. CM p5 Hemoraia subarahnoidiana este produsa de : (pg.2557)\*\ subarachnoid hemorrhage is produced by:
A) [ ]Boala hipertensiva\*\ hypertensive disease
B) [ ]sangereri intraneoplazice\*\ intraneoplastic bleeding
C) [x]rupturii unui anevrism sacular\*\ rupture of a saccular aneurysm
D) [x]rupturi unei malformatii arterio-venoase\*\ rupture of arterio-venous malformation
E) [ ]traumatis cranian inchis\*\ closed cranial trauma
---------------------------------------------------------------------
766. CM p5 Urmatoarele afirmatii sunt adevarate in ceea ce priveste simptomatologia determinata de boala aterotrombotica a
arterei cerebrale medii: (2562)\*\ The following statements are true regarding the symptoms caused by middle cerebral artery
atherothrombotic disease
A) [x]In afazia Wernicke fara pareza este implicata ramura inferioara a arterei cerebrale medii\*\ In Wernicke aphasia without
paresis inferior branch of middle cerebral artery is involved
B) [x]Sindromul Gerstmann poate aparea in leziunile emisfera dominanta\*\ Gerstmann syndrome can occur in dominant hemisphere lesions
C) [ ]Hemiasomatognozia indica faptul ca este implicata ramificatia inferioara a arterei cerebrale mijlocii in emisfera dominanta\*\
Hemiasomatognosia indicates that the inferior branch of middle cerebral artery in the dominant hemisphere is involved
D) [x]Afazia de conducere releva afectarea operculului parietal\*\ conductive aphasia reveals parietal opercule involvment
E) [x]Apractognozia emisferei minore indica afectarea lobului parietal nedominant\*\ Minor hemisphere apractognosia reveals
non-dominant parietal lobe involvement
---------------------------------------------------------------------
767. CM p5 In endocardita infectioasa embolii septici pot duce la: (2575)\*\ In infectious endocarditis, septic emboli may produce:
A) [x]abcese cerebrale\*\ cerebral abscess
B) [x]anevrisme micotice\*\ mycotic aneurysm
C) [ ]meningite\*\ meningitis
D) [x]hemoragie subarahnoidiana\*\ subarachnoidian haemorrhage
E) [x]hemoragie intracerebrala\*\ intracerebral haemorrhage
---------------------------------------------------------------------
768. CM p5 Despre fiziopatologia ischemiei si infarctului cerebral sunt adevarate urmatoarele afirmatii: (2557, 2558)\*\
Regarding the pathophysiology of ischemia and cerebral infarction following statements are true:
A) [x]Insuficienta metabolica a tesutului cerebral apare in primele 10 secunde ale opririi irigatiei cerebrale\*\ Metabolic
insufficiency of brain tissue occurs in the first 10 seconds of stopping of brain irrigation
B) [ ]Persistenta tulburarilor de perfuzie determina recuperare completa a deficitului\*\ persistence in perfusion disturbance
determines complete recuperation of the deficit
C) [x]Persistenta ischemiei pe perioade lungi determina necroza franca\*\ persistence of ischemia over long periods causes franc necrosis
D) [ ]Edemul aparut in urma necrozei unor teritorii intinse nu determina niciodata efect de masa\*\ edema appearing after necrosis
of large areas never causes mass effect
E) [x]Ateroscleroza cu trombembolism este o cauza frecventa.\*\ atherosclerosis with thromboembolism is a common cause.
---------------------------------------------------------------------
769. CM p5 Cele mai frecvente localizari ale hemoragiei intracerebrale hipertensive sunt: (2578)\*\ The most common locations
of hypertensive intracerebral hemorrhage are:
A) [x]ganglionii bazali\*\ basal ganglia
B) [x]cerebelul profund\*\ deep cerebellum
C) [x]punte\*\ pons
D) [ ]lobul occipital\*\ occipital lobe
E) [ ]bulb\*\ Bulb
---------------------------------------------------------------------
770. CM p5 Principalele riscuri ale angiografiei cerebrale selective sunt: (2570)\*\ Main risks of selective cerebral angiography are
A) [x]reactii alergice la substanta de contrast\*\ Allergic reactions to contrast material
B) [ ]insuficienta hepatica\*\ liver failure
C) [x]insuficienta renala\*\ renal failure
D) [ ]tahiaritmii\*\ tachyarrhythmias
E) [x]AVC\*\ CVA
---------------------------------------------------------------------

103
771. CM p5 Printre factorii de risc pentru accidentul vascular ischemic se numara: (2572)\*\risk factors for ischemic stroke include:
A) [x]hipertensiunea arteriala\*\ Hypertension
B) [x]diabetul zaharat\*\ diabetes
C) [x]fumatul\*\ smoking
D) [ ]hemofilia\*\ haemophilia
E) [x]valorile crescute ale colesterolului plasmatic\*\ increased serum cholesterol values
---------------------------------------------------------------------
772. CM p5 [M262612] Despre zonele anastomotice ale circulatiei cerebrale sunt ADEVARATE urmatoarele afirmatii: (2559
(Fig. 366-1))\*\ About anastomotic areas of cerebral circulation the following statements are true:
A) [x]Canalele anstomotice ale zonei de granita se realizeaz? ?i intre artera cerebrala anterioara ?i artera cerebrala medie\*\
anastomotic channel of the border area is realised between anterior cerebral artery and middle cerebral artery
B) [ ]Canalele anastomotice care apar in interiorul orbitei: intre artera cerebrala posterioara si ramura oftalmica a arterei carotide interne\*\
anastomotic channels that appear inside the orbit: between posterior cerebral artery and ophthalmic branch of the internal carotid artery
C) [x]Canalele anastomotice in intregime extracraniene se realizeaza intre ramurile musculare ale arterelor cervicale ascendente si
ramurile musculare ale arterei ocipitale.\*\ completely extracranial anastomotic channels are made between muscular branches of
ascending cervical artery and muscular branches of the occipital artery.
D) [x]Canalele anastomotice care apar in interiorul orbitei se realizeaza intre ramuri ale arterei carotide externe si ramura
oftalmica a arterei carotide interne\*\ anastomotic channels that appear inside the orbit are made between the branches of external
carotid artery and ophthalmic branch of internal carotid artery
E) [ ]Canalele anastomotice in intregime extracraniene se realizeaza intre ramurile musculare ale arterelor cervicale descendente
si ramurile musculare ale arterei ocipitale.\*\ entire extracranial anastomotic channels are made between muscular branches of
descending cervical arteries and muscular branches of the occipital artery
---------------------------------------------------------------------
773. CM p5 Dintre urmatoarele afirmatii referitoare la infarctele lacunare, selectati-le pe cele adevarate: (2568)\*\ The following
statements regarding lacunar infarct, select those which are true
A) [x]au dimensiuni mici, de 3 -4 mm, pana la 1- 2 cm\*\ are small, 3 -4 mm to 1-2 cm
B) [ ]au dimensiuni mici, de 3 - 4 cm\*\ are small, 3-4 cm
C) [x]se pot manifesta clinic prin hemipareza ataxica de partea opusa leziunii\*\ may manifest clinically by hemiparesis ataxia on
the opposite side of the lesion
D) [ ]se pot manifesta clinic prin hemipareza ataxica si hemianopsie de aceeasi parte cu leziunea\*\ may manifest clinically by
hemiparesis ataxia and hemianopia on the same side with the lesion
E) [x]se pot manifesta clinic prin dizartrie si o neindemanare a mainii sau a bratului contralateral\*\ may manifest clinically with
dysarthria and clumsiness of contralateral hand or arm
---------------------------------------------------------------------
774. CM p5 [C2523088] Reducerea generalizata a fluxului sanguin cerebral determinata de hipertensiunea sistemica produce:
(2557)\*\ generalized reduction of cerebral blood flow caused by systemic hypotension produces
A) [x]sincope\*\ syncope
B) [ ]hemoragie subarahnoidiana\*\ subarachnoid hemorrhage
C) [x]infarcte in zonele de granita dintre teritoriile de distributie ale arterelor cerebrale mari\*\ infarct in the border areas of
distribution territories of large cerebral arteries
D) [ ]hemoragii pontine\*\ Pontine hemorrhage
E) [x]necroza cerebrala intinsa\*\ extended cerebral necrosis
---------------------------------------------------------------------
775. CM p5 [M2626193] Sindromul bulbar lateral poate fi determinat de ocluzia urmatoarelor vase: \*\ Lateral bulbar syndrome
may be caused by occlusion following vessels:
A) [x]artera vertebrala\*\ vertebral artery
B) [x]artera cerebeloasa\*\ cerebellar artery
C) [ ]artera mediobazilara\*\ mediobasilar artery
D) [x]artera bulbara medie\*\ medial bulbar artery
E) [x]artera bulbara superioara\*\ superior bulbar artery
---------------------------------------------------------------------
776. CM p5 [C2523082] Printre aspectele clinice care sugereaza un mecanism embolic al accidentelor vasculare cerebrale, se
numara: (pag. 2576)\*\ The clinical aspects that suggest a mechanism of embolic stroke, include: (p. 2576)
A) [x]sindromul plegic limitat la nivelul bratului sau al mainii\*\ plegic syndrome limited to the arm or hand
B) [x]pareza faciala si afazia sau dizartrie, fara alte deficite motorii\*\ aphasia or dysarthria and facial paresis, without other motor deficits
C) [ ]deficitul motor tetraplegic, brusc instalat\*\ sudden onset of tetraplegic muscular weakness
D) [x]sindroame manifestate exclusiv prin afazie Broca sau Wernicke\*\ syndromes manifested exclusively by Broca or Wernicke aphasia
E) [x]aparitia unor crize epileptice dupa accidentul vascular cerebral\*\ The occurrence of seizures after stroke
---------------------------------------------------------------------
777. CM p5 In ocluzia arterei cerebrale medii se pot intalni urmatoarele semne clinice: (2562)\*\ which are the signs in the
middle cerebral artery occlusion:
A) [x]afazie\*\ aphasia
B) [x]hemipareza controlaterala\*\ hemiparesis controlateral

104
C) [x]paralizia miscarilor globilor oculari spre partea opusa leziunii\*\ paralysis of movement eyeballs to the opposite side of the lesion
D) [x]hemianopsie homonima\*\ homonymous hemianopia
E) [ ]cecitate corticala\*\ cortical blindness
---------------------------------------------------------------------
778. CM p5 Specificati care din urmatoarele afirmatii sunt adevarate in legatura cu accidentele vasculare trombotice: (2558)\*\
Specify which of the following statements are true about thrombotic stroke
A) [x]prezinta frecvent o simptomatologie fluctuanta, agravata in cateva minute sau ore\*\ symptoms often fluctuate and
aggravate in a few minutes or hours
B) [x]pot fi intalnite in poliarterita nodoasa\*\ can be seen in polyarthritis nodosa
C) [x]pot fi intalnite in cadrul unor boli hematologice, cum ar fi policitemia, siclemia, purpura trombotica trombocitopenica\*\
can be found in the blood diseases such as polycythemia, sickle cell anemia, thrombotic thrombocytopenic purpura
D) [ ]nu sunt niciodata precedate de accidente ischemice tranzitorii\*\ are never preceded by transient ischemic attack
E) [x]pot fi precedate de accidente ischemice tranzitorii\*\ may be preceded by transient ischemic attack
---------------------------------------------------------------------
779. CM p5 [C1223039] Care sunt tipurile de edem cerebral care pot sa apara la nivel celular? (2558)\*\ What type of cerebral
edema that may occur at the cellular level?
A) [x]citotoxic\*\ cytotoxic
B) [x]vasogenic\*\ vasogenic
C) [x]interstitial\*\ interstitial
D) [x]ischemic\*\ ischemic
E) [ ]neurogenic\*\ neurogenic
---------------------------------------------------------------------
780. CM p5 [C2523072] In cazul pacientilor cu hemoragie subarahnoidiana (HSA), vasospasmul: (2581,2583)\*\ In patients with
subarachnoid hemorrhage (SAH), vasospasm
A) [ ]apare frecvent dupa o luna de la debut\*\ occurs after one month from the onset
B) [ ]apare frecvent dupa aprox. o luna - trei luni de la debut\*\ occurs after approx. one month to three months from the onset
C) [x]apare frecvent la 4-14 zile dupa hemoragia subarahnoidiana initiala\*\ occurs commonly 4-14 days after initial
subarachnoid hemorrhage
D) [x]reprezinta o complicatie frecventa a a hemoragiei subarahnoidiene\*\ is a frequent complication subarachnoid hemorrhage
E) [ ]are implicatii minore pentru morbiditatea si mortalitatea dupa HAS anevrismale\*\ has minor implications for morbidity and
mortality following SAH
---------------------------------------------------------------------
781. CS p4 [CS270295] Articulatiile cele mai frecvent afectate in artita reactiva sunt, cu exceptia: (2098)\*\ most commonly
affected joints in reactive arthritis are, except:
A) [ ]articulatia subtalara\*\ Subtalar joint
B) [ ]glezna\*\ Ankle
C) [ ]genunchi\*\ Knees
D) [ ]interfalangiana a halucelui\*\ Interphalanges of the hallucis
E) [x]metacarpofalangiana\*\ Metacarpophalanges
---------------------------------------------------------------------
782. CS p4 [CS270293] Referitor la HSID (hiperostoza scheletala idiopatica difuza) sunt adevarate, cu exceptia: (p.2096)\*\ With
reference to HSID (diffuse idiopathic skeletal hiperostosis) are true, except:
A) [ ]cacificarea importanta a ligamentelor paraspinoase\*\ Important calcification of the paraspinous ligaments
B) [x]spatiile intervertebrale nu sunt pastrate\*\ Intervetebral spaces are not kept the same
C) [ ]osificarea ligamentelor paraspinoase\*\ Ossification of the paraspinous ligaments
D) [ ]apare aspectul de ''ceara prelinsa''\*\ Has the aspect of folded wax
E) [ ]articulatiile diartrodiale nu sunt afectate\*\ Diartrodiale articulations are not affected
---------------------------------------------------------------------
783. CS p4 Doza de sulfasalazina utilizata in spondilita anchilozanta este: (2096)\*\ Dose of sulfasalazine used in treatment of
ankylosing spondilitis is
A) [ ]0,5 g/zi\*\ 2-3mg/day
B) [ ]1 g/zi\*\2-3g/zi
C) [x]2-3 g/zi\*\ 2-3 mg / kg of body weight/ day
D) [ ]2-3 g/saptamana\*\ 7.5 - 15 mg / week
E) [ ]0,5 g/kgc/zi\*\ 2-3g/ week
---------------------------------------------------------------------
784. CS p4 [CS270292] Referitor la diagnosticul SA prin analize de laborator, sunt adevarate, cu exceptia: (p.2096)\*\ Regarding
the laboratory diagnosis of SA are true, except:
A) [ ]anemie usoara normocroma, normocitara\*\ Light anemia, normochromis, normocytic
B) [ ]fosfataza alcalina crescuta, la pacientii cu forma severa de boala\*\ Alkaline phosphatase increased, with pacients with severe form
C) [ ]scaderea capacitatii vitale\*\ Decrease in vital capacities
D) [x]HLA27 este prezent la aproximativ 80%din pacienti\*\ HLA27 is present in approximative 80% of patients
E) [ ]masuratorile fluxului aerian sunt normale\*\ Measures of the air flow are normal

105
---------------------------------------------------------------------
785. CS p4 [CS27004] Artrita reactiva poate fi insotita de urmatoarele simtome generale, cu exceptia: (pg 2098)\*\ Reactive
arthritis can be accompanied with the following general symtoms, with exception: (page 2098)
A) [ ]febra\*\ Fever
B) [ ]scaderea in greutate\*\ Loss of weight
C) [ ]oboseala\*\ Tiredness
D) [x]anorexia\*\ Anorexia
E) [ ]stare generala alterata\*\ General state altered
---------------------------------------------------------------------
786. CS p4 [CS27001] Spondilita anchilozanta se asociaza cu antigenul de histocompatibilitate (pag.2094)\*\ Anchyliusing
spondilits is associated with histocompatibility antigen : (page 2094)
A) [ ]HLA DR 4\*\ HLA DR4
B) [ ]HLA DR 3\*\ HLA DR3
C) [x]HLA B27\*\ HLA B27
D) [ ]HLA B26\*\ HLA B26
E) [ ]HLA Dw 16\*\ HLA Dw16
---------------------------------------------------------------------
787. CS p4 [CS27012] In spondilita anchilozanta , sacroileita este una din : (pag. 2094)\*\ In anchilosying spondylitis ,
sacroileitis is one of: (pag. 2094)
A) [ ]manifestarile initiale\*\ Initial Manifestation
B) [ ]manifestarile tardive\*\ Tardive manifestation
C) [x]manifestrile precoce\*\ Precoce manifestation
D) [ ]complicatiile bolii\*\ Complication of diseasea
E) [ ]manifestarile absente\*\ Absence of manifestations
---------------------------------------------------------------------
788. CS p4 [CS27026] Diagnosticul artritei reactive este: (pag. 2098)\*\ diagnosis of reactive arthritis is
A) [ ]clinic si radiologic\*\ Clinically and radiologically
B) [ ]radiologic\*\ Radiologically
C) [x]clinic\*\ Clinically
D) [ ]radiologic si de laborator\*\ Radiologic and by labs
E) [ ]clinic si de laborator\*\ Clinically and of laborator
---------------------------------------------------------------------
789. CM p5 [CM27038] Bacterii identificate ca fiind declansatoare pentru artitra reactiva sunt: (2097)\*\ Bacteria identified as
triggers for reactive artitra are:
A) [x]Salmonella\*\ Salmonella
B) [x]Y. enterocolitica\*\ Y. enterocolitica
C) [x]C. jejuni\*\ C. jejuni
D) [x]C. trachomatis\*\ C. trachomatis
E) [ ]E. coli\*\ E. coli
---------------------------------------------------------------------
790. CM p5 Care dintre urmatoarele afirmatii privind modificarile de laborator din spondilita anchilozanta sunt adevarate ?
(2096)\*\ Which of the following statements on ankylosing spondylitis in women is not true
A) [x]cresterea vitezei de sedimentare a eritrocitelor la majoritatea pacientilor cu boala activa\*\ there is a high prevalence of
peripheral arthritis
B) [x]nivelurile serice de IgA sunt frecvent crescute\*\ there is a high prevalence of IgA nephropathy
C) [ ]factorul reumatoid este constant prezent\*\ there is a high prevalence of aortic insufficiency
D) [ ]anticorpii antinucleari sunt constant prezenti\*\ disease progresses more frequently to stiffen the spine totally
E) [x]cresterea nivelului proteinei C reactive la majoritatea pacientilor cu boala activa\*\ there is a high prevalence of isolated neck stiffness
---------------------------------------------------------------------
791. CM p5 Care medicamente sunt eficiente in spondilita ankilozanta:\*\ What medications are effective in ankylosing ankilozanta:
A) [ ]saruri de Au;\*\ Gold salts
B) [x]indometacin;\*\ indomethacin
C) [ ]agenti imunosupresivi;\*\ immunosuppressive agents,
D) [x]fenilbutazona;\*\ phenylbutazone;
E) [x]sulfasalazina.\*\ sulphasalazine
---------------------------------------------------------------------
792. CM p5 Artrita gonococica se caracterizeaza prin : (2099)\*\ Gonnococcal arthrtitis is characterised by:
A) [ ]simptomele predomina la nivelul extremitatii inferioare\*\ Symptoms predominantly at the level of the inferior extermities
B) [ ]durere de spate\*\ back pain
C) [x]leziuni tegumentare veziculare caracteristice\*\ characterisitc lesions of bladder tegument.
D) [x]raspunde la antibioterapie\*\ responds to antibiotic therapy
E) [x]tenosinovita tinde sa afecteze in mod egal extremitatile superioare si inferioare\*\ The tenosinovita tends to affect in equal
ways both superior and inferior extremities

106
---------------------------------------------------------------------
793. CM p5 [CM27019] Sunt adevarate urmatoarele afirmatii despre tratamentul AR: (pg. 2100)\*\ The following statements are
true about treatment of AR
A) [x]tratamentul de prima intentie e reprezentat de indometacin\*\ The treatment of first intention is represented by indomethacin
B) [ ]doza max. de sulfasalazina este de 15 mg/sapt.\*\ The maximum dose of sulfasalazine is 15 mg / week
C) [x]doza max. de sulfasalazina este de 3 g/zi\*\ The maximum dose of sulfsalazine is 3 g/ day
D) [ ]glucocorticoizii sistemici sunt folositi de rutina\*\ Systemic Glucocorticoid are used routinely
E) [x]tratamentul antibiotic prompt si adecvat al unei uretrite induse de Chlamydia poate perveni AR ulterioara\*\ Prompt and
adequate treatment of urethritis caused by chlamydia can further prevent AR
---------------------------------------------------------------------
794. CM p5 [CM27033] Modul tipic de prezentare in spondilartropatia cu debut juvenil consta in: (p2100)\*\ The typical
presentation consists of juvenile onset spondilartropatia (p2100)
A) [x]frecventa la baieti\*\ common in boys
B) [ ]varsta peste 16 ani\*\ age over 16 years
C) [x]oligoartrita asimetrica predominanta la membrele inferioare\*\ oligoartrita asymmetric predominant in lower limbs
D) [x]entezita\*\
E) [ ]sinovita\*\ synovitis
---------------------------------------------------------------------
795. CM p5 Spondilita anchiloizanta se poate complica cu: (2096)\*\ Ankylosing Spondilitis can be complicated with
A) [ ]fractura de membru inferior\*\ leg fracture
B) [x]fractura a coloanei vertebrale\*\ spine fracture
C) [x]tetraplegie\*\ tetraplegia
D) [x]sindromul coada de cal\*\ ponytail syndrome
E) [x]fibroza progresiva a lobului superior pulmonary\*\ progressive fibrosis of the upper lobe pulmonary
---------------------------------------------------------------------
796. CM p5 [CM27008] Bacterii declansatoare ale artritei reactive sunt: \*\ Bacterial triggers for reactive arthrtitis are:
A) [x]Shigella\*\ Shigella
B) [x]Salmonella\*\ Salmonella
C) [x]C. thrachomatis\*\ C. thrachomatis
D) [x]Y. enterocolitica\*\ Y. enterocolitica
E) [ ]Moraxella catarralis\*\ Moraxella catarralis
---------------------------------------------------------------------
797. CM p5 Care dintre urmatoarele evenimente nu reprezinta potentiale complicatii tardive ale spondilitei anchilozante ?
(2096)\*\ Which of these events are potential late complications of ankylosing spondylitis?
A) [ ]Fibroza progresiva a lobului pulmonar superior\*\ progressive fibrosis of the upper lung lobe
B) [ ]Amiloidoza\*\ Amyloidosis
C) [ ]Blocul atrioventricular\*\ heart block
D) [x]Splenomegalia si leucopenia\*\ splenomegaly and leukopenia
E) [x]Pleurezia si/sau pericardita\*\ Pleurisy and / or pericarditis
---------------------------------------------------------------------
798. CM p5 [CM27056] In cazul in care artrita reactiva nu raspunde la AINS se pot folosi: (pag. 2100)\*\ In case the reactive
arthritis isn't responding to NSAIDs (AINS) may be used:
A) [x]Azatioprina\*\ Azathioprine
B) [ ]Ciclosporina\*\ Cyclosporine
C) [x]Metotrexat\*\ Methotrexate
D) [ ]Saruri de aur\*\ Gold salts
E) [ ]Penicilamina\*\ Penicillamine
---------------------------------------------------------------------
799. CM p5 [CM27074] Articulatiile cel mai frecvent afectate in artrita reactiva sunt: (pag. 2098)\*\ The most commonly affected
joints in reactive arthritis are:
A) [ ]sold si umeri (articulatiile centurilor)\*\ The hip and shoulder (joints belts)
B) [x]metatarsofalangienele si interfalangiana a halucelui\*\ metatarsofalangienele and interfalangiana of hallux
C) [ ]coaloana cervicala\*\ cervical colon
D) [x]genunchiul\*\ knee
E) [ ]degetele mainii\*\ fingers of the hand
---------------------------------------------------------------------
800. CM p5 Urmatoarele afirmatii despre artrita reactiva sunt adevarate:(2097)\*\The following statements about reactive arthritis are true:
A) [x]se intalneste predominant la indivizii care au mostenit gena HLA-B27\*\ is found predominantly in individuals who have
inherited the gene HLA-B27
B) [x]boala e frecventa intre 18-40 ani\*\ The disease is common between 18-40 years
C) [ ]boala e frecventa sub 5 ani si la varstnici\*\ the disease is common in five years and older
D) [x]artrita reactiva postveneriana e mai frecventa la barbati\*\ Postvenerian Reactive arthritis is more common in men
E) [ ]artrita reactiva postveneriana e mai frecventa la femei\*\ Postvenerain reactive arthritis is more common in women

107
---------------------------------------------------------------------
801. CM p5 [CM27017] Manifestari urogenitale din AR sunt: (pg. 2098)\*\ Urogenital manifestations of reactive arthritis are:
A) [x]Uretita\*\ Urethritis
B) [x]Prostatita\*\ Prostatitis
C) [x]Cervicita\*\ Cervicitis
D) [ ]Vaginita\*\ Vaginitis
E) [x]Salpingita\*\ Salphingitis
---------------------------------------------------------------------
802. CM p5 [CM27012] Artropatia psoriazica si artrita reactiva au in comun: (pg 2099)\*\ Psoriatic Arthropathy and reactive
arthritis have in common
A) [ ]debutul gradat\*\ gradual onset
B) [x]asimetria articulatiilor afectate\*\ Asymmetry of joints affected
C) [ ]debutul acut\*\ Acute onset
D) [x]leziuni tegumentare similare histologic\*\ Lesions of skin with similar histology
E) [x]afectarea unghiilor\*\ Nail damage
---------------------------------------------------------------------
803. CM p5 [CM27072] Modificarile de laborator din artrita reactiva sunt: (2098)\*\ Laboratory changes in reactive arthritis are:
A) [ ]anemie severa\*\ Severe anemia
B) [ ]reactanti de faza acuta normali\*\ normal acutphase reaction
C) [x]HLA B 27 pozitiv in procent variabil\*\ HLA B 27 positive variable percentage
D) [x]lichid sinovial :leucocitoza cu neutrofilie\*\ synovial fluid: leukocytosis with neutrophilia
E) [x]uneori culturi pozitive la nivelul mucoasei infectate\*\ sometimes positive cultures infected mucosa
---------------------------------------------------------------------
804. CM p5 Tratamentul spondilartropatiei nediferentiate este: (2100)\*\ Undifferentiated Spondyloarthropathy treatment is
A) [x]AINS\*\ NSAIDs
B) [ ]Saruri de aur\*\ Gold Salts
C) [x]Terapia fizica\*\ Physical Therapy
D) [ ]Penicilina\*\ Penicillin
E) [x]Similar cu cel al altor spondilartropatii\*\ Similar to that of other spondyloarthropathy
---------------------------------------------------------------------
805. CM p5 [CM27071] In artritele reactive sunt intalnite urmatoarele modificari patologice: (pag. 2097)\*\ In reactive arthritis
are met the following pathological changes:
A) [ ]sinoviala diferita histologic de cea din artropatiile inflamatorii\*\ Histology of the synovium of different inflammatory artropatii
B) [x]entezita\*\ Entezita
C) [ ]modificari reumatice\*\ Rheumatic changes
D) [x]keratoma blenoragicum\*\ Keratoderma gonorrhea
E) [x]leziuni de tip psoriazic\*\ Psoriasic injuries
---------------------------------------------------------------------
806. CM p5 [CM27006] Tratamentul ARe include (pag 2099, 2100)\*\ Treatment for Reactive Arthritis includes
A) [ ]Penicilamina\*\ Pencillamine
B) [x]Indometacin\*\ Indomethacin
C) [ ]Saruri de aur\*\ Gold Salts
D) [x]Sulfasalazina\*\ Sulfasalazine
E) [x]Metotrexat\*\ Methotrexate
---------------------------------------------------------------------
807. CM p5 [CM27042] Modul tipic de prezentare in spondilartropatia cu debut juvenil este: (pg.2100)\*\ The typical way of
presentation in spondilartropatia with juvenile debut is:
A) [ ]Oligoartrita simetrica predominant la nivelul membrelor inferioare\*\ Symmetrical oligoarthritis predominant to the inferior limbs;
B) [ ]Oligoartrita asimetrica predominant la nivelul membrelor superioare\*\ Asymmetrical oligoartrita predominant to the superior limbs;
C) [x]Oligoartrita asimetrica predominant la nivelul membrelor inferioare\*\ Asymmetrical oligoartrita predominant to the
inferior limbs;
D) [x]Entezita fara alte manifestari extraarticulare\*\ Entezita without any other extra-articular changes;
E) [ ]Entazita asociata cu alte manifestari extraarticulare\*\ Entezita associated with other extra-articular changes
---------------------------------------------------------------------
808. CM p5 [CM27049] Sunt manifestari clinice ale artritei reactive : (pg2098)\*\ Which of the followings are clinical
manifestation of reactive arthritis:
A) [ ]stare de bine general\*\ Feeling generally good;
B) [x]sacroileita acuta\*\ Acute sacroilietis
C) [x]uretrita\*\ Urethritis
D) [x]tendinita\*\ Tendinitis
E) [x]fasceita\*\ Fasceitis
---------------------------------------------------------------------

108
809. CM p5 [CM165975] leziunile cutaneo-mucoase din artrita reactiva sunt urmatoarele: (pag 2098)\*\ Musculo cutaneous
lesions in reactive arthritis are the following
A) [ ]ulceratii orale profunde, tranzitorii, adesea simptomatice\*\ profound oral ulceration, transitory, often symptomatic
B) [x]keratoderma blenorrhagica pe plante si palme\*\ keratoderma blenorrhagica of soles and palms
C) [ ]keratoderma blenorrhagica cu leziuni extinse la pacientii imunocompetenti\*\ keratoderma blenorrhagica with extensive
lesions in immunocompetent patient
D) [ ]balanita circinata la pacientii circumcisi\*\ cicinate balantitis in circumcised patients
E) [x]cruste similare cu cele din keratoderma blenoragica la pacientii circumcisi\*\ crusts similar with some of keratoderma
blenorrhagica in circumcised patients
---------------------------------------------------------------------
810. CM p5 Pot constitui manifestari clinice ale artritei reactive: (2098)\*\ May show clinical manifestations of reactive arthritis:
A) [x]Artrita asimetrica, aditiva\*\ Asymmetrical arthritis, aditive
B) [ ]Orhita\*\ Orhita
C) [x]Balanita\*\ Balanita
D) [x]Degetul ''in carnacior''\*\ The finger in carnacior - sausage shape
E) [x]Febra\*\ Fever
---------------------------------------------------------------------
811. CS p4 [M1453013] Cea mai frecventa manifestare nervoasa in lupusul meritematos sistemic este: (pag. 2063)\*\ The most
common manifestation is nervous systemic lupus meritematos
A) [ ]psihoza\*\ psychosis
B) [ ]cefaleea\*\ headache
C) [ ]infarctul focal\*\ focal myocardial
D) [x]disfunctia cognitiva usoara\*\ mild cognitive dysfunction
E) [ ]disfunctia hipotalamica\*\ hypothalamic dysfunction
---------------------------------------------------------------------
812. CS p4 Cu nefrita lupica se asociaza titruri crescute de: (2062)\*\ lupica nephritis is associated with elevated titers
A) [ ]anticoagulant lupic\*\ Anticoagulant lupic
B) [ ]anticorpi antiRo/La(SS-A/SS-B)\*\ antibodies antiRo / In (SS-A/SS-B)
C) [ ]anticrpi antihistone\*\ anticrpi antihistone
D) [ ]anticorpi antifosfolipide\*\ antiphospholipid antibodies
E) [x]IgG anti-AND\*\ IgG anti-DNA
---------------------------------------------------------------------
813. CS p4 [M2653087] Lupusul eritematos discoid (LED): (pag. 2063)\*\ discoid lupus erythematosus (LED)
A) [ ]Se intilneste la aproximativ 5% din pacientii cu LES\*\ It meets about 5% of patients with SLE
B) [x]Leziunile sunt localizate pe ariile cutanate expuse la soare\*\ Skin lesions are located in areas exposed to sunlight
C) [ ]Nu are un caracter desfigurant\*\ He has a disfigured character
D) [ ]Leziunile sunt reversibile, nu lasa cicatrici\*\ The lesions are reversible, do not leave scars
E) [ ]Peste 20% din pacientii cu LED dezvolta ulterior LES\*\ Over 20% of patients subsequently develop SLE LED
---------------------------------------------------------------------
814. CS p4 Deformarile articulatiilor la pacientii cu lupus eritematos sistemic:(2062)\*\
A) [x]Neobisnuite (la aproximativ 10% dintre pacienti)\*\ Neobisnuite (la aproximativ 10% dintre pacienti)
B) [ ]Frecvente (peste trei sferturi dintre pacienti)\*\ Frecvente (peste trei sferturi dintre pacienti)
C) [ ]Foarte frecvente (aproape la toti pacientii)\*\ Foarte frecvente (aproape la toti pacientii)
D) [ ]Constante si patognomonice\*\ Constante si patognomonice
E) [ ]Absente\*\ Absente
---------------------------------------------------------------------
815. CS p4 [M2653085] Urmatoarele afirmatii sunt corecte: (pag. 2063)\*\ The following statements are correct:
A) [ ]Titrul inalt de Ac anti ADN dc se asociaza cu dermatita din lupusul subacut\*\ Pin high titre anti-DNA in DC is associated
with lupus subacute dermatitis
B) [ ]Anticoagulantul lupic este corelat cu nefrita lupica\*\ anticoagulant lupic is correlated with nephritis lupica
C) [x]Trombozele sunt mai frecvente la cei cu Ac anticardiolipina in titru inalt\*\ thromboses are more common in patients with
anticardiolipin Action on high strength
D) [ ]Hipocomplementemia este prezenta la majoritatea bolnavilor cu lupus indus medicamentos\*\ Hipocomplementemia is
present in most patients with drug-induced lupus
E) [ ]Lupusul neonatal este produs prin trecerea anticorpilor materni anti Sm prin placenta\*\ Neonatal lupus is caused by the
passage of maternal anti-Sm antibodies through the placenta
---------------------------------------------------------------------
816. CS p4 [M2653088] Ac antinucleari (AAN): (pag. 2065)\*\ Action antinuclear (ANA)
A) [ ]Sunt specifici LES\*\ There are specific LES
B) [x]Pot fi prezenti si la persoanele sanatoase\*\ Can be present in healthy people
C) [ ]Spre deosebire de factorul reumatoid, incidenta ei nu creste cu inaintarea in varsta\*\ Unlike RF, its incidence increases with age not
D) [ ]Testul negativ exclude diagnosticul de LES\*\ negative test excludes the diagnosis of SLE
E) [ ]Titrul crescut nu reprezinta un marker de activitate al bolii lupice\*\ high titre is not a marker of disease activity lupice

109
---------------------------------------------------------------------
817. CS p4 Decelarea in serul pacientilor cu lupus eritematos sistemic a anticorpilor anti-P ribozomal se coreleaza cu: (2063)\*\
detection in serum of patients with systemic lupus erythematosus ribosomal P antibodies correlates with
A) [ ]tromboze recidivante\*\ recurrent thrombosis
B) [ ]avorturi spontane\*\ spontaneous abortions
C) [ ]hemoliza autoimuna\*\ Autoimmune hemolysis
D) [x]psihoza sau depresia datorita afectarii SNC\*\ psychosis or depression due to CNS damage
E) [ ]afectarea renala\*\ kidney damage
---------------------------------------------------------------------
818. CS p4 [M1153001] Rash-ul malar apare in urmatoarele afectiuni: (2063)\*\ Malar Rashes appear on these disorders
A) [ ]lupus discoid\*\ discoid lupus
B) [ ]sclerodermie\*\ scleroderma
C) [x]lupus eritematos sistemic\*\ Systemic lupus erythematosus
D) [ ]artrita reumatoida\*\ Rheumatoid Arthritis
E) [ ]boala Lyme\*\ Lyme disease
---------------------------------------------------------------------
819. CM p5 Factori de prognostic nefavorabil in boala lupica sunt:(2066)\*\ unfavorable prognostic factors in disease are lupica
A) [x]Hipertensiunea arteriala\*\ High blood pressure
B) [x]Creatinina serica de 1,8mg%\*\ The serum creatinine 1.8 mg%
C) [ ]Proteinuria de 2g/24 h\*\ Proteinuria of 2g/24 h
D) [x]Starea socioeconomica precara\*\ Poor socioeconomic status
E) [x]Hipoalbuminemia si hipocomplementemia in momentul diagnosticului\*\ hipocomplementemia and hypoalbuminemia at diagnosis
---------------------------------------------------------------------
820. CM p5 [M1153096] Nefropatia lupica severa se asociaza cu: (2063)\*\ nephropathy is associated with severe lupica
A) [ ]prezenta poliartritei\*\ This arthritis
B) [x]hipocomplentemie\*\ hipocomplentemie
C) [x]titru crescut de anticorpi anti-ADNds ( dublu catenar)\*\ increased strength of anti-ADNds (double helix)
D) [ ]sexul feminin\*\ female
E) [x]anomalii urinare persistente\*\ persistent urinary abnormalities
---------------------------------------------------------------------
821. CM p5 Manifestarile pulmonare din lupusul eritematos sistemic, cuprind:(2065)\*\pulmonary manifestations of SLE, include:
A) [ ]accese bronhospastice\*\ fits bronhospastice
B) [x]pleurezie\*\ pleurisy
C) [x]hipertensiune pulmonara\*\ Pulmonary hypertension
D) [x]pneumonie interstitiala\*\ interstitial pneumonia
E) [ ]formatiuni nodulare\*\ nodular formations
---------------------------------------------------------------------
822. CM p5 [M2253148] Lupusul eritematos sistemic este mai frecvent urmatoarele grupuri populationale: (2062)\*\ Systemic
lupus erythematosus is more common following population groups:
A) [x]Negrii\*\ Black
B) [x]Hispanici si asiatici\*\ Hispanics and Asians
C) [ ]Semiti\*\ Semitic
D) [ ]Toti albii din Statele Unite\*\ All Whites in the United States
E) [ ]Toti albii din Europa\*\ All Whites in Europe
---------------------------------------------------------------------
823. CM p5 [M2253155] Autoanticorpii din lupusul eritematos sistemic sunt directionati impotriva: (pag. 2062)\*\ autoantibodies
in systemic lupus erythematosus is directed against:
A) [x]Unor molecule proprii organismului (self)\*\ The body's own molecules (self)
B) [x]Unor constituente ale eritrocitelor sau trombocitelor\*\ Some constituents of erythrocytes or platelets
C) [x]Unor antigene straine care mimeaza antigenele proprii (self)\*\ Some foreign antigens that mimic their own antigens (self)
D) [ ]Unor structuri din creasta neurala\*\ structures of neural crest
E) [ ]Unor hormoni, de ex. estrogeni\*\ Some hormones, for example. estrogen
---------------------------------------------------------------------
824. CM p5 [M2653265] Urmatoarele manifestari pleuropulmonare pot apare in cadrul LES: (pag. 2065)\*\ pleuropulmonary
following symptoms may occur within SLE
A) [x]Pneumonia lupica cu raspuns favorabil la glucocorticoizi\*\ Pneumonia lupica with favorable response to corticosteroids
B) [x]Hemoragia masiva intraalveolara\*\ massive hemorrhage intraalveolara
C) [x]Revarsatul pleural\*\ break of pleural
D) [ ]Sdr Caplan\*\ SDR Caplan
E) [x]Pneumonia infectioasa, cea mai frecventa cauza de infiltrat pulmonar in LES\*\ infectious pneumonia, the most common
cause of pulmonary infiltrates in SLE
---------------------------------------------------------------------

110
825. CM p5 [M1353114] In care din urmatoarele entitati pot fi intalniti anticorpii anti-RNP: (pag. 2063)\*\ Which of these
entities can be found anti-RNP
A) [ ]spondilita anchilozanta\*\ Ankylosing spondylitis
B) [x]polimiozita\*\ polymyositis
C) [x]lupus eritematos sistemic\*\ Systemic lupus erythematosus
D) [x]sclerodermie\*\ scleroderma
E) [x]boala mixta a tesutului conjunctiv\*\ mixed connective tissue disease
---------------------------------------------------------------------
826. CM p5Ce medicatie ati alege pentru tratamentul unei paciente cu LES care are pe prim-plan artralgii si astenie? (2067)\*\
What you choose medication to treat a patient with SLE who has the spotlight pain and fatigue?
A) [ ]glucocorticoizi in doze medii\*\ medium-dose glucocorticoids
B) [x]antiinflamatoare nesterioidiene\*\ inflammatory nesterioidiene
C) [x]antimalarice\*\ antimalarial
D) [ ]azatioprina\*\ azathioprine
E) [ ]pulse-terapie cu metilprednisolon\*\ methylprednisolone pulse therapy
---------------------------------------------------------------------
827. CM p5 Care din urmatoarele afirmatii sunt adevarate in ceea ce priveste prezenta Ac anti-nucleari la pacientii cu LES
(2065)\*\ Which of the following statements are true regarding this Anti-Nuclear Action in patients with SLE
A) [x]diagnosticul de LES este confirmat de prezenta anticorpilor antinucleari\*\ The diagnosis of SLE is confirmed by this
antinuclear antibodies
B) [x]Ac antinucleari reprezinta cel mai bun test screening\*\ Action antinuclear are the best screening test
C) [ ]Un test AAN pozitiv este specific pentru LES\*\ A positive ANA test is specific for SLE
D) [x]Ac antinucleari apar in titruri scazute la unii indivizi normali\*\Action antinuclear appear in low titers in some normal individuals
E) [x]Ac antinucleari pot fi prezenti si in alte boli autoimune, infectii virale, procese inflamatorii cronice\*\ Action antinuclear
may be present in other autoimmune diseases, viral infections, chronic inflammatory processes
---------------------------------------------------------------------
828. CM p5 [M1653145] Copiii nascuti din mame cu LES prezinta: (2066)\*\ Babies born to mothers with SLE shows:
A) [ ]Anomalii fetale induse de glucocorticoizii administrati mamei pentru suprimarea activitatii bolii\*\ fetal abnormalities
induced by maternal glucocorticoids administered to suppress disease activity
B) [ ]Trombocitoza tranzitorie\*\ transient Thrombocytosis
C) [x]Eruptii tegumentare\*\ skin rash
D) [x]Rar bloc AV permanent\*\ Rare permanent AV block
E) [x]Trombocitopenie tranzitorie\*\ Transient thrombocytopenia
---------------------------------------------------------------------
829. CM p5 [M2553236] Care din modificarile histologice renale in lupusul eritematos sistemic impun teapie imunosupresiva:
(2065)\*\ Which of renal histological changes in systemic lupus erythematosus requiring immunosuppressive stake
A) [x]membranoproliferarea\*\ membranoproliferarea
B) [x]proliferarea difuza\*\ diffuse proliferation
C) [x]proliferarea focala\*\ focal proliferation
D) [ ]vasculita necrozanta\*\ necrotizing vasculitis
E) [ ] vmembranoasa fara proliferare\*\ membranous proliferation without
---------------------------------------------------------------------
830. CM p5 Lupusul eritematos sistemic este o boala sistemica care: (2062)\*\ Systemic lupus erythematosus is a systemic disease
A) [ ]este mai frecventa la rasa alba\*\ It is more common in whites
B) [x]rezulta din distrugere tisulara\*\ result in tissue damage
C) [x]afecteaza in special femeile\*\ mainly affects women
D) [ ]are o prevalenta de 1,5-2 cazuri la 100.000 locuitori in mediul urban\*\ has a prevalence of 1.5-2 cases per 100,000
inhabitants in urban areas
E) [x]apare de obicei la varsta procreatiei\*\ usually occurs at age procreation
---------------------------------------------------------------------
831. CM p5 [M2353221] Care sunt manifestarile neuro-psihice mai putin frecvente in LES (pag. 2063)\*\ What are neuro-
psychiatric events less frequent in SLE
A) [x]disfunctia cerebeloasa\*\ cerebellar dysfunction
B) [x]infarctele focale\*\ focal infarctions
C) [x]psihoza\*\ psychosis
D) [x]sindroamele organice cerebrale\*\ organic brain syndromes
E) [ ] vdisfunctia cognitiva usoara\*\ mild cognitive dysfunction
---------------------------------------------------------------------
832. CM p5 [M1153102] Tratamentul pacientilor cu lupus eritematos sistemic include: (2067,2068)\*\ Treatment of patients with
systemic lupus erythematosus include:
A) [x]metilprednisolon\*\ methylprednisolone
B) [x]ciclofosfamida\*\ cyclophosphamide
C) [ ]salazopirina\*\ salazopirina

111
D) [x]hidroxiclorochina\*\ hydroxychloroquine
E) [x]plasmafereza\*\ plasmapheresis
---------------------------------------------------------------------
833. CM p5 [M2253186] Anomaliile hematologice ale pacientilor cu lupus eritematos sistemic includ de regula: (2065)\*\
hematological abnormalities of patients with systemic lupus erythematosus usually include:
A) [ ]Trombocitoza\*\ Thrombocytosis
B) [ ]Leucocitoza cu neutrofilie importanta\*\ Leukocytosis with neutrophilia important
C) [x]Trombopenia\*\ Trombopenia
D) [x]Anemia\*\ Anemia
E) [ ]Poliglobulia\*\ Poliglobulia
---------------------------------------------------------------------
834. CM p5 Care din urmatoarele medicamente pot induce sindroame lupus-like (2066)\*\ Which of these drugs may induce
lupus-like syndromes
A) [ ]methotrexatul\*\ methotrexate
B) [x]D-penicilamina\*\ D-penicillamine
C) [x]hidralazina\*\ hidralazina
D) [ ]hidroxiclorochina\*\ hydroxychloroquine
E) [x]chinidina\*\ quinidine
---------------------------------------------------------------------
835. CM p5 Lupusul eritematos cutanat subacut este caracterizat prin: (2063)\*\ subacute cutaneous lupus erythematosus is characterized by:
A) [ ]afectarea sistemului nervos central\*\ central nervous system
B) [x]dermatite recurente extensive\*\ Extensive recurrent dermatitis
C) [x]prezenta anticorpilor anti-Ro(SS-A)\*\ presence of anti-Ro (SS-A)
D) [x]prezenta antigenului HLA-DR3\*\ this antigen HLA-DR3
E) [ ]prezenta anticorpilor anti-ADNds ( dublu catenar)\*\ this anti-ADNds (double helix)
---------------------------------------------------------------------
836. CM p5 Miopatia la pacientii cu lupus eritematos sistemic poate fi consecutiva: (2062)\*\ myopathy in patients with systemic
lupus erythematosus may be consecutive
A) [x]Proceselor inflamatorii musculare\*\ muscle inflammation
B) [ ]Hiposodemiei\*\ Hiposodemiei
C) [x]Hipokaliemiei\*\ hypokalemia
D) [x]Tratamentului cu glucocorticoizi\*\ Treatment with glucocorticoids
E) [x]Tratamentului cu hidroxiclorochina\*\ Treatment with hydroxychloroquine
---------------------------------------------------------------------
837. CM p5 Care din urmatoarele manifestari clinice si paraclinice se asociaza cu prezenta anticorpilor anti-fosfolipide ?
(2063)\*\ Which of the following clinical and laboratory manifestations associated with this anti-phospholipid antibodies?
A) [x]tromboza\*\ Thrombosis
B) [x]avorturi spontane\*\ spontaneous abortions
C) [x]trombocitopenia\*\ thrombocytopenia
D) [ ]hemoliza\*\ hemolysis
E) [x]boala valvulara cardiaca\*\ heart valve disease
---------------------------------------------------------------------
838. CM p5 [M1353123] Pentru care din urmatoarele manifestari sistemice se poate folosi hidroxiclorochina (antimalarice de
sinteza) ca tratament de fond in lupusul eritematos sistemic? (pag. 2067)\*\ To which of these systemic manifestations can be
used hydroxychloroquine (antimalarial synthetic) as background therapy in systemic lupus erythematosus?
A) [ ]serozita\*\ seriousness
B) [x]manifestari cutanate\*\ Skin manifestations
C) [x]artrita\*\ Arthritis
D) [x]astenia fizica\*\ Physical fatigue
E) [ ]manifestari oculare\*\ Ocular manifestations
---------------------------------------------------------------------
839. CM p5 Care dintre urmatoarele manifestari cardiovasculare se intalnesc frecvent la pacientii cu lupus eritematos sistemic:
(2065)\*\ Which of these cardiovascular events are found frequently in patients with systemic lupus erythematosus
A) [ ]Hipertensiunea arteriala\*\ High blood pressure
B) [ ]Anevrismul aortic disecant\*\ dissecting aortic aneurysm
C) [ ]Anevrismele cerebrale\*\ brain aneurysms
D) [x]Pericardita\*\ pericarditis
E) [x]Endocardita Libman-Sachs\*\ Endocarditis Libman-Sachs
---------------------------------------------------------------------
840. CM p5 [M2253184] In care dintre urmatoarele situatii pot apare anticorpi antinucleari: (pag. 2065)\*\ Which of the
following situations may occur antinuclear antibody
A) [x]Lupus eritematos sistemic\*\ Lupus erythematosus
B) [x]Alte boli autoimune in afara lupus-ului\*\ Other non-lupus autoimmune disease site

112
C) [x]Boli inflamatorii cronice\*\ chronic inflammatory diseases
D) [x]Infectii virale\*\ Viral Infections
E) [ ]Diabet zaharat\*\ Diabetes mellitus
---------------------------------------------------------------------
841. CS p4 [C2229031] Urmatoarele afirmatii cu privire la operatia Halstead sunt adevarate, cu exceptia: (1201)\*\ following
statements on Halstead surgery are true, except
A) [ ]in caz de asociere a radioterapiei, radionecrozele se pot extinde la grilajul costal, devenind foarte greu de tratat\*\ In case of
combination of radiotherapy, radionecrosis can extend the grid of the rib, becoming very difficult to treat
B) [ ]isi propune indepartarea in bloc a sanului, muschilor pectorali si a tesutului limfoganglionar axilar\*\ aims at bloc removing
of breast, pectoral muscles and axillary lymph nodes tissue
C) [x]are avantajul ca prin pastrarea muschiului pectoral mare, functionalitatea bratului este mai buna, iar aspectul estetic se
schimba mai putin\*\ has the advantage by keeping the large pectoral muscle, the arm is better functionality and appearance changes less
D) [ ]asigura cel mai bine ridicarea complexului fascial si a tesutului limfoganglionar interpectoral\*\ ensure best lift of fascial
complex and interpectoral lymph nodes tissue
E) [ ]evidarea limfoganglionara incepe de la virful axilei, continuand in lungul venei, extirpind toate grupele ganglionare
regionale\*\ lymph nodes prominence starts at the top of armpit, continuing along the vein, removing all groups of regional lymph nodes
---------------------------------------------------------------------
842. CS p4 [C2229029] Conduita terapeutica in cancerul mamar este conditionata de urmatorii factori, cu exceptia: (1198)\*\
therapy conduct in breast cancer is conditioned by the following factors except:
A) [ ]markeri histopatologici de prognostic\*\ Pathological prognostic markers
B) [ ]elementele de agresivitate tumorala\*\ tumor aggressiveness items
C) [ ]stadiul evolutiv al bolii\*\ evolutionary stage of disease
D) [x]nivelul seric al antigenelor MCA\*\ serum levels of antigens MCA
E) [ ]ritmul de evolutie al tumorii\*\ The rhythm of tumor evolution
---------------------------------------------------------------------
843. CS p4 [C2229109] Ca si factori de risc in cancerul mamar se pot mentiona urmatorii, cu exceptia: (1188-1189)\*\ as risk
factors for breast cancer may mention the following, except:
A) [ ]menarha precoce (inainte de 12 ani) si menopauza tardiva (dupa 55 ani)\*\ early menarche (before 12 years) and late
menopause (after 55 years)
B) [ ]modificari ale genelor NM23, p53\*\ changes in gene NM23, p53
C) [ ]expunerea la anumite virusuri AND\*\ exposure to certain DNA viruses
D) [x]iradierea regiunii toracice in special dupa 30 ani\*\ irradiation of thoracic region especially after 30 years
E) [ ]tulburarile endocrine, cum ar fi hipo sau hipertiroidia sau excesul estrogenic\*\ endocrine disorders such as hypo or
hyperthyroidism or excess estrogen
---------------------------------------------------------------------
844. CS p4 [C2229022] Se pot enumera ca si factori de risc endogeni in cancerul de san urmatorii: (pag. 1188-1189)\*\ The
following may be listed as endogenous risk factors in breast cancer:
A) [x]nuliparitatea sau prima sarcina dupa 30 de ani\*\ Nulliparous or first pregnancy after 30 years
B) [ ]contraceptivele orale, mai ales cind sunt administrate inainte de prima sarcina dusa la termen\*\ oral contraceptives,
especially when administered before the first pregnancy taken to term
C) [ ]varsta - maxim de frecventa in grupele de virsta 35-39 ani si un al doilea varf, intre 60 si 65 de ani\*\ age - maximum
frequency in the 35-39 years age groups and a second peak between 60 and 65
D) [ ]transmiterea modificata a genei BRCA 2\*\ changed transmission of BRCA 2 gene
E) [ ]expunerea sanilor la radiatii ultraviolete mai ales la persoanele care prezinta mastopatie benigna difuza sau in placard\*\
breasts exposure to ultraviolet especially those showing benign mastopathy lump
---------------------------------------------------------------------
845. CS p4 [C1229005] In diseminarea hematogena la distanta a cancerului mamar primul filtru in calea celulelor neoplazice este
reprezentat de: (1191) In the remote marrow release of breast cancer, the first filter in the way of cancer cells is represented by
A) [ ]coloana vertebrala si oasele bazinului\*\ The spine and pelvic bones
B) [ ]ficat\*\ liver
C) [ ]encefal\*\ encephalon
D) [x]plamini\*\ lung
E) [ ]tegumente\*\ skin
---------------------------------------------------------------------
846. CS p4 [C1629021] Boala Paget a sanului are originea in: (pag. 1195)\*\ Paget's Disease of the breast originates in: (p. 1195)
A) [ ]lobii glandei mamare\*\ The mammary gland lobes
B) [ ]in tegument\*\ in the skin
C) [x]in celulele epiteliului canalelor galactofore de calibru mare\*\ galactophore channels of large size in the epithelial cells
D) [ ]intraductal in subcutis\*\ translatable into subcutis
E) [ ]in mamelon\*\ the nipple
---------------------------------------------------------------------

113
847. CS p4 [C2529043] Categoria T4a reprezinta pentru cancerul glandei mamare: (1197)\*\ T4a category is for breast cancer
A) [ ]microinvazie tumorala\*\ microinvasive tumor
B) [x]tumora extinsa la peretele toracic\*\ The tumor extended to the chest wall
C) [ ]tumora extinsa la muschiul pectoral\*\ tumor extended to the pectoral muscle
D) [ ]aspectul de ''coaja de portocala'' al tegumentelor sanului\*\ appearance of "orange peel" skin of the breast
E) [ ]prezenta nodulilor de permeatie la acelasi san\*\ presence of permeate nodules at the same breast
---------------------------------------------------------------------
848. CS p4 Gradul histologic Gx in cancerul de san inseamna: (pag. vol.I. pag.1197)\*\ Gx histological grade(stage), in breast cancer, means:
A) [ ]nediferentiere\*\ undifferentiated
B) [ ]mediu diferentiat\*\ medium differentiated
C) [x]nu poate fi stabilit\*\ can not be set
D) [ ]slab diferentiat\*\ poorly differentiated
E) [ ]bine diferentat\*\ well differentiated
---------------------------------------------------------------------
849. CM p5 Care sunt factorii de risc endogeni in cancerul de san:(1188)\*\What are the endogenous risk factors for breast cancer
A) [ ]contraceptivele orale\*\ Oral contraceptives
B) [x]nuliparitatea\*\ nulliparous
C) [x]prima sarcina dupa 30 de ani\*\ first pregnancy after 30 years
D) [ ]factorii virali\*\ viral factors
E) [x]lipsa alaptarii\*\ lack of breastfeeding
---------------------------------------------------------------------
850. CM p5 [C1229075] Operatia Halsted: (1201-1202)\*\ Halsted operation
A) [ ]este astazi cea mai indicata in tratamentul cancerului mamar\*\ Today is the most appropriate treatment of breast cancer
B) [x]are sechele mai severe decat procedeele Patey si Madden (impotenta functionala a membrului corespunzator, aspect
inestetic, plexalgii)\*\ have more severe effects than Patey and Madden procedures (functional impotence of corresponding
member,unaesthetic look, plexalgii)
C) [x]este generatoare de brat gros monstruos in unele cazuri\*\ generating monstrous thick arm, in some cases
D) [ ]nu necesita radio-chimioterapie adjuvanta\*\ does not require adjuvant radio chemotherapy
E) [x]are in prezent indicatii restrinse\*\ is having restricted indications , nowadays
---------------------------------------------------------------------
851. CM p5 [C2629184] Contraindicatiile chirurgiei limitate in cadrul categoriei terapeutice A la cancerul mamar sunt: (1199)\*\
Contra limited surgery in the breast cancer therapeutic category are:
A) [ ]tumora mai mica de 2,5 cm\*\ tumor less than 2.5 cm
B) [x]sarcina\*\ pregnancy
C) [x]carcinomul lobular invaziv\*\ invasive lobular carcinoma
D) [ ]la bolnavele ce nu au fost iradiate anterior\*\ the sick that have not been previously irradiated
E) [ ]tumori situate in cadranul supero-extern\*\ tumors located in supero-external quadrant
---------------------------------------------------------------------
852. CM p5 [C1429092] Cancerul mamar la barbat: (pag. 1196)\*\ Breast cancer in men
A) [ ]este foarte frecvent;\*\ It is very common;
B) [x]este mult mai rar decat la femeie;\*\ is much rarer than in women;
C) [ ]reprezinta peste 1% din totalitatea cancerelor la barbat;\*\ represents over 1% of all cancers in men;
D) [ ]incidenta lui a inceput sa fie tot mai mica;\*\ its incidence began to be getting smaller;
E) [x]se recunosc ca implicate in etiologia lui tulburari hormonale;\*\ is recognized as involved in the etiology of hormonal disorders;
---------------------------------------------------------------------
853. CM p5 [C2329148] Urmatoarele forme clinice ale cancerului mamar se caracterizeaza printr-un prognostic grav, cu
exceptia: (1195-1196)\*\ The following clinical forms of breast cancer is characterized by a serious prognosis, except:
A) [x]schirul atrofic\*\ atrophic scar
B) [x]boala Paget\*\ Paget's disease
C) [ ]la debut mastita acuta carcinomatoasa\*\ carcinomatosa acute mastitis , at their beginning
D) [x]cancerul mamar bilateral cu stadiu I\*\ bilateral breast cancer, stage I
E) [ ]cancerul mamar multicentric\*\ multicentre breast cancer
---------------------------------------------------------------------
854. CM p5 [C1329083] Diagnosticul de certitudine in cancerul mamar se pune prin urmatoarele metode: (1195)\*\ certain
diagnosis of breast cancer is obtained by using the following methods:
A) [ ]ecografie\*\ ultrasound
B) [x]excizia sectoriala mamara cu examen histopatologic la gheata, pentru cazurile cu indicatie initial chirurgicala\*\ Sectoral
excision of breast and histopathological exam with ice, in cases of initial surgery indication
C) [x]biopsia incizionala pentru mastita carcinomatoasa cand celelalte explorari sunt negative\*\ Incision biopsy for mastitis
carcinomatosa when other explorations are negative
D) [ ]tomografia computerizata\*\ CT scan
E) [ ]rezonanta magnetica cu substanta de contrast\*\ magnetic resonance imaging with contrast material
---------------------------------------------------------------------

114
855. CM p5 Diagnosticul diferential al cancerului mamar se face cu: (1194-1195)\*\ differential diagnosis of breast cancer to be made with:
A) [x]granulomul lipofagic\*\ lipofagic granuloma
B) [ ]boala Mondor (tromboflebita venei axilare), care poate produce retractia cutanata a sanului\*\ Mondor disease (axillary vein
thrombophlebitis), which may cause skin retraction of breast
C) [x]tumora Phyllodes\*\ Phyllodes tumor
D) [x]mastopatia benigna\*\ benign mastopathy.
E) [x]mastopatia nodulara\*\ nodular mastopathy
---------------------------------------------------------------------
856. CM p5 [C1629108] Tumoarea de san maligna este: (1193)\*\ malignant breast tumor is
A) [x]dura\*\ Hard.
B) [ ]dureroasa\*\ Painful
C) [x]aderenta la tesuturi\*\ tissues adherent
D) [ ]bine delimitata\*\ well delimited
E) [ ]suprafata regulata\*\ Regular surface
---------------------------------------------------------------------
857. CM p5 [C2529165] Care sunt elementele tumorii primare maligne cu localizare la nivelul glandei mamare care decid tipul
interventiei chirurgicale (1203)\*\ What are the elements to determine the type of surgery, in case of primary malignant tumor,
localized in the mammary gland
A) [x]diametrul tumorii primare\*\ primary tumor diameter
B) [x]localizarea tumorii primare\*\ location of primary tumor
C) [x]tipul histopatologic tumoral\*\ histological type of tumor
D) [ ]starea adenopatiei locoregionale\*\ status of locoregional adenopathy
E) [x]protocolul radioterapiei postoperatorii\*\ Postoperative radiotherapy protocol
---------------------------------------------------------------------
858. CM p5 Mamografia in cancerul de san evidentiaza: (1194)\*\ Mammography in breast cancer highlights:
A) [x]spiculi\*\ spiculi
B) [ ]opacitate net conturata\*\ net shaped opacity
C) [x]opacitate cu contur difuz\*\ opacity with diffuse contour
D) [ ]lichid\*\ liquid
E) [x]microcalcificari\*\ microcalcification
---------------------------------------------------------------------
859. CM p5 [C2229134] Printre factorii de prognostic biologici ai cancerului mamar, se numarasi urmatorii: (pag. 1198)\*\
Among biological factors of breast cancer prognosis , there are:
A) [x]ploidia AND\*\ DNA ploidy
B) [ ]invazia intravasculara\*\ intravascular invasion
C) [x]receptori estrogenici si progesteronici\*\ estrogen and progesterone receptors
D) [ ]infiltratul inflamator peritumoral (limfocitar)\*\ peritumoral(lymphoma) inflammatory infiltrate
E) [x]catepsina D\*\ cathepsin D
---------------------------------------------------------------------
860. CM p5 [C1629102] Boala Paget a sanului se caracterizeaza prin: (1195)\*\ Paget's Disease of the breast is characterized by:
A) [ ]tumora situata sub mamelon\*\ tumor located under the nipple
B) [x]eritem\*\ erythema
C) [x]ulceratie mamelonara\*\ nipple ulceration
D) [x]prurit\*\ pruritus
E) [ ]dureri\*\ pain
---------------------------------------------------------------------
861. CM p5 [C1529095] Care dintre aspectele de mai jos sugereaza boala neoplazica mamara avansata loco-regional: (1190)\*\
What aspect from below suggests the loco-regionally advanced neoplasic breast disease:
A) [x]adenopatia axilara ipsilaterala clinic palpabila;\*\ ipsilateral axillary adenopathy clinically palpable;
B) [x]edemul sanului;\*\ breast swelling;
C) [x]adenopatie subclaviculara;\*\ subclavicular adenopathy;
D) [x]bratul gros ipsilateral;\*\ Thick ipsilateral arm;
E) [ ]adenopatia supraclaviculara ipsilaterala clinic palpabila\*\ ipsilateral supraclavicular adenopathy ,clinically palpable.
---------------------------------------------------------------------
862. CM p5 Cancerul mamar se caracterizeaza prin urmatoarele: (1189)\*\ Breast cancer is characterized by the following:
A) [x]majoritatea cancerelor mamare sunt dependente de factori hormonali (estrogenii secretati de ovar si de suprarenala)\*\ Most
breast cancers are dependent on hormonal factors (estrogen secreted by the ovary and the suprarenal)
B) [ ]pana la descoperirea clinica (4-5) cm sau imagistica a unui cancer mamar pot trece mai multi ani\*\ many years can take up
to the clinic (4-5) cm or imagery discovery of breast cancer
C) [x]cancerul mamar are de cele mai multe ori o evolutie locala care poate dura cativa ani, tumora putand avea diametrul de sub
1 cm\*\ Breast cancer having mostly a local trend which can last several years, the tumor may have a diameter of less than 1 cm
D) [ ]aproximativ 15% din cancerele mamare au o evolutie foarte rapida, boala generalizandu-se in cateva luni\*\ Approximately
15% of breast cancers have a very rapid evolution, the disease becoming general in a few months

115
E) [x]nodulii de permeatie sunt produsi prin patrunderea celulelor sub forma de coloana in vasele limfatice dermice\*\ lumps of
permeate are produced by the entering of the column cells into dermal lymphatic vessels
---------------------------------------------------------------------
863. CM p5 Factorii prognostici histologici in cancerul mamar sunt: (1198)\*\ histological prognostic factors of breast cancer, are:
A) [ ]ritmul de evolutie al tumorii\*\ rate of tumor evolution
B) [x]gradul de diferentiere\*\ degree of differentiation
C) [ ]receptorii estrogenici si progesteronici\*\ estrogen and progesterone receptors
D) [x]starea ganglionilor limfatici axilari\*\ axillary lymph node status
E) [x]volumul tumorii\*\ tumor volume
---------------------------------------------------------------------
864. CM p5 Tumorile epiteliele ale sanului sunt reprezentate de: (1198)\*\ Epithelial tumors of breast , are represented by:
A) [ ]limfoame\*\ lymphoma
B) [x]carcinoamele lobulare\*\ lobular carcinoma
C) [x]carcinoamele ductale in situ\*\ ductal carcinoma in situ
D) [x]boala Paget\*\ Paget's disease
E) [ ] cystosarcoma Phyllodes maligne\*\ malignant Phyllodes cystosarcoma
---------------------------------------------------------------------
865. CM p5 Urmatorii factori se coreleaza cu un prognostic nefavorabil: (1198)\*\ The following factors are correlated with an
unfavorable prognosis
A) [x]catepsina D\*\ cathepsin D
B) [ ]prezenta receptorilor estrogenici si progesteronici\*\ presence of estrogen and progesterone receptors
C) [x]c-erb-B2\*\ c-erb-B2
D) [x]aneuploidia\*\ aneuploidy
E) [x]multicentricitatea\*\ multicentred
---------------------------------------------------------------------
866. CM p5 [CS119568] Urmatoare afirmatii sunt adevarate: (1195)\*\ Next statements are true:
A) [x]In boala Paget a sanului apare uneori o scurgere mamelonara\*\in Paget's disease of the breast, sometimes there is a nipple discharge
B) [ ]mastopatia nodulara este aderenta la tegument\*\ nodular mastopatia is adherent to skin
C) [x]boala fibrochistica e o afectiune genetica\*\ fibrocystic disease is a genetic disorder
D) [x]in boala Paget a sanului invazia axilara e frecventa\*\ in Paget's disease of the breast , axillary invasion is frequent
E) [ ]in tumora Phyllodes adenopatia axilara e frecventa\*\ in Phyllodes tumor, axillary adenopathy is frequent
---------------------------------------------------------------------
867. CM p5 Semnele clinice de debut ale bolii Paget sunt: (1195)\*\ Clinical signs for the beginning of Paget's disease, are:
A) [x]prurit mamelonar\*\ itching nipple
B) [x]eritem mamelonar\*\ erythema nipple
C) [ ]tumora in san cu ulcerarea tegumentelor\*\ tumor in the breast with skin ulceration
D) [ ]ulceratie mamelonara circulara\*\ circular nipple ulceration
E) [ ]de la debut mamelonul se retracta prin tumora ulcerata\*\ from the beginning, the nipple retracted by ulcerated tumor
---------------------------------------------------------------------
868. CM p5 Indicatie chirurgicala ca prima secventa terapeutica o au (1199)\*\ Surgery, as a first sequence therapy is recommended in case of
A) [x]Tis\*\ Tis
B) [x]T1N0M0\*\ T1N0M0
C) [ ]T1N1M0\*\ T1N1M0
D) [ ]T2N1M0\*\ T2N1M0
E) [ ]T3N1M0\*\ T3N1M0
---------------------------------------------------------------------
869. CM p5 Urmatoarele forme clinice ale cancerului mamar se caracterizeaza printr-un prognostic grav: (1195-1196) \*\ The
following clinical forms of breast cancer is characterized by a severe prognosis
A) [ ]schirul atrofic\*\ atrophic schirul
B) [ ]boala Paget la debut\*\ Paget's disease, in the beginning
C) [x]mastita acuta carcinomatoasa\*\ acute mastitis carcinomatosa
D) [ ]cancerul mamar bilateral in stadiul 1\*\ bilateral breast cancer, stage 1
E) [x]cancerul mamar multicentric\*\ multicentre breast cancer
---------------------------------------------------------------------
870. CM p5 [C1429090] Factorii de risc endogeni in cancerul de san sunt: (1188)\*\ Endogenous risk factors of breast cancer are:
A) [ ]alcoolul;\*\ alcohol;
B) [x]obezitatea mai ales in postmenopauza;\*\ obesity especially in postmenopausal;
C) [ ]expunerea prelungita la unde electromagnetice;\*\ prolonged exposure to electromagnetic waves;
D) [x]nuliparitatea;\*\ nulliparity.
E) [x]prima sarcina dupa varsta de 30 de ani;\*\ first pregnancy after the age of 30 years
---------------------------------------------------------------------

116
871. CS p4 [M2630064] Care din urmatoarele afirmatii sunt false: (29-44,45)\*\ Which of these statements are false:
A) [ ]Proteinele din laptele de mama sunt influentate de variatiile aportului alimentar al mamei;\*\ The proteins in breast milk are
influenced by variations in food intake of the mother;
B) [ ]Proteinele din laptele de mama sunt alcatuite din cazeina si proteinele lactoserului ;\*\ Mother's milk proteins are composed
of casein and whey proteins;
C) [ ]Laptele de tranzitie de la ziua 4-6 pana in ziua a 10-a ;\*\ Milk transition from day 4-6 until the 10th day;
D) [ ]Laptele matur isi definitiveaza compozitia intre a 10-a si a 30-a zi dupa nastere ;\*\ milk composition between the couple
completes his 10th and 30th days after birth;
E) [x]Compozitia laptelui matur este constanta pe tot parcursul alimentatiei\*\ The composition of mature milk is constant
throughout the food
---------------------------------------------------------------------
872. CS p4 [M1130004] Necesarul de vitamine pentru sugari este corect, cu EXCEPTIA: (27, 28)\*\ The needs of vitamins for
infants is correct, except:
A) [x]Vitamina A: 750 g (2250 u\*\ Vitamin A: 750 mg (2250 U
B) [ ]Vitamina B12: 0,3 g/zi\*\ Vitamin B12: 0.3 mg / day
C) [ ]Vitamina C: 20-30 mg/zi\*\ Vitamin C: 20-30 mg / day
D) [ ]Vitamina D: 100 g (400 u\*\ Vitamin D: 100 mg (400 u
E) [ ]Vitamina E: 3 mg/zi\*\ Vitamin E 3 mg / day
---------------------------------------------------------------------
873. CS p4 Contraindicatii materne ale alimentatiei naturale sunt urmatoarele, cu EXCEPTIA: (44)\*\ Contradictions of maternal
natural food are the following, except:
A) [ ]tuberculoza activa\*\ active tuberculosis
B) [ ]starile febrile, starile septice\*\ fever, sepsis
C) [x]diabetul\*\ diabetes
D) [ ]infectia HIV diagnosticata la mama\*\ Mother diagnosed HIV
E) [ ]neoplaziile\*\ malignancies
---------------------------------------------------------------------
874. CS p4 [M2530062] Necesarul de lipide din alimentatie trebuie sa asigure: (26)\*\ needs fat in the diet should provide:
A) [ ]10-20% din totalul ratiei calorice\*\ 10-20% of total calories
B) [x]35-40% din totalul ratiei calorice\*\ 35-40% of total calories
C) [ ]40-60%din totalul ratiei calorice\*\ 40-60% of total calories
D) [ ]20-35% din totalul ratiei calorice\*\ 20-35% of total calories
E) [ ]Peste 60%din totalul ratiei calorice\*\ Over 60% of total calories
---------------------------------------------------------------------
875. CS p4 Urmatoarele stari patologice ale mamei contraindica alimentatia la san, in afara de: (44)\*\ following the mother's
pathological contraindications to breast feeding, except for:
A) [x]Lues\*\ Lues
B) [ ]Tuberculoza activa\*\ Active Tuberculosis
C) [ ]Stare febrila\*\ feverish
D) [ ]Stare septica\*\ sepsis
E) [ ]Infectie HIV\*\ HIV Infection
---------------------------------------------------------------------
876. CS p4 Necesarul de apa a unui nou nascut la termen este de: (23, tabel 2.1)\*\ water needs of a new term is born
A) [ ]220 ml/kg/zi\*\ 220 ml / kg / day
B) [x]100 - 150 ml/kg/zi\*\ 100-150 ml / kg / day
C) [ ]90 -100 ml/kg/zi\*\ 90 to 100 ml / kg / day
D) [ ]50 -100 ml/kg/zi\*\ 50 -100 ml / kg / day
E) [ ]40 -50 ml/kg/zi\*\ 40 -50 ml / kg / day
---------------------------------------------------------------------
877. CS p4 Urmatoarele afirmatii referitoare la ratia calorica a sugarului sunt adevarate, cu exceptia: (23)\*\ The following
statements about the calories your baby are true, except:
A) [ ]Metabolismul bazal reprezinta la sugar 50 kcal/kg;\*\ basal metabolism infant is 50 kcal / kg;
B) [x]Necesarul de crestere este de 0,5-1 kcal pentru fiecare gram de spor ponderal;\*\ The need for growth is 0.5 to 1 kcal per
gram of weight gain;
C) [ ]Nou nascutul creste intr-un ritm optim cu 100kcal/kg/zi daca sursa este laptele matern si cu 10% mai multe calorii daca
sugarul este alimentat artificial;\*\ New baby is growing at an optimal pace 100kcal/kg/zi if the source is milk and 10% more
calories if the baby is fed artificial;
D) [ ]Necesarul caloric in primul an de viata se cifreaza la 80-120 kcal/kg;\*\ caloric requirements in the first year of life amounts
to 80-120 kcal / kg;
E) [ ]Raportul ideal calorii/proteine este de 32-35 kcal pentru fiecare gram de proteine\*\ Report ideal calorie / protein is 32-35
kcal per gram protein
---------------------------------------------------------------------

117
878. CS p4 Identificati afirmatia incorecta despre rolul vitaminei A:(27)\*\ Identify the incorrect statement about the role of vitamin A
A) [ ]Doza recomandata de vitamina A este de 450g/zi la sugari\*\ The recommended dose of vitamin A in infants is 450g/zi
B) [ ]Surse importante de vitamina A sunt laptele, oul, ficatul de peste\*\ Important Sources of vitamin A are milk, eggs, fish liver
C) [ ]Provitamina A este de origine vegetala\*\ Provitamin A is of plant origin
D) [ ]Hemeralopia este un semn al hipovitaminozei A\*\ hemeralopia is a sign of Hypovitaminosis A
E) [x]xeroftalmia nu este legata de metabolismul vitaminei A\*\ dry eye is not related to vitamin A metabolism
---------------------------------------------------------------------
879. CM p5 Tipurile de formule pentru sugari sunt: \*\ types of infant formula are:
A) [x]formule hiperenergetice, sarace in sodiu\*\ hiperenergetice formula, low in sodium
B) [x]formule de continuare\*\ formulas
C) [x]formule adaptate\*\ adjusted formula
D) [ ]formule hiperlactozate\*\ Formula hiperlactozate
E) [ ]formule cu acid piruvic\*\ pyruvic acid formula
---------------------------------------------------------------------
880. CM p5 Diversificarea precoce a alimentatiei are urmatoarele avantaje: (43)\*\ early diversification of food has the following advantages:
A) [x]Favorizeaza dezvoltarea structurilor orale solicitate in procesul de masticatie\*\ foster the development of oral structures
required in the process of mastication
B) [x]Induce cu usurinta un ritm mai alert de crestere si spor ponderal\*\ induction with ease of rapid growth and weight gain
C) [x]Ofera un aport suplimentar de vitamine, fier, fibre\*\ Provides an additional intake of vitamins, iron, fiber
D) [ ]Favorizeaza obezitatea de aport\*\ Helps obesity intake
E) [ ]Proteinele vegetale au valoare biologica inferioara celor din lapte\*\ vegetable protein have lower biological value of milk
---------------------------------------------------------------------
881. CM p5 Formulele de lapte praf pentru sugarii sanatosi sunt reprezentate de: (35)\*\ milk powder formulas for healthy infants are:
A) [x]formule de start\*\ The formula home
B) [x]formule de continuare\*\ formulas
C) [ ]formule speciale\*\ Specific formula
D) [ ]formule hiperenergetice\*\ Formula hiperenergetice
E) [ ]preparate din lapte de vaca\*\ preparations from cow
---------------------------------------------------------------------
882. CM p5 Care din urmatoarele sunt formule speciale de lapte: (38, 40, 41, 42)\*\ Which of these are special milk formula
A) [ ]Bebelac;\*\ Bebelac;
B) [ ]Conformil;\*\ Conformil
C) [x]Alprem;\*\ Alprem;
D) [x]AL110\*\ AL110
E) [x]Isomil\*\ Isomil
---------------------------------------------------------------------
883. CM p5 [M1230113] Urmatoarele vitamine sunt liposolubile: (27)\*\ The following are fat-soluble vitamins
A) [x]vitamina E\*\ Vitamin E
B) [x]vitamina D\*\ Vitamin D
C) [x]vitaminele A si K\*\ vitamins A and K
D) [ ]vitamina B12\*\ B12
E) [ ]vitamina B6\*\ vitamin B6
---------------------------------------------------------------------
884. CM p5 [M1530138] Care din urmatoarele afirmatii in legatura cu vitamina E sunt adevarate? (28)\*\ Which of the following
statements about vitamin E are true?
A) [x]cel mai important rol este cel antioxidant\*\ The most important antioxidant role is
B) [x]previne retinopatia prin prematuritate\*\ prevent retinopathy in prematurity
C) [ ]nu este esentiala pentru crestere si dezvoltare\*\ It is essential for growth and development
D) [x]deficienta sa la prematuri poate induce o forma de anemie hemolitica\*\ its deficiency in premature infants may induce a
form of hemolytic anemia
E) [x]sursele naturale sunt uleiurile vegetale (soia, floarea soarelui)\*\ The natural sources are vegetable oils (soy, sunflower)
---------------------------------------------------------------------
885. CM p5 [M1130102] Identificati afirmatiile inexacte referitoare la formulele de continuare (follow-up): (38, 39)\*\ Identify
inaccurate statements about formulas (follow up):
A) [x]Sunt recomandate sugarilor cu varsta cuprinsa intre 1 -6 luni\*\ They are recommended for infants aged 1 -6 months
B) [ ]Cantitatea de proteine este comparabila cu a formulelor de start\*\ The amount of protein is comparable formulas home
C) [ ]Hidratii de carbon sunt reprezentati de lactoza, maltodextrina si amidon\*\ carbohydrates are represented by lactose,
maltodextrin and starch
D) [x]Nu contin adausuri speciale\*\ It contains special additives
E) [ ]Sunt suplimentate cu fier\*\ They are supplemented with iron
---------------------------------------------------------------------

118
886. CM p5 [M2530145] Care din urmatoarele afirmatii despre vitamina D sunt corecte? (28)\*\ Which of the following
statements about vitamin D is correct?
A) [x]Sursele alimentare importante de vitamina D sunt pestele, oul, untul\*\ The major food sources of vitamin D are fish, egg, butter
B) [x]Laptele uman contine o cantitate mica de vitamina D liposolubila\*\ Human milk contains a small amount of fat-soluble vitamin D
C) [ ]Vitamina D2 se sintetizeaza in piele sub actiunea razelor ultraviolete\*\ Vitamin D2 is synthesized in the skin under UV rays
D) [ ]Formulele de lapte imbogatite in vitamina D acopera necesarul\*\ fortified milk formulas in the vitamin D requirement covers
E) [ ]Rahitismul apare frecvent la sugarul alimantat natural\*\ alimantat infant rickets commonly occurs in nature
---------------------------------------------------------------------
887. CM p5 [M1430129] Care dintre urmatoarele afirmatii despre lactoferina este corecta: (31)\*\ Which of the following
statements is correct about lactoferina
A) [x]O glicoproteina din zer\*\ A glycoprotein from whey
B) [ ]Identificata in sucul intestinal\*\ Identified in the intestinal juice
C) [x]Identificata in lacrimi si sudoare\*\ Identified in tears and sweat
D) [x]Identificata ca factor de crestere\*\ Identified as a growth factor
E) [x]Identificata in sucul pancreatic\*\ identified in pancreatic juice
---------------------------------------------------------------------
888. CM p5 Lipidele din alimentatie au functii: (25)\*\ fats in the diet have functions
A) [x]cea mai importanta sursa de energie\*\ The most important energy source
B) [x]rol structural\*\ The structural role
C) [x]vehicul pentru vitaminele liposolubile\*\ vehicle for fat-soluble vitamins
D) [ ]vehicul pentru vitaminele hidrosolubile\*\ vehicle for water soluble vitamins
E) [ ]rol antiinfectios\*\ anti-infection role
---------------------------------------------------------------------
889. CM p5 Formulele de lapte din soia sunt indicate in: (39)\*\ soy milk formulas are indicated (39)
A) [x]Galactozemie\*\ The galactosemia
B) [ ]Fibroza chistica\*\ Cystic Fibrosis
C) [x]Alergia la proteinele din laptele de vaca\*\ Allergy to cow milk proteins
D) [ ]Tirozinemie\*\ tyrosinemia
E) [x]Intoleranta la lactoza\*\ Lactose intolerance
---------------------------------------------------------------------
890. CM p5 ''Falimentul'' alimentatiei naturale este cel mai frecvent opera medicului pediatru, care recurge cu mare usurinta la
alimentatia artificiala din: (45)\*\ natural food is the most common operations pediatrician who use the ease of artificial nutrition
A) [x]comoditate;\*\ convenience;
B) [x]necunoastere;\*\ ignorance;
C) [x]supraaprecierii valorii formulelor;\*\ supraaprecierii value formulas
D) [ ]costului redus;\*\ low cost;
E) [ ]gratuitatii acordatede MS.\*\ gratuity granted by MS.
---------------------------------------------------------------------
891. CM p5 Identificati afirmatiile incorecte despre formulele de start: (34,35)\*\ Identify incorrect statements about formulas home
A) [ ]Se administreaza de la nastere pana la 4-6 luni\*\ It manages from birth until 4-6 months
B) [x]Au ca sursa de proteine soia\*\ The source of soy protein
C) [x]Formulele hipoalergenice sunt indicate in diareea cronica a sugarului\*\ hypoallergenic formulas are given in chronic diarrhea of infant
D) [x]Pot fi administrate pana la 3 ani\*\ Can be administered up to 3 years
E) [ ]gustul neplacut este datorat cantitatii mari de aminoacizi liberi\*\ bad taste is due to the large amounts of amino acids
---------------------------------------------------------------------
892. CM p5 Urmatoarele afirmatii in legatura cu compozitia formulelor pentru sugari sanatosi sunt corecte, cu exceptia: (33,
34)\*\ The following statements about the composition of healthy infant formulas are correct, except:
A) [ ]Raportul cazeina/proteine din zer este 40/60\*\ Report of casein / whey protein is 40/60
B) [x]Hidratii de carbon sunt reprezentati de glucoza\*\ carbohydrates are represented by glucose
C) [x]Lipidele sunt reprezentate in exclusivitate de trigliceride cu lanturi medii de atomi de carbon (MTC)\*\ Lipids are
represented exclusively by medium chain triglycerides of carbon (MTC)
D) [ ]Concentratiile de electroliti sunt similare celor din laptele de femeie\*\ concentrations of electrolytes are similar to those of milk woman
E) [x]Toate formulele contin fier\*\ All formulas contain iron
---------------------------------------------------------------------
893. CM p5 [M1230110] Formulele de start pentru sugar, care pot fi administrate de la nastere pana la 6 luni (un an), sunt:
(34,35)\*\ home for infant formulas, which can be administered from birth to 6 months (one year) are:
A) [ ]formule hipercalorice\*\ The calorie formula
B) [ ]formule elementale\*\ elemental formulas
C) [ ]formule hiperenergetice\*\ Formula hiperenergetice
D) [x]formule adaptate\*\ formula adapted
E) [x]formule hipoalergenice/hipoantigenice\*\ hypoallergenic formula / hipoantigenice
---------------------------------------------------------------------

119
894. CM p5 [M2530152] Care din urmatoarele afirmatii reprezinta caracteristici ale alimentatiei artificiale la sugar? (45)\*\
Which of these statements are characteristics of artificial infant feeding?
A) [x]se administreaza la ore fixe\*\ is given at fixed hours
B) [ ]cantitatea de produs pe 24 de ore este jumatate din nevoia de lichide\*\ quantity of product per 24 hours is half of the need for liquid
C) [x]numarul de mese depinde de varsta si greutatea copilului\*\ number of meals depends on the child's age and weight
D) [x]numarul de mese depinde de tiparul alimentar al copilului\*\ number of meals depends on the child's food pattern
E) [ ]in cadrul acestui tip de alimentatie nu se stabileste o relatie afectiva intre mama si copil\*\ In this type of diet does not
establish an emotional relationship between mother and child
---------------------------------------------------------------------
895. CM p5 [M2730187] Laptele matern contine: (pag. 30)\*\ Breast milk contains:
A) [x]proteine 1,1/100ml\*\ protein 1.1 / 100ml
B) [ ]proteine 2,4 g/100ml\*\ protein 2.4 g/100ml
C) [x]hidrati de carbon (lactoza) 6-7 g/100ml\*\ carbohydrates (lactose) 6-7 g/100ml
D) [ ]lipide 8 g/100ml\*\ lipid 8 g/100ml
E) [x]electroliti\*\ electrolyte
---------------------------------------------------------------------
896. CM p5 Anemia din primele 6 - 8 saptamani de viata se datoreaza: (27)\*\ Anemia in the first 6-8 weeks of life is due to:
A) [ ]Alimentatiei\*\ Food
B) [ ]Absorbtiei scazute a fierului\*\ Low iron absorption
C) [x]Scaderii cantitatii de hemogobina\*\ decrease the amount of hemogobina
D) [x]Scaderii precursorilor eritroizi\*\ decrease precursors eritroizi
E) [x]Duratei scurte de viata a hematiilor ce contin hemoglobina fetala\*\ Short-lived of fetal hemoglobin-containing red cells
---------------------------------------------------------------------
897. CM p5 Sursele importante de Vitamina D sunt: (pag. 27)\*\ important sources of vitamin D are:
A) [x]origine in piele sub actiunea razelor ultraviolete\*\ original skin under UV rays
B) [x]ou\*\ egg
C) [ ]morcov, spanac\*\ carrot, spinach
D) [x]peste\*\ over
E) [x]unt\*\ butter
---------------------------------------------------------------------
898. CM p5 [M1330124] Dintre adausurile speciale pentru formule pentru sugari mentionati care sunt acizii grasi esentiali care
nu pot fi sintetizati in organism: (43)\*\ The special additives for infant formula mentioned which are essential fatty acids that can
not be synthesized in the body
A) [ ]taurina\*\ taurine
B) [ ]carnitina\*\ Carnitine
C) [x]acidul linoleic\*\ linoleic acid
D) [ ]lactuloza\*\ lactulose
E) [x]acidul alfa -linoleic\*\ alpha-linolenic acid
---------------------------------------------------------------------
899. CM p5 Principii ale unei diversificari corecte a alimentatiei sunt: (43)\*\ principles of proper nutrition is a diversification
A) [ ]Primul aliment introdus este sucul de fructe la 4 luni\*\ The first food is brought fruit juice to 4 months
B) [x]La 5 luni masa de fructe va inlocui o masa de lapte\*\ At 5 months of fruit mass will replace a meal of milk
C) [ ]Fainosul de grau este optim la 4 luni\*\ Fainosul wheat is optimal to 4 months
D) [ ]Carnea de orice tip se introduce la 5-6 luni\*\ The meat of any kind is introduced at 5-6 months
E) [x]Albusul de ou, pestele si capsunile se introduc dupa 1 an,\*\ egg whites, fish and strawberries are inserted after a year
---------------------------------------------------------------------
900. CM p5 Care din urmatoarele sunt contraindicatii permanente ale alimentatiei la san: (44)\*\ Which of these are permanent
contraindications to breast feeding
A) [ ]Ragadele ;\*\ Ragadele;
B) [ ]Luesul mamei ;\*\ Luesul mother;
C) [ ]Mastita;\*\ mastitis;
D) [x]Septicemia mamei;\*\ Septicemia mother;
E) [x]Tuberculoza activa a mamei\*\ Tuberculosis active mother
---------------------------------------------------------------------
901. CS p4 [M1431029] Neutropenia la nou-nascut este declarata la un numar mai mic de: (136) \*\ Neutropenia in the newborn
is declared in a smaller number
A) [x] 1500/mm3, \*\ 1500/mm3
B) [ ] 500/mm3, \*\ 500/mm3,
C) [ ] 1900/mm3, \*\ 1900/mm3
D) [ ] 2300/mm3, \*\ 2300/mm3
E) [ ] Toate variantele \*\ All versions
---------------------------------------------------------------------

120
902. CS p4 [M1331021] Care semn clinic sau de laborator nu este gasit in meningita purulenta a nou nascutului (138) \*\ Which
clinical sign or laboratory is not found in purulent meningitis of the newborn
A) [ ] convulsii \*\ convulsion
B) [ ] bombarea fontanelei \*\ bulging fontanelle
C) [ ] varsaturi \*\ vomiting
D) [ ] proteinorahia cu valori ridicate \*\ high proteinorahia
E) [x] hiperglicorahia \*\ hiperglicorahia
---------------------------------------------------------------------
903. CS p4 [M2631074] Care din urmatorii agenti etiologici este agentul clasic al artritei supurate si osteomielitei la nou-nascut:
(139) \*\ Which of the following etiologic agents is classic agent in suppurated arthritis and osteomyelitis in the newborn
A) [x] Stafilococ auriu; \*\ Staphylococcus aureus;
B) [ ] Streptocooc betahemolitic grup \*\ Streptocooc beta-hemolytic group B
C) [ ] Klebsiella; \*\ Klebsiella;
D) [ ] Proteus; \*\ Proteus;
E) [ ] E. Coli \*\ E. coli
---------------------------------------------------------------------
904. CS p4 Terapia infectiei neonatale herpetice se realizeaza cu: (144) \*\ Therapy of neonatal herpes infection is achieved by:
A) [ ] Ganciclovir \*\ ganciclovir
B) [ ] Ribavirin \*\ Ribavirin
C) [ ] Interferon \*\ Interferon
D) [x] Aciclovir \*\ Acyclovir
E) [ ] ZDV \*\ ZDV
---------------------------------------------------------------------
905. CS p4 [M2631073] Urmatoarele sunt semne precoce ale meningitei neo-natale, cu exceptia: (138) \*\ The following are
early signs of neo-natal meningitis, except:
A) [ ] Convulsii; \*\ convulsions;
B) [ ] Bombarea fontanelei anterioare; \*\ bulging anterior fontanelle
C) [ ] Tulburarile de termoreglare a temperaturii; \*\ Disorders of thermoregulation in temperature;
D) [x] Opistotonus; \*\ Opistotonus;
E) [ ] Varsaturi \*\ vomiting
---------------------------------------------------------------------
906. CS p4 [M1331024] Semnele clinice de sifilis congenital sunt urmatoarele in afara de unul: (145) \*\ Clinical signs of
congenital syphilis are these but one
A) [ ] rinita persistenta unilaterala \*\ unilateral persistent rhinitis
B) [ ] hepatosplenomegalie \*\ hepatosplenomegaly
C) [ ] icter \*\ jaundice
D) [ ] periostita si osteocondrita \*\ periostitis and osteocondrita
E) [x] pemfigus la nivelul trunchiului si a membrelor \*\ pemphigus on the trunk and limbs
---------------------------------------------------------------------
907. CS p4 [M1531032] Standardul de aur pentru diagnosticul pozitiv al infectiei cu HIV la nou-nascut este (143) \*\ Gold
standard for positive diagnosis of HIV infection in the newborn is
A) [ ] testul ELISA \*\ ELISA
B) [ ] testul Westernblott \*\ test Westernblott
C) [x] determinarea antigenului viral (ARN-HIV) prin PCR \*\ Determination of viral antigen (HIV RNA) by PCR
D) [ ] determinarea limfocitelor CD4 \*\ determination of CD4 lymphocytes
E) [ ] determinarea raportului limfocitelor CD4/CD8 \*\ determination of lymphocyte CD4/CD8 ratio
---------------------------------------------------------------------
908. CS p4 [M2831081] Date de laborator cu valoare predictiva pentru sepsis sunt urmatoarele, cu exceptia: (136,137) \*\
Laboratory data with predictive value for sepsis are the following, except:
A) [ ] Leucocitoza cu neutrofilie / nr leucocite < 5000 \*\ Leukocytosis with neutrophilia / No leukocytes <5000
B) [ ] Proteina C reactiva > 5 mg% \*\ C-reactive protein> 5 mg%
C) [ ] Lactacidemia > 2 mmol / l \*\ Lactacidemia> 2 mmol / l
D) [ ] Cresterea Il 6 > 100 pg / ml \*\ Increased Il 6> 100 pg / ml
E) [x] Indice leucocitar < 0,2 \*\ leukocyte index <0.2
---------------------------------------------------------------------
909. CM p5 Sepsisul tardiv al nou-nascutului se caracterizeaza-prin: (135) \*\ Late sepsis newborn is characterized by:
A) [x] Debut dupa un ''interval liber'' de 5 zile \*\ Onset after a "free interval" of 5 days
B) [ ] Defineste intodeauna infectiile materno-fetale \*\ Define always the maternal-fetal infection
C) [ ] Simptomatologia este specifica \*\ symptoms is specific
D) [x] Nerecunoscut precoce, se ajunge rapid la socul refractar si disfunctia organica multipla \*\ early recognition is quickly
reach refractory shock and multiple organic dysfunction
E) [ ] Toate variantele de mai sus \*\ All of the above
---------------------------------------------------------------------

121
910. CM p5 [M1531129] Vaccinarea antihepatita virala B (144) \*\ Antihepatitis viral B Vaccination
A) [x] se face in tara noastra tuturor nou-nascutilor la termen in prima zi de viata\*\is done in our country in all newborns in the first day of life
term
B) [x] se face la prematuri la varsta de 2 luni (la externarea din maternitate) \*\ is done on the premature age of 2 months (at
discharge from maternity)
C) [x] se face concomitent cu imunizarea cu imunoglobulina specifica (HBIG) pentru copiii nascuti din mame AgHBs pozitive \*\
is done concomitant with immunization with specific immunoglobulin (HBIG) for children born to HBsAg positive mothers
D) [x] permite continuarea alimentatiei naturale la copiii din mame AgHBs pozitive \*\ allowed continuation natural food to
children of HBsAg positive mothers
E) [ ] este inclusa intre vaccinarile obligatorii ale nou-nascutului chiar si in tarile cu portaj antigenic mic \*\ is included in the
compulsory vaccinations of the newborn even in countries with low antigenic porting
---------------------------------------------------------------------
911. CM p5 [M1131089] In legatura cu sepsis-ul neonatal urmatoarele afirmatii sunt corecte: (134, 135, 136) \*\ In connection
with neonatal sepsis the following statements are correct: (134, 135, 136)
A) [x] Diagnosticul se sustine pe hemocultura pozitiva, in prezenta unor semne clinice sugestive \*\ The diagnosis is supported by
the positive blood cultures in the presence of clinical signs suggestive
B) [x] Un nou nascut cu semne clinice de sepsis si reactanti de faza acuta pozitivi poate fi tratat ca sepsis chiar fara confirmare
bacteriologica, deoarece pozitivarea reactantilor de faza acuta coincide cu bacteriemia \*\ A newborn with clinical signs of sepsis
and positive acute phase reaction can be treated as sepsis even without bacteriological confirmation, since the positive value of
acute phase reactants coincides with bacteraemia
C) [ ] Sepsis-ul neonatal cu debut precoce este de natura nozocomiala \*\ Neonatal Sepsis early debut is of nosocomial nature
D) [ ] Punctia lombara va fi efectuata obligatoriu oricarui nou nascut suspect de sepsis neonatal \*\ lumbar puncture will be made
compulsory for any newborn suspected with neonatal sepsis
E) [x] Prevenirea sepsis-ului neonatal cu streptococ B se face cu penicilina injectabila administrata mamei inainte de nastere \*\
Prevention of neonatal sepsis with site B streptococcus with penicillin injection is administered to the mother before birth of baby
---------------------------------------------------------------------
912. CM p5 Sindromul Gregg intalnit in infectiile perinatale:\*\ Gregg Syndrome met in perinatal infections:
A) [ ] intalnim iridociclita; \*\ we see iridocyclitis;
B) [x] este dat de rubeola; \*\ is given by rubeola;
C) [x] prezenta surditatii face parte din tabloul clinic; \*\ deafness is part of the clinical picture;
D) [ ] nu avem retard mental; \*\ no mental retardation;
E) [ ] Treponema palidum face parte din etiologie. \*\ Treponema palidum part of etiology
---------------------------------------------------------------------
913. CM p5 [M2231193] Care afirmatii referitoare la sepsisul neonatal cu debut tardiv nu sunt valabile: (135) \*\ Which
statements about late-onset neonatal sepsis are not valid:
A) [x] disfunctia organica multipla este neobisnuita; \*\ multiple organic dysfunction is unusual;
B) [ ] interval liber pana la debut mai mare de 5 zile; \*\ free interval until the onset of more than five days;
C) [ ] sunt intotdeauna nozocomiale; \*\ is always nosocomial;
D) [x] nu asociaza soc septic; \*\ does not associate septic shock;
E) [ ] apare mai frecvent la prematuri \*\ is more common in premature
---------------------------------------------------------------------
914. CM p5 [M2231174] Despre sifilisul congenital se poate afirma ca: (144-145) \*\ About congenital syphilis can be said:
A) [x] poate determina rinita unilaterala; \*\ may cause unilateral rhinitis;
B) [x] asociaza hepatosplenomegalie si icter; \*\ associated hepatosplenomegaly and jaundice;
C) [ ] poate determina surditate; \*\ may cause deafness;
D) [x] asociaza osteocondrita si periostita; \*\associate osteocondrita and periostitis;
E) [ ] nu determina afectare osteo-articulara \*\ not cause damage osteo-articular
---------------------------------------------------------------------
915. CM p5 [M1531132] Complicatiile acute ale meningitei bacteriene la nou-nascut pot include: (139) \*\ Complications of
acute bacterial meningitis in the newborn may include:
A) [ ] microcefalia \*\ microcephaly
B) [x] hidrocefalia \*\ hydrocephalus
C) [x] colectia subdurala \*\ subdural collection
D) [x] ventriculita \*\ ventriculita
E) [x] abcesul cerebral \*\ Cerebral abscess
---------------------------------------------------------------------
916. CM p5 Care afirmatii sunt false despre meningita neonatala? (138) \*\ What are false statements about neonatal meningitis?
A) [x] nu este o cauza principala de mortalitate neonatala; \*\ It is not a leading cause of neonatal mortality;
B) [ ] apar tulburari de reglare a temperaturii; \*\ disorders of temperature control occur;
C) [ ] este implicata E. coli tipul K1; \*\ type E. coli K1 is involved;
D) [x] nu sunt obligatorii culturile centrale; \*\ Not mandatory Cultural Central;
E) [x] apare pleiocitoza cu numar crescut de limfocite \*\ appear pleiocytosis with increased number of lymphocytes
---------------------------------------------------------------------

122
917. CM p5 Examenele de laborator care demonstreaza afectarea multisistemica in septicemia neonatala, sunt: (137-138) \*\
Laboratory tests demonstrating impairment in neonatal sepsis multisistemica are:
A) [x] Alterarea homeostaziei l \*\ Altered homeostasis l
B) [x] Tuburari hidroelectrolitice si acidobazice severe; \*\ Tuburari hidroelectrolitice and acid-base severe
C) [x] Hiperbilirubinemie, citoliza \*\ Hyperbilirubinemia, cytolysis
D) [x] Tulburari ale hemostazei \*\ Disorders of hemostasis
E) [ ] Nici una dintre variantele de mai sus \*\ None of the above
---------------------------------------------------------------------
918. CM p5 [M2231134] Despre manifestarile clinice ale sepsisului neonatal se poate afirma: (135) \*\ On the clinical
manifestations of neonatal sepsis can say:
A) [ ] sepsisul cu debut tardiv apare in primele 14 zile; \*\ late-onset sepsis occurs in the first 14 days;
B) [ ] in sepsisul cu debut tardiv apare tahicardie; \*\ in late-onset sepsis occurs tachycardia;
C) [ ] convulsiile apar constant in sepsisul cu debut precoce; \*\ convulsions appear constant occur early onset sepsis;
D) [x] apare meteorism abdominal; \*\ abdominal meteorism appears
E) [x] apare hipotensiune in afara unui sindrom de deshidratare \*\ hypotension occurs outside of a syndrome of dehydration
---------------------------------------------------------------------
919. CM p5 [M2231143] Care afirmatii sunt false despre diagnosticul sepsisului neonatal? (135-136) \*\ What are false
statements about the diagnosis of neonatal sepsis?
A) [ ] doar culturile centrale au valoare pentru sustinerea diagnosticului; \*\ only the central culture have value to support the diagnosis;
B) [x] preferabil hemocultura se recolteaza din cateterul venos central; \*\ blood cultures harvested preferably from the central venous catheter;
C) [ ] cultura pozitiva din LCR sau urocultura au aceeasi semnificatie ca si hemocultura; \*\ positive culture of CSF or urine
culture have the same meaning as blood cultures;
D) [x] un volum de 1 ml de sange nu este suficient pentru hemocultura; \*\ a volume of 1 ml of blood is not enough blood cultures;
E) [ ] examinarea LCR este obligatorie daca se suspecteaza meningita \*\ CSF examination is obligatory if meningitis is suspected
---------------------------------------------------------------------
920. CM p5 Care afirmatii sunt adevarate despre infectia neonatala? (134) \*\ Which statements are true about neonatal infection?
A) [ ] Listeria monocytogenes este caracteristic prezenta in sectiile de prematuri; \*\ Listeria monocytogenes is a characteristic
present in sections of premature;
B) [x] se indica antibioterapie intrapartum daca factorii de risc se cumuleaza; \*\ indicates intrapartum antibiotherapy if risk factors add up;
C) [x] Heamophilus influenzae netipabil poate da infectii transmise vertical; \*\ Heamophilus influenzae netipabil can give
vertically transmitted infections;
D) [x] infectia cu Listeria poate avea o forma tardiva si una cu debut precoce; \*\ Listeria infection can have a late form and an early onset;
E) [ ] infectiile nozocomiale se manifesta in primele 3 zile de viata \*\ Nosocomial infection occurs in the first three days of life
---------------------------------------------------------------------
921. CM p5 Tratamentul oftalmiei gonococice neonatale se face cu: (142) \*\ Treatment in neonatal gonococcal ophthalmopathy
A) [x] Cefotaxim 100 mg/kg/zi; \*\ cefotaxime 100 mg / kg / day;
B) [ ] Cefotaxim 15 mg/kg/zi; \*\ cefotaxime 15 mg / kg / day;
C) [x] Ceftriaxon 125 mg/kg/zi; \*\Ceftriaxone 125 mg / kg / day;
D) [ ] Streptomicina 10 mg/kg/zi; \*\ Streptomycin 10 mg / kg / day;
E) [ ] Trimetoprim 50 mg/kg/zi \*\ Trimethoprim 50 mg / kg / day
---------------------------------------------------------------------
922. CM p5 [M2231155] Care afirmatii sunt adevarate? (139-140) \*\ Which statements are true?
A) [ ] osteomielita neonatala are localizare epifizara; \*\ neonatal osteomyelitis has epifizara location;
B) [x] se indica interventie chirurgicala in caz de ventriculita in meningita neonatala; \*\ surgery indicated in cases of ventriculitis
in neonatal meningitis;
C) [x] otita medie la nou nascut are risc crescut de transformare in otomastoidita; \*\ otitis media to the newborn has an increased
risk of transformation otomastoidita;
D) [x] stafilococul auriu secretor de toxine determina leziuni buloase; \*\ toxin-secreting Staphylococcus aureus cause bullous lesions;
E) [x] omfalita se poate complica cu peritonita \*\ omfalita may be complicated by peritonitis
---------------------------------------------------------------------
923. CM p5 Factori de risc pentru aparitia infectiilor bacteriene perinatale sunt: \*\ Risk factors for perinatal bacterial infections are:
A) [x] ruperea prematura a mebranelor --> cresc riscul de corioamniotita; \*\ Premature rupture of casings -> increased risk of corioamniotita;
B) [ ] metereologici; \*\ metereologici;
C) [ ] astroologici; \*\ astroologici;
D) [x] fetali; \*\ fetali;
E) [x] existenta febrei la gravida in timpul travaliului. \*\ existence of fever in pregnant women during labor
---------------------------------------------------------------------
924. CM p5 [M1131087] Infectia perinatala cu streptococ hemolitic grup B are urmatoarele caracteristici: (pag. 134) \*\
Perinatal infection with haemolytic streptococcus group B has the following characteristics: (p. 134)
A) [ ] Este cea mai frecventa etiologie intalnita in sepsis-ul neonatal tardiv \*\ The most common etiology found in late neonatal sepsis site
B) [x] Este cea mai frecventa etiologie intalnita in sepsis-ul neonatal precoce \*\ The most common etiology found in your early neonatal
sepsis
C) [x] Este favorizata de ruptura prematura a membranelor amniotice \*\ It is favored by premature rupture of amniotic membranes
D) [x] Manifestarea pulmonara impune diagnostic cu detresa respiratorie precoce a noului nascut \*\ lung manifestation imposes

123
diagnosis with early respiratory distress of new born
E) [ ] Este intalnita mai ales la nou nascuti la termen si postmaturi \*\ It is especially common in newborns at term and postmaturi
---------------------------------------------------------------------
925. CM p5 Care afirmatii nu sunt false despre fiziopatologia sepsisului neonatal? (137) \*\ Which statements are NOT false
about the pathophysiology of neonatal sepsis?
A) [ ] TNF activeaza fibrinoliza; \*\ TNF activates fibrinolysis;
B) [ ] proteina C reactiva favorizeaza inflamatia; \*\ C-reactive protein favourises inflammation;
C) [ ] IL6 scade la nou nascutii cu infectie sistemica; \*\ IL6 decreased in newborns with systemic infection;
D) [x] IL1beta activeaza coagularea; \*\ IL1beta activated clotting;
E) [x] trombina stimuleaza factorii proinflamatori \*\ Thrombin stimulates proinflamatori factors
---------------------------------------------------------------------
926. CM p5 [M2231213] Testele care pot identifica infectia cu Treponema pallidum la nou nascut sunt: (145) \*\ The tests that
may identify Treponema pallidum infection to the newborn are:
A) [ ] AAN; \*\ ANA;
B) [x] VDRL; \*\ VDRL;
C) [x] FTA-Abs; \*\ FTA-ABS;
D) [ ] RAST; \*\ RAST;
E) [x] MHA-TP \*\ MHA-TP
---------------------------------------------------------------------
927. CM p5 [M2231197] LCR-ul in meningita neonatala asociaza: (137) \*\ CSF in neonatal meningitis
A) [x] peste 100 celule/mm3; \*\ over 100 cells/mm3;
B) [ ] predominanta limfocitelor; \*\ lymphocyte predominant;
C) [x] predominanta polimorfonuclearelor; \*\ polymorphonuclears predominant;
D) [ ] proteinorahie sub 40 mg \*\ proteinorahie less than 40 mg
E) [x] glicorahie sub 40 mg/dl \*\ glicorahie below 40 mg / dL
---------------------------------------------------------------------
928. CM p5 [M2231167] Despre infectia HIV se pot afirma urmatoarele: (143,144) \*\ About HIV can be stated:
A) [x] transmiterea intrauterina este favorizata de inflamatii ale placentei; \*\ intrauterine transmission is favored by inflammation
of the placenta;
B) [x] prematuritatea este un factor de risc; \*\ prematurity is a risk factor;
C) [x] interzicerea alaptarii poate preveni infectarea dupa nastere; \*\ interdiction breastfeeding may help prevent infection after birth;
D) [x] transmiterea intrapartum se poate face prin transfuzie materno-fetala; \*\ intrapartum transmission can be achieved by
maternal-fetal transfusion;
E) [ ] HIV-ARN PCR exprima incarcatura virala intracelulara \*\ HIV RNA PCR viral load expressed intracellular
---------------------------------------------------------------------
929. CM p5 Care afirmatii sunt adevarate despre sepsisul neonatal? (140-141) \*\ Which statements are true about neonatal sepsis?
A) [x] oftalmia gonococica poate conduce la cheratita si orbire; \*\ Ophthalmic and gonococcal keratitis can lead to blindness;
B) [x] Stafilococul aureu este agentul ''clasic'' al osteomielitei neonatale; \*\ Staphylococcus aureus is classic agent of neonatal osteomyelitis;
C) [ ] gonococul poate determina endoftalmie necrozanta; \*\ gonorrhea can cause necrotizing endophthalmitis;
D) [x] Cefotaximul este cel mai utilizat antibiotic la nou nascut; \*\ Cefotaxim is most commonly used antibiotics in the newborn;
E) [ ] otita medie supurata poate fi determinata de streptococul hemolitic de grup B \*\ otitis media with effusion may be caused
by hemolytic streptococcus group B
---------------------------------------------------------------------
930. CM p5 Printre criteriile de risc septic la nou-nascut se numara: (137) \*\ The septic risk criteria in the newborn include:
A) [x] Raportul leucocitar > 0,2 \*\ leukocyte ratio> 0.2
B) [x] Leucocite < 5 000/mm3 \*\ leukocytes <5 000/mm3
C) [x] VSH >15 mm/ora \*\ ESR> 15 mm / hour
D) [x] Cresterea nivelului de haptoglobina \*\ Increasing the level of haptoglobin
E) [ ] Nici una din variantele de mai sus \*\ None of the above options
---------------------------------------------------------------------
931. CS p4 Cea mai frecventa cauta a colitei hemoragice este: (349) \*\ The most frequent search of hemorrhagic colitis is:
A) [ ] E Coli enteropatogen \*\ E. coli enteropathogens
B) [ ] E Coli enterotoxigen \*\ E. coli enterotoxigen
C) [x] E Coli enterohemoragic \*\ E. coli enterohaemorrhagic
D) [ ] E Coli enteroadeziv \*\ E. coli enteroadeziv
E) [ ] E Coli enteroinvaziv \*\ E. coli enteroinvaziv
---------------------------------------------------------------------
932. CS p4 Care etiologie virala este mai des intalnita in diareea acuta: (349) \*\ What is the most common viral etiology in acute diarrhea
A) [ ] adenovirusul; \*\ adenovirus;
B) [ ] picornavirusul; \*\ picornavirusul;
C) [x] rotavirusul; \*\ Rotavirus;
D) [ ] parainfluenzae tip B; \*\ parainfluenzae type B;
E) [ ] parainfluenzae tip A; \*\ parainfluenzae type A;

124
---------------------------------------------------------------------
933. CS p4 Tratamentul dietetic al diareii acute care evolueaza la un sugar de 3 luni alimentat artificial se face in felul urmator, cu
o singura exceptie: (354, 355) \*\ Dietary treatment of acute diarrhea that develops in an artificially fed infant of three months is
as follows, with one exception
A) [x] Continuarea alimentatiei anterioara imbolnavirii \*\ Continuation of previous food
B) [ ] Solutii orale de rehidratare orala (gesol) \*\ oral rehydration solutions Oral (gesol)
C) [ ] Dieta de tranzitie cu supa de morcov \*\ transition diet of carrot soup
D) [ ] Realimentarea progresiva cu lapte delactozat \*\ gradually recharge delactosed milk
E) [ ] Realimentarea progresiva cu lapte de soia daca se suspecteaza alergie la proteinele laptelui de vaca \*\ Progressive recharge
with soy milk if suspected cow's milk protein allergy
---------------------------------------------------------------------
934. CS p4 [M1132014] Urmatoarele afirmatii in legatura cu fiziopatologia diareii acute sunt corecte, in afara de: (pag. 351) \*\
The following statements about the pathophysiology of acute diarrhea are correct, except:
A) [ ] Accelerarea peristaltismului intestinal limiteaza absorbtia apei si electrolitilor din lumen \*\ Increased peristalsis, limit
absorption of water and electrolytes in the lumen
B) [ ] E interferat procesul de transport celular activ pt apa si sodiu \*\ It interferes with active cellular transport process for water and sodium
C) [ ] Lichidele pierdute pe cale digestiva sunt izotone \*\ digestive fluids which are lost are isotonic
D) [x] Este tulburata in special digestia proteinelor \*\ It especially disturbes protein digestion
E) [ ] Activitatea dizaharidelor intestinale este scazuta \*\ There is a low activity of intestinal disaccharides
---------------------------------------------------------------------
935. CS p4 [M1132016] Urmatoarele afirmatii in legatura cu diareea acuta sunt corecte, in afara de: (349) \*\ The following
statements about acute diarrhea are correct, except:
A) [ ] Diareea acuta de etiologie infectioasa se transmite pe cale fecal/orala \*\ Unexplained Acute infectious diarrhea is
transmitted by fecal / oral route
B) [x] Diareile acute de etiologie virala nu asociaza sindrom de deshidratare acuta \*\ viral etiology of acute diarrheal syndrome is
associated with acute dehydration
C) [ ] in diareile acute de etiologie virala, rotavirusul este cel mai frecvent intalnit \*\ the viral etiology of acute diarrhea,
Rotavirus is the most frequently encountered
D) [ ] Rotavirusul este un important agent nozocomial \*\ Rotavirus is a major agent of nosocomial
E) [ ] Rotavirusul este responsabil de diareile acute contactate in spital in timpul sezonului rece \*\ Rotavirus is responsible for
acute diarrheal encountered in the hospital during the cold season
---------------------------------------------------------------------
936. CS p4 [M1332025] Solutia (Gesol) folosita pentru rehidratare orala in diareea acuta contine urmatorii compusi cu
EXCEPTIA: (354) \*\ Solution (Gesol) used for oral rehydration in acute diarrhea contains the following compounds except:
A) [ ] NaCl \*\ NaCl \*\
B) [ ] Bicarbonat de Sodiu \*\ sodium bicarbonate
C) [ ] KCl \*\ KCl
D) [x] Carbonat de Calciu \*\ calcium carbonate
E) [ ] Glucoza \*\ Glucose
---------------------------------------------------------------------
937. CS p4 Urmatoarele mecanisme de aparare ale gazdei impotriva agentilor patogeni ai diareei acute sunt adevarate, cu
EXCEPTIA: (349) \*\ The following mechanisms of host defense against pathogens of acute diarrhea are true, except:
A) [ ] Aciditate gastrica \*\ gastric acid
B) [ ] Secretie locala adecvata de IgA secretor \*\ Secretion of appropriate local secretory IgA
C) [ ] Motilitatea intestinala \*\ intestinal motility
D) [x] Stimularea adenilciclazei enterocitare \*\ Stimulation enterocytic adenocyclase
E) [ ] Microflora saprofita intestinala \*\ saprophytic intestinal microflora
---------------------------------------------------------------------
938. CS p4 Mentionati carui tip de E Coli apartine serotipul 157 H 7 (349) \*\ Mention the type of which E. coli serotype 157
belongs to H 7
A) [ ] enteropatogen \*\ enteropathogens
B) [ ] enterotoxigen \*\ enterotoxigen
C) [ ] enteroinvaziv \*\ enteroinvaziv
D) [x] enterohemoragic \*\ enterohaemorrhagic
E) [ ] enteroadeziv \*\ enteroadeziv
---------------------------------------------------------------------
939. CM p5 [M2532226] Mecanismul de aderenta in producerea bolii diareice acute este specific urmatorilor germeni: (351) \*\
Bonding mechanism in producing acute diarrheal disease is specific germ next
A) [ ] Shigella \*\ Shigella
B) [x] E Coli enteropatogen \*\ E. coli enteropathogens
C) [x] E Coli enterohemoragic \*\ E. coli enterohaemorrhagic
D) [ ] Salmonella \*\ Salmonella
E) [ ] Vibrio cholerae \*\ Vibrio cholerae

125
---------------------------------------------------------------------
940. CM p5 [M2232200] Care afirmatii sunt adevarate despre semnele clinice din diareea acuta la copil? (352) \*\ Which
statements are true about the clinical signs of acute diarrhea in children?
A) [ ] diareile cu enteroinvazivi nu se insotesc de febra; \*\ not enteroinvazivi diarrhea accompanied by fever;
B) [x] infectia dizenterica asociaza tenesme si modificare a tonusului anal; \*\ infection and dysentery associated tenesme
modified anal tone;
C) [x] pot aparE Colici, manifestate prin agitatie; \*\ colic may occur, manifested by agitation;
D) [ ] diareea cu rotavirus apare fara prodroame; \*\ rotavirus diarrhea occurs without prodroame;
E) [x] apare anorexie \*\ is anorexia
---------------------------------------------------------------------
941. CM p5 [M1232103] Dintre antibioticele recomandate in gastroenterita cu Shigella la copil fac parte: (356) \*\ The
recommended antibiotics with Shigella gastroenteritis in children include:
A) [x] Ampicilina \*\ Ampicillin
B) [ ] Eritromicina \*\ Erythromycin \*\
C) [ ] Tetraciclina \*\ Tetracycline
D) [ ] Metronidazolul \*\ Metronidazole
E) [x] Acidul nalidixic \*\ nalidixic acid
---------------------------------------------------------------------
942. CM p5 [M2232194] Care medicatie este indicata in shigelloze? (356) \*\ What medication is indicated in shigelloze?
A) [ ] Metronidazol; \*\ Metronidazole;
B) [x] Biseptol; \*\ Biseptol;
C) [x] floroquinolone; \*\ floroquinolone;
D) [x] Ampicilina; \*\ Ampicillin;
E) [ ] Tetraciclina \*\ Tetracycline
---------------------------------------------------------------------
943. CM p5 [M2232184] Care afirmatii sunt false? (pag. 351) \*\ What statements are false?
A) [ ] shiga-toxina poate determina convulsii; \*\ Shiga-toxin can cause seizures;
B) [ ] citotoxinele actioneaza asupra unor mediatori ai inflamatiei; \*\ citotoxinele act on mediators of inflammation;
C) [x] Campylobacter pylori actioneaza prin mecanism citotoxic; \*\ cytotoxic mechanism works by Campylobacter pylori;
D) [ ] E Coli enterohemoragic actioneaza prin mecanism citotoxic; \*\ E. coli enterohaemorrhagic works by cytotoxic mechanism;
E) [x] Shigella, cel mai tipic agent citotoxic, este capabila sa actioneze si prin aderenta \*\ Shigella, the most typical cytotoxic
agent, is able to act in adherence
---------------------------------------------------------------------
944. CM p5 Etiologia infectioasa a bolii diareice acute poate fi suspectata in urmatoarele situatii:(348) \*\ Infectious etiology of
acute diarrheal disease may be suspected in the following situations:
A) [x] Diareile din cresa; \*\ Diarrhea in day care;
B) [x] Diareile aparute in alte colectivitati de sugari; \*\ diarrhea occurred in other collectivities of infants;
C) [x] Diareile nosocomiale; \*\ Nosocomial diarrhea;
D) [x] Diareile aparute in familii cu nivel socio-cultural scazut; \*\ diarrhea occurred in families with lower socio-cultural level;
E) [ ] Diareile aparute la schimbarea preparatului de lapte \*\ diarrhea appeared to change the milk preparation
---------------------------------------------------------------------
945. CM p5 [M1232099] In boala diareica acuta urmatorii agenti etiologici survin endemic: (348) \*\ The etiological agents
following acute diarrheal disease endemic occur
A) [x] rotavirus \*\ Rotavirus
B) [x] calicivirus \*\ calicivirus
C) [x] astrovirus \*\ astrovirus
D) [ ] coronavirus \*\ Coronavirus \*\
E) [ ] rinovirus \*\ rhinovirus \*\
---------------------------------------------------------------------
946. CM p5 Produsele dietetice avand la baza proteinele din lapte sunt: (357) \*\ Dietetic products based on milk proteins are:
A) [x] Humana H \*\ Human H
B) [x] Humana H + MCT \*\ Human H + MCT
C) [x] Milupa HN 25 \*\ Milupa HN 25
D) [ ] Milupa 2 \*\ Milupa 2
E) [x] Morinaga NL 33 \*\ 33 NL Morinaga
---------------------------------------------------------------------
947. CM p5 [M2532236] Medicamentele antidiareice actioneaza prin: (355) \*\ Antidiaretic drugs work by (355)
A) [x] Ameliorarea motilitatii intestinale \*\ Improving intestinal motility
B) [x] Ameliorarea microflorei intestinale \*\ Improving the intestinal microflora
C) [x] Adsorbtie \*\ Absorption
D) [x] Scaderea secretiei intestinale \*\ decrease intestinal secretion
E) [ ] Cresterea rezistentei organismului la infectii \*\ Increased resistance to infection
---------------------------------------------------------------------

126
948. CM p5 [M2232168] Pierderile usoare de lichide se vor corecta dupa principiile: (354) \*\ Slight loss of liquid will be correct
by the following principles:
A) [x] vor fi inlocuite in primele 4 ore; \*\ will be replaced in the first 4:00;
B) [ ] vor fi inlocuite in primele 10 ore; \*\ will be replaced in the first 10 hours;
C) [x] cantitatea pentru sugar va fi de 50 ml/kg; \*\ amount for child will be 50 ml / kg;
D) [ ] cantitatea pentru sugar va fi de 200 ml/kg; \*\ amount for child will be 200 ml / kg;
E) [x] daca nu varsa se folosesc solutii orale de rehidratare \*\ if you do not pour used oral rehydration solutions
---------------------------------------------------------------------
949. CM p5 [M2232181] Care afirmatii sunt adevarate referitor la mecanismul diareei prin germeni enteroinvazivi? (350) \*\
Which statements are true regarding the mechanism by germs enteroinvazivi diarrhea?
A) [ ] germenul prolifereaza strict la nivelul intestinului subtire; \*\ proliferating germ strictly in the small intestine;
B) [x] forteaza enterocitul sa treaca la endocitoza si sa inglobeze germenul; \*\ enterocitul forces to go to endocitoza and encompassing germ;
C) [x] este necesara adeziunea germenilor prin fimbrii sau pili; \*\ is required by fimbriata or pili adherence germs;
D) [x] microorganismul se multiplica in enterocit; \*\ organism multiplies in the enterocytes;
E) [x] apare hiperemie, edem si exsudat intraluminal \*\ is redness, swelling and intraluminal exudate
---------------------------------------------------------------------
950. CM p5 [M1132091] Urmatorii factori sunt considerati protectori pentru a evita aparitia diareii la sugar: (351) \*\ The
following factors are considered to prevent the occurrence of diarrhea in infants:
A) [x] Alimentatia naturala \*\ The natural diet
B) [x] Starea buna de nutritie \*\ good nutrition
C) [ ] Vaccinari obligatorii efectuate la timp \*\ mandatory vaccinations carried out on time
D) [ ] Administrarea zilnica de vitamina D oral \*\ Oral administration of vitamin D daily
E) [ ] Administrarea periodica de vitamine \*\ Administration of vitamin Periodicals
---------------------------------------------------------------------
951. CM p5 [M2232167] In deshidratarea severa sunt prezente: (353) \*\ In severe dehydration these symptoms are present: A)
[x] ochi incercanati; \*\ ringed eye;
B) [x] tegumente uscate; \*\ dry skin;
C) [ ] poliurie; \*\ polyuria;
D) [x] sete vie; \*\ thirsty come;
E) [x] scadere in greutate \*\ weight loss
---------------------------------------------------------------------
952. CM p5 Care din urmatoarele afirmatii nu reprezinta semne si simptome ale bolii diareice acute: (352) \*\ Which of these
statements are not signs and symptoms of acute diarrheal disease
A) [ ] scaune diareice \*\ diarrhea
B) [ ] colici intestinale \*\ intestinal colic
C) [x] apetit exagerat \*\ excessive appetite
D) [ ] varsaturi \*\ vomiting
E) [x] scaune steatoreice \*\ Seat steatorrhea
---------------------------------------------------------------------
953. CM p5 [M1432121] Boala diareica acuta cu Clostridium Dificile este sensibila la urmatoarele antibiotice, in afara de: (356)
\*\ Acute diarrheal disease with Clostridium Difficult is sensitive to these antibiotics, except for:
A) [x] Ampicilina \*\ Ampicillin
B) [x] Cefotaxim \*\ cefotaxime
C) [ ] Vancomiciyne \*\ Vancomiciyne
D) [x] Gentamicina \*\ Gentamicin
E) [ ] Metronidazol \*\ Metronidazole
---------------------------------------------------------------------
954. CM p5 Mentionati bacteriile care nu produc diaree prin enteroaderenta: (351) \*\ Mention bacteria which cause diarrhea by
enteroaderenta:
A) [x] Vibrio cholerae; \*\ Vibrio cholerae;
B) [x] Shigella; \*\ Shigella;
C) [x] E Coli enteroinvaziv; \*\ E. coli enteroinvaziv;
D) [ ] E Coli enteropatogen; \*\ E. coli enteropathogens;
E) [ ] E Coli enterohemoragic \*\ E. coli enterohaemorrhagic
---------------------------------------------------------------------
955. CM p5 Care bacterii pot produce diaree atat prin mecanismul citotoxic cat si de enteroaderenta? (351) \*\ So bacteria can
cause diarrhea and cytotoxic mechanism of enteroaderenta?
A) [ ] Clostridium difficile; \*\ Clostridium difficile;
B) [ ] Salmonella; \*\ Salmonella;
C) [ ] Vibrio cholerae; \*\ Vibrio cholerae;
D) [x] E Coli enteropatogen; \*\ E. coli enteropathogens;
E) [x] E Coli enterohemoragic \*\ E. coli enterohaemorrhagic
---------------------------------------------------------------------

127
956. CM p5 [M2532233] Solutia electrolitica de rehidratare orala contine urmatorii compusi: (354) \*\ Oral rehydration
electrolyte solution containing the following compounds:
A) [x] KCl \*\ KCl
B) [x] NaCl \*\ NaCl
C) [ ] Bicarbonat de calciu \*\ calcium bicarbonate
D) [x] Bicarbonat de sodiu \*\ Sodium bicarbonate
E) [x] Glucoza \*\ Glucose
---------------------------------------------------------------------
957. CM p5 Agentii etiologici bacterieni ai diareilor se transmit: (348) \*\ Bacterial etiologic agents of diarrheal be transmitted:
A) [ ] pe cale aerica; \*\ about aerica;
B) [x] pe cale fecal-orala; \*\ the fecal-oral route;
C) [x] alimente contaminate; \*\ contaminated food;
D) [ ] pe cale hematogena; \*\ by marrow;
E) [x] apa contaminata \*\ contaminated water
---------------------------------------------------------------------
958. CM p5 [M2232183] Care afirmatii sunt adevarate despre mecanismul citotoxic de producere a diareei? (350) \*\ Which
statements are true about the cytotoxic mechanism of production of diarrhea?
A) [x] citotoxinele pot produce moartea celulei; \*\ citotoxinele can cause cell death;
B) [ ] cel mai tipic agent bacterian care actioneaza prin acest mecanism este Salmonella; \*\ the most typical bacterial agent that
acts by this mechanism is Salmonella;
C) [ ] shiga-toxina este stimulatoare a sintezei de proteine; \*\ Shiga-toxin is stimulating protein synthesis;
D) [ ] Vibrio cholerae actioneaza prin acest mecanism; \*\ Vibrio cholerae act through this mechanism;
E) [x] shiga-toxina este secretogena \*\ Shiga-toxin is secretogena
---------------------------------------------------------------------
959. CM p5 [M1132095] Urmatoarele antibiotice sunt recomandabile in tratamentul diareilor acute bacteriene: (356) \*\ The
following antibiotics are recommended in the treatment of acute bacterial diarrhea
A) [x] Ampicilina \*\ Ampicillin
B) [x] Cloramfenicol \*\ Chloramphenicol
C) [ ] Penicilina \*\ Penicillin
D) [ ] Oxacilina \*\ Oxacilline
E) [x] Acid nalidixic \*\ nalidixic acid
---------------------------------------------------------------------
960. CM p5 [M2232188] Care afirmatii sunt adevarate despre E Coli enterohemoragic? (351) \*\ Which statements are true about
enterohaemorrhagic E. coli?
A) [ ] toxina are o fractiune termostabila; \*\ toxin is thermostable fraction;
B) [ ] poate actiona prin mecanism invaziv; \*\ The mechanism may act through invasive;
C) [x] tipul O157 H7 este cauza colitei hemoragice; \*\ type O157 H7 causes hemorrhagic colitis;
D) [x] poate actiona prin mecanism citotoxic; \*\ cytotoxic mechanism may act through;
E) [ ] poate actiona prin mecanism toxigenic \*\ The mechanism may act by toxigenic
---------------------------------------------------------------------
961. CS p4 [CS33036] Caile de invadare a parenchimului pulmonar sunt urmatoarele cu o exceptie: (199) \*\ Ways of invasion of
lung parenchyma with one exception are the following:
A) [ ] aerogen \*\ airborne
B) [ ] hemetogen \*\ hemetogen
C) [ ] iatrogen prin bronhoscopie \*\ iatrogenic by bronchoscopy
D) [ ] prin plagi penetrante \*\ by penetrating wounds
E) [x] limfatic \*\ Lymph
---------------------------------------------------------------------
962. CS p4 [CS33030] Faringita streptococica dureaza: (pg 173) \*\ strep throat lasts:
A) [ ]1-4 zile \*\ 1-4 days
B) [x]7-10 zile \*\ 7-10 days
C) [ ]2-5 zile\*\ 2-5 days
D) [ ]4-8 zile \*\ 4-8 days
E) [ ]4-8 saptamani \*\ 4-8 weeks
---------------------------------------------------------------------
963. CS p4 [CS33014] In etiologia epiglotitei este implicat in 95% din cazuri urmatorul germene: (Pg. 177)\*\ epiglotitei etiology
is involved in 95% of germ following:
A) [ ] Streptococul beta hemolitic\*\ beta-hemolytic Streptococcus
B) [ ] Pneumococul\*\ pneumococcus
C) [ ] Haemophilus influenzae tip A\*\ Haemophilus influenzae type
D) [ ] Stafilococul\*\ Staphylococcus
E) [x] Haemophilus influenzae tip B\*\ Haemophilus influenzae type B
---------------------------------------------------------------------

128
964. CS p4 [CS33015] Prioritatea terapeutica absoluta in fata evidentei epiglotitei consta in : (Pg. 178)\*\ Therapeutic absolute
priority before epiglotitei record consists of:
A) [ ]Antibioterapie\*\ antibiotic
B) [ ]Corticoterapie administrata i\*\corticotherapy administered and
C) [x]Restabilirea permeabilitatii cailor aeriene\*\Restoring airway permeability
D) [ ]Oxigenoterapia\*\oxygen
E) [ ]Aerosoli cu epinefrina racemica\*\racemic epinephrine aerosol
---------------------------------------------------------------------
965. CS p4 [CS33076] Examenele de laborator in pneumonia stafilococica la copil evidentiaza: (pag 215) \*\ Laboratory
examinations in staphylococcal pneumonia in children highlights:
A) [ ] Anemia hipercroma \*\ Anemia dark
B) [x] Devierea la stanga a formulei leucocitare \*\ deviation to the left of the leucocyte formula
C) [ ] Proteina negativa \*\ negative protein
D) [ ] Fibrinogen seric scazut \*\ Fibrinogen decreased serum
E) [ ] VSH normal \*\ Normal ESR
---------------------------------------------------------------------
966. CS p4 [CS33052] Obstructia cailor aeriene superioare la copil in etajul subglotic produce: (pg 178) \*\ Airway obstruction in
children occur in the floor subglotic
A) [ ] disfagie \*\ dysphagia
B) [ ] pozitie ridicata in sezut \*\ sitting upright
C) [ ] trismus \*\ Lockjaw
D) [ ] voce capitonata \*\ Voice upper segment
E) [x] febra 38 grade \*\ 38 degrees fever
---------------------------------------------------------------------
967. CS p4 [CS33016] Afirmatia falsa despre obstructia inflamatorie a laringelui este : (pg 177)\*\ False statement about
inflammatory obstruction of the larynx is:
A) [ ]crupul se caracterizeaza prin tuse, voce ragustita, stridor\*\ The croup is characterized by coughing, ragustita voice, stridor
B) [ ]sridorul care se modifica o data cu pozitia capului si gitului sugereaza leziune supraglotica\*\sridorul which change position
once the head and neck injury suggests supraglotica
C) [x]leziunile obstruante supraglotice determina de obicei un stridor mai accentuat in timpul plinsului si diminuat pin ala
disparitie in timpul somnului\*\lesions blocked supraglotice cause stridor usually stronger during that one pin fell weeping and
disappearance during sleep
D) [ ]crupul poate fi insotit de semne de insuf resp acuta de tip obstructiv superior\*\croup may be accompanied by signs of acute
resp inspire higher obstructive type
E) [ ]susceptibilitatea virstelor mici la obstructie laringiana rezulta din dimensiunile reduse ale laringelui\*\ Small ages
susceptibility to laryngeal obstruction resulting from the reduced size of the larynx
---------------------------------------------------------------------
968. CS p4 Sistemul pediatric in scor radiologic nu foloseste in pneumonii: (201)\*\ pediatric scoring system does not use in
radiological pneumonia
A) [ ]Infiltrate pulmonare\*\pulmonary infiltrates
B) [ ]Pleurezie\*\ Pleurisy
C) [ ]Pneumatocele\*\ Pneumatocele
D) [ ]Atelectaziie \*\ Atelectaziie
E) [x]Pneumotorax\*\ Pneumothorax
---------------------------------------------------------------------
969. CM p5 [CM33153] Diagnosticul diferential al pneumoniei pneumococice la copilul mare se face cu urmatoarele: \*\
Differential Diagnosis of pneumococcal pneumonia in children than it is with these:
A) [x] atelectazia \*\ atelectasis
B) [x] aspirarea de corp strain \*\ Foreign body aspiration
C) [x] abces pulmonar \*\ Lung abscess
D) [ ] bronsiolita \*\ bronchiolitis
E) [x] TBC pulmonara cu suprainfectie bacteriana \*\ pulmonary tuberculosis with bacterial superinfection
---------------------------------------------------------------------
970. CM p5 [CM33031] Pneumoniile atipice au urmatoarele caracteristici clinice si paraclinice : (pg 194) \*\ Have atypical
pneumonia following clinical and laboratory features:
A) [ ] febra > 40 C \*\ fever> 40 C
B) [ ] examen fizic pulmonar cu modificari specifice \*\ lung physical examination with specific changes
C) [x] sunt produse de agenti etiologici nebacterieni \*\ etiologic agents produced nebacterieni
D) [x] radiografia pleuro-pulmonara arata afectarea insterstitu \*\ X-rays show damage insterstitu pleuro-pulmonary
E) [x] prezinta tuse si tahipnee \*\ shows cough and tachypnea
---------------------------------------------------------------------

129
971. CM p5 [CM33040] In etiologia crupului viral, virusurile care acopera 2/3 din cazuri sunt: (Pg. 179) \*\ The etiology of viral
croup viruses that covers two thirds of cases are:
A) [x] Virusuri paragripale \*\ Viruses paragripale
B) [ ] Rhinovirusuri \*\ Rhinovirusuri
C) [ ] Virusul gripal \*\ influenza virus
D) [ ] Virusul rujeolic \*\ Measles virus
E) [x] Adenovirusul \*\ Adenovirus
---------------------------------------------------------------------
972. CM p5 Complicatiile pneumoniei pneumococice la copil sunt:(208)\*\Pneumococcal pneumonia complications in children are:
A) [x] Pleurezia pneumococica \*\ Pleurisy pneumococcal
B) [x] Meningita pneumococica \*\ pneumococcal meningitis
C) [x] Pericardita pneumococica \*\ pneumococcal pericarditis
D) [ ] Pielonefrita pneumococica \*\ Pyelonephritis pneumococcal
E) [ ] Cistita pmeumococica \*\ Cystitis pmeumococica
---------------------------------------------------------------------
973. CM p5 Constituie semne sau simptome de obstructie supraglotica: (180) \*\ Are signs or symptoms of obstruction supraglotica:
A) [x] Disfagie \*\ Dysphagia
B) [ ] Tuse ''latratoare'' bitonala \*\ Cough "barking" bitonic
C) [x] Febra mare \*\ high fever
D) [x] Trismus \*\ Lockjaw
E) [ ] Voce ragusita aspra \*\ rough hoarse voice
---------------------------------------------------------------------
974. CM p5 [CM33034] Sugarul cu pneumonie determinata de Chlamydia poate prezenta: (196) \*\ Infants caused by Chlamydia
pneumonia may present:
A) [ ] Stare generala extrem de grava \*\ The general condition very grave
B) [ ] Febra peste 39C \*\ fever over 39 C
C) [x] Conjunctivita rebela la terapia clasica \*\ conjunctivitis therapy Rebel Classic
D) [x] Crize paroxistice de tuse \*\ Depression paroxysmal cough
E) [x] Crize de apnee \*\ Depression apnea
---------------------------------------------------------------------
975. CM p5 [CM33095] Incidentele si accidentele toracocentezei pot fi: (218) \*\ Incidents and accidents thoracentesis may be:
A) [x] Punctionarea plamanului cu hemoragie consecutiva \*\ puncturing lung with consecutive bleeding
B) [x] Hemoragie intercostala prin ranirea pachetului vasculo-nervos \*\ bleeding from intercostal nerve injury-Vascular package
C) [ ] Emfizem cutanat, daca lumenul acului este prea mic si nu permite evacuarea eficienta a aerului pleural aflat sub presiune \*\
Emphysema skin, if lumen needle is too small and does not allow escape of air under pressure pleural
D) [x] Traumatizarea ficatului \*\ liver trauma
E) [x] Traumatizarea cordului \*\ cord trauma
---------------------------------------------------------------------
976. CM p5 [CM33199] Alegeti variantele corecte in pneumonia pneumococica la copil: (202) \*\ Choose the right ones in
pneumococcal pneumonia in children
A) [x] Propagarea procesului pneumonic se limiteaza la un lobul sau lob pulmonar,putand fi intalnita si diseminarea hematogena
\*\ The propagation process is limited to one lung lobe or lung lobe, can be seen and dissemination marrow
B) [x] Hemoculturile se pozitiveaza in 20-30% din cazuri \*\ blood cultures are pozitiveaza in 20-30% of cases
C) [ ] Gradul de suspiciune pt. bacteriemia pneumococica creste daca varsta copilului e intre 6-24 luni,leucocitoza e
>15.000/mm3 si febra >39 grade, chiar daca copilul nu pare grav bolnav \*\degree of suspicion for. pneumococcal bacteraemia
increased if the child is between 6-24 months old, leukocytosis is> 15.000/mm3 and fever> 39 degrees, even if your child seems seriously ill
D) [ ] Pleurezia si pericardita pneumococica se caracterizeaza printr-un lichid seros,cu cantitate mica de fibrina \*\ Pneumococcal
pleurisy and pericarditis is characterized by a serous fluid, with small amount of fibrin
E) [x] Bacteriemia e tranzitorie si se remite rapid sub tratament \*\ bacteraemia is transient and resolves quickly with treatment
---------------------------------------------------------------------
977. CM p5 [CM33070] Protocolul de investigatii in bronsiolita acuta la copil cuprinde: (191) \*\ Protocol investigations in acute
bronchiolitis in children include:
A) [x] hemoleucograma \*\ blood count
B) [x] radiografia toracica \*\ radiography toracal \*\
C) [x] izolarea virusului prin tehnica PCR \*\ isolation of virus by PCR
D) [ ] bronhoscopie \*\ bronchoscopy
E) [ ] toracotomie \*\ thoracotomy
---------------------------------------------------------------------
978. CM p5 [CM33080] Criterii de diferentiere intre etiologia bacteriana si cea virala in infectiile respiratorii la copil pot fi: (186)
\*\ Criteria for the differentiation between bacterial and viral etiology of respiratory infections in children may be:
A) [ ] Radiografia permite diferentierea clara \*\ X-rays allow clear differentiation
B) [ ] Asocierea conjunctivitei si a wheezingului pledeaza pentru etiologie bacteriana \*\ The combination of conjunctivitis and
bacterial etiology of wheezing advocates

130
C) [ ] Complicarea cu otita sugereaza etiologia virala \*\ Complicating otitis suggests viral etiology
D) [x] Asocierea conjunctivitei si a wheezingului pledeaza pentru etiologie virala \*\ Pair plead for conjunctivitis and wheezing viral etiology
E) [x] Complicarea cu otita sugereaza etiologie bacteriana \*\ Complicating bacterial etiology suggests otitis
---------------------------------------------------------------------
979. CM p5 Tratamentul pneumoniei stafilococice la copil include: (216) \*\ Treatment of staphylococcal pneumonia in children include:
A) [x] Tratament antibiotic \*\ antibiotic treatment
B) [x] Drenarea colectiilor purulente \*\ drain purulent collections
C) [x] Oxigenoterapie \*\ oxygen
D) [x] Reechilibrare hidro-electrolitica \*\ fluid and electrolyte rebalancing
E) [ ] Tonice cardiace \*\ Cardiac Tonic
---------------------------------------------------------------------
980. CM p5 [CM33202] Cele mai noi medicamente folosite in tratamentul infectiei cu Pneumocystis carinii la bolnavii cu SIDA
sunt:\*\ Most new drugs used to treat Pneumocystis carinii infection in patients with AIDS are:
A) [ ] trimetraxatul \*\ trimetraxatul
B) [ ] piritreximul \*\ piritreximul
C) [x] difluorometil ornitina \*\ difluorometil ornithine
D) [x] dapson+protoxalt de fier \*\ dapsone + protoxalt iron
E) [ ] cotrimoxazolul si pentamidina \*\ trimoxazole is warranted, and pentamidine
---------------------------------------------------------------------
981. CM p5 [CM33206] Dintre efectele adverse ale pentamidinei se citeaza: () \*\ The adverse effects of pentamidine are cited: ()
A) [x] afectarea functiei renale \*\ impaired renal function
B) [x] anomalii ale functiei hepatice \*\ abnormal liver function
C) [x] hipoglicemie \*\ hypo
D) [x] tulburari hematologice \*\ Blood
E) [ ] inhibarea dihidrofolatreductazei \*\ inhibition dihidrofolatreductazei
---------------------------------------------------------------------
982. CM p5 [CM33188] Criteriile pentru ventilatia artificiala in crupul viral la copil sunt: (pag. 182) \*\ Criteria for artificial
ventilation of viral croup in children are:
A) [x] Cianoza \*\ cyanosis
B) [ ] PaO2 > 50 mmHg \*\ PaO2> 50 mmHg
C) [ ] PaCO2 < 50 mmHg \*\ PaCO2 <50 mmHg
D) [x] Tahicardie, tahipnee \*\ Tachycardia, tachypnea
E) [x] Tulburari ale constientei \*\ Disorders of Consciousness
---------------------------------------------------------------------
983. CM p5 [CM33083] Pot constitui manifestari clinice de bronsiolita: (191) \*\ May be clinical manifestations of bronchiolitis:
A) [ ] Submatitate pulmonara difuza \*\ diffuse pulmonary Submatitate
B) [x] Wheezing \*\ wheezing
C) [x] Polipnee \*\ Polipnee
D) [x] Cianoza \*\ cyanosis
E) [x] Dilatarea aripilor nasului \*\ Dilatation nose wings
---------------------------------------------------------------------
984. CM p5 [CM33001] In laringita acuta subglotica se intalneste: (179) \*\ In acute laryngitis subglotica meets:
A) [ ] Fenomene de insuficienta respiratory de tip obstructive inferior \*\ The phenomena of lower obstructive type respiratory failure
B) [x] Tuse aspra , latratoare \*\ Cough harsh, barking
C) [x] Disfagie e absenta \*\ Dysphagia is absent
D) [ ] Murmurul vesicular nu e diminuat bilateral \*\ is not diminished bilateral vesicular murmur
E) [x] Edemul inflamator al corzilor vocale \*\ inflammatory edema of vocal cords
---------------------------------------------------------------------
985. CM p5 [CM33122] Despre epiglotita la copil se poate afirma: (177) \*\ About epiglottitis in children can say:
A) [x] Este o mare urgenta pediatrica \*\ A large pediatric emergency
B) [ ] 80% din cazurile de epiglotita au ca agent patogen Streptococus pneumoniae \*\ 80% of cases of epiglottitis are pneumoniae
pathogen Streptococus
C) [x] 95% din cazurile de epiglotita sunt determinate de H \*\ 95% of cases of epiglottitis are caused by H
D) [x] Asociaza sialoree cu stridor \*\ Associate sialoree with stridor
E) [x] Are frecventa maxima intre 2 si 7 ani \*\ Does the maximum frequency between 2 and 7 years
---------------------------------------------------------------------
986. CM p5 [CM33106] Cauze rare de pneumonie la copil: (pag186) \*\ Rare cases of pneumonia in children (pag186)
A) [x] virusul varicelo-zosterian \*\ The varicella-zoster virus
B) [ ] rhinovirusul \*\ rhinovirusul
C) [x] legionella \*\ Legionella
D) [ ] adenovirus \*\ adenovirus
E) [x] coronavirus \*\ Coronavirus
---------------------------------------------------------------------

131
987. CM p5 [CM33115] Constituie criterii de exsudat: (pag 215) \*\ Is exudate criteria:
A) [ ] PMN>500/mm3 \*\ PMN> 500/mm3
B) [x] Densitatea >1016 \*\ density> 1016
C) [x] Glucoza<60 mg/dl \*\ glucose <60 mg / dL
D) [ ] PMN < 1000/mm3 \*\ neutrophils <1000/mm3
E) [x] Ph <7,3 \*\ pH <7.3
---------------------------------------------------------------------
988. CM p5 Printre cauze de wheezing la copil se numara : (192) \*\ Among the causes of wheezing in children include:
A) [x] inele vasculare \*\ Vascular rings
B) [x] traheomalacie \*\ traheomalacie
C) [ ] histoplasmoza alergica bronho-pulmonara \*\ histoplasmosis allergic lung
D) [ ] candidoza pulmonara \*\ pulmonary candidiasis
E) [x] aspergiloza alergica bronho-pulmonara \*\ lung allergic aspergillosis
---------------------------------------------------------------------
989. CM p5 Care dintre urmatoarele variante ce caracterizeaza diagnosticul de laborator al pneumoniilor bacteriene la copil sunt
adevarate? (206) \*\ Which of the following characterizing laboratory diagnosis of bacterial pneumonia in children are real?
A) [ ] Leucocitoza peste 12 \*\ Leukocytosis over 12
B) [x] Leucocitoza peste 20000 \*\ Leukocytosis over 20,000
C) [x] Leucopenie<5000/mm3 \*\ Leucopenia <5000/mm3
D) [ ] Proteina C reactiva absenta \*\ absence of C-reactive protein
E) [x] Proteina C reactiva prezenta,cu valori >20 mg/l \*\ C-reactive protein present, with values> 20 mg / l
---------------------------------------------------------------------
990. CM p5 [CM33029] Cauzele cele mai frecvente de infectii acute de cai respiratorii la sugarii sub 6 luni sunt : (pg 183) \*\ The
most frequent causes of acute respiratory tract infections in infants under six months are:
A) [x] deficiente imunitare locale si generale \*\ Local and general immune deficiencies
B) [ ] existenta asocierii terenului atopic \*\ combination of land existing atopic
C) [ ] virulenta crescuta a agentilor etiologici \*\ increased virulence of etiologic agents
D) [x] diametrul redus al cailor aeriene \*\ diameter of small airways
E) [x] complianta mare al peretelui toracic \*\ large compliance of chest wall
---------------------------------------------------------------------
991. CS p4 Urmatoarele date sunt corecte in convulsii, cu exceptia: (514,515,516)\*\The following data are correct in convulsions, except:
A) [ ] in tratamentul crizei de convulsii medicamentul de electie este diazepamul\*\ in the treatment of seizures medicine crisis the
choice is diazepamul
B) [x] Varsta de debut a convulsiilor febrile este peste 5 ani\*\ age of onset of febrile convulsiilor is over 5 years
C) [ ] Acidul valproic sau sarea sodica a acestuia e singurul antiepileptic al carui spectru de actiune cuprinde toate tipurile de
epilepsii\*\Valproic Acid or salt sodica thereof shall be the sole antiepileptic whose spectrum of action covers all types of epilepsii
D) [ ] Nu se trateaza prima criza de convulsii mai ales daca se suspecteaza o epilepsie idiopatica\*\ do not treat the first crisis of
seizures especially if idiopatica is suspecteaza an epilepsy
E) [ ] Doza anticonvulsivanta de diazepam este de 0,3-0,5 mg/kg/zi\*\anticonvulsivanta Dose of diazepam is 0.3-0.5 mg/kg/day
---------------------------------------------------------------------
992. CS p4 Medicatia entiepileptica cuprinde urmatoarele grupe de medicamente, cu exceptia uneia: (514-516)\*\antiepileptic
medications include the following groups of drugs, except one:
A) [ ] Acidul valproic (VPA) sau sarea sodica a acestuia ;\*\ valproic acid (VPA) or its sodium;
B) [ ] Hidantoinele (fenitoina) ;\*\ Hidantoinele (phenytoin);
C) [ ] Benzodiazepinele antiepileptice (clonazepam, diazepam) ;\*\ Benzodiazepine antiepileptic (Clonazepam, diazepam);
D) [x] Antidepresivele triciclice (antidepin);\*\ tricyclic antidepressants (antidepin)
E) [ ] Analogi ai acidului gama-amino-butiric (vigabrantin, gabapentin)\*\ analogues of gamma-amino butyric acid (vigabrantin, gabapentin)
---------------------------------------------------------------------
993. CS p4 Convulsiile tonico-clonice ale copilului (pag. 508)\*\Tonico-clonice convulsions of the child
A) [ ] debuteaza intotdeauna insidios, precedate de aura\*\ Debuts always insidious, preceded by an aura
B) [ ] sunt cele mai putin severe convulsii\*\ are the less severe seizures
C) [x] respiratia este stertoroasa, bolnavul devine cianotic\*\ breathing is the patient becomes stertoroasa, cianotic
D) [ ] faza clonica initiala este urmata de faza tonica\*\ clonica initial phase is followed by phase DC
E) [ ] bolnavul nu este niciodata amnezic post criza\*\ the patient is never amnezic post crisis
---------------------------------------------------------------------
994. CS p4 Antiepilepticele in asociere cu ACt sau corticoterapie se utilizeaza in tratamentul: (513)\*\Antiepileptics in
combination with ACt or are used in treatment of:
A) [ ] epilepsiilor idiopatice\*\ idiopathic epilepsy
B) [x] sindromului West\*\ West syndrome
C) [ ] epilepsiilor criptogenice\*\ cryptogenic epilepsy
D) [ ] sindromului Lennox-Gastaut\*\ Lennox-Gastaut syndrome
E) [ ] convulsiilor febrile\*\ febrile convulsions
---------------------------------------------------------------------

132
995. CS p4 In cadrul convulsiilor generalizate ale copilului nu se includ convulsiile: (508)\*\In generalized seizures of children
are not included the following seizures
A) [ ] absentele tipice\*\ typical absence
B) [ ] absentele atipice\*\ atypical absence
C) [ ] mioclonice\*\ mioclonice
D) [ ] atone\*\ atone
E) [x] Jacksoniene\*\ Jacksoniene
---------------------------------------------------------------------
996. CS p4 Se defineste ca status epileptic la copil orice convulsie, indiferent de etiologie, care se prelungeste peste: (517)\*\It
defines the child as epilaptical status epileptic any convulsions, regardless of any etiology, which extends over:
A) [ ] 20 minute\*\ 20 minutes
B) [ ] 40 minute\*\ 40 minutes
C) [x]30 minute\*\ 30 minutes
D) [ ] 1ora\*\ 1ora
E) [ ] 24 ore\*\ 24 hours
---------------------------------------------------------------------
997. CS p4 Copilul cu convulsii partiale complexe nu prezinta: (508)\*\Child with complex partial seizures not presents:
A) [ ] stare confuzionala, fara pierderea completa a constientei\*\ confusional state, without complete loss of consciousness
B) [x] pierderea completa a constientei\*\ complete loss of consciousness
C) [ ] automatisme motorii\*\ motor automatisms
D) [ ] micropsii\*\ micropsii
E) [ ] macropsii\*\ macropsii
---------------------------------------------------------------------
998. CS p4 Crizele febrile complexe se caracterizeaza prin urmatoarele, cu exceptia: (518)\*\complex febrile seizures are
characterized by the following, except:
A) [ ] Clonii unilaterale\*\ unilateral Clones
B) [ ] Durata mai mare de 30 min\*\ 30 min longer
C) [x] Deficit hemiplegic permanent\*\ Deficit permanent hemiplegia
D) [ ] Repetarea crizelor in 24 ore\*\ Repeated seizures in 24 hours
E) [ ] Risc crescut de sechele neurologice\*\Increased risk of neurological sequelae
---------------------------------------------------------------------
999. CM p5 Convulsiile febrile ''complexe'' se caracterizeaza prin: (519)\*\"complex" febrile convulsions is characterized by:
A) [x] debut inaintea varstei de 18 luni\*\ debut before the age of 18 months
B) [x] antecedente de suferinta neonatala\*\ a history of neonatal pain
C) [ ] durata sub 30 minute\*\ duration under 30 minutes
D) [ ] manifestari motorii de tip clonic generalizate\*\ motor manifestations of generalized clonic type
E) [x] deficit hemiplegic post-critic\*\ Post-critical shortage hemiplegia
---------------------------------------------------------------------
1000. CM p5 Tabloul clinic la copilul cu convulsii generalizate sub forma de absente, este urmatorul: (508) \*\Clinical picture in
children with generalized convulsions under absence form, is the following :
A) [x] includ petit mal\*\includes petit mal
B) [x] bolnavul nu cade in timpul atacului\*\patients dont fall during the attack
C) [x] constau in oprirea brusca si de scurta durata a activitatii motorii, cu privire ''in gol''\*\it consists of sudden stop and short
duration motor activities, with staring a blank spot
D) [x] ocazional se asociaza devierea globilor oculari si clipitul rapid\*\occasionally deviation of ocular globe with rapid blinking associate
E) [ ] bolnavul cade in timpul atacului\*\patients fall during the attack
---------------------------------------------------------------------
1001. CM p5 Determinarea nivelului seric al medicamentelor antiepileptice la copil se indica: (516-517)\*\ Determining the
serum level of antiepileptic drugs in children indicates :
A) [x] nu este obligatoriu in tratamentul curent al epilepsiei\*\it is not obligatory in current treatment of epilepsy
B) [x] se impune in statusul epileptic la un bolnav tratat anterior\*\ it is inflicted in status epilepticus in a patient treated previously
C) [x] se impune la pacientii care necesita politerapie\*\it is inflicted in patients who need polytherapy
D) [x] se indica in convulsiile necontrolate, la copiii cu boli hepatice sau renale\*\it is indicated in uncontrolled convulsions, in
children with hepratic or renal diseases
E) [ ] este obligatorie pentru toti pacientii\*\it is obligatory for all patients
---------------------------------------------------------------------
1002. CM p5 Urmatoarele afirmatii sunt valabile in cazul convulsiilor febrile la copil: (518, 519)\*\The following statements are
valid in the case of the febrile child convulsions
A) [x] sunt mai frecvente la baieti\*\ are more common in boys
B) [x] apar in prima zi a unei afectiuni acute febrile\*\appear on the first day of acute febrile disease
C) [ ] sunt declansate de scaderea rapida a temperaturii corporale\*\are initiated by the dropping of the body temperature
D) [ ] nu sunt citate cazuri de antecedente familiale de convulsii febrile\*\no are cited cases of familial antecedents of febrile seizures
E) [ ] durata lor depaseste frecvent 30 de minute\*\the duration of their frequently in excess of 30 minutes

133
---------------------------------------------------------------------
1003. CM p5 Crizele epileptice partiale la copil sunt determinate si se caracterizeaza prin: (507) \*\ Partial epileptic seizures in
children are determined and characterized by :
A) [x] sunt expresia afectarii partiale a unei singure emisfere cerebrale\*\they are expressions of partial effections of a single
cerebral hemisphere
B) [x] sunt expresia afectarii in totalitate a unei singure emisfere cerebrale\*\they are expressions of total effections of a single
cerebral hemisphere
C) [ ] starea de constienta a bolnavului, in timpul atacului convulsiv nu este pastrata\*\ consciousness state of the patient, during
the convulsive attack is not reserved
D) [x] starea de constienta a bolnavului, in timpul atacului convulsiv este pastrata\*\consciousness state of the patient, during the
convulsive attack is reserved
E) [x] in timpul crizei pot fi afectate temporar unele functii cognitive si vorbirea\*\during the seizure some cognitive and speaking
functions can temporarily be affected
---------------------------------------------------------------------
1004. CM p5 Bolnavul cu epilepsie simptomatica prezinta adesea anomalii neurologice si deficit intelectual important in acest
sens, care dintre urmatoarele afirmatii sunt corecte: (511-513)\*\The patient with symptomatic epilepsy and neurological
abnormalities often present significant intellectual deficit in this sense, which of the following statements is correct:
A) [ ] intarzierea in dezvoltarea psihomotorie se intalneste foarte rar in spasmele infantile\*\meets Infantile spasms rarely in
delayed psychomotor development
B) [x] in spasmele infantile se noteaza pe EEG aspectul de hipsaritmie\*\Infantile spasms are notes in the EEG appearance of hipsaritmie
C) [x] Tratamentul in spasmele infantile impune asocierea de antiepileptice, corticoterapie sau de ACt\*\Treatment requires a
combination of anti-epileptic infantile spasms, glucocorticoids or ACT
D) [ ] Criza convulsiva izolata necesita supraveghere si tratament cu anticonvulsivante\*\ isolated seizures require supervision and
treatment with anticonvulsant
E) [ ] Potentialul convulsiv inregistrat EEG, fara crize manifeste are indicatie terapeutica cu un medicament
anticonvulsivant\*\EEG recorded seizure potential without therapeutic indication crisis has manifested an anticonvulsant drug
---------------------------------------------------------------------
1005. CM p5 Convulsii epileptice primitiv generalizate la copil sunt determinate si se caracterizeaza prin: (506)\*\ In epileptic
seizures of children the following modifications are produced:
A) [x] par a avea o crestere a excitabilitatii intregului cortex cerebral\*\ a big number of neurons discharhe synchronously and
with high frequency
B) [x] stimulii aferenti catre cortexul hiperexcitabil, plecati de la centrii din formatiunea reticulara a trunchiului declanseaza
convulsiile\*\there are GABA-ergic neuron anomalies
C) [x] la acesti pacienti, activitatea convulsiva debuteaza sincron, in toate ariile cortexului cerebral\*\calcium ion influx in
neuronal cell and exit of the potassium from the cell
D) [ ] sunt prezente numai la sugari\*\the normal balance between excitators and inhibitor influences of neuronal cell activities is broken
E) [x] crizele convulsive sunt recurente\*\inhibitor influences of neuronal cell activities increase
---------------------------------------------------------------------
1006. CM p5 Care din urmatoarele afirmatii privind modificarile electroencefalografice din convulsii sunt corecte (506-507)\*\
Which of the following statements on the changes electroencefalografice of seizures are correct
A) [x] Un focar epileptogen cronic in cortexul cerebral poate determina activitate neuronala anormala in ariile omologe din
emisfera de partea opusa\*\ an outbreak in the cerebral cortex in chronic epileptogen may cause abnormal condition in task
neuronala omologe areas in the northern hemisphere the opposing side
B) [x] Exista convulsii electrice, fara corespondent clinic\*\ there are no corresponding seizures, clinical trial
C) [x] Manifestarile clinice sugestive fara corespondent electric pe EEG, trebuie interpretate ca false convulsii\*\ clinical
manifestations suggestive without corresponding electric on EEG, should be interpreted as false seizures
D) [x] Absenta grafoelementelor specific epileptice pe o registrare EEG semnifica doar ca in momentul acelei inregistrari nu a
existat nici o descarcare neuronala\*\ the absence of specificepileptic grafoelements on a registration EEG signify only that
monet of that recordings there was no neuronal download
E) [ ] Convulsiile cu evolutie jacksoniana se datoreaza unei leziuni focale localizate in cortexul senzitiv\*\ Convulsions with
evolution jacksoniana comprises a focal lesions localized in prefrontal cortex
---------------------------------------------------------------------
1007. CM p5 Urmatoarele afirmatii referitoare la EEG in epilepsia copilului sunt exacte: (pag. 506) Following affirmations
regarding to EEG in epilepsy in children are correct :
A) [x] manifestarile clinice de tip convulsiv trebuie sa aiba corespondent sincron pe inregistrarea EEG\*\clinical manifestations of
convulsive type must have correspondent synchrone on EEG registration
B) [x] exista convulsii electrice fara corespondent clinic\*\there are electrical convulsions without clinical correspondance
C) [ ] exista convulsii tipice epileptice fara corespondent EEG\*\there are typical epileptic convulsions without corespondent EEG
D) [x] absenta grafoelementelor specifice epileptice, pe o inregistrare EEG, semnifica doar ca in momentul acelei inregistrari nu a
existat nici o descarcare neuronala\*\absent specific epileptic graphoelements, on a EEG registration, signify only that in the
moment of registration there wasnt any neuronal discharge
E) [x] inregistrarea EEG pe durata a 24 ore are o semnificatie mai mare diagnostica\*\EEG registration of 24 hour duration has a
bigger diagnostic significance

134
---------------------------------------------------------------------
1008. CM p5 Efectul anticonvulsivant neinsotit de sedare este marele avantaj al: (514)\*\unaccompanied anticonvulsant effect of
sedation is of great advantage :
A) [ ] acidului valproic\*\ valproic acid
B) [x] fenitoinei\*\ fenitoinei
C) [ ] fenobarbitalului\*\ fenobarbitalului
D) [ ] etosuccimidului\*\ etosuccimidului
E) [x] carbamazepinei\*\carbamazepinei
---------------------------------------------------------------------
1009. CM p5 Evolutia si prognosticul convulsiilor febrile la copil: (519)\*\] Evolution and prognosis of febrile convulsions in children are:
A) [x] in marea majoritate a cazurilor sunt favorabile\*\favorable in most cases
B) [x] la 1/3 din cazuri recidivele survin cel mai adesea in anul imediat urmator primei crize\*\in 1/3 of the cases relapses occur
most frequently in following year after the first seizure
C) [x] recidivele dispar dupa varsta de 4-5 ani\*\ relapses dissapear after 4-5 years of age
D) [x] varsta sub 18 luni este un factor de risc pentru recidiva\*\age under 18 months id a risk factor for relapse
E) [ ] dezvoltarea psihica si cognitiva este afectata la toti copiii\*\pshycological and cognitive development is affected in all children
---------------------------------------------------------------------
1010. CM p5 Tratamentul crizei de convulsii febrile se face cu: (pag. 520)\*\febrile seizures treatment is done with:
A) [x]Diazepam (iv)\*\ Diazepam (iv)
B) [x] Diazepam (rectal)\*\ Diazepam (rectal)
C) [ ] Fenobarbital (oral)\*\ Phenobarbital (oral)
D) [x] Masuri antitermice (metode fizice si medicamentoase)\*\ Measures physical and antitermice ()
E) [ ] Acid valproic (oral)\*\valproic Acid (oral)
---------------------------------------------------------------------
1011. CM p5 Convulsiile partiale cu simptome senzoriale la copil sunt secundare afectarii urmatoarelor zone cerebrale: (508)
Partial convulsions with sensory symptoms in children are secondary to the effections of following cerebral zones :
A) [x] afectarea cortexului parietal se poate manifesta prin senzatii tranzitorii de furnicaturi, intepaturi, ameteala, de o parte a
corpului\*\parietal cortex effection can manifest by transient sensation of pins and needles, prickle, numbness, in one side of the body
B) [x] afectarea lobului occipital determina convulsii vizuale\*\occipital lobe effection determines visual convulsions
C) [x] tumorile de lobi temporali se manifesta precoce prin convulsii olfactive\*\temporal lobe tumors manifest precociously by
olfactive convulsions
D) [ ] afectarea lobului occipital determina convulsii atone\*\occipital lobe effection determines atonic convulsions
E) [ ] afectarea lobului temporal determina absente atipice\*\temporal lobe effection determines atipic absences
---------------------------------------------------------------------
1012. CM p5 Amnezia crizei convulsive apare in: (pag. 508)\*\Historical amnesia and whooping cough appears in crisis:
A) [x] convulsiile tonico-clonice\*\ convulsions tonico-clonice
B) [ ] convulsiile partiale complexe\*\ convulsions complex partial
C) [x] absentele tipice\*\ Typical absence
D) [ ] convulsiile mioclonice\*\ convulsions mioclonice
E) [ ] convulsiile partiale cu simptome vegetative\*\ partial convulsions with vegetative symptoms with
---------------------------------------------------------------------
1013. CM p5 Identificati afirmatiile corecte din urmatoarele date referitoare la actiunile diferitelor tipuri de medicamente cu
actiune antiepileptica: (520)\*\Identify the correct affirmations from the the following data regarding the different types of drugs with
antiepileptical action:
A) [x] Acidul valproic sau derivatii sai este singurul antiepileptic care poate fi recomandat in toate tipurile de epilepsie\*\
Valproic Acid: or its is the only modern antiepileptic which may be recommended in all types of epilepsy
B) [x] Fenitoina este un antiepileptic la care actiunea anticonvulsivanta nu este insotita de sedare\*\ Fenitoina is an
anticonvulsivant in wich the antiepileptic action is not accompanied by sedation
C) [ ] Diazepamul este un anticonvulsivant eficient cu actiune de lunga durata\*\ Diazepamul is a anticonvulsivant effective long-term action
D) [x] Etosuccimid poate induce ca efect advers un sindrom lupus like\*\ Etosuccimid may induce adverse effect as a syndrome lupus like
E) [ ] in tratamentul epilepsiei medicul va alege medicamentele anticonvulsivante care nu au nici un fel de efecte adverse\*\ in
treatment for epilepsy medicines anticonvulsivante doctor will choose which do not have any adverse effects
---------------------------------------------------------------------
1014. CM p5 Diagnosticul convulsiilor febrile la copil se bazeaza pe urmatoarele criterii obligatorii: (518) The diagnostic in
febrile child convulsion is based on the following mandatory criteria:
A) [ ] febra egala sau mai mare de 39C\*\ fever equal to or greater than 39 C
B) [x] durata sub 15 minute\*\ duration less than 15 minutes
C) [ ] durata sub 5 minute\*\ duration less than 5 minutes
D) [x] absenta anomaliilor neurologice in perioadele intercritice\*\ absence of neurological anomalies in intercritical periods
E) [x] EEG normal in perioadele intercritice\*\ EEG in intercritice periods
---------------------------------------------------------------------

135
1015. CM p5 Statusul epileptic (starea de rau convulsiv) la copil poate surveni in: (509)\*\] Status epilepticus (bad convulsive
state) in children can occur in:
A) [ ] in deshidratarea extracelulara gradul II a sugarului\*\ in extracellular dehydration of the infant gr II
B) [x] infectii ale SNC\*\CNS infections
C) [x] traumatism cranian\*\cranial trauma
D) [x] ruptura de anevrism cerebral
E) [ ] intoxicatii grave
---------------------------------------------------------------------
1016. CM p5Convulsiile febrile complexe sunt caracterizate prin: (519) complex febrile Convulsions are characterized by:
A) [x] unilateralitatea manifestarilor motorii de tip clonic\*\ motor type clonic unilateral manifestasion
B) [ ] criza cu durata sub 15-30 de minute\*\ crisis lasting less than 15-30 minutes
C) [x] deficit hemiplegic postcritic\*\ deficit hemiplegic postcritic
D) [x] risc crescut de sechele neurologice\*\ increased risk of neurological sequelae
E) [x] aparitia la copiii cu antecedente de suferinta neonatala sau dismaturitate\*\the appearance of the children with a history of
suffering, neonatal or dismaturitaty
---------------------------------------------------------------------
1017. CM p5 Convulsiile epileptice partiale simple cu semne motorii la copil se manifesta clinic prin: (507) Simple partial
epileptic convulsions with motor signs in children are manifested clinically by :
A) [x] debuteaza sub forma unor clonii la un singur grup de muschi (adesea flexorii degetelor)\*\onset is under the form of some
cloning in a single muscle group (frequently flexors of fingers)
B) [x] convulsiile se extind la grupele musculare vecine (evolutie Jacksoniana)\*\convulsions extend to neighbour muscle groups
(Jacksonian evolution)
C) [x] prin extindere intereseaza o parte intreaga a corpului\*\extension involves an entire side of the body
D) [x] bolnavul ramane constient\*\ patient remains conscious
E) [ ] in timpul atacului convulsiv copilul este inconstient\*\child is unconscious during the convulsive attack
---------------------------------------------------------------------
1018. CM p5 In declansarea crizelor epileptice la copil: ( 506)\*\The onset seizures in children
A) [x] sunt implicati in mod special neuronii inhibitori, a caror influenta scade\*\ neurons are involved in particular inhibitors,
whose influence decreases
B) [x] neuronii inhibitori folosesc ca substanta neurotransmitatoare acidul gama-aminobutiric (GABA)\*\ neurons inhibitors used
as gamma-aminobutyric acid neurotransmitter substance (GABA)
C) [ ] anomalia neuronilor GABA-ergici este singura cauza specifica care determina convulsii in toate tipurile de epilepsie\*\
GABA-neurons ergici anomaly is only due to that cause specific types of epileptic seizures in all
D) [x] exista factori familiali predispozanti\*\ there are familial factors predisposing
E) [x] intervine o descarcare electrica excesiva a neuronilor cerebrali\*\ there is a excessive electrical discharges of brain neurons
---------------------------------------------------------------------
1019. CM p5 Urmatorele afrimatii, referitoare la epilepsia copilului, sunt corecte: (507) Following affirmations regarding the childhood
epilepsy are correct:
A) [x] lipsa de repetabilitate a unor convulsii epileptice se inregistreaza de obicei sub tratament\*\absence of repetation of some
epileptic convulsions is registered usually under treatment
B) [x] reaparitia crizelor la sistarea tratamentului anticonvulsivant este semnalata la 15-50% din cazuri\*\reappearance of seizures
after stopping anticonvulsant treatment is reported in 15-50% of the cases
C) [x] durata medie a activitatii epileptice este apreciata, in general, la 10 ani de la prima criza\*\average duration of epileptic
activity is appreciated, in general, after 10 years from first seizure
D) [x] la 50% din cazurile de la copil durata medie a activitatii epileptice este de numai 2-3 ani\*\in 50% of the cases of children
the average duration of epileptic activity is only 2-3 years
E) [ ] crizele epileptice din sindromul West au un prognostic bun\*\epileptic seizures of West Syndrome have a good prognosis
---------------------------------------------------------------------
1020. CM p5 Convulsiile febrile simple (benigne) la copil se caracterizeaza prin: (519)\*\simple febrile Convulsions (benign) the
child is characterized by:
A) [x] sunt cele mai frecvente convulsii febrile\*\ are the most common febrile seizures
B) [ ] crizele sunt de lunga durata\*\ crises are long
C) [x] nu apar manifestari respiratorii\*\ does not appear Respiratory manifestations
D) [ ] se prezinta ca manifestari motorii de tip clonic, unilaterale\*\ motor show as manifestations of type clonic, unilateral
E) [ ] prezinta risc crescut de sechele neurologice\*\ presents increased risk of neurological sequelae
---------------------------------------------------------------------
1021. CS p4 Substratul integrarii din ciclul replicativ al HIV este: (424)\*\Substrate integration of the HIV replicative cycle
A) [ ] ARN liniar flancat de cele doua regiuni repetitive lungi\*\Linear RNA flanked by the two long repetitive regions
B) [ ] ADN circular flancat de cele doua regiuni repetitive scurte\*\Circular DNA flanked by the two short repetitive regions
C) [ ] ADN circular flancat de cele doua regiuni repetitive lungi\*\Circular DNA flanked by the two long repetitive regions
D) [x] ADN liniar flancat de cele doua regiuni repetitive lungi\*\Linear DNA flanked by the two long repetitive regions
E) [ ] ARN circular flancat de cele doua regiuni repetitive lungi\*\Circular RNA flanked by the two long repetitive region
---------------------------------------------------------------------

136
1022. CS p4 In cadrul infectiei cu HIV, un bolnav cu leucoplakie paroasa si limfocite CD4 200-499 poate fi incadrat in stadiul
(433-434)\*\In HIV infection, a patient with hairy leucoplakie and CD4 200-499 lymphocytes can be framed in the state:
A) [ ] A2\*\A2
B) [ ] B1\*\ B1
C) [x] B2\*\ B2
D) [ ] C1\*\ C1
E) [ ] C2\*\C2
---------------------------------------------------------------------
1023. CS p4 Alegeti afirmatia falsa cu privire la modificarile medulare in HIV: (438)\*\Choose the false statement about bone
marrow changes in HIV
A) [x] sint caracteristice pentru infectia cu HIV\*\Are characteristic of HIV infection
B) [ ] aspectele mielodisplazice sint intotdeauna prezente\*\Myelodysplastic issues are always present
C) [ ] raportul mieloide/eritroblasti este crescut\*\Report of myeloid / eritroblasti is increased
D) [ ] o celularitate crescuta este frecvent intilnita\*\ A cell is frequently encountered elevated
E) [ ] fibroza medulara moderata este constant prezenta\*\Moderate marrow fibrosis is consistently present
---------------------------------------------------------------------
1024. CS p4 Raspunsul imun specific, umoral si celular este determinat de (425)\*\Specific immune response, humoral and
cellular is determined by
A) [ ] ficat\*\Liver
B) [ ] splina\*\Spleen
C) [ ] creier\*\Brain
D) [x] ganglioni\*\Node
E) [ ] pancreas\*\Pancreatic
---------------------------------------------------------------------
1025. CS p4 In ce categorie clinico-imunologica se incadreaza o persoana cu HIV ce prezinta adenopatie persistenta generalizata
si un nivel al limfocitelor CD4 de 250 celulemmc? (433) ()\*\What clinical and immunological category fit a person with HIV
presenting persistent generalized adenopathy and a level of 250 celulemmc and CD4 lymphocytes ?
A) [ ] A1\*\A1
B) [x] A2\*\ A2
C) [ ] B2\*\B2
D) [ ] C2\*\C2
E) [ ] C3\*\C3
---------------------------------------------------------------------
1026. CS p4 Infectia HIV/SIDA in lume inregistreaza numarul cel mai mare de infectati in: (428-9)\*\HIV / AIDS in the world
recorded the highest number of infection in:
A) [ ] europa de vest\*\Western Europe
B) [ ] africa de nord\*\North Africa
C) [x] africa subsahariana\*\Sub-Saharan Africa
D) [ ] asia de sud-est\*\ South East Asia
E) [ ] america latina\*\Latin America
---------------------------------------------------------------------
1027. CS p4 Principala cauza de cecitate la un bolnav infectat HIV-SIDA este: (440)\*\The main cause of blindness in a patient
infected with HIV-AIDS
A) [ ] Toxoplasmoza retiniana\*\Retinal toxoplasmosis
B) [x] Retinita cu citomegalovirus\*\Cytomegalovirus retinitis
C) [ ] Retinita candidozica\*\Candida retinitis
D) [ ] Pneumocistoza\*\Pneumocistoza
E) [ ] Necroza retiniana acuta\*\ Acute retinal necrosis
---------------------------------------------------------------------
1028. CS p4 Principala manifestare urinara la bolnavii infectati cu HIV:(437)\*\The main urinary manifestation in patients infected with HIV:
A) [ ] Piuria\*\Piura
B) [x] Proteinuria\*\ Proteinuria
C) [ ] Macrohematuria\*\Macrohematuria
D) [ ] Microhematuria\*\Microhematuria
E) [ ] Infectia urinara\*\Urinary Infection
---------------------------------------------------------------------
1029. CM p5 Mecanismele imunologice implicate in stabilirea infectiei cronice cu HIv sunt:\*\immunological mechanisms
involved in establishing chronic HIV infection are:
A) [ ] inhibarea productiei MHC1\*\inhibition of production MHC1
B) [x] pierderea de clone TCD4 si HIV specifice\*\loss of specific clones and HIV TCD4
C) [x] pierdere de clone TCD8 si HIV specifice\*\loss of specific clones and HIV TCD8
D) [x] acumularea timpurie LTc HIV specifice in cantitate mai mare in sange\*\accumulation of HIV-specific LTC early in
greater quantity in the blood

137
E) [ ] acumularea timpurie LTc HIV specifice in cantitate mai mare in tesutul limfoid\*\HIV-specific LTC early accumulation in
excess of lymphoid tissue
---------------------------------------------------------------------
1030. CM p5 Referitor la infectia cu HIV la femei nu sunt adevarate afirmatiile:(449)\*\for HIV infection in women is not true statements:
A) [ ] transmiterea se produce mai usor la femeie decat la barbat\*\transmission occurs more easily in women than in men
B) [x] In urma unui contact sexual vaginal neprotejat cu un barbat HIV-seropozitiv, riscul de infectare este de 2%\*\After an
unprotected vaginal intercourse with an HIV-seropositive men, the risk of infection is 2%
C) [ ] Riscul de infectare dupa mai multi ani de viata sexuala neprotejata cu un barbat HIV-seropozitiv este de 10-45%\*\Risk of
infection after years of unprotected sex with an HIV-seropositive men is 10-45%
D) [x] Prezenta unei BTS amplifica riscul de transmitere de 20 de ori\*\The transmission of STDs increase the risk 20 times
E) [ ] Vaginita candidozica poate fi prima manifestare clinica\*\Vaginitis candida may be the first clinical manifestation
---------------------------------------------------------------------
1031. CM p5 Din suferintele cardiace din HIV se numara ()\*\Affect on heart of HIV include
A) [x] aritmii\*\Arrhythmias
B) [ ] cardiomiopatie hipertrofica\*\Hypertrophic cardiomyopathy
C) [x] pericardita limfocitara\*\Lymphocytic pericarditis
D) [x] endocardita nonbacteriana\*\Endocarditis nonbacteriana
E) [x] moarte subita\*\Sudden death
---------------------------------------------------------------------
1032. CM p5 In fazele initiale ale infectiei HIV: (425)\*\In the early stages of HIV
A) [x] ne confruntam cu asa numita fereastra imunologica''\*\We are dealing with so-called 'immunological window "
B) [x] in plasma se detecteaza ARN HIV\*\Plasma HIV RNA is detected
C) [ ] noul nivel de ARN este desemnat ca punct fix(set point'')\*\A new level of RNA is designated as a fixed point (set point)
D) [ ] infectia poate fi confirmata de prezenta anticorpilor anti-HIV\*\The infection can be confirmed by this anti-HIV
E) [x] incarcatura virala a ggl limfatici o depaseste pe cea a celulelor mononucleare circulante\*\GGL viral load of nodes exceeds
than that circulating mononuclear cells
---------------------------------------------------------------------
1033. CM p5 In fereastra imunologica infctia HIV poate fi dovedita prin:\*\The immunological window inefctia HIV can be proved by:
A) [x] Detectarea antigenului p24\*\Detection of p24 antigen
B) [ ] Anticorpi anti HIV-1\*\anti HIV-1
C) [x] Cultivarea HIV\*\Growing HIV
D) [x] Evidentierea acizilor nucleici umani prin PCR\*\PCR highlight human nucleic acids
E) [ ] Anticorpi anti HIV-2\*\anti HIV-2
---------------------------------------------------------------------
1034. CM p5 Trmobopenia la bolnavii HIV are urmatoarele cauze:(438)\*\Trmobopenia in HIV patients has the following causes:
A) [x] distrugere imunologica\*\immune destruction
B) [x] hematopoieza ineficienta\*\ineffective hematopoiesis
C) [ ] distrugere excesiva in splina\*\excessive destruction in the spleen
D) [ ] afectare directa a trombocitelor de catre HiV\*\directly affected by HIV platelet
E) [x] efecte adverse ale medicamentelor\*\Adverse effects of drugs
---------------------------------------------------------------------
1035. CM p5 Despre neoplaziile oportuniste la persoanele infectate HIV sunt adevarate: (441)\*\About opportunistic
malignancies in HIV infected people are true:
A) [x] Sarcomul Kaposi este neoplazia oportunista cea mai frecventa\*\Kaposi's sarcoma is the most common opportunistic neoplasia
B) [ ] Boala Hodgkin este revelatoare in SIDA\*\Hodgkin's disease in AIDS is revealing
C) [x] Limfomul Burkitt apre la bolnavii cu imunodepresie moderata\*\likes Burkitt lymphoma in patients with moderate immunodepression
D) [ ] Limfoamele constituie neoplazia cea mai frecventa\*\Lymphomas are the most common neoplasia
E) [x] Incidenta boali Hodgkin este mult crescuta la bolnavii cu infectie HIV comparativ cu populatia generala\*\Incidence of
Hodgkin's disease is significantly increased in patients with HIV infection than the general population
---------------------------------------------------------------------
1036. CM p5 In fazele initiale ale infectiei cu HIV: (425)\*\In the early stages of HIV infection
A) [ ] Celulele mononucleare circulante contin cantitati mult mai amri de HIV decat ggl\*\Circulating mononuclear cells contain
abundant amri HIV more than GGL
B) [x] Are loc o transmitere a HIV intre celulele limfoide ganglionare vecine\*\An HIV transmission takes place between
neighboring ganglion cells in lymphoid
C) [x] In structurile limfoide are loc o multiplicare virala continua la rate inalte\*\In lymphoid structures occurs continuous viral
multiplication at high rate
D) [x] In aceasta perioada testele de screening pentru detectia Ac anti-HIV nu permit confirmarea infectiei\*\At this time
screening tests for the detection of AC anti HIV do not allow confirmation of HIV infection
E) [ ] In aceasta perioada testele de screening pentru detectia Ac anti-Hiv permit confirmarea infectiei\*\At this time of screening
tests for detection of AC anti-HIV confirm to demonstrate infection
---------------------------------------------------------------------

138
1037. CM p5 ''Sanctuarele'' HIV din organism sunt: (pag.422)\*\"sanctuaries" of HIV in the body are:
A) [ ] sangele\*\blood
B) [x] sistemul nervos\*\nervous system
C) [ ] ganglionii limfatici\*\lymph nodes
D) [x] organele genitale\*\genital organs
E) [ ] plamanii\*\lung
---------------------------------------------------------------------
1038. CM p5 Functiile polipeptidului VPU (Pag. 423)\*\VPU polypeptide functions
A) [ ] influenteaza celulele care nu se divid\*\non-dividing cells influence
B) [x] modularea joasa a CD4+\*\modulation of CD4 + low
C) [ ] blocheaza diviziunea celulara\*\block cell division
D) [x] creste eliberarea virionilor de la suprafata celulelor infectate\*\increased release of virions from infected cells surface
E) [ ] perturbarea activitatii celulelor T\*\disruption of T cell activity
---------------------------------------------------------------------
1039. CM p5 Categoria clinica B (simptomatologie medie) din cadrul infectiei cu HIV la copil include (446)\*\clinical category B
(symptoms average) in HIV infection in children includes
A) [x] pneumonie interstitial limfoida\*\pneumonie interstitial limfoida A: lymphocytic interstitial pneumonia
B) [x] hepatita\*\hepatitis
C) [ ] candidoza esofagiana/pulmonara\*\esophageal candidiasis / lung
D) [ ] pneumonia cu Pneumocystis carinii\*\Pneumocystis carinii pneumonia
E) [x] leiomiosarcom\*\leiomiosarcom
---------------------------------------------------------------------
1040. CM p5 Definitia sdr.casectizant include: (440)\*\Sdr.casectizant (wasting syndrome) definition includes:
A) [x] Scadere ponderala involuntara de cel putin 10%\*\ Involuntary weight loss of at least 10%
B) [x] Absenta oricarei infectii\*\Freedom from infection
C) [ ] Febra prelungita mai mult de 2 saptamani\*\ Prolonged fever for more than two weeks
D) [ ] Diaree intermitenta\*\Intermittent Diarrhea
E) [ ] Scadere ponderala involuntara de cel putin 20%\*\Involuntary weight loss of at least 20%
---------------------------------------------------------------------
1041. CM p5 Diagnosticul diferential al primoinfectiei HIV se face cu: (443)\*\Differential Diagnosis of HIV primoinfectiei do with:
A) [ ] Oreion\*\mumps
B) [x] Mononucleoza infectioasa\*\Infectious Mononucleosis
C) [x] Viroze respiratorii\*\respiratory virus
D) [x] Hepatita\*\Hepatitis
E) [ ] Pneumonie\*\ Pneumonia
---------------------------------------------------------------------
1042. CM p5 In celulele infectate s-au observat urmatoarele forme de ADN viral:(424)\*\The infected cells were observed in
these forms of viral DNA
A) [ ] ARN liniar flancat de o LTR localizat in citoplasma\*\Linear RNA flanked by an LTR located in the cytoplasm
B) [ ] ADN liniar flancat de cele 2 LTR localizat exclusiv in nucleu\*\Linear DNA flanked by the two LTR located exclusively in the nucleus
C) [x] ADN liniar flancat de cele doua LTR localizat in citoplasma\*\Linear DNA flanked by two LTR located in the cytoplasm
D) [x] ADN liniar flancat de cele doua LTR localizat in nucleu\*\Linear DNA flanked by two LTR located in the nucleus
E) [ ] forme circulare aflate in citoplasma\*\ Circular shapes found in the cytoplasm
---------------------------------------------------------------------
1043. CM p5 Reprezinta etape ale ciclului replicativ al HIV: (423-424)\*\Is the HIV replicative cycle stages:
A) [ ] Multiplicarea\*\Multiplication
B) [x] Reverstranscrierea\*\Reverstranscrierea
C) [ ] Adeziunea\*\Adherence
D) [x] Atasarea si penetrarea\*\attachment and penetration
E) [x] Integrarea\*\Integration
---------------------------------------------------------------------
1044. CM p5 Care dintre urmatoarele microorganisme enumerate genereaza infectii oportuniste la nivelul sistemului nervos
central la o persoana aflata in stadiul de SIDA? (438-439)\*\Which of these organisms generates opportunistic infections listed in
the central nervous system to a person in the state of AIDS
A) [x] Toxoplasma gondii\*\Toxoplasma gondii
B) [x] virusul citomegalic\*\cytomegalovirus
C) [x] Cryptococcus neoformans\*\Cryptococcus neoformans
D) [ ] Neisseria meningitides\*\Neisseria meningitides
E) [x] bacilul Koch\*\bacillus Koch
---------------------------------------------------------------------
1045. CM p5 Markerii clinici utilizati ca factori de predictie a progresiei infectiei HIV sunt: (444)\*\clinical markers used as
predictor of progression of HIV infection are:)
A) [ ] Tahicardia\*\Tachycardia

139
B) [x] Candidoza orala\*\Oral candidiasis
C) [x] Diareea trenanta\*\Diarrhea dragged
D) [ ] Paloarea\*\ pallor
E) [x] Febra\*\Fever
---------------------------------------------------------------------
1046. CM p5 Markerii laborator de progresie spre SIDA sunt ()\*\laboratory markers of progression to AIDS ()
A) [ ] anticorpii antiHIV specifici\*\antiHIV specific antibodies
B) [ ] CD4+ >500/mm3\*\CD4 +> 500/mm3
C) [ ] Trombocitopenia\*\Thrombocytopenia
D) [x] ARN viral\*\viral RNA
E) [x] B2microglobulina\*\B2microglobulina
---------------------------------------------------------------------
1047. CM p5 Numaratoarea limfocitelor CD4 are importanta clinica prin (441)\*\CD4 cell count has clinical importance
A) [x] permite incadrarea bolnavilor in categorie imunologica\*\allows the classification of patients in immunological category
B) [ ] este utila la persoanele suspecte de infectie acuta sau cu debut recent\*\is useful in suspected acute infection or recent onset
C) [x]orienteaza diagnosticul diferential\*\differential diagnosis oriented
D) [x] ofera o baza relationala pentru initierea unui tratament\*\offers a relational basis for initiating treatment
E) [x] bun indicator de prognostic\*\The best indicator of prognosis
---------------------------------------------------------------------
1048. CM p5 Celule susceptibile de infectia cu HIV sunt: (425)\*\cells susceptible to HIV infection are:
A) [x] Limfocite T CD4+\*\CD4 + T lymphocytes
B) [x] Fibroblaste\*\fibroblasts
C) [x] Oligodendrocite\*\oligodendrocytes
D) [ ] Osteoclaste\*\osteoclasts
E) [ ] Eritrocite\*\Erythrocytes
---------------------------------------------------------------------
1049. CM p5 In etapa timpurie si medie a infectiei cu HIV: (425)\*\The early and medium stage of HIV infection
A) [x] nivelul circulant al HIV e mai mic decat nivelul din ganglionii limfatici\*\Circulating levels of HIV is lower than in lymph nodes
B) [ ] antigenele virale plasmatice sunt detectabile la titruri mari\*\Plasma viral antigens are detectable in high titers
C) [x] nivelul ARN-HIV scade\*\HIV RNA level decreases
D) [ ] ARN-HIV inregistreaza niveluri ondulante timp de luni/ani\*\HIV RNA levels corrugated record for months / years
E) [x] nivelul limfocitelor T CD4+ scade la 200-300/ mm cub\*\CD4 + T lymphocyte level decreased to 200-300 per mm cube
---------------------------------------------------------------------
1050. CM p5 Genomul viral HIV prezinta urmatoarele proprietati: (pag 423)\*\HIV viral genome has the following properties:
A) [ ] e format din molecule de ADN\*\Is composed of DNA molecules
B) [x] format din 9 gene codificatoare de proteine\*\Genes are encoded by nine protien
C) [ ] genele gag si pol sunt implicate in diverse etape ale replicarii virale\*\Gag and pol genes are involved in various stages of
viral replication
D) [x] genele pot fi majore, reglatoare si accesorii\*\Genes are major regulating and accessories
E) [x] e format din 2 molecule de ARN\*\Is composed of two RNA molecules
---------------------------------------------------------------------
1051. CS p4 In tiplu III de leziune splenica traumatica se descriu urmatoarele caracteristici exceptand'' (2104)\*\In type III
traumatic splenic injury, it is described by the following characteristics except:
A) [ ] hematomul subcapsular ce intereseaza peste 50% din suprafata\*\subcapsular hematoma involves more than 50% of surface
B) [x] devascularizarea a peste 25% din organ\*\devascularization over 25% of the organ
C) [ ] hematomul intraparenchimatos cu diametrul peste 5 cm\*\intraparenchymatous hematoma with a diameter more than 5 cm
D) [ ] ruptura de parenchim cu adancime mare de 3 cm\*\rupture of the parenchyma with a large depth of 3 cm
E) [ ] ruptura de parenchim care intereseaza vasele trbeculare\*\rupture of the parenchyma which involves the trabecular vessels
---------------------------------------------------------------------
1052. CS p4 Ruptura de splina in doi timpi se produce cel mai frecvent in: (2104)\*\The second time splenic rupture occurs, it is
most frequently in:
A) [ ] Primele 24 ore\*\The first 24 hours
B) [ ] Dupa luni de zile\*\After months
C) [x] Primele 2 - 3 zile\*\The first 2 - 3 days
D) [ ] Primele 2 - 3 saptamani\*\The first 2-3 weeks
E) [ ] Tipul V de ruptura\*\type V of rupture
---------------------------------------------------------------------
1053. CS p4 Care din urmatoarele elemente clinice sunt mai putin probabile in aparitia unui revarsat Morel-Lavalle:
(2094)\*\Which of the following clinical elements are less likely probable in the appearance of Morel-Lavalle lesion:
A) [ ] Bombarea tegumentelor, fluctuenta\*\swelling of the skin, fluctuation
B) [ ] Echimoze cutanate\*\cutaneous ecchymosis
C) [ ] Tegumente reci, cianotice, insensibile\*\cold skin, cyanotic, and insensitive
D) [x] Fluctuenta, crepitatii, caldura locala\*\Fluctuation, crepitations, local heat

140
E) [ ] Necroza tegumentara tardiva\*\late skin necrosis
---------------------------------------------------------------------
1054. CS p4 In ce tip de leziune abdominala traumatica, se evidentiaza semnul BOUCHACOURT? (2094)\*\What type of
traumatic abdominal injury, is proven by the BOUCHACOURT sign?
A) [ ] eventratie postcontuzionala\*\post-contusional eventration
B) [ ] revarsat Morel-Lavalle\*\Morel-Lavalle wound
C) [x] hematom subaponevrotic\*\subaponeurotic hematoma
D) [ ] hematom properitoneal\*\properitoneal hematoma
E) [ ] hernie postcontuzionala\*\post-contusional hernia
---------------------------------------------------------------------
1055. CS p4 Care dintre structurile anatomice enumerate mai jos este obligatoriu lezata pentru ca o plaga abdominala sa fie
considerata penetranta? (2096)\*\Which of the anatomical structures listed below is mandatory for an abdominal wound
considered to be penetrating?
A) [ ] tegumentele\*\skin
B) [ ] aponevroza\*\aponeurosis
C) [ ] viscerele parenchimatoase\*\parenchymatous viscera
D) [ ] epiploonul\*\mesentery
E) [x] peritoneul parietal\*\parietal peritoneum
---------------------------------------------------------------------
1056. CS p4 Semnul Mandel poate apare in: (2098)\*\Mandel Sign can appear in:
A) [ ] ocluzia intestinala prin volvulus de intestin subtire\*\intestinal obstruction by volvulus of the small intestine
B) [ ] invaginatia intestinala\*\ intestinal invagination
C) [x] sindrom de iritatie peritoneala\*\peritoneal irritation syndrome
D) [ ] pancreatita acuta edematoasa\*\acute edematous pancreatitis
E) [ ] ocluzia intestinala prin volvulus de sigmoid\*\intestinal obstruction with volvulus of the sigmoid
---------------------------------------------------------------------
1057. CS p4 Tehnica ''mesh wrapping'' in tratamentul leziunilor traumatice hepatice are o mortalitate de: (2106)\*\The technique
of "mesh wrapping" in the treatment of traumatic hepatic lesions has a mortality of:
A) [x] 25-37%\*\25-37%
B) [ ] Sub5 %\*\under 5%
C) [ ] Jumatate din cazuri\*\half of all cases
D) [ ] 66-75%\*\66-75%
E) [ ] Tehnica este indicata numai pentru leziunile splenice\*\the technique is indicated only for splenic lesions
---------------------------------------------------------------------
1058. CS p4 Ruptura mezenterului situata in apropierea radacinii acestuia, se caracterizeaza prin: (pag. 2108)\*\Rupture of the
mesentery located near its root, is characterized by:
A) [ ] angajarea unei anse in zona de ruptura, cu aparitia ocluziei intestinale\*\ the engagement is always within rupture zone, with
the appearance of intestinal obstruction
B) [ ] aparitia semnelor de peritonita\*\appearance of signs of peritonitis
C) [x] devitalizarea ansei\*\devitalization a large portion of the intestine
D) [ ] hemoragie masiva\*\massive hemorrhage
E) [ ] aparitia hematomului retroperitoneal\*\the appearance of retroperitoneal hematoma
---------------------------------------------------------------------
1059. CM p5 In perioada primelor 24-48 de ore, prognosticul hematomului retroperitoneal post-traumatic, depinde de:
(2114)\*\During the first 24-48 hours, the prognosis of post-traumatic retroperitoneal hematoma depends on
A) [ ] aparitia insuficientei renale acute\*\the appearance of acute renal failure
B) [x] intensitatea socului traumatic\*\intensity of traumatic shock
C) [ ] continuarea parezei intestinale\*\continuation of intestinal paresis
D) [x] interesarea plexului celiac\*\celiac plexus involvment
E) [x] intensitatea socului hemoragic\*\the intensity hemorrhagic shock
---------------------------------------------------------------------
1060. CM p5 Peritonita tardiva aparuta in evolutia bolnavilor cu contuzie abdominala este rezultatul unuia dintre urmatoarele
mecanisme:(2095)\*\Late peritonitis occurring in the evolution of patients with abdominal contusion is the result of one of the
following mechanisms:
A) [x] translocatia bacteriana favorizata de socul hemoragic\*\bacterial translocation favorized by hemorrhagic shock
B) [ ] ruptura unui hematom subcapsular splenic\*\rupture of a splenic subcapsular hematoma
C) [ ] plaga a colonuluui transvers\*\a wound in the transverse colon
D) [x] eliminarea unei escare parietale intestinale\*\removal of a parietal intestinal eschar
E) [x] necroza tardiva a unei anse, secundara rupturii sau dezinsertiei mezoului\*\late necrosis, secondary rupture or removal of mezoului
---------------------------------------------------------------------
1061. CM p5 Care sunt semnele clasice ale hemobiliei post-traumatice: (2107)\*\What are classic signs of post-traumatic hemobilia
A) [x] icter de tip mecanic;\*\jaundice of the mechanical type;
B) [ ] icter hemolitic;\*\hemolytic jaundice;

141
C) [x] durere in hipocondrul drept de tip colicativ;\*\pain in right hypochondrium of colic type;
D) [ ] febra de tip septic;\*\fever of type septic;
E) [x] hemoragii digestive exteriorizate prin hematemeza, melena\*\gastrointestinal hemorrhage revealed by hematemesis,
melena
---------------------------------------------------------------------
1062. CM p5 Care sunt formele anatomo-patologice ce pot apare in cazul unui traumatism colonic? (2109-2110)\*\What are the
anatomo-pathologic forms that can appear in the case of colonic injury?
A) [x] contuzia simpla minora\*\simple minor contusion
B) [x] rupturi complete\*\complete rupture
C) [x] infarctele entero-mezenterice\*\entero-mesenteric infarctions
D) [x] exploziile\*\bursts/expolsions (?)
E) [ ] stenoza intestinala tardiva\*\late intestinal stenosis
---------------------------------------------------------------------
1063. CM p5 Care dintre afirmatiile referitoare la traumatismele esofagului abdominal sunt false? (2100)\*\Which of the
statements about abdominal esophageal trauma are false?
A) [ ] ingestia de corpi straini ascutiti si manevrele iatrogene reprezinta etiologia cea mai frecvent intalnita\*\ingestion of sharp
foreign bodies and iatrogenic maneuvers represent the most frequent etiology
B) [x] cele mai multe leziuni ale esofagului terminal se datoreaza plagilor abdominale penetrante\*\most lesions of the terminal
esophagus are due to penetrating abdominal wounds
C) [ ] clinic se manifesta prin dureri vii retroxifoidiene sau retrosternale, disfagie si stare febrila persistenta\*\is clinically
manifested by pain coming retro-xyphoidial or retrosternal, dysphagia and persistent feverish state
D) [x] tratamentul este exclusiv chirurgical\*\treatment is exclusively surgical
E) [x] tranzitul baritat eso-gastric este de mare utilitate diagnostica\*\esophageal-gastric barium transit has the most diagnostic value
---------------------------------------------------------------------
1064. CM p5 Care dintre afirmatiile de mai jos referitoare la plagile abdominale sunt adevarate? (2096)\*\Which of the
statements below about abdominal wounds are true?
A) [ ] apar prin actiunea indirecta a agentului vulnerant\*\occur through indirect actions of the vulnerable agent
B) [ ] plagile abdominale penetrante nu intereseaza peritoneul\*\penetrating abdominal wounds do not involve peritoneum
C) [x] toate plagile abdominale sunt considerate infectate\*\all abdominal wounds are considered infected
D) [ ] pot fi prezente si hematoame parietale\*\parietal hematoma may be present as well
E) [x] plagile se definesc prin existenta unei solutii de continuitate la nivelul tegumentelor\*\the wounds are defined by the
existence through solution of continuity at level of the skin
---------------------------------------------------------------------
1065. CM p5 Hemobilia se manifesta prin: (2107)\*\Hemobilia is manifested by:
A) [ ] Tablou clinic cu abdomen acut hemoragic\*\clinical picture of acute abdominal hemorrhage
B) [x] Icter mecanic\*\mechanical jaundice
C) [x] Melena\*\melena
D) [ ] Soc\*\Shock
E) [x] Dureri in hipocondrul drept\*\Pain in right hypochondrium
---------------------------------------------------------------------
1066. CM p5 Care sunt viscerele abdominale cel mai frecvent exteriorizate printr-o evisceratie abdominala traumatica
(2095)\*\What are the abdominal viscera most frequently externalized through a traumatic abdominal evisceration:
A) [x] intestinul subtire\*\small intestine
B) [ ] duodenul\*\duodenum
C) [ ] pancreasul\*\pancreas
D) [x] colonul transvers\*\ transverse colon
E) [x] epiploonul\*\mesentery
---------------------------------------------------------------------
1067. CM p5 Diagnosticul intraoperator al leziunilor semnificative pancreatice post-traumatice se poate stabili prin:
(2102)\*\Intraoperative diagnosis of significant pancreatic post-traumatic lesions can be established through:
A) [ ] deschiderea larga a ligamentului gastro-colic si controlul fetei posterioare unde se pot descoperi leziuni in oglinda\*\The
wide opening of the gastro-colic ligament and control of the posterior face where you can find smooth lesions
B) [ ] mobilizarea colonului atunci cand sunt suspectate leziuni posterioare corporeo-caudale\*\mobilize the colon when posterior
corporal-caudal injuries are suspected
C) [x] manevra Kocher completata cu mobilizarea flexurii hepatice si portiuniia treia a doudenului pana la vasele mezenterice
superioare\*\the complete Kocher maneuver to mobilize the hepatic flexure and third portion of the duodenum up to the superior
mesenteric vessels
D) [x] inspectia potiunii retroperitoneale a duodenului si fetei posterioare a capului pancreatic\*\ inspection of the retroperitoneal
portion of the duodenum and posterior face of the head of the pancreas
E) [ ] tomografia computerizata ce poate aduce elemente decisive in diagnosticul leziunilor pancreatice\*\computerized
tomgraphy that can provide decisive elements in the diagnosis of pancreatic lesions
---------------------------------------------------------------------

142
1068. CM p5 Triada simtomatica clasica a hemobiliei cuprinde: (165)\*\The classic symptomatic triad of hemobilia comprises:
A) [x] icter\*\jaundice
B) [ ] stare febrila\*\feverish state
C) [ ] distensie abdominala\*\abdominal distension
D) [ ] hepatomegalie dureroasa\*\painful hepatomegaly
E) [x] HDS\*\superior digestive hemorrhage
---------------------------------------------------------------------
1069. CM p5 Care dintre leziunile traumatice ale intestinului subtire si mezenterului poate determina aparitia unei ocluzii intestinale?
(2108)\*\Which of the traumatic injuries of the small intestine and mesentery can determine the appearance of intestinal occlusions?
A) [x] hematomul parietal\*\parietal hematoma
B) [ ] escara parietala\*\parietal eschar
C) [ ] ruptura completa\*\complete rupture
D) [ ] hematomul mezenterului\*\mesenteric hematoma
E) [x] rupturile mezenterului\*\mesenteric rupture
---------------------------------------------------------------------
1070. CM p5 In cazul traumatismelor abdominale cu hemoragie abundenta, manevra PRINGLE, consta in: (2106)\*\In the case of
abdominal trauma with abundant hemorrhage, the Pringle maneuver, consists of:
A) [ ] aplicarea unei pense pe artera splenica\*\application of forceps to the splenic artery
B) [x] clampajul digital al pediculului hepatic\*\digital clamp of the hepatic pedicle
C) [ ] clampajul digital al arterei mezenterice superioare\*\digital clamp of the superior mesenteric artery
D) [ ] aplicarea unei pense pe trunchiul celiac\*\application of forceps to the celiac trunk
E) [x]aplicarea unei pense pe artera hepatica si vena porta\*\application of forceps to the hepatic artery and portal vein
---------------------------------------------------------------------
1071. CM p5 Semnul Blumberg poate fi pozitiv in: (2097)\*\Blumberg sign may be positive
A) [ ] etilism acut\*\acute alcoholism
B) [x] contuzii de perete abdominal\*\abdominal wall contusion
C) [ ] dupa administrarea de opiacee\*\after administration of opioids
D) [x] distensii intestinale paretice\*\distension due to intestinal paresis
E) [ ] eventratii posttraumatice\*\post-traumatic eventration
---------------------------------------------------------------------
1072. CM p5 Care din urmatoarele reprezinta indicatii clare pentru tomografie computerizata abdominala la traumatizati?
(2099)\*\Which of the following represent clear indications for abdominal computerized tomography in trauma patients?
A) [x] bolnavi stabili hemodinamic, dar cu examen clinic abdominal echivoc\*\patients which are hemodynamically stable, but
with ambigious clinical examination abdomen
B) [x] bolnavi cu traumatism de coloana vertebrala\*\patients with spinal column injury
C) [ ] bolnavi instabili hemodinamic si cu examen clinic abdominal echivoc\*\hemodynamically unstable patients with ambigious
clinical abdominal exam
D) [ ] bolnavi cu fracturi pelvine fara sangerare semnificativa\*\patients with pelvic fractures without significant bleeding
E) [ ] bolnavi cu traumatisme craniene deschise\*\patients with open head injury
---------------------------------------------------------------------
1073. CM p5 Prin ce se manifesta clinic perforatia esofagului abdominal? (2100)\*\How does abdominal esophageal perforation manifest?
A) [ ] varsaturi alimentare\*\vomiting food
B) [ ] dispnee, tuse seaca\*\dyspnea, dry cough
C) [x] stare febrila persistenta\*\persistent feverish state
D) [x] disfagie\*\dysphagia
E) [x] dureri vii retroxifoidiene sau retrosternale\*\pain coming retro-xyphoidial or retrosternally
---------------------------------------------------------------------
1074. CM p5 Flegmonul piostercoral retroperitoneal secundar leziunilor traumatice ale colonului se traduce prin: (2110)\*\The
piostercoral (?) pus of secondary retroperitoneal traumatic lesions of the colon is transmitted through
A) [x] crepitatii gazoase\*\gaseous crepitation
B) [x] tumefactie si durere lombara\*\swelling and back pain
C) [ ] disparitia matitatii hepatice\*\the disappearance liver dullness
D) [x] sindrom septic\*\septic syndrome
E) [x] lichid hiperseptic fetid sau puroi la punctie\*\ hyperseptic, fetid fluid or pus at puncture
---------------------------------------------------------------------
1075. CM p5 Care din urmatoarele afirmatii referitoare la traumatismele colonului sunt adevarate: (2109)\*\Which of the
following statements are true about colon trauma
A) [x] sunt grave\*\are serious
B) [ ] sunt frecvente (aparand in 50% din cazurile cu plagi penetrante)\*\are frequent (appearing in 50% cases with penetrating wounds)
C) [x] complicatiile infectioase sunt severe\*\the infectious complications are severe
D) [x] caracterul de gravitate este dat de septicitatea deosebita a continutului intestinului gros\*\The character of severity is shown
by the unusual septic content of the large intestine
E) [ ] complicatiile hemoragice sunt severe\*\hemorrhagic complications are severe

143
---------------------------------------------------------------------
1076. CM p5 Referitor la hematomul properitoneal posttraumatic urmatoarele afirmatii sunt adevarate cu exceptia (2094)\*\On
post-traumatic properitoneal hematoma, the following statements are true except
A) [x] apare dupa contuzii violente ce intereseaza musculatura lombara\*\occurs after violent contusion which involves the
thoracic musculature
B) [ ] se manifesta deseori prin sindrom Reily\*\often manifests thorough Reily syndrome
C) [x] tratamentul chirurgical se impune de urgenta in toate cazurile\*\surgery treatment is required to establish an emergency in all cases
D) [ ] evolueaza frecvent spre supuratie\*\frequently evolves towards suppuration
E) [ ] se poate prezenta ca un pseudosindrom de ocluzie intestinala paralitica\*\can present with a pseudo-syndrome of paralytic
intestinal obstruction
---------------------------------------------------------------------
1077. CM p5 Care sunt formele anatomo-patologice ce pot apare in cazul unui traumatism duodenal? (2101)\*\What are the
anatomo-pathologic forms that can appear in the case of a duodenal trauma?
A) [ ] hematomul mezenterului\*\mesenteric hematoma
B) [x] contuzia simpla cu echimoze subseroase\*\simple contusion with sub-serous ecchymosis
C) [x] ruptura completa\*\complete rupture
D) [x] contuzia cu escara\*\contusion with eschar
E) [ ] explozia duodenului\*\duodenal explosion
---------------------------------------------------------------------
1078. CM p5 Leziunile traumatice ale pancreasului evolueaza fazic, parcurgand urmatoarele etape: (2103)\*\Traumatic pancreatic
injuries evolve in phases by completing the following steps:
A) [x] stare de soc\*\state of shock
B) [ ] tablou clinic de ocluzie intestinala\*\clinical picture of intestinal obstruction
C) [x] interval liber\*\free interval
D) [x] tablou clinic de pancreatita acuta\*\clinical picture of acute pancreatitis
E) [ ] sindrom peritonitic\*\peritonitic syndrome
---------------------------------------------------------------------
1079. CM p5 Tratamentul chirurgical al plagilor intestinului subtire cuprinde: (2109)\*\Surgical treatment in wounds of the small
intestine include:
A) [ ] Enteroplicatura;\*\enteroplication;
B) [x] Hemostaza este primul gest util pentru stoparea pierderilor volemice;\*\Hemostasis is the first useful gesture to stop volemic losses;
C) [ ] Sutura simpla a oricaror leziuni;\*\simple suture of any injuries;
D) [ ] Splenectomia;\*\splenectomy;
E) [x] Plagile mari sau multiple si leziunile intinse ale mezenterului vor fi rezolvate prin enterectomie;\*\large or multiple wounds
and extensive lesions of mesentery will be resolved by enterectomy;
---------------------------------------------------------------------
1080. CM p5 Care sunt tehnicile chirurgicale curente folosite pentru rezolvarea leziunilor traumatice ale colonului?
(2110)\*\What are the current surgical techniques used to solve traumatic lesions of the colon?
A) [ ] rezectia anterioara Dixon\*\anterior Dixon resection
B) [x] colostomia\*\colostomy
C) [x] reparatia primara\*\primary repair
D) [x] rezectia cu anastomoza primara\*\resection with primary anastomosis
E) [ ] ileo-sigmoidostomia\*\ileo-sigmoidostomy
---------------------------------------------------------------------
1081. CS p4 Cancerele gastrice precoce slab diferentiate reprezinta:\*\Poorly differentiated early gastric cancers are:
A) [ ]80%\*\80%
B) [ ]70%\*\70%
C) [ ]50%\*\50%
D) [x]30%\*\30%
E) [ ]3%\*\3%
---------------------------------------------------------------------
1082. CS p4 Cel mai frecvent semn de cancer gastric este:\*\The most common sign of gastric cancer is:
A) [ ]hematemeza masiva\*\ Massive haematemesis
B) [ ]greata si varsaturile\*\nausea and vomiting
C) [ ]hepatomegalia\*\hepatomegaly
D) [x]anorexia cu scadere ponderala\*\anorexia with weight loss
E) [ ]disfagia\*\Dysphagia
---------------------------------------------------------------------
1083. CS p4 Incidenta ce mai ridicata a CG din intreaga lume esteintalnita in: (1205)\*\The highest incidence of gastric cancer worldwide is in
A) [ ]Statele Unite\*\United States
B) [ ]Malaezia\*\Malaysia
C) [x]Japonia\*\Japan
D) [ ]Chile\*\Chile

144
E) [ ]Islanda\*\Iceland
---------------------------------------------------------------------
1084. CS p4 Urmatoarele afirmatii referitoare la cancerul gastric sunt adevarate,cu exceptia: (1205)\*\] The following statements
are true regarding gastric cancer, except:
A) [ ]cancerul gastric este o tumora bilogic agresiva\*\gastric cancer is a biologically aggressive tumour
B) [ ]tumorile benigne ale stomacului sunt rare\*\benign tumors of the stomach are rare
C) [ ]adenocarcinomul gastric este responsabil pentru 95% din numarul total de tumori gastrice maligne\*\Gastric
adenocarcinoma is responsible for 95% of all malignant gastric tumors
D) [ ]dieta a fost cel mai studiat factor de risc pentru cancerul gastric\*\diet has been the most studied risk factor for gastric cancer
E) [x]ulcerul duodenal este un marker pentru dezvoltarea in continuare a cancerului gastric\*\Duodenal ulcer is a marker for
further development of gastric cancer
---------------------------------------------------------------------
1085. CS p4 Peste 90% din tumorile stomacului sunt: (1205)\*\Over 90% of stomach tumors are:
A) [ ]benigne\*\Benign
B) [x]maligne\*\ Malignant
C) [ ]leiomioame\*\ leiomyoma
D) [ ]leiosarcoame\*\ leiomyoma
E) [ ]polipoide\*\polypoid
---------------------------------------------------------------------
1086. CS p4 Riscul mai mare de aparitie al cancerului gastric este la persoanele cu grupa de sange : (1205)\*\higher risk of
developing gastric cancer is in people with blood type
A) [ ]0I\*\0I
B) [x]AII\*\All
C) [ ]BIII\*\BIII
D) [ ]ABIV\*\ABIV
E) [ ]BIII cu Rh-\*\BIII cu Rh-
---------------------------------------------------------------------
1087. CS p4 In stadializarea TMN: Tumora care penetreaza seroasa, fara interesarea structurilor adiacente este: (1207)\*\ In TMN
staging: serous tumor that penetrates without involving adjacent structures is
A) [ ]T1\*\T1
B) [ ]T2\*\T2
C) [ ]T2a\*\T2a
D) [x]T3\*\T3
E) [ ]T4\*\T4
---------------------------------------------------------------------
1088. CS p4 Cel mai frecvent semn de cancer gastric este: (1207)\*\The most common sign of gastric cancer is:
A) [x]anorexia cu scadere ponderala\*\anorexia with weight loss
B) [ ]dureri pelvine cu constipatie\*\pelvic pain with constipation
C) [ ]greata\*\nausea
D) [ ]hematemeza masiva\*\massive haematemesis
E) [ ]disfagia\*\ Dysphagia
---------------------------------------------------------------------
1089. CM p5 Selectati afirmatiile corecte referitoare la cancerul gastric precoce: (1208)\*\Select correct statements about early gastric cancer
A) [ ]tipul II C consta in leziuni subdenivelate,cu aspect erodat,de ulceratie profunda\*\ type II C lesions are subdenivelate,
looking eroded by deep ulceration
B) [x]supravietuirea la 5 ani cand sunt interesati ganglionii limfatici este de aprox 70%\*\survival at five years when lymph nodes
are involved is about 70%
C) [ ]tipurile I,II A,II B au o morfologie ulcerativa\*\ type I, IIA, IIB have ulcerative morphology
D) [ ]celulele canceroase pot invada musculara proprie in tipul III(leziuni escavate)\*\Cancer cells can invade its muscle in type
III (excavated lesions)
E) [x]interesarea ganglionilor limfatici predispune frecvent la recurente sistemice\*\involvement of lymph nodes predisposes to
systemic recurrence
---------------------------------------------------------------------
1090. CM p5 [CM37009] Despre tratamentul pacientilor cu cancer gastric se pot afirma urmatoarele: (1208,1209)\*\On the
treatment of patients with gastric cancer, the following can be stated:
A) [x]este in primul rand chirurgical\*\ is primarily surgical
B) [x]cea mai frecventa operatie efectuata pentru vindecare este gastrectomia radicala subtotala\*\The most common surgery
performed to cure is radical subtotal gastrectomy
C) [ ]radio si chimioterapia sunt extrem de utile\*\Radio and chemotherapy are extremely useful
D) [x]rezectia ofera singura posibilitate de vindecare a cancerului gastric\*\resection offers the only possibility of cure of gastric cancer
E) [x]gastrectomia este procedeul principal cu o mortalitate globala de 8%\*\ Gastrectomy is the main process with a global
mortality of 8%
---------------------------------------------------------------------

145
1091. CM p5 [CM37017] Prognosticul in CG e influentat de ()\*\Prognosis of GC is influenced by ()
A) [ ]marimea tumorii\*\ tumor size
B) [ ]hemoragii\*\bleeding
C) [x]invazia ganglionara\*\lymph node invasion
D) [x]profunzimea invaziei in peretel gastric\*\depth of invasion in gastric wall
E) [ ]obstructia progresiva\*\progressive obstruction
---------------------------------------------------------------------
1092. CM p5 [CM37013] Nivelul D3 de rezectie implica ganglionii aflati: (1209)\*\D3 resection level nodes are involved
A) [ ]In jurul arterei hepatice comune\*\ Around the Common hepatic artery
B) [x]In lungul ligamentului hepatoduodenal\*\Along the hepatoduodenal ligament
C) [ ]In jurul trunchiului celiac\*\Around the celiac trunk
D) [x]In jurul capului pancreasului\*\Around the head of pancreas
E) [x]La radacina mezenterului intestinului subtire\*\At the root of small intestine mesentery
---------------------------------------------------------------------
1093. CM p5 [CM37080] Tipul difuz de cancer gastric: (1206)\*\diffuse type of gastric cancer:
A) [ ]pare sa fie mai mult corelat cu influenata factorilor de mediu\*\seems to be more influenced by environmental factors
B) [x]incidenta lui relativa a crescut prin scaderea incidentei tipul intestinal\*\Relative incidence increased by decreasing the
incidence of intestinal type
C) [x]apare mai frecvent la oamenii tineri\*\is more common in young people
D) [ ]se asociaza cu metaplazia\*\ is associated with metaplasia
E) [x]se dezvolta prin mutatii ale tipului de celula din glandele gasrtice normale\*\develop mutations in the cellular type from
normal gastric glands
---------------------------------------------------------------------
1094. CM p5 [CM37033] Tipurile macroscopice de cancer gastric: (1205)\*\macroscopic types of gastric cancers
A) [x]superficial\*\superficial
B) [x]polipoid\*\polypoid
C) [ ]ulcerovegetant\*\ulcerovegetant
D) [x]ulcerative\*\ulcerative
E) [x]schiros\*\schiros
---------------------------------------------------------------------
1095. CM p5 Evenimentele moleculare care apar in patogenia celulei epiteliale, de la benign la malign, pot fi evenimente
precoce: (1207)\*\molecular events occurring in the pathogenesis of epithelial cells from benign to malignant, may be early events
A) [x]Instabilitate genetica\*\genetic instability
B) [ ]Supraexpresia factorului epidermal de crestere\*\ overexpression of epidermal growth factor
C) [x]Mutatia p53\*\p53 mutations
D) [ ]Actvarea oncogenelor\*\oncogenes activation
E) [x]Activitatea telomerazei\*\: telomerase activity
---------------------------------------------------------------------
1096. CM p5 Insamantarea peritoneala, intr-un cancer gastric poate determina: (1207)\*\peritoneal seeding, in gastric cancer may cause:
A) [x]ascita masiva\*\massive ascites
B) [x]tumora Krukenberg\*\ Krukenberg tumor
C) [x]semnul Blummer\*\Blummer sign
D) [ ]sindrom Meig\*\Meig syndrome
E) [ ]tumora Bremmer\*\Meig syndrome
---------------------------------------------------------------------
1097. CM p5 [CM37029] Leiomiosarcomul\*\Leiomyosarcoma
A) [ ]este cea mai frecventa dupa adenocarcinoamele gastrice\*\It is most common after gastric adenocarcinomas
B) [ ]are de obici dimensiuni mici,cresterea lui fiind f lenta\*\is usually small, its growth is very slow
C) [x]metastazeaza frecvent la nivelul ficatului\*\frequently metastasizes to the liver
D) [x]nu raspunde la chimio,radioterapie\*\ does not respond to chemotherapy, radiotherapy
E) [x]diagnosticul se pune de obicei datorita unei hemoragii gastro-intestinale sau consec malnutritiei\*\The diagnosis is made
usually due to gastrointestinal bleeding or malnutrition
---------------------------------------------------------------------
1098. CM p5 [CM37015] Referitor la limfomul gastric,sunt adevarate afirmatiile: (1209)\*\About gastric lymphoma, the
following are true statements:
A) [ ]Hemoragia apare intr-o proportie ridicata\*\Bleeding occurs is a high proportion
B) [x]Leziunea se prezinta ca o ingrosare a pliurilor epiteliale ale mucoasei\*\The lesion appears as a thickening of the epithelial mucosal folds
C) [x]Diagnosticul de certitudine este pus prin biopsie\*\ correct diagnosis is made by biopsy
D) [ ]Radioterapia prezinta o rata ridicata de morbiditate\*\Radiotherapy has a high rate of morbidity
E) [x]Satietatea precoce se datoreaza infiltrarii neoplazice progresive a peretelui gastric\*\Early Satiety is due to progressive
neoplastic infiltration of gastric wall
---------------------------------------------------------------------

146
1099. CM p5 [CM37067] Privitor la etiologia CG: (1205)\*\Regarding the etiology of CG:
A) [x]nitritii formeaza compusi mutageni atunci cand vin in contact cu acizii biliari intr-o cavitate gastrica stimulata\*\nitrite form
mutagenic compounds when in contact with bile acids in a stimulated gastric cavity
B) [x]aclorhidria reprezinta un factor de risc pentru CG atunci cand se supraadauga colonizarea bacteriana\*\achlorhydria is a risk
factor for GC when bacterial colonization is excessive
C) [ ]aclorhidria determinata de utilizarea pe termen lung a inhibitorilor pompei de protoni si a antagonistilor receptorilor H2 se
asociaza cu o incidenta crescuta a CG\*\achlorhydria caused by long-term use of proton pump inhibitors and H2 receptor
antagonists is associated with a high incidence of GC
D) [x]ulcerul duodenal e un factor de protectie contra CG\*\duodenal ulcer is a protective factor against GC
E) [x]alimentatia sarata reprezinta un factor de risc\*\ salty diet is a risk factor
---------------------------------------------------------------------
1100. CM p5 [CM37070] Gastrectomia radicala subtotala: (1208): \*\radical subtotal gastrectomy
A) [ ]e cea mai frecventa operatie efectuata in scop paliativ\*\Is the most common palliative surgery
B) [x]presupune excizia a 50-85% din stomac\*\50-85% involves excision of the stomach
C) [ ]limfadenectomia nu e necesara datorita metastazarii pe cale hematogena a carcinoamelor\*\lymphadenectomy is not
necessary due to haematogenous metastasis
D) [ ]se efectueaza cand leziunea neoplazica e situata la nivelul cardiei\*\is done when the neoplastic lesion is found in the cardia
E) [x]continuitatea e restabilita utilizand o gastrojejunostomie\*\ continuity is reestablished using a gastrojejunostomy
---------------------------------------------------------------------
1101. CM p5 [CM37088] In stadiile avansate ale cancerului gastric apar: \*\ in advanced gastric cancer occur:
A) [x]nodulul Virchow\*\Virchow node
B) [x]semnul Blumer\*\ Blumer sign
C) [ ]semnul Rowsing\*\Rowsing sign
D) [x]nodulul Sister-Joseph\*\-Sister Joseph nodule
E) [x]tumora Krukenberg\*\Krukenberg tumor
---------------------------------------------------------------------
1102. CM p5 [CM37098] Tipul intestinal al cancerului gastric: (1206)\*\intestinal type of gastric cancer
A) [x]apare pe o portiune modificata de metaplazie\*\appears on a modified portion of metaplasia
B) [x]displazia severa ar trebui sa constituie o indicatie de rezectie gastrica\*\severe dysplasia should be an indication of gastric resection
C) [ ]metaplazia intestinala indica iminenta sau coexistenta unui cancer gastric\*\intestinal metaplasia indicate imminent or
coexistence of gastric can
D) [ ]50% din tumori apar pe un stomac cu aclorhidrie\*\50% of tumors occur in the stomach with achlorhydria
E) [x]este tipul predominant\*\ is the predominant type
---------------------------------------------------------------------
1103. CM p5 Despre limfom sunt adevarate urmatoarele afirmatii ()\*\About lymphoma, the following statements are true
A) [ ]satietatea precoce este semn premonitor pt invadarea cardiei\*\ Early Satiety is a sign premonition for cardia invasion
B) [x]hemoragia apare rar\*\bleeding occurs rarely
C) [x]anorexia si scaderea in greutatea sunt cele mai frecvente\*\anorexia and weight loss are the most common
D) [x]radioterpaia singura determina remisiune pe termen lung\*\Only radiotherapy causes long-term remission
E) [x]supravietuire la 5ani este de 85 % cand tumora e limitata la stomac\*\Survival at 5years is 85% when the tumor is limited to the stomach
---------------------------------------------------------------------
1104. CM p5 [CM37104] Urmatoarele afirmatii nu sunt adevarate: (1207)\*\The following statements are true:
A) [x]nodulul lui Virchow este ganglionul palpabil in fosa subclaviculara stinga\*\Virchow's node is palpable in the left
supraclavicular fossa
B) [ ]nodulul Sister- Joseph reprezinta o metastaza ombilicala\*\-Sister Joseph nodule is an umbilical metastasis
C) [x]nodulul lui Virchow este ganglionul palpabil in fosa subclaviculara dreapta\*\Virchow's node is palpable in the right
supraclavicular fossa
D) [x]tumora Krukenberg este metastaza pancreasului\*\Krukenberg tumor is metastasis of the pancreas
E) [x]semnul lui Blumer apare in diseminarea mediastinala\*\Blumer's sign appears in mediastinal dissemination
---------------------------------------------------------------------
1105. CM p5 [CM37006] Tipurile de cancer gastric macroscopic sunt: (1205)\*\macroscopic gastric cancer types are:
A) [x]ulcerativ\*\ulcerative
B) [x]polipoid\*\polypoid
C) [x]cu localizare superficiala\*\the superficial location
D) [x]schiros\*\schiros
E) [ ]cu localizare profunda\*\with deep location
---------------------------------------------------------------------
1106. CM p5 [CM37081] Tipul celular cu inel in pecete (1206)\*\cell type with signet ring
A) [x]este determinat de secretia intracelulara de mucine\*\is determined by intracellular secretion of mucus
B) [x]este asociat cu cancerul schiros\*\is associated with schiros cancer
C) [ ]este determinat de secretia extracelulara de mucine\*\ is determined by the extracellular secretion of mucus
D) [ ]este asociat cu cancerul polipoid\*\is associated with polypoid cancer
E) [x]nu este asociat cu cancerul ulcerativ\*\is not associated with ulcerative cancer

147
---------------------------------------------------------------------
1107. CM p5 Selectati afirmatiile false legate de limfosarcomul gastric: (1209)\*\Select false statements related to gastric lymphosarcoma
A) [ ]poate fi manifestarea unei boli infiltrative sistemice\*\may be the manifestation of a systemic infiltrative disease
B) [x]gastrectomia este tratamentul de electie\*\gastrectomy is the treatment of choice
C) [x]este diagnosticat de regula in urma unei hemoragii gastrointestinale\*\is usually diagnosed after a gastrointestinal hemorrhage
D) [ ]diagnosticul este stabilit prin endoscopie si biopsie\*\The diagnosis is established by endoscopy and biopsy
E) [x]este cea mai rara dintre tumorile gastrice maligne\*\is the rarest of malignant gastric tumors
---------------------------------------------------------------------
1108. CM p5 [CM37075] Evenimetele moleculare precoce, in ceea ce privesc ocogeneza cancerului gastric, sunt: (1207)\*\early
molecular events in which gastric cancer metastasizes are:
A) [ ]activarea oncogenelor\*\activation of oncogenes
B) [ ]supraexpresia factorului epidermoid de crestere\*\Epidermoid growth factor overexpression
C) [x]instabilitatea genetica\*\Genetic instability
D) [x]activitatea telomerazei\*\ telomerase activity
E) [x]mutatia p53\*\p53 mutation
---------------------------------------------------------------------
1109. CM p5 [CM37024] Stadializarea TNM in neoplasmul gastric ()\*\TNM staging in gastric cancer ()
A) [ ]T2 reprezinta invadarea muscularei dar fara depasirea ei\*\T2 is muscle invasion without overfulfilling it
B) [ ]Tis este tumora limitata la mucoasa cu penetrarea membranei bazale in lamina proprie\*\Tis is tumor penetration limited to
the basement membrane lining the lamina propria
C) [ ]N2 cuprinde gg perigastrici sub 3 cm de tumora primara\*\N2 includes perigastric lymph nodes less than 3 cm from primary tumor
D) [x]N3 cuprinde gg paraaortici\*\N3 includes paraaortic lymph nodes
E) [x]N3 cuprinde gg mezenterici\*\N3 includes mesenteric lymph nodes
---------------------------------------------------------------------
1110. CM p5 [CM37107] Cancerul gastric precoce: (pg 1208)\*\early gastric cancer
A) [ ]nu intereseaza niciodata ganglionii limfatici\*\Does not involve lymph nodes
B) [x]este limitat la mucoasa si submucoasa\*\limited to mucosa and submucosa
C) [x]este detectat in 8-25% din cazuri in SUA\*\is detected in 8-25% of cases in the U.S.
D) [ ]tipul IIA are leziuni plate\*\ is detected in 8-25% of cases in the U.S.
E) [x]tipul II C are leziuni subdenivelate\*\ type II C has subdenivelate lesions
---------------------------------------------------------------------
1111. CS p4 [C2526060] Rechilibrarea volemica a bolnavului cu ocluzie intestinala se face dupa evaluarea pierderilor (aspiratie,
varsatura, diureza, etc) prin perfuzii cu solutii izotone de ser fiziologic si glucoza in doza de (pag. 2180)
A) [ ] 10-20 ml/ kg corp
B) [x] 30-50 ml/kg corp
C) [ ] 100-150 ml/kg corp
D) [ ] 100-150 ml/metru patrat suprafata corporala
E) [ ] 1500 ml ser fiziologic indiferent de greutate
---------------------------------------------------------------------
1112. CS p4[C1226004] Triada Konig descrisa in stenozele incomplete ale intestinului subtire cuprinde: (pag. 2173)
A) [ ] Zgomote hidroaerice care survin pe o perioada de acalmie, urmate de emisie de scaun
B) [ ] Colici de lupta cu accentuarea zgomotelor hidroaerice si ulterior perioade de acalmie
C) [x] Zgomote hidroaerice survenite dupa o ''colica de lupta'', urmate de scaune si ameliorare
D) [ ] Scaune asociate cu ''colici de lupta'' pe fond de distensie abdominala
E) [ ] Zgomote hidroaerice survenite dupa o ''colica de lupta'' urmate de ameliorare completa
---------------------------------------------------------------------
1113. CS p4 [C2226029] In care categorie de ocluzii apar de la inceput tulburari de circulatie parietala: (pag. 2171)
A) [x] volvulare
B) [ ] tulburari metabolice
C) [ ] colica biliara
D) [ ] hematoame postoperatorii
E) [ ] bride
---------------------------------------------------------------------
1114. CS p4 [C2326044] Obiectivele tratamentului in ocluzia intestinala sunt: (pag. 2180)
A) [ ] aspiratie naso-gastrica, rezolvarea cauzei de ocluzie, profilaxia recidivelor, corectarea volemiei
B) [x] reechilibrare hidro-electrolitica si metabolica, decompresiunea abdominala, rezvoltarea cauzei de ocluzie, prolilaxia recidivelor
C) [ ] clisma evacuatorie, aspiratie naso-gastrica, corectarea volemiei, rerzolvarea cauzei de ocluzie
D) [ ] reechilibrare hidro-electrolitica, aspiratie naso-gastriuca, stimularea motilitatii intestinale, clisma evacuatoriea
E) [ ] radiografie abdominala fara pregatire, aspiratie naso-gastrica, suprimarea cauzei de ocluzie, profilaxia recidivelor
---------------------------------------------------------------------
1115. CS p4 [C2526050] Ce este ileusul biliar? (pag. 2169)
A) [ ] o forma particulara de ocluzie functionala care insoteste colecistita gangrenoasa
B) [x] o ocluzie prin obstructie cu obstacol intraluminal (calcul biliar)

148
C) [ ] ocluzie dinamica secundara colecistopancreatitelor acute
D) [ ] ocluzia coledocului terminal printr-un calcul biliar migrat din vezicula biliara
E) [ ] atrezia congenitala a coledocului
---------------------------------------------------------------------
1116. CS p4 [C2826068] Ingrijirile postoperatorii in ocluziile intestinale constau in: (pag. 2182)
A) [ ] Reechilibrare sustinuta a bolnavului
B) [ ] Antibiotice cu spectru larg
C) [ ] Medicatie pentru stimularea reluarii tranzitului intestinal
D) [ ] Prevenirea complicatiilor postoperatorii
E) [x] Toate de mai sus
---------------------------------------------------------------------
1117. CS p4 [C1626027] Care din urmatoarele afirmatii privind ocluziile dinamice sunt adevarate: (pag. 2167)
A) [x] nu au obstacol
B) [ ] lumenul este partial stenozat
C) [ ] se asociaza cu tulburari circulatorii
D) [ ] se produc prin volvulare
E) [ ] se produc prin strangulare
---------------------------------------------------------------------
1118. CS p4 [C1526018] Care din afirmatiile referitoare la ocluziile prin invaginatie sunt adevarate: (pag. 2l69)
A) [ ] sunt ocluzii dinamice;
B) [ ] sunt ocluzii prin obstructie;
C) [ ] sunt favorizate de un mezou lung;
D) [x] apar datorita unei hiperperistaltici intestinale;
E) [ ] prespune telescoparea segmentului caudal in cel cranial
---------------------------------------------------------------------
1119. CM p5 [1235677] Ocluziile dinamice se produc prin: (pg 2169)
A) [x] hipoxie
B) [x] hemoragii digestive
C) [ ] TBC
D) [x] deshidratare
E) [ ] b Chron
---------------------------------------------------------------------
1120. CM p5. [C2226100] Din punct de vedere etiopatogenetic, ocluziile se clasifica in: (pag. 2168)
A) [x] dinamice
B) [ ] primitive
C) [ ] cronice
D) [ ] secundare
E) [x] mecanice
---------------------------------------------------------------------
1121. CM p5. [C2526160] In ocluziile intestinale prin strangulare durerea este: (pag. 2172-2173)
A) [x] brusca, intensa, continua, sincopala
B) [ ] surda, insotita de distensie treptata
C) [x] insotita de paloare, transpiratii, anxietate, stare de soc
D) [ ] progresiva, sub forma de colici de lupta
E) [ ] predomina semnele generale, durerea fiind de mica intensitate
---------------------------------------------------------------------
1122. CM p5 [C1526093] Ocluzia postoperatorie tardiva: (pag. 2180)
A) [ ] poate fi paralitica sau mecanica;
B) [x] este intotdeauna mecanica;
C) [ ] rezolvarea ei se poate face printr-o clisma evacuatorie;
D) [ ] apare dupa orice interventie operatorie ce deschide abdomenul;
E) [x] rezolvarea ei este numai chirurgicala
---------------------------------------------------------------------
1123. CM p5. [C2526164] Distensia abdominala este simetrica, generalizata de la inceput sau se generalizeaza ulterior in
urmatoarele tipuri de ocluzie intestinala: (pag. 2173)
A) [x] ocluziile paralitice
B) [ ] volvulusul de sigmoid
C) [ ] invaginatia intestinala
D) [ ] ocluziile duodeno-jejunale
E) [x] ocluziile joase
---------------------------------------------------------------------
1124. CM p5. [C2626190] Modalitatile de decompresie abdominala in ocluzia intestinala sunt: (pag. 2181)
A) [x] Intubarea recto-sigmoidiana cu o sonda Faucher

149
B) [ ] Rezectia segmentului intestinal afectat
C) [x] Instalarea unei sonde nazo-gastrice
D) [ ] Devolvulare sau dezinvaginare urmata de enterectomie segmentara in caz de devitalizarea acestora
E) [x] Golirea intraoperatorie a anselor pline de continut sero-lichidian
---------------------------------------------------------------------
1125. CM p5 [C1226072] Distensia ansei intestinale aparuta in ocluzia intestinala antreneaza o serie de perturbari ale
homeostaziei si fiziologiei intestinale si generale, reprezentate de: (pag. 2171)
A) [x] Tulburari de motilitate intestinala
B) [ ] Alcaloza in ocluziile joase, consecinta a pierderilor ionice
C) [x] Tulburari de absorbtie intestinala
D) [ ] Vasodilatatie periferica generalizata cu fenomene de furt sangvin
E) [x] Oligurie prin deshidratare si pierderile ionilor de sodiu
---------------------------------------------------------------------
1126. CM p5. [C2226115] Semnele generale intalnite in ocluzii sunt: (pag. 2174)
A) [x] anxietate
B) [ ] bradicardie
C) [ ] hipertensiunea arteriala
D) [x] greturi
E) [x] paloare
---------------------------------------------------------------------
1127. CM p5. [C2326143] La varstnici ocluziile se datoresc: (pag. 2180)
A) [ ] leziunilor neurologice induse de ateroscleroza,
B) [x] cancerelor colonice,
C) [ ] mega-dolicocolonului,
D) [x] volvulusului de sigmoid,
E) [x] inflamatiilor intraperitoneale (apendicite, colecistite)
---------------------------------------------------------------------
1128. CM p5. [C2526161] Varsaturile precoce sunt caracteristice pentru: (pag. 2173)
A) [ ] ocluziile joase
B) [ ] ocluziile dinamice
C) [x] ocluziile inalte
D) [x] ocluziile prin strangulare
E) [ ] neoplasmul de unghi splenic
---------------------------------------------------------------------
1129. CM p5. [C2526150] Ocluziile dinamice prin hipersimpaticotonie apar in: (pag. 2169-2170)
A) [ ] tbc intestinal
B) [x] traumatismele cranio-cerebrale
C) [x] torsiuni ale viscerelor abdominale
D) [ ] hipocalcemie
E) [ ] intoxicatia cu stricnina
---------------------------------------------------------------------
1130. CM p5 [C1526096] Diagnosticul diferential al ocluziilor intestinale se poate face cu: (pag. 2175)
A) [x] dilatatia acuta gastrica;
B) [x] infarctul entero-mezenteric;
C) [x] infarctul de miocard;
D) [ ] diverticulul Meckel;
E) [x] tumori gigante intraperitoneale
---------------------------------------------------------------------
1131. CM p5. [C2926200] In ocluzia intestinala prin strangulare: (pag. 2173)
A) [ ] Distensia abdominala se instaleaza lent;
B) [ ] Nu apare distensia abdominala;
C) [ ] Distensia abdominala este simetrica;
D) [x] Distensia abdominala este asimetrica;
E) [x] Distensia abdominala se instaleaza brusc;
---------------------------------------------------------------------
1132. CM p5. [C2526155] Distensia ansei intestinale secundara obstructiei determina staza venoasasi capilara, urmata de
tulburari de permeabilitate capilara Care sunt consecintele acestei importante tulburari fiziopatologice (pag. 2170-2171)
A) [x] edemul parietal
B) [ ] necroza ansei situate in amonte de obstructie
C) [x] acumularea de lichide in lumenul intestinal (sectorul III)
D) [x] ascita ocluziei
E) [ ] hiperpristaltism
---------------------------------------------------------------------

150
1133. CM p5 [C2526158] Ce tip de ocluzii intestinale sunt precedate de febra, mici frisoane si dureri abdominale difuze? (2172)
A) [ ] invaginatia intestinala
B) [ ] neoplasmele stenozante de jonctiune rectosigmoidiana
C) [x] ocluziile postoperatorii
D) [x] ocluziile inflamatorii
E) [ ] volvulusul de sigmoid
---------------------------------------------------------------------
1134. CM p5 [C2526166] In ocluziile intestinale, semnele generale sunt in functie de etiopatogenia ocluziei si momentul
examinarii In ocluziile prin strangulare, debutul sindromului ocluziv este insotit de urmatoarele semne generale: (p2174)
A) [ ] scadere ponderala
B) [x] anxietate, paloare tahicardie
C) [x] hipotensiune
D) [x] stare de soc
E) [ ] inapetenta selectiva
---------------------------------------------------------------------
1135. CM p5. [C2526167] in ocluziile intestinale, semnele care sugereaza deshidratarea severa sunt: (pag. 2174)
A) [x] oliguria
B) [x] faciesul hipocratic
C) [ ] edemele carentiale
D) [x] febra
E) [x] hipotensiunea
---------------------------------------------------------------------
1136. CM p5 [C1326082] Ocluziile prin obstructie (obturare) se pot produce prin: (pag. 2169)
A) [x] tumori
B) [x] compresiune extrinseca
C) [ ] infarct entero-mezenteric
D) [x] ghem de ascarizi
E) [x] leziuni inflamatorii intestinale specifice sau nespecifice
---------------------------------------------------------------------
1137. CM p5. [C2226120] Ocluzia prin obstructie se caracterizeaza prin: (pag. 2177)
A) [x] precedata de o suferinta cronica
B) [ ] debut cu dureri intense
C) [ ] meteorismul se instaleza rapid
D) [ ] starea generala se altereaza rapid
E) [x] durerile mai putin intense se continua cu ''colici de lupta''
---------------------------------------------------------------------
1138. CM p5. [C2226111] Varsaturile apar precoce dupa durere in ocluziile: (pag. 2173)
A) [x] inalte
B) [x] prin strangulare
C) [ ] postoperatorii
D) [ ] paralitice
E) [ ] joase
---------------------------------------------------------------------
1139. CM p5 Irigografia are indicatii limitate in ocluziile intestinale Ea poate confirma obstructia si ofera date referitoare la
sediul obstructiei In care tipuri de ocluzie intestinala irigografia poate fi In acelasi timp o metoda terapeutica? (p2174-2175)
A) [x] invaginatia intestinala
B) [ ] cancerul de colon drept
C) [x] volvulusul de sigmoid
D) [ ] ileusul meconial
E) [ ] ocluziile dinamice
---------------------------------------------------------------------
1140. CM p5. [C2226109] In ocluziile mecanice, ansa craniala: (pag. 2172)
A) [x] este destinsa
B) [x] are diametrul intre 4-10 cm
C) [x] este plina cu lichid si gaze
D) [ ] nu prezinta edem parietal
E) [ ] prezinta peristaltica
---------------------------------------------------------------------
1141. CS p4 Care din urmatoarele simptome apartine apendicitei acute: (1382)\*\ Which of the following symptoms belong to
acute appendicitis
A) [ ] disfagia\*\ Dysphagia
B) [ ] sialoreea\*\ Sialoreea
C) [x] anorexia\*\Anorexia

151
D) [ ] regurgitatia\*\Regurgitation
E) [ ] sughitul\*\ Hiccups
---------------------------------------------------------------------
1142. CS p4 [CS39021] Intr-o apendicita acuta necomplicata numarul leucocitelor, predominant PMN, este in jurul valorilor de:
(pg 1383)\*\ In uncomplicated acute appendicitis the number of leukocytes, predominantly PMN is around the values of:
A) [x] 10 000-18 000/mm3\*\ 10 000-18 000/mm3
B) [ ] < 10000/mm3\*\< 10000/mm3\
C) [ ] > 18000/mm3\*\> 18000/mm3
D) [ ] 6000/mm3\*\ 6000/mm3
E) [ ] < 5000/mm3\*\ < 5000/mm3
---------------------------------------------------------------------
1143. CS p4 [CS39069] Primul simptom al apendicitei acute, intalnit la peste 95% dintre pacienti este: (pag 1382)\*\The first
symptom of acute appendicitis, met over 95% of patients is:
A) [ ]leucocitoza\*\Leukocytosis
B) [ ]febra\*\Fever
C) [ ]durerea abdominala\*\Abdominal pain
D) [x]anorexia\*\Anorexia
E) [ ]constipatia\*\Constipation
---------------------------------------------------------------------
1144. CS p4 Distensia lumenului apendicular continua datorita: (p.1382)\*\ Appendicular lumen distension continue because
A) [ ]secretiei pulsatile a mucoasei intestinale\*\Pulsatile secretion of intestinal mucus
B) [ ]multiplicarii lente a bacteriilor locale din apendice\*\Slow local bacterial multiplication from appendix
C) [x]cresterii presiunii intraapendiculare\*\Increasing intrappendicular pressure
D) [ ]suprimarii presiunii venoase\*\Suppression of venous pressure
E) [ ]infarctelor elipsoidale de la nivelul marginii antimezenterice\*\Elipsoidal infarct at the level of the antimezenteric margin
---------------------------------------------------------------------
1145. CS p4 Tratamentul apendicitei acute la gravide este: (p1386)\*\Treatment of acute appendicitis in pregnancy is:
A) [x]chirurgical\*\Surgical
B) [ ]antibiotic\*\Antibiotic
C) [ ]antispastic\*\Antispastic
D) [ ]antiinflamator\*\Antiinflammatory
E) [ ]antialgic\*\Analgesic
---------------------------------------------------------------------
1146. CS p4 Rolul cel mai important al laparoscopiei in apendicita acuta este: (p1388)\*\ The most important role of laparoscopy
in acute appendicitis is:
A) [ ] permite vizualizarea in intregime a cavitatii abdominale\*\ Allow complete visualisation of abdominal cavity
B) [x] evaluarea femeilor tinere care au simptome diferite de cele ale apendicitei clasice si a pacientilor cu diagnostic
incert\*\Assessment of young women who have symptoms different from classic appendicitis and patients with uncertain diagnosis
C) [ ] timpul operator este folosit eficient\*\Operation time is followed efficiently
D) [ ] reducerea ratei infectiilor postoperatorii\*\Reduced postop infection rate
E) [ ] diferentierea de patologia ginecologica acuta\*\ Differential diagnosis of acute gynaecologic pathology
---------------------------------------------------------------------
1147. CS p4 [CS39066] Imagini fals pozitive la ecografia in apendicita acuta sunt urmatoarele, cu exceptia: (pag. 1383)\*\False
positive images on echography in acute appendicitis are the following except:
A) [ ]proces inflamator periapendicular\*\Periappendicular inflammatory process
B) [ ]dilatarea trompelor uterine\*\Dilated fallopian tubes
C) [ ]resturi de fecale neevacuate\*\Non evacuated fecal waste
D) [ ]obezi\*\Obese
E) [x]apendice retrocecal\*\Retrocecal appendix
---------------------------------------------------------------------
1148. CS p4 [CS39031] In gastroenterita cu Salmonella intalnim: (Pg. 1385)\*\ In gastroenteritis with salmonella we meet:
A) [ ] Leucocitoza\*\ Leukocytosis
B) [ ] Leucopenie\*\ Leukopenia
C) [x] Leucocite normale\*\ Normal Leukocyte
D) [ ] Devierea la stanga a formulei leucocitare\*\ Deviation to the left of the leukocyte formula
E) [ ] Limfocitoza\*\ Lymphocytosis
---------------------------------------------------------------------
1149. CM p5 [CM39102] Cel mai comun diagnostic preoperator eronat este in ordine descrescatoare frecventei (p1385)\*\The
most common preop misdiagnosis is in descending frequency:
A) [x]limfadenita mezenterica, BIP,chist ovarian bilateral,ruptura folicul de graaf, gastroenterita acuta\*\Mesenteric
lymphadenitis, BIP, Bilateral Ovarian cyst, Graff follicle rupture, Acute gastroenteritis
B) [ ]BIP,limfangita mezenterica,ruptura folicul de graaf,chist ovarian,gastroenterita acuta\*\BIp, Mesenteric lymphangitis,
rupture of the graff follicle, Ovarian cyst, acute gastroenteritis

152
C) [x]limfadenita mezenterica,boala inflamatorie acuta pelvina,,chist ovarian bilateral\*\Mesenteric lymphadenitis,Acute pelvic
inflammatory disease, bilateral ovarian cyst
D) [ ]diverticul Mekel,BIP,RUptura foliculului de graaf, torsiune de ovar\*\Meckel diverticulum, BIP, Rupture of the graff
follicle, Ovary torsion
E) [ ]diverticul Mekel,ruptura de folicul de graaf,limfadenita mezenterica\*\Meckel diverticulum, graff follicle rupture,
mesenteric lymphadenitis
---------------------------------------------------------------------
1150. CM p5 Manifestarile clinice ale apendicitei acute sunt: (p1382)\*\Clinical manifestation of acute appendicitis are
A) [x]durerea abdominala\*\Abdominal pain
B) [x]anorexia\*\Anorexia
C) [x]voma\*\Vomiting
D) [x]constipatia\*\Constipation
E) [ ]hemoptizia\*\Hemoptysis
---------------------------------------------------------------------
1151. CM p5 [CM39029] Cele mai frecvent izolate microorganisme in apendicite sunt: (Pag. 1382)\*\The most frequent
microorganism isolated in appendicitis
A) [x]Bacteroides fragilis\*\Bacteroides fragilis
B) [ ]Bacilul piocianic\*\Bacilul piocianic
C) [x]Escherichia coli\*\Escherichia coli
D) [ ]Bacteroides subtilis\*\: Bacteroides subtilis
E) [ ]Mycoplasma\*\: Mycoplasma
---------------------------------------------------------------------
1152. CM p5 [CM39129] Apendicele - aspect ecografic normal: (p.1383)\*\The Appendix - normal echographic appearance
A) [x]structura tubulara inchisa la un capat\*\closed tubular structure
B) [x]usor compresibil\*\easily compressible
C) [x]diamentrul <5 mm\*\the diameter<5 mm
D) [ ]diametrul > 6 mm\*\the diameter > 6 mm
E) [ ]aspect de semiluna\*\crescent appearance
---------------------------------------------------------------------
1153. CM p5 [CM39111] Germenii cei mai frecvent izolati in cadrul apendicitelor acute sunt (pg1382)\*\germs most commonly
isolated in the acute apendicitelor are
A) [x]Bacteroides fragilis\*\The Bacteroides fragilis
B) [ ]Stafilococ\*\Staphylococcus
C) [x]E Coli\*\E Coli
D) [ ]Camylobacter\*\Camylobacter
E) [ ]Yersinia\*\Yersinia
---------------------------------------------------------------------
1154. CM p5 Distensia apendicului in apendicita acuta determina:(1382)\*\appendectomy in acute appendicitis cause distension
A) [ ]oprirea tranzitului pentru gaze si fecale\*\Stopping for gas transit and faecal
B) [x]greata\*\nausea
C) [x]vome\*\vomiting
D) [x]durere mai intensa\*\more intense pain
E) [ ]inflamarea anexei drepte\*\ inflammation Annex straight
---------------------------------------------------------------------
1155. CM p5 [CM39165] Apendicita acuta: (Pag 1381)\*\Acute appendicitis is:
A) [x]Este una dintre cele mai frecvente afectiuni chirurgicale\*\one of the most frequent surgical diseases
B) [ ]Este mai frecventa la sexul masculin, incidenta crescid paralel cu virsta,\*\it is more frequent with males, with an increased
incidence proportion due to agin
C) [x]Incidenta creste paralel cu dezvoltarea tesutului limfoid, avind un apogeu la tinerete\*\the incidence increases in proportion
with the development of lymphatic tissue, with a peak in the young early life
D) [ ]Factorul dominant cauzant este obstructia lumenului datorate hipertrofiei tesutului limfoid apendicular\*\ the dominant
cause is the obstructed lumen due to the hypertrophy of the appendicular lymphatic tissue
E) [x]Frecventa obstructiei creste proportional cu severitatea procesului inflamator\*\The rate of incidence of obstruction
increases directly proportional to the inflammation process.
---------------------------------------------------------------------
1156. CM p5 [CM39004] Cele mai severe complicatii precoce aparute in apendicita acuta sunt: (pag. 1389)\*\The most severe
early complication appearing in acute appendicitis are:
A) [x]septice\*\Sepsis
B) [x]infectia plagii\*\Wound infection
C) [ ]perforatia apendiculara\*\Appendiculat perforation
D) [ ]peritonita\*\Peritonitis
E) [x]abcesele\*\Abscess
---------------------------------------------------------------------

153
1157. CM p5 Abcesele intraabdominale secundare perforatiei sau gangrenei apendiculare se localizeaza cu predilectie in:
(p1390)\*\ Intraabdominal abscesses following perforation or appendicular gangrene are mainly localized in:
A) [x]fosa apendiculara\*\ the appendicular fossa
B) [x]fundul de sac Douglas\*\the cul-de-sac of Douglas
C) [x]spatiul subhepatic\*\the subhepatic area
D) [ ]spatiul suprahepatic\*\the suprahepatic area
E) [x]spatiul dintre ansele intestinale\*\the space between intenstinal ansas
---------------------------------------------------------------------
1158. CM p5 Perforatia apendiculara se poate suspecta in caz de: (p1384)\*\Appendicular perforation is suspected in case of:
A) [x]febra peste 39 grade\*\fever higher than 39! C
B) [x]leucocitoza peste 18000/mmc\*leukocitosis over 18000/mmc\
C) [ ]leucopenie sub 4000/mmc\*\leucopenia under 4000/mmc
D) [ ]febra peste 41 grade\*\fever higher than 41! C
E) [ ]trombocitopenie\*\ thrombocytopenia
---------------------------------------------------------------------
1159. CM p5 Perforatia apendiculara (pag 1384)\*\Appendicular perforation
A) [x]apare distal de obstructie de-a lungul marginii antemezenterice\*\Appear distal to the obstruction along the antemesenteric margin
B) [x]febra > 39 grade\*\Fever > 39 degrees
C) [x]leucocite> 18000/mmc\*\Leukocytes > 18000/mmc
D) [ ]absenta febrei\*\No fever
E) [ ]absenta durerii abdominale\*\No abdominal pain
---------------------------------------------------------------------
1160. CM p5 In apendicita acuta procesul inflamator intereseza: (p.1382)\*\In acute appendicitis acute inflammation interest:
A) [ ]ileonul terminal\*\Terminal ileum
B) [ ]marele epiploon\*\Big Epiploon
C) [x]seroasa apendiculara\*\Appendix serrosa
D) [x]peritoneul parietal regional\*\Regional Parietal peritoneum
E) [ ]cecul\*\Caecum
---------------------------------------------------------------------
1161. CM p5 [CM39137] Apendicita la gravide: (pag. 1386)\*\Appendicitis with pregnancy :
A) [x]diagnosticul devine dificil pe masura dezvoltarii sarcinii daca apendicele e plasat lateral si superior\*\ the more advanced
the pregnancy, the more difficult the diagnosis if the appendix is positioned up and sideways
B) [ ]poate sa apara doar pe parcursul primelor 2 trimestre\*\can occur only during the first two semesters
C) [ ]laparoscopia este contraindicata\*\laparoscopy is not recommended
D) [x]poate sa apara in orice moment al sarcinii\*\may occur at any time during pregnancy
E) [x]durerea abdominala si apararea musculara sunt prezente\*\abdominal pain and muscular defense are present
---------------------------------------------------------------------
1162. CM p5 [CM39103] Situsuri predilecte pentru abcesele intraabdominale dezvoltate pos perforatie apendiculara sunt:
(p1390)\*\Favorite sites for for intraabdominal abscess after appendix perforation are:
A) [ ]spatiul suprahepati\*\Suprahepatic space
B) [x]spatiul subhepatic\*\Subhepatic space
C) [x]spatiul dintre ansele intestinale\*\Space inbetween intestinal loops
D) [x]fundul de sac Douglas\*\Base of douglas pouch
E) [ ]fisa ischio-rectala\*\Ischio-Rectal sheath
---------------------------------------------------------------------
1163. CM p5 [CM39119] Poate da o imagine fals pozitiva la ecografie, pentru dg de apendicita acuta: (pg 1383)\*\May give a
false positive ultrasound for acute appendicitis diagnosis:
A) [x]proces inflamator periapendicular determinat de inflamatia tesuturilor limitrofe\*\Inflammatory process periappendicular
determined by lymphoid tissue inflammation
B) [x]dilatare a trompelor uterine\*Dilated fallopian tubes\
C) [x]resturi de fecale neevacuate ce mimeaza un apendicolit\*\Fecal Remnants not evacuated which mimic appendicolitis
D) [ ]limitare process inflamtor la varful apendicelui\*\Limit of inflammatory process at the appendix peak
E) [x]la obezi datorita tesutului adipos apendice incompresibil\*\ Adipose tissue in obese due to appear incompressible
---------------------------------------------------------------------
1164. CM p5 Cele mai frecvente bacterii intr-o apendicita acuta sunt:(1382)\*\The most frequent bacteria in acute appendicitis are:
A) [ ]Lactobacilus\*\Lactobacilus
B) [x]Bacteroides fragilis\*\Bacteroides fragilis
C) [ ]Pseudomonas\*\Pseudomonas
D) [x]E\*\E
E) [ ]Bacteroides splanchicus\*\Bacteroides splanchicus
---------------------------------------------------------------------
1165. CM p5 [CM39006] Semnul psoasului: (pg 1382)\*\Psoas sign:
A) [x]indica un focar iritativ in vecinatatea muschiului\*\Indicated a focal irritation in the vicinity of the muscle

154
B) [ ]se mai numeste semnul Rowsing\*\Is also named Rowsing sign
C) [x]se realizeaza cu pacientul in decubit lateral stang\*\Is done with patient in the left lateral decubitus
D) [ ]este pozitiv daca produce aparare musculara\*\Is positive if muscular defense is produced
E) [ ]se realizeaza cu pacientul in supinatie\*\\Is done with patient in supine *\
---------------------------------------------------------------------
1166. CM p5 [CM39083] Diagnosticul diferential al apendicitei acute se face cu urmatoarele afectiuni ginecologice: (Pg.
1386)\*\Differential diagnosis in acute appendicitis can be made with the following gynaecologic diseases:
A) [x]Endometrioza\*\Endometriosis
B) [ ]Fibromul uterin subseros\*Subseros uterine fibroma\
C) [ ]Chist ovarian netorsionat\*\Ovarian cyst not torsioned
D) [ ]Diverticul Maeckel\*\Ovarian cyst not torsioned
E) [x]Ruptura foliculului Graaf\*\Rupture of the graff follicle
---------------------------------------------------------------------
1167. CM p5 [CM39026] Dg diferential in apendicita acuta depinde de urmat factori majori ()\*\Differential diagnosis in acute
appendicitis depends on the following major factors
A) [x]pozitia anatomica\*\Anatomic position
B) [ ]localizarea durerii\*\Pain localisation
C) [x]sex\*\Gender
D) [x]varsta\*\Age
E) [x]stadiul procesului inflamator\*\Stage of the inflammatory process
---------------------------------------------------------------------
1168. CM p5 [CM39168] Factorii principali implicate in mortalitatea prin apendicita acuta sunt: (Pag. 1389)\*\The important
lethal factors in acute appendicitis are:
A) [x]Perforatiile aparute anterior tratamentului chirurgical\*\perforations that occurred before the surgery treatment
B) [x]Virsta pacientului\*\the patient's age
C) [ ]Starea de nutritie\*\nutrition
D) [ ]Ocluzia intestinala\*\intestinal occlusion
E) [ ]Sexul\*\the patient's sex
---------------------------------------------------------------------
1169. CM p5 Diagnosticul diferential al apendicitei acute se poate face cu urmatoarele afectiuni genito-urinare masculine:
(1385)\*\Differential diagnosis in acute appendicitis can be done with the following male genitor-urinary pathology:
A) [ ]hidrocel\*\Hydrocele
B) [x]torsiunea de testicul\*\Testicular torsion
C) [x]epididimita acuta\*\Acute epididymitis
D) [ ]orhita acuta\*\Acute orchitis
E) [x]inflamatia veziculelor seminale\*\Inflammation of seminal vesicle
---------------------------------------------------------------------
1170. CM p5 Cele mai frecvente specii de microrganisme ce au fost cultivate din lichidul peritoneal in apendicitele gangrenoase,
perforate: (1382)\*\The most frequent microorganism cultured in the peritoneal fluid in perforated gangrenous appendix:
A) [ ]Peptostreptococul\*\Peptostreptococul
B) [x]Bacterodeides fragilis\*\Bacterodeides fragilis
C) [ ]Bacteroides spahnicus\*\Bacteroides spahnicus
D) [x]Escheria Coli\*\Escheria Coli
E) [ ]Lactobacilul\*\Lactobacilul
---------------------------------------------------------------------
1171. CS p4 Cu privire la eliminarea sursei de contaminare din peritonite sunt false urmatoarele afirmatii (p2141,2142)\*\The
source of contamination removal from peritonitis following statements are false
A) [ ]Calea de abord si tehnica operatorie variaza cu localizarea si natura patologica a leziunii\*\Route of approach and surgical
techniques vary with location and nature of the pathological lesion
B) [ ]Excizia si sutura perforatiei unui viscer prezinta riscul dezunirii\*\Excision and suture perforation of visceral dezunirii at risk
C) [x]Drenajul extern al organului perforat se foloseste la toti bolnavii\*\External drainage of the perforated body is used in all patients
D) [ ]Rezectia sursei primare de infectie este de preferat\*\Resection of primary source of infection is preferable
E) [ ]Prin celioscopie se poate efectua evacuarea puroiului, lavajul peritoneal si tratarea perforatiei\*\By celioscopy may be pus
discharge, and treatment of peritoneal lavaje perforation
---------------------------------------------------------------------
1172. CS p4 [C1325007] Peritonitele primare la cirotici: (p2137)\*\Primary peritonitis in cirrhotic patients:
A) [x]Sunt infectii monomicrobiene\*\Are mono microbial Infections
B) [ ]Cel mai frecvent sunt produse de coci\*\The most frequently produced by cocci
C) [ ]Peste jumatate din bolnavi sunt asimptomatici\*\Over half of patients are asymptomatic
D) [ ]Lichidul de ascita este steril\*\Ascitis fluid is sterile
E) [ ]Diagnosticul se confirma prin hemocultura\*\Diagnosis is confirmed by blood cultures
---------------------------------------------------------------------

155
1173. CS p4 [C2625063] Principiile tratamentului chirurgical in peritonitele acute secundare au fost enuntate de Kirschner inca
din 1926. Acestea sunt urmatoarele, cu exceptia: (2141)\*\] Principles of surgical treatment in secondary acute peritonitis were set
forth by Kirschner in 1926. They are the following, except:
A) [ ]Eliminarea sursei de contaminare\*\Remove source of contamination
B) [ ]Reducerea contaminarii\*\Reducing contamination
C) [x]Tratamentul antibiotic este veriga terapeutica esentiala, substituind cu succes chirurgia\*\Antibiotic treatment is essential
therapeutic ring, replacing successfully the surgery;
D) [ ]Tratarea infectiei reziduale\*\Treatment of residual infection
E) [ ]Prevenirea recurentei infectiei\*\Prevention of recurrent infection
---------------------------------------------------------------------
1174. CS p4 [C1525020] Care afirmatie din enunt referitoare la peritonitele secundare este adevarata: (p2118)\*\\ Which
statement referring the secondary peritonitis is true:
A) [ ]constituie mai putin de 5% din totalul peritonitelor\*\Is less than 5% of total peritonitis
B) [ ]frecvent se asociaza cu debutul sindromului de disfunctie multipla de organe;\*\Frequently associated with onset of multiple
organ dysfunction syndrome;
C) [ ]reprezinta localizarea de catre peritoneu a infectiei\*\Represents the location of the peritoneum to infection
D) [ ]sunt frecvent monomicrobiene\*\Are frequently mono microbial
E) [x]sunt datorate mai ales distrugerii tractului digestiv si constituie grupul cel mai numeros (peste 90%) din totalul
peritonitelor\*\due mainly by destruction of digestive tract and is the largest group (90%) of total peritonitis
---------------------------------------------------------------------
1175. CS p4 Care dintre peritonitele acute pot debuta prin diaree (p2130)\*\ Which of acute peritonitis can start with diarrhea
A) [ ]peritonita gonococic?\*\Gonococcal peritonitis?
B) [x]peritonita pneumococic? sau streptococic?\*\Pneumococcal peritonitis? or strep
C) [ ]peritonita cu piocianic\*\Peritonitis by Pseudomonas
D) [ ]peritonitele nozocomiale\*\Nosocomial peritonitis
E) [ ]peritonitele postoperatorii\*\Postoperative peritonitis
---------------------------------------------------------------------
1176. CS p4 [C2525046] Inflamatia peritoneului determina conform legii lui Stokes: (2128)\*\According to Stokes' law
inflammation of the peritoneum determine:
A) [ ]vasodilatatia vaselor mezenterice\*\mesenteric vessels vasodilatation
B) [x]paralizia musculaturii netede intestinale\*\Paralysis of intestinal smooth muscle
C) [ ]spasmul musculaturii netede intestinale\*\Intestinal smooth muscle spasm
D) [ ]cresterea permeabilitatii capilare\*\Increased capillary permeability
E) [ ]paralizia musculaturii abdominale\*\Abdominal muscle paralysis
---------------------------------------------------------------------
1177. CS p4 [C2825065] Care dintre urmatoarele fac parte din principalele cauze ale abcesului subfrenic in peritonita localizata?
(2150)\*\Which of these are part of the main causes of subfrenic abscess in localized peritonitis ?
A) [ ]Perforatia gastrica sau duodenala\*\Gastric or duodenal perforation
B) [ ]Apendicita\*\Appendicitis
C) [ ]Angiocolita\*\Angiocolitis
D) [ ]Abces sau chist de pancreas\*\Pancreatic abscess or cyst
E) [x]Toate de mai sus\*\All the above
---------------------------------------------------------------------
1178. CS p4 [C2525045] Diametrul orificiilor contractile (''stomata'') din peritoneul diafragmatic este de: (pag. 2124)\*\The
diameter of contractile holes ("stoma") of the peritoneal diaphragm is:
A) [ ]5-6 microni\*\5-6 microns
B) [ ]9-10 microni\*\9-10 microns
C) [x]8-12 microni\*\8-12 microns
D) [ ]10-14 microni\*\10 to 14 microns
E) [ ]12-14 microni\*\12 to 14 microns
---------------------------------------------------------------------
1179. CM p5 [C2825221] Care din afirmatiile de mai jos sunt adevarate cu privire la peritonitele acute primare? (pag.
2137)\*\Which of the following statements are true about acute primary peritonitis?
A) [ ]Apar in prezenta unui focar infectios intraabdominal\*\Appear in the presence of intra-abdominal infectious outbreak
B) [x]Pot apare la orice varsta, dar sunt prevalente la copil\*\Can occur at any age but are more prevalent in children
C) [x]Clinic se manifesta cu semne generale de infectie\*\Clinical signs manifest general infection
D) [ ]In majoritatea cazurilor sunt polimicrobiene\*\In most cases are polymicrobial
E) [ ]Tratamenul peritonitelor primare se bazeaza pe tratamentul chirurgical\*\treatment of peritonitis based on primary surgery
---------------------------------------------------------------------
1180. CM p5 [C1325075] Peritonitele acute se clasifica in: (pag. 2117)\*\Acute peritonitis are classified in:
A) [x]Peritonite primare\*\Primary Peritonitis
B) [x]Peritonite secundare\*\Secondary Peritonitis
C) [ ]Peritonite simultane\*\Peritonitis simultaneous

156
D) [x]Peritonite tertiare\*\Tertiary Peritonitis
E) [x]Abcese intraabdominale\*\intra abdominal abscess
---------------------------------------------------------------------
1181. CM p5 [C2525152] Clasificarea etiopatogenica a peritonitelor (modificarea clasificarii Hamburg) imparte peritonitele in:
(p2118)\*\Etiopathogenic classification of peritonitis (changing the classification of Hamburg) divides peritonitis into:
A) [ ]peritonite acute difuze\*\acute diffuse peritonitis
B) [x]peritonite primare\*\primary peritonitis
C) [x]peritonite secundare\*\secondary peritonitis
D) [x]peritonite tertiare\*\Tertiary peritonitis
E) [x]abcese intraabdominale\*\abdominal abscess
---------------------------------------------------------------------
1182. CM p5 [C1225071] In peritonitele acute celula tinta pentru endotoxina este macrofagul, pe care se fixeaza prin urmatoarele
tipuri de receptori (p2120)\*\In acute peritonitis the target cell for endotoxin is macrophage, on which is fixed by these types of
receptors
A) [x]CD14\*\ CD14
B) [x]LDL acetilati\*\Acetylated LDL
C) [ ]CD4\*\CD4
D) [x]Glicoproteina\*\Glycoprotein
E) [x]CD18\*\CD18
---------------------------------------------------------------------
1183. CM p5 Principiile tratamentului chirurgical al peritonitelor acute expuse de Kirschner se refera la: (p2141)\*\Principles of
surgical treatment in acute peritonitis by exposed Kirschner refers to
A) [x]Eliminarea sursei de contaminare\*\Remove source of contamination
B) [ ]Interventie tardiva\*\Intervention late
C) [x]Reducerea contaminarii\*\Reducing contamination
D) [ ]Rezectia sursei primare nu se executa de electie\*\Resection of primary source does not perform elective
E) [x]Tratarea infectiei reziduale si prevenirea recurentiei infectie\*\ Treatment of residual infection and infection prevention appellants
---------------------------------------------------------------------
1184. CM p5 Care dintre urmatoarele criterii clinice definesc SIRS in peritonita acuta? (p2126)\*\Which of the following clinical
criteria defining SIRS in acute peritonitis?
A) [ ]Temperatura rectala >37C sau <35C\*\Rectal temperature> 37c or <35C
B) [x]Ritm cardiac >90 batai/minut\*\Heart rate> 90 beats / minute
C) [ ]Ritm respirator <20 respiratii/minut\*\Respiratory rate <20 breaths / minute
D) [x]Pa CO2 <32 mmHg\*\Pa CO2 <32 mmHg
E) [ ]Leucocite >8000/mm3\*\WBC> 8000/mm3
---------------------------------------------------------------------
1185. CM p5 In definirea SIRS (Sistemic Inflamatory Response Syndrome) intra urmatoarele criterii (2126)\*\In SIRS definition
(Systemic Inflamatory Response Syndrome) enter the following criteria
A) [ ]Temperatura (rectala) > 39 C sau <36 C\*\Temperature (rectal)> 39 C or <36A C
B) [x]Ritm cardiac > 90 batai/min\*\Heart rate> 90 beats / min
C) [ ]Ritm respirator >25 respiratii/min sau PaCO2 <32 mmHg\*\Respiratory rate> 25 breaths / min or PaCO2 <32 mmHg
D) [x]Leucocite >12000/mmc sau <4000/mmc sau 10% neutrofile tinere\*\WBC> 12000/mmc or < 4000/mmc or 10% young neutrophils
E) [ ]pH ser <7,24\*\Serum pH <7.24
---------------------------------------------------------------------
1186. CM p5 Peritonitele acute primare au urmatoarele cracteristici: (2137)\*\Primary acute peritonitis have the following
characteristics
A) [x]sunt prevalente la copil, pe un teren nefrotic\*\Primary acute peritonitis have the following characteristics (p. 2137)
B) [x]contractura este mai rar intalnita decat apararea musculara\*\contracture is less common than muscular defense
C) [ ]in majoritatea cazurilor sunt polimicrobiene\*\ in most cases are poly microbial
D) [ ]tratamentul peritonitelor primare se bazeaza pe chirurgie\*\primary peritonitis treatment is based on surgery
E) [ ]au evolutie favorabila\*\ have a favorable evolution
---------------------------------------------------------------------
1187. CM p5 Care dintre urmatoarele afirmatii legate de examenele paraclinice in peritonitele acute difuze sunt false:
(p2132)\*\Which of the following statements relating to paraclinical examinations in acute diffuse peritonitis are false:
A) [ ]Radiografia abdominala simpla arata stergerea umbrei psoasului\*\Simple abdominal radiograph shows delete psoas shadow
B) [ ]Leucopenia poate fi prezenta la varstnici si este semn de gravitate\*\the leukopenia may be present in the elderly and is a
sign of seriousness
C) [x]Tomografia computerizata se practica de rutina\*\computer tomography is a routine practice
D) [x]Punctia lavaj a cavitatii peritoneale este contraindicata\*\Lavage punction of peritoneal cavity is contraindicated
E) [ ]Celioscopia ofera posibilitatea infectarii intregii cavitati peritoneale\*\Celioscopy allows inspection of the entire peritoneal
cavity
---------------------------------------------------------------------

157
1188. CM p5 [C2925225] In peritonita biliara fara perforatie aparenta au fost identificati urmatorii factori (pag 2134)\*\The
biliary peritonitis without apparent perforation were identified following factors
A) [x]mecanic\*\Mecanical
B) [x]infectios\*\Infectious
C) [x]vascular\*\Vascular
D) [x]enzimatic\*\Enzyme
E) [ ]imunologic\*\Immunological
---------------------------------------------------------------------
1189. CM p5 Tabloul clinic in peritonitele difuze postoperatorii poate simula: (2135)\*\The clinical picture in diffuse
postoperative peritonitis may simulate:
A) [x]embolia pulmonara\*\Pulmonary embolism
B) [ ]insuficienta renala acuta\*\acute renal failure
C) [x]infarctul miocardic\*\myocardial infarction
D) [x]septicemia\*\ septicemia
E) [ ]accidentul vascular cerebral\*\stroke
---------------------------------------------------------------------
1190. CM p5 Diagnosticul diferential al peritonitelor acute difuze se face cu: (2140)\*\Differential dgs.of acute diffuse peritonitis is done with:
A) [x]Abdomenul acut medical\*\FMedical acute abdomen
B) [ ]Tumori cerebrale cu manifestari digestive\*\Brain tumors with gastrointestinal manifestations
C) [ ] Falsul abdomen acut chirurgical\*\False surgical acute abdomen
D) [ ]Sarcina\*\ Pregnancy
E) [x]Alte cauze de abdomen acut chirurgical\*\Other causes of acute surgical abdomen
---------------------------------------------------------------------
1191. CM p5 [C2225127] In diagnosticul diferential al peritonitei cu abdomenul acut medical intra in discutie: (p2140)\*\The
differential diagnosis of peritonitis with acute abdomen medically we refer to (join the discussion)
A) [x]colica abdominala saturnina\*\abdominal colic saturnine
B) [x]porfiria acuta intermitenta\*\Acute intermittent porphyria
C) [x]infarctul splenic\*\spleen infarction
D) [ ]infarctul miocardic acut\*\acute myocardial infarction
E) [x]infarctul renal\*\Renal infarction
---------------------------------------------------------------------
1192. CM p5 [C2525186] Care dintre afirmatiile legate de delimitarea spatiului suprahepatic drept sunt adevarate:
(p2149)\*\Which of the statements related to the delimitation of right supra hepatic space are true:
A) [x]superior - diafragmul\*\Higher (superior) - diaphragm
B) [x]inferior - fata superioara lob drept hepatic\*\Higher (superior) - diaphragm
C) [ ]posterior - ligamentul falciform\*\(posterior) - falciform ligament
D) [ ]stanga - ligament coronar\*\Left - coronary ligament
E) [x]dreapta - peretele abdominal\*\ Right - abdominal wall
---------------------------------------------------------------------
1193. CM p5 [C1525092] Spatiul subdiafragmatic (subfrenic) cuprinde urmatoarele subdiviziuni (pag. 2148-
2149)\*\Subdiafragmatic (subfrenic)space includes the following subdivisions
A) [x]spatiul suprahepatic drept\*\Right suprahepatic space
B) [x]spatiul suprahepatic stang;\*\Right suprahepatic space
C) [ ]loja renala;\*\: renal lodge;
D) [x]bursa omentala\*\omentum
E) [x]spatiul suhepatic drept\*\Subhepatic right space(side)
---------------------------------------------------------------------
1194. CM p5 Care din urmatoarele afirmatii legate de peritonitele prin perforatia intestinului subtire in febra tifoida sunt
adevarate:(2134)\*\Which of the following statements related to peritonitis by small intestine perforation in typhoid fever are true:
A) [ ]in prezent sunt frecvente\*\Currently, there are frequent
B) [x]sunt grave deoarece se dezvolta la bolnavi cu reactivitate scazuta\*\is serious because it develops in patients with low reactivity
C) [ ]de obicei perforatiile intestinale sunt multiple la 15-20 cm de unghiul ileo-cecal\*\ usually the intestinal perforations are
multiple 15-20 cm ileo-caecal angle
D) [x]peritonita apare mai frecvent in saptamana a treia de evolutie a bolii\*\peritonitis occurs more frequently in the third week of the disease
E) [ ]perforatiile din febra tifoida se manifesta ca o peritonita localizata\*\perforation of typhoid fever manifests as a localized peritonitis
---------------------------------------------------------------------
1195. CM p5 [C2225112] Diagnosticul peritonitei difuze produse prin perforatia ulcerului gastric sau duodenal se bazeaza pe:
(pag. 2134)\*\Diagnosis of diffuse peritonitis caused by gastric or duodenal ulcer perforation is based on:
A) [x]antecedente de ulcer\*\The history of ulcer
B) [x]durere brusca si violenta\*\sharp pain and violence
C) [ ]aparare musculara\*\defensive muscle
D) [x]contractura musculara\*\muscle contracture
E) [ ]silentium abdominal\*\Abdominal silentium (silent abdomen

158
---------------------------------------------------------------------
1196. CM p5 Formele astenice ale peritonitei se caracterizeaza prin: (2139)\*\Asthenic forms of peritonitis is characterized by
A) [x]forma intalnita la varstnici\*\as seen in elderly
B) [x]semnele locale trec pe planul doi\*\local signs cross on the 2
nd
level
C) [ ]apare insuficienta cardio-vasculara\*\Cardio-vascular insufficiency occurs
D) [ ]tomografia computerizata nu poate aduce date suplimentare\*\CT scan can not provide additional data
E) [ ]interventia chirurgicala este contraindicata\*\surgery is contraindicated
---------------------------------------------------------------------
1197. CM p5 [C2825218] Care dintre urmatorii factori sunt definitorii pentru insuficienta multipla de organ(MODS), in
peritonitele acute? (2126)\*\Which of the following factors are defining multiple organ failure (MODs) in acute peritonitis?
A) [x]Ritm cardiac <54/min\*\Heart rate <54/min
B) [x]Ritm respirator <5/min sau >49/min\*\Respiratory rate <5/min or> 49/min
C) [x]Debit urinar <479mm/24h\*\Urinary flow rate <479mm/24h
D) [ ]Nr leucocite >1000/mm3\*\No WBC> 1000/mm3
E) [ ]Hematocrit >20%\*\Hematocrit> 20%
---------------------------------------------------------------------
1198. CM p5 [THMC234] Complicatiile mai frecvente ale drenajului percutan pt abcesele intraperitoneale sunt: (2151)\*\Most
common complications of percutaneous drainage for intraperitoneal abscesses are:
A) [x]Suprainfectia\*\Overgrowth
B) [x]Obturarea tubului de dren\*\Overgrowth
C) [x]Perforatia digestiva\*\Digestive perforation
D) [x]Apar in in 0-15% din cazuri\*\Appears in 0-15% of cases
E) [ ]Imposibilitatea drenajului complet\*\Inability to completely drain
---------------------------------------------------------------------
1199. CM p5 Diagnosticul clinic de peritonita este dificil la: (2139)\*\Clinical diagnosis of peritonitis is difficult in:
A) [x]Varstnici\*\Elderly
B) [x]Imunosupresati\*\Immuno suppressed
C) [ ]Bolnave aflate la ciclul menstrual\*\Sick at menstruation
D) [x]Bolnavi spitalizati in unitati de terapie intensiva\*\patients in intensive care units
E) [ ]Bolnavi alergici\*\allergic patients
---------------------------------------------------------------------
1200. CM p5 Examenul obiectiv al abdomenului in peritonite poate arata: (2130, 2131)\*\Objective examination of the abdomen
in peritonitis may reveal(show):
A) [ ]Abdomen imobil, rigid, indiferent de cauza peritonitei si de momentul evolutiv\*\rigidly, immobile abdomen regardless of
the cause peritonitis and evolutionary time
B) [x]Semnul Blumberg pozitiv\*\Blumberg sign positive
C) [x]Balonare abdominala in peritonita veche\*\Abdominal bloating in old peritonitis
D) [x]Rigiditate musculara maxima (''abdomen de lemn'') cu caracterele:dureroasa, tonica, permanenta invincibila\*\Maximum
muscle rigidity( wood abdomen) with characters: painful, tonic, permanent, invincible
E) [ ]Durere generalizata la percutie fara intensificare intr-o anumita zona\*\Generalized pain in percussion without
intensification in a certain area
---------------------------------------------------------------------
1201. CS p4 Cea mai eficienta masura profilactica in litiaza urinara este: (2838)\*\The most effective prophylactic measure in urinary stones is
A) [ ]repausul fizic;\*\Bed rest;
B) [ ]cura de sete;\*\Cure for thirst
C) [x]cura de diureza;\*\Diuresis cure
D) [ ]alimentatia hipercalorica;\*\High calorie diet
E) [ ]alimentatia hipocalorica.\*\Low calorie diet.
---------------------------------------------------------------------
1202. CS p4 Reprezinta factori de risc ai litiazei urinare, cu EXCEPTIA:\*\ are risk factors for urinary lithiasis, except:
A) [ ]tulburari ale metabolismului fosfatic\*\ Phosphorous metabolic disorders
B) [ ]starea de incordare\*\ state of tension
C) [ ]tulburari discrinice\*\ discrinic disturbances
D) [x]hidratarea excesiva\*\ excessive hydration
E) [ ]ereditatea\*\ Heredity
---------------------------------------------------------------------
1203. CS p4 [C1446013] Dintre indicatiile terapeutice primare ale monoterapiei prin nefrolitotomie percutanata nu fac parte si:
\*\The therapeutic indications of monotherapy by primary percutaneous Nephrolithotomy do not include
A) [ ]Calculii renali cu diametrul peste 3 cm;\*\Kidney stones than 3 cm in diameter;
B) [ ]Calculii coraliformi;\*\Coraliformi stones;
C) [x]Calculii renali multipli, cu diametru sub 2 cm;\*\Multiple kidney stones, less than 2 cm in diameter;
D) [ ]Calculii de cistina;\*\Stones of cystine;
E) [ ]Calculii renali asociati cu stenoza jonctiunii pielo-ureterale.\*\Associated with kidney stones pyeloureteral junction stenosis.

159
---------------------------------------------------------------------
1204. CS p4 Prezenta insuficientei renale la un pacient litiazic renal cu rinichi controlateral normal morfofunctional traduce:
\*\The presence of renal failure in a patient with urinary lithiasis on the contralateral normal morphofunctional kidney can be
explain as
A) [ ]existenta unei obstructii si la nivelul cailor excretorii din partea rinichiului normal morfofunctional\*\The existence of
obstructions in the excretory tract of the normal morphofunctional kidney
B) [x]existenta unei colectii septice in rinichiul litiazic obstructiv\*\Existence of a collection septic substance in the obstructed kidney
C) [ ]existenta unei creatinemii normale\*\Existence of normal creatinine level
D) [ ]existenta obligatorie a unei obstructii subvezicale\*\mandatory existence of an obstruction below the bladder
E) [ ]nici una dintre raspunsurile de mai sus\*\None of the above
---------------------------------------------------------------------
1205. CS p4 Care dintre urmatoarele tipuri de calculi urinari este radiotransparent: (2827)\*\Which of the following types of
urinary calculi is radiotransparent
A) [ ]fosfat de calciu\*\Calcium phosphate
B) [ ]oxalat de calciu\*\Calcium oxalate
C) [ ]fosfat amoniaco-magnezian\*\Ammonium-magnesium phosphate
D) [x]xantina\*\Xanthine
E) [ ]nici unul din calculii enumerati mai sus\*\Any of the stones above
---------------------------------------------------------------------
1206. CS p4 Hipercalciuria renala se trateaza cu: (pg 2839)\*\renal hypercalciuria is treated with
A) [ ]vitamina B6\*\Vitamin B6
B) [x] \*\ortofosfati\*\Orthophosphate
C) [ ]acid chenodezoxicolic\*\chenodeoxycholic acid
D) [ ]pirofosfati\*\Pyrophosphate
E) [ ]D-pinicilamina\*\D-pinicilamina
---------------------------------------------------------------------
1207. CS p4 Cea mai comuna cauza de hipercalcemie asociata litiazei urinare este: (2827)\*\The most common cause of urinary
lithiasis in association with hypercalcemia is
A) [x]hiperparatiroidismul primar\*\Primary hyperparathyroidism
B) [ ]imobilizari prelungite\*\prolonged imobilisation
C) [ ]hipertiroidismul\*\Hyperthyroidism
D) [ ]spasmofilia\*\Spasmophilia
E) [ ]hipervitaminoza D\*\Hypervitaminosis D
---------------------------------------------------------------------
1208. CS p4 Lacuna cu ''mantel simptom'' pe urografia intravenoasa sugereaza un: (2831)\*\ Lacuna with Mantel's symptoms on
intravenous Urography suggests a
A) [x]calcul radiotransparent\*\ radiotransparent calculi
B) [ ]chist renal\*\ Renal cyst
C) [ ]adenom de prostata\*\ Adenoma of prostate
D) [ ]calcul radioopac\*\ Calculation radiopaque
E) [ ]cancer urotelial\*\ urotelial cancer
---------------------------------------------------------------------
1209. CM p5 [C2646194] Un calcul la nivelul ureterului lombar inferior, de cca 7 mm are indicatie de: (2834)\*\A calculi at the
level of the ureter at the inferior lumbar about 7 mm is an indication of:
A) [ ]ureterolitotomie\*\Ureterolitotomy
B) [ ]ureterolitotomie laparoscopica\*\Laparoscopic ureterolitotomy
C) [ ]NLP\*\NLP
D) [x]tratament conservator\*\Conservative treatment
E) [x]in unele cazuri ESWL\*\ESWL in some cases
---------------------------------------------------------------------
1210. CM p5
. [C2546183] In litiaza urinara, litotritia extracorporeala cu unde de soc (ESWL) este contraindicata in: (pg 2835)\*\In urinary
lithiasis extracorporeal shock waves lithotripsy (ESWL) is contraindicated in
A) [ ]litiaza coraliforma;\*\Coraliform stones
B) [x]insuficienta renala;\*\Renal failure;
C) [ ]litiaza ureterala;\*\Ureteral lithiasis;
D) [x] graviditate;\*\Pregnancy
E) [x]coagulopatii.\*\Coagulopathy.
---------------------------------------------------------------------
1211. CM p5 [C2346145] Calculul uretral este sugerat de: (pg 2829)\*\Urethral calculus is suggested by:
A) [ ]dureri hipogastrice\*\hypogastric pain
B) [x]disurie marcata\*\marked dysuria
C) [x]mictiuni in jet slab\*\weak stream urination

160
D) [x]dureri perineale\*\perineal pain
E) [ ] dureri lombare\*\back pain
---------------------------------------------------------------------
1212. CM p5 Dintre factorii de risc ai litiazei urinare fac parte si: (pg 2825)\*\The risk factors of urinary lithiasis are
A) [x]Tulburarile metabolismului calcic;\*\Calcium metabolism disorders;
B) [ ]Expunerea la temperaturi reduse\*\Exposure to low temperatures
C) [x]Factorii genetici;\*\Genetic factors;
D) [ ]Compozitia crescuta in azotati a apei potabile;\*\The composition of drinking water high in nitrates;
E) [x]Excesul alimentar proteic.\*\Excess protein food.
---------------------------------------------------------------------
1213. CM p5 [C2646188] In cazul anuriei obstructive: (pg 2830)\*\In obstructive anuria
A) [x]apare hiperpotasemie\*\appears hyperkalemi
B) [ ]apare hipopotasemie\*\Appears hypokalemia
C) [ ]apare retentia acuta de urina\*\Acute retention of urine occurs
D) [ ]apare retentia cronica de urina\*\Chronic retention of urine occurs
E) [x]trebuie sa instituim un drenaj intern sau extern al caii urinare superioare\*\one must establish an internal or external
drainage of the upper urinary track
---------------------------------------------------------------------
1214. CM p5 [C2546182] Litotritia extracorporeala cu unde de soc(ESWL) este ineficienta in urmatoarele conditii: (pg
2836)\*\Extracorporeal shock waves lithotripsy (ESWL) is ineffective in these conditions:
A) [ ]pacientii slabi;\*\Weak patients;
B) [x]rinichi ectopic pelvin;\*\Ectopic kidney
C) [x]litiaza vezicala;\*\Bladder stones
D) [x]calcul impactat;\*\impacted calculi
E) [ ]calcul imobil.\*\immobile calculi.
---------------------------------------------------------------------
1215. CM p5 [C2246125] Urmatoarele afirmatii privind litotritia extracorporeala sunt corecte: (pg 2832)\*\The following
statements are correct for extracorporeal lithotripsy:
A) [x] localizarea calculilor se face radiologic si/sau ecografic\*\Location calculus is radiological and / or the ultrasound
B) [ ] este un procedeu invaziv\*\Is an invasive procedure
C) [x] produce dezintegrarea calculului cu unde de soc produse extracorporeal\*\Extracorporeal shock waves produces decay
products of calculi
D) [ ] nu se poate efectua in conditii de ambulator\*\cannot be performed in ambulatory conditions
E) [ ] necesita intotdeauna anestezie/analgezie\*\always require anesthesia / analgesia
---------------------------------------------------------------------
1216. CM p5 [C2646191] Cu ajutorul ecografului decelam: (pg 2831)\*\ultrasound detects
A) [x]calculii radiotransparenti din vezica\*\Bladder stones which are radiotransparent
B) [ ]calculii radioopaci din ureterul iliac\*\Radiopaque stones in the iliac ureter
C) [x]atat calculii radioopaci cat si cei radiotransparenti situati in vezica urinara\*\Both radiotransparent and radiopaque stones
located in the bladder
D) [x]calculii renali radioopaci\*\Radiopaque kidney stones
E) [ ]modificarile functionale ale rinichiului\*\Functional changes in kidney
---------------------------------------------------------------------
1217. CM p5 [C2546186] Scintigrafia renala este utila in: (pg 2831)\*\Renal scintigraphy is useful in:
A) [x]rinichiul mut urografic;\*\Silent kidney Urography
B) [ ]rinichiul ectopic;\*\Ectopic kidney
C) [ ]rinichiul dublu;\*\Double kidney;
D) [ ]rinichiul malrotat;\*\Malrotated kidney
E) [x]insuficienta renala.\*\Kidney failure.
---------------------------------------------------------------------
1218. CM p5 [C1446081] Printre factorii de risc prerenali implicati in litogeneza urinara se numara si: (pg 2825-2826)\*\Prerenal
risk factors involved in urinary lithogenesis include:
A) [x]Varsta;\*\Age;
B) [x]Tulburarile metabolismului calcic;\*\Calcium metabolism disorders;
C) [ ]Scaderea volumului urinar;\*\Decreased urine volume;
D) [x]Alimentatia;\*\Diet;
E) [ ]Hipercalciuria.\*\Hypercalciuria
---------------------------------------------------------------------
1219. CM p5 [C2546159] Intre factorii de risc ai litiazei urinare pot fi enumerati urmatorii: (pg 2825)\*\The risk factors of
urinary lithiasis can be listed as:
A) [x]tulburarile metabolismului calcic;\*\Calcium metabolism disorders
B) [x]denutritia;\*\denutrition;
C) [x]excesul alimentar proteic;\*\Excess protein food;

161
D) [ ]polidipsia;\*\Polydipsia
E) [x]ereditatea.\*\Heredity.
---------------------------------------------------------------------
1220. CM p5 [C2546172] Hematuria din litiaza renala este: (pg 2829)\*\Hematuria resulting from kidney stones is
A) [ ]initiala;\*\Initial;
B) [x]totala;\*\total
C) [ ]terminala;\*\Terminal;
D) [x]de efort;\*\with effort
E) [ ]in doi timpi.\*\in two times
---------------------------------------------------------------------
1221. CM p5 [C2546171] Care din urmatoarele elemente patogenice sunt implicate in producerea nefralgiei: (pg 2829)\*\Which
of these elements are involved in producing pathogenic nephralgia
A) [ ]obstructia completa;\*\Complete obstruction;
B) [x]obstructia incompleta;\*\Incomplete obstruction;
C) [ ]obstructia acuta;\*\Acute obstruction;
D) [x]obstructia cronica;\*\Chronic Obstructive;
E) [ ]obstructia subvezicala.\*\Subvesiscular obstruction
---------------------------------------------------------------------
1222. CM p5 Care sunt caracteristicile colicii renale litiazice? (2828, 2829)\*\What are the characteristics of renal lithiasis colic?
A) [ ]poate apare ca singurul semn\*\May occur as the only sign
B) [x]durerea apare brusc si are un caracter provocat\*\Pain occurs suddenly and has usually a provocative character
C) [ ]durerea iradieaza spre virful piciorului\*\Irradiates to tip of the foot
D) [ ]ca si in abdomenul acut bolnavul are o pozitie antalgica\*\As in the acute abdomen colic the patient has an analgesic position
E) [x]poate sa apara la bolnav fara istoric litiazic sau urinar cunoscut\*\May occur in patients without known history or urinary lithiasis
---------------------------------------------------------------------
1223. CM p5 Indicatiile ESWL in tratamentul litizi urinare sunt: (p2835)\*\Indications of ESWL treatment of urinary lithiasis are:
A) [x]calculi renali cu diametrul maxim de 2-3 cm\*\Stones with maximum of diameter of 2-3 cm
B) [ ]calculi renali cistinici\*\Cystine stones
C) [ ]calculi vezicali\*\Bladder stones
D) [x]calculi ureterali lombari si pelvini\*\lumbar pelvic ureteral calculi
E) [ ]B,C,D\*\B, C, D
---------------------------------------------------------------------
1224. CM p5 Urmatoarele afirmatii legate de litiaza urinara sunt corecta: (2828)\*\The following affirmations about urinary
lithiasis are correct
A) [x]ureeaza este produsa de majoritatea bacteriilor Gram negative\*\Urease is prodused mostly caused by gram-negative bacteria
B) [x]litiaza struvitica este tipul de litiaza post-infectie\*\struvite stones occur post-infection
C) [x]litiaza struvitica este moderat radioopaca\*\struvite stones are moderately radiopaque
D) [ ]iritatia cronica de contact generata de calcul generata de calcul poate degenera in adenocarcinom renal\*\chronic contact
irritation of calculi can degenerate in renal adenocarcinoma
E) [ ]corect B,C,D\*\B,C,D
---------------------------------------------------------------------
1225. CM p5 [C2246129] Chirurgia deschisa a litiazei urinare se limiteaza actualmente la urmatoarele situatii: (pg 2837)\*\Open
surgery in urinary lithiasis is currently limited to the following situations
A) [x]litiaza coraliforma dispusa preponderent in calice\*\coraliform stones arranged predominantly in the calyces potassium
B) [x]litiaza renala pe rinichi in ectopie pelvina sau incrucisata\*\kidney stones or ectopic crossed kidney
C) [ ]graviditate\*\Pregnancy
D) [ ]diabet zaharat\*\iabetes
E) [ ]pacient pediatric\*\pediatric patient
---------------------------------------------------------------------
1226. CM p5 Nefralgia cronica, in cadrul clinicii litiazei urinare: (2829)\*\Clinically chronic nephralgia in urinary tract lithiasis
A) [x]tradeaza obscturctia cronica incompleta;\*\reveals incomplete obstruction
B) [x]este carecteristica litiazei inclavate in tija caliceala;\*\reveals an obstructed calyceal lithiasis
C) [ ]durerea este paroxistica;\*\is associated with a paroxysmal pain;
D) [ ]semnul Giordano este negativ;\*\D: has a negative Giordano sign;
E) [x]Giordano pozitiv.\*\has a positive Giordano sign.
---------------------------------------------------------------------
1227. CM p5 [C1346075] Caracteristicile unei colici renale ce indica prezenta unui calcul in ureterul distal sunt: (pg 2828-
2829)\*\The characteristics of renal colic indicating the presence of a distal ureteral calculi are:
A) [ ]iradiere spre organele genitale externe si fata interna a coapsei\*\Radiation to the external genital organs and internal front of thigh
B) [x]iradierea ascendenta in lomba\*\accentuated irradiation in the lumba region
C) [x]asocierea cu polakiuria\*\Association with polakiuria
D) [ ]pozitia antalgica\*\Positional antalgia
E) [x]tenesme vezicale\*\bladder tenesmus

162
---------------------------------------------------------------------
1228. CM p5 Urmatoarele afirmatii privind litiaza cistinica sunt false cu exceptia: (2826)\*\The following statements are falsefor
cystine stones except
A) [x]este o tubulopatie de natura genetica\*\Is a genetic tubulopathy
B) [ ]are o incidenta de aproximativ 25% in cadrul litiazei urinare\*\Has an incidence of approximately 25% in urinary lithiasis
C) [x]afecteaza varsta tanara (debut in copilarie)\*\Affects young age (childhood onset)
D) [ ]evolutie lent progresiva\*\Slowly progressive
E) [x]uneori duce inexorabil la insuficienta renala si deces timpuriu\*\Sometimes leads inexorably to renal failure and early death
---------------------------------------------------------------------
1229. CM p5 Cele mai importante masuri de metafilaxie a litiazei urinare oxalice sunt: (2839)\*\The most important
metaphylaxic treatment of urinary oxalic lithiasis are
A) [x]dieta restrictiva in oxalati\*\Diet restricted in oxalate
B) [ ]alcalinizarea urinii\*\Alkalinisation of urine
C) [x]administrarea de vitamina B6\*\Administration of vitamin B6
D) [ ]tratamentul cu D-penicilamina\*\Treatment with D-penicillamine
E) [ ]dieta restrictiva in proteine animale\*\Diet restricted in animal protein
---------------------------------------------------------------------
1230. CM p5 [C1446083] In litiaza reno-ureterala la gravida urmatoarele afirmatii nu sunt adevarate: (2829-2830)\*\concerning
renoureteral lithiasis in pregnant the following statements are true:
A) [ ]Se caracterizeaza prin episoade frecvente de pielonefrita acuta;\*\It is characterized by frequent episodes of acute pyelonephritis;
B) [ ]Are o incidenta de 1/3000 de internari obstetricale;\*\It has an incidence of 1 / 3000 of obstetric hospitalization;
C) [x]Impune intreruperea sarcinii;\*\causes abortion;
D) [x]Are o incidenta de 1/2500 de nasteri;\*\It has an incidence of 1 / 2500 live births;
E) [ ]Sunt frecvente infectiile urinare persistente, refractare terapeutic.\*\Persistent urinary tract infections are common and treatment-resistant.
---------------------------------------------------------------------
1231. CS p4 [C1547020] Care dintre urmatoarele afirmatii despre hematuria din adenomul de prostata este corecta: (pag. 2909)
\*\ Which of the following statements about haematuria in prostate adenoma is correct
A) [ ] face parte din tabloul clinic clasic al bolii, alaturi de disurie si polakiurie; \*\ forms part of the classic clinical picture of the
disease, with dysuria and polakiurie;
B) [ ] nu apare in tabloul clinic decat daca pacientul are, in afara afectiunii prostatice, si o alta cauza de sangerare (de exemplu
cancer renal); \*\ Not in the clinical picture unless the patient has the disease outside the prostate, and another cause of bleeding
(eg renal cancer);
C) [ ] este intotdeauna abundenta si poate duce la retentie completa prin cheaguri; \*\ is always plentiful and can lead to complete
retention by clots;
D) [x] nu reprezinta un semn foarte frecvent in adenomul de prostata; \*\ not a very common sign in prostate adenoma;
E) [ ] este patognomonica pentru litiaza vezicala secundara adenomului \*\ is pathognomonic for bladder stones secondary adenoma
---------------------------------------------------------------------
1232. CS p4 Cancerele de prostata sunt in marea lor majoritate: (pag. 2920) \*\ Prostate cancers are mostly:
A) [ ] sarcoame \*\ sarcomas
B) [ ] lipoame \*\ lipomas
C) [ ] mioloposarcoame \*\ myoloposarcoma
D) [x] adenocarcinoame \*\ adenocarcinoma
E) [ ] carcinoame tranzitionale \*\ Transitional cell carcinoma
---------------------------------------------------------------------
1233. CS p4 Dintre urmatorii markeri utilizati in diagnosticul cancerului de prostata, doar unul mai are valoare semnificativa la
ora actuala: (2929) \*\ From the following markers used in diagnosis of prostate cancer, only one has significant value at present
A) [ ] LDH; \*\ LDH;
B) [x] Fosfataza acida prostatica; \*\ prostatic acid phosphatase;
C) [ ] Leucinaminopeptidaza; \*\ Leucinaminopeptidaza;
D) [ ] Colesterolul urinar; \*\ urinary cholesterol;
E) [ ] Fosfataza alcalina serica \*\ serum alkaline phosphatase
---------------------------------------------------------------------
1234. CS p4 [C2247030] Doza de Omnic in tratamentul adenomului de prostataeste: (pag. 2916) \*\ The dose of Omnic in the
treatment of prostate adenoma is:
A) [ ] 8-10 mg/zi \*\ 8-10 mg / day
B) [ ] 4-8 mg/zi \*\ 4-8 mg / day
C) [x] 0,4-0,8 mg/zi \*\ from 0.4 to 0.8 mg / day
D) [ ] 0,04-0,08 mg/zi \*\ 0.04 to 0.08 mg / day
E) [ ] 0,8-1 mg/zi \*\ 0.8 to 1 mg / day
---------------------------------------------------------------------
1235. CS p4 Greutatea medie a prostatei la adult este: (pag. 2905) \*\ Average weight of prostate in adults is:
A) [ ] 2-4 g \*\ 2-4 g
B) [ ] 10-15 g \*\ 10-15 g

163
C) [x] 15-20 g \*\ 15-20 g
D) [ ] 20-100 g \*\ 20-100 g
E) [ ] 100-200 g \*\ 100-200 g
---------------------------------------------------------------------
1236. CS p4 Care din urmatoarele manifestari clinice ale adenomului de prostata nu este caracteristica in faza de prostatism:
(2908) \*\ Which of the following clinical manifestations of prostate adenoma is not characteristic in prostatism phase
A) [ ] polakiurie \*\ polakiurie
B) [ ] disurie \*\ dysuria
C) [ ] diminuarea jetului urinar \*\ decrease in urinary flow
D) [x] incontinenta urinara \*\ urinary incontinence
E) [ ] jet urinar terminal intrerupt \*\ terminal interrupted urinary stream
---------------------------------------------------------------------
1237. CS p4 [C1548019] Tratamentul de electie in cancerul de prostata localizat este: (p2930) \*\ Treatment of choice in
localized prostate cancer is:
A) [ ] Orhidectomia; \*\ Orhidectomy;
B) [x] Prostatectomia radicala; \*\ radical prostatectomy;
C) [ ] Radioterapia; \*\ radiotherapy;
D) [ ] Crioterapia; \*\ Cryotherapy
E) [ ] Hormonoterapia \*\ hormonotherapy
---------------------------------------------------------------------
1238. CS p4 Tehnica cea mai sigura de apreciere a adenopatiei neoplazice pelvine in cancerul de prostata este: (2927) \*\ Best
technique for assessing pelvic adenopathy cancer Prostate cancer is:
A) [ ] echografia \*\ Echography
B) [ ] computer-tomografia \*\ computer tomography
C) [x] limfadenectomia pelvina \*\ Pelvic lymphadenectomy
D) [ ] RMN \*\ MRI
E) [ ] radiografia de bazin \*\ radiography pool
---------------------------------------------------------------------
1239. CM p5 Mepartricina (Ipertrofan): (2916) \*\ Mepartricina (Ipertrofan)
A) [ ] inhiba alfa-5-reductaza \*\ inhibit 5 alpha-reductase
B) [x] scade concentratia serica a estrogenilor \*\ estrogen decreases serum concentrations of
C) [ ] determina relaxarea colului vezical \*\ bladder cause relaxation of Article
D) [x] scade concentratia estrogenilor la nivel prostatic \*\ concentration decreases prostate estrogen level
E) [x] diminua hiperplazia stromei \*\ reduce stromal hyperplasia
---------------------------------------------------------------------
1240. CM p5 Printre complicatiile adenomului de prostatase numara: (p2909-2910) \*\ The complications include prostatic adenoma
A) [x] Cistita cronica \*\ Cystitis chronic
B) [x] Litiaza vezicala \*\ bladder lithiasis
C) [x] Adenomita \*\ adenoma
D) [x] Retentia completa de urina \*\ Full retention of urine
E) [ ] Tumora renala \*\ Kidney Tumor
---------------------------------------------------------------------
1241. CM p5 Semnele iritative ale adenomului de prostatasunt reprezentate de:(2909 \* Irritative signs of prostate adenoma are represented by:
A) [x] polakiurie nocturnasi diurna \*\ polakiurie nocturnasi subsistence
B) [x] imperiozitate mictionala \*\ imperiozitate mictionala
C) [x] disconfort mictional (durere, arsura) \*\ mictional discomfort (pain, burning)
D) [ ] hematurie initiala \*\ hematuria page
E) [ ] hematurie terminala \*\ terminal haematuria
---------------------------------------------------------------------
1242. CM p5 [C2847219] Adenomectomia deschisa: (pag. 2917) \*\ Open adenomectomy:
A) [x] se poate efectua transvezical, retropubic sau perineal \*\ can be transvesical, retropubic, or perineal
B) [ ] nu se recomanda in cazul adenoamelor peste 60 de grame \*\ is note recommended in the case of adenoma heavier than 60 grams
C) [x] complicatia majora imediata este hemoragia \*\ the immediate major complication is the hemorrhage
D) [x] orhiepididimita poate sa apara postoperator \*\ orchiepididimitis can occur post surgical procedure
E) [x] ejacularea retrograda apare postoperator \*\ retrograde ejaculation occurs post surgical procedure
---------------------------------------------------------------------
1243. CM p5 [C2247127] Examinarea urografica la pacientii cu adenom de prostataeste obligatorie: (2912) \*\ Consideration of
urography in patients with prostate adenoma is mandatory
A) [ ] La toti pacientii cu adenom de prostata \*\ In all patients with prostate adenoma
B) [x] La pacientii cu adenom si hematurie \*\ In patients with adenoma and haematuria
C) [x] La pacientii cu adenom si altapatologie urinaraasociata \*\ In patients with adenoma and other pathologic urine association
D) [ ] La pacientii cu adenom necomplicat \*\ In patients with adenoma uncomplicated
E) [ ] Cand cistoscopia nu transeazacauza hematuriei \*\ When cystoscopy not transeazacauza hematuria

164
---------------------------------------------------------------------
1244. CM p5 [C2847225] Evolutia clinica a adenomului de prostata cuprinde urmatoarele faze: (pag. 2909) \*\ The clinical
evoution of prostate adenoma includes the following stages:
A) [ ] Preprostatism \*\ Preprostatism
B) [x] Prostatism \*\ Prostatism
C) [x] Retentie incompleta fara distensie \*\ Incomplete retention without distension
D) [x] Retentie incompleta cu distensie \*\ Incomplete retention with distension
E) [ ] Retentie completa de urina \*\ Complete urinary retention
---------------------------------------------------------------------
1245. CM p5 [C2248141] Polakiuria in cancerul de prostata: (pag. 2924) \*\ Polakiuria in prostate cancer
A) [x] este asemanatoare cu cea din adenomul de prostata \*\ is similar to that of prostate adenoma
B) [ ] este intalnita pe tot parcursul zilei \*\ is encountered throughout the day
C) [x] nu este legata de volumul tumorii prostatice \*\ is not related to prostate tumor volume
D) [x] se explica prin iritatia tumoralaa colului vezical \*\ cervix tumors can be explained by bladder irritation
E) [x] are intensitate variabila \*\ has variable intensity
---------------------------------------------------------------------
1246. CM p5 [C2847224] Secretia interna a prostatei cuprinde urmatorii produsi: (2907) \*\ Internal secretion of the prostate
consists of the following substances:
A) [x] Antigenul prostatic specific (PSA) \*\ prostate-specific antigen (PSA)
B) [x] Gamma-seminoproteina \*\ gamma-seminoprotein
C) [x] Antigenul specific membranar prostatic \*\ specific prostatic membrane antigen
D) [x] Fosfataze acide \*\ acid phosphatases
E) [ ] Glucoza \*\ glucose
---------------------------------------------------------------------
1247. CM p5 [C2648193] Care dintre urmatorele afirmatii sunt corecte privind anatomia patologica a cancerului de prostata?
(pag. 2921,2922) \*\ Which of the following assertions are correct about the prostate cancer?
A) [x] stadiul final este carcinomatoza prostato-pelvina, sau _pelvisul inghetat_ \*\ the final stage is prostatic-pelvian
carcinomatosis or the frozen pelvis_
B) [ ] cancerele prostatice sunt in marea lor majoritate sarcoame \*\ the vast majority of prostate cancers are sarcomas
C) [x] G2 inseamna adenocarcinom mediu diferentiat conform clasificarii UICC \*\ G2 stands for average differentiated
adenocarcinoma according to the UICC classification
D) [x] Scorul Gleason se calculeaza isumind valoarea aspectului celular dominant si cel minoritar \*\ Gleason score is calculated
by adding the values of both dominant and minor cell aspect
E) [ ] Invazia rectului se realizeaza in stadii initiale \*\ rectal invasion is made in incipient stages
---------------------------------------------------------------------
1248. CM p5 [C2248114] Factorii de risc principali in cancerul de prostatasunt: (2920) \*\ Main risk factors in cancer prostate is
A) [x] rasa \*\ Race
B) [ ] dieta bogatain grasimi \*\ high fat diet
C) [ ] factorii hormonali \*\ hormonal factors
D) [ ] vitamina \*\ Vitamin
E) [x] istoricul familial \*\ Family history
---------------------------------------------------------------------
1249. CM p5 Displazia intraductala (PIN) se caracterizeaza prin: (2920) \*\ Intraductal dysplasia (PIN) is characterized by:
A) [x] acini de aspect normal; \*\ root normal aspect;
B) [ ] hiperplazie atipica adenomatoasa; \*\ atypical adenomatous hyperplasia;
C) [x] atipii celulare; \*\ atypical cells,
D) [ ] necroza celulara; \*\ cell necrosis,
E) [ ] microinvazie \*\ microinvasive
---------------------------------------------------------------------
1250. CM p5 [C1247088] Tratamentul minim-invaziv al adenomului de prostata include: (2917, 2918) \*\ Minimal-invasive
treatment of prostate adenoma include:
A) [x] terapia cu laser \*\ Laser therapy
B) [x] HIFU \*\ HIFU
C) [x] TUNA \*\ TUNA
D) [x] Electrovaporizarea transuretrala \*\ Electrovaporization transurethral
E) [ ] TUIP \*\ TUIP
---------------------------------------------------------------------
1251. CM p5 [C2247141] Adenomectomia deschisa: (pag. 2917) \*\ Open adenonectomy
A) [ ] Se practicala majoritatea pacientilor cu adenom de prostata \*\ It is practiced most patients with prostate adenoma
B) [x] Se indicain adenoamele mari \*\ The large adenomas indicated \*\
C) [x] Complicatia majora imediata este hemoragia \*\ bleeding complication major immediate
D) [ ] Principiul interventiei variazain functie de abord \*\ Principle intervention approaches depending variation
E) [x] Are complicatii tardive \*\ late complications has

165
---------------------------------------------------------------------
1252. CM p5 [C2847217] Retentia incompleta de urina cu distensie vezicala data de adenomul de prostata se caracterizeaza prin:
(pag. 2907) \*\ Incomplete urinary retention with bladder distension caused by prostate adenoma is characterized by:
A) [x] glob vezical \*\ bladder globe
B) [ ] reziduu vezical sub 100 ml \*\ urine residue under 100 ml
C) [x] reziduu vezical mai mare de 300-350 ml \*\ urine residue higher than 300-350 ml
D) [ ] ureterohidronefroza unilaterala \*\ one-sided urethra hydronephrosis
E) [x] falsa incontinenta de urina \*\ treacherous urine incontinence
---------------------------------------------------------------------
1253. CM p5 [C2647198] In adenomul prostatic, faza de retentie incompleta fara distensie, se caracterizeaza prin: (2908) \*\ In
prostate adenoma the incomplete retention without distension is characterised by:
A) [x] aparitia rezidiului vezical ce nu depaseste capacitatea fiziologica a vezicii \*\ the apparition of bladder residue which does
not outweigh the physiological capacity of the bladder
B) [ ] aparitia rezidiului vezical ce depaseste capacitatea fiziologica a vezicii \*\ the apparition of the urinary residue which
outweighs the physiological capacity of the bladder
C) [x] permanentizarea polakiuriei diurne \*\ the fixation of daytime polakiury
D) [ ] permanentizarea nicturiei \*\ the fixation of micturition
E) [ ] dezvoltarea lobului prostatic median \*\ the growth of median prostate lobe
---------------------------------------------------------------------
1254. CM p5 [C2247128] Uretrocistoscopia la pacientii cu adenom de prostata se caracterizeaza prin: (pag. 2914) \*\
Urethrocystoscopy in patients with prostate adenoma is characterized by:
A) [x] Este obligatorie la pacientii cu adenom si hematurie \*\ It is mandatory in patients with adenoma and heamaturia
B) [ ] Nu este prima etapa inaintea rezectiei endoscopice \*\ It is not stady before the first endoscopic resection
C) [x] Evidentiaza permeabilitatea uretrei \*\ Evidenced permeability urethra
D) [ ] Nu poate evalua capacitatea vezicii urinare \*\ Unable to assess bladder capacity
E) [x] Evidentiaza vezica fortata \*\ Highlight bladder forced
---------------------------------------------------------------------
1255. CM p5 [C1248081] Blocada androgenica maxima se realizeaza prin una din urmatoarele asocieri: (2932) \*\ Maximal
androgen blockade is achieved by a combination of the following:
A) [ ] orhiectomie + analogie de LH-RH \*\ The analogy of LHRH + orchidectomy
B) [x] analogie de LH-RH + antiandrogeni \*\ LH-RH analogy + antiandrogens
C) [ ] analogie de LH-RH + estrogeni \*\ analogy of LHRH + estrogen
D) [x] orhiectomie+ antiandrogeni \*\ orchidectomy + Antiandrogens
E) [ ] orhiectomie + estrogeni \*\ orchidectomy + estrogen
---------------------------------------------------------------------
1256. CM p5 Ipotezele privind etiologia adenomului periuretral sunt: (2906) \*\ Assumptions periuretral adenoma etiology are:
A) [ ] hipogonadismul \*\ hypogonadism
B) [x] reinductia sinusului uro-genital \*\ uro-genital sinus reinductia
C) [ ] blocada androgenica \*\ androgen blockade
D) [ ] teoria maladiei de camp urotelial \*\ urotelial field theory of disease
E) [x] stimularea estrogenica \*\ to stimulate estrogen
---------------------------------------------------------------------
1257. CM p5 Semnele obstructive in adenomul de prostata sunt: (pag. 2909) \*\ Signs of obstruction in prostate adenoma are :
A) [ ] disconfortul mictional \*\ mictional discomfort
B) [ ] polakiuria diurna \*\ polakiuria diurnal
C) [x] scaderea calibrului si fortei jetului urinar \*\ decreased urinary stream caliber and force
D) [ ] imperiozitatea mictionala \*\ mictional imperosity
E) [x] senzatia de evacuare vezicala incompleta \*\ the feeling of incomplete bladder evacuation
---------------------------------------------------------------------
1258. CM p5 Potentialul invaziv al cancerului de prostata creste proportional cu:(2922)\*\Invasive potential of prostate cancer rises with
A) [ ] dimensiunea tumorii \*\ tumor size
B) [ ] varsta pacientului \*\ patient age
C) [x] grading-ul tumoral \*\ tumor grading and site
D) [ ] numarul de rude barbati \*\ number of male relatives
E) [x] scorul Gleason \*\ Gleason score
---------------------------------------------------------------------
1259. CM p5 Care afirmatii despre limfadenectomia pelvina sunt adevarate:(2927) \*\ The following statements about real pelvine are
lymphadenectomy
A) [x] se poate realiza laparoscopic \*\ can be done laparoscopically
B) [x] este metoda de electie pentru aprecierea adenopatiei pelvine \*\ is the method of choice for assessing pelvic adenopathy
C) [ ] prezervarea drenajului limfatic medial de artera iliaca externa previne edemul limfatic al membrelor pelvin \*\ preservation
of lymphatic drainage of the medial external iliac artery to prevent lymph edema of the pelvic limb
D) [ ] se realizeazaintotdeauna prin chirurgie deschisa \*\ is realized always by open surgery

166
E) [ ] nici un raspuns corect \*\ no one right answer
---------------------------------------------------------------------
1260. CM p5 Explorarile obligatorii ca screening la barbatii de peste 45 ani pentru decelarea cancerului de prostata sunt
reprezentate de: (2925) \*\ Mandatory exploration for screening of men over 45 years to detect prostate cancer are:
A) [x] tuseu rectal \*\ rectal touch
B) [ ] ecografie abdominala \*\ abdominal ultrasound
C) [x] PSA \*\ PSA
D) [ ] PAP \*\ PAP
E) [x] ecografie transrectala \*\ Ultrasound transrectal
---------------------------------------------------------------------
1261. CS p4 [CS43071] Cea mai frecventa cauza de HDS este: (pg.1067)\*\The most common cause of HDS is:
A) [ ]gastrita acuta hemoragica\*\Acute hemorrhagic gastritis
B) [ ]esofagita\*\esophagitis
C) [ ]hernia hiatala\*\hiatal hernia
D) [ ]varice esofagiene\*\esophageal varices
E) [x]ulcerul peptic\*\peptic ulcer
---------------------------------------------------------------------
1262. CS p4 [CS43057] TIPS este metoda folosita: (pag 1069)\*
A) [ ]pentru toti pacientii cu HDS\*\
B) [x]pentru complicatiile refractare ale hipertensiunii portale\*\
C) [ ]ca o punte catre transplantul splenic\*\
D) [ ]pentru pacientii cu HDI*\
E) [ ]la pacientii cu metastaze hepatice\*\
---------------------------------------------------------------------
1263. CS p4 [CS43028] In hemoragiile digestive inferioare raportul uree/creatinina este mai mic de: (pg 1066)\*\The lower
gastrointestinal bleeding ratio urea / creatinine is less than
A) [ ]36:1\*\36:1
B) [x]20:1\*\20:1
C) [ ]25:1\*\25:1
D) [ ]35:1\*\35:1
E) [ ]40:1\*40:1\
---------------------------------------------------------------------
1264. CS p4 Intr-o hemoragie digestiva pacientul prezinta initial: (p1066)\*\In a patient presents initially digestive hemorrhage
A) [x]Bradicardie\*\Bradycardia
B) [ ]Sindromul insuficientei organice multiple\*\Multiple organ failure syndrome
C) [ ]Tahicardie\*\Tachycardia
D) [ ]Instabilitate cardiovasculara\*\Cardiovascular instability
E) [ ]Insuficienta renala\*\ renal failure
---------------------------------------------------------------------
1265. CS p4 Hematemeza are urmatoarele caracteristici cu exceptia \*\Hematemesis has the following characteristics except
A) [ ]reprezinta varsatura cu sange care poate fi digerat in stomac\*\ is vomiting blood that can be digested in the stomach
B) [ ]poate fi nedureroasa\*\can be painless
C) [x]hemobilia determina frecvent hematemeza\*\hemobilia often cause haematemesis
D) [ ]poate contine varsatura cu sange nealterat si proaspat\*\ may include vomiting blood and fresh unaltered
E) [ ]sangerarile rapide pot determina si varsaturi cu cheaguri\*\rapid bleeding and vomiting can lead to clots
---------------------------------------------------------------------
1266. CS p4 Cea mai frecventa cauza de HDS e reprezentata de (pg 1067)\*\The most common cause of HDS is represented by
A) [x]ulcer peptic\*\ peptic ulcer
B) [ ]rupere varice esofagiene\*\esophageal varices rupture
C) [ ]sdr Mallory-Weiss\*\ SDR Mallory-Weiss
D) [ ]gastritele datorate AINS\*\gastritis caused by NSAIDs
E) [ ]esofagita de reflux\*\ reflux esophagitis
---------------------------------------------------------------------
1267. CS p4 [CS43075] Hemoragiile digestive sunt mai frecvente: (1066)\*\Gastrointestinal bleeding are more common:
A) [ ]copii\*\Children
B) [ ]adolescenti\*\Teenagers
C) [x]persoanele in varsta\*\ elderly
D) [ ]adultul tanar\*\young adult
E) [ ]sugari\*\infants
---------------------------------------------------------------------
1268. CS p4 Primul test diagnostic efectuat dupa stabilizarea pacientului in HDS este: (p1068)\*\First diagnostic test performed
after stabilizing the patient's HDS is:
A) [ ]scintigrafia cu eritrocite marcate cu tecmetiu\*\red blood cell scintigraphy with marked tecmetiu

167
B) [x]endoscopia digestiva superioara\*\upper GI endoscopy
C) [ ]arteriografie\*\arteriography
D) [ ]endoscopia digestiva inferioara\*\lower digestive endoscopy
E) [ ]radiografie cu bariu\*\X-ray with barium
---------------------------------------------------------------------
1269. CM p5 Cauze de hemoragii digestive superioare masive pot fi: (pg.1067-1068) cases of massive upper gastrointestinal
bleeding can be:
A) [ ]sindromul Mallory-Weiss\*\Mallory-Weiss syndrome
B) [ ]neoplasmul gastric\*\gastric cancer
C) [x]malformatiile vasculare Dieulafoy\*\Dieulafoy vascular malformations
D) [x]hernia hiatala\*\hiatal hernia
E) [x]fistule aorto-enterice\*\aorto-enteric fistulae
---------------------------------------------------------------------
1270. CM p5 [CM43028] Lezinile angiodisplazice: ()\*\ Angiodysplasia lesions: ()
A) [ ]determina HDI cronica\*\cause chronic HDI
B) [x]determina HDI masiva\*\cause massive IDH
C) [ ]sunt congenitale\*\are congenital
D) [x] diagnosticate prin angiografie\*\are diagnosed by angiography
E) [ ]au diametrul>5mm\*\diameter> 5mm
---------------------------------------------------------------------
1271. CM p5 [CM43021] Ulcerul duodenal hemoragic : ()\*\ Duodenal peptic ulcer bleeding: ()
A) [x]este de 4 ori mai frecvent ca ulcerul gastric hemoragic\*\ is 4 times more frequent as gastric ulcer bleeding
B) [ ]se mai numeste ulcer Cushing\*\ is called Cushing's ulcers
C) [x]este indicat de disparitia durerii odata cu aparitia hemoragiei\*\is indicated by disappearance of pain with the advent of bleeding
D) [ ]este indicat de pirozis si arsura retrosternala\*\ is indicated by heartburn and chest burning
E) [ ]este indicat de varsaturi initiale fara sange urmate de aparitia durerii si sangerarii\*\ is indicated by initial vomiting blood
without pain and bleeding
---------------------------------------------------------------------
1272. CM p5 [CM43032] Melena are urmatoarele caracteristici () melena has following features ()
A) [x]poate persista 5-7 zile dupa o hemoragie de 2 U de sange\*\may persist for 5-7 days after a hemorrhage of 2 U of blood
B) [ ]persistenta testului guaiac pozitiv pana la 3 sapatamani,semnifica continuarea hemoragiei\*\ persistent positive guaiac test
up to three weeks signifies further bleeding
C) [x]trebuie o pierdere minima de 10ml/zi pt ca testul guaiac sa fie pozitiv\*\10ml/day is the minimum loss for the guaiac test was positive
D) [x]aproape intotdeaua apare ca urmare a unei HDS\*\almost always occurs as a result of HDS
E) [x]Fe determina test guaiac negativ,cu colorare in negru-verzui a scaunului\*\iron gives a negative guaiac test, with black-green stool
---------------------------------------------------------------------
1273. CM p5 [CM43076] In sindromul Mallory-Weiss: (pg 1067) In Mallory-Weiss syndrome
A) [ ]initial apare hematemeza\*\ initially appears haematemesis
B) [x]varsaturile initiale sunt fara sange\*\ initial vomiting there is no blood
C) [x]este sangerarea prin eroziuni ale mucoasei eso-gastrice\*\ is bleeding from esophageal-gastric mucosal erosions
D) [x]la >90% hemoragia se opreste spontan\*\> 90% bleeding stops spontaneously
E) [ ]tratamentul consta in scleroterapie prompta\*\prompt treatment consists of sclerotherapy
---------------------------------------------------------------------
1274. CM p5 Substantele care pot determina gastrita acuta hemoragica sunt: (1067)\*\Substances that can cause acute
hemorrhagic gastritis are:
A) [x]AINS -uri\*\NSAIDs
B) [x]alcool\*\Alcohol
C) [x]cortico steroizi\*\cortical steroids
D) [ ]ser fiziologic\*\saline
E) [x]K oral\*\K Oral
---------------------------------------------------------------------
1275. CM p5 Hemoragia digestiva superioara poate fi determinata de: (pg 1067) Upper GI bleeding can be caused by:
A) [x].sindromul Mallory-Weis\*\.Syndrome Mallory-Weis
B) [x].hernia hiatala\*\.hiatal hernia
C) [x].gastrita\*\gastritis
D) [ ].neoplasm duodenal\*\Duodenal cancer
E) [x].ulcerul gastric\*\stomach ulcer
---------------------------------------------------------------------
1276. CM p5 [CM43110] Alegeti factorii de risc pentru ulcer de stres (pg 1068)
A) [x]hipotensiunea
B) [ ]pneumonia bacteriana
C) [x]insuficienta renala
D) [x]Arsurile

168
E) [ ]Insuficienta cardiaca
---------------------------------------------------------------------
1277. CM p5 [CM43063] Hemoragia de la nivelul intestinului subtire: (p1070) Bleeding from the small intestine
A) [x].Este o cauza rara de hemoragie digestiva inferioara\*\. It is a rare cause of lower GI bleeding
B) [x].Reprezinta frecvent un diagnostic de excludere\*\Is often a diagnosis of exclusion
C) [ ].Atunci cand are loc, este masiva\*\When occurs it is is massive
D) [x].Poate avea drept cauza sdr.Peutz-Jeghers\*\ Maybe because of peutz-jeghers syndrome
E) [x].De cele mai multe ori nu pune in pericol viata pacientului\*\.most often it is not life-threatening
---------------------------------------------------------------------
1278. CM p5 Factorii de risc asociati ulcerului de stress sunt: (p1068) Ulcer risk factors associated with stress are:
A) [ ]HTA\*\ Hypertension\*\.
B) [x]Politraumatismele\*\Politrauma\*\.
C) [x]Icter\*\ Jaundice\*\.
D) [ ]Insuficienta cardiaca\*\heart failure\*\.
E) [x]Sepsis\*\Sepsis\*\.
---------------------------------------------------------------------
1279. CM p5 [CM43001] Ulcerul de stres are ca factori de risc: (P1068)\*\Stress ulcer risk factors
A) [x]Politraumatismul\*\poly trauma
B) [x] \*Insuficienta respiratorie\*\ respiratory failure
C) [ ]Insuficienta cardiaca\*\Heart Failure
D) [x]Icterul\*\Jaundice
E) [x]Insuficienta renala\*\renal failure
---------------------------------------------------------------------
1280. CM p5 [CM43046] In hemoragiile digestive superioare (pg 1066) In upper gastrointestinal bleeding
A) [x]ureea poate creste la 30-50 ml/dl\*\ urea may rise to 30-50 ml / dl
B) [x]raportul uree/creatinina este mai mare de 36:1\*\ratio urea / creatinine is greater than 36:1
C) [x]raportul uree/creatinina poate avea valoare prognostica si diagnostica\*\ratio urea / creatinine may have prognostic and diagnostic value
D) [ ]raportul creatinina/uree este mai mare de 36:1\*\ratio creatinine / urea is greater than 36:1
E) [ ]raportul uree/creatinina este mai mic de 20:1\*\ratio urea / creatinine is less than 20:1
---------------------------------------------------------------------
1281. CM p5 [CM43042] Screeningul cu scintigrafie cu Tc se face in caz de () Tc scintigraphy screening is done in case of ()
A) [x]HDI la cei cu stabilitate hemodinamica\*\HDI in patients with hemodynamic stability
B) [x]Sangerari prelungite\*\prolonged bleeding
C) [x]Ex baritata neconcludent\*\inconclusive barium meal exam
D) [x]Risc pentru tratamentul chirurgical crescut\*\increased risk for surgery
E) [ ]Risc de neoplazii colo-rectale\*\ Risk of colo-rectal cancer
---------------------------------------------------------------------
1282. CM p5 [CM43082] Leziunile angiodisplazice ale colonului: (pg 1070, 1071) Angiodisplazice lesions of the colon
A) [ ]se asociaza cu leziuni vasculare ale viscerelor\*\ vascular lesions associated with visceral lesions
B) [x]sunt degenerative\*\ are degenerative\*\
C) [ ]sunt congenitale sau neoplazice\*\ are congenital or cancerous
D) [x]diagnosticul este pus cu acuratete de angiografie\*\ The diagnosis is made accurately by angiography
E) [ ]coloscopia nu le poate diagnostica\*\colonoscopy can not diagnose\*\
---------------------------------------------------------------------
1283. CM p5 [CM43064] In patogenia HDS avand drept cauza ulcerul de stress, pot fi implicate: (pag 1068) In the pathogenesis
of SDH with stress ulcer as the cause, which mechanisms may be involved:
A) [x]. Activarea citokinelor\*\Activation of cytokines\*\.
B) [x]. Vasoconstrictia splahnica\*\.vasoconstriction splahnica\*\.
C) [ ]. Stressul psihic cronic\*\.chronic psychological stress\*\.
D) [x]. Coagulopatiile\*\ coagulopathy.\*\.
E) [x]. Sepsisul\*\Sepsis\*\.
---------------------------------------------------------------------
1284. CM p5 [CM43049] Intr-o hemoragie digestive cand se pierde cel putin 20% din volumul sanguine circulant: (pg
1068)\*\.[CM43049] in gastrointestinal bleeding when loss of at least 20% of circulating blood volume occurs
A) [ ].hemoragia este de gradul I\*\.The bleeding is of degree 1\*\.
B) [x].hemoragia este de gradul II\*\. Grade II hemorrhage\*\.
C) [x].TA scade cu 20mmHg cand pacientul este ridicat in sezut\*\. BP decreases by 20mmHg when the patient stands up\*\.
D) [x].Amplitudinea pulsului scade sau frecventa creste cu 25 bpm cand pacientul este ridicat in sezut\*\.pulse amplitude
decreases and frequency increases to 25 bpm when the patient gets up from sitting\*\.
E) [x].Este nevoie de transfuzii\*\.transfusion is needed\*\.
---------------------------------------------------------------------
1285. CM p5 [CM43068] Majoritatea pacientilor: (pag 1066) [CM43068] Most patients
A) [x]Pot suporta o hemoragie digestiva de gradul I fara a intra in soc\*\can support a digestive hemorrhage degree without going into shock

169
B) [ ]Intra in soc daca pierd prin hemoragie rapida 10-15% din volumul intravascular\*\Get into shock if the bleeding quickly lose 10-15% of
the intravascular
C) [x]Suporta o hemoragie rapida daca e vorba de 10-15% din volumul intravascular\*\tolerates a bleeding when it comes to 10-15% of the
intravascular volume
D) [ ]Intra in soc dupa pierderea a mai mult de 15% din volumul intravascular, indiferent de viteza sangerarii si de raspunsul pacientului\*\Get
into shock after losing more than 15% of intravascular volume, irrespective of bleeding and the patient response rate
E) [ ]Sunt hipotensivi in urma unei hemoragii de gradul I\*\They are hypotensive after a grade 1 hemorrhage degree
---------------------------------------------------------------------
1286. CM p5 Despre utilizarea scintigrafiei cu eritrocite marcate cu technetiu in HDS sunt adevarate afirmatiile : (Pg. 1069)
About using scintigraphy with technetium marked erythrocytes in HDS are true statements:
A) [x]Detecteaza rata sangerarii de 0,1-0,2 ml/min\*\Detects bleeding rate of 0.1 to 0.2 ml / min
B) [ ]Ajuta la localizarea HDS\*\ help locate HDS
C) [ ]Inlocuieste definitiv arteriografia\*\ Replace final arteriography
D) [x]Nu ajuta la localizarea HDS\*\doesn't help locate HDS
E) [x]E folosita frecvent inaintea arteriografiei\*\ It is commonly used before arteriography
---------------------------------------------------------------------
1287. CM p5 Varsaturile in zat de cafea indica o hemoragie digestiva:(1066)\*\ Coffee ground vomiting indicate a digestive hemorrhage
A) [ ].Masiva\*\.massive
B) [x].Lenta\*\slow
C) [x].Cu originea proximal de unghiul Treitz\*\. The origin proximal to Treitz angle
D) [ ].Rapida\*\. Fast
E) [ ].Cu originea distal de unghiul Treitz\*\The origin distal to Treitz angle
---------------------------------------------------------------------
1288. CM p5 Melena: (pg 1066) Melena
A) [x]reprezinta pasajul transanal al materiilor fecale ametecate cu sange modificat de culoare neagra, ca smoala si cu un miros
caracteristic\*\ transanal passage of feces mixed with blood appearing black with a characteristic odor
B) [ ]apar cand s-au pierdut 30 ml de sange la nivelul tractulu gastrointestinal\*\ appear when 30 ml of blood is lost from the
gastrointestinal tract
C) [x]miroul caracteristi rezulta in urma actiunii hidrogenului sulfurat asupra fierului din molecula de hem\*\smell results from
the action of hydrogen sulphide on iron from heme molecule
D) [x]apar, de obicei, ca urmare a unei hemoragii digestive superioare\*\usually occur as a result of an upper gastrointestinal bleeding
E) [x]melena fara hematemeza indica o leziune distala ligmentului Treitz\*\ melena without haematemesis indicate a lesion distal to ligment
Treitz
---------------------------------------------------------------------
1289. CM p5 Leziunile angiodisplazice colonice au ca si caracteristici: (P1070-1071)\*\ Angiodisplastic lesions in the colon are:
A) [x]Sunt leziuni degenerative\*\There are degenerative lesions
B) [ ]Colonoscopia le diagnosticheaza cu acuratete\*\Colonoscopy to diagnose accurately
C) [ ]Se asociaza cu leziuni vasculare ale viscerelor\*\vascular lesions associated with visceral
D) [x]Nu se asociaza cu leziuni vasculare ale pielii\*\Not associated with vascular skin lesions
E) [x]Au un diametru mai mic de 5 mm\*\have a diameter smaller than 5 mm
---------------------------------------------------------------------
1290. CM p5 Ganglionul Virchow: ()Virchow Node ()
A) [x]este localizat supraclavicular stanga\*\It is located left supraclavicular
B) [ ]este localizat supraclavicular dreapta\*\ is located right supraclavicular
C) [x]sugereaza un proces malign intraabdominal\*\ suggest a malignant intra-abdominal process
D) [ ]se intalneste in tumorile benigne de col uterin\*\ is found in benign tumors of the cervix
E) [ ]sugereaza ub proces malign intracranian\*\suggest intracranial malignant process
---------------------------------------------------------------------
1291. CS p4 Care nu sunt factori intriseci implicati in etiopatogenia fracturilor: (p2304)\*\ Which of the following are not
intrinsic factors involved in etiopathogenesis fractures:
A) [ ]Rezistenta la oboseala sau stress\*\ Resistance to fatigue or stress
B) [ ]Densitatea\*\ density
C) [x]Regiunile anatomice expuse mai frecvent la traumatisme\*\ anatomical regions most frequently exposed to trauma
D) [ ]Curba solicitare-deformare\*\application-deformation curve
E) [ ]Capacitate de absorbtie a energiei\*\energy absorption capacity
---------------------------------------------------------------------
1292. CS p4 Care este cea mai grava complicatie imediata a fracturilor? (2311)\*\ What is the most serious immediate
complication of fractures?
A) [ ]Interpozitia de parti moi intre fragmentele fracturii\*\ Interpose of the soft tissue between fracture fragments;
B) [ ]Prinderea intre fragmantele fracturii a unui trunchi nervos\*\The fixation between the fracture segments of a nerve trunk;
C) [x]Fractura deschisa\*\ Open fracture;
D) [ ]Hidartroza genunchiului\*\ Hydrarthrosis (effusion) of the Knee joint ;
E) [ ]Retentia urinara\*\ Urinary retention.
---------------------------------------------------------------------

170
1293. CS p4 Varsta la care apar cel mai frecvent fracturile este: (pg .2301)\*\ Age at which fractures occur most frequently is:
A) [x]intre20-40 ani\*\ Between 20-40 years
B) [ ]intre1-20 ani\*\ Between 1-20 y
C) [ ]intre 40-60 ani\*\Between 40-60 y
D) [ ]intre10-20 ani\*\Between 10-20 y
E) [ ]dupa 60 de ani\*\After age of 60
---------------------------------------------------------------------
1294. CS p4 In etiopatogenia fracturilor,urmatoarele afirmatii sunt corecte cu exceptia\*\Concerning the pathogenesis of the
fractures, the following statements are correct Except:
A) [ ]este afectata preponderent varsta cuprinsa intre 20-40 de ani\*\The ages between 20-40 are more affected
B) [x]cele mai frecvent expuse sunt diafiza tibiala si epifiza proximala a radiusului\*\The most frequently exposed to are the shaft
of tibia and the proximal epiphysis of radius.
C) [ ]fracturile de col sunt mai frecvente la varstnici\*\Fracture of femoral neck are more frequent in the elderly
D) [ ]copiii sunt frecvent expusi traumatismelor,dar elasticitatea oaselor scade frecventa fracturilor\*\Children frequently expose
to trauma, but bone elasticity reduces the frequency of fractures.
E) [ ]factorii extrinseci,implicati in fracturi sunt datorita actiunii unor forte exterioare\*\The extrinsic factors implicated in
fractures are due to the action of external force.
---------------------------------------------------------------------
1295. CS p4 [CS44009] Selectati afirmatia falsa legata de imobilizarea chirurgicala a fracturilor (osteosinteza): (pag 2317-
2320)\*\selects the false statement related to the surgical immobilization of a fracture (osteosynthesis)
A) [ ]osteosinteza cu placa si suruburi presupune reducerea cu focar deschis a focarului de fractura\*\Osteosynthesis with plate
and screws requires reduction with open focus of the fracture
B) [x]osteosinteza centromedulara este indicatia de electie pentru fracturile oaselor antebratului\*\Centromedullary osteosynthesis
is the best indication for the forearm fractures.
C) [ ]suruburile de corticala au filet putin adanc si cu pas mic\*\Cortical screws have fiber, small and a bit deep
D) [ ]osteosinteza cu placa a ramas indicata in fracturile epifizo-metafizo-diafizare\*\Osteosynthesis with plate is still indicated in
the epiphyso-metaphyiso -diaphyseal fractures
E) [ ]pentru fracturile pertrohanteriene se utilizeaza in general DHS\*\For the peritrochanter fractures, DHS is utilized usually
---------------------------------------------------------------------
1296. CS p4 [CS44000] Fractura de ulna ar putea fi codificata prin (pg 2309)\*\ Fractures of Ulna can be codified through:
A) [ ]cifra 1\*\Number 1
B) [x]cifra 2\*\Number 2
C) [ ]cifra 3\*\Number 3
D) [ ]cifra 4\*\Number 4
E) [ ]cifra 5\*\Number 5
---------------------------------------------------------------------
1297. CS p4 La varstnici sunt mai frecvente fracturile: ()\*\For the elderly the most common fractures are:
A) [ ]diafizei tibiale\*\ Tibial shaft;
B) [ ]maleolei externe\*\External malleolus;
C) [x]extremitatii proximale femurale\*\ Proximal femoral extremity;
D) [ ]epifizei distale a radiusului\*\Distal epiphysis of radius;
E) [ ]femurale supracondiliene\*\ Supracondylar fracture of femur
---------------------------------------------------------------------
1298. CS p4 Folosirea placii de osteosinteza in fracturi are ca indicatie de electie: (pg2319)\*\ Using plate osteosynthesis in
fracture is indicated in:
A) [x]fractura antebratutului\*\Fracture of the forearm shaft
B) [ ]Fracturile femurului\*\Femur fracture
C) [ ]Fracturile tibiei\*\Tibia fracture
D) [ ]Fracturile de humerus\*\ Fracture of the humerus
E) [ ]Fracturile de bazin\*\ Fracture of the pelvis.
---------------------------------------------------------------------
1299. CM p5 Conform clasificarii fracturilor deschise (Gustilo si Anderson), fractura de gradul II (pag 2312)\*\ From the
classification of open fractures (Gustilo and Anderson), fracture grade II:
A) [x]Este o fractura cu plaga cutanata de peste 2 cm\*\A fracture with more than 2 cm skin wound
B) [x]Este produsa de o forta de energie moderata\*\The energy produced by a moderate force
C) [ ]Este insotita de devitalizare musculara si poluare intensa\*\It is accompanied by intense contamination, muscle wasting
D) [ ]Nu este o fractura cominutiva\*\There is a comminuted fracture
E) [ ]Asociaza leziuni ale axului vascular principal\*\lesions of principal vascular axis are associated
---------------------------------------------------------------------
1300. CM p5 [CM44091] Pot fi complicatii tardive generale: (pg2312)\*\ Late general complications can be:
A) [ ]Embolia grasoasa pulmonara\*\pulmonary embolism, fatty
B) [x]Litiaza renala\*\ kidney stones
C) [x]Osteoporoza\*\Osteoporosis

171
D) [ ]CID\*\DIC
E) [ ]Bronhopneumonia\*\Bronchopneumonia
---------------------------------------------------------------------
1301. CM p5 Dintre factorii intriseci implicati in determinarea susceptibilitatii la fractura fac parte: (pg 2304-2305)\*\The
intrinsic factors involved in determining susceptibility to fracture are:
A) [x]capacitatea de absorbtie a energiei\*\The energy absorption capacity
B) [x]curba solicitare deformare si modelul lui Young\*\deformation curve and Young's model
C) [x]rezistenta la oboseala sau la stress\*\resistance to fatigue or stress
D) [x]densitatea\*\density
E) [ ]marimea fortei agentului contodent\*\size of blunt agent force
---------------------------------------------------------------------
1302. CM p5 [CM44065] Sunt mecanisme de producere a fracturilor indirecte : (pg. 2303)\*\ The followings are indirect
mechanisms producing fracture:
A) [ ]mecanism de insurubare\*\The screw mechanism
B) [x]mecanism de incovoiere\*\bending mechanism
C) [x]mecanism de torsiune\*\ torsion (twisting) mechanism
D) [x]mecanism de compresiune\*\compression mechanism
E) [x]mecanism de smulgere\*\pulling (avulsion) mechanism
---------------------------------------------------------------------
1303. CM p5 Embolia grasoasa pulmonara are urmatoarele caracteristici, cu exceptia: (2310) Fatty pulmonary embolism has
following features, except:
A) [ ]clinic, semne de hipoxie\*\ clinical signs of hypoxia
B) [x]cresterea numarului de trombocite\*\increased number of platelets
C) [x]o metoda de profilaxie este administrarea de heparina\*\ a method of prophylaxis is the administration of heparin
D) [x]PO2 normala\*\normal pO2
E) [ ]cresterea lipazei serice\*\increased serum lipase
---------------------------------------------------------------------
1304. CM p5 [CM44057] Fractura angrenata este: (p2306)\* Engaged fracture is:
A) [x]o fractura completa\*\A complete fracture
B) [x]are 2 fragmente\*\ has two parts
C) [ ]are 4 fragmente\*\ has 4 pieces
D) [x]se produce prin telescoparea fragmentului diafizar in metaepifiza\*\ produced by telescoping diaphysis in metaphysis
E) [ ]produce telescoparea metaepifizei in epifiza\*\produces telescoping of metaphysis in epiphysis
---------------------------------------------------------------------
1305. CM p5 Semnele generale ale fracturilor apar mai frecvent in: (p2307)\*\General signs of fractures occur more frequently in:
A) [x]Politraumatisme\*\ polytrauma (multiple injuries)
B) [x]Polifracturi\*\multiple fractures
C) [ ]fracturi inchise\*\closed fracture
D) [x]fracturi deschise\*\open fracture
E) [ ]fracturi ale membrului superior\*\ upper limb fractures
---------------------------------------------------------------------
1306. CM p5 Coplicatiile tardive generale ale fracturilor sunt: (pag 2312-2314)\*\ General late complications of fractures are:
A) [x]litiaza renala\*\kidney stones
B) [x]osteoporoza\*\osteoporosis
C) [ ]calus vicios\*\ vicious callus
D) [ ]pseudartroza\*\pseudarthrosis
E) [ ]necroza aseptica\*\ Aseptic necrosis
---------------------------------------------------------------------
1307. CM p5 Cele mai frecvene mecanisme de producere ale fracturilor sunt: (pg 2302-2303)\*\ The most often mechanisms
producing fractures are:
A) [x]mecanismul de incovoiere\*\ bending mechanism *\
B) [ ]mecanismul direct\*\direct mechanism *\
C) [x]mecanismul de torsiune\*\torsion mechanism *\
D) [x]mecanismul de compresiune\*\ compression mechanism
E) [x]mecanismul de smulgere\*\pulling (avulsion) mechanism
---------------------------------------------------------------------
1308. CM p5 [CM44045] Semne locale subiective in fracturi pot fi: (Pg. 2307)\*\ Subjective local signs in fractures may be:
A) [ ]Pozitii vicioase\*\vicious position
B) [ ]Scurtarea membrului\*\Shorter limb
C) [ ]Deformare si tumefactie\*\deformation and swelling
D) [x]Impotenta functionala\*\Functional Impotence
E) [x]Dureri la nivelul fracturii\*\ Pain at the site
---------------------------------------------------------------------

172
1309. CM p5 Tija zavorata (Grosse si Kempf): \*\ closing , piped(zavorata??) rod (Grosse and Kempf):
A) [x]s-a imagnat pentru a extinde indicatia tijei in fracturile din treima distala si proximala a diafizelor oaselor lungi, precum si
pentru fracturile cominutive\*\s-a imagnat (is spread??) due to the extend indication of rod in fractures of distal and proximal
thirds diaphysis (shafts) of long bones, as well as comminuted fractures
B) [ ]zavorarea se realizeaza atat proximal cat si distal(zavorata dinamic)\*\ latching (closing) is performed both proximally and
distally (dynamic pipe)
C) [x]dinamizarea tijei permite compresiunea focarului in timpul mersului\*\ dynamic rod allows compression when walking
D) [x]dupa 6-8 saptamani se poate scoate surubul cel mai departat de fractura (dinamizarea tijei)\*\after 6-8 weeks screw can be
taken out away from fracture (dynamic rod)
E) [ ]dupa 6-8 zile se poate scoate surubul cel mai departat de fractura (dinamizarea tijei)\*\after 6-8 days screw can be taken out ,
as possible, away from fracture (dynamic rod)
---------------------------------------------------------------------
1310. CM p5 Semnele de certitudine in diagnosticul fracturilor sunt: (2308)\*\ Signs of certainty in the diagnosis of fractures are:
A) [x]mobilitate anormala\*\abnormal mobility
B) [ ]atitudine vicioasa\*\vicious attitude
C) [x]netransmisibilitatea miscarilor\*\ not transferable movements
D) [x]crepitatia osoasa\*\bone crepitation
E) [ ]deformarea locala\*\ Local deformation
---------------------------------------------------------------------
1311. CM p5 Dintre factorii intrinseci favorizanti ai fracturilor fac parte:(p2304-2305)\*\The intrinsic factors favoring fractures:
A) [x]capacitatea de absorbtie a energiei\*\The energy absorption capacity
B) [x]curba solicitare-deformare\*\ application-deformation curve\*\
C) [x]modelul lui Young(raportul dntre unitatea de solicitare si unitatea de deformare)\*\Young's model (ratio between
application unit and deformation unit)\*\
D) [ ]rezistenta la efort prelungit este crescuta\*\ is increased resistance to prolonged effort\*\
E) [x]densitatea(fracturi pe os normal sau pe os patologic)\*\density (normal bone fracture or bone disease)\*\
---------------------------------------------------------------------
1312. CM p5 Suruburile de spongie folosite la tratamentul fracturilor (pg2317)\*\Sponge screws used in fracture treatment:
A) [x]sunt folosite pentru fracturile epifizare\*\are used for epiphyseal fractures
B) [ ]pot fi folosite cu succes in fracturile diafizare oblice lungi si spiroide\*\can be used successfully in long and spiroid oblique
fractures of diaphysis
C) [x]au filet rar si pas adanc\*\they rarely step deep groove
D) [ ]au filet cu pas mic\*\have threaded with small step
E) [ ]sunt folosite pentru reducerea ortopedica a fracturii\*\is used for orthopedic fracture reduction
---------------------------------------------------------------------
1313. CM p5 Semnele de probabilitate dupa Radulescu in fracturi sunt: (pag.2308)\*\ Signs of probability of a fracture, after Radulescu are:
A) [x]Echimoza\*\Ecchymosis
B) [x]Durere in punct fix\*\Fixed Pain
C) [x]Atitudine vicioasa\*\ vicious attitude
D) [ ]Crepitatie osoasa\*\bone Crepitation
E) [x]Deformare locala\*\ Local deformation
---------------------------------------------------------------------
1314. CM p5 Embolia grasoasa pulmonara, ca urmare a fracturilor, are urmatoarele semne clinice: (pg 2310)\*\ Fat pulmonary
embolism due to fractures, has the following clinical signs:
A) [x]tahipnee\*\tachypnea
B) [ ]cresterea umarului de trombocite\*\ increased platelet count
C) [x]somnolenta\*\ somnia
D) [ ]opacitati mari, multiple la RX pulmonar\*\Multiple large opacity in the chest X-ray
E) [ ]globule de grasime in urina\*\ fat globules in urine
---------------------------------------------------------------------
1315. CM p5 Care dintre urmatorii sunt factori intrinseci importanti in determinarea susceptibilitatii la fractura? (p2306)\*\
Which of the following are important intrinsic factors in determining susceptibility to fracture?
A) [x]capacitatea de absortie a energiei\*\The energy absorption capacity
B) [x]curba solicitare-deformare si modelul lui Young\*\application-deformation curve and Young's model
C) [x]rezistenta la oboseala sau la stres\*\ resistance to fatigue or stress
D) [x]densitatea\*\density
E) [ ]forta exterioara\*\external force
---------------------------------------------------------------------
1316. CM p5 Urmatoarele fac parte din complicatiile tardive locale ale unei fracturi: (pag 2312)\*\ The followings are part of the
local late complications of a fracture:
A) [x]calusul vicios\*\ vicious callus
B) [x]intarzierea in consolidare\*\ delay in union
C) [x]redoarea articulatiilor vecine focarului de fractura\*\ stiffness of neighboring joints

173
D) [ ]osteoporoza\*\osteoporosis
E) [ ]litiaza renala\*\ kidney stones
---------------------------------------------------------------------
1317. CM p5 Semnele locale de probabilitatea ale fracturii pot fi intalnite si in: (p2308) local signs of probability of fractures can be found in:
A) [ ]urticarie\*\Urticaria
B) [x]contuzii\*\contusion
C) [x]luxatii\*\luxation
D) [ ]eritem polimorf\*\erythema multiforme
E) [ ]eritem nodos\*\erythema nodosum
---------------------------------------------------------------------
1318. CM p5 Oasele susceptibile, in cadrul fracturilor la necroza osoasa sunt (pg2314)\*\ bones susceptible to fracture in the bone necrosis are:
A) [x]Capul femural\*\femoral head
B) [ ]Osul trapezoid\*\trapezoid bone
C) [x]Scafoidul\*\scaphoid
D) [ ]Humerusul\*\humerus
E) [x]Corpul astragalului\*\Body of astragalus
---------------------------------------------------------------------
1319. CM p5 Urmatoarele afirmatii sunt adevarate (pag 2312-2314)\*\ The following statements are true:
A) [x]Calusul vicios se poate asocia cu angulare sau decalaj\*\ vicious callus may be associated with angulation or gap
B) [ ]Distrofia simpatica reflexa se evidentiaza radiografic ca o zona de osteoporoza localizata, unica\*\reflex sympathetic
dystrophy evidenced radiographically as a localized area of osteoporosis, only
C) [x]Necroza aseptica determina redoare articulara si durere\*\ aseptic necrosis cause pain and joint stiffness
D) [ ]Pseudartroza reprezinta neconsolidarea articulatiei in intervalul mediu de timp\*\ pseudarthrosis represents nonunion of
joints in medium interval time
E) [ ]La mobilizarea membrului cu pseudartroza apare durere\*\ in pseudarthrosis , pain appears with limb movement
---------------------------------------------------------------------
1320. CM p5 Complicatii imediate generale ale fracturilor sunt: (pag 2311)\*\ Fractures general immediate complications are:
A) [x]Embolia grasoasa pulmonara\*\pulmonary fat embolism\*\
B) [x]Coagulare intravasculara diseminata\*\ disseminated intravascular coagulation\*\
C) [x]Bronhopneumonia\*\ Bronchopneumonia\*\
D) [ ]Litiaza renala\*\kidney stones\*\
E) [ ]Sindromul de detresa respiratorie a adultului\*\ The adult respiratory distress syndrome\*\
---------------------------------------------------------------------
1321. CS p4 [ARS00001] Cea mai obisnuita cauza a arsurilor este: (pg 228)\*\Most usual cause of burns is:
A) [ ]prin flacara\*\ through flame
B) [x]prin contact cu lichide fierbinti\*\ through contact with boiled liquids
C) [ ]prin explozie\*\through explosion
D) [ ]contactcu carbuna incinsi\*\through hot coals
E) [ ]contact cu metale incinse\*\ through contact with hot metals
---------------------------------------------------------------------
1322. CS p4 Transportul cu elicopterul al pacientilor cu arsuri este de preferat cand distanta dintre spital si centrul de tratament
este (pg230)\*\The transport with helicopter of burned patients is preffered when the distance between the hospital and the
treatment centre is:
A) [ ]intre 80 si 220 km\*\between 80 and 220 km
B) [x]intre 80 si 240 km\*\between 80 and 240 km
C) [ ]intre 70 si 220 km\*\between 70 and 220 km
D) [ ]mai mica de 80 km\*\ less thn 80 km
E) [ ]mai mare de 240 km\*\ more than 240 km
---------------------------------------------------------------------
1323. CS p4 Dupa agresiunea termica exista o diminuare marcata a concentratiei serice totale a: ()\*\After a thermic aggresion /
burn, there is recorded a decrease in seric concentration of:
A) [ ]GCSF\*\GCSF
B) [ ]IgA\*\IgA
C) [ ]IgM\*\IgM
D) [x]IgG\*\IgG
E) [ ]GM-CSF\*\GM-CSF
---------------------------------------------------------------------
1324. CM p5 In privinta dextranului, utilizat in tratamentul arsurilor sunt adevarate urmatoarele: (pag 241)\*\Regarding the
dextran, used to treat burns, the following are true:
A) [x]dehtranul este excretat de rinichi cu eliminarea a 40% in primele 24h, iar restul este metabolizat lent\*\Dextran is excreted
by the kidneys with the elimination of 40% in the first 24 hours and the remainder is metabolized slowly
B) [x]dextran70 se asociaza cu risc de reactii alergice\*\Dextran70 is associated with the risk of allergic reactions
C) [x]dextranul este un coloid constituit din molecule de glucoza polimerizate in lanturi\*\Dextran is a colloid consisting of

174
glucose molecules polymerized in chains
D) [x]dextranul cu greutate moleculara medie de 40000 este cunoscut ca dextran cu greutate moleculara mica\*\Dextran with
average molecular weight of 40,000 is known as Dextran with low molecular weight
E) [ ]dextran 40 se asociaza cu risc de reactii alergice\*\Dextran40 is associated with risk of allergic reactions
---------------------------------------------------------------------
1325. CM p5 Sunt adevarate afirmatiile urmatoare: (234)\*\\The following statements are true:
A) [ ]arsurile pe toata grosimea se vindeca numai prin retractarea plagii\*\Full thickness burns heal only by the retraction of the wound
B) [ ]Arsurile de grad IV implica epidermul si toate straturile dermului fara extensia mai in profunzime\*\IV degree burns involve
the epidermis and all the dermis layers without deeper extension
C) [x]Arsurile superficiale devin eritematoase fara insa de aparitia de vezicule\*\Superficial burns becomes erythematous but
without the appearance of blistering
D) [x]Arsurile dermice profunde afecteaza si stratul reticular al dermului\*\Deep dermal burns affect the reticular dermis layer
E) [x]Arsurile dermice superficiale daca este prevenita infectia se vindeca spontan in mai putin de 3 saptamini\*\Superficial
dermal burns heal spontaneously if the infection is prevented in less than three weeks
---------------------------------------------------------------------
1326. CM p5 Severitatea unei arsuri este dependenta de: (pag.232)\*\The severity of a burn is dependent of:
A) [x]marime\*\Size
B) [x]profunzime\*\Depth
C) [x]segmentul afectat\*\The affected segment
D) [ ]afectarea sau nu a extremitatii cefalice\*\Affecting or not of the cephalic extremity
E) [ ]pierderea sau nu a constientei\*\The loss of consciousness or not
---------------------------------------------------------------------
1327. CM p5 [CM45254] Severitatea leziunilor cauzate de arsuri depinde de: (pg 229)\*\Burn lesions severity depens on:
A) [x]suprafata totala a arsurii\*\The total burn surface
B) [x]profunzimea arsurii\*\the depth of the burn
C) [ ]mecanismul ce a produs arsura\*\The mechanism which caused the burn
D) [x]varsta pacientului\*\The age of patient
E) [x]leziunile asociate arsurii\*\The associated lesions to the burn
---------------------------------------------------------------------
1328. CM p5 Urmatorele afirmatii referitoare la arsurile produse prin explozie sunt adevarate: (pg.228)\*\The following
allegations regarding the burns produced by explosive are true:
A) [ ]reprezinta a doua cauza obisnuita de arsuri\*\It represents the second common cause of burns
B) [x]se distribuie,in general,pe toata suprafata corpului\*\Are distributed, generally, over the whole body
C) [x]sunt preponderent dermice\*\Are primarily dermal
D) [x]se vindeca fara a necesita grefe extise de piele\*\They heal without requiring extend skin grafts
E) [ ]sunt limitate ca extindere\*\Are limited as extension
---------------------------------------------------------------------
1329. CM p5 In protocolul de evaluare nutritionala al pacientilor arsi parametrii urmariti sunt: (pag 254)\*\In the protocol of
nutritional evaluation of burned patients the parameters are as follows:
A) [x]greutate\*\Weight
B) [ ]teste cutanate ale hipersensibilitatii intaziate,numarul total de limfocite,C3,IgM\*\Skin test of the delayed hypersensitivity,
the total number of lymphocytes, C3, IgM
C) [x]aportul nutritive din toate sursele (oral,sonda de alimentare,parenteral)\*\The nutrient intake from all sources (oral food
probe, parenteral)
D) [x]calorimetrie indirecta\*\Indirect calorimetry
E) [x]albumina serica,transferina,prealbumina,proteina care leaga retinolul\*\Serum albumin, transferrin, prealbumina, the protein
that binds retinol
---------------------------------------------------------------------
1330. CM p5 Despre arsurile superficiale de gradul I se poate afirma cu exceptia: (p234)\*\Regarding the first degree superficial
burns it can be said with the exception:
A) [x]dupa 2-3 zile eritemul si edemul se intensifica\*\After 2-3 days the redness and swelling intensifies
B) [ ]dupa 2-3 zile eritemul si edemul descresc\*\After 2-3 days the redness and swelling decrease in intensity
C) [ ]dupa a 4-a zi apare fenomenul de cojire\*\after the 4th day appears the phenomenon of scaling
D) [x]nu sunt dureroase\*\Are not painful
E) [x]intereseaza atat dermul cat si epidermul\*\Are looking both the dermis and epidermis
---------------------------------------------------------------------
1331. CM p5 Severitatea unei arsuri este dependenta de: (pag 232)\*\The severity of a burn depends on:
A) [ ]etiologia arsurii;\*\The etiology of burn
B) [x]marimea arsurii;\*\The burn size
C) [x]profunzimea arsurii;\*\The burn depth
D) [x]segmentu anatomic afectat;\*\The anatomically affected segment;
E) [ ]lipsa posibilitatilor de acordare a ingrijirilor medicale;\*\\No possibility of granting medical care*\
---------------------------------------------------------------------

175
1332. CM p5 Arsurile de gradul III (pag 234)\*\Third degree burns:
A) [x]Implica toate straturile dermului\*\It involves all layers of dermis
B) [ ]De obicei se decoloreaza la digitopresiune\*\Usually fade when digital pressure
C) [ ]Rareori determina cicatrici hipertrofice\*\Rarely causes hypertrophic scars
D) [ ]Implica si tesutul adipos subcutanat\*\It involves the subcutaneous fat tissue too
E) [x]Simptomatologia poate semana cu cea a unei arsuri dermice profunde\*\The symptoms may resemble with that of a deep dermal burns
---------------------------------------------------------------------
1333. CM p5 Socul trmic in cazul pacientului ars se caracterizeaza prin : (pg. 239)\*\Thermal shock in burned patients is
characterized by:
A) [ ]edem cerebral\*\Cerebral edema
B) [x]scaderea debitului cardiac\*\Decreased cardiac output
C) [x]oligurie\*\Oliguria
D) [x]scaderea lichidului extracelular\*\Reduction of extracellular fluid
E) [x]scaderea volumului plasmatic\*\Decrease in the volume of plasma
---------------------------------------------------------------------
1334. CM p5 Arsurile profunde de gradul II sunt caracterizate prin: (p234)\*\Deep second degree burns are characterized by:
A) [x]cuprind stratul reticular al dermului\*\They include the reticular layer of the dermis
B) [x]cand se aplica o presiune pe leziune,reumplerea apare foarte lent sua poate fi absenta\*\When pressure is applied on the
lesion, refilling occurs very slowly or may be absent
C) [x]veziculele apar imediat dupa injurie\*\Blistering occur immediately after injury
D) [x]imediat dupa injurie suprafata plagii apare ca un amestec de pete roz si albe\*\Immediately after injury the wound surface
appears as a mixture of pink and white spots
E) [ ]exercitiile fizice nmu sunt obligatorii pentru recuperare\*\Physic exercises are not mandatory for recovery
---------------------------------------------------------------------
1335. CM p5 Severitatea leziunii cauzate de arsuri este proportionala cu : (p229)\*\The severity of injury caused by burns is proportional to:
A) [x]suprafata totala a arsurii\*\The total area of burn
B) [x]profunzimea ei\*\Its profundity
C) [x]varsta\*\Age
D) [ ]cauza ce a produs arsura\*\The cause that produced the burning
E) [x]afectiunile preexistente si cele asociate arsurii\*\The pre-existing conditions and the ones associated to the burning
---------------------------------------------------------------------
1336. CM p5 Arsurile gradul 1: (pag 234)\*\First degree burns:
A) [ ]implica stratrul reticular al dermului;\*\It involves the reticular layer of dermis;
B) [ ]produc vezicule;\*\It produces blistering
C) [x]devin eritematoase prin vasodilatatie dermica;\*\: It becomes erythematous with dermal vasodilatation
D) [x]sunt destul de dureroase;\*\Is quite painful
E) [x]implica numai epidermul\*\It involves only the epidermis
---------------------------------------------------------------------
1337. CM p5 Debitul urinar necesar la pacientii cu cu lezini termice majore este de : (pg.243)\*\] The necessary urinary flow in
patients with major thermal injuries is of:
A) [x]1500-2000 ml/24h la adulti\*\1500-2000 ml/24h in adults
B) [ ]2000-2500ml/24h la adulti\*\2000-2500ml/24h in adults
C) [x]3-4ml/kg/h la copii\*\3-4ml/kg/h in children
D) [ ]2-3 ml/kg/h la copii\*\2-3 ml / kg / h in children
E) [ ]1,5-2,5 ml/kg/h la copii\*\1.5 to 2.5 ml / kg / h in children
---------------------------------------------------------------------
1338. CM p5 Principalii derivati ai acidului arahidonic in raspunsul la arsura sunt: (p238)\*\The main derivatives of the
arachidonic acid in response to the burn are:
A) [x]PGE2 e produsul major al metabolismului acidului arahidonic,produsa de macrofage si mediata partial de
endotoxina\*\PGE2 is the major product of arachidonic acid metabolism, produced by macrophages and partially mediated by endotoxin
B) [ ]PGE2 stimuleaza productia de IL-2\*\PGE2 stimulates the production of IL-2
C) [x]metabolizarea acidului arahidonic se face pe o cale calciu dependenta si o alta calciu independenta\*\Arachidonic acid
metabolism is made by a calcium-dependent pathway and another independent calcium pathway
D) [x]tromboxanulB are valori crescute imediat post arsura si in episoadele septice\*\Thromboxan B has elevated values
immediately after burn and in eptic episodes
E) [ ]leucotrienaB exercita un puternic efect anti-chemotactic pentru neutrofile\*\Leukotriene B exert a powerful anti-chemo
tactic effect for neutrophils
---------------------------------------------------------------------
1339. CM p5 Despre infectia din arsuri este adevarat : (pg254,255)\*\Regarding the infection from burns is true:
A) [x]incidenta infectiei si a sepsisului creste odata cu cresterea marimii arsurii\*\The incidence of infection and of the sepsis
increases with the burn size
B) [ ]hipertermia e prezenta la pacientii cu arsuri doar in infectie\*\Hyperthermia is present only in patients with burn infection
C) [x]hipotermia indica in mod obisnuit sepsisul produs frecvent de microorganisme gram negative\*\Hypothermia usually

176
indicates sepsis, frequently produced by gram negative micro-organisms
D) [x]trombocitopenia repezinta una din amnifestarile majore ale infectiei\*\Thrombocytopenia represents one of the major
manifestations of the infection
E) [x]cea mai comuna localizare a infectiilor letale este cea de la nivelul tractlui respirator\*\The most common location for the
fatal infection is that of the respiratory tract
---------------------------------------------------------------------
1340. CM p5 Urmatoarele afirmatii prin explozie sunt adevarate: (pg.228)\*\The following statements regarding the burns by
explosion are true:
A) [ ]sunt pe locul 4 ca frecventa\*\Are on the fourth place as frequency
B) [x]se distribuie in general pe toata pielea expusa\*\Are generally distributed on all exposed skin
C) [x]sunt preponderent dermice\*\Are primarily dermal
D) [x]se vindeca, in general, fara a necesita grefe extinse de piele\*\It heal, usually without requiring extensive skin grafts
E) [x]se pot asocia cu leziuni termice importante la nivelul cailor respiratorii superioare\*\Can be associated with important
thermal lesions in upper airway
---------------------------------------------------------------------
1341. CM p5 Arsurile dermice profunde : (pagina 234)\*\Deep dermal burns:
A) [ ]implica toate straturile dermului\*\Involve all layers of dermis
B) [ ]nu determina formarea de cicatrici\*\Does not cause the formation of scars
C) [x]pacientul se plange mai mult de disconfort decat de durere\*\The patients complain of discomfort more than for the pain
D) [ ]nu se albesc la digitopresiune\*\Do not turn white in digital pressure
E) [x]plaga e adesea mai putin sensibila la intepatura decat pielea normala inconjuratoare\*\The wound is frequently less sensitive
to sting than normal surrounding skin
---------------------------------------------------------------------
1342. CM p5 Arsurile electrice pot produce: (256)\*\Electrical burns may cause:
A) [x]Infarct miocardic\*\Myocardial infarction
B) [ ]pericardita\*\Pericarditis
C) [x]Contuzie miocardica\*\Contusion myocardial
D) [x]Ruptura de perete cardiac\*\Heart wall rupture
E) [x]Insuficienta valvulara acuta\*\Acute valve failure
---------------------------------------------------------------------
1343. CM p5 Despre rolul histaminei i socul termic se pot face uramtoarele afirmatii: (pag.237)\*\Regarding the role of histamine
and thermal shock the following statements can be done:
A) [x]este responsabila de faza precoce a permeabilitatii capilare crescute dupa producerea arsurilor\*\Is responsible of the early
phase of the increased capillary permeability after the burns
B) [ ]este responsabila de faza tardiva a permeabilitatii capilare crescute dupa producerea arsurilor\*\Is responsible of the late
phase of the increased capillary permeability after the burns
C) [x]este eliberata de mastocite\*\Is released by the mast cells
D) [ ]atinge nivelul maxim in primele 3 ore postarsura\*\Reach the peak in the first 3 hours post-burning
E) [ ]maximul este atins in ziua 3\*\Maximum is reached in day 3
---------------------------------------------------------------------
1344. CM p5 Arsurile produse prin explozie: (pag228)\*\The burnings made by an explosion:
A) [ ]sunt pe locul 2 ca frecventa\*\Are on the second place as frequency
B) [x]hainele sunt protectoare impotriva arsurilor prin explozie\*\Clothes are protective against burns in explosion
C) [x]se distribuie pe toata pielea expusa\*\Is distributed on all the exposed skin
D) [x]sunt preponderent dermice\*\Are predominantly dermal
E) [ ]necesita grefe extinse de piele\*\It need extensive skin grafts
---------------------------------------------------------------------
1345. CM p5 La un pacient care a suferit arsuri imunitatea este afectata: (239)\*\To a patient who suffered burns the immunity is affected:
A) [ ]scad nivelurile de Ig M\*\It lowers the levels of Ig M
B) [ ]scad nivelurile de Ig A\*\It lowers the levels of Ig A
C) [x]Scad nivelurile de Ig G\*\It decreases the levels of Ig G
D) [x]Scade activitatea complementului\*\It decreases the complement activity
E) [x]este deficitara productia GCSF\*\GCSF production is poor
---------------------------------------------------------------------
1346. CM p5 [CM45221] In arsurile electrice sunt frecvent distruse in intregime: (pag.256)
A) [x]Degetele\*\Toes
B) [x]Gambele\*\Legs
C) [x]Antebratele\*\Forearms
D) [ ]Trunchiul\*\Trunk
E) [x]Mainile\*\Hands
---------------------------------------------------------------------
1347. CM p5 In tratamentul local avantajele exciziei in plan suprafascicular sunt: (pag. 249)\*\In the local treatment the
advantages of excision in suprafascicular plan are:

177
A) [x]Determina un pat cu viabilitate certa\*\Determine a bed with brawl viability
B) [x]Garourile pot fi folosite de rutina pentru extremitati\*\Tourniquets can be used routinely to extremities
C) [ ]Timpul operator este mai scurt\*\The operator time is shorter
D) [x]Hemoragia intraoperatorie este mai mica decat in excizia tangentiala\*\Intra operative bleeding is less than tangential excision
E) [x]Necesita mai putina experienta pentru obtinerea unui pat optim\*\It requires less experience to obtain an optimal bed
---------------------------------------------------------------------
1348. CM p5 [CM45093] Arsurile de gradul I se deosebesc de cele de gradul II prin urmatoarele caracteristici: (p234)\*\\First
degree burns are different from those of grade II by the following characteristics:
A) [ ]produc vezicule\*\They cause blistering
B) [ ]implica numai dermul\*\It involves only the dermis
C) [x]implica epidermal\*\It involves the epidermal
D) [x]nu produc vezicule\*\Do not produce blistering
E) [ ]nu sunt dureroase\*\Are not painful
---------------------------------------------------------------------
1349. CM p5 [CM45101] Urmatoarele citokine sunt corelate cu raspunsul la agresiunea termica (p238)\*\The following
cytokines are correlated with the response to thermal aggression:
A) [x]TNF-alfa, IL-1, IL-6\*\TNF-alpha, IL-1, IL-6
B) [ ]numai IL-6 si IL-2\*\only IL-6 and IL-2
C) [x]IL-2, IL-8\*\IL-2, IL-8
D) [ ]IL-3,IL-4 si TNF-beta\*\IL-3, IL-4 and TNF-beta
E) [x]IL-2 este supresata si se coreleaza cu durata timpului scurs de la agresiunea termica\*\IL-2 is suppressed and correlates with
the length of time since the thermal aggression
---------------------------------------------------------------------
1350. CM p5 Legat de profilaxia antitetanica in arsuri putem afirma, CU EXCEPTIA: \*\Related to the anti tetanus prophylaxis in
burns we can say, except:
A) [ ]imunizarea in ultimii 5 ani nu mai necesita tratament\*\Immunization in the last five years do not require treatment
B) [ ]imunizarea in ultimii 10 ani necesita rapel cu anatoxina\*\Immunization in the past 10 years require anatoxin booster
C) [x]imunizarea in ultimii 10 ani nu mai necesita tratament\*\Immunization in the last 10 years do not require treatment
D) [x]imunizarea in ultimii 5 ani necesita ser imun\*\Immunization in the past five years require immune serum
E) [x]imunizarea in ultimii 10 ani necesita evaluarea starii imunologice inaintea administrarii serului imun\*\Immunization in the
past 10 years require the evaluation of the immune status before administering the immune serum
---------------------------------------------------------------------
1351. CS p4 [CS46081] Herniile femurale: (pag.1583)\*\femoral hernias
A) [x]Reprezinta o forma de hernie inghinala directa\*\It is a form of direct inguinal hernia
B) [ ]Reprezinta o forma de hernie inghinala indirecta\*\is a form of indirect inguinal hernia
C) [ ]Sunt frecvente\*\They are frequent
D) [ ]Cel mai frecvent se prezinta ca o masa reductibila de dimensiunile unei nuci\*\The most commonly presents as a reducible
mass the size of a walnut
E) [ ]Reprezinta 25% din herniile inghinale\*\25% of inguinal hernias
---------------------------------------------------------------------
1352. CS p4 Condesarea fasciala in regiunea vaselor epigastrice inferioare este cunoascut sub numele de: (p1594)\*\fascial
condensation of inferior epigastric vessels in the region is known as the:
A) [ ]Bandeleta lui Thomson\*\bandage Thomson
B) [x]Ligamentul Hesselbach\*\Hesselbach ligament
C) [ ]Ligamentul Henle\*\ligament Henle
D) [ ]Fascia transversalis\*\Fascia transversalis
E) [ ]Tractul iliopubic\*\Tractor iliopubic
---------------------------------------------------------------------
1353. CS p4 Semnul Howship-Romberg apare in: (pag 1602)\*\Howship-Romberg sign appears
A) [ ]hernie inghinala indirecta\*\indirect inguinal hernia
B) [ ]hernie inghinala directa\*\direct inguinal hernia
C) [ ]hernie femurala\*\femoral hernia
D) [x]hernie obturatorie\*\\Hernia shutter*\
E) [ ]hernie perineala\*\perineal hernia
---------------------------------------------------------------------
1354. CS p4 Interventia chirurgicala clasica pentru hernia ombilicala este: (pag.1601)\*\classic surgery for an umbilical hernia is:
A) [ ]tehnica Marcy\*\Technical Marcy
B) [ ]tehnica Cheatle-Henry\*\Technical Cheatle-Henry
C) [x]tehnica Mayo\*\Technical Mayo
D) [ ]tehnica Lichtenstein\*\Lichtenstein technique
E) [ ]tehnica Stopa\*\Stopa technique
---------------------------------------------------------------------


178
1355. CS p4 [CS46020] Manevra taxis reprezinta : (pag.1582)\*\taxis maneuver is:
A) [ ]iesirea completa a sacului herniar la nivelul peretelui\*\Full output of the hernial sac in the wall
B) [ ]iesirea intraparietala a sacului herniar\*\output of the hernial sac intraparietal
C) [x]reducerea manuala a sacului de hernie\*\manual reduction of hernia sac
D) [ ]prezenta sacului herniar in interiorul cavitatii\*\hernial sac inside the cavity
E) [ ]reducerea spontana a sacului de hernie\*\spontaneous reduction of the hernia sac
---------------------------------------------------------------------
1356. CS p4 [CS46019] Marimea herniei este determinata de : (pag.1582)\*\hernia size is determined by:
A) [ ]orificiul herniar\*\hernial orifice
B) [ ]marimea viscerului herniat\*\size of the herniated viscera
C) [x]dimensiunea gatului herniei si a volumului sacului destines\*\size and volume neck hernia sac destines
D) [ ]defectul peretelui cavitatii de unde se produce hernia\*\cavity wall where the defect occurs hernia
E) [ ]nici una de mai sus\*\none of the above
---------------------------------------------------------------------
1357. CS p4 Cea mai mare rata a strangularii dintre toate herniile o are:(p1583)\*\The highest rate of strangulation of hernias has:
A) [ ]hernia inghinala\*\inguinal hernia
B) [ ]hernia ombilicala\*\umbilical hernia
C) [x]hernia femurala\*\femoral hernia
D) [ ]hernia epigastrica\*\epigastric hernia
E) [ ]hernia pelvina\*\pelvic hernia
---------------------------------------------------------------------
1358. CS p4 [CS46030] Herniile parastomale : (pag.1602)\*\parastomale hernias
A) [x]interferaza cu irigatia colostomei si aderarea pungii de colostoma\*\interfere with colostomy irrigation and adhering colostomy bag
B) [ ]nu interfereaza cu irigatia colostomei\*\do not interfere with colostomy irrigation
C) [ ]nu interfereaza cu aderarea pungii de colostoma\*\does not interfere with the accession of colostomy bag
D) [ ]herniile paracolostomice sunt mai rare decat cele paraileostomice\*\paracolostomic hernias are less common than paraileostomic
E) [ ]se prefera pt\*\is preferred for
---------------------------------------------------------------------
1359. CM p5 Despre herniile inghinale indirecte sunt adevarate: (pg 1587)\*\which is true about indirect inguinal hernias
A) [x]toate sunt congenitale\*\All are congenital
B) [ ]80% sunt congenitale\*\80% are congenital
C) [x]se datoreaza unui proces vaginal patent\*\is due to a patent vaginal process
D) [ ]prezenta potentialului de dezvoltare a unei hernii inseamna ca aceasta se va dezvolta la un moment dat\*\This potential
development of a hernia means that it will develop at a time
E) [x]inchiderea procesului vaginal continua pana la 2 ani\*\Vaginal closure process continues until two years
---------------------------------------------------------------------
1360. CM p5 [CM46021] Continutul sacului intr-o hernie inghinala indirecta, poate fi obtinut prin alunecarea: (1587)\*\The
contents of the bag in a indirect inguinal hernia can be achieved by slipping:
A) [x]colonului sigmoid\*\sigmoid colon
B) [x]cecului\*\cecum
C) [x]ureterului\*\ureter
D) [ ]vezicii urinare\*\bladder
E) [ ]duodenului\*\duodenum
---------------------------------------------------------------------
1361. CM p5 Urmatoarele proteze folosite pentru hernioplastie sunt elastice, semirigide, cu memorie plastica si se curbeaza cand
sunt intinse in 2 directii odata: (1592)\*\prosthetic material for hernioplasty, porous, slightly elastic, semirigid, and relatively
heavy, and contain plastic memory and buckle when bent in two directions at once
A) [x]Surgipro\*\Surgipro
B) [ ]Mersilene\*\Mersilene
C) [x]Marlex\*\Marlex
D) [x]Prolene\*\Prolene
E) [ ]Gore-tex\*\Gore-tex
---------------------------------------------------------------------
1362. CM p5 Factori implicati in etiologia herniilor abdominale sunt, CU EXCEPTIA: ()\*\Factors involved in the etiology of
abdominal hernias are, except:
A) [ ]presiunea intraabdominala\*\abdominal pressure
B) [x]inciziile inalte pentru apendicectomie\*\high incisions for appendectomy
C) [ ]fumatul\*\smoking
D) [ ]diverse boli de tesut conjunctiv\*\various connective tissue diseases
E) [x]cancerul de colon\*\colon cancer
---------------------------------------------------------------------
1363. CM p5 Despre inelul profund al canalului inghinal sunt adevarate:(p1585)\*\which is true about ring of deep inguinal canal:
A) [ ]stalpul superior este format de bandeleta Thompson\*\The upper pole is formed by Thompson sling

179
B) [ ]stalpul superior este format de tractul iliopubic\*\upper pole tract consists of iliopubic
C) [x]stalpul inferior este format de arcul crural profund\*\lower pole is composed of deep crural arch
D) [x]marginea mediala este formata de aponevroza muschiuli transvers si de fascia transversalis\*\medial edge is formed by
transverse muscular aponeurosis and transversalis fascia
E) [x]marginea laterala este formata de transversul abdominal\*\edge side is formed by the transverse abdominal
---------------------------------------------------------------------
1364. CM p5 In ceea ce priveste herniile inghinale, inelul profund este format din: (pg 1585)\*\In terms of inguinal hernias, deep
ring is composed of:
A) [ ]aponevroza transversului, lateral\*\aponeurosis transverse side
B) [x]aponevroza transversului,medial\*\transverse aponeurosis, medial
C) [x]fascia transvralis,medial\*\transvralis fascia, medially
D) [ ]muschiul transvers abdominal,medial\*\transverse abdominal muscle, medial
E) [x]muschiul transvers abdominal, lateral\*\transverse abdominal muscle, lateral
---------------------------------------------------------------------
1365. CM p5 Cura chirurgicala a herniilor post incizionale la obezi are o morbiditate crescuta datorita urmatoarelor afectiuni
asociate: (p1602)\*\surgical treatment of hernias after incision in obese is due to the following conditions associated with
increased morbidity
A) [x]HTA\*\Hypertension
B) [x]diabet zaharat\*\diabetic
C) [x]afectiuni cardiace si renale\*\heart disease and kidney
D) [x]intertrigo purulent\*\intertrigo foul
E) [ ]degenerarii grase a muschilor laterali abdominali\*\fatty degeneration of the lateral abdominal muscles
---------------------------------------------------------------------
1366. CM p5 [CM46202] Locul de aparitie al herniilor congenitale spontane sau traumatice este: (pag 1601)\*\Place of
occurrence of spontaneous or traumatic hernia is congenital
A) [ ]A De-a lungul portiunii subombilicale a liniei semilunare Spiegel\*\A portion along the semilunar line subombilicale Spiegel
B) [x]B Prin triunghiul superior Grynfeltt\*\B The upper triangle Grynfeltt
C) [ ]C Prin triunghiul inferior Grynfeltt\*\C The lower triangle Grynfeltt
D) [x]D Prin triunghiul inferior Petit\*\D The lower triangle of Petit
E) [ ]E Prin triunghiul superior Petit\*\E The upper triangle of Petit
---------------------------------------------------------------------
1367. CM p5 Codronul spermatic contine: (1586)\*\spermatic cord contains:
A) [x]canal deferent\*\vas deferent
B) [ ]canal epididimar\*\channel epididimas
C) [x]grasime\*\Fat
D) [x]artera testiculara\*\Testicular artery
E) [x]nervi vegetativi\*\autonomic nerves
---------------------------------------------------------------------
1368. CM p5 Zone herniare rare sunt: (pag. 1582)\*\rare hernia Zone
A) [x]perineu\*\The perineum
B) [x]gaurile obturatorii si sciatice\*\obturator orifice and sciatic
C) [ ]linia semilunara Spieghel\*\semilunar line Spieghel
D) [x]triunghi lombar superior Grynfeltt\*\triangular upper lumbar Grynfeltt
E) [x]triunghiul lombar inferior Petit\*\lower lumbar triangle Petit
---------------------------------------------------------------------
1369. CM p5 Din punctul de vedere al chirurgului care opereaza o hernie, important este stratul profund aponevroticofascial al
abdomenului, format din: (pg 1584)\*\From the viewpoint of the surgeon who operated a hernia, the structurally important
aponevroticofascial deep layer of the abdomen, consisting of:
A) [x]aponevroza transversului\*\transverse aponeurosis
B) [ ]ligamentul inghinal\*\inguinal ligament
C) [x]muschiul transvers abdominal\*\transverse abdominal muscle
D) [x]fascia transversalis\*\fascia transversalis
E) [ ]muschiul oblic intern\*\internal oblique muscle
---------------------------------------------------------------------
1370. CM p5 Cordonul spermatic contine: (p1586)\*\the spermatic cord contains
A) [x]Canalul deferent\*\vas deferens
B) [ ]Nervul genitofemural\*\Nerve genitofemoral
C) [x]Artera testiculara\*\Testicular artery
D) [x]Artera canalului deferent\*\vas deferens artery
E) [ ]Vasele cremasteriene\*\cremasteriene vessels
---------------------------------------------------------------------
1371. CM p5 Cauzele principale ale herniei postincizionale sunt (pag 1602)\*\The main causes of incisional hernias are
A) [ ]A Hipertensiunea\*\Hypertension

180
B) [ ]B Afectiunile cardiace\*\heart disease
C) [ ]C Diabetul\*\Diabetes
D) [x]D Obezitatea\*\Obesity
E) [x]E Infectiile\*\Infections
---------------------------------------------------------------------
1372. CM p5 [CM46214] Hernia epigastrica: ()\*\epigastric hernia: ()
A) [x]apare de-a lungul linie albe;\*\occurs along the linea alba
B) [x]frecvent este ireductibila;\*\frequently is irreducible
C) [x]pot fi multiple si mici;\*\may be multiple and small
D) [ ]apare de-a lungul linie Spiegel;\*\occurs along the line Spiegel
E) [ ]frecvent este insotita de protuzia epigastrului.\*\is frequently accompanied by epigastric protrusion
---------------------------------------------------------------------
1373. CM p5 [CM46172] Herniile pelvine: (pag.1602)\*\pelvic hernias
A) [x]Sunt rare\*\There are rare
B) [x]Cele mai frecvente sunt herniile obturatorii\*\The most common are obturator hernias
C) [ ]Nu apar la batrani\*\Not to old
D) [ ]Sunt mai putin frecvente la sexul feminin\*\They are less common in women
E) [x]Apar la casectici\*\with cachectic appearance
---------------------------------------------------------------------
1374. CM p5 Factorii care determian incapacitatea fascieie transversalis de a retien sacul visceral in orificiul miopectinela sunt:
(p 1588) \*\what are the Factors that determine the inability of fascia transversalis to retain orifice myopectinal:
A) [ ]clinostatismul\*\supine
B) [x]deficitul muscular\*\muscle deficit
C) [x]distensia abdominala din ascita\*\abdominal distension from ascites
D) [x]deformarile osoase ale pelvisului\*\skeletal deformities of the pelvis
E) [ ]operatiile abdominale in antecedente\*\a history of abdominal surgery
---------------------------------------------------------------------
1375. CM p5 Hernia postincizionala sau eventratia postoperatorie are urmatoarele repercusiuni: \*\incisional hernia or
postoperative eventration has the following consequences:
A) [ ]imbunatatirea miscarii diafragmului;\*\improvement of diaphragmatic movement
B) [x]disfunctia respiratorie;\*\respiratory dysfunction;
C) [x]edemul mezenterului;\*\swelling of mesentery;
D) [x]durerea de spate;\*\back pain
E) [ ]edemul Quinke.\*\Quinke edema
---------------------------------------------------------------------
1376. CM p5 Durerea prin dezaferentare aparuta in urma hernioplastiilor are urmatoarele caracteristici: (pag 1599)\*\by definition
pain occurred after hernioplasty has the following characteristics:
A) [x]Are caracter de arsura cu debut tardiv\*\has the nature of late-onset burn
B) [ ]Variaza cu pozitia\*\Varies with position
C) [x]Au loc frecvent exacerbari paroxistice\*\They occur frequently paroxysmal exacerbations
D) [x]Percutia locului nu determina accentuarea durerii\*\Percussion site does not cause increased pain
E) [ ]Are debut precoce\*\has early onset
---------------------------------------------------------------------
1377. CM p5 Stratul aponevrotico-fascial al transversului aflat la marginea superioara a aponevrozei femurale mai este numit si:
(pag 1584)\*\aponeurotico-fascial layer on a side of the transverse upper femoral aponeurosis is called
A) [ ]Arcul aponevrotic al muschiului transvers abdominal\*\aponeurotic arch of transverse abdominal muscle
B) [x]Tractul ileopubic\*\ileopubic Tract
C) [x]Arcul crural profund\*\deep crural arch
D) [ ]Pilierul superior al inelului profund\*\upper pillar deep ring
E) [x]Bandeleta lui Thomson\*\bandage Thomson
---------------------------------------------------------------------
1378. CM p5 Despre hernia lombara se poate spune: ()\*\About lumbar hernia can say:
A) [ ]se poate trata prin inchidere simpla in cele mici\*\\can be treated by simple closure in small*\
B) [x]triunghiul petit este acoperit de fascia superficiala\*\Petit triangle is covered by superficial fascia
C) [ ]triunghiul Grynfelt este marginit de oblicul intern,sacrospinali si coasta a Xa\*\Grynfelt triangle is bordered by the internal
oblique, and coast sacrospinali X
D) [x]cele congenitale sau traumatice sunt rare\*\those are rare congenital or traumatic
E) [x]h difuze mari se produc frecvent dupa nefrectomie\*\diffuse large hernia occur frequently after nephrectomy
---------------------------------------------------------------------
1379. CM p5 Factorii de risc sau predispozanti pentru hernia ombilicala sunt: (pag 1601)\*\risk factors predisposing to an
umbilical hernia are:
A) [x]A Obezitatea\*\To Obesity
B) [ ]B Varsta inaintata\*\old age

181
C) [x]C Sarcinile\*\Tasks
D) [x]D Sexul feminin\*\Female gender
E) [ ]E Sexul masculin\*\male
---------------------------------------------------------------------
1380. CM p5 Despre hernia ombilicala este adevarat ca : ()\*\About navel hernia is true:
A) [x]la sugar se inchide spontan daca este mai mica de 1 cm\*\If smaller than 1 cm, in babies, it closes spontaneusly
B) [ ]strangularea cecului este frecventa\*\Caecum strangulation is frequent
C) [ ]hernioplastia Mayo este tehnica clasica cel mai frecvent folosita ca tratament\*\Mayo hernioplasty is a classical technique
mostly used as treatment
D) [x]defectul mai mare de 2 cm la sugar trebuie tratat chirurgical\*\If the defect is bigger than 2 cm, in babies, it needs a surgery treatment
E) [ ]cand defectul este mic se poate sutura cu cateva fire din poliester\*\If the defect is small, it can be sutured with some
polyester fibers
---------------------------------------------------------------------
1381. CS p4 TSH crescut si horm tiroidieni crescuti pledeaza pentru\*\ Increased TSH and thyroid horm advocates raised:
A) [x] hipetiroidism hipofizar \*\ hipetiroidism pituitary
B) [ ] hipotalamic \*\ hypothalamic
C) [ ] normotiroidism \*\ normotiroidism
D) [ ] adenom toxic \*\ Toxic adenoma
E) [ ] tiroidita subacauta \*\ thyroiditis subacauta
---------------------------------------------------------------------
1382. CS p4 La adultii tineri cu hipotiroidie si cardiopatie ischemica doza de levotiroxina este : (Pag132) \*\ In young adults with
hypothyroidism and coronary heart disease is the dose of levothyroxine
A) [ ] 50-100g/zi \*\ 50-100g/zi
B) [x] 25g/zi \*\ 25g/zi
C) [ ] 1-2 g/kgc/zi \*\ 1-2 g/kgc/zi
D) [ ] Nu se administreaza in sarcina \*\ Do not give in charge
E) [ ] Nici una din valorile de mai sus \*\ None of the above values
---------------------------------------------------------------------
1383. CS p4 Doza initiala de levo-tiroxina la tineri fara cardiopatie ischemica este: (132) \*\ Initial dose-thyroxine threoform
without coronary heart disease in young people is
A) [ ] 80-200 micrograme/zi \*\ 80-200 micrograms / day
B) [x] 50-100 micrograme/zi \*\ 50-100 micrograms / day
C) [ ] 25 micrograme/zi \*\ 25 micrograms / day
D) [ ] 150 micrograme/zi \*\ 150 micrograms / day
E) [ ] 30-50 micrograme/zi \*\ 30-50 micrograms/day
---------------------------------------------------------------------
1384. CS p4 [Hipertiroidismul se manifesta prin urmatoarele, cu exceptia:(p119)\*\ Hyperthyroidism occurs in the following, except:
A) [ ] Prurit \*\ Pruritus
B) [ ] Fatigabilitate \*\ fatigue
C) [x] Apetit scazut (frecvent la tineri) \*\ poor appetite (often in young people)
D) [ ] Fibrilatia atriala \*\ Atrial fibrillation
E) [ ] Onicoliza \*\ Onicoliza
---------------------------------------------------------------------
1385. CS p4 Despre hipotiroidism in sarcina nu este adevarat ca: (p132) \*\ About hypothyroidism in pregnancy is not true that
A) [ ] Se recomanda monitorizarea TSH si FT4 la 3 luni \*\ It is recommended that monitoring of TSH and FT4 in three months
B) [ ] Exista o hipertiroxinemie fiziologica \*\ There is a physiological hipertiroxinemie
C) [ ] In sarcina cresc proteinele de legare a tiroxinei \*\ The growing burden of thyroxine binding proteins
D) [ ] T4 total nu are valoare diagnostica \*\ total T4 has no diagnostic value
E) [x] Este necesara scaderea dozei de levo-tiroxina \*\ It is necessary to lower-dose thyroxine threoform
---------------------------------------------------------------------
1386. CS p4 Antitiroidianul de sinteza cel mai utilizat la gravidele cu hipertiroidism este: (124) \*\ Synthetic antithyroid most
pregnant women with hyperthyroidism is used to:
A) [ ] metiltiouracil \*\ metiltiouracil
B) [ ] metimazol \*\ methimazole
C) [ ] tirazol \*\ tirazol
D) [x] propiltiouracil \*\ propiltiouracil
E) [ ] carbimazol \*\ carbimazol
---------------------------------------------------------------------
1387. CS p4 In screening-ul mixedemului congenital, este sugestiva o valoare a TSH: (pag. 133) \*\ In screening congenital
mixoedema is suggestive of a TSH value
A) [ ] mai mare de 10 mU/l \*\ more than 10 mU / l
B) [ ] mai mica de 20 mU/l \*\ less than 20 mU / l
C) [ ] mai mare de 25 mu/l \*\ greater than 25 mU / l

182
D) [ ] mai mare de 30 mU/l \*\ greater than 30 mU / l
E) [x] mai mare de 20mU/l \*\ more than 20mU / l
---------------------------------------------------------------------
1388. CS p4 Care din urmatoarele afirmatii cu privire la tratamentul insuficientei de corticosuprarenala primara asociata cu hipotiroidism e
adevarata:(132)\*\Which of the following statements on the treatment of cortical insufficiency associated with primary hypothyroidism is true:
A) [ ] se administreaza numai levo-tiroxina \*\ is given only threoform-thyroxine
B) [ ] se administreaza dexametazona si levo-tiroxina \*\ dexamethasone is administered and threoform-thyroxine
C) [ ] se administreaza concomitent levo-tiroxina si prednison \*\ concomitant threoform-thyroxine and prednisone
D) [x] se administreaza prednison si apoi levo-tiroxina \*\ and then administer prednisone threoform-thyroxine
E) [ ] se administreaza levo-tiroxina si apoi prednison \*\ threoform-thyroxine is given and then prednisone
---------------------------------------------------------------------
1389. CM p5 Un deficit moderat de iod este indicat de: /*/ A moderate iodine deficiency is indicated by:
A) [ ] o prevalenta a gusii ( copii 7-14 ani) de 5-19,9% /*/ The prevalence of the goiter (children 7-14 years) of 5 - 19.9%
B) [x] o iodurie de 20-49 micrograme la litru /*/ An iodide of 20-49 micrograms per liter
C) [x] prevalenta TSH neonatal peste 5microU/ml intre 20-39,9% /*/ A prevalence of neonatal TSH above 5microU/ml between 20-39.9%
D) [x] o prevalenta a gusii ( copii 7-14 ani) de 20-29,9% /*/ A prevalence of the goiter (children 7-14 years) of 20 - 29.9%
E) [ ] o iodurie sub 20 micrograme la litru /*/ iodine below 20 micrograms per liter
---------------------------------------------------------------------
1390. CM p5 Dintre complicatiile hipotiroidismului clinic manifest sau subclinic fac parte : (pg. 131) /*/ Between the
complications of clinically manifest or subclinical hypothyroidism are:
A) [x] depresia /*/ Depression /*/
B) [x] limfomul primitiv tiroidian /*/ Primitive thyroid lymphoma
C) [ ] fibrilatia atriala /*/ Atrial fibrillation
D) [x] ateroscleroza /*/ Atherosclerosis
E) [ ] insuficienta cardiaca congestiva /*/ Congestive heart failure
---------------------------------------------------------------------
1391. CM p5Forme clinice de tireotoxicoza fara hipertiroidism sunt:(120)/*/The clinical forms of thyrotoxicosis without hyperthyroidism are:
A) [ ] boala basedow graves/*/Graves' disease
B) [x] tiroidita indolora/*/: Painless thyroiditis
C) [x] tiroidita subacuta/*/Subacute thyroiditis
D) [x] tireotoxicoza din struma ovarii/*/Thyrotoxicosis from the ovarian Struma
E) [x] tireotoxicoza factitia/*/Thyrotoxicosis factitive
---------------------------------------------------------------------
1392. CM p5 Afirmatii adevarate sunt : (pg121)/*/Affirmations are true:
A) [ ] in hipertiroidismul factice tiroglobulina serica e crescuta/*/In artificial hyperthyroidism the tiroglobulin is increased
B) [x] in adenomul toxic tiroidian la scintigrama se evidentiaza un nodul hiperfixant/*/In toxic thyroid adenoma, on the
scintigram is evidenced a hiperfixant nodule
C) [x] in adenomul toxic tiroidian e inhibata fixarea iodului radioactiv la nivelul tesutului tiroidian extranodular/*/In toxic
adenoma of thyroid is inhibited the radioiodine fixation in the extranodular thyroid tissue
D) [ ] in hipertiroidismul indus de iod ioduria e absenta/*/In the iodine-induced hyperthyroidism the iodine is absent
E) [x] in tiroidita subacuta gusa e dureroasa/*/In the subacute thyroiditis the goiter is painful
---------------------------------------------------------------------
1393. CM p5 Cauzele principale de hipotiroidism primar la adult sunt:(130)/*/The main causes of primary hypothyroidism in adults are:
A) [x] leziunile autoimune /*/ Autoimmune lesions
B) [x] tratament radical cu iod radioactiv sau cura chirurgicala /*/ Radical treatment with radioactive iodine or surgical treatment
C) [ ] sdr. Sheehan /*/ SDR. Sheehan
D) [x] deficitul de iod /*/ Iodine deficiency
E) [ ] insuficienta hipotalamo-hipofizara /*/ The hypothalamic-pituitary insufficiency
---------------------------------------------------------------------
1394. CM p5 Hipotiroidismul congenital: (p145)/*/Congenital hypothyroidism:
A) [ ] presupune prezenta leziunilor SNC ireversibile de la nastere/*/It assumes the irreversible CNS lesions presence from birth
B) [x] leziunile SNC se pot preveni prin administrarea tiroxinei la nastere/*/CNS lesions may be prevented by the administration
of thyroxine at birth
C) [ ] functia tiroidei postnatal este corespunzatoare aportului iodat/*/Postnatal thyroid function is adequate to the intake of iodate
D) [x] Functia tiroidei postnatal este deficitara permanent/*/Postnatal thyroid function is always poor
E) [ ] toate afirmatiile de mai sus sunt false/*/All the above statements are false
---------------------------------------------------------------------
1395. CM p5Indicatii pt tiroidectomie partiala reprezinta: (p.123)/*/Indications for partial thyroidectomy are:
A) [ ] recidiva dupa I2 radioactiv/*/Relapse after I2 radioactive
B) [x] gusa mare/*/Large goiter
C) [ ] varsta peste 20 de ani/*/Age over 20 years
D) [x] preferinta pacientului/*/Patient preference
E) [x] fenomene de compresiune/*/Compression phenomena

183
---------------------------------------------------------------------
1396. CM p5 La probele paraclinice de rutina se pot evidentia modificari, care nu sunt diagnostice: (p 129)/*/The routine
laboratory tests can reveal changes that are not diagnosed:
A) [x] Colesterol seric crescut./*/Increased serum cholesterol
B) [x] Cresterea moderata a transaminazelor./*/Moderate increase of transaminases
C) [x] Homocistinurie serica moderat crescuta./*/Moderately elevated homocystinuria serum
D) [x] Dilipidemie cu LDL-colesterol crescut./*/Duslipidemia with LDL increased cholesterol
E) [ ] Hiprenatremie./*/Hypernatremia
---------------------------------------------------------------------
1397. CM p5 ATS nu se recomanda: (pag.123,124)/*/ATS is not recommended in:
A) [ ] sarcina/*/Pregnancy
B) [x] tiroidita subacuta/*/Subacute thyroiditis
C) [x] tiroidita indusa de amiodarona/*/Amiodarone-induced thyroiditis
D) [ ] gusa mica/*/Small goiter
E) [ ] la primul episod/*/In the first episode
---------------------------------------------------------------------
1398. CM p5 Identificati va rog judetele declarate endemice pentru deficitul de iod moderat clinic manifest din Romania
A) [ ] Ialomita/*/Ialomita
B) [x] Maramures/*/Maramures
C) [ ] Ilfov/*/Ilfov
D) [ ] Arad/*/Arad
E) [x] Prahova/*/Prahova
---------------------------------------------------------------------
1399. CM p5 In hipotiroidismul hipotalamo-hipofizar, explorarile de laborator releva: (p129)/*/ In hypothalamic-pituitary
hypothyroidism, laboratory explorations reveal:
A) [x] TSH plasmatic scazut/*/ Low serum TSH
B) [x] TSH plasmatic normal /*/Normal serum TSH
C) [x] FT4 scazut /*/ Low FT4
D) [ ] FT4 crescut /*/ Increased FT4
E) [ ] FT4 normal /*/ Normal FT4
---------------------------------------------------------------------
1400. CM p5 Dg diferential al hipertiroidismului se face cu: (p121)/*/Differential Dg of hyperthyroidism is made by:
A) [ ] sdr hipercolinergice/*/SDR hyper colinergic
B) [x] sdr maniacale/*/Manic SDR
C) [ ] HTA/*/Hypertension
D) [x] DZ clinic manifest/*/Clinically manifest diabetes
E) [x] Feocromocitom/*/Pheochromocytoma
---------------------------------------------------------------------
1401. CM p5 Urmatoarele semne si simptome pot sa apara atat in hipertiroidism cat si in hipotiroidism: /*/ The following signs
and symptoms can occur in both hyperthyroidism and hypothyroidism:
A) [x] alopecia /*/ Alopecia /*/
B) [ ] constipatia /*/ Constipation /*/
C) [x] amenoreea /*/ Amenorrhea
D) [x] scaderea libidoului /*/ Decreased libido /*/
E) [ ] prurit /*/ Pruritus /*/
---------------------------------------------------------------------
1402. CM p5 Forma neurologica a cretinismului endemic se caracterizeaza prin: (145) /*/ The neurological form of endemic
cretinism is characterized by:
A) [x] diplegie spastica /*/ Spastic diplegia
B) [ ] disgenezie a epifizei capului femural /*/ Dysgenesis of the femoral head epiphysis
C) [x] hipotiroidism subclinic /*/ Subclinical hypothyroidism
D) [ ] ROT diminuate /*/ ROT reduced
E) [ ] gusa absenta /*/ The absence of goiter /*/
---------------------------------------------------------------------
1403. CM p5 Clasificarea NOSPECS a modificarilor oculare din Boala Graves (p127)/*/NOSPECS classification of the eye
changes of Graves' disease:
A) [ ] cls 0 fara semne, numai semne clinice/*/Grade 0, no signs, only clinical signs
B) [x] cls 2 afectarea tes moi/*/Grade 2 damage soft woven
C) [x] cls 3 exoftalmie/*/Grade 3 protruding
D) [ ] cls 4 leziuni corneene/*/Grade 4 cornea lesions
E) [x] cls 6 afectarea nervului optic/*/6 grade, optic nerve damage
---------------------------------------------------------------------


184
1404. CM p5 Cazurile de gusa polinodulara si boala Graves necesita supraveghere endocrinologica datorita (p126)/*/The cases of
poli -nodular goiter and the Graves' disease require endocrinologist supervision due to:
A) [x] riscului de recidiva a hipertiroidismului dupa oprirea ATS sau dupa un tratament radical/*/The risk of relapse of
hyperthyroidism after the ATS stopping or after a radical treatment
B) [x] pentru evidentiarea non-compliantei terapeutice la unii pacienti hipotiroidieni cu tratament substitutiv/*/For outlining the
non-adherence therapeutic in some hypothyroid patients with substitute treatment
C) [ ] risc de hipertiroidism dupa tratament medical (ATS si euthyrox)/*/Risk of hyperthyroidism after medical treatment (ATS
and euthyrox)
D) [ ] riscului de deces al pacientului/*/The risk of death of the patient
E) [x] risc de hipotiroidism dupa tratamente radicale ( chirurgie si iod radioactiv)/*/The risk of hypothyroidism after radical
treatment (surgery and radioactive iodine)
---------------------------------------------------------------------
1405. CM p5 In criza tireotoxica apar: (128) /*/the thyrotoxic crisis occurs:
A) [x] Febra /*/ Fever
B) [x] Tulburari cardiovasculare /*/ Cardiovascular Disorders
C) [x] Deshidratare /*/ Dehydration
D) [ ] Hipertensiune arteriala /*/ Hypertension
E) [ ] Paloare /*/ Pallor
---------------------------------------------------------------------
1406. CM p5 Despre cretinismul endemic nu sunt adevarate urmatoarele afirmatii: (145, 146)/*/About endemic cretinism the
following statements are not true:
A) [x] deficitul de iod elemental nu are efect propriu asupra creierului/*/The elemental iodine deficiency has no effect on the brain
B) [ ] in patogenia formei mixedematoase exista deficit de seleniu/*/ In the mix edematous form pathogenesis there is selenium deficiency
C) [x] in forma mixedematoasa sunt prezente surdomutismul si diplegia spastica/*/In the mix edematous form are presented the
deaf-and-dumb and spastic dysplagia
D) [x] forma neurologica prezinta disgenezie epifizara a capului femural/*/The neurological form show the epiphysis dysgenesis
of the femoral head
E) [x] cauza cretinismului produsului de conceptie e excesul de iod/*/The cause of cretinism of the product of conception is the excess iodine
---------------------------------------------------------------------
1407. CM p5 Unele medicamente, mai ales pe fondul unei tiroidite cronice, pot induce hipotiroidism: (130)/*/Some drugs,
especially for a chronic thyroiditis, can cause hypothyroidism:
A) [x] amiodarona;/*/Amiodarone;
B) [ ] propranolol;/*/Propranolol;
C) [ ] acid valproic;/*/Valproic acid
D) [x] litiu;/*/Lithium
E) [ ] fenitoina./*/Phenytoin.
---------------------------------------------------------------------
1408. CM p5 TSH supresat apare in urmatoarele situatii: (122)/*/Suppressed TSH appears in the following situations:
A) [x] Hipertiroidism clinic manifest/*/Hyperthyroidism clinical manifestations
B) [x] Hipertiroidism subclinic/*/Hyperthyroidism subclinical
C) [x] Dupa administrare de glucocorticoizi/*/After administration of glucose- corticoids
D) [x] Depresie majora/*/Major depression
E) [ ] Dupa administrare de beta-blocante/*/After administration of beta blockers
---------------------------------------------------------------------
1409. CM p5 Forma severa de hipotiroidism: (129)/*/severe form of hypothyroidism:
A) [ ] apare un infiltrat localizat;/*/There is a localized infiltrate;
B) [x] se numeste mixedem;/*/Is called myxedema;
C) [x] infiltratul contine glicozaminoglicani;/*/The infiltrate contains glycosaminoglycans;
D) [x] apare un infiltrat generalizat in tegumente, seroase, viscere;/*/Is a generalized infiltrated in the skin, serous, viscera;
E) [ ] apare si in adenomul toxic tiroidian./*/Appears in toxic thyroid adenoma.
---------------------------------------------------------------------
1410. CM p5 Hipotiroidismul se clasifica in functie de: (pag.130)/*/Hypothyroidism is classified according to:
A) [x] localizarea leziunii /*/ The location of lesion
B) [x] gradul insuficientei tiroidiene primare /*/ The degree of primary thyroid failure
C) [x] durata/*/Duration
D) [x] varsta la care apare /*/ The age when it appears
E) [ ] necesitatile terapeutice /*/ Therapeutic needs
---------------------------------------------------------------------
1411. CS p4 In cancerul de col uterin, care este cea mai frecvent intalnita cale de extensie: (p3070) \*\ In cervical cancer, which is
the most common way to add:
A) [x] din aproape in aproape, ca o ''patade ulei'' \*\ step by step, as an "oil patade"
B) [ ] calea limfatica \*\ via lymphatics
C) [ ] calea hematogena \*\ path marrow

185
D) [ ] calea limfaticasi hematogena \*\ path limfaticasi marrow
E) [ ] nici una din cele de mai sus \*\ none of the above
---------------------------------------------------------------------
1412. CS p4 [C2650058] Cat reprezinta durata expunerii in cazul sistemului Stokholm de tratament radiologic in cazul cancerului
de col uterin? (p3074) \*\ What is the duration of exposure for radiation treatment system of Stockholm where cervical cancer?
A) [ ] 6-8 zile \*\ 6-8 days
B) [ ] 2-3 zile \*\ 2-3 days
C) [x] 27-30 ore \*\ 27-30 hours
D) [ ] 12-18 ore \*\ 12-18 hours
E) [ ] 6-8 ore \*\ 6-8 hours
---------------------------------------------------------------------
1413. CS p4 Stadializarea cancerului de col uterin asociat cu sarcina este mai dificila datorita: (p3073) \*\ Staging of cervical
cancer associated with pregnancy is more difficult because:
A) [ ] hormonilor de sarcina; \*\ The hormones of pregnancy;
B) [ ] ascensiunii uterului in abdomen; \*\ rise of the uterus in the abdomen;
C) [ ] constipatiei; \*\ constipation;
D) [x] imbibitiei hidrice din parametre; \*\ water imbibitiei of parameters;
E) [ ] prezentei hemoroizilor \*\ this hemorrhoids
---------------------------------------------------------------------
1414. CS p4 Stadiul II b (stadializ.FIGO) a cancerului de col reprezinta: (p3072) \*\ Stage IIb (FIGO staging) is cervical cancer
A) [ ] invazia 1/3 caudale a vaginului, fara atingerea peretilor excavatiei, in caz de invazie a parametrelor; \*\ The invasion of
third tail of the vagina, without touching the walls of excavations, in case of invasion of parameters;
B) [ ] invazia vaginului fara interesarea parametrelor;\*\ invasion of the vagina without involving parameters;
C) [ ] invazia parametrelor pana la peretele excavatiei si / sau hidronefroza sau rinichi nefunctional; \*\ wall invasion parameters
to excavation and / or hydronephrosis or kidney unfunctional;
D) [x] invazia parametrelor, dar nu pana la peretele excavatiei; \*\ invasion parameters, but not until the excavation wall;
E) [ ] leziune mai mare de 4 cm; \*\ lesion larger than 4 cm;
---------------------------------------------------------------------
1415. CS p4 Rolul factorului infectios in etiologia cancerului de col uterin este sustinut de prezenta: (pag. 3069) \*\ The role of
infectious factor in the etiology of cervical cancer is supported by this:
A) [ ] virusul Epstein -Barr; \*\ Epstein-Barr virus;
B) [ ] HIV; \*\ HIV;
C) [x] virus herpes simplex tip 2; \*\ herpes simplex virus type 2;
D) [ ] virusul rubeolic; \*\rubella;
E) [ ] virus herpes simplex tip 1; \*\ herpes simplex virus type 1;
---------------------------------------------------------------------
1416. CS p4 In cancerul de col si sarcina, stabilirea stadialitatii este:(p3073)\*\In cervical cancer and pregnancy, stadialitatii setting is:
A) [ ] facila \*\ Easy
B) [ ] facila in prezenta computer tomografiei \*\ easy in this computer tomography
C) [x] dificila datorita imbibatiei hidrice \*\ difficult because water mbibatiei
D) [ ] dificila in functie de prezentatie \*\ hard depending on the presentation
E) [ ] dificilala prima sarcina \*\ difficult first pregnancy
---------------------------------------------------------------------
1417. CS p4 Cate cure de polichimioterapie pot fi efectuate in cazul tratamentului asociat al sarcomului de col uterin? (p. 3078)
\*\ Polichimioterapie How many courses of treatment may be conducted in association with cervical sarcoma?
A) [ ] 2-4 \*\ 2-4
B) [ ] 4-6 \*\ 4-6
C) [ ] 6-8 \*\ 6-8
D) [ ] 8-10 \*\ 8-10
E) [x] 10-12 \*\ 10-12
---------------------------------------------------------------------
1418. CS p4 Strategia terapeutica in stadiul 0 al neoplasmului de col uterin la bolnave peste 40 de ani cuprinde: (pag. 3076) \*\
Therapeutic strategy of stage 0 cervical cancer in patients over 40 years include:
A) [ ] brahiterapie utero-vaginala si/sau interventie chirurgicala de tip oncologic la 5-6 saptamani postiradiere \*\ utero-vaginal
brachytherapy and / or type oncological surgery in 5-6 weeks postiradiere
B) [ ] teleterapie si/sau interventie chirurgicala \*\ teleterapie and / or surgery
C) [ ] chimioterapie si/sau interventie chirurgicala \*\ chemotherapy and / or surgery
D) [ ] radioterapie \*\ radiotherapy
E) [x] histerectomie totala cu conservarea anexelor \*\ total hysterectomy with conservation Annexes
---------------------------------------------------------------------
1419. CM p5 Tratamentul chirurgical al cancerului de col uterin: (p3073) \*\ Surgical treatment of cervical cancer
A) [ ] este doar paleativ \*\ It is only palliative
B) [x] urmareste in primul rand prognosticul vital \*\ aims primarily vital prognosis

186
C) [x] sacrifica functionalitatea in favoarea radicalitatii \*\ sacrificing functionality in favor radicalitatii
D) [ ] urmareste pastrarea functionalitatii, nu este radical \*\ follow preservation functionality is not radically
E) [x] extirpa dincolo de limitele aparente ale leziunii tumorale cu extirparea in bloc a cailor de propagare \*\ remove the lesion
beyond the apparent tumor with removal of horses spread block
---------------------------------------------------------------------
1420. CM p5 Care sunt timpii operatori care fac parte din histerectomia radicala? (pag. 3073) \*\ What time operators as part of
radical hysterectomy?
A) [x] Extirparea 1/3 craniale a vaginului; \*\ removal of third cranial to the vagina;
B) [ ] Extirparea trigonului vezical; \*\ removal of bladder trigonal;
C) [x] Extirparea ligamentelor utero-sacrate; \*\ utero-sacral ligament removal;
D) [x] Extirparea parametrelor; \*\ removal of parameters;
E) [x] Extirparea ganglionilor iliaci externi \*\ external iliac lymph removal
---------------------------------------------------------------------
1421. CM p5 [Clasificarea histologica a cancerului de col uterin se face astfel: (p3070) \*\ Histologic classification of cervical
cancer is as follows:
A) [ ] tumori epiteliale benigne \*\ Benign epithelial tumors
B) [x] tumori epiteliale maligne \*\ Malignant epithelial tumors
C) [x] tumori nonepiteliale maligne \*\ nonepiteliale malignant tumors
D) [x] tumori secundare \*\ secondary tumors
E) [ ] tumori nonepiteliale benigne \*\ Benign tumors nonepiteliale
---------------------------------------------------------------------
1422. CM p5 Tratamentul in cancerul de col stadiul Ia2 include urmatoarele, cu exceptia: (p3076) \*\ Treatment Ia2 stage
cervical cancer include the following, except:
A) [ ] brahiterapie 60 Gy in punctele A din parametre \*\ brachytherapy 60 Gy in point A of parameters
B) [x] histerectomie totala cu anexectomie bilaterala la 5-6 saptamani dupa radioterapie \*\ total hysterectomy with bilateral
anexectomy 5-6 weeks after radiotherapy
C) [x] momochimioterapie cu taxani \*\ momochimioterapie with taxanes
D) [ ] brahiterapie 10-20 Gy postoperator la bontul vaginal \*\ 10-20 Gy postoperative Brachytherapy to the vaginal stump
E) [x] teleterapie 60 Gy \*\ 60 Gy teleterapie
---------------------------------------------------------------------
1423. CM p5 Factorii infectiosi incriminati in etiologia cancerului de col uterin sunt: (p3069) \*\ Infectious factors incriminated
in the etiology of cervical cancer are:
A) [ ] herpes simplex virus tip 1 (HSV-1) \*\ The herpes simplex virus type 1 (HSV-1)
B) [x] herpes simplex virus tip 2 (HSV-2) \*\ Herpes simplex virus type 2 (HSV-2)
C) [x] human papiloma virus (HPV) \*\ human papilloma virus (HPV)
D) [ ] parvo virus \*\ Parvo Virus
E) [ ] HIV (SIDA) \*\ HIV (AIDS)
---------------------------------------------------------------------
1424. CM p5 Precizati care sunt factorii favorizanti in etiologia cancerului de col uterin: (p3069) \*\ Clarify which factors
favored etiology of cervical cancer
A) [ ] multiparitatea; \*\ multiparity;
B) [x] debutul vietii sexuale la varsta tanara; \*\ onset of sexual activity at young age;
C) [x] status socio-economic scazut; \*\ low socio-economic status;
D) [ ] bacilul DO-DERLEIN; \*\ bacillus DDERLEIN;
E) [ ] circumcizia partenerului sexual \*\ circumcision sexual partner
---------------------------------------------------------------------
1425. CM p5 Etiologia cancerului de col uterin este cunoscuta (p 3069) \*\ Etiology of cervical cancer is known
A) [ ] cu precizie \*\ The precise
B) [x] nu este cunoscuta \*\ not known
C) [x] exista factori favorizanti incriminati \*\ no risk factor incriminated
D) [ ] nu exista factori favorizanti \*\ no risk factor
E) [x] este urmarita prin studii epidemiologice efectuate pe loturi populationale cu mare valabilitate statistica \*\ is followed by
epidemiological studies conducted on population-groups with high statistical validity
---------------------------------------------------------------------
1426. CM p5 Brahiterapia in cancerul de col uterin trebuie sa acopere cu doza tumoriciala ''volumul tinta'': (p3075) \*\
Brachytherapy in Cervical Cancer tumoriciala dose should cover "target volume"
A) [x] uterul \*\ uterus
B) [x] partea proximala a parametrelor (punctul A) \*\the proximal parameters (point A)
C) [x] treimea superioaraa vaginului \*\ third superioaraa vagina
D) [ ] treimea inferioaraa vaginului \*\ third inferioara a vagina \*\
E) [ ] ovarele \*\ ovaries
---------------------------------------------------------------------


187
1427. CM p5 Pentru stadializarea cancerului de col uterin: (pag. 3071) \*\ For staging of cervical cancer
A) [x] se folosesc doua stadializari, TNM si FIGO \*\ doua stadializari used, TNM and FIGO
B) [ ] se foloseste doar stadializarea FIGO \*\ Use only the FIGO staging
C) [ ] se foloseste doar stadializarea TNM \*\ TNM staging is used only
D) [x] stadializarea FIGO permite o foarte corecta codificare terapeutica \*\ FIGO staging corecta codificare given a therapeutic
E) [x] stadializarea FIGO este cea folositacu predilectie de ginecologi si radioterapeuti \*\ FIGO staging is the predilection of
gynecologists and radioterapeuti folosita cu
---------------------------------------------------------------------
1428. CM p5 In tratamentul radiologic al cancerului de col uterin se folosesc: (p3074) \*\ The radiological treatment of cervical cancer using:
A) [x] radionuclidul cesiu (137Cs) \*\ radionuclide cesium (137Cs)
B) [x] radionuclidul iridiu ( 192Ir ) \*\ radionuclide iridium (192Ir)
C) [ ] nici unul dintre acestia \*\ none of them
D) [ ] radionuclidul strontiu \*\ radionuclide strontium
E) [ ] fototerapia bioptron \*\ phototherapy bioptron
---------------------------------------------------------------------
1429. CM p5 Tratamentul sarcomului de col uterin: (pag. 3078) \*\ Treatment of cervical sarcoma
A) [x] impune o atentie speciala \*\ requires special attention
B) [x] se practica brahiterapia preoperatorie in scop hemostatic \*\ preoperative practica brahiterapia haemostatic purposes
C) [x] se practica polichimioterapia postoperatorie \*\ Postoperative practica polichimioterapia
D) [ ] nu se practica cura chirurgicala \*\ no surgical practica cura
E) [ ] nu impune atentie speciala \*\ does not require special attention
---------------------------------------------------------------------
1430. CM p5 Teleterapia cancerului de col uterin utilizeaza: (pag. 3075) \*\ Teleterapia cervical cancer using:
A) [x] fascicule de radiatii Gamma (telecobaltoterapia) \*\ Gamma radiation beam (telecobaltoterapia)
B) [x] fotoni X \*\ Photon X
C) [x] electroni (acceleratori liniari si betatron) \*\electrons (linear accelerator and betatron)
D) [ ] iradieri cu activitati mari si timp de expunere foarte scurt \*\ irradiation with high activity and very short exposure time
E) [ ] sistemul Paris \*\ Paris System
---------------------------------------------------------------------
1431. CM p5 Complicatiile imediat ale tratamentului chirurgical al cancerului de col uterin includ: (pag. 3074) \*\ Immediate
complications of surgical treatment of cervical cancer include:
A) [x] hemoragii \*\ bleeding
B) [x] leziuni ale ureterelor \*\ ureteral injury
C) [x] leziuni ale vezicii urinare \*\ lesions of the bladder
D) [x] leziuni ale anselor intestinale \*\ damage to the intestinal loops
E) [ ] fistulele tractului urinar \*\ urinary fistula
---------------------------------------------------------------------
1432. CM p5 Tratamentul citostatic in cancerul de col uterin are urmatoarele indicatii: (p3075) \*\ Chemotherapy in cervical
cancer has the following indications:
A) [x] adjuvant in terapia complexa radiochirurgicala \*\ adjuvant in complex therapy radiochirurgicala
B) [x] prezenta metastazelor ganglionare, ovariene sau in tesutul parametrial \*\ this node metastases, ovarian tissue or parameters
C) [x] poate fi asociat cu o cura scurta de iradiere \*\ may be associated with radiation cura scurta de
D) [ ] se aplica in formele incipiente ale bolii \*\ apply early forms of disease
E) [ ] in cazul recidivelor sau metastazelor la distanta \*\ If recurrences or distant metastases
---------------------------------------------------------------------
1433. CM p5 Precizati care sunt formele particulare de cancer de col uterin (pag. 3071, 3073) \*\ Clarify which particular forms
of cervical cancer
A) [x] adenocarcinomul \*\ adenocarcinoma
B) [ ] cancerul de col asociat cu fibrom uterin \*\ Cervical cancer associated with uterine fibroids
C) [x] cancerul de col asociat cu sarcina \*\ cervical cancer associated with pregnancy
D) [ ] blastomul de col uterin \*\ cervical blastomul
E) [ ] microcarcinomul \*\ microcarcinomul
---------------------------------------------------------------------
1434. CM p5 Complicatiile tardive in cadrul tratamentului chirurgical ale cancerului de col uterin, sunt dominate de: (pag. 3074)
\*\ Late complications in the surgical treatment of cervical cancer, are dominated by: (p. 3074)
A) [x] disfunctia vezicala \*\ bladder dysfunction
B) [x] fistule ale tractului urinar \*\ urinary tract fistulae
C) [x] formatiuni limfochistice si limfedem \*\ formation and lymphedema limfochistice
D) [ ] hemoragii prin leziuni ale vaselor iliace \*\ bleeding from injuries of iliac vessels
E) [ ] hemoragii ale vaselor din fose obturative \*\ bleeding vessels of septic root
---------------------------------------------------------------------
1435. CM p5 Care sunt factorii favorizanti in aparitia cancerului de col uterin? (pag. 3069) \*\ What are the factors favoring the
occurrence of cervical cancer?

188
A) [x] debutul precoce al vietii sexuale, inainte de 17 ani \*\ Early onset of sexual activity before 17 years
B) [ ] parteneri sexuali circumscrisi \*\ circumscribed sexual partners
C) [ ] rapoarte sexuale frecvente \*\ report frequent sexual
D) [ ] nasteri multiple \*\ Multiple births
E) [x] fumatul \*\ smoking
---------------------------------------------------------------------
1436. CM p5 [C2250114] Care din urmatoarele afirmatii sunt corecte: (p3069) \*\ Which of the following statements is correct:
A) [x] herpes simplex virus tip 2 (HSV-2) este initiatorului ce actioneaza ca factor mutagen \*\ The herpes simplex virus type 2
(HSV-2) is what actioneaza ca initiatorul mutagenic factor
B) [x] human papiloma virus (HPV) este promotorul aparitiei leziunii\*\Human papilloma virus (HPV) is promotorul lesion appearance
C) [x] posibilitatea biologica a rolului HPV in oncogeneza cervicala este evidentiata prin faptul ca acesta determina infectie
persistentaa epiteliuli metaplastic in zona scuamo-columnara\*\possible biological role of HPV cervical oncogeneza is evidenced
by the fact ca acesta determina infectie persistent a epitelilui metaplastic scuamo-columnar zone
D) [x] toate afirmatiile de mai sus sunt corecte \*\ all above statements are correct
E) [ ] nici una din afirmatiile de mai sus nu sunt corecte \*\ none of the above statements are correct
---------------------------------------------------------------------
1437. CM p5 Simptomele din faza initiala a cancerului de col sunt:(p3071)\*\Symptoms of the initial stage of cervical cancer are:
A) [x] secretia apoasa; \*\ The watery secretion;
B) [ ] disurie; \*\ dysuria;
C) [ ] hematurie; \*\ hematuria;
D) [ ] durere in flancuri sau membre inferioare; \*\ pain in the flanks or legs;
E) [x] scurgere redusa, nemirositoare, de obicei cu striuri sangvinolente, aparute de regula dupa microtraumatisme; \*\ low
leakage, nemirositoare usually with grooves sanguinolent, typically occurs after microtraumatisme;
---------------------------------------------------------------------
1438. CM p5 Selectati afirmatiile false legate de tratamentul citostatic in cancerul de col: (p3075) \*\ Select false statements
related to chemotherapy treatment of cervical cancer
A) [x] este indicat in formele precoce de boala \*\ shown in early forms of disease
B) [x] indicatia si initierea chimioterapiei nu necesita investigatii cardiovasculare si renale \*\ indication and initiation of
chemotherapy do not require investigation of cardiovascular and renal
C) [ ] este indicat in cazul recidivelor si metastazelor la distanta, in asociere cu radioterapie \*\ is indicated if recurrences and
distant metastases in combination with radiotherapy
D) [x] taxanii se pot utiliza in monoterapie secventiala \*\ taxanii can be used in sequential monotherapy
E) [ ] este indicat in prezenta metastazelor ganglionare, ovariene sau in tesutul parametrial diagnosticate dupa radio-chirurgie \*\
is indicated in the presence of lymph node metastases, ovarian tissue or radio parameters diagnosed after surgery
---------------------------------------------------------------------
1439. CM p5 In cancerul de col uterin, in faza avansata apare: (p3071) \*\ In cervical cancer in advanced stage appears
A) [ ] o scurgere redusa, nemirositoare cu striuri sangvine ce apare dupa microtraumatisme \*\ a low leakage, nemirositoare with
blood grooves appearing after microtraumatisme
B) [x] sangerare abundenta, uneori urat mirositoare \*\ heavy bleeding, sometimes foul-smelling
C) [x] durere in membrele inferioare \*\ sore legs
D) [x] hematurie \*\ haematuria
E) [x] sangerari rectale \*\ rectal bleeding
---------------------------------------------------------------------
1440. CM p5 Diagnosticul pozitiv de cancer de col uterin in stadii incipiente se precizeaza cu ajutorul: (p3071) \*\ Positive
diagnosis of cervical cancer in its early stages is specified by
A) [x] testului LAHM SCHILLER; \*\ test Lahm Schiller;
B) [ ] testului LUGOL; \*\ Lugol test;
C) [x] biopsia tintita colposcopic; \*\ Target colposcopic biopsy;
D) [x] screening citologic; \*\ cytological screening;
E) [ ] frotiului citohormonal vaginal \*\ citohormonal vaginal smear
---------------------------------------------------------------------
1441. CS p4 La sfarsitul lunii a III-a de sarcina fundul uterului se palpeaza: (p74) \*\ At the end of the third month of pregnancy,
the uterus fundus is palpable:
A) [ ]la nivelul ombilicului \*\at the umbilicus
B) [ ]la nivelul xifoidului \*\the xiphoid level
C) [x]la jumatatea distantei pubo-ombilicale \*midway pubo-umbilical\
D) [ ]la jumatatea distantei xifo-ombilicale \*\midway xipho-umbilical
E) [ ]la nivelul simfizei pubiene \*\at the level of the pubic symphysis
---------------------------------------------------------------------
1442. CS p4 Semnul Hegar decelat la tactul vaginal combinat in cadrul examenului local din sarcina consta in: (p75) \*\Hegar
sign detected at the vaginal tact combined during the local examination in pregnancy consist of :
A) [ ] consistenta pastoasaa corpului uterin, care poate fi deprimat digital cu usurinta \*\ pasty consistenty of the uterine body,
which can be easily depressed by the fingers

189
B) [ ] umplerea fundurilor de sac vaginale de catre corpul uterin globulos \*\ filling the fundus of the vaginal sac by the uterine globular body
C) [x] inmuierea istmului uterin \*\softenng of the uterine isthmus
D) [ ] mobilitatea accentuata a corpului uterin fata de istm/col \*\ the emphasized mobility of the uterine body towards the isthmus/cervix
E) [ ] datoritaconsistentei pastoase uterul gravid scapagreu din manafatade cel negravid care alunecaintre degete ca simburele de
cireasa \*\ Due to the pasty consistency, the pregnant uterus is hard to slip from hand in comparison to the non-pregnant which
slips between fingers like the cherry nuts
---------------------------------------------------------------------
1443. CS p4 Cresterea ponderala normala a unei gravide normoponderale in cele 9 luni de sarcina va fi de: (p78) \*\ he normal
weight growth of a pregnant woman in the 9 months of pregnancy will be:
A) [x] 10-12 kg \*\ 10-12 kg
B) [ ] 8-9 kg \*\ 8-9 kg
C) [ ] 7-8 kg \*\ 7-8 kg
D) [ ] 5-6 kg \*\ 5-6 kg
E) [ ] 20kg \*\ 20kg
---------------------------------------------------------------------
1444. CS p4 [C1254006] In ansamblu, toate diametrle stramtorii medii ale bazinului osos sunt de aproximativ: (pag. 92)
\*\Overall, all the medium strait diameters of the bony pelvis are about:
A) [ ]10cm \*\10cm
B) [x]11cm \*\11cm
C) [ ]12cm \*\12cm
D) [ ]10,5 cm \*\10,5 cm
E) [ ]9cm \*\ 9cm
---------------------------------------------------------------------
1445. CS p4 [C1454015] Diametrul biparietal al craniului fetal la o sarcina la termen are valoarea normala: (pag. 94)
\*\Biparietal diameter of the fetal skull to a term pregnancy has normal value of:
A) [ ]7cm \*\7cm
B) [ ]7,5 cm \*\7.5 cm
C) [ ]8cm \*\ 8cm
D) [x]9,5 cm \*\9.5 cm
E) [ ]10cm \*\10cm
---------------------------------------------------------------------
1446. CS p4 [C1254005] Modificarile de forma, volum si consistenta a uterului sunt semne (pag. 75) \*\Changes in shape,
volume and consistency of the uterus are signs (p. 75)
A) [ ]decelabile prin inspectie \*\Detectable by inspection
B) [x]decelabile prin tact vaginal combinat \*\Detectable by combined vaginal cycle
C) [ ]decelabile doar ecografic \*\Detectable only by ultrasound
D) [ ]fetale de sarcina \*\fetal pregnancy
E) [ ]ce nu pot deveni de certitudine a prezentei sarcinii \*\ who cannot be certain of the presence of pregnancy
---------------------------------------------------------------------
1447. CS p4 Care din urmatoare semne clinice de sarcina (de probabilitate) reprezinta semnul Hegar: (p75) \*\Which of the
following clinical signs of pregnancy (of probability) represents the Hegar sign:
A) [ ]mobilitatea accentuata a corpului uterin fata de istm/col \*\Accentuated mobility of the uterine body towards the isthmus/cervix
B) [x]inmuierea istmului uterin \*\ softening of the uterine isthmus
C) [ ]umplerea fundurilor de sac vaginale de catre corpul uterin globulos \*\The filling of the fundus of the vaginal sac by the
globular uterine body
D) [ ]consistenta pastoasa a corpului uterin \*\ pasty consistency of the uterine body
E) [ ]uterul gravid scapa greu din mina fata de cel negravid care aluneca intre degete ca simburele de cireasa \*\The pregnant
uterus hardly escapes from hand in comparism with the non-pregnant uterus which slips between fingers like cherry seeds
---------------------------------------------------------------------
1448. CS p4 Dupa luarea in evidenta, o gravida va fi urmarita periodic: (77)\*\After registration, a pregnant woman will be
followed regularly:
A) [ ]trimestrial \*\ trimesterly
B) [ ]bilunar in trimestrul I \*\bi-monthly in the first trimester
C) [x]lunar in primele doua trimestre \*\ monthly in the first two trimesters
D) [ ]saptamanal in trimestrul I \*\weekly in first timester
E) [ ]ocazional \*\ Occasionally
---------------------------------------------------------------------
1449. CM p5 La examenul cu valve in timpul sarcinii putem observa: (74) \*\At the valve examination during pregnancy we can observe:
A) [x] coloratia violacee a peretilor vaginali \*\ The purple coloration of vaginal walls
B) [ ] corpul uterin marit de volum \*\ corpul uterin marit de volum
C) [x] fanta vulvara mai dehiscenta cu orificiul vulvar lax \*\ fanta vulvara mai dehiscenta cu orificiul vulvar lax
D) [x] umectare mai intensa a vaginului \*\more intensive wetting of the vagina
E) [ ] colul ramolit, inmuiat, de consistenta scazuta \*\cervix decrepit, soft, low consistency

190
---------------------------------------------------------------------
1450. CM p5 [C2254155] Igena sarcinii presupune masuri profilactice pentru protectia mamei si copilului Care din urmatoarele
recomandari sunt corecte in acest sens: (p88-89) \*\ The pregnancy hygiene requires preventive measures to protect the mother
and the child. Which of these recommendations are correct in this respect:
A) [x] interzicerea consumului de alcool si tutun in sarcina \*\ ban alcohol and tobacco during pregnancy
B) [ ] combaterea constipatiei cu laxative \*\ control constipation with laxatives
C) [x] permiterea raporturilor sexuale cu frecventamoderata \*\allowing sex with frequent moderation
D) [x] evitarea expunerii gravidei la stress, emotii \*\ pregnant women avoid exposure to stress, emotions
E) [x] evitarea eforturilor fizice mari \*\ avoid large physical effort
---------------------------------------------------------------------
1451. CM p5 [C2254135] La inspectia clinica a unei gravide in primul trimestru se pot decela: (pag. 73-74) \*\ On clinical
inspection of the first trimester of pregnancy someone can detect:
A) [x] masca de sarcina \*\ The mask of pregnancy
B) [x] pigmentatia liniei albe abdominale \*\ abdominal pigmentation white line
C) [x] aparitia de varice \*\ the appearance of varicose veins
D) [x] pigmentatia organelor genitale \*\ genital pigmentation
E) [ ] fundul uterin situat la citeva laturi de deget suprasimfizar \*\ the back of the uterus at a finger distance
---------------------------------------------------------------------
1452. CM p5 Varsta gestationala poate fi gresit calculata in urmatoarele conditii: (p76) \*\Gestational age may be wrongly
calculated in the following conditions:
A) [x]menstruatii neregulate \*\irregular periods
B) [x]notarea gresitaa datei ultimei menstruatii \*\ the wrong date of periods
C) [x]lipsei de luare in evidentaa gravidei (absenta primei consultatii prenatale) \*\ lack of taking pregnancy into consideration
(absence of first prenatal consultation
D) [ ]masurare a parametrilor ecografici \*\ measurement of ultrasound parameters
E) [ ]masurarea inaltimii fundului uterin \*\measurement of uterine height bed
---------------------------------------------------------------------
1453. CM p5 Care din urmatoarele elemente formeaza micul bazin ? (p91) \*\ Which of these elements form the small pelvis?
A) [x] marginea superioara a simfizei pubiene \*\ The upper edge of pubic symphysis
B) [x] corpul pubelui \*\ pubic body
C) [x] liniile nenumite \*\ unnamed lines
D) [ ] cavitatea cotiloida \*\ cotyloid cavity
E) [x] articulatiile sacroiliace \*\ sacroiliac joints
---------------------------------------------------------------------
1454. CM p5 In mod normal uterul gravid este: (pag. 75) \*\ Normally pregnant uterus is
A) [ ] Dureros la palpare \*\ Painful to touch
B) [x] Nedureros la palpare \*\ painless to palpation
C) [x] Piriform \*\ Piriform
D) [x] Globulos \*\ globular
E) [x] Elastic \*\Elastic
---------------------------------------------------------------------
1455. CM p5 Examenul clinic in primul trimestru de sarcina ofera date despre (p74-75) \*\ The clinical examination in the first
trimester provides data for:
A) [x] Col \*\ Uterine cervix
B) [x] Istm uterin \*\uterine isthmus
C) [x] Corp uterin \*\ endometrium
D) [ ] Anexe \*\Attachments
E) [x] Vulva si vagin \*\Vulva and vagina
---------------------------------------------------------------------
1456. CM p5 Cu toate ca elemtele subiective intr-o sarcina sunt variable si nepatognomonice, cele neuropsihice pot fi
reprezentate de: \*\Although the subjective elements in a pregnancy are variable and not pathognomonic, the neuropsychological
ones may be represented by:
A) [x] iritabilitate; \*\ irritability;
B) [ ] letargie; \*\ lethargy;
C) [x] emotivitate; \*\ emotion;
D) [ ] abulie; \*\ aboulia (loss of will power)
E) [x] labilitate psihica. \*\psychic liability
---------------------------------------------------------------------
1457. CM p5 In cadrul masurarii pelvimetriei externe a bazinului obstetrical, diametrul antero-posterior se defineste ca masurind:
(p83) \*\In measuring the external pelvic metre of the obstetrical pelvis, anterior-posterior diameter is defined as measuring:
A) [ ]distanta intre punctele cele mai indepartate ale crestelor iliace \*\The distance between the farthest points of the iliac crests
B) [ ]distanta intre cele douaspine iliace antero-superioare \*\ distance between the two anterior-superior iliac spine
C) [x]distanta intre fata anterioara a simfizei pubiene si varful apofizei spinoase a vertebrei 5 lombare \*\ distance between the

191
front of the pubic symphysis and the tip of the spinal apophyses of the 5
th
lumbar vertebra
D) [x]20 cm \*\ 20 cm
E) [ ]24 cm \*\24 cm
---------------------------------------------------------------------
1458. CM p5 Care sunt testele biofizice utilizate in supravegherea starii fatului ? (100) \*\What are the biophysical tests used in
monitoring foetal status?
A) [ ]roll over - test \*\roll over - test
B) [ ]EKG \*\ ECG
C) [ ]EEG \*\EEG
D) [x]cardiotocografia antepartum \*\ antepartum cardiotocography
E) [x]ecografia \*\ultrasound
---------------------------------------------------------------------
1459. CM p5 Care din urmatoarele afirmatii, in ceea ce priveste regimul alimentar in sarcina, sunt adevarate: (p88) \*\ Which of
the following statements regarding diet in pregnancy are true:
A) [x] nevoile energetice sunt de 2500-3000 calorii/zi \*\ The energy needs are 2500-3000 calories / day
B) [x] necesarul protidic este de 1,5 grame/kg corp din care jumatate sub formade proteine animale \*\ the protein requirement is
1.5 g / kg of body weight of which half is animal protein
C) [x] nevoile de fier sunt crescute la 30 miligrame/zi, fatade 10-15 miligrame/zi \*\ iron needs are increased to 30 mg / day, in
comparison 10 to 15 milligrams / day
D) [ ] glucidele trebuie saatinganivelul de 500-1000gr/zi \*\The carbohydrate needs to reach the level of 500-1000 grams per day
E) [x] glucidele trebuie saatinganivelul de 350-400gr/zi \*The carbohydrate needs to reach the level of 350-400 grams per day
---------------------------------------------------------------------
1460. CM p5 Care din urmatoarele antecedente gincologice obstetricale includ gravida in categoria celor cu risc obstetrical
crescut: (97) \*\ Which of the following obstetric and gynecology history include the pregnant woman in the category of the ones
with high obstetrical risk?
A) [x] uter cicatriceal \*\ uterine scar
B) [x] sterilitate tratata \*\treated infertility
C) [ ] alcoolism \*\ alcoholism
D) [ ] nefropatii \*\ kidney diseases(nephropathies)
E) [x] avort, nastere prematura \*\abortion, premature birth
---------------------------------------------------------------------
1461. CM p5 Uterul gravid in luna a V-a: (76) \*\ The pregnant uterus at the 5
th
month:
A) [x] Are inaltimea de 20 cm \*\ height of 20 cm
B) [x] Atinge cicatricea ombilicala \*\ \Touch the umbilical scar maxlength*\
C) [ ] Are 28-30 cm inaltime \*\ has 28 to 30 cm in height
D) [ ] E la jumatatea distantei ombilic-apendice xifoid \*\ is half the distance of the unmblical-appendix xiphoid
E) [ ] E suprasimfizar \*\ It is at two finger distance from the suprasymphyis
---------------------------------------------------------------------
1462. CM p5 Pentru diagnosticul de sarcina in trimestrul I, la inspectie au valoare orientativa urmatoarele semne: (p73-74) \*\For
diagnosis of pregnancy in the first trimester, on inspection the following signs have orientative value:
A) [x] Masca de sarcina \*\ The mask of pregnancy
B) [x] Pigmentarea liniei albe \*\ Pigmentation of white line
C) [ ] Vergeturile de culoare alb-sidefie \*\ pearly-white stretch marks
D) [x] Pigmentarea organelor genitale \*\ genital pigmentation
E) [x] Hiperpigmentarea areolelor mamare \*\ Hyperpigmentation of mammary areola
---------------------------------------------------------------------
1463. CM p5 Colul uterin al multiparelor la termen este: (p90) \*\The uterine cervix of the multiparous woman at full-term is:
A) [ ]mai lung de 2,5 cm \*\ 2.5 cm longer
B) [x]cu orificiul intern inchis \*\ the internal opening closed
C) [x]ramolit \*\senile
D) [x]cu orificiul extern dehiscent \*\ the external orifice dehiscence
E) [ ]cilindric \*\cylindrical
---------------------------------------------------------------------
1464. CM p5 Alimentatia recomandata femeii gravide este : (p77) \*\ Recommended diet of pregnant women is:
A) [x]Rationala \*\Rational
B) [x]Normocalorica \*\ Normocaloric
C) [x]Echilibrata \*\Equilibrium
D) [ ]Hiperproteica \*\Hyperprotein
E) [ ]Hiposodata \*\Hypersodium
---------------------------------------------------------------------
1465. CM p5 Bolta craniana la fat este alcatuita din urmatoarele oase, (p93) \*\The foetal cranial arch, consists of these bones:
A) [ ]Etmoid; \*\ ethmoid;
B) [x]Doua parietale; \*\Two parietal;

192
C) [x]Doua temporale; \*\ Two temporal
D) [x]Frontal; \*\ Frontal;
E) [x]Occipital \*\Occipital
---------------------------------------------------------------------
1466. CM p5 Pentru diagnosticul de sarcina, existenta amenoreei are valoare daca: (p73) \*\ For diagnosis of pregnancy,
amenorrhea existence has value if:
A) [x]femeia este tanara \*\ The woman is young
B) [x]femeia este sanatoasa \*\the woman is healthy
C) [x]femeia are menstruatia normala \*\ the woman has regular menses
D) [x]femeia nu alapteaza \*\ woman is not breast feeding
E) [ ]femeia urmeaza un tratament cu Penicilina \*\a woman following treatment with penicillin
---------------------------------------------------------------------
1467. CM p5 Care din urmatoarele semne sunt semne de probabilitate materne de sarcina ? (75) \*\ Which of these pregnancy
signs are of maternal probability?
A) [x]semnul Hegar \*\Hegar sign
B) [x]semnul McDonald \*\sign McDonald
C) [x]semnul Bonnair \*\sign Bonnair
D) [x]semnul Piscacek \*\sign Piscacek
E) [ ]semnul Babinski \*Babinski sign\
---------------------------------------------------------------------
1468. CM p5 Diametrele stramtorii superioare sunt: (pag. 92) \*\The superior narrowing diameters are:
A) [ ]diametrul promonto-subpubian = 10 cm \*\ promonto-subpubian diameter = 10 cm
B) [x]diametrul transvers median, util = 12,5-13 cm \*\ transverse median diameter, utilize = 12.5 to 13 cm
C) [x]diametrul retro-pubian (util sau conjugata vera) = 10,8 cm \*\ Retro-pubic diameter (useful or conjugated Vera) = 10.8 cm
D) [x]diametrul transvers maxim = 13,5 cm \*\ maximum transverse diameter = 13.5 cm
E) [ ]diametrele oblice (stang si drept) = 11-12 cm \*\ oblique diameters (left and right) = 11-12 cm
---------------------------------------------------------------------
1469. CM p5 Care dintre urmatoarele conditii se incadreaza la factori intranatali in vederea depistarii gravidelor cu risc: (p98)
\*\ Which of these conditions fall under ante-natal factors to detect pregnancies at risk
A) [ ] hemoragie in primul trimestru \*\ bleeding in first trimester
B) [x] hemoragie recenta \*\ recent haemorrhage
C) [x] membrane rupte de peste 6 ore faradeclansarea contractiilor \*\ membranes ruptured more than 6:00 hours without the
beginning of contractions
D) [x] procidentade cordon \*\procidentia(sinking or prolapse) of the cord
E) [ ] travalii de peste 12 ore la primipare \*\ labors over 12 hours in primiparous
---------------------------------------------------------------------
1470. CM p5 In cadrul examenului obiectiv efectuat in primul trimestru de sarcina, informatii utile pentru stabilirea diagnosticului sunt
furnizate de: (p73-74) \*\ The objective examination carried out in the first trimester, useful information for diagnosis provides
A) [x]inspectia generala \*\ general inspection
B) [x]inspectia sanilor \*\ Breast inspection
C) [x]palparea sanilor si abdomenului \*\palpation of the breasts and abdomen
D) [ ]percutia abdominala \*\ abdominal percussion
E) [ ]auscultatia \*\auscultation
---------------------------------------------------------------------
1471. CS p4 Urmatoarea afirmatie despre Arrenoblastoame este adevarata (1835) \*\The following statement is true about Arrenoblastoame
A) [x]este o tumora cu celule Sertoli-Leydig \*\ Is a Sertoli-Leydig cell tumor
B) [ ]e o tumora cu celule germinale \*\Is a germ cell tumor
C) [ ]se manifesta prin precocitate sexuala la fetite \*\It manifests by sexual precocity in girls
D) [ ]e o tumora cu celule granuloase \*\ Is a granulosa cell tumor
E) [ ]pot fi insotite de sdr Meig \*\ It can be accompanied by Meigs syndrome
---------------------------------------------------------------------
1472. CS p4 Urmatoarele afirmatii despre vestigiile ductului Wolffian sunt corecte, cu EXCEPTIA\*\ The following statements
about Wolffian duct remains correct, except
A) [ ]adesea nu pot fi diferentiate clinic de tumorile ovariene \*\ Often can not be clinically differentiated from ovarian tumors
B) [ ]sunt mici chisturi uniloculare \*\ Are small unilocular cysts
C) [x]sunt chisturi ovariene \*\ are ovarian cysts
D) [ ]se pot torsiona \*\can be torsioned
E) [ ]se pot infarctiza \*\Can be infarcted
---------------------------------------------------------------------
1473. CS p4 Precizati care afirmatie este falsa: (p1834) \*\Specify which statement is false:
A) [x]Chisturile foliculare reprezinta foliculii de Graaf nerupti, micsorati \*\Follicular cysts represents small unbroken Graafian follicles
B) [ ]Chisturile corpului galben pot atinge dimensiuni de 10-11 cm \*\Corpus luteum cysts can reach sizes of 10-11 cm
C) [ ]Endometrioamele constituie majoritatea chisturilor ciocolatii \*\ Endometriomas consists of mostly chocolate cysts

193
D) [ ]Vestigiile ductului Wolffian sunt mici chisturi uniloculare \*\Vestiges of the Wolffian duct are small unilocular cysts
E) [ ]Vestigiile ductului Mullerian pot ap ca tumori chistice paraovariene \*\Mullerian duct artifacts can appear as paraovarian cystic tumors
---------------------------------------------------------------------
1474. CS p4 Chisturile foliculare sunt: (p1834) \*\ Follicular cysts are:
A) [ ]chisturi ciocolatii \*\ Chocolate cyst
B) [ ]chisturi de corp galben \*\ corpus luteum cysts
C) [x]foliculi de graaf mariti,nerupti \*\ Large, unbroken Graafian folicule
D) [ ]tumori paraovariene \*\ Paraovarian tumors
E) [ ]mici chisturi inflamatorii ale fimbriei terminale \*\ Small Inflammatory cysts of the terminal fimbria
---------------------------------------------------------------------
1475. CS p4 Cele mai frecvente tumori benigne pelviene la femei sunt:(p1834)\*\The most common benign pelvic tumors in women are:
A) [ ]polipii \*\Polyps
B) [x]leiomioamele \*\Leiomyomas
C) [ ]chisturile foliculare \*\ Follicular cysts
D) [ ]tumori cu celule din granuloasa \*\ Granulosa cell tumors
E) [ ]adenomioza \*\ Adenomyosis
---------------------------------------------------------------------
1476. CS p4 Tumorile ovariene cele chist non-neoplazice sunt, cu exceptia:(1834)\*\Ovarian tumors that are non-neoplastic cysts are, except:
A) [ ]chisturilor foliculare \*\Follicular cysts
B) [ ]vestigiile ductului Wolffian \*\Vestiges of the Wolffian duct
C) [ ]endometrioamelor \*\Endometrioamas
D) [x]chistadenoamelor \*\Cystadenomas
E) [ ]chisturile corpului galben \*\ Corpus luteum cysts
---------------------------------------------------------------------
1477. CS p4 Cea mai frecventa localizare leiomioamelor (tumori uterine benigne) este: (1835) \*\The most frequent location of
leiomioamelor (benign uterine tumors) is:
A) [ ]Submucoasa \*\Submucosa
B) [ ]Intracavitara \*\Intracavitarary
C) [ ]Prolabat \*\ Prolapse
D) [x]Intramural \*\ Intramural
E) [ ]Pediculat \*\Pediculated
---------------------------------------------------------------------
1478. CS p4 Tumori ovariene nefunctionale sunt: (1834) \*\Functional ovarian tumors are:
A) [x] chistadenoamele \*\ Cystadenoamas
B) [ ] tumori cu celule tecale \*\Theca cell tumors
C) [ ] struma ovarii \*\ Ovarian Stroma
D) [ ] tumori cu celule Sertoli \*\ Sertoli cell tumors
E) [ ] formate din tesut tiroidian \*\ Consists of thyroid tissue
---------------------------------------------------------------------
1479. CM p5 Chisturile foliculare: (p1834) \*\ Follicular cysts
A) [ ]Prin rupere pot produce infarctul ovarului sau al trompei si ovarului \*\ By rupture they can cause ovarian infarction or of
ovarian trunk and the ovary
B) [x]Pot regresa spontan \*\ Can regress spontaneously
C) [x]Sunt non-neoplazici \*\ Are non-neopleazic
D) [ ]Sunt foliculi de Graaf rupti \*\ Are broken Graafian follicles
E) [x]Se pot complica prin torsionare \*\Can be complicated by torsioning
---------------------------------------------------------------------
1480. CM p5 In sindromul Meig: (pag 1835) \*\Meig's syndrome
A) [x] fibroamele ovariene sunt insotite de ascita si hidrotorax \*\ Ovarian fibroids are accompanied by ascites and hydrothorax
B) [ ] acumularea de lichid insoteste fibroamele ovariene > 2 cm \*\Accumulation of fluid accompanies ovarian fibroids of > 2 cm
C) [x] in cancerele ovariene se produce o pleurezie citologic benigna, situatie denumita sindrom pseudo-Meig \*\ Ovarian cancer
produces a benign cytologic pleurisy, a condition called pseudo-Meig's syndrome
D) [ ] acumularile lichidiene persista dupa excizia fibromului \*\ Fluid accumulation persists after excision of fibroid
E) [x] lichidul de ascita apare prin obstructia limfaticelor ovariene de catre tumora \*\ Ascites fluid occurs through by ovarian
lymphatic obstruction of the tumor
---------------------------------------------------------------------
1481. CM p5 Leiomioamele pot fi localizate : (pg 1835) \*\ Leiomyomas can be located:
A) [x]intramural \*\ Intramural
B) [x]prolabat \*\Prolapsed
C) [x]pediculat \*\ Pediculated
D) [ ]subcervical \*\Subcervical
E) [x]subseros \*\ Subserous
---------------------------------------------------------------------

194
1482. CM p5 Vestigiile duct Muller au urmatoarele trasaturi cu exceptia: \*\Muller duct vestiges have following features except:
A) [x]sunt asemanatoare clinic cu tumorile ovariene \*\are clinically similar to ovarian tumors
B) [ ]sunt paraovariene \*\Are paraovarian
C) [ ]chisturi inflamatorii \*\Inflammatory cysts
D) [x]sunt de dimensiuni mari \*\Are large
E) [ ]sunt localizate frecvent pe fimbria terminala \*\are frequently located in the terminal fimbria
---------------------------------------------------------------------
1483. CM p5 Tratamentul in leiomioame presupune : (pg 1836) \*\ Treatment of leiomyomas involves:
A) [ ] in prezenta unei tumori mici efectuarea chemoreductiei \*\In the presence of small tumors chemoreduction is performed
B) [x] expectativa pt marea majoritate a tumorilor asimptomatice \*\ Expectations for the vast majority of asymptomatic tumors
C) [x] interventia histeroscopica pentru majoritatea tumorilor pediculate din cavitaea endometriala \*\ Hysteroscopy surgery for
most pediculated tumors in the endometrial cavities
D) [x] utiliz. Nafarelinului sau Leuprolidului Acetat ca si chemoreductoare\*\The use of Nafareline or acetate Leuprolide as chemoreductors
E) [ ] indepartarea laparoscopica a tumorilor prolabate \*\ Laparoscopic removal of Prolapsed tumors
---------------------------------------------------------------------
1484. CM p5 Interventia chirurgicala a leiomiomului trebuie sa tina cont de:(p1835) \*\Leiomyoma surgery must take into account:
A) [x]Varsta pacientei \*\Age of patient
B) [x]Numarul de copii doriti \*\The number of children wanted
C) [x]Reactia la posibila pierdere a functiei de reproducere \*\ Reaction to the possible loss of reproductive function
D) [ ]Locul de munca \*\Workplace
E) [x]Dorinta pacientei \*\Desire of patient
---------------------------------------------------------------------
1485. CM p5 Evidentiati afirmatiile corecte: (p1834,1835)\*\Emphasize the correct statements:
A) [ ]Chisturile corpului galben pot atinge dimesiune de maxim 10-11mm\*\Corpus luteum cysts may reach a maximum size of 10-11mm
B) [ ]Vestigiile ductului Wolffian sunt tumori ovariene \*\Wolffian duct vestiges are ovarian tumors
C) [x]Cea mai frecventa localizare a leiomioamelor este cea intramurala \*\The most common of location leiomyoamas is intramural
D) [ ]Struma ovarii poate sa produca uneori tabloul clinic al unei hipotiroidii \*\Ovarian stromas can sometimes produce a clinical picture of
hypothyroidism
E) [x]Chisturile corpului galben pot mima o sarcina ectopica \*\Corpus luteum cysts can mimic an ectopic pregnancy
---------------------------------------------------------------------
1486. CM p5 Lichenul scleros are urmatoarele caracteristici\*\ Lichen sclera has the following characteristics
A) [x] reprezinta o iritatie cronica \*\ Is a chronic irritation
B) [x] se afla pe zone vulvare albe \*\ Is on the White vulvar area
C) [x] pruriginos \*\ Pruritic
D) [ ] de regula este o atrofie a mucoasei scleroasa \*\Usually, is a sclera mucosa atrophy
E) [ ] leziune premaligna \*\ Premalignant lesion
---------------------------------------------------------------------
1487. CM p5 Modalitatile evolutive ale chisturilor foliculare sunt: (p1834)\*Evolutionary ways of follicular cysts are:
A) [x]Ruperea \*\ Rupturing
B) [ ]Malignizarea \*\ Malignancy
C) [x]Torsionarea \*\ Torsioning
D) [ ]Infectia \*\Infection
E) [x]Regresia spontana \*\ Spontaneous Regression
---------------------------------------------------------------------
1488. CM p5 Teratomul matur se caracterizeaza prin: (p1835)\*\ Mature teratoma is characterized by:
A) [x] ia nastere din celulele germinale totipotente ale ovarului\*\arise from totipotent ovarian germ cells
B) [x] contin mase calcificate(uneori la radiografie apar dinti sau fragmente osoase)\*contain calcified masses ( sometimes
appearing teeth or bone fragments in the radiograph)\
C) [x] contin tesut endo,ecto si mezodermal\*\containing endo , ecto and mesoderm tissue
D) [ ] materialul vascos si grasos continut poate produce pritonita bacteriana daca se revarsa in timpul intervebntiei\*\ viscous
material and fat content can cause bacterial peritonitis if it flows during surgery.
E) [ ] indiferent de varsta,nu se va prezerva masa de tesut ovarian functional\*\ any age , will not preserve functional ovarian tissue mass
---------------------------------------------------------------------
1489. CM p5 Chisturile foliculare : (pg 1834) \*\ Follicular cysts
A) [x] se pot rupe, determinand iritatia peritoneala \*\ They can break, causing peritoneal irritation
B) [ ] nu pot simula adevaratele chisturi \*\Can not simulate true cysts
C) [x] reprezinta foliculi de Graaf nerupti, mariti \*\ Represents large, unbroken Graafian follicles
D) [x] se pot torsiona, producand infarctul ovarului +/- al trompei \*\ Can be torsioned, producing ovarian infarction +/- the fallopian tube
E) [ ] nu pot regresa sponta \*\Can not regress spontaneously
---------------------------------------------------------------------
1490. CM p5 Adenomioza : (1836)\*\ Adenomyosis :
A) [ ] poate mima o sarcina ectopica\*\ may mimic an ectopic pregnancy
B) [x] apare, mai ales, in timpul perioadei reproductive\*\occurs mainly during reproductive period

195
C) [x] este cunoscuta si sub numele de endometrioza corpului uterin\*\is known as the endometriosis of the body of uterus
D) [x] poate determina marirea uterului\*\can cause uterine enlargement
E) [x] apare ,mai ales, la femeile ce au avut un numar mare de sarcini\*\occurs mainly in women who have had a number of pregnancies
---------------------------------------------------------------------
1491. CM p5 Tumora Brenner : (1835) \*\ Brenner Tumor
A) [x] este o tumora epiteliala rara \*\is a rare epithelial tumor
B) [x] in general nu secreta hormoni \*\ in general, it does not secrete hormones
C) [ ] secreta estrogen si progesteron \*\ it secretes estrogen and progesterone
D) [ ] secreta numai estrogen \*\it secretes only estrogen
E) [x] are potential malign redus \*\ it has a low malignant potential
---------------------------------------------------------------------
1492. CM p5 Tumora Brenner: (Pag1835) \*\ Brenner Tumor
A) [x]Este o tumora epiteliala rara care in general nu secreta hormoni\*\ It is a rare epithelial tumor which generally do not secrete hormones
B) [ ]Elementele epiteliale nu sunt similare vestigiilor Walthard \*\Epithelial elements are not similar with walthard remains
C) [ ]Apare predominant la persone tinere \*\ Occurs predominantly young staff
D) [x]Are un mic potential malign \*\ Has a low malignant potential
E) [x]Simpla ovarectomie este de obicei terapia suficienta, iar prognosticul este excelent \*\ Simple ovarectomy is usually
sufficient therapy and prognosis is excellent
---------------------------------------------------------------------
1493. CM p5 Despre CIS (carcinomul in situ) vulvar (p1836) \*\About CIS (carcinoma in situ) of the vulva
A) [x] asemanator clinic si histologic cu CIS cervical \*\ It is similar clinically and histologically with cervical CIS
B) [x] boala Bowen afecteaza zone limitate la nivelul elementelor scuamoase\*\Bowen's disease affects limited areas in the squamous elements
C) [ ] se pot observa celule paget mari,cu citoplasma putina \*\ One can see large Paget cells with little cytoplasm
D) [x] ca terapie, excizia locala largita e utila \*\ As therapy, large local excision is useful
E) [x] se poate folosi laser local \*\ Laser can be used locally
---------------------------------------------------------------------
1494. CM p5 Care din urmatoarele modificari degenerative sunt posibile pentru leiomiomul uterin:(p.1835)\*\Which of these degenerative
changes are possible for uterine leiomyoma :
A) [x]calcificarea \*\ calcification
B) [ ]leucoplazia \*\leukoplakia
C) [x]degenerescenta grasoasa \*\ fatty degeneration
D) [ ]hiperplazia glandulo-chistica \*\ glandulo - cystic hyperplasia
E) [x]sarcomatoasa \*\sarcomatosis
---------------------------------------------------------------------
1495. CM p5 Tumora Brenner: (1835) \*\ Brenner Tumor
A) [ ]are prognostic rezervat \*\has a reserved prognosis
B) [ ]apare predominant la persoanele foarte tinere \*\ occurs predominantly in very young people
C) [x]histologic este similara vestigiilor Walthard \*\ histologically are similar to Walthard vestiges
D) [x]prognosticul este excelent \*\ prognosis is excellent
E) [x]in general nu secreta hormoni \*\generally does not secrete hormones
---------------------------------------------------------------------
1496. CM p5 Tumorile ovariene BENIGNE sunt: (p 1834)\*\BENIGN ovarian tumors are :
A) [x] Chisturi non-neoplazice\*\Non - neoplastic cysts
B) [ ] Tumori neoplazice\*\ neoplastic tumors
C) [x] Tumori nefunctionale\*\non - functional tumors
D) [x] Tumori functionale\*\ Functional tumors
E) [ ] Tumori mixte\*Mixed Tumors\
---------------------------------------------------------------------
1497. CM p5 Urmatoarele afirmatii despre teratomul matur sunt adevarate (1835)\*\ The following statements are true about mature teratoma
A) [ ] e mai frecvent intre 40-60 ani\*\ most frequently between 40-60 years
B) [ ] se trateaza prin histerectomie cu anexectomie bilaterala\*\ is treated by hysterectomy with bilateral anexectomy
C) [x] este un chist dermoid benign\*\ is a benign dermoid cyst
D) [x] ia nastere din celulele totopotentiale ovariene\*\ arise from totopotentiale ovarian cells
E) [x] e o tumora cu celule germinative\*\ is a germ cell tumor
---------------------------------------------------------------------
1498. CM p5 Despre tecoame se poate afirma ca: (1835) \*\ About tecoma, we can say :
A) [ ] cele cu elemente celulare granuloase sunt intotdeauna benigne \*\ the ones with granulosa cell elements are always benign
B) [ ] sunt mai frecvente la femeile tinere, pana la 20 ani \*\are most common in young women , up to 20 years
C) [x] sunt mai frecvente la femeile adulte cu un maxim de aparitie intre 40-60 ani \*\ are most common in adult females with a
maximum occurrence between 40-60 years
D) [ ] daca se depisteaza la femeile tinere se practica histerectomie totala cu anexectomie bilaterala \*\ if it is found in young
women, total hysterectomy with bilateral anexectomy id performed
E) [x] la femeile adulte se asociaza cu carcinomul endometrial \*\ in adult women it is asociated with endometrial carcinoma

196
---------------------------------------------------------------------
1499. CM p5 [CM50063] Selectati tumorile ovariene benigne: (p1834) \*\Select benign ovarian tumors
A) [x] Chistadenoame \*\Cystadenomas
B) [x] Endometrioamec \*\Endometrioma
C) [ ] histurile Naboth \*\Naboth cysts
D) [x] struma ovari \*\ Ovarian Stroma
E) [x] chisturi non-neoplazice \*\ Non-neoplastic cysts
---------------------------------------------------------------------
1500. CM p5 Urmatoarele afirmatii despre struma ovarii sunt adevarate: (1835)\*\The following statements about ovarian Stroma are true :
A) [x]reprezinta tesut tiroidian detectabil macroscopic in ovar \*\ represents thyroid tissue macroscopically detectable in the ovary
B) [ ]reprezinta tesut tiroidian detectabil microscopic in trompa \*\ represents thyroid tissue microscopically detectable in the fallopian tube
C) [x]poate sa produca un tablou clinic de hipertiroidism \*\can produce a clinical picture of hyperthyroidism
D) [x]poate fi un element predominant intr-un chist dermoid \*\may be a predominant element in a dermoid cyst
E) [ ]poate sa produca un tablou clinic de hipotiroidism \*\can produce a clinical picture of hypothyroidism